<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41299324</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>Could GSTP1, PTEN and NKX3.1 gene expression be novel markers in the relationship between prostate cancer and epigenetics?</ArticleTitle><Pagination><StartPage>1825</StartPage><MedlinePgn>1825</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1825</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-025-15077-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although numerous treatment modalities exist for Prostate Cancer (PCa) with a complex pathophysiology, a significant worldwide health concern for males, early identification remains the paramount factor influencing disease prognosis. Proposed new biomarkers, including GSTP1, PTEN, and NKX3.1, may provide predictive and prognostic functions, hence enhancing the efficacy of PSA in diagnosing prostate cancer. Epigenetic variables associated with nutrition influence the blood gene expression levels of the new biomarkers GSTP1, PTEN, and NKX3.1. This study aimed to elucidate the correlation between nutrition-related epigenetic variables and the expression of the tumor suppressor genes GSTP1, PTEN, and NKX3.1 in benign prostate and prostate cancer patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was conducted with 41 newly diagnosed prostate cancer and 42 benign prostate patients, all aged 40 years and older. Participants had specific anthropometric measurements taken, and seven-day food records were kept. Serum levels of novel biochemical markers GSTP1, PTEN, and NKX3.1 were measured using an Enzyme-Linked Immunosorbent Assay (ELISA) method. Expression analyses of tumor-protective GSTP1, PTEN, and NKX3.1 genes were performed on prostate tissues obtained from fresh prostate biopsies taken from the groups and were associated with nutritional status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A significant relationship was found between the serum levels of GSTP1, PTEN, and NKX3.1, which are important in the formation and treatment of prostate cancer, and Gleason grade, tumor stage, and surgical margin status (p&#x2009;&lt;&#x2009;0.05). However, significant relationships were found between many macro and micronutrients obtained from the dietary pattern and effective in epigenetic pathways and GSTP1, PTEN, and NKX3.1 gene expressions (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings of this investigation corroborated the notion that prospective novel markers, including GSTP1, PTEN, and NKX3.1, may serve predictive and prognostic functions in prostate cancer, hence enhancing the efficacy of PSA in its diagnosis. Dietary trends may influence the optimization of many epigenetic processes. Targeted therapeutic nutritional interventions designed to enhance gene expression will facilitate the formulation of prostate cancer prevention methods.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ko&#xe7;ak</LastName><ForeName>Tevfik</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4096-6796</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Dietetics, Faculty of Health Sciences, G&#xfc;m&#xfc;&#x15f;hane University, G&#xfc;m&#xfc;&#x15f;hane, 29100, Turkey. tkocak@gumushane.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acar-Tek</LastName><ForeName>Nil&#xfc;fer</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8772-9608</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Ankara, 06490, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yesil</LastName><ForeName>S&#xfc;leyman</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0437-9615</Identifier><AffiliationInfo><Affiliation>Department of Urology, School of Medicine, Gazi University, Ankara, 06490, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erg&#xfc;n</LastName><ForeName>Mehmet Ali</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9696-0433</Identifier><AffiliationInfo><Affiliation>Department of Medical Genetics, School of Medicine, Gazi University, Ankara, 06490, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Icer</LastName><ForeName>Yusuf</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6488-4472</Identifier><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant Number TDK-2022-7566</GrantID><Agency>Gazi University Scientific Research Projects Coordination Unit</Agency><Country/></Grant><Grant><GrantID>Grant Number TDK-2022-7566</GrantID><Agency>Gazi University Scientific Research Projects Coordination Unit</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.3.67</RegistryNumber><NameOfSubstance UI="D051059">PTEN Phosphohydrolase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.67</RegistryNumber><NameOfSubstance UI="C494929">PTEN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="D051549">Glutathione S-Transferase pi</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.5.1.18</RegistryNumber><NameOfSubstance UI="C496556">GSTP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C491178">NKX3-1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051059" MajorTopicYN="Y">PTEN Phosphohydrolase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051549" MajorTopicYN="Y">Glutathione S-Transferase pi</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="Y">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="Y">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="Y">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diet</Keyword><Keyword MajorTopicYN="N">Epigenetic</Keyword><Keyword MajorTopicYN="N">GSTP1</Keyword><Keyword MajorTopicYN="N">Novel biomarker</Keyword><Keyword MajorTopicYN="N">PTEN and NKX3.1gene expression</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Ethics Committee Approval for the study was obtained from the Gazi University Hospital Clinical Research Ethics Committee, under the Republic of T&#xfc;rkiye Ministry of Health, on 15 November 2021, with the reference number 103. Clear explanations were provided for the parents with regard to the purpose of the study, after which written informed consent was obtained from all the parents in accordance with the Declaration of Helsinki (World Medical Association). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>27</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41299324</ArticleId><ArticleId IdType="pmc">PMC12659125</ArticleId><ArticleId IdType="doi">10.1186/s12885-025-15077-w</ArticleId><ArticleId IdType="pii">10.1186/s12885-025-15077-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zaorsky N, et al. Causes of death among cancer patients. Ann Oncol. 2016;28(2):400&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5834100</ArticleId><ArticleId IdType="pubmed">27831506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">38572751</ArticleId></ArticleIdList></Reference><Reference><Citation>Derne&#x11f;i &#xdc;. <i>Avrupa &#xdc;roloji Derne&#x11f;i Prostat Kanseri K&#x131;lavuzu</i>. 2022 . https://uroturk.org.tr</Citation></Reference><Reference><Citation>Guo CC, Czerniak B. Updates of prostate cancer from the 2022 world health organization classification of the urinary and male genital tumors. J Clin Translational Pathol, 2023(000): pp. 0&#x2013;0. 10.14218/jctp.2022.00029</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11007763</ArticleId><ArticleId IdType="pubmed">38605939</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosun&#xf6;z &#x130;K, Do&#x11f;an SD. ERKEKLER&#x130;N PROSTAT KANSER&#x130; TARAMALARINA &#x130;L&#x130;&#x15e;K&#x130;N TUTUMLARI VE B&#x130;LG&#x130; D&#xdc;ZEYLER&#x130;. Izmir Democracy Univ Health Sci J. 5(3): pp. 651&#x2013;63. 10.52538/iduhes.1128216</Citation></Reference><Reference><Citation>Gonzalgo ML, Isaacs WB. Molecular pathways to prostate cancer. J Urol. 2003;170(6):2444&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">14634448</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003;349(4):366&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">12878745</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrique R, Jer&#xf3;nimo C. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol. 2004;46(5):660&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15474280</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnekenburger M, Karius T, Diederich M. Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis. Front Pharmacol. 2014;5:170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4100573</ArticleId><ArticleId IdType="pubmed">25076909</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles BL. Phosphatase and tensin homologue deleted on chromosome 10: extending its ptentacles. Int J Biochem Cell Biol. 2009;41(4):757&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2940266</ArticleId><ArticleId IdType="pubmed">18950730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittmann MM. Chromosome 10 alterations in prostate adenocarcinoma. Oncol Rep. 1998;5(6):1329&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769364</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin J, et al. Gene of the month: NKX3. 1. J Clin Pathol. 2022;75(6):361&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">34996754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurel B, et al. NKX3. 1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010;34(8):1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3072223</ArticleId><ArticleId IdType="pubmed">20588175</ArticleId></ArticleIdList></Reference><Reference><Citation>Supic G, Jagodic M, Magic Z. Epigenetics: a new link between nutrition and cancer. Nutr Cancer. 2013;65(6):781&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">23909721</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiers I, Shanks JH, Bostwick DG. Glutathione S-transferase Pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology. 2007;39(3):299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">17558856</ArticleId></ArticleIdList></Reference><Reference><Citation>Benesh EC, et al. Maternal high-fat diet induces hyperproliferation and alters Pten/Akt signaling in prostates of offspring. Sci Rep. 2013;3(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857567</ArticleId><ArticleId IdType="pubmed">24322661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H-n, et al. Curcumin downregulates homeobox gene NKX3. 1 in prostate cancer cell LNCaP. Acta Pharmacol Sin. 2007;28(3):423&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17303007</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivappa N, et al. Association between dietary inflammatory index and prostate cancer among Italian men. Br J Nutr. 2015;113(2):278&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433863</ArticleId><ArticleId IdType="pubmed">25400225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Friso, Choi S-W. DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging. J Nutr Biochem. 2009;20(12):917&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2783701</ArticleId><ArticleId IdType="pubmed">19733471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornish D, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 2008;105(24):8369&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430265</ArticleId><ArticleId IdType="pubmed">18559852</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2009;&#x2013; &#x2206;&#x2206;CT method. Methods. 2001;25(4):402&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Rak&#x131;c&#x131;o&#x11f;lu N et al. Yemek ve Besin foto&#x11f;raf katalo&#x11f;u. Hatibo&#x11f;lu Yay&#x131;nevi, 2012. 1. https://www.ankaranobel.com/yemek-ve-besin-fotograf-katalogu-olcu-ve-miktarlar</Citation></Reference><Reference><Citation>Merdol T. <i>Kurum i&#xe7;in Standart Yemek Tarifeleri.</i> 2011.</Citation></Reference><Reference><Citation>Kumar A, Sharma M. The prostate gland. In: basics of human andrology: a textbook. Springer; 2017. p. 537. 10.1007/978-981-10-3695-8_2</Citation></Reference><Reference><Citation>Who J, F.E. Consultation. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser. 2003;916i&#x2013;viii:p1&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">12768890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56(5):303&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236591</ArticleId></ArticleIdList></Reference><Reference><Citation>Waskom ML. Seaborn: statistical data visualization. J Open Source Softw. 2021;6(60):3021.</Citation></Reference><Reference><Citation>Simoes GF et al. An overview on prostate pathophysiology: new insights into prostate cancer clinical diagnosis. Pathophysiology-Altered Physiological States Brazil: IntechOpen, 2018: pp. 183&#x2013;202. 10.5772/intechopen.74269</Citation></Reference><Reference><Citation>Morote J, et al. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol. 2000;37(5):537&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">10765091</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichler R, et al. Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer. Cancer Sci. 2017;108(4):663&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5406598</ArticleId><ArticleId IdType="pubmed">28107600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamoah K, et al. Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer. J Clin Oncol. 2015;33(25):2789&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550692</ArticleId><ArticleId IdType="pubmed">26195723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekhoacha M, et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9457814</ArticleId><ArticleId IdType="pubmed">36080493</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes Dev. 2000;14(19):2410&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11018010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6497009</ArticleId><ArticleId IdType="pubmed">31068988</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, et al. The association of marital status and mortality among men with early-stage prostate cancer treated with radical prostatectomy: insight into post-prostatectomy survival strategies. Cancer Causes Control. 2019;30(8):871&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6739072</ArticleId><ArticleId IdType="pubmed">31214808</ArticleId></ArticleIdList></Reference><Reference><Citation>Pudrovska T, Anishkin A. Clarifying the positive association between education and prostate cancer: a Monte Carlo simulation approach. J Appl Gerontol. 2015;34(3):293&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198504</ArticleId><ArticleId IdType="pubmed">24652869</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantin T, et al. The role and significance of bioumoral markers in prostate cancer. Cancers. 2021;13(23):5932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656561</ArticleId><ArticleId IdType="pubmed">34885045</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalona WJ, Beiser JA, Smith DS. Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol. 1997;158(6):2162&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9366336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendari A, et al. Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score as a predictive value of incidental prostate cancer for patients going for transurethral resection of the prostate (TURP): A Single-Center study. Cureus. 2024;16(4):e57736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11074009</ArticleId><ArticleId IdType="pubmed">38716011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, et al. Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003&#x2013;2010. BMC Urol. 2025;25(1):3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11706081</ArticleId><ArticleId IdType="pubmed">39762822</ArticleId></ArticleIdList></Reference><Reference><Citation>Velkovska TM, Ruseva AL. Antioxidant status in patients with hyperplasia and prostate cancer. J Biomed Clin Res. 2024;17:167&#x2013;76.</Citation></Reference><Reference><Citation>Bozkurt A, et al. The evaluation of oxidative stress parameters in the benign prostatic hyperplasia, prostatitis and prostate cancer. Ortado&#x11f;u T&#x131;p Dergisi. 2019;11(3):315&#x2013;21.</Citation></Reference><Reference><Citation>Pizent A, et al. Environmental Exposure to Metals, Parameters of Oxidative Stress in Blood and Prostate Cancer: Results from Two Cohorts. Antioxidants. 2022;11(10):2044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9598453</ArticleId><ArticleId IdType="pubmed">36290767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, et al. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer. 2011;105(1):65&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137397</ArticleId><ArticleId IdType="pubmed">21654682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen I, et al. Sensitivity of HOXB13 as a diagnostic immunohistochemical marker of prostatic origin in prostate cancer metastases: comparison to PSA, prostein, androgen receptor, ERG, NKX3. 1, PSAP, and PSMA. Int J Mol Sci. 2017;18(6):1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485975</ArticleId><ArticleId IdType="pubmed">28555048</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, et al. Increased serum levels of miR&#x2013;214 in patients with PCa with bone metastasis May serve as a potential biomarker by targeting PTEN. Oncol Lett. 2019;17(1):398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6313214</ArticleId><ArticleId IdType="pubmed">30655780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahon KL, et al. Serum free methylated glutathione S-transferase 1 DNA levels, survival, and response to docetaxel in metastatic, castration-resistant prostate cancer: post hoc analyses of data from a phase 3 trial. Eur Urol. 2019;76(3):306&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">30466891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuntar I, et al. GSTP1, GSTM1 and GSTT1 genetic polymorphisms and total serum GST concentration in stable male COPD. Acta Pharm. 2014;64(1):117&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">24670356</ArticleId></ArticleIdList></Reference><Reference><Citation>Koparal M, et al. Prognostic significance of surgical margin status and Gleason grade at the positive surgical margin in predicting biochemical recurrence after radical prostatectomy in a Turkish patient cohort. The Bulletin of Urooncology. 2021;20:1.</Citation></Reference><Reference><Citation>Kurose H, et al. Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor. Mol Clin Oncol. 2022;16(4):82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8892462</ArticleId><ArticleId IdType="pubmed">35251633</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S, et al. Oxidative stress and antioxidant status in high-risk prostate cancer subjects. Diagnostics. 2020;10(3):126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151307</ArticleId><ArticleId IdType="pubmed">32120827</ArticleId></ArticleIdList></Reference><Reference><Citation>Singal R, Van Wert J, Bashambu M. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res. 2001;61(12):4820&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11406558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergez-Hern&#xe1;ndez F, Irigoyen-Arredondo M, Mart&#xed;nez-Camberos A. A systematic review of mechanisms of <i>PTEN</i> gene down-regulation mediated by MiRNA in prostate cancer. Heliyon. 2024;10(15):e34950.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11320309</ArticleId><ArticleId IdType="pubmed">39144981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethel CR, et al. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with Gleason score and chromosome 8p deletion. Cancer Res. 2006;66(22):10683&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17108105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pidsley R, et al. Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer. BJUI Compass. 2024;5(12):1299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11685177</ArticleId><ArticleId IdType="pubmed">39744075</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinos T, et al. Association between ERG/PTEN genes and pathologic parameters of prostate cancer with an emphasis on Gleason score: a literature review. Cancer Diagn Progn. 2023;3(3):291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10165374</ArticleId><ArticleId IdType="pubmed">37168967</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayramo&#x11f;lu Z, Bet&#xfc;l &#xdc;. Molecular pathways of prostate carcinoma. Mustafa Kemal &#xdc;niversitesi T&#x131;p Dergisi. 2020;11(41):118&#x2013;23.</Citation></Reference><Reference><Citation>Sirintrapun SJ, Parwani AV. Molecular pathology of the genitourinary tract: prostate and bladder. Surg Pathol Clin. 2008;1(1):211&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">26837907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen C, et al. Loss of PTEN accelerates NKX3. 1 degradation to promote prostate cancer progression. Cancer Res. 2019;79(16):4124&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6753942</ArticleId><ArticleId IdType="pubmed">31213464</ArticleId></ArticleIdList></Reference><Reference><Citation>Sooreshjani MA, et al. LIMK2-NKX3. 1 engagement promotes castration-resistant prostate cancer. Cancers. 2021;13(10):2324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8151535</ArticleId><ArticleId IdType="pubmed">34066036</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Shukla GC, Gupta S. Microrna regulating glutathione s-transferase P1 in prostate cancer. Curr Pharmacol Rep. 2015;1(2):79&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4354897</ArticleId><ArticleId IdType="pubmed">25774339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y, et al. A statistical method for identifying differential gene&#x2013;gene co-expression patterns. Bioinformatics. 2004;20(17):3146&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">15231528</ArticleId></ArticleIdList></Reference><Reference><Citation>Glantzounis G, et al. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16375736</ArticleId></ArticleIdList></Reference><Reference><Citation>Benli E, et al. Comparison of serum uric acid levels between prostate cancer patients and a control group. Cent Eur J Urol. 2018;71(2):242&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051366</ArticleId><ArticleId IdType="pubmed">30038817</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Huang J, Wong MCS. Association between serum uric acid and prostate cancer risk in East Asian populations: a Mendelian randomization study. Eur J Nutr. 2023;62(3):1323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36542132</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, et al. Serum uric acid and prostate cancer: findings from the NHANES (2007&#x2013;2020). Front Oncol. 2024;14:1354235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11543348</ArticleId><ArticleId IdType="pubmed">39512774</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaglia N, Frontini-L&#xf3;pez YR, Zadra G. Prostate cancer progression: as a matter of fats. Front Oncol. 2021;11:719865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8353450</ArticleId><ArticleId IdType="pubmed">34386430</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson WJ, et al. Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol. 2010;183(1):345&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3089950</ArticleId><ArticleId IdType="pubmed">19914662</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaglia N, Frontini-L&#xf3;pez YR, Zadra G. Prostate cancer progression: as a matter of fats. Front Oncol, 2021: p. 2951. 10.3389/fonc.2021.719865</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8353450</ArticleId><ArticleId IdType="pubmed">34386430</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrane MM. Vitamin A regulation of gene expression: molecular mechanism of a prototype gene. J Nutr Biochem. 2007;18(8):497&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">17320364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok DE, et al. The effects of long-term daily folic acid and vitamin B 12 supplementation on genome-wide DNA methylation in elderly subjects. Clin Epigenetics. 2015;7:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4644301</ArticleId><ArticleId IdType="pubmed">26568774</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei SP, et al. Dietary magnesium deficiency impaired intestinal structural integrity in grass carp (<i>Ctenopharyngodon idella</i>). Sci Rep. 2018;8(1):12705.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107577</ArticleId><ArticleId IdType="pubmed">30139942</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad AS, Bao B. Molecular mechanisms of zinc as a Pro-Antioxidant mediator: clinical therapeutic implications. Antioxid (Basel), 2019. 8(6):164 -185. 10.3390/antiox8060164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6617024</ArticleId><ArticleId IdType="pubmed">31174269</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. The American journal of surgical pathology. 2016;40(2):244&#x2013;52. 10.1097/PAS.0000000000000530</Citation><ArticleIdList><ArticleId IdType="pubmed">26492179</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad, A.S. and B. Bao, Molecular Mechanisms of Zinc as a Pro-Antioxidant Mediator: Clinical Therapeutic Implications. Antioxidants (Basel), 2019. 8(6). 10.3390/antiox8060164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6617024</ArticleId><ArticleId IdType="pubmed">31174269</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrero MJ, et al. Nutritional epigenetics in cancer. Adv Nutr. 2022;13(5):1748&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9526851</ArticleId><ArticleId IdType="pubmed">35421212</ArticleId></ArticleIdList></Reference><Reference><Citation>Babakhanlou R, Gowin K. <i>The impact of diet and nutrition on prostate cancer&#x2013;food for thought?</i>. Curr Oncol Rep. 2025;27:1.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11958419</ArticleId><ArticleId IdType="pubmed">39954205</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41108343</PMID><DateCompleted><Year>2025</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2161-3311</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Current nutrition reports</Title><ISOAbbreviation>Curr Nutr Rep</ISOAbbreviation></Journal><ArticleTitle>Nutrition, Environment, and Genetics in Colorectal Cancer. Epigenetics and Possible Future Perspective.</ArticleTitle><Pagination><StartPage>111</StartPage><MedlinePgn>111</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">111</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13668-025-00701-9</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">This review provides an overview of the relationship among nutritional, environmental, and genetic factors in the development of the chronic inflammatory state, starting from the inflammatory bowel disease (IBD) up to the onset of Colorectal Cancer (CRC). Finally, it also examines potential prospects and future topics of research taking into account the relation between nutrition and epigenetic factors.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Evidence indicates&#xa0;that genetic and lifestyle-related factors play a crucial role in CRC etiology. Dietary intake may induce epigenetic alterations which in turn, result in carcinogenesis. Several bioactive components can modify epigenetic mechanisms, required for gene activation or silencing, thus, representing a potential way of preventing CRC. The gene-diet interaction analysis suggested some functions and pathways that may affect the CRC development. In this view, personalized nutrition, which is an approach that combines with new omics technologies, could represent a new possible key for personalized prevention and treatment in association with other cancer prevention and chemotherapeutic therapies.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Brandolino</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine and Aging, "G. D'Annunzio" University, Via Dei Vestini, Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Franzago</LastName><ForeName>Marica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Aging, "G. D'Annunzio" University, Via Dei Vestini, Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murmura</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricci</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatta</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuppia</LastName><ForeName>Liborio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitacolonna</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine and Aging, "G. D'Annunzio" University, Via Dei Vestini, Chieti-Pescara, 66100, Chieti, Italy. e.vitacolonna@unich.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), "G. D'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy. e.vitacolonna@unich.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Nutr Rep</MedlineTA><NlmUniqueID>101587480</NlmUniqueID><ISSNLinking>2161-3311</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="Y">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="Y">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015212" MajorTopicYN="N">Inflammatory Bowel Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diet</Keyword><Keyword MajorTopicYN="N">Environment</Keyword><Keyword MajorTopicYN="N">Inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">Nutrigenomics</Keyword><Keyword MajorTopicYN="N">One health</Keyword><Keyword MajorTopicYN="N">Precision nutrition</Keyword></KeywordList><CoiStatement>Declarations. Institutional Review Board Statement: Not applicable. Informed Consent: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>10</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>10</Month><Day>18</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41108343</ArticleId><ArticleId IdType="pmc">PMC12535513</ArticleId><ArticleId IdType="doi">10.1007/s13668-025-00701-9</ArticleId><ArticleId IdType="pii">10.1007/s13668-025-00701-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akimoto N, et al. Rising incidence of early-onset colorectal cancer &#x2014; a call to action. Nat Rev Clin Oncol. 2021;18(4):230&#x2013;43. 10.1038/s41571-020-00445-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994182</ArticleId><ArticleId IdType="pubmed">33219329</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12&#x2013;49. 10.3322/caac.21820.</Citation><ArticleIdList><ArticleId IdType="pubmed">38230766</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbecka M, Berbecki M, Gliwa AM, Szewc M, Sitarz R. Managing colorectal cancer from ethology to interdisciplinary treatment: the gains and challenges of modern medicine. Int J Mol Sci. 2024;25(4):2032. 10.3390/ijms25042032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10889298</ArticleId><ArticleId IdType="pubmed">38396715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu VA, Gheorghe G, Bacalbasa N, Chiotoroiu AL, Diaconu C. Colorectal cancer: from risk factors to oncogenesis. Medicina (Mex). 2023;59(9):1646. 10.3390/medicina59091646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10537191</ArticleId><ArticleId IdType="pubmed">37763765</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233&#x2013;54. 10.3322/caac.21772.</Citation><ArticleIdList><ArticleId IdType="pubmed">36856579</ArticleId></ArticleIdList></Reference><Reference><Citation>Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">18280327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. Prim Prev Colorectal Cancer Lifestyle Nutr Exerc. 2005;166:177&#x2013;211. 10.1007/3-540-26980-0_13.</Citation><ArticleIdList><ArticleId IdType="pubmed">15648191</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang PS, Chen T, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009;124(10):2406&#x2013;15. 10.1002/ijc.24191.</Citation><ArticleIdList><ArticleId IdType="pubmed">19142968</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmus JD, Kotler DL, Kastenberg DM, Kistler CA. The gut microbiome and colorectal cancer: a review of bacterial pathogenesis. J Gastrointest Oncol. 2018;9(4):769&#x2013;77. 10.21037/jgo.2018.04.07.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6087872</ArticleId><ArticleId IdType="pubmed">30151274</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Tao Z, Yang H, Zhang C. Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms. Front Oncol. 2024;14:1366544. 10.3389/fonc.2024.1366544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11100318</ArticleId><ArticleId IdType="pubmed">38764574</ArticleId></ArticleIdList></Reference><Reference><Citation>Alatab S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990&#x2013;2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17&#x2013;30. 10.1016/S2468-1253(19)30333-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026709</ArticleId><ArticleId IdType="pubmed">31648971</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen C, Knudsen A, Arnesen EK, Hatlebakk JG, Sletten IS, Fadnes LT. Diet, food, and nutritional exposures and inflammatory bowel disease or progression of disease: an umbrella review. Adv Nutr. 2024;15(5):100219. 10.1016/j.advnut.2024.100219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11063602</ArticleId><ArticleId IdType="pubmed">38599319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardel&#x10d;&#xed;kov&#xe1; A, &#x160;oltys J, Moj&#x17e;i&#x161; J. Oxidative stress, inflammation and colorectal cancer: an overview. Antioxidants. 2023;12(4):901. 10.3390/antiox12040901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10135609</ArticleId><ArticleId IdType="pubmed">37107276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalchin M, Baker A-M, Graham TA, Hart A. Predicting colorectal cancer occurrence in IBD. Cancers (Basel). 2021;13(12):2908. 10.3390/cancers13122908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8230430</ArticleId><ArticleId IdType="pubmed">34200768</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaeger R, et al. Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease. Gastroenterology. 2016;151(2):278-287.e6. 10.1053/j.gastro.2016.04.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472377</ArticleId><ArticleId IdType="pubmed">27063727</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res. 2016;9(12):887&#x2013;94. 10.1158/1940-6207.CAPR-16-0124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289746</ArticleId><ArticleId IdType="pubmed">27679553</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology. 2016;150(4):931&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5270616</ArticleId><ArticleId IdType="pubmed">26764183</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker AM, Cross W, Curtius K, Al Bakir I, Choi CHR, Davis HL, et al. Evolutionary history of human colitis-associated colorectal cancer. Gut. 2019;68:985&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580738</ArticleId><ArticleId IdType="pubmed">29991641</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Jin Z, Li X, Wu L, Jin J. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis. Clin Transl Oncol. 2017;19(8):1018&#x2013;27. 10.1007/s12094-017-1634-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">28243990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucaf&#xf2; M, Curci D, Franzin M, Decorti G, Stocco G. Inflammatory bowel disease and risk of colorectal cancer: an overview from pathophysiology to pharmacological prevention. Front Pharmacol. 2021;12:772101. 10.3389/fphar.2021.772101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8563785</ArticleId><ArticleId IdType="pubmed">34744751</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt M, et al. mTORC1 inactivation promotes colitis-induced colorectal cancer but protects from APC loss-dependent tumorigenesis. Cell Metab. 2018;27(1):118-135.e8. 10.1016/j.cmet.2017.11.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">29275959</ArticleId></ArticleIdList></Reference><Reference><Citation>Grazioso TP, Brandt M, Djouder N. Diet, microbiota, and colorectal cancer. iScience. 2019;21:168&#x2013;87. 10.1016/j.isci.2019.10.011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889474</ArticleId><ArticleId IdType="pubmed">31669832</ArticleId></ArticleIdList></Reference><Reference><Citation>Divella R, Daniele A, Savino E, Paradiso A. Anticancer effects of nutraceuticals in the Mediterranean diet: an epigenetic diet model. Cancer Genomics. 2020;17(4):335&#x2013;50. 10.21873/cgp.20193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7367609</ArticleId><ArticleId IdType="pubmed">32576579</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassotta M, et al. Possible role of nutrition in the prevention of inflammatory bowel disease&#x2013;related colorectal cancer: a focus on human studies. Nutrition. 2023;110:111980. 10.1016/j.nut.2023.111980.</Citation><ArticleIdList><ArticleId IdType="pubmed">36965240</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonoush M, et al. The association between different types of dietary carbohydrates and colorectal cancer: a case-control study. Front Nutr. 2022;9:898337. 10.3389/fnut.2022.898337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9315347</ArticleId><ArticleId IdType="pubmed">35903447</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellens J, Vissers E, Matthys C, Vermeire S, Sabino J. Personalized dietary regimens for inflammatory bowel disease: current knowledge and future perspectives. Pharmacogenomics Pers Med. 2023;16:15&#x2013;27. 10.2147/PGPM.S359365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9842524</ArticleId><ArticleId IdType="pubmed">36660362</ArticleId></ArticleIdList></Reference><Reference><Citation>Schottenfeld D, Beebe-Dimmer J. &#x201c;Chronic inflammation: a common and important factor in the pathogenesis of Neoplasia.&#x201d; CA Cancer J Clin. 2006;56(2):69&#x2013;83. 10.3322/canjclin.56.2.69.</Citation><ArticleIdList><ArticleId IdType="pubmed">16514135</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangoni K, Dorneles G, Da Silva DM, Pinto LP, Rossoni C, Fernandes SA. Diet as an epigenetic factor in inflammatory bowel disease. World J Gastroenterol. 2023;29(41):5618&#x2013;29. 10.3748/wjg.v29.i41.5618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10701328</ArticleId><ArticleId IdType="pubmed">38077158</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravi F, et al. Nutrient dietary patterns and the risk of colorectal cancer: a case&#x2013;control study from Italy. Cancer Causes Control. 2010;21(11):1911&#x2013;8. 10.1007/s10552-010-9619-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">20680437</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedirko V, et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2010;19(1):280&#x2013;91. 10.1158/1055-9965.EPI-09-0448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2805163</ArticleId><ArticleId IdType="pubmed">20056649</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244-1260.e16. 10.1053/j.gastro.2014.12.035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409470</ArticleId><ArticleId IdType="pubmed">25575572</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342&#x2013;57. 10.1038/nrc3691.</Citation><ArticleIdList><ArticleId IdType="pubmed">24705652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women&#x2019;s Health Initiative (WHI) limited-access data set. Am J Clin Nutr. 2011;94(4):1144&#x2013;9. 10.3945/ajcn.111.015032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173029</ArticleId><ArticleId IdType="pubmed">21880848</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33&#x2013;44. 10.1056/NEJMoa1809944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6425757</ArticleId><ArticleId IdType="pubmed">30415629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. Exploration and identification of vitamin D and related genes as potential biomarkers for colorectal tumors. OncoTargets Ther. 2025;18:129&#x2013;45. 10.2147/OTT.S495066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11769849</ArticleId><ArticleId IdType="pubmed">39872437</ArticleId></ArticleIdList></Reference><Reference><Citation>La Vecchia C, et al. Dietary total antioxidant capacity and colorectal cancer: a large case-control study in Italy: total antioxidant capacity and colorectal cancer. Int J Cancer. 2013;133(6):1447&#x2013;51. 10.1002/ijc.28133.</Citation><ArticleIdList><ArticleId IdType="pubmed">23444117</ArticleId></ArticleIdList></Reference><Reference><Citation>AlZaabi A, Younus HA, Al-Reasi HA, Al-Hajri R. Could environmental exposure and climate change be a key factor in the rising incidence of early onset colorectal cancer? Heliyon. 2024;10(16):e35935. 10.1016/j.heliyon.2024.e35935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11386049</ArticleId><ArticleId IdType="pubmed">39258208</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol. 2016;70(1):395&#x2013;411. 10.1146/annurev-micro-102215-095513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5541233</ArticleId><ArticleId IdType="pubmed">27607555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Barnich N, Nguyen H. Microbiota, inflammation and colorectal cancer. Int J Mol Sci. 2017;18(6):1310. 10.3390/ijms18061310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5486131</ArticleId><ArticleId IdType="pubmed">28632155</ArticleId></ArticleIdList></Reference><Reference><Citation>Huyghe JR, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51(1):76&#x2013;87. 10.1038/s41588-018-0286-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6358437</ArticleId><ArticleId IdType="pubmed">30510241</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele SR, Park GE, Johnson EK, Martin MJ, Stojadinovic A, Maykel JA, et al. The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system. Diseases of the colon. Dis Colon Rectum. 2014;57(3):303&#x2013;10. 10.1097/DCR.0b013e3182a586e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24509451</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YA, et al. Genetic risk score, combined lifestyle factors and risk of colorectal cancer. Cancer Res Treat. 2019;51(3):1033&#x2013;40. 10.4143/crt.2018.447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6639208</ArticleId><ArticleId IdType="pubmed">30336659</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Jia G, Wen W, Shu X-O, Zheng W. Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK biobank. Am J Clin Nutr. 2021;113(4):810&#x2013;20. 10.1093/ajcn/nqaa404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023827</ArticleId><ArticleId IdType="pubmed">33675346</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Liu Y. A reasonable diet promotes balance of intestinal microbiota: prevention of precolorectal cancer. BioMed Res Int. 2019;2019:1&#x2013;10. 10.1155/2019/3405278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6683831</ArticleId><ArticleId IdType="pubmed">31428633</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-P&#xe9;rez J, et al. Residential proximity to industrial pollution sources and colorectal cancer risk: a multicase-control study (MCC-Spain). Environ Int. 2020;144:106055. 10.1016/j.envint.2020.106055.</Citation><ArticleIdList><ArticleId IdType="pubmed">32827807</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenwitheesuk K, Peansukwech U, Jenwitheesuk K. Accumulated ambient air pollution and colon cancer incidence in Thailand. Sci Rep. 2020;10(1):17765. 10.1038/s41598-020-74669-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575563</ArticleId><ArticleId IdType="pubmed">33082474</ArticleId></ArticleIdList></Reference><Reference><Citation>Venugopal A, Carethers JM. Epidemiology and biology of early onset colorectal cancer. EXCLI J. 2022;21:162. 10.17179/EXCLI2021-4456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8859644</ArticleId><ArticleId IdType="pubmed">35221839</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, et al. Cancer and ongoing climate change: who are the most affected? ACS Environ Au. 2023;3(1):5&#x2013;11. 10.1021/acsenvironau.2c00012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9853937</ArticleId><ArticleId IdType="pubmed">36691655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F, et al. Impact of ambient air pollution on colorectal cancer risk and survival: insights from a prospective cohort and epigenetic Mendelian randomization study. EBioMedicine. 2024;103:105126. 10.1016/j.ebiom.2024.105126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11035091</ArticleId><ArticleId IdType="pubmed">38631091</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Keenan JI, Shaw IC, Frizelle FA. Could microplastics be a driver for early onset colorectal cancer? Cancers. 2023;15(13):3323. 10.3390/cancers15133323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10340669</ArticleId><ArticleId IdType="pubmed">37444433</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun JH, Oh JE, Shim J-K, Kwak Y-L, Cho JS. &#x201c;Effects of bisphenol A on the proliferation, migration, and tumor growth of colon cancer cells: In vitro and in vivo evaluation with mechanistic insights related to ERK and 5-HT3.&#x201d; Food Chem Toxicol. 2021;158:112662. 10.1016/j.fct.2021.112662.</Citation><ArticleIdList><ArticleId IdType="pubmed">34743013</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong X, et al. Lipidomic biomarkers: potential mediators of associations between urinary bisphenol A exposure and colorectal cancer. J Hazard Mater. 2022;427:127863. 10.1016/j.jhazmat.2021.127863.</Citation><ArticleIdList><ArticleId IdType="pubmed">34848068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong X, et al. Bisphenol a exacerbates colorectal cancer progression through enhancing ceramide synthesis. Toxicology. 2025;511:154054. 10.1016/j.tox.2025.154054.</Citation><ArticleIdList><ArticleId IdType="pubmed">39809339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulanda S, Janoszka B. Consumption of thermally processed meat containing carcinogenic compounds (polycyclic aromatic hydrocarbons and heterocyclic aromatic amines) versus a risk of some cancers in humans and the possibility of reducing their formation by natural food additives&#x2014;a literature review. Int J Environ Res Public Health. 2022;19(8):4781. 10.3390/ijerph19084781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9024867</ArticleId><ArticleId IdType="pubmed">35457645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinkeng A, Taylor FL, Cheong SH, Song H, Merchant JL. Early onset colorectal cancer: molecular underpinnings accelerating occurrence. Cell Mol Gastroenterol Hepatol. 2025;19(2):101425. 10.1016/j.jcmgh.2024.101425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11731505</ArticleId><ArticleId IdType="pubmed">39510499</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng T, Lam AK, Gopalan V. Diet derived polycyclic aromatic hydrocarbons and its pathogenic roles in colorectal carcinogenesis. Crit Rev Oncol Hematol. 2021;168:103522. 10.1016/j.critrevonc.2021.103522.</Citation><ArticleIdList><ArticleId IdType="pubmed">34748942</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyte IJ, Albinet A, Harrison RM. On-road traffic emissions of polycyclic aromatic hydrocarbons and their oxy- and nitro- derivative compounds measured in road tunnel environments. Sci Total Environ. 2016;566:1131&#x2013;42. 10.1016/j.scitotenv.2016.05.152.</Citation><ArticleIdList><ArticleId IdType="pubmed">27312273</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesi GO, Iniaghe PO, Lari B, Obi-Iyeke G, Ossai JC. Polycyclic aromatic hydrocarbons (PAHs) in leafy vegetables consumed in southern Nigeria: concentration, risk assessment and source apportionment. Environ Monit Assess. 2021;193(7):443. 10.1007/s10661-021-09217-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34169353</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A, Nawrot TS, Baccarelli AA. Hallmarks of environmental insults. Cell. 2021;184(6):1455&#x2013;68. 10.1016/j.cell.2021.01.043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9396710</ArticleId><ArticleId IdType="pubmed">33657411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen R, Schymanski EL, Barab&#xe1;si AL, Miller GW. The exposome and health: where chemistry meets biology. Science. 2020;367(6476):392&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227413</ArticleId><ArticleId IdType="pubmed">31974245</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer&#x2014;mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455&#x2013;65. 10.1038/nrendo.2014.94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374431</ArticleId><ArticleId IdType="pubmed">24935119</ArticleId></ArticleIdList></Reference><Reference><Citation>Duraiyarasan S, Adefuye M, Manjunatha N, Ganduri V, Rajasekaran K. Colon cancer and obesity: a narrative review. Cureus. 2022. 10.7759/cureus.27589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9433794</ArticleId><ArticleId IdType="pubmed">36059323</ArticleId></ArticleIdList></Reference><Reference><Citation>Aglago EK, et al. A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk. Cancer Res. 2023;83(15):2572&#x2013;83. 10.1158/0008-5472.CAN-22-3713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10391330</ArticleId><ArticleId IdType="pubmed">37249599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandic M, Li H, Safizadeh F, Niedermaier T, Hoffmeister M, Brenner H. Is the association of overweight and obesity with colorectal cancer underestimated? An umbrella review of systematic reviews and meta-analyses. Eur J Epidemiol. 2023;38(2):135&#x2013;44. 10.1007/s10654-022-00954-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905196</ArticleId><ArticleId IdType="pubmed">36680645</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, et al. Implication of obesity and gut microbiome dysbiosis in the etiology of colorectal cancer. Cancers. 2023;15(6):1913. 10.3390/cancers15061913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10047102</ArticleId><ArticleId IdType="pubmed">36980799</ArticleId></ArticleIdList></Reference><Reference><Citation>Doaei S, et al. Interactions between macro-nutrients&#x2019; intake, FTO and IRX3 gene expression, and FTO genotype in obese and overweight male adolescents. Adipocyte. 2019;8(1):386&#x2013;91. 10.1080/21623945.2019.1693745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6948981</ArticleId><ArticleId IdType="pubmed">31771407</ArticleId></ArticleIdList></Reference><Reference><Citation>Speakman JR. The &#x2018;Fat mass and obesity related&#x2019; (FTO) gene: mechanisms of impact on obesity and energy balance. Curr Obes Rep. 2015;4(1):73&#x2013;91. 10.1007/s13679-015-0143-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">26627093</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzago M, Di Nicola M, Fraticelli F, Marchioni M, Stuppia L, Vitacolonna E. Nutrigenetic variants and response to diet/lifestyle intervention in obese subjects: a pilot study. Acta Diabetol. 2022;59(1):69&#x2013;81. 10.1007/s00592-021-01787-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758637</ArticleId><ArticleId IdType="pubmed">34480216</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholamalizadeh M, et al. Are the FTO gene polymorphisms associated with colorectal cancer? A meta-analysis. J Gastrointest Cancer. 2021;52(3):846&#x2013;53. 10.1007/s12029-021-00651-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34212310</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Wang L, Du M, He H. FTO in oral diseases: functions, mechanisms, and therapeutic potential. FASEB J. 2024;38(20):e70115. 10.1096/fj.202401406RR.</Citation><ArticleIdList><ArticleId IdType="pubmed">39436191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Zhang F, Wang J. FTO effects the proliferation, invasion, and glycolytic metabolism of colon cancer by regulating PKM2. J Cancer Res Clin Oncol. 2025;151(1):36. 10.1007/s00432-024-06073-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11739181</ArticleId><ArticleId IdType="pubmed">39820532</ArticleId></ArticleIdList></Reference><Reference><Citation>Singar S, Nagpal R, Arjmandi BH, Akhavan NS. Personalized nutrition: tailoring dietary recommendations through genetic insights. Nutrients. 2024;16(16):2673. 10.3390/nu16162673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11357412</ArticleId><ArticleId IdType="pubmed">39203810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson LR, et al. Guide and position of the International Society of Nutrigenetics/Nutrigenomics on personalised nutrition: Part 1 - fields of precision nutrition. Lifestyle Genom. 2016;9(1):12&#x2013;27. 10.1159/000445350.</Citation><ArticleIdList><ArticleId IdType="pubmed">27169401</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzago M, Santurbano D, Vitacolonna E, Stuppia L. Genes and diet in the prevention of chronic diseases in future generations. Int J Mol Sci. 2020;21(7):2633. 10.3390/ijms21072633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7178197</ArticleId><ArticleId IdType="pubmed">32290086</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzago M, Pilenzi L, Di Rado S, Vitacolonna E, Stuppia L. The epigenetic aging, obesity, and lifestyle. Front Cell Dev Biol. 2022;10:985274. 10.3389/fcell.2022.985274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514048</ArticleId><ArticleId IdType="pubmed">36176280</ArticleId></ArticleIdList></Reference><Reference><Citation>Riscuta G. Nutrigenomics at the interface of aging, lifespan, and cancer prevention. J Nutr. 2016;146(10):1931&#x2013;9. 10.3945/jn.116.235119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5037878</ArticleId><ArticleId IdType="pubmed">27558581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins VA, Bresette W, Johnstone L, Hallmark B, Chilton FH. Genomics in personalized nutrition: Can you &#x2018;Eat for your genes&#x2019;? Nutrients. 2020;12(10):3118. 10.3390/nu12103118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599709</ArticleId><ArticleId IdType="pubmed">33065985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni L, Gabbianelli R. Primers on nutrigenetics and nutri(epi)genomics: origins and development of precision nutrition. Biochimie. 2019;160:156&#x2013;71. 10.1016/j.biochi.2019.03.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">30878492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassem NM, Abdelmegid YA, El-Sayed MK, Sayed RS, Abdel-Aalla MH, Kassem HA. Nutrigenomics and microbiome shaping the future of personalized medicine: a review article. J Genet Eng Biotechnol. 2023;21(1):134. 10.1186/s43141-023-00599-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10665279</ArticleId><ArticleId IdType="pubmed">37993702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang T, Cho S, Choi J-Y, Kang D, Shin A. Genome-wide interaction study of dietary intake and colorectal cancer risk in the UK biobank. JAMA Netw Open. 2024;7(2):e240465. 10.1001/jamanetworkopen.2024.0465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10900970</ArticleId><ArticleId IdType="pubmed">38411962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor ED, Giovannucci EL. Gene-diet interactions and their impact on colorectal cancer risk. Curr Nutr Rep. 2015;4(1):13&#x2013;21. 10.1007/s13668-014-0114-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383391</ArticleId><ArticleId IdType="pubmed">25844273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimeno-Valiente F, et al. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Sci Rep. 2020;10(1):3723. 10.1038/s41598-020-60476-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7048834</ArticleId><ArticleId IdType="pubmed">32111877</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh AS, et al. Proteomics-based comparative mapping of the secretomes of human brown and white adipocytes reveals EPDR1 as a Novel Batokine. Cell Metab. 2019;30(5):963-975.e7. 10.1016/j.cmet.2019.10.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">31668873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YA, et al. Dietary flavonoids, CYP1A1 genetic variants, and the risk of colorectal cancer in a Korean population. Sci Rep. 2017;7(1):128. 10.1038/s41598-017-00117-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427897</ArticleId><ArticleId IdType="pubmed">28273931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatuphonprasert W, Kondo S, Jarukamjorn K, Kawasaki Y, Sakuma T, Nemoto N. Potent modification of inducible CYP1A1 expression by flavonoids. Biol Pharm Bull. 2010;33(10):1698&#x2013;703. 10.1248/bpb.33.1698.</Citation><ArticleIdList><ArticleId IdType="pubmed">20930378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sales NMR, Pelegrini PB, Goersch MC. Nutrigenomics: definitions and advances of this new science. J Nutr Metab. 2014;2014:1&#x2013;6. 10.1155/2014/202759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984860</ArticleId><ArticleId IdType="pubmed">24795820</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen BC, Marsit CJ. Epigenomics in environmental health. Front Genet. 2011;2. 10.3389/fgene.2011.00084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268636</ArticleId><ArticleId IdType="pubmed">22303378</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiaogang H, Sharma M, Saif I, Ali G, Li X, Salama E-S. The role of nutrition in harnessing the immune system: a potential approach to prevent cancer. Med Oncol. 2022;39(12):245. 10.1007/s12032-022-01850-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36180759</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics. 2010;1(3&#x2013;4):101&#x2013;16. 10.1007/s13148-010-0011-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024548</ArticleId><ArticleId IdType="pubmed">21258631</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsamanoudy A, Mohamed Neamat-Allah M, Hisham Mohammad F, Hassanien M, Nada H. The role of nutrition related genes and nutrigenetics in understanding the pathogenesis of cancer. J Microsc Ultrastruct. 2016;4(3):115. 10.1016/j.jmau.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6014201</ArticleId><ArticleId IdType="pubmed">30023217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecca M, Picerno S, Cortellino S. The killer&#x2019;s web: interconnection between inflammation, epigenetics and nutrition in cancer. Int J Mol Sci. 2024;25(5):2750. 10.3390/ijms25052750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10931665</ArticleId><ArticleId IdType="pubmed">38473997</ArticleId></ArticleIdList></Reference><Reference><Citation>Reglero C, Reglero G. Precision nutrition and cancer relapse prevention: a systematic literature review. Nutrients. 2019;11(11):2799. 10.3390/nu11112799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893579</ArticleId><ArticleId IdType="pubmed">31744117</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre-Portol&#xe9;s C, Fern&#xe1;ndez L, Ram&#xed;rez De Molina A. Precision nutrition for targeting lipid metabolism in colorectal cancer. Nutrients. 2017;9(10):1076. 10.3390/nu9101076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5691693</ArticleId><ArticleId IdType="pubmed">28956850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapienza C, Issa J-P. Diet, nutrition, and cancer epigenetics. Annu Rev Nutr. 2016;36(1):665&#x2013;81. 10.1146/annurev-nutr-121415-112634.</Citation><ArticleIdList><ArticleId IdType="pubmed">27022771</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011;3(4):503&#x2013;18. 10.2217/epi.11.71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3197720</ArticleId><ArticleId IdType="pubmed">22022340</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro DO, Sassaki LY, Chebli JMF. Interaction between diet and genetics in patients with inflammatory bowel disease. World J Gastroenterol. 2024;30(12):1644&#x2013;50. 10.3748/wjg.v30.i12.1644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11008370</ArticleId><ArticleId IdType="pubmed">38617734</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou TY, et al. Nutrient-gene interaction in colon cancer, from the membrane to cellular physiology. Annu Rev Nutr. 2016;36(1):543&#x2013;70. 10.1146/annurev-nutr-071715-051039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5034935</ArticleId><ArticleId IdType="pubmed">27431370</ArticleId></ArticleIdList></Reference><Reference><Citation>Bariol C, et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol. 2003;162(4):1361&#x2013;71. 10.1016/S0002-9440(10)63932-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1851239</ArticleId><ArticleId IdType="pubmed">12651628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J, Xu Q, Yuan Y. Single nucleotide polymorphisms and sporadic colorectal cancer susceptibility: a field synopsis and meta-analysis. Cancer Cell Int. 2018;18(1):155. 10.1186/s12935-018-0656-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6180373</ArticleId><ArticleId IdType="pubmed">30337837</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: an updated meta-analysis based on 59 case-control studies. Gene. 2020;734:144391. 10.1016/j.gene.2020.144391.</Citation><ArticleIdList><ArticleId IdType="pubmed">32001373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich CM, et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Colorectal Adenomas C677T MTHFR Polymorph Evid Gene-Environ Interact. 1999;8(8):659&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">10744125</ArticleId></ArticleIdList></Reference><Reference><Citation>Eussen SJPM, et al. Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1328&#x2013;40. 10.1158/1055-9965.EPI-09-0841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2880712</ArticleId><ArticleId IdType="pubmed">20447924</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari A, Torrezan GT, Carraro DM, Aguiar Junior S. Association of folate and vitamins involved in the 1-carbon cycle with polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and global DNA methylation in patients with colorectal cancer. Nutrients. 2019;11(6):1368. 10.3390/nu11061368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6627304</ArticleId><ArticleId IdType="pubmed">31216671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieroth R, Paver S, Day S, Lammersfeld C. Folate and its impact on cancer risk. Curr Nutr Rep. 2018;7(3):70&#x2013;84. 10.1007/s13668-018-0237-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132377</ArticleId><ArticleId IdType="pubmed">30099693</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkman MT, Crofts S, Green H. The use of nutrigenomics and nutritional biomarkers with standard care of long-term recurrent metastatic rectal cancer: a case report. Front Oncol. 2024;14:1451675. 10.3389/fonc.2024.1451675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11646835</ArticleId><ArticleId IdType="pubmed">39687889</ArticleId></ArticleIdList></Reference><Reference><Citation>Doaei S, Hajiesmaeil M, Aminifard A, Mosavi-Jarrahi SA, Akbari ME, Gholamalizadeh M. Effects of gene polymorphisms of metabolic enzymes on the association between red and processed meat consumption and the development of colon cancer; a literature review. J Nutr Sci. 2018;7:e26. 10.1017/jns.2018.17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6176493</ArticleId><ArticleId IdType="pubmed">30305892</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsaounou K, et al. Colon cancer: from epidemiology to prevention. Metabolites. 2022;12(6):499. 10.3390/metabo12060499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9229931</ArticleId><ArticleId IdType="pubmed">35736432</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Molero J, et al. The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis. BMC Med Genet. 2017;18(1):122. 10.1186/s12881-017-0485-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5661920</ArticleId><ArticleId IdType="pubmed">29084532</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaibhav S, Shirbhate E, Kore R, Vishwakarma S, Parveen S. Microbial metabolites-induced epigenetic modifications for inhibition of colorectal cancer: current status and future perspectives. Mini-Rev Med Chem. 2024;25(1):76&#x2013;93. 10.2174/0113895575320344240625080555.</Citation><ArticleIdList><ArticleId IdType="pubmed">38982701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultman SJ. Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol Nutr Food Res. 2017;61(1):1500902. 10.1002/mnfr.201500902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5161716</ArticleId><ArticleId IdType="pubmed">27138454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40975498</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2156-5376</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2025</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Advances in nutrition (Bethesda, Md.)</Title><ISOAbbreviation>Adv Nutr</ISOAbbreviation></Journal><ArticleTitle>A Systematic Review of Food-Derived DNA Methyltransferase Modulators: Mechanistic Insights and Perspectives for Healthy Aging.</ArticleTitle><Pagination><StartPage>100521</StartPage><MedlinePgn>100521</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100521</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.advnut.2025.100521</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2161-8313(25)00159-0</ELocationID><Abstract><AbstractText>DNA methylation represents a crucial epigenetic mechanism orchestrating gene expression, cellular homeostasis, and the aging trajectory. Dysregulation of DNA methyltransferases (DNMTs)-the enzymes catalyzing this process-has been implicated in a wide spectrum of chronic conditions, including cancer, cardiovascular and metabolic disorders, and neurodegenerative diseases. Emerging evidence suggests that food-derived bioactive compounds can act as DNMT inhibitors, reshaping epigenetic landscapes. This systematic review, registered in PROSPERO (CRD42022320316), critically evaluated in vitro, in vivo animal, and ex vivo studies investigating the effects of dietary bioactives on DNMT expression and activity. A thorough search of PubMed up to 23 May, 2025, yielded 103 studies, of which 76 met the inclusion criteria. Eligible publications were original, peer-reviewed, and provided evidence from in vitro, in vivo animal, or ex vivo models. Frequently studied bioactives included epigallocatechin-3-gallate, curcumin, genistein, resveratrol, sulforaphane, and folate. Notably, nearly 90% of studies reported DNMT inhibition-often dose- and time-dependent. Approximately 21% defined minimal effective concentrations, predominantly for isolated compounds. Several studies described synergistic interactions between bioactives, and emerging data highlighted the gut microbiota's mediating role in epigenetic modulation. Despite promising outcomes, the predominance of preclinical evidence and variability in experimental protocols and dosing limit the immediate translational impact. Nonetheless, current findings underscore the promise of dietary DNMT modulators as foundational elements for precision nutrition strategies aimed at promoting healthy aging and mitigating age-associated disease risk. The potential application of DNA methylation age as a biomarker of biological aging has been increasingly supported by recent literature, reinforcing its relevance in future nutritional epigenetics research. Further well-designed clinical trials are warranted to assess long-term efficacy, safety, and bioavailability of these compounds and to validate their use in personalized epigenetic interventions using biological aging markers. This review was funded by the European Union-Next Generation EU, PNRR Project Age-It (DM 1557 11.10.2022), and the University of Padua SID Grant (2024DCTV1SIDPROGETTI-00194).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campisi</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cannella</LastName><ForeName>Luana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visioli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavanello</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy; Occupational Medicine Unit, University Hospital of Padua, Padua, Italy; Centre of Studies and Activities for Space CISAS "G. Colombo" of University of Padua, Padua, Italy. Electronic address: sofia.pavanello@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Nutr</MedlineTA><NlmUniqueID>101540874</NlmUniqueID><ISSNLinking>2161-8313</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D015254">DNA Modification Methylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073656" MajorTopicYN="Y">Healthy Aging</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015254" MajorTopicYN="Y">DNA Modification Methylases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="Y">Phytochemicals</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">DNMT inhibitors</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">anti-aging benefits</Keyword><Keyword MajorTopicYN="N">biological age</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">dietary molecules</Keyword><Keyword MajorTopicYN="N">natural extracts</Keyword><Keyword MajorTopicYN="N">nutri-epigenetics</Keyword><Keyword MajorTopicYN="N">personalized interventions</Keyword></KeywordList><CoiStatement>Conflict of interest The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>17</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>20</Day><Hour>19</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40975498</ArticleId><ArticleId IdType="pmc">PMC12554032</ArticleId><ArticleId IdType="doi">10.1016/j.advnut.2025.100521</ArticleId><ArticleId IdType="pii">S2161-8313(25)00159-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Castruita P.A., Pi&#xf1;a-Escudero S.D., Renter&#xed;a M.E., Yokoyama J.S. Genetic, social, and lifestyle drivers of healthy aging and longevity. Curr. Genet. Med. Rep. 2022;10:25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10686287</ArticleId><ArticleId IdType="pubmed">38031561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Liu H., Hu Q., Wang L., Liu J., Zheng Z., et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Sig. Transduct. Target. Ther. 2022;7:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637765</ArticleId><ArticleId IdType="pubmed">36336680</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung I., An J., Ko M. Epigenetic regulators of DNA cytosine modification: promising targets for cancer therapy. Biomedicines. 2023;11:654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10045866</ArticleId><ArticleId IdType="pubmed">36979633</ArticleId></ArticleIdList></Reference><Reference><Citation>Men J., Wang X., Zhou Y., Huang Y., Zheng Y., Wang Y., et al. Neurodegenerative diseases: epigenetic regulatory mechanisms and therapeutic potential. Cell. Signal. 2025;131</Citation><ArticleIdList><ArticleId IdType="pubmed">40089090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Zhang H., Huang S., Yin L., Wang F., Luo P., et al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Sig. Transduct. Target. Ther. 2022;7:1&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9233709</ArticleId><ArticleId IdType="pubmed">35752619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.-L., Lin Z.-J., Li C.-C., Lin X., Shan S.-K., Guo B., et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Sig. Transduct. Target. Ther. 2023;8:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981733</ArticleId><ArticleId IdType="pubmed">36864020</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimohammadi M., Makaremi S., Rahimi A., Asghariazar V., Taghadosi M., Safarzadeh E. DNA methylation changes and inflammaging in aging-associated diseases. Epigenomics. 2022;14:965&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">36043685</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf3;th D.M., Szeri F., Ashaber M., Muazu M., Sz&#xe9;kv&#xf6;lgyi L., Ar&#xe1;nyi T. Tissue-specific roles of de novo DNA methyltransferases. Epigenetics Chromatin. 2025;18:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11740433</ArticleId><ArticleId IdType="pubmed">39819598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Kutateladze T.G. Diet and the epigenome. Nat. Commun. 2018;9:3375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113284</ArticleId><ArticleId IdType="pubmed">30154441</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsoi F.T., Neri-Numa I.A., de Oliveira W.Q., de Ara&#xfa;jo F.F., Pastore G.M. Dietary polyphenols and their relationship to the modulation of noncommunicable chronic diseases and epigenetic mechanisms: a mini-review. Food Chem. (Oxf). 2023;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9793217</ArticleId><ArticleId IdType="pubmed">36582744</ArticleId></ArticleIdList></Reference><Reference><Citation>del Saz-Lara A., L&#xf3;pez de las Hazas M.C., Visioli F., D&#xe1;valos A. Nutri-epigenetic effects of phenolic compounds from extra virgin olive oil: a systematic review. Adv. Nutr. 2022;13:2039&#x2013;2060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9526845</ArticleId><ArticleId IdType="pubmed">35679085</ArticleId></ArticleIdList></Reference><Reference><Citation>Park L.K., Friso S., Choi S.-W. Nutritional influences on epigenetics and age-related disease. Proc. Nutr. Soc. 2012;71:75&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051144</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya T., Castej&#xf3;n M.L., Mu&#xf1;oz-Garc&#xed;a R., Alarc&#xf3;n-de-la-Lastra C. Epigenetic linkage of systemic lupus erythematosus and nutrition. Nutr. Res. Rev. 2023;36:39&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">34392862</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock T., Badang L., Ferguson B., Martinez-Guryn K. The interplay between diet, gut microbes, and host epigenetics in health and disease. J. Nutr. Biochem. 2021;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8355029</ArticleId><ArticleId IdType="pubmed">33789148</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeran S.M., Patel S.N., Tollefsbol T.O. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLOS ONE. 2010;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897894</ArticleId><ArticleId IdType="pubmed">20625516</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid S., Dar A.A., Shahryari V., Hirata H., Ahmad A., Saini S., et al. Dahiya Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 2010;116:66&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954042</ArticleId><ArticleId IdType="pubmed">19885928</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter S., Gupta S.C., Park B., Goel A., Aggarwal B.B. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011;6:93&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3092901</ArticleId><ArticleId IdType="pubmed">21516481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jylh&#xe4;v&#xe4; J., Pedersen N.L., H&#xe4;gg S. Biological age predictors. EBioMedicine. 2017;21:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5514388</ArticleId><ArticleId IdType="pubmed">28396265</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi M., Liviero F., Maestrelli P., Guarnieri G., Pavanello S. DNA methylation-based age prediction and telomere length reveal an accelerated aging in induced sputum cells compared with blood leukocytes: a pilot study in COPD patients. Front. Med. 2021;8 doi: 10.3389/fmed.2021.690312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.690312</ArticleId><ArticleId IdType="pmc">PMC8342924</ArticleId><ArticleId IdType="pubmed">34368190</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F.-H., Wang H.-T., Kong Q.-P. Dynamic DNA Methylation during aging: a &#x201c;Prophet&#x201d; of age-related outcomes. Front. Genet. 2019;10:107. doi: 10.3389/fgene.2019.00107/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00107/full</ArticleId><ArticleId IdType="pmc">PMC6387955</ArticleId><ArticleId IdType="pubmed">30833961</ArticleId></ArticleIdList></Reference><Reference><Citation>Salameh Y., Bejaoui Y., El Hajj N. DNA methylation biomarkers in aging and age-related diseases. Front. Genet. 2020;11:171. doi: 10.3389/fgene.2020.00171/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00171/full</ArticleId><ArticleId IdType="pmc">PMC7076122</ArticleId><ArticleId IdType="pubmed">32211026</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavanello S., Campisi M., Tona F., Lin C.D., Iliceto S. Exploring epigenetic age in response to intensive relaxing training: a pilot study to slow down biological age. Int. J. Environ. Res. Public Health. 2019;16:3074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747190</ArticleId><ArticleId IdType="pubmed">31450859</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi M., Cannella L., Paccagnella O., Brazzale A.R., Agnolin A., Grothe T., et al. Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life. Geroscience. 2025;47:4253&#x2013;4290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12181487</ArticleId><ArticleId IdType="pubmed">40064804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff-Ferrari H.A., Vellas B., Rizzoli R., Kressig R.W., da Silva J.A.P., Blauth M., et al. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324:1855&#x2013;1868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7656284</ArticleId><ArticleId IdType="pubmed">33170239</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Peng A., Huang C. Suppression of colon cancer growth by berberine mediated by the intestinal microbiota and the suppression of DNA methyltransferases (DNMTs) Mol. Cell. Biochem. 2024;479:2131&#x2013;2141.</Citation><ArticleIdList><ArticleId IdType="pubmed">37639199</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsanosi S., Sheikh R.A., Sonbul S., Altayb H.N., Batubara A.S., Hosawi S., et al. The potential role of Nigella sativa seed oil as epigenetic therapy of cancer. Molecules. 2022;27:2779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9101516</ArticleId><ArticleId IdType="pubmed">35566130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M., Tollefsbol T.O. Combinatorial epigenetic mechanisms of sulforaphane, genistein, and sodium butyrate in breast cancer inhibition. Exp. Cell Res. 2022;416</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12302910</ArticleId><ArticleId IdType="pubmed">35447103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitzman R.T., Dunlap T.L., Howell C.E., Chen S.-N., Vollmer G., Pauli G.F., et al. 6-Prenylnaringenin from hops disrupts ER&#x3b1;-mediated downregulation of CYP1A1 to facilitate estrogen detoxification. Chem. Res. Toxicol. 2020;33:2793&#x2013;2803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349113</ArticleId><ArticleId IdType="pubmed">32986415</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan N., Parbin S., Kausar C., Kar S., Mawatwal S., Das L., et al. Paederia foetida induces anticancer activity by modulating chromatin modification enzymes and altering pro-inflammatory cytokine gene expression in human prostate cancer cells. Food Chem. Toxicol. 2019;130:161&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">31112703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaram M.K., Unni S., Somvanshi P., Bhardwaj T., Mandal R.K., Hussain A., et al. Genistein modulates signaling pathways and targets several epigenetic markers in HeLa cells. Genes (Basel) 2019;10:955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6947182</ArticleId><ArticleId IdType="pubmed">31766427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaram M., Hussain A., Haque S., Raina R., Afroze N. Quercetin modifies 5&#x2032;CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells. J. Cell. Biochem. 2019;120:18357&#x2013;18369.</Citation><ArticleIdList><ArticleId IdType="pubmed">31172592</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng Y.-P., Hung P.-F., Ku W.-Y., Chang C.-Y., Wu B.-H., Wu M.-H., et al. The inhibitory activity of gallic acid against DNA methylation: application of gallic acid on epigenetic therapy of human cancers. Oncotarget. 2017;9:361&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5787471</ArticleId><ArticleId IdType="pubmed">29416619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappe K., Pointner A., Switzeny O.J., Magnet U., Tomeva E., Heller J., et al. Counteraction of oxidative stress by vitamin E affects epigenetic regulation by increasing global methylation and gene expression of MLH1 and DNMT1 dose dependently in Caco-2 Cells, Oxid. Med. Cell. Longev. 2018;2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944233</ArticleId><ArticleId IdType="pubmed">29854080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewinska A., Adamczyk-Grochala J., Deregowska A., Wnuk M. Sulforaphane-induced cell cycle arrest and senescence are accompanied by DNA hypomethylation and changes in microrna profile in breast cancer cells. Theranostics. 2017;7:3461&#x2013;3477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596436</ArticleId><ArticleId IdType="pubmed">28912888</ArticleId></ArticleIdList></Reference><Reference><Citation>Aumsuwan P., Khan S.I., Khan I.A., Ali Z., Avula B., Walker L.A., et al. The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro. Arch. Biochem. Biophys. 2016;591:98&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">26682631</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyanapalli S.S.S., Li W., Fuentes F., Guo Y., Ramirez C.N., Gonzalez X.-P., et al. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells. Pharmacol. Res. 2016;114:175&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5396455</ArticleId><ArticleId IdType="pubmed">27818231</ArticleId></ArticleIdList></Reference><Reference><Citation>Kala R., Tollefsbol T.O. A novel combinatorial epigenetic therapy using resveratrol and pterostilbene for restoring estrogen receptor-&#x3b1; (ER&#x3b1;) expression in ER&#x3b1;-negative breast cancer cells. PLOS ONE. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861292</ArticleId><ArticleId IdType="pubmed">27159275</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F.-P., Zhou H.-K., Bu H.-Q., Chen Z.-Q., Zhang H., Xu L.-P., et al. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A, and ppENK. Oncol. Rep. 2016;35:1941&#x2013;1949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4774670</ArticleId><ArticleId IdType="pubmed">26782786</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Cheng Y., Wang K., Liu R., Yang X., Wen H., et al. Peperomin E reactivates silenced tumor suppressor genes in lung cancer cells by inhibition of DNA methyltransferase. Cancer Sci. 2016;107:1506&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5084666</ArticleId><ArticleId IdType="pubmed">27501331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kala R., Shah H.N., Martin S.L., Tollefsbol T.O. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent &#x3b3;-H2AX and telomerase regulation in triple-negative breast cancer. BMC Cancer. 2015;15:672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4603342</ArticleId><ArticleId IdType="pubmed">26459286</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.A., Hussain A., Sundaram M.K., Alalami U., Gunasekera D., Ramesh L., et al. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncol. Rep. 2015;33:1976&#x2013;1984.</Citation><ArticleIdList><ArticleId IdType="pubmed">25682960</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Kedhari Sundaram M., Hamza A., Quraishi U., Gunasekera D., Ramesh L., et al. Sulforaphane reverses the expression of various tumor suppressor genes by targeting DNMT3B and HDAC1 in human cervical cancer cells. Evid. Based Complement. Alternat. Med. 2015;2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4487331</ArticleId><ArticleId IdType="pubmed">26161119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M., Son M., Ryu E., Shin Y.S., Kim J.G., Kang B.W., et al. Quercetin-induced apoptosis prevents EBV infection. Oncotarget. 2015;6:12603&#x2013;12624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4494961</ArticleId><ArticleId IdType="pubmed">26059439</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubecka-Pietruszewska K., Kaufman-Szymczyk A., Stefanska B., Cebula-Obrzut B., Smolewski P., Fabianowska-Majewska K. Sulforaphane alone and in combination with clofarabine epigenetically regulates the expression of DNA methylation-silenced tumour suppressor genes in human breast cancer cells, J. Nutrigenet. Nutrigenomics. 2015;8:91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">26372775</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseley V.R., Morris J., Knackstedt R.W., Wargovich M.J. Green tea polyphenol epigallocatechin 3-gallate contributes to the Degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells. Anticancer Res. 2013;33:5325&#x2013;5333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4017340</ArticleId><ArticleId IdType="pubmed">24324066</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilpi A., Parbin S., Sengupta D., Kar S., Deb M., Rath S.K., et al. Mechanisms of DNA methyltransferase&#x2013;inhibitor interactions: procyanidin B2 shows new promise for therapeutic intervention of cancer. Chem. Biol. Interact. 2015;233:122&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">25839702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Wu J., Zheng F., Tang Q., Yang L., Li L., et al. &#x3b2;-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPK&#x3b1; signalling pathways in human lung cancer cells: the role of Sp1. J. Cell. Mol. Med. 2015;19:630&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369819</ArticleId><ArticleId IdType="pubmed">25598321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam A., Li K.M., Razmovski-Naumovski V., Nammi S., Chan K., Li G.Q. Gallic acid protects against endothelial injury by restoring the depletion of DNA methyltransferase 1 and inhibiting proteasome activities. Int. J. Cardiol. 2014;171:231&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">24388544</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-Gonzalez X., Fuentes F., Su Z.-Y., Kong A.-N.T. Apigenin reactivates Nrf2 antioxidative stress signaling in mouse skin epidermal JB6 P+ cells through epigenetic modifications. AAPS J. 2014;16:727&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4070251</ArticleId><ArticleId IdType="pubmed">24830944</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldanha S.N., Kala R., Tollefsbol T.O. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate, Exp. Cell. Res. 2014;324:40&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4043227</ArticleId><ArticleId IdType="pubmed">24518414</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z.-Y., Zhang C., Lee J.H., Shu L., Wu T.-Y., Khor T.O., et al. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane. Cancer Prev. Res. 2014;7:319&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">24441674</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Q., Bai Q., Zou L.-Y., Zhang Q.-Y., Zhou Y., Chang H., et al. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells. Genes Chromosomes Cancer. 2014;53:422&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">24532317</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Amin K.S., Jagadeesh S., Baishay G., Rao P.G., Barua N.C., et al. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol. Cancer. 2013;12:99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3851847</ArticleId><ArticleId IdType="pubmed">24001151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Landen C.N., Li Y., Alvarez R.D., Tollefsbol T.O. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 downregulation. Exp. Cell. Res. 2013;319:697&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3577973</ArticleId><ArticleId IdType="pubmed">23333498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza S., Sharma G., Parshad R., Gupta S.D., Pandya P., Ralhan R. Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J. Breast Cancer. 2013;16:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3625766</ArticleId><ArticleId IdType="pubmed">23593078</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z.-Y., Khor T.O., Shu L., Lee J.H., Saw C.L.-L., Wu T.-Y., et al. Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation. Chem. Res. Toxicol. 2013;26:477&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">23441843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Su Z.-Y., Khor T.O., Shu L., Kong A.-N.T. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem. Pharmacol. 2013;85:1398&#x2013;1404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4123317</ArticleId><ArticleId IdType="pubmed">23416117</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H., Zhang R., Tesfaye D., Tholen E., Looft C., H&#xf6;lker M., et al. Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells. Epigenetics. 2012;7:1379&#x2013;1390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528693</ArticleId><ArticleId IdType="pubmed">23092945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Song H., Hu H., Cui L., You C., Huang L. Trichosanthin inhibits DNA methyltransferase and restores methylation-silenced gene expression in human cervical cancer cells. Mol. Med. Rep. 2012;6:872&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">22825485</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeran S.M., Patel S.N., Li Y., Shukla S., Tollefsbol T.O. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLOS ONE. 2012;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360625</ArticleId><ArticleId IdType="pubmed">22662208</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaid M., Prasad R., Singh T., Jones V., Katiyar S.K. Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators. Toxicol. Appl. Pharmacol. 2012;263:122&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3407315</ArticleId><ArticleId IdType="pubmed">22749965</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A., Wong C.P., Yu Z., Williams D.E., Dashwood R.H., Ho E. Promoter demethylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin. Epigenetics. 2011;3:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257546</ArticleId><ArticleId IdType="pubmed">22303414</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeran S.M., Patel S.N., Chan T.-H., Tollefsbol T.O. A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT Repression in human breast cancer cells. Cancer Prev. Res. 2011;4:1243&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128170</ArticleId><ArticleId IdType="pubmed">21411498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandakumar V., Vaid M., Katiyar S.K. (&#x2212;)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p 16 INK4a , by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 2011;32:537&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066414</ArticleId><ArticleId IdType="pubmed">21209038</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu L., Khor T.O., Lee J.H., Boyanapalli S.S.S., Huang Y., Wu T.Y., et al. Epigenetic CpG demethylation of the promoter and reactivation of the expression of neurog1 by curcumin in prostate LNCaP cells. AAPS J. 2011;13:606&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3231852</ArticleId><ArticleId IdType="pubmed">21938566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.P., Nguyen L.P., Noh S.K., Bray T.M., Bruno R.S., Ho E. Induction of regulatory T cells by green tea polyphenol EGCG. Immunol. Lett. 2011;139:7&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4125122</ArticleId><ArticleId IdType="pubmed">21621552</ArticleId></ArticleIdList></Reference><Reference><Citation>Paluszczak J., Krajka-Ku&#x17a;niak V., Baer-Dubowska W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 2010;192:119&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">19840838</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M., Shukla S., Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer. 2010;126:2520&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2874465</ArticleId><ArticleId IdType="pubmed">19856314</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoutsis A.J., Lamore S.D., Wondrak G.T., Selmin O.I., Romagnolo D.F. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J. Nutr. 2010;140:1607&#x2013;1614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139234</ArticleId><ArticleId IdType="pubmed">20631324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hervouet E., Debien E., Campion L., Charbord J., Menanteau J., Vallette F.M., et al. Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeat elements and genes governing apoptosis and proliferation. Clin. Cancer Res. 2009;15:3519&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pubmed">19451595</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Liu L., Andrews L.G., Tollefsbol T.O. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer. 2009;125:286&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995334</ArticleId><ArticleId IdType="pubmed">19358274</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Liu S., Xie Z., Pavlovicz R.E., Wu J., Chen P., et al. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J. Pharmacol. Exp. Ther. 2009;329:505&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2672871</ArticleId><ArticleId IdType="pubmed">19201992</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid S., Dar A.A., Ahmad A.E., Hirata H., Kawakami K., Shahryari V., et al. BTG3 tumor suppressor gene promoter demethylation, histone modification, and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009;30:662&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664457</ArticleId><ArticleId IdType="pubmed">19221000</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Chen D., Yang C.S. Dietary polyphenols may affect DNA methylation. J. Nutr. 2007;137:223S&#x2013;228S.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182830</ArticleId></ArticleIdList></Reference><Reference><Citation>Fini L., Selgrad M., Fogliano V., Graziani G., Romano M., Hotchkiss E., et al. Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J. Nutr. 2007;137:2622&#x2013;2628.</Citation><ArticleIdList><ArticleId IdType="pubmed">18029474</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagadeesh S., Sinha S., Pal B.C., Bhattacharya S., Banerjee P.P. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem. Biophys. Res. Commun. 2007;362:212&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">17698033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.J., Zhu B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis. 2006;27:269&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">16081510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stresemann C., Brueckner B., Musch T., Stopper H., Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 2006;66:2794&#x2013;2800.</Citation><ArticleIdList><ArticleId IdType="pubmed">16510601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M.Z., Chen D., Sun Y., Jin Z., Christman J.K., Yang C.S. Reversal of hypermethylation and reactivation of p16INK4a, RAR&#x3b2;, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res. 2005;11:7033&#x2013;7041.</Citation><ArticleIdList><ArticleId IdType="pubmed">16203797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.J., Shim J.Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005;68:1018&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">16037419</ArticleId></ArticleIdList></Reference><Reference><Citation>Stempak J.M., Sohn K.-J., Chiang E.-P., Shane B., Kim Y.-I. Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis. 2005;26:981&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">15695236</ArticleId></ArticleIdList></Reference><Reference><Citation>Traka M., Gasper A.V., Smith J.A., Hawkey C.J., Bao Y., Mithen R.F. Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J. Nutr. 2005;135:1865&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="pubmed">16046710</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhail K.L., France D., Cornell-Kennon S., Gerwick W.H. Peyssonenynes A and B, novel enediyne oxylipins with DNA methyl transferase inhibitory activity from the red marine alga Peyssonnelia caulifera. J. Nat. Prod. 2004;67:1010&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">15217284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;a I.C., Gautschi J.T., Wang G.Y.S., Sanders M.L., Schmitz F.J., France D., et al. Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J. Org. Chem. 2003;68:3866&#x2013;3873.</Citation><ArticleIdList><ArticleId IdType="pubmed">12737565</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagojevi&#x107; J., Stanimirovi&#x107; Z., Glavini&#x107; U., Vakanjac S., Raduki&#x107; Z., Mirilovi&#x107; M., et al. Impact of supplemented nutrition on semen quality, epigenetic-related gene expression, and oxidative status in boars. Animals (Basel) 2024;14:3297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11591274</ArticleId><ArticleId IdType="pubmed">39595349</ArticleId></ArticleIdList></Reference><Reference><Citation>Remely M., Ferk F., Sterneder S., Setayesh T., Kepcija T., Roth S., et al. Vitamin E modifies high-fat diet-induced increase of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL/6J male mice. Nutrients. 2017;9:607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490586</ArticleId><ArticleId IdType="pubmed">28613268</ArticleId></ArticleIdList></Reference><Reference><Citation>Remely M., Ferk F., Sterneder S., Setayesh T., Roth S., Kepcija T., et al. EGCG prevents high-fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL/6J male mice. Oxid. Med. Cell. Longev. 2017;2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241499</ArticleId><ArticleId IdType="pubmed">28133504</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning S.M., Wang P., Said J., Magyar C., Castor B., Doan N., et al. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J. Nutr. Biochem. 2012;23:1537&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3374889</ArticleId><ArticleId IdType="pubmed">22405694</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Xu W., Huang Y., Huang X., Xu L., Lv Z. Genistein demethylates the promoter of CHD5 and inhibits neuroblastoma growth in vivo. Int. J. Mol. Med. 2012;30:1081&#x2013;1086.</Citation><ArticleIdList><ArticleId IdType="pubmed">22960751</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal A., Piyathilake C., Hara Y., Katiyar S.K. Exceptionally high protection of photocarcinogenesis by topical application of (&#x2014;)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia. 2003;5:555&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1502572</ArticleId><ArticleId IdType="pubmed">14965448</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Liu H., Gong X.L., Wu L.Y., Wen B. Effect of evodiamine and berberine on the interaction between DNMTs and Target micro-RNAs during malignant transformation of the colon by TGF-&#x3b2;1. Oncol. Rep. 2017;37:1637&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pubmed">28098901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny I.P., Karpf A.R., James S.R., Melnyk S., Han T., Tryndyak V.P. Epigenetic alterations in the brains of Fisher 344 rats induced by long-term administration of folate/methyl-deficient diet. Brain Res. 2008;1237:25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18694733</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Chen M., Wu H., Li Y., Tollefsbol T.O. Maternal epigenetic regulation contributes to prevention of estrogen receptor-negative mammary cancer with broccoli sprout consumption. Cancer Prev. Res. (Phila). 2020;13:449&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7203003</ArticleId><ArticleId IdType="pubmed">32184225</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M.C., Maso V., Torello C.O., Ferro K.P., Saad S.T.O. The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin. Epigenetics. 2018;10:139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225654</ArticleId><ArticleId IdType="pubmed">30409182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng F., Wu J., Tang Q., Xiao Q., Wu W., Hann S.S. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1. J. Cell. Mol. Med. 2018;22:600&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742731</ArticleId><ArticleId IdType="pubmed">28840963</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Meeran S.M., Tollefsbol T.O. Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ER&#x3b1; expression. Sci. Rep. 2017;7:9345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570897</ArticleId><ArticleId IdType="pubmed">28839265</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Peng Y., Wu L.-C., Xie Z., Deng Y., Hughes T., et al. Curcumin downregulates DNA methyltransferase 1 and plays an antileukemic role in acute myeloid leukemia. PLOS ONE. 2013;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572185</ArticleId><ArticleId IdType="pubmed">23457487</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Xie Z., Jones W., Pavlovicz R.E., Liu S., Yu J., et al. Curcumin is a potent DNA hypomethylation agent. Bioorg. Med. Chem. Lett. 2009;19:706&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">19112019</ArticleId></ArticleIdList></Reference><Reference><Citation>McCubrey J.A., Lertpiriyapong K., Steelman L.S., Abrams S.L., Yang L.V., Murata R.M., et al. Effects of resveratrol, curcumin, berberine, and other nutraceuticals on aging, cancer development, cancer stem cells, and microRNAs. Aging (Albany NY) 2017;9:1477&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5509453</ArticleId><ArticleId IdType="pubmed">28611316</ArticleId></ArticleIdList></Reference><Reference><Citation>Siopis G., Porter J. Contribution of biological age&#x2013;predictive biomarkers to nutrition research: a systematic review of the current evidence and implications for future research and clinical practice. Adv. Nutr. 2022;13:1930&#x2013;1946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9526820</ArticleId><ArticleId IdType="pubmed">35612976</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:3156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015143</ArticleId><ArticleId IdType="pubmed">24138928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannum G., Guinney J., Zhao L., Zhang L., Hughes G., Sadda S., et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell. 2013;49:359&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780611</ArticleId><ArticleId IdType="pubmed">23177740</ArticleId></ArticleIdList></Reference><Reference><Citation>Reale A., Tagliatesta S., Zardo G., Zampieri M. Counteracting aged DNA methylation states to combat aging and age-related diseases. Mech. Ageing Dev. 2022;206</Citation><ArticleIdList><ArticleId IdType="pubmed">35760211</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira B., Correia F.P., Alves I.A., Costa M., Gameiro M., Martins A.P., et al. Epigenetic reprogramming as a key to reverse aging and increase longevity. Ageing Res. Rev. 2024;95</Citation><ArticleIdList><ArticleId IdType="pubmed">38272265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40900385</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2730-6011</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Discover oncology</Title><ISOAbbreviation>Discov Oncol</ISOAbbreviation></Journal><ArticleTitle>Application of Mendelian randomization in the discovery of risk factors for cancer from 2014 to 2024: a bibliometric review.</ArticleTitle><Pagination><StartPage>1683</StartPage><MedlinePgn>1683</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1683</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12672-025-03515-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Cancer represents a significant threat to human health, resulting in considerable suffering and placing strain on the medical system. Mendelian randomization (MR) is a cutting-edge technique widely utilized in epidemiological studies, demonstrating distinct advantages in identifying risk factors associated with various diseases. In recent times, there has been considerable interest in MR studies within cancer research. Researchers are increasingly utilizing MR to explore potential risk factors and mechanisms related to cancer, which enables researchers to evaluate the causal relationship between genetic variation and cancer risk more accurately, serving as a crucial foundation for cancer prevention and treatment.</AbstractText><AbstractText Label="METHODS">This study conducted a bibliometric analysis of MR research in cancer, documented in the Science Network (WOS) Index from 2014 to 2024. By systematically retrieving and summarizing relevant literature, the analysis covered data points such as countries, institutions, authors, journals, publications, keywords, exposures and outcomes.</AbstractText><AbstractText Label="RESULTS">The study included 1211 articles written by 5810 scholars affiliated with 1254 organizations in 66 nations, published in 302 journals. China, UK, USA and Australia emerged as the leading countries involved. The key affiliations included the University of Bristol, Karolinska Institute, Sichuan University and Zhejiang University. Prominent journals include &#x2018;Frontiers in Oncology&#x2019;, &#x2018;Frontiers in Genetics&#x2019;, &#x2018;International Journal of Cancer&#x2019; and &#x2018;Scientific Reports&#x2019;. The keyword analysis indicated that obesity was the most frequently cited exposure factor in cancer-related MR literature, followed by body mass index, inflammation and smoking. Breast cancer was the most common outcome factor, followed by colorectal cancer, prostate cancer and lung cancer.</AbstractText><AbstractText Label="CONCLUSION">More and more attention has been paid to the research of MR in tumors, revealing a variety of potential risk factors. However, some risk factors found by MR analysis (such as obesity on lung cancer subtypes) also have contradictory effects, highlighting the complexity of the specific causal relationship between exposure factors and cancer. Future research needs to focus on three directions: integrating cross-omics data (such as epigenetics, single cell analysis) to analyze the mechanism of tumor microenvironment; we use longitudinal MR and Bayesian model to optimize the robustness of causal inference. Strengthen cross-ethnic verification and GWAS data construction of rare cancers, and promote the transformation of MR findings into precise prevention strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Junchi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Heilongjiang University of Chinese Medicine, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Heilongjiang University of Chinese Medicine, Harbin, China. doctwdy@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heilongjiang University of Chinese Medicine Affiliated Second Hospital, Harbin, China. doctwdy@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yixiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Heilongjiang University of Chinese Medicine, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xinzhe</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Heilongjiang University of Chinese Medicine, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Haibin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Heilongjiang University of Chinese Medicine, Harbin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Discov Oncol</MedlineTA><NlmUniqueID>101775142</NlmUniqueID><ISSNLinking>2730-6011</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bibliometric analysis</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">Tumor</Keyword><Keyword MajorTopicYN="N">Visualization analysis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>12</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40900385</ArticleId><ArticleId IdType="pmc">PMC12408435</ArticleId><ArticleId IdType="doi">10.1007/s12672-025-03515-x</ArticleId><ArticleId IdType="pii">10.1007/s12672-025-03515-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">34086348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadelu T, Rebbeck TR. The rising burden of cancer in low- and middle-human development index countries. Cancer. 2021;127(6):2864&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34086352</ArticleId></ArticleIdList></Reference><Reference><Citation>Yvonne W, Aude J-F, Phiona B. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study. Lancet Glob Health. 2024;12(6):e947&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11126368</ArticleId><ArticleId IdType="pubmed">38762297</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025157</ArticleId><ArticleId IdType="pubmed">31812369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyuna S, Jacques F, Rebecca LS, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.ca. Cancer J Clin. 2021;71(3):209&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Fan Y, Tang W, et al. Identification of ALYREF in pan-cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer. Sci Rep. 2024;14(1):6270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10942997</ArticleId><ArticleId IdType="pubmed">38491127</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvio MP, Nazareth A J,Auro DG. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis. J Gastrointest Oncol. 2024;15(1):33&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10932683</ArticleId><ArticleId IdType="pubmed">38482212</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Liu X, Dai H, et al. Association of lymphocyte subsets with the efficacy and prognosis of PD-1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study. BMC Gastroenterol. 2024;24(1):113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10943815</ArticleId><ArticleId IdType="pubmed">38491354</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzanne ES, Carolynn G, Brian DN, et al. Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a National cohort study. Lancet Oncol. 2023;24(11):1242&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">37922929</ArticleId></ArticleIdList></Reference><Reference><Citation>Laura EB, Jeremy AG, Scott HP, et al. Assessing the gold Standard&#x2013;Lessons from the history of rcts.n engl. J Med. 2016;374(22):2175&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">27248626</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey Smith G, Ebrahim S. Mendelian randomization&#x2019;: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip CH, Stephen B, Kaitlin HW, et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr. 2016;103(4):965&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4807699</ArticleId><ArticleId IdType="pubmed">26961927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Baird D, Borges MC, et al. Recent developments in Mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711966</ArticleId><ArticleId IdType="pubmed">29226067</ArticleId></ArticleIdList></Reference><Reference><Citation>James Y, Kaitlin HW, Rebecca CR, et al. Causal inference in cancer epidemiology: what is the role of Mendelian Randomization?Cancer. Epidemiol Biomarkers Prev. 2018;27(9):995&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522350</ArticleId><ArticleId IdType="pubmed">29941659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Zhang Y, Feng S, et al. Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: a bibliometric analysis. CNS Neurosci Ther. 2023;29(10):2940&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10493663</ArticleId><ArticleId IdType="pubmed">37088947</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing S, Wang JYS, Wu H. Interleukin-6 signaling pathway in Mendelian randomization: A 10-year bibliometric analysis.medicine. (Baltimore). 2024;103(14):e37507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10994451</ArticleId><ArticleId IdType="pubmed">38579070</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan N. Ludo W.Citation-based clustering of publications using CitNetExplorer. VOSviewer Scientometrics. 2017;111(2):1053&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5400793</ArticleId><ArticleId IdType="pubmed">28490825</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eck N, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883932</ArticleId><ArticleId IdType="pubmed">20585380</ArticleId></ArticleIdList></Reference><Reference><Citation>Marie BS, Chaomei C, John H, H. CiteSpace. II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc.2005;2005:724-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560567</ArticleId><ArticleId IdType="pubmed">16779135</ArticleId></ArticleIdList></Reference><Reference><Citation>Venable GT, Shepherd BA, Loftis CM, et al. Bradford&#x2019;s law: identification of the core journals for neurosurgery and its subspecialties. J Neurosurg. 2016;124(2):569&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">26339849</ArticleId></ArticleIdList></Reference><Reference><Citation>Haycock PC, Burgess S, Nounu A, et al. Association between telomere length and risk of cancer and Non-Neoplastic diseases A Mendelian randomization study. JAMA Oncol. 2017;2(5):636&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5638008</ArticleId><ArticleId IdType="pubmed">28241208</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou N, Dimou n, tsilidis kk, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020;11(1):597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6992637</ArticleId><ArticleId IdType="pubmed">32001714</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras-Torres R, Johansson M, Gaborieau V, et al. The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study. JNCI J Natl Cancer Inst. 2017;109(9):djx012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5721813</ArticleId><ArticleId IdType="pubmed">28954281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nead KT, Sharp SJ, Thompson DJ, et al. Evidence of a causal association between insulinemia and endometrial cancer: a Mendelian randomization analysis. JNCI J Natl Cancer Inst. 2015;107(9):djv178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4572886</ArticleId><ArticleId IdType="pubmed">26134033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang CA, Doherty JA, Burgess S, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet. 2015;24(18):5356&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550826</ArticleId><ArticleId IdType="pubmed">26138067</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh KM, Codd V, Rice T, et al. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015;6(40):42468&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4767445</ArticleId><ArticleId IdType="pubmed">26646793</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Kar S, Carter P, et al. Is type 2 diabetes causally associated with cancer risk?? Evidence from a two-sample. Mendelian randomization study. Diabetes. 2020;69(7):1588&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306131</ArticleId><ArticleId IdType="pubmed">32349989</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornish AJ, Law PJ, Timofeeva M, et al. Modifiable pathways for colorectal cancer: a Mendelian randomisation analysis. Lancet Gastroenterol Hepatol. 2020;5(1):55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026696</ArticleId><ArticleId IdType="pubmed">31668584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Liu G, Hung RJ, et al. Causal relationships between body mass index, smoking and lung cancer: univariable and multivariable Mendelian randomization. Int J Cancer. 2020;148(5):1077&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845289</ArticleId><ArticleId IdType="pubmed">32914876</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras-Torres R, Johansson M, Haycock P, et al. Obesity, metabolic factors and risk of different histological types of lung cancer: a Mendelian randomization study. PLoS One. 2017;12(6):e0177875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464539</ArticleId><ArticleId IdType="pubmed">28594918</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden Jack, Smith George Davey, burgess Stephen. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40897307</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2304-3873</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Chinese clinical oncology</Title><ISOAbbreviation>Chin Clin Oncol</ISOAbbreviation></Journal><ArticleTitle>Bibliometric and visualization analysis of cancer associated with intestinal flora through genetics and epigenetics from 1991 to 2024.</ArticleTitle><Pagination><StartPage>39</StartPage><MedlinePgn>39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/cco-25-13</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intestinal flora, or gut microbiota, has increasingly been recognized for its potential role in cancer development and progression. Beyond direct interactions with systemic organs, gut microbiota and its metabolites can modulate epigenetic processes such as DNA methylation, histone modification, and non-coding RNA regulation. This study aims to bridge this gap by conducting a bibliometric and visualization analysis of the scientific literature on cancer associated with intestinal flora.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We utilized bibliometric software to examine publication trends, citation patterns, and collaborative networks within the field. Visualization techniques were applied to pinpoint influential authors, institutions, and countries. The analysis encompassed a comprehensive search of relevant databases to gather data on publications related to intestinal flora and cancer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our findings indicate a substantial rise in publications over recent decades, signifying an intensifying focus on the intestinal flora-cancer connection. Key research hotspots identified include the microbiota's role in colorectal cancer, the interplay between microbiota and the host immune system, the epigenetic impacts of gut microbiota on cancer development, and the promise of microbiota-targeted therapies for cancer treatment. The analysis also revealed a network of prominent researchers, leading institutions, and countries at the forefront of this research area.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study offers a panoramic view of the current research on cancer associated with intestinal flora and underscores potential avenues for future exploration. The insights gleaned from our bibliometric and visualization analysis may guide the development of targeted strategies for cancer prevention and treatment, harnessing the power of the gut microbiota.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Zhejiang Key Laboratory of Maternal and Infant Health, Hangzhou, China; Department of Gynecology and Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Keyi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Hengyi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Wentian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Economics &amp; Trade, Henan Finance University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Lab of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Tizhen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Reproduction and Genetics &amp; Pediatric Orthopedics, Dongguan Maternal and Child Health Care Hospital, Dongguan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Baobiao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Reproduction and Genetics &amp; Pediatric Orthopedics, Dongguan Maternal and Child Health Care Hospital, Dongguan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Oncology, Nanjing Hospital of Chinese Medicine, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin Clin Oncol</MedlineTA><NlmUniqueID>101608375</NlmUniqueID><ISSNLinking>2304-3865</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="Y">Bibliometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Host immune</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">intestinal flora</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>22</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40897307</ArticleId><ArticleId IdType="doi">10.21037/cco-25-13</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40869316</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>16</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Vitamin D as an Epigenetic Regulator: A Hypothetical Mechanism for Cancer Prevention via Inhibition of Oncogenic lncRNA HOTAIR.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7997</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms26167997</ELocationID><Abstract><AbstractText>Cancer remains a leading cause of mortality worldwide, arising from a complex interplay of genetic, epigenetic, and environmental factors. Although the role of micronutrients in cancer development has received limited attention, growing evidence suggests that vitamins, particularly vitamin D, may influence oncogenic pathways. This hypothesis manuscript explores the potential interaction between vitamin D and the oncogenic long non-coding RNA HOTAIR, providing a novel mechanistic explanation for the inverse correlation between vitamin D status and cancer risk. We support our hypothesis with in silico docking evidence, suggesting that vitamin D binds to bioactive domains within the structured regions of HOTAIR, potentially disrupting its interaction with chromatin regulators such as PRC2. This concept may offer a novel approach to cancer prevention and therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trujano-Camacho</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratorio de Gen&#xf3;mica Funcional, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Tlalnepantla Estado de M&#xe9;xico 54090, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Biology PhD Program, DCBS, Universidad Aut&#xf3;noma Metropolitana-Iztapalapa, Mexico City 09340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulido-Capiz</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><Identifier Source="ORCID">0000-0001-9650-2555</Identifier><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica, Facultad de Medicina Mexicali, Universidad Aut&#xf3;noma de Baja California, Mexicali 21100, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Gonz&#xe1;lez</LastName><ForeName>Victor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9421-3730</Identifier><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica, Facultad de Medicina Mexicali, Universidad Aut&#xf3;noma de Baja California, Mexicali 21100, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Urrutia</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5307-2003</Identifier><AffiliationInfo><Affiliation>Laboratorio de Gen&#xf3;mica Funcional, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Tlalnepantla Estado de M&#xe9;xico 54090, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Plasencia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8593-8211</Identifier><AffiliationInfo><Affiliation>Laboratorio de Gen&#xf3;mica Funcional, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Tlalnepantla Estado de M&#xe9;xico 54090, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C561566">HOTAIR long untranslated RNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="Y">Vitamin D</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HOTAIR</Keyword><Keyword MajorTopicYN="N">cancer epigenetics</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">lncRNAs</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40869316</ArticleId><ArticleId IdType="pmc">PMC12386503</ArticleId><ArticleId IdType="doi">10.3390/ijms26167997</ArticleId><ArticleId IdType="pii">ijms26167997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F., Laversanne M., Sung H., Ferlay J., Siegel R.L., Soerjomataram I., Jemal A. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2024;74:229&#x2013;263. doi: 10.3322/caac.21834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21834</ArticleId><ArticleId IdType="pubmed">38572751</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Zhu W., Thompson P., Hannun Y.A. Evaluating Intrinsic and Non-Intrinsic Cancer Risk Factors. Nat. Commun. 2018;9:3490. doi: 10.1038/s41467-018-05467-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05467-z</ArticleId><ArticleId IdType="pmc">PMC6113228</ArticleId><ArticleId IdType="pubmed">30154431</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;ld&#x131;r&#x131;m-Kahr&#x131;man S. Non-Intrinsic Cancer Risk Factors. Exp. Oncol. 2023;43:290&#x2013;297. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-4.16804.</Citation><ArticleIdList><ArticleId IdType="doi">10.32471/exp-oncology.2312-8852.vol-43-no-4.16804</ArticleId><ArticleId IdType="pubmed">34967549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames B.N., Wakimoto P. Are Vitamin and Mineral Deficiencies a Major Cancer Risk? Nat. Rev. Cancer. 2002;2:694&#x2013;704. doi: 10.1038/nrc886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc886</ArticleId><ArticleId IdType="pubmed">12209158</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy A.-L., Pouteau E., Marquez D., Yilmaz C., Scholey A. Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence. Nutrients. 2020;12:228. doi: 10.3390/nu12010228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12010228</ArticleId><ArticleId IdType="pmc">PMC7019700</ArticleId><ArticleId IdType="pubmed">31963141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle D.D. Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chem. Biol. 2014;21:319&#x2013;329. doi: 10.1016/j.chembiol.2013.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2013.12.016</ArticleId><ArticleId IdType="pmc">PMC3968073</ArticleId><ArticleId IdType="pubmed">24529992</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Leischner C., Helling T., Burkard M., Marongiu L. Vitamins as Possible Cancer Biomarkers: Significance and Limitations. Nutrients. 2021;13:3914. doi: 10.3390/nu13113914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113914</ArticleId><ArticleId IdType="pmc">PMC8622959</ArticleId><ArticleId IdType="pubmed">34836171</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedik E. Sources of Vitamin D for Humans. Int. J. Vitam. Nutr. Res. 2022;92:118&#x2013;125. doi: 10.1024/0300-9831/a000733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0300-9831/a000733</ArticleId><ArticleId IdType="pubmed">34658250</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C. Vitamin D and Its Target Genes. Nutrients. 2022;14:1354. doi: 10.3390/nu14071354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14071354</ArticleId><ArticleId IdType="pmc">PMC9003440</ArticleId><ArticleId IdType="pubmed">35405966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz A., Grant W.B. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022;14:1448. doi: 10.3390/nu14071448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14071448</ArticleId><ArticleId IdType="pmc">PMC9003337</ArticleId><ArticleId IdType="pubmed">35406059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheeley M.P., Andolino C., Kiesel V.A., Teegarden D. Vitamin D Regulation of Energy Metabolism in Cancer. Br. J. Pharmacol. 2022;179:2890&#x2013;2905. doi: 10.1111/bph.15424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15424</ArticleId><ArticleId IdType="pmc">PMC9703876</ArticleId><ArticleId IdType="pubmed">33651382</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziano S., Johnston R., Deng O., Zhang J., Gonzalo S. Vitamin D/Vitamin D Receptor Axis Regulates DNA Repair during Oncogene-Induced Senescence. Oncogene. 2016;35:5362&#x2013;5376. doi: 10.1038/onc.2016.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2016.77</ArticleId><ArticleId IdType="pmc">PMC5050051</ArticleId><ArticleId IdType="pubmed">27041576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle D.D. Vitamin D Regulation of and by Long Non Coding RNAs. Mol. Cell. Endocrinol. 2021;532:111317. doi: 10.1016/j.mce.2021.111317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2021.111317</ArticleId><ArticleId IdType="pubmed">34015414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao N., Li Y., Li J., Gao Z., Yang Z., Li Y., Liu H., Fan T. Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers. Front. Oncol. 2020;10:598817. doi: 10.3389/fonc.2020.598817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.598817</ArticleId><ArticleId IdType="pmc">PMC7775490</ArticleId><ArticleId IdType="pubmed">33392092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan H., Bu P. Non-Coding RNA in Cancer. Essays Biochem. 2021;65:625&#x2013;639. doi: 10.1042/ebc20200032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/ebc20200032</ArticleId><ArticleId IdType="pmc">PMC8564738</ArticleId><ArticleId IdType="pubmed">33860799</ArticleId></ArticleIdList></Reference><Reference><Citation>Statello L., Guo C.-J., Chen L.-L., Huarte M. Gene Regulation by Long Non-Coding RNAs and Its Biological Functions. Nat. Rev. Mol. Cell Biol. 2021;22:96&#x2013;118. doi: 10.1038/s41580-020-00315-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00315-9</ArticleId><ArticleId IdType="pmc">PMC7754182</ArticleId><ArticleId IdType="pubmed">33353982</ArticleId></ArticleIdList></Reference><Reference><Citation>Obuse C., Hirose T. Functional Domains of Nuclear Long Noncoding RNAs: Insights into Gene Regulation and Intracellular Architecture. Curr. Opin. Cell Biol. 2023;85:102250. doi: 10.1016/j.ceb.2023.102250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2023.102250</ArticleId><ArticleId IdType="pubmed">37806294</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Liu S., Zhu H. The Sequence, Structure and Evolutionary Features of HOTAIR in Mammals. BMC Evol. Biol. 2011;11:102. doi: 10.1186/1471-2148-11-102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2148-11-102</ArticleId><ArticleId IdType="pmc">PMC3103462</ArticleId><ArticleId IdType="pubmed">21496275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Zheng H., Wang C., Lu X., Zhao X., Li X. Insight into HOTAIR Structural Features and Functions as Landing Pads for Transcription Regulation Proteins. Biochem. Biophys. Res. Commun. 2017;485:679&#x2013;685. doi: 10.1016/j.bbrc.2017.02.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.02.100</ArticleId><ArticleId IdType="pubmed">28235488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Qian X., Wang Z., Zhou X. The HOTAIR LncRNA: A Remarkable Oncogenic Promoter in Human Cancer Metastasis. Oncol. Lett. 2021;21:302. doi: 10.3892/ol.2021.12563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2021.12563</ArticleId><ArticleId IdType="pmc">PMC7905531</ArticleId><ArticleId IdType="pubmed">33732378</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C., Yang Y., Yang Y., Guo L., Huang J., Liu X., Wu C., Zou J. Long Noncoding RNA (LncRNA) HOTAIR Affects Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer by Upregulating MiR-613. Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 2018;26:725&#x2013;734. doi: 10.3727/096504017X15119467381615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096504017X15119467381615</ArticleId><ArticleId IdType="pmc">PMC7844735</ArticleId><ArticleId IdType="pubmed">29187267</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama H., Tamai K., Shibuya R., Nakamura M., Mochizuki M., Yamaguchi K., Kawamura S., Tochigi T., Sato I., Okanishi T., et al. Long Non-Coding RNA HOTAIR Promotes Cell Migration by Upregulating Insulin Growth Factor&#x2013;Binding Protein 2 in Renal Cell Carcinoma. Sci. Rep. 2017;7:12016. doi: 10.1038/s41598-017-12191-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12191-z</ArticleId><ArticleId IdType="pmc">PMC5607269</ArticleId><ArticleId IdType="pubmed">28931862</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Jiang H., Zhou H., Ying X., Wang Z., Yang Y., Xu W., He X., Li Y. Lentivirus-Mediated Silencing of HOTAIR LncRNA Restores Gefitinib Sensitivity by Activating Bax/Caspase-3 and Suppressing TGF-&#x3b1;/EGFR Signaling in Lung Adenocarcinoma. Oncol. Lett. 2018;15:2829&#x2013;2838. doi: 10.3892/ol.2017.7656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2017.7656</ArticleId><ArticleId IdType="pmc">PMC5778865</ArticleId><ArticleId IdType="pubmed">29467862</ArticleId></ArticleIdList></Reference><Reference><Citation>Toden S., Zumwalt T.J., Goel A. Non-Coding RNAs and Potential Therapeutic Targeting in Cancer. Biochim. Biophys. Acta Bba-Rev. Cancer. 2020;1875:188491. doi: 10.1016/j.bbcan.2020.188491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2020.188491</ArticleId><ArticleId IdType="pmc">PMC7856203</ArticleId><ArticleId IdType="pubmed">33316377</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatemi R.P., Salah-Uddin S., Modarresi F., Khoury N., Wahlestedt C., Faghihi M.A. Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen. SLAS Discov. 2015;20:1132&#x2013;1141. doi: 10.1177/1087057115594187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087057115594187</ArticleId><ArticleId IdType="pmc">PMC4576503</ArticleId><ArticleId IdType="pubmed">26173710</ArticleId></ArticleIdList></Reference><Reference><Citation>Norouzi A., Motaghi M., Hassanshahi G., Nazari-Robati M. Exploring the Expression Profile of Vitamin D Receptor and Its Related Long Non-Coding RNAs in Patients with Acute Lymphoblastic Leukemia. Rev. Assoc. Med. Bras. 2021;67:1113&#x2013;1117. doi: 10.1590/1806-9282.20210451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20210451</ArticleId><ArticleId IdType="pubmed">34669855</ArticleId></ArticleIdList></Reference><Reference><Citation>Naiini M.R., Saeidi K., Azarian A., Bahramzadeh K., Nazari-Robati M. Expression Analysis of Vitamin D Receptor-Associated Long Noncoding RNAs in Patients with Relapsing-Remitting Multiple Sclerosis. Bratisl. Med. J. 2024;125:107&#x2013;112. doi: 10.4149/BLL_2024_018.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2024_018</ArticleId><ArticleId IdType="pubmed">38219064</ArticleId></ArticleIdList></Reference><Reference><Citation>Somarowthu S., Legiewicz M., Chill&#xf3;n I., Marcia M., Liu F., Pyle A.M. HOTAIR Forms an Intricate and Modular Secondary Structure. Mol. Cell. 2015;58:353&#x2013;361. doi: 10.1016/j.molcel.2015.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.03.006</ArticleId><ArticleId IdType="pmc">PMC4406478</ArticleId><ArticleId IdType="pubmed">25866246</ArticleId></ArticleIdList></Reference><Reference><Citation>Spokoini-Stern R., Stamov D., Jessel H., Aharoni L., Haschke H., Giron J., Unger R., Segal E., Abu-Horowitz A., Bachelet I. Visualizing the Structure and Motion of the Long Noncoding RNA HOTAIR. RNA. 2020;26:629&#x2013;636. doi: 10.1261/rna.074633.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.074633.120</ArticleId><ArticleId IdType="pmc">PMC7161352</ArticleId><ArticleId IdType="pubmed">32115425</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C., Qu K., Zhong F.L., Artandi S.E., Chang H.Y. Genomic Maps of Long Noncoding RNA Occupancy Reveal Principles of RNA-Chromatin Interactions. Mol. Cell. 2011;44:667&#x2013;678. doi: 10.1016/j.molcel.2011.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.08.027</ArticleId><ArticleId IdType="pmc">PMC3249421</ArticleId><ArticleId IdType="pubmed">21963238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Wang Y., Zhang J., Wang Q., Han L., Mei M., Kang C. Targeted Design and Identification of AC1NOD4Q to Block Activity of HOTAIR by Abrogating the Scaffold Interaction with EZH2. Clin. Epigenetics. 2019;11:29. doi: 10.1186/s13148-019-0624-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-019-0624-2</ArticleId><ArticleId IdType="pmc">PMC6376746</ArticleId><ArticleId IdType="pubmed">30764859</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.-C., Hung T., Argani P., Rinn J.L., et al. Long Non-Coding RNA HOTAIR Reprograms Chromatin State to Promote Cancer Metastasis. Nature. 2010;464:1071&#x2013;1076. doi: 10.1038/nature08975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08975</ArticleId><ArticleId IdType="pmc">PMC3049919</ArticleId><ArticleId IdType="pubmed">20393566</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L., Jin M., Nam A.-R., Park J.-E., Bang J.-H., Oh D.-Y., Bang Y.-J. Anti-Tumor Effects of NVP-BKM120 Alone or in Combination with MEK162 in Biliary Tract Cancer. Cancer Lett. 2017;411:162&#x2013;170. doi: 10.1016/j.canlet.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2017.10.002</ArticleId><ArticleId IdType="pubmed">29024814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Zhou L., Wu L.-M., Lai M.-C., Xie H.-Y., Zhang F., Zheng S.-S. Overexpression of Long Non-Coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation. Ann. Surg. Oncol. 2011;18:1243&#x2013;1250. doi: 10.1245/s10434-011-1581-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-011-1581-y</ArticleId><ArticleId IdType="pubmed">21327457</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdeahad H., Avan A., Pashirzad M., Khazaei M., Soleimanpour S., Ferns G.A., Fiuji H., Ryzhikov M., Bahrami A., Hassanian S.M. The Prognostic Potential of Long Noncoding RNA HOTAIR Expression in Human Digestive System Carcinomas: A Meta-analysis. J. Cell. Physiol. 2019;234:10926&#x2013;10933. doi: 10.1002/jcp.27918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27918</ArticleId><ArticleId IdType="pubmed">30569489</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S., King P., Liang E., Guo A.A., Liu M. LncRNA HOTAIR Sponges MiR-301a-3p to Promote Glioblastoma Proliferation and Invasion through Upregulating FOSL1. Cell. Signal. 2022;94:110306. doi: 10.1016/j.cellsig.2022.110306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2022.110306</ArticleId><ArticleId IdType="pmc">PMC9058208</ArticleId><ArticleId IdType="pubmed">35292358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Zhu J., Fu Y., Li C., Wu B. LncRNA HOTAIR Promotes Breast Cancer Progression through Regulating the MiR-129-5p/FZD7 Axis. Cancer Biomark. 2021;30:203&#x2013;212. doi: 10.3233/CBM-190913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CBM-190913</ArticleId><ArticleId IdType="pubmed">33104019</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng X., Liu H., Ruan J., Du M., Wang L., Mao J., Cai Y., Lu X., Chen W., Huang Y., et al. HOTAIR/MiR-1277-5p/ZEB1 Axis Mediates Hypoxia-Induced Oxaliplatin Resistance via Regulating Epithelial-Mesenchymal Transition in Colorectal Cancer. Cell Death Discov. 2022;8:310. doi: 10.1038/s41420-022-01096-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-022-01096-0</ArticleId><ArticleId IdType="pmc">PMC9263107</ArticleId><ArticleId IdType="pubmed">35798695</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang Z., Shi H., Li H., Li L., Fang R., Cai X., Liu B., Zhang X., Ye L. HBXIP and LSD1 Scaffolded by LncRNA Hotair Mediate Transcriptional Activation by C-Myc. Cancer Res. 2016;76:293&#x2013;304. doi: 10.1158/0008-5472.CAN-14-3607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-14-3607</ArticleId><ArticleId IdType="pubmed">26719542</ArticleId></ArticleIdList></Reference><Reference><Citation>Moena D., Nardocci G., Acevedo E., Lian J., Stein G., Stein J., Montecino M. Ezh2-dependent H3K27me3 Modification Dynamically Regulates Vitamin D3-dependent Epigenetic Control of CYP24A1 Gene Expression in Osteoblastic Cells. J. Cell. Physiol. 2020;235:5404&#x2013;5412. doi: 10.1002/jcp.29428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.29428</ArticleId><ArticleId IdType="pmc">PMC7056562</ArticleId><ArticleId IdType="pubmed">31907922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Jia R., Chen M., Wang J., Huang F., Shi M., Sheng H., Xu L. Antagonizing EZH2 Combined with Vitamin D3 Exerts a Synergistic Role in Anti-fibrosis through Bidirectional Effects on Hepatocytes and Hepatic Stellate Cells. J. Gastroenterol. Hepatol. 2023;38:441&#x2013;450. doi: 10.1111/jgh.16126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.16126</ArticleId><ArticleId IdType="pubmed">36652457</ArticleId></ArticleIdList></Reference><Reference><Citation>Laugesen A., H&#xf8;jfeldt J.W., Helin K. Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer. Cold Spring Harb. Perspect. Med. 2016;6:a026575. doi: 10.1101/cshperspect.a026575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a026575</ArticleId><ArticleId IdType="pmc">PMC5008062</ArticleId><ArticleId IdType="pubmed">27449971</ArticleId></ArticleIdList></Reference><Reference><Citation>Seraphin G., Rieger S., Hewison M., Capobianco E., Lisse T.S. The Impact of Vitamin D on Cancer: A Mini Review. J. Steroid Biochem. Mol. Biol. 2023;231:106308. doi: 10.1016/j.jsbmb.2023.106308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2023.106308</ArticleId><ArticleId IdType="pmc">PMC10330295</ArticleId><ArticleId IdType="pubmed">37054849</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Ren Y., Wang Y., Tan Y., Wang Q., Cai J., Zhou J., Yang C., Zhao K., Yi K., et al. A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Theranostics. 2019;9:4608&#x2013;4623. doi: 10.7150/thno.35188.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.35188</ArticleId><ArticleId IdType="pmc">PMC6643429</ArticleId><ArticleId IdType="pubmed">31367244</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z., Zhang Y., Li H., Zhou Y., Zhang Q., Chen R., Jin T., Hu K., Li S., Wang Y., et al. Vitamin D Promotes the Cisplatin Sensitivity of Oral Squamous Cell Carcinoma by Inhibiting LCN2-Modulated NF-&#x39a;B Pathway Activation through RPS3. Cell Death Dis. 2019;10:936. doi: 10.1038/s41419-019-2177-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-2177-x</ArticleId><ArticleId IdType="pmc">PMC6901542</ArticleId><ArticleId IdType="pubmed">31819048</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovachka S., Panosetti M., Grimaldi B., Azoulay S., Giorgio A.D., Duca M. Small Molecule Approaches to Targeting RNA. Nat. Rev. Chem. 2024;8:120&#x2013;135. doi: 10.1038/s41570-023-00569-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41570-023-00569-9</ArticleId><ArticleId IdType="pubmed">38278932</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Fan J., Wang B., Traugh N., Chen Q., Liu J.S., Li B., Liu X.S. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77:e108&#x2013;e110. doi: 10.1158/0008-5472.CAN-17-0307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0307</ArticleId><ArticleId IdType="pmc">PMC6042652</ArticleId><ArticleId IdType="pubmed">29092952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrashekar D.S., Karthikeyan S.K., Korla P.K., Patel H., Shovon A.R., Athar M., Netto G.J., Qin Z.S., Kumar S., Manne U., et al. UALCAN: An Update to the Integrated Cancer Data Analysis Platform. Neoplasia. 2022;25:18&#x2013;27. doi: 10.1016/j.neo.2022.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neo.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC8788199</ArticleId><ArticleId IdType="pubmed">35078134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40805232</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>15</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Exposome Perspective: Environmental and Infectious Agents as Drivers of Cancer Disparities in Low- and Middle-Income Countries.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2537</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers17152537</ELocationID><Abstract><AbstractText>Cancer disparities in low- and middle-income countries (LMICs) arise from multifaceted interactions between environmental exposures, infectious agents, and systemic inequities, such as limited access to care. The exposome, a framework encompassing the totality of non-genetic exposures throughout life, offers a powerful lens for understanding these disparities. In LMICs, populations are disproportionately affected by air and water pollution, occupational hazards, and oncogenic infections, including human papillomavirus (HPV), hepatitis B virus (HBV), <i>Helicobacter pylori</i> (<i>H. pylori</i>), human immunodeficiency virus (HIV), and neglected tropical diseases, such as schistosomiasis. These infectious agents contribute to increased cancer susceptibility and poor outcomes, particularly in immunocompromised individuals. Moreover, climate change, food insecurity, and barriers to healthcare access exacerbate these risks. This review adopts a population-level exposome approach to explore how environmental and infectious exposures intersect with genetic, epigenetic, and immune mechanisms to influence cancer incidence and progression in LMICs. We highlight the critical pathways linking chronic exposure and inflammation to tumor development and evaluate strategies such as HPV and HBV vaccination, antiretroviral therapy, and environmental regulation. Special attention is given to tools such as exposome-wide association studies (ExWASs), which offer promise for exposure surveillance, early detection, and public health policy. By integrating exposomic insights into national health systems, especially in regions such as sub-Saharan Africa (SSA) and South Asia, LMICs can advance equitable cancer prevention and control strategies. A holistic, exposome-informed strategy is essential for reducing global cancer disparities and improving outcomes in vulnerable populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dlamini</LastName><ForeName>Zodwa</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-8012-3646</Identifier><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alaouna</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marutha</LastName><ForeName>Tebogo</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3622-321X</Identifier><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mkhize-Kwitshana</LastName><ForeName>Zilungile</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0373-9973</Identifier><AffiliationInfo><Affiliation>Department of Life and Consumer Sciences, College of Agriculture and Science &amp; Environmental Sciences, Science Campus, University of South Africa, Florida 1709, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbodi</LastName><ForeName>Langanani</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Parktown, Johannesburg 2193, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauke-Malinga</LastName><ForeName>Nkhensani</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0914-5946</Identifier><AffiliationInfo><Affiliation>Department of Plastic, Reconstructive and Aesthetic Surgery, Steve Biko Academic Hospital University of Pretoria, Hatfield 0028, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luvhengo</LastName><ForeName>Thifhelimbil E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Parktown, Johannesburg 2193, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marima</LastName><ForeName>Rahaba</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5050-7350</Identifier><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hull</LastName><ForeName>Rodney</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skepu</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8121-5617</Identifier><AffiliationInfo><Affiliation>Next Generation Health, Division 1, Council for Scientific and Industrial Research, Meiring Naude Road, Brummeria, Pretoria 0001, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntwasa</LastName><ForeName>Monde</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6400-8867</Identifier><AffiliationInfo><Affiliation>Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Translational Research, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown 2193, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damane</LastName><ForeName>Botle Precious</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0003-3060-5572</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Health Sciences, Steve Biko Academic Hospital, University of Pretoria, Hatfield 0028, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosoane</LastName><ForeName>Benny</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5588-3221</Identifier><AffiliationInfo><Affiliation>Department of Anatomical Pathology, National Health Laboratory Services, Tshwane Academic Division, University of Pretoria, Pretoria 0002, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbatha</LastName><ForeName>Sikhumbuzo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Health Sciences, Steve Biko Academic Hospital, University of Pretoria, Hatfield 0028, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phakathi</LastName><ForeName>Boitumelo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8991-6060</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Nelson R Mandela School of Medicine, University of Kwa-Zulu Natal, 719 Umbilo Road, Durban 4001, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaba</LastName><ForeName>Moshawa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anatomical Pathology, Dr George Mukhari Academic Laboratory, National Health Laboratory Services, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chokwe</LastName><ForeName>Ramakwana Christinah</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0002-1006-912X</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, College of Science, Engineering, and Technology, University of South Africa, Florida Park, Johannesburg 1709, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edge</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Charlotte Maxeke Hospital, University of Witwatersrand, Johannesburg 2193, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbita</LastName><ForeName>Zukile</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3179-8169</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Microbiology and Biochemistry, University of Limpopo, Sovenga 0727, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanyile</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Faculty of Health Sciences, Steve Biko Academic Hospital, University of Pretoria, Hatfield 0028, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molefi</LastName><ForeName>Thulo</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1236-842X</Identifier><AffiliationInfo><Affiliation>SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Hatfield 0002, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Faculty of Health Sciences, Steve Biko Academic Hospital, University of Pretoria, Hatfield 0028, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>57029</GrantID><Agency>African Medical Research Council Clinician Researcher Programme (SAMRC-CRP)</Agency><Country/></Grant><Grant><GrantID>138139</GrantID><Agency>South African Medical Research Council (SAMRC)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV-related cancers</Keyword><Keyword MajorTopicYN="N">cancer inequities</Keyword><Keyword MajorTopicYN="N">environmental exposures</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">exposome</Keyword><Keyword MajorTopicYN="N">global health disparities</Keyword><Keyword MajorTopicYN="N">low- and middle-income countries (LMICs)</Keyword><Keyword MajorTopicYN="N">oncogenic infections (HPV, HBV, and H. pylori)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funding sources had no role in the study design, data interpretation, or publication decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40805232</ArticleId><ArticleId IdType="pmc">PMC12345750</ArticleId><ArticleId IdType="doi">10.3390/cancers17152537</ArticleId><ArticleId IdType="pii">cancers17152537</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F., Parkin D.M., Gnangnon F., Tshisimogo G., Peko J.-F., Adoubi I., Assefa M., Bojang L., Awuah B., Koulibaly M., et al. Cancer in sub-Saharan Africa in 2020: A review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 2022;23:719&#x2013;728. doi: 10.1016/S1470-2045(22)00270-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(22)00270-4</ArticleId><ArticleId IdType="pubmed">35550275</ArticleId></ArticleIdList></Reference><Reference><Citation>Omotoso O., Teibo J.O., Atiba F.A., Oladimeji T., Paimo O.K., Ataya F.S., Batiha G.E.-S., Alexiou A. Addressing cancer care inequities in sub-Saharan Africa: Current challenges and proposed solutions. Int. J. Equity Health. 2023;22:189. doi: 10.1186/s12939-023-01962-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-023-01962-y</ArticleId><ArticleId IdType="pmc">PMC10496173</ArticleId><ArticleId IdType="pubmed">37697315</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen K., Rydz E., Peters C.E. Inequalities in Environmental Cancer Risk and Carcinogen Exposures: A Scoping Review. Int. J. Environ. Res. Public Health. 2023;20:5718. doi: 10.3390/ijerph20095718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20095718</ArticleId><ArticleId IdType="pmc">PMC10178444</ArticleId><ArticleId IdType="pubmed">37174236</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzha B.T., Matubu A., Nyandoro G., Mubata H.O., Moyo E., Murewanhema G., Chirenje Z.M. The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review. Tumour Virus Res. 2024;18:200289. doi: 10.1016/j.tvr.2024.200289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvr.2024.200289</ArticleId><ArticleId IdType="pmc">PMC11298656</ArticleId><ArticleId IdType="pubmed">38977263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotez P.J., Kamath A. Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden. PLoS Neglected Trop. Dis. 2009;3:e412. doi: 10.1371/journal.pntd.0000412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000412</ArticleId><ArticleId IdType="pmc">PMC2727001</ArticleId><ArticleId IdType="pubmed">19707588</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia M.J., Pakharukova M.Y., Rinaldi G., Mordvinov V.A., Brindley P.J., G&#xe4;rtner F., Vale N. Helminth infection-induced carcinogenesis: Spectrometric insights from the liver flukes, Opisthorchis and Fasciola. Exp. Results. 2020;1:e40. doi: 10.1017/exp.2020.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/exp.2020.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Vineis P., Dagnino S. An evolutionary perspective for the exposome. Exposome. 2024;4:osae008. doi: 10.1093/exposome/osae008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/exposome/osae008</ArticleId><ArticleId IdType="pmc">PMC7617335</ArticleId><ArticleId IdType="pubmed">39867564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright R.J., Hanson H.A. A tipping point in cancer epidemiology: Embracing a life course exposomic framework. Trends Cancer. 2022;8:280&#x2013;282. doi: 10.1016/j.trecan.2022.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2022.01.016</ArticleId><ArticleId IdType="pubmed">35181274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild C.P. Complementing the Genome with an &#x201c;Exposome&#x201d;: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology. Cancer Epidemiol. Biomark. Prev. 2005;14:1847&#x2013;1850. doi: 10.1158/1055-9965.EPI-05-0456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-05-0456</ArticleId><ArticleId IdType="pubmed">16103423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerken J., Vincent G.T., Zapata D., Barron I.G., Zapata I. Comprehensive assessment of pesticide use patterns and increased cancer risk. Front. Cancer Control Soc. 2024;2:1368086. doi: 10.3389/fcacs.2024.1368086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcacs.2024.1368086</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope C.A., Coleman N., Pond Z.A., Burnett R.T. Corrigendum to &#x201c;fine particulate air pollution and human mortality: 25+ years of cohort studies&#x201d; [environ. Res. 183 (2020) 108924] Environ. Res. 2020;191:109974. doi: 10.1016/j.envres.2020.109974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2020.109974</ArticleId><ArticleId IdType="pubmed">33181974</ArticleId></ArticleIdList></Reference><Reference><Citation>Radfard M., Hashemi H., Baghapour M.A., Samaei M.R., Yunesian M., Soleimani H., Azhdarpoor A. Prediction of human health risk and disability-adjusted life years induced by heavy metals exposure through drinking water in fars province, Iran. Sci. Rep. 2023;13:19080. doi: 10.1038/s41598-023-46262-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46262-1</ArticleId><ArticleId IdType="pmc">PMC10625539</ArticleId><ArticleId IdType="pubmed">37925586</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer N., Kleter G., de Nijs M., Rau M.L., Derkx R., van der Fels-Klerx H.J. The aflatoxin situation in Africa: Systematic literature review. Compr. Rev. Food Sci. Food Saf. 2021;20:2286&#x2013;2304. doi: 10.1111/1541-4337.12731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1541-4337.12731</ArticleId><ArticleId IdType="pubmed">33682354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull R., Mbele M., Makhafola T., Hicks C., Wang S.M., Reis R., Mehrotra R., Mkhize-Kwitshana Z., Kibiki G., Bates D., et al. Cervical cancer in low and middle-income countries (Review) Oncol. Lett. 2020;20:2058&#x2013;2074. doi: 10.3892/ol.2020.11754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2020.11754</ArticleId><ArticleId IdType="pmc">PMC7400218</ArticleId><ArticleId IdType="pubmed">32782524</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo G.E.M., Cabibbo G., Crax&#xec; A. Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses. 2022;14:986. doi: 10.3390/v14050986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050986</ArticleId><ArticleId IdType="pmc">PMC9146458</ArticleId><ArticleId IdType="pubmed">35632728</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirani M., Pakzad R., Haddadi M.H., Akrami S., Asadi A., Kazemian H., Moradi M., Kaviar V.H., Zomorodi A.R., Khoshnood S., et al. The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: A systematic review and meta-analysis. BMC Infect. Dis. 2023;23:543. doi: 10.1186/s12879-023-08504-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08504-5</ArticleId><ArticleId IdType="pmc">PMC10439572</ArticleId><ArticleId IdType="pubmed">37598157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Saavedra S., Pietil&#xe4; T.K., Zapico A., de los Reyes-Gavil&#xe1;n C.G., Pajari A.-M., Gonz&#xe1;lez S. Dietary Nitrosamines from Processed Meat Intake as Drivers of the Fecal Excretion of Nitrosocompounds. J. Agric. Food Chem. 2024;72:17588&#x2013;17598. doi: 10.1021/acs.jafc.4c05751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.4c05751</ArticleId><ArticleId IdType="pmc">PMC11311235</ArticleId><ArticleId IdType="pubmed">39072357</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia L., Oyang L., Lin J., Tan S., Han Y., Wu N., Yi P., Tang L., Pan Q., Rao S., et al. The cancer metabolic reprogramming and immune response. Mol. Cancer. 2021;20:28. doi: 10.1186/s12943-021-01316-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-021-01316-8</ArticleId><ArticleId IdType="pmc">PMC7863491</ArticleId><ArticleId IdType="pubmed">33546704</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmanuel B.N., Peter D.A., Peter M.O., Adedayo I.S., Olaifa K. Helicobacter pylori infection in Africa: Comprehensive insight into its pathogenesis, management, and future perspectives. J. Umm Al-Qura Univ. Appl. Sci. 2024;11:378&#x2013;401. doi: 10.1007/s43994-024-00166-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43994-024-00166-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaboli M.C., Ocvirk S., Khan Mirzaei M., Eberhart B.L., Valdivia-Garcia M., Metwaly A., Neuhaus K., Barker G., Ru J., Nesengani L.T., et al. Diet changes due to urbanization in South Africa are linked to microbiome and metabolome signatures of Westernization and colorectal cancer. Nat. Commun. 2024;15:3379. doi: 10.1038/s41467-024-46265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-46265-0</ArticleId><ArticleId IdType="pmc">PMC11032404</ArticleId><ArticleId IdType="pubmed">38643180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K., dos-Santos-Silva I., Leon D.A., Douglas I.J., Smeeth L. Association of BMI with overall and cause-specific mortality: A population-based cohort study of 3&#xb7;6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944&#x2013;953. doi: 10.1016/S2213-8587(18)30288-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(18)30288-2</ArticleId><ArticleId IdType="pmc">PMC6249991</ArticleId><ArticleId IdType="pubmed">30389323</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Bakar N., Wan Ibrahim W.N., Mohd Faudzi S.M. Arsenic contamination in rice and drinking water: An insight on human cognitive function. J. Hazard. Mater. Adv. 2025;17:100543. doi: 10.1016/j.hazadv.2024.100543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hazadv.2024.100543</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintero Santofimio V., Amaral A.F.S., Feary J. Occupational exposures in low- and middle-income countries: A scoping review. PLOS Glob. Public Health. 2024;4:e0003888. doi: 10.1371/journal.pgph.0003888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0003888</ArticleId><ArticleId IdType="pmc">PMC11567621</ArticleId><ArticleId IdType="pubmed">39546491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai R., El-Zaemey S., Dorji N., Rai B.D., Fritschi L. Exposure to Occupational Hazards Among Health Care Workers in Low- and Middle-Income Countries: A Scoping Review. Int. J. Environ. Res. Public Health. 2021;18:2603. doi: 10.3390/ijerph18052603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052603</ArticleId><ArticleId IdType="pmc">PMC7967386</ArticleId><ArticleId IdType="pubmed">33807727</ArticleId></ArticleIdList></Reference><Reference><Citation>Herceg Z. Epigenetic Mechanisms as an Interface Between the Environment and Genome. Adv. Exp. Med. Biol. 2016;903:3&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">27343085</ArticleId></ArticleIdList></Reference><Reference><Citation>Avis W., Bartington S. Monitoring Air Quality in Low- Income and Lower Middle-Income Countries. The Institute of Development Studies and Partner Organisations; Brighton, UK: 2020.</Citation></Reference><Reference><Citation>Kimanya M.E., Routledge M.N., Mpolya E., Ezekiel C.N., Shirima C.P., Gong Y.Y. Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data. PLoS ONE. 2021;16:e0247281. doi: 10.1371/journal.pone.0247281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247281</ArticleId><ArticleId IdType="pmc">PMC7951873</ArticleId><ArticleId IdType="pubmed">33705417</ArticleId></ArticleIdList></Reference><Reference><Citation>Okello S., Akello S.J., Dwomoh E., Byaruhanga E., Opio C.K., Zhang R., Corey K.E., Muyindike W.R., Ocama P., Christiani D.D. Biomass fuel as a risk factor for esophageal squamous cell carcinoma: A systematic review and meta-analysis. Environ. Health. 2019;18:60. doi: 10.1186/s12940-019-0496-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12940-019-0496-0</ArticleId><ArticleId IdType="pmc">PMC6604279</ArticleId><ArticleId IdType="pubmed">31262333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakafu L.L., Mselle T.F., Mwaiselage J.D., Maunda K.K., Eddin B.S., Zafereo M.E. Thyroid Cancer and Iodine Deficiency Status: A 10-Year Review at a Single Cancer Center in Tanzania. OTO Open. 2018;2:2473974X18777238. doi: 10.1177/2473974X18777238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2473974X18777238</ArticleId><ArticleId IdType="pmc">PMC6239144</ArticleId><ArticleId IdType="pubmed">30480218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikarwar A., Golaz V. Substantial increase in population exposure to multiple environmental burdens in sub-Saharan Africa (2000&#x2013;2019) Environ. Res. Lett. 2024;19:044068. doi: 10.1088/1748-9326/ad376b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1748-9326/ad376b</ArticleId></ArticleIdList></Reference><Reference><Citation>Echendu A.J., Okafor H.F., Iyiola O. Air Pollution, Climate Change and Ecosystem Health in the Niger Delta. Soc. Sci. 2022;11:525. doi: 10.3390/socsci11110525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/socsci11110525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nriagu J., Udofia E., Ekong I., Ebuk G. Health Risks Associated with Oil Pollution in the Niger Delta, Nigeria. Int. J. Environ. Res. Public Health. 2016;13:346. doi: 10.3390/ijerph13030346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph13030346</ArticleId><ArticleId IdType="pmc">PMC4809009</ArticleId><ArticleId IdType="pubmed">27007391</ArticleId></ArticleIdList></Reference><Reference><Citation>Marais E.A., Wiedinmyer C. Air Quality Impact of Diffuse and Inefficient Combustion Emissions in Africa (DICE-Africa) Environ. Sci. Technol. 2016;50:10739&#x2013;10745. doi: 10.1021/acs.est.6b02602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.est.6b02602</ArticleId><ArticleId IdType="pubmed">27611340</ArticleId></ArticleIdList></Reference><Reference><Citation>Oghenetega O.B., Okunlola M.A., Ana G.R.E.E., Morhason-Bello O., Ojengbede O.A. Exposure to oil pollution and maternal outcomes: The Niger Delta prospective cohort study. PLoS ONE. 2022;17:e0263495. doi: 10.1371/journal.pone.0263495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263495</ArticleId><ArticleId IdType="pmc">PMC9090450</ArticleId><ArticleId IdType="pubmed">35235569</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakubu O. Addressing Environmental Health Problems in Ogoniland Through Implementation of United Nations Environment Program Recommendations: Environmental Management Strategies. Environments. 2017;4:28. doi: 10.3390/environments4020028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/environments4020028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson G. Occupational respiratory diseases in the South African mining industry. Glob. Health Action. 2013;6:19520. doi: 10.3402/gha.v6i0.19520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/gha.v6i0.19520</ArticleId><ArticleId IdType="pmc">PMC3556678</ArticleId><ArticleId IdType="pubmed">23364097</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira J.S., Bolhar R., Master S., Wilson A.H. Mineralogical, Petrological and Geochemical Characterisation of Chrysotile, Amosite and Crocidolite Asbestos Mine Waste from Southern Africa in Context of Risk Assessment and Rehabilitation. Minerals. 2023;13:1352. doi: 10.3390/min13101352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/min13101352</ArticleId></ArticleIdList></Reference><Reference><Citation>Harikannan N., Vinodh S., Antony J. Analysis of the relationship among industry 4.0 technologies, sustainable manufacturing practices and organizational sustainable performance using structural equation modelling. TQM J. 2023;37:42&#x2013;72. doi: 10.1108/TQM-02-2023-0044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/TQM-02-2023-0044</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.N., Nurs C.Z.B., Mofizul Islam M., Islam M.R., Rahman M.M. Household air pollution from cooking and risk of adverse health and birth outcomes in Bangladesh: A nationwide population-based study. Environ. Health. 2017;16:57. doi: 10.1186/s12940-017-0272-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12940-017-0272-y</ArticleId><ArticleId IdType="pmc">PMC5470285</ArticleId><ArticleId IdType="pubmed">28610581</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardi P., Montenegro A., Beltrami H., Eby M. Deforestation Induced Climate Change: Effects of Spatial Scale. PLoS ONE. 2016;11:e0153357. doi: 10.1371/journal.pone.0153357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153357</ArticleId><ArticleId IdType="pmc">PMC4839769</ArticleId><ArticleId IdType="pubmed">27100667</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamwesigye D., Doli A., Hlavackova P. REDD+: An Analysis of Initiatives in East Africa Amidst Increasing Deforestation. Eur. J. Sustain. Dev. 2020;9:224&#x2013;237. doi: 10.14207/ejsd.2020.v9n2p224.</Citation><ArticleIdList><ArticleId IdType="doi">10.14207/ejsd.2020.v9n2p224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukong A.K., Van Walbeek C., Ross H. Lifestyle and Income-Related Inequality in Health in South Africa. Int. J. Equity Health. 2017;16:103. doi: 10.1186/s12939-017-0598-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-017-0598-7</ArticleId><ArticleId IdType="pmc">PMC5477415</ArticleId><ArticleId IdType="pubmed">28629356</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian F., Ogundiran T., Hou N., Ndom P., Gakwaya A., Jombwe J., Morhason-Bello I., Adebamowo C., Ademola A., Ojengbede O., et al. Alcohol Consumption and Breast Cancer Risk Among Women in Three Sub-Saharan African Countries. PLoS ONE. 2014;9:e106908. doi: 10.1371/journal.pone.0106908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0106908</ArticleId><ArticleId IdType="pmc">PMC4157846</ArticleId><ArticleId IdType="pubmed">25198723</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Montes E., Salamanca-Fern&#xe1;ndez E., Garcia-Villanova B., S&#xe1;nchez M.J. The Impact of Plant-Based Dietary Patterns on Cancer-Related Outcomes: A Rapid Review and Meta-Analysis. Nutrients. 2020;12:2010. doi: 10.3390/nu12072010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072010</ArticleId><ArticleId IdType="pmc">PMC7400843</ArticleId><ArticleId IdType="pubmed">32640737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sammon A.M., Iputo J.E. Maize meal predisposes to endemic squamous cancer of the oesophagus in Africa: Breakdown of esterified linoleic acid to the free form in stored meal leads to increased intragastric pge2 production and a low-acid reflux. Med. Hypotheses. 2006;67:1431&#x2013;1436. doi: 10.1016/j.mehy.2006.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2006.05.037</ArticleId><ArticleId IdType="pubmed">16824700</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler A.M., Hergesheimer C., Brisbois B., Wittman H., Yassi A., Spiegel J.M. Food sovereignty, food security and health equity: A meta-narrative mapping exercise. Health Policy Plan. 2014;30:1078&#x2013;1092. doi: 10.1093/heapol/czu109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/heapol/czu109</ArticleId><ArticleId IdType="pmc">PMC4559116</ArticleId><ArticleId IdType="pubmed">25288515</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillaume D., Waheed D.-e.-N., Schleiff M., Muralidharan K.K., Vorsters A., Limaye R.J. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries. PLoS ONE. 2024;19:e0291990. doi: 10.1371/journal.pone.0291990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0291990</ArticleId><ArticleId IdType="pmc">PMC10791006</ArticleId><ArticleId IdType="pubmed">38227567</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabiu K., Alausa T., Akinlusi F., Davies N., Shittu K., Akinola O. Parental acceptance of human papillomavirus vaccination for adolescent girls in Lagos, Nigeria. J. Fam. Med. Prim. Care. 2020;9:2950. doi: 10.4103/jfmpc.jfmpc_102_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_102_20</ArticleId><ArticleId IdType="pmc">PMC7491808</ArticleId><ArticleId IdType="pubmed">32984154</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsu V.D., LaMontagne D.S., Atuhebwe P., Bloem P.N., Ndiaye C. National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects. Prev. Med. 2021;144:106335. doi: 10.1016/j.ypmed.2020.106335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2020.106335</ArticleId><ArticleId IdType="pmc">PMC7957340</ArticleId><ArticleId IdType="pubmed">33678232</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoye J.O., Ofodile C.A., Adeleke O.K., Obioma O. Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: A 20-year systematic review. Epidemiol. Health. 2021;43:e2021039. doi: 10.4178/epih.e2021039.</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2021039</ArticleId><ArticleId IdType="pmc">PMC8510839</ArticleId><ArticleId IdType="pubmed">34044477</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes K. Soil-Transmitted Helminth Infections: Travelers Beware. Iowa State University; Ames, IA, USA: 2022.</Citation></Reference><Reference><Citation>Barnabas R.V., Brown E.R., Onono M., Bukusi E.A., Njoroge B., Winer R.L., Donnell D., Galloway D., Cherne S., Heller K., et al. Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE study): Study protocol for a randomized controlled trial. Trials. 2021;22:661. doi: 10.1186/s13063-021-05608-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05608-8</ArticleId><ArticleId IdType="pmc">PMC8475401</ArticleId><ArticleId IdType="pubmed">34579786</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh I.S., Park S.-H. Immune-Mediated Liver Injury in Hepatitis B Virus Infection. Immune Netw. 2015;15:191. doi: 10.4110/in.2015.15.4.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2015.15.4.191</ArticleId><ArticleId IdType="pmc">PMC4553257</ArticleId><ArticleId IdType="pubmed">26330805</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray F., Laversanne M., Sung H., Ferlay J., Siegel R.L., Soerjomataram I., Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 2024;74:229&#x2013;263. doi: 10.3322/caac.21834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21834</ArticleId><ArticleId IdType="pubmed">38572751</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang M.H., Chen D.S. Prevention of Hepatitis B. Cold Spring Harb. Perspect. Med. 2015;5:a021493. doi: 10.1101/cshperspect.a021493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a021493</ArticleId><ArticleId IdType="pmc">PMC4355249</ArticleId><ArticleId IdType="pubmed">25732034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Yan L., Liu Y., Qu C., Ni J., Li H. The Burden and Trends of Primary Liver Cancer Caused by Specific Etiologies from 1990 to 2017 at the Global, Regional, National, Age, and Sex Level Results from the Global Burden of Disease Study 2017. Liver Cancer. 2020;9:563&#x2013;582. doi: 10.1159/000508568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508568</ArticleId><ArticleId IdType="pmc">PMC7548973</ArticleId><ArticleId IdType="pubmed">33083281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaquet A., Odutola M., Ekouevi D.K., Tanon A., Oga E., Akakpo J., Charurat M., Zannou M.D., Eholie S.P., Sasco A.J., et al. Cancer and HIV infection in referral hospitals from four West African countries. Cancer Epidemiol. 2015;39:1060&#x2013;1065. doi: 10.1016/j.canep.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canep.2015.09.002</ArticleId><ArticleId IdType="pmc">PMC4679441</ArticleId><ArticleId IdType="pubmed">26375806</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J., Nagel E., Carlucci J.G., Edmonds A., Kinikar A., Anderson K., Leroy V., Machado D., Yin D.E., Tulio Luque M., et al. Integration of HIV care into maternal and child health services in the global IeDEA consortium. Front. Glob. Women&#x2019;S Health. 2023;4:1066297. doi: 10.3389/fgwh.2023.1066297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgwh.2023.1066297</ArticleId><ArticleId IdType="pmc">PMC10150067</ArticleId><ArticleId IdType="pubmed">37139173</ArticleId></ArticleIdList></Reference><Reference><Citation>Camandaroba M.P.G., Araujo R.L.C.d., Silva V.S.e., Mello C.A.L.d., Riechelmann R.P. Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: Systematic review and meta-analysis. J. Gastrointest. Oncol. 2018;10:48&#x2013;60. doi: 10.21037/jgo.2018.10.08.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jgo.2018.10.08</ArticleId><ArticleId IdType="pmc">PMC6351309</ArticleId><ArticleId IdType="pubmed">30788159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim Khalil A., Mpunga T., Wei F., Baussano I., de Martel C., Bray F., Stelzle D., Dryden-Peterson S., Jaquet A., Horner M.J., et al. Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. Int. J. Cancer. 2021;150:761&#x2013;772. doi: 10.1002/ijc.33841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33841</ArticleId><ArticleId IdType="pmc">PMC8732304</ArticleId><ArticleId IdType="pubmed">34626498</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohner E., B&#xfc;tikofer L., Schmidlin K., Sengayi M., Maskew M., Giddy J., Taghavi K., Moore R.D., Goedert J.J., Gill M.J., et al. Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int. J. Cancer. 2019;146:601&#x2013;609. doi: 10.1002/ijc.32260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.32260</ArticleId><ArticleId IdType="pmc">PMC6898726</ArticleId><ArticleId IdType="pubmed">31215037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattelan A.M., Mazzitelli M., Presa N., Cozzolino C., Sasset L., Leoni D., Bragato B., Scaglione V., Baldo V., Parisi S.G. Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years. Cancers. 2023;16:70. doi: 10.3390/cancers16010070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16010070</ArticleId><ArticleId IdType="pmc">PMC10777974</ArticleId><ArticleId IdType="pubmed">38201498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesicioglu T., Sengul D. Histopathological helicobacter pylori verification and related regimen in the presence of esophageal strictures secondary to surgical procedures for the esophageal cancer. Cancer Rep. Rev. 2018;2:1000167. doi: 10.15761/CRR.1000167.</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/CRR.1000167</ArticleId></ArticleIdList></Reference><Reference><Citation>Risch H.A. Pancreatic cancer: Helicobacter pylori Colonization, N-Nitrosamine exposures, and ABO blood group. Mol. Carcinog. 2011;51:109&#x2013;118. doi: 10.1002/mc.20826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20826</ArticleId><ArticleId IdType="pubmed">22162235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Cai H., Sasazuki S., Tsugane S., Zheng W., Cho E.R., Jee S.H., Michel A., Pawlita M., Xiang Y.-B., et al. Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in china, japan, and korea. Int. J. Cancer. 2016;140:591&#x2013;599. doi: 10.1002/ijc.30477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.30477</ArticleId><ArticleId IdType="pmc">PMC5531280</ArticleId><ArticleId IdType="pubmed">27759938</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinarong C., Siramolpiwat S., Wongcha-um A., Mahachai V., Vilaichone R.-K. Improved Eradication Rate of Standard Triple Therapy by Adding Bismuth and Probiotic Supplement for Helicobacter pylori Treatment in Thailand. Asian Pac. J. Cancer Prev. 2014;15:9909&#x2013;9913. doi: 10.7314/APJCP.2014.15.22.9909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2014.15.22.9909</ArticleId><ArticleId IdType="pubmed">25520127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi Z., Masoodi M., Aslani Z., Naghshi S., Khalighi Sikaroudi M., Shidfar F. Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: A case&#x2013;control study. BMC Gastroenterol. 2022;22:413. doi: 10.1186/s12876-022-02488-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-022-02488-3</ArticleId><ArticleId IdType="pmc">PMC9450302</ArticleId><ArticleId IdType="pubmed">36068529</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia T.-W., Melville S., Utzinger J., King C.H., Zhou X.-N. Soil-Transmitted Helminth Reinfection after Drug Treatment: A Systematic Review and Meta-Analysis. PLoS Neglected Trop. Dis. 2012;6:e1621. doi: 10.1371/journal.pntd.0001621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001621</ArticleId><ArticleId IdType="pmc">PMC3348161</ArticleId><ArticleId IdType="pubmed">22590656</ArticleId></ArticleIdList></Reference><Reference><Citation>Maizels R.M., Balic A., Gomez-Escobar N., Nair M., Taylor M.D., Allen J.E. Helminth parasites&#x2014;Masters of regulation. Immunol. Rev. 2004;201:89&#x2013;116. doi: 10.1111/j.0105-2896.2004.00191.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2004.00191.x</ArticleId><ArticleId IdType="pubmed">15361235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dlamini Z., Molefi T., Khanyile R., Mkhabele M., Damane B., Kokoua A., Bida M., Saini K.S., Chauke-Malinga N., Luvhengo T.E., et al. From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa. Oncol. Ther. 2023;12:1&#x2013;11. doi: 10.1007/s40487-023-00248-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40487-023-00248-1</ArticleId><ArticleId IdType="pmc">PMC10881925</ArticleId><ArticleId IdType="pubmed">37910378</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastille E., Frede A., McSorley H.J., Gr&#xe4;b J., Adamczyk A., Kollenda S., Hansen W., Epple M., Buer J., Maizels R.M., et al. Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog. 2017;13:e1006649. doi: 10.1371/journal.ppat.1006649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006649</ArticleId><ArticleId IdType="pmc">PMC5627963</ArticleId><ArticleId IdType="pubmed">28938014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.-T., Luk J.M., Wigler M., Hannon G.J., et al. Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach. Cell. 2006;125:1253&#x2013;1267. doi: 10.1016/j.cell.2006.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.030</ArticleId><ArticleId IdType="pmc">PMC3026384</ArticleId><ArticleId IdType="pubmed">16814713</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke A. A systematic review of the effects of hepatitis B and C virus on the progression of liver fluke infection to liver cancer. Trop. Dis. Travel Med. Vaccines. 2024;10:6. doi: 10.1186/s40794-023-00215-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40794-023-00215-8</ArticleId><ArticleId IdType="pmc">PMC10941421</ArticleId><ArticleId IdType="pubmed">38486298</ArticleId></ArticleIdList></Reference><Reference><Citation>von B&#xfc;low V., Lichtenberger J., Grevelding C.G., Falcone F.H., Roeb E., Roderfeld M. Does Schistosoma Mansoni Facilitate Carcinogenesis? Cells. 2021;10:1982. doi: 10.3390/cells10081982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081982</ArticleId><ArticleId IdType="pmc">PMC8393187</ArticleId><ArticleId IdType="pubmed">34440754</ArticleId></ArticleIdList></Reference><Reference><Citation>Roderfeld M., Padem S., Lichtenberger J., Quack T., Weiskirchen R., Longerich T., Schramm G., Churin Y., Irungbam K., Tschuschner A., et al. Schistosoma mansoni Egg&#x2013;Secreted Antigens Activate Hepatocellular Carcinoma&#x2013;Associated Transcription Factors c-Jun and STAT3 in Hamster and Human Hepatocytes. Hepatology. 2019;72:626&#x2013;641. doi: 10.1002/hep.30192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.30192</ArticleId><ArticleId IdType="pmc">PMC7496692</ArticleId><ArticleId IdType="pubmed">30053321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sul&#x17c;yc-Bielicka V., Ko&#x142;odziejczyk L., Adamska M., Skotarczak B., Jaczewska S., Safranow K., Bielicki P., K&#x142;adny J., Bielicki D. Colorectal cancer and Blastocystis sp. infection. Parasites Vectors. 2021;14:200. doi: 10.1186/s13071-021-04681-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13071-021-04681-x</ArticleId><ArticleId IdType="pmc">PMC8048192</ArticleId><ArticleId IdType="pubmed">33853659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209&#x2013;249. doi: 10.3322/caac.21660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipour M. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J. Gastrointest. Cancer. 2020;52:23&#x2013;30. doi: 10.1007/s12029-020-00518-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12029-020-00518-5</ArticleId><ArticleId IdType="pmc">PMC7487264</ArticleId><ArticleId IdType="pubmed">32926335</ArticleId></ArticleIdList></Reference><Reference><Citation>Engin A.B., Karahalil B., Karakaya A.E., Engin A. Exposure to Helicobacter pylori and Serum Kynurenine to Tryptophan Ratio in Patients with Gastric Cancer. Pteridines. 2010;21:110&#x2013;120. doi: 10.1515/pteridines.2010.21.1.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/pteridines.2010.21.1.110</ArticleId><ArticleId IdType="pmc">PMC4375588</ArticleId><ArticleId IdType="pubmed">25834331</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh E., Naidu G., Davies M.-A., Bohlius J. Hiv-associated malignancies in children. Curr. Opin. HIV AIDS. 2017;12:77&#x2013;83. doi: 10.1097/COH.0000000000000331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000331</ArticleId><ArticleId IdType="pmc">PMC5340073</ArticleId><ArticleId IdType="pubmed">27685986</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos N.G., Kim J.J., Castle P.E., Ortendahl J.D., O&#x2019;Shea M., Diaz M., Goldie S.J. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int. J. Cancer. 2011;130:2672&#x2013;2684. doi: 10.1002/ijc.26269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.26269</ArticleId><ArticleId IdType="pmc">PMC3314721</ArticleId><ArticleId IdType="pubmed">21717458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitariho G.K., Tuhebwe D., Tigaiza A., Nalugya A., Ssekamatte T., Kiwanuka S.N. Knowledge, perceptions and uptake of human papilloma virus vaccine among adolescent girls in Kampala, Uganda; a mixed-methods school-based study. BMC Pediatr. 2023;23:368. doi: 10.1186/s12887-023-04174-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-023-04174-z</ArticleId><ArticleId IdType="pmc">PMC10351135</ArticleId><ArticleId IdType="pubmed">37461002</ArticleId></ArticleIdList></Reference><Reference><Citation>Deignan C., Swartz A., Cooper S., Colvin C.J. Stakeholders&#x2019; Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review. Vaccines. 2021;9:496. doi: 10.3390/vaccines9050496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050496</ArticleId><ArticleId IdType="pmc">PMC8150903</ArticleId><ArticleId IdType="pubmed">34065961</ArticleId></ArticleIdList></Reference><Reference><Citation>Mugisha E., LaMontagne D.S., Katahoire A.R., Murokora D., Kumakech E., Seruyange R., Tsu V.D. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda. Afr. Health Sci. 2015;15:33. doi: 10.4314/ahs.v15i1.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v15i1.5</ArticleId><ArticleId IdType="pmc">PMC4370128</ArticleId><ArticleId IdType="pubmed">25834528</ArticleId></ArticleIdList></Reference><Reference><Citation>Amponsah-Dacosta E., Blose N., Nkwinika V.V., Chepkurui V. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration with Other Adolescent Health Services? Front. Public Health. 2022;10:799984. doi: 10.3389/fpubh.2022.799984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.799984</ArticleId><ArticleId IdType="pmc">PMC8841655</ArticleId><ArticleId IdType="pubmed">35174123</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C., Yu S., Zhang J., Wu X., Dou Z., Li Z., Yang E., Zhang L. Hepatitis B or C viral infection and the risk of cervical cancer. Infect. Agents Cancer. 2022;17:54. doi: 10.1186/s13027-022-00466-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-022-00466-8</ArticleId><ArticleId IdType="pmc">PMC9624004</ArticleId><ArticleId IdType="pubmed">36320009</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Chang C.-C.H., Marsh G.M., Wu F. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. Eur. J. Cancer. 2012;48:2125&#x2013;2136. doi: 10.1016/j.ejca.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2012.02.009</ArticleId><ArticleId IdType="pmc">PMC3374897</ArticleId><ArticleId IdType="pubmed">22405700</ArticleId></ArticleIdList></Reference><Reference><Citation>Adekanle O., Ndububa D.A., Olowookere S.A., Ijarotimi O., Ijadunola K.T. Knowledge of Hepatitis B Virus Infection, Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis Among Hospital Workers in a Nigerian Tertiary Hospital. Hepat. Res. Treat. 2015;2015:439867. doi: 10.1155/2015/439867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/439867</ArticleId><ArticleId IdType="pmc">PMC4320901</ArticleId><ArticleId IdType="pubmed">25685549</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiels M.S., Engels E.A. Evolving epidemiology of HIV-associated malignancies. Curr. Opin. HIV AIDS. 2017;12:6&#x2013;11. doi: 10.1097/COH.0000000000000327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000327</ArticleId><ArticleId IdType="pmc">PMC5240042</ArticleId><ArticleId IdType="pubmed">27749369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasco A.J., Jaquet A., Boidin E., Ekouevi D.K., Thouillot F., LeMabec T., Forstin M.-A., Renaudier P., N&#x2019;Dom P., Malvy D., et al. The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa. PLoS ONE. 2010;5:e8621. doi: 10.1371/journal.pone.0008621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008621</ArticleId><ArticleId IdType="pmc">PMC2799672</ArticleId><ArticleId IdType="pubmed">20066157</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanyenze R.K., Bwanika J.B., Beyeza-Kashesya J., Mugerwa S., Arinaitwe J., Matovu J.K.B., Gwokyalya V., Kasozi D., Bukenya J., Makumbi F. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda. Glob. Health Action. 2017;10:1380361. doi: 10.1080/16549716.2017.1380361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16549716.2017.1380361</ArticleId><ArticleId IdType="pmc">PMC5678455</ArticleId><ArticleId IdType="pubmed">29035163</ArticleId></ArticleIdList></Reference><Reference><Citation>Emru K., Abebaw T.-A., Abera A. Role of awareness on cervical cancer screening uptake among HIV positive women in Addis Ababa, Ethiopia: A cross-sectional study. Women&#x2019;s Health. 2021;17:17455065211017041. doi: 10.1177/17455065211017041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17455065211017041</ArticleId><ArticleId IdType="pmc">PMC8188969</ArticleId><ArticleId IdType="pubmed">34096400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugano K., Tack J., Kuipers E.J., Graham D.Y., El-Omar E.M., Miura S., Haruma K., Asaka M., Uemura N., Malfertheiner P. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353&#x2013;1367. doi: 10.1136/gutjnl-2015-309252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2015-309252</ArticleId><ArticleId IdType="pmc">PMC4552923</ArticleId><ArticleId IdType="pubmed">26187502</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalali B., Mej&#xed;as-Luque R., Javaheri A., Gerhard M.H. pylori Virulence Factors: Influence on Immune System and Pathology. Mediat. Inflamm. 2014;2014:426309. doi: 10.1155/2014/426309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/426309</ArticleId><ArticleId IdType="pmc">PMC3918698</ArticleId><ArticleId IdType="pubmed">24587595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao X., Peng Q., Lu Y., Li S., Qin X., Chen Z., Chen J. Glutathione s-transferase gene gstm1, gene-gene interaction, and gastric cancer susceptibility: Evidence from an updated meta-analysis. Cancer Cell Int. 2014;14:127. doi: 10.1186/s12935-014-0127-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12935-014-0127-3</ArticleId><ArticleId IdType="pmc">PMC4255933</ArticleId><ArticleId IdType="pubmed">25477765</ArticleId></ArticleIdList></Reference><Reference><Citation>Canzian F., Rizzato C., Stein A., Flores-Luna L., Camorlinga-Ponce M., Mendez-Tenorio A., Chen W., Kasamatsu E., Mercedes Bravo M., Torres J., et al. Phylogenetic origin of Helicobacter pylori pathogenicity island and risk of stomach cancer and high-grade premalignant gastric lesions. Eur. J. Cancer Prev. 2023;32:301&#x2013;304. doi: 10.1097/CEJ.0000000000000779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CEJ.0000000000000779</ArticleId><ArticleId IdType="pmc">PMC10073236</ArticleId><ArticleId IdType="pubmed">36719829</ArticleId></ArticleIdList></Reference><Reference><Citation>Emileva Krasteva M. Genetics. IntechOpen; London, UK: 2024. Environmental Stress, Epigenetic Modifications, Adaptation, and Disease: A Fine Interplay.</Citation></Reference><Reference><Citation>Islam R., Zhao L., Wang Y., Lu-Yao G., Liu L.-Z. Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis. Cancers. 2022;14:4502. doi: 10.3390/cancers14184502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14184502</ArticleId><ArticleId IdType="pmc">PMC9496897</ArticleId><ArticleId IdType="pubmed">36139662</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogribny I.P., Rusyn I. Advances in Experimental Medicine and Biology. Springer; New York, NY, USA: 2012. Environmental Toxicants, Epigenetics, and Cancer; pp. 215&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281087</ArticleId><ArticleId IdType="pubmed">22956504</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva M., De Albuquerque B., Allyrio T., De Almeida V., Cobucci R., Bezerra F., Andrade V., Lanza D., De Azevedo J., De Ara&#xfa;jo J., et al. The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review) Biomed. Rep. 2021;15:60. doi: 10.3892/br.2021.1436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2021.1436</ArticleId><ArticleId IdType="pmc">PMC8165754</ArticleId><ArticleId IdType="pubmed">34094536</ArticleId></ArticleIdList></Reference><Reference><Citation>Inokawa Y., Inaoka K., Sonohara F., Hayashi M., Kanda M., Nomoto S. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncol. Lett. 2016;12:3662&#x2013;3668. doi: 10.3892/ol.2016.5141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2016.5141</ArticleId><ArticleId IdType="pmc">PMC5104146</ArticleId><ArticleId IdType="pubmed">27900050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.Y., Kim G.-D. Particulate Matter-Induced Emerging Health Effects Associated with Oxidative Stress and Inflammation. Antioxidants. 2024;13:1256. doi: 10.3390/antiox13101256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox13101256</ArticleId><ArticleId IdType="pmc">PMC11505051</ArticleId><ArticleId IdType="pubmed">39456509</ArticleId></ArticleIdList></Reference><Reference><Citation>McHale C.M., Zhang L., Smith M.T. Current understanding of the mechanism of benzene-induced leukemia in humans: Implications for risk assessment. Carcinogenesis. 2011;33:240&#x2013;252. doi: 10.1093/carcin/bgr297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgr297</ArticleId><ArticleId IdType="pmc">PMC3271273</ArticleId><ArticleId IdType="pubmed">22166497</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hajj H., Hemida R., Taumberger N., Friko I., Gassama O., Ramogola-Masire D., Gubena F., Ikpeze O., Nakazzi C.B., Gultekin M. Advancing cervical cancer prevention in Africa: ESGO&#x2019;S strategic initiatives and collaborative efforts. Int. J. Gynecol. Cancer. 2025:101841. doi: 10.1136/ijgc-2024-006059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ijgc-2024-006059</ArticleId><ArticleId IdType="pubmed">39299755</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong S., Zhang T., Tang L., Li Y. Cytokines and chemokines in HBV Infection. Front. Mol. Biosci. 2021;8:805625. doi: 10.3389/fmolb.2021.805625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.805625</ArticleId><ArticleId IdType="pmc">PMC8674621</ArticleId><ArticleId IdType="pubmed">34926586</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica L., Ordovas J.M., Volkov A., Lamb J.J., Stone P.M., Minich D., Leary M., Class M., Metti D., Larson I.A., et al. Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine. Nutrients. 2022;14:768. doi: 10.3390/nu14040768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14040768</ArticleId><ArticleId IdType="pmc">PMC8876337</ArticleId><ArticleId IdType="pubmed">35215417</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteves F., Rueff J., Kranendonk M. The Central Role of Cytochrome p450 in Xenobiotic Metabolism&#x2014;A Brief Review on a Fascinating Enzyme Family. J. Xenobiotics. 2021;11:94&#x2013;114. doi: 10.3390/jox11030007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jox11030007</ArticleId><ArticleId IdType="pmc">PMC8293344</ArticleId><ArticleId IdType="pubmed">34206277</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C., Hequn C., Longfei L., Long W., Zhi C., Feng Z., Jinbo C., Chao L., Xiongbing Z. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis. Oncotarget. 2016;8:3246&#x2013;3258. doi: 10.18632/oncotarget.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13702</ArticleId><ArticleId IdType="pmc">PMC5356879</ArticleId><ArticleId IdType="pubmed">27911277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gor&#x105;cy J., Bogacz A., Uzar I., Wolek M., &#x141;ochy&#x144;ska M., Zi&#x119;tek P., Czerny B., Cymbaluk-P&#x142;oska A., Modliborski P., Kami&#x144;ski A. The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer. Biomolecules. 2021;11:1024. doi: 10.3390/biom11071024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11071024</ArticleId><ArticleId IdType="pmc">PMC8301863</ArticleId><ArticleId IdType="pubmed">34356648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendeu-Foyet M.G., C&#xe9;n&#xe9;e S., Koudou Y., Tr&#xe9;tarre B., R&#xe9;billard X., Cancel-Tassin G., Cussenot O., Boland A., Olaso R., Deleuze J.F., et al. Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study. Int. J. Cancer. 2020;147:3119&#x2013;3129. doi: 10.1002/ijc.33139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33139</ArticleId><ArticleId IdType="pubmed">32506468</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyesola O.O., Souza C.O.S., Loke P.n. The Influence of Genetic and Environmental Factors and Their Interactions on Immune Response to Helminth Infections. Front. Immunol. 2022;13:869163. doi: 10.3389/fimmu.2022.869163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.869163</ArticleId><ArticleId IdType="pmc">PMC9103684</ArticleId><ArticleId IdType="pubmed">35572520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H., Feng Y., Fan P., Guo Y., Kuerban G., Chang C., Yao X., Peng Y., Wang R. HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer. Infect. Agents Cancer. 2021;16:61. doi: 10.1186/s13027-021-00395-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-021-00395-y</ArticleId><ArticleId IdType="pmc">PMC8447512</ArticleId><ArticleId IdType="pubmed">34530896</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifert F., Eisenbl&#xe4;tter R., Beckmann J., Sch&#xfc;rmann P., Hanel P., Jentschke M., B&#xf6;hmer G., Strau&#xdf; H.-G., Hirchenhain C., Schmidmayr M., et al. Association of two genomic variants with HPV type-specific risk of cervical cancer. Tumour Virus Res. 2023;16:200269. doi: 10.1016/j.tvr.2023.200269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvr.2023.200269</ArticleId><ArticleId IdType="pmc">PMC10415783</ArticleId><ArticleId IdType="pubmed">37499979</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei T.T.Y., Aung H.H., Tung W.S., Naing C. Association between IL-10 gene polymorphisms (&#x2212;&#x2009;1082 A/G, -819 T/C, -592 A/C) and hepatocellular carcinoma: A meta-analysis and trial sequential analysis. BMC Cancer. 2023;23:842. doi: 10.1186/s12885-023-11323-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-023-11323-1</ArticleId><ArticleId IdType="pmc">PMC10492326</ArticleId><ArticleId IdType="pubmed">37684564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima Y., Machida Y.J. DNA&#x2013;protein crosslinks from environmental exposure: Mechanisms of formation and repair. Environ. Mol. Mutagen. 2020;61:716&#x2013;729. doi: 10.1002/em.22381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/em.22381</ArticleId><ArticleId IdType="pmc">PMC7575214</ArticleId><ArticleId IdType="pubmed">32329115</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorodetska I., Kozeretska I., Dubrovska A. BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. J. Cancer. 2019;10:2109&#x2013;2127. doi: 10.7150/jca.30410.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.30410</ArticleId><ArticleId IdType="pmc">PMC6548160</ArticleId><ArticleId IdType="pubmed">31205572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiatt R.A., Breen N. The Social Determinants of Cancer. Am. J. Prev. Med. 2008;35:S141&#x2013;S150. doi: 10.1016/j.amepre.2008.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2008.05.006</ArticleId><ArticleId IdType="pmc">PMC10773976</ArticleId><ArticleId IdType="pubmed">18619394</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero Y. World cancer day 2021: Prevention, awareness and accountability in tobacco control. Tob. Prev. Cessat. 2021;7:8. doi: 10.18332/tpc/132803.</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tpc/132803</ArticleId><ArticleId IdType="pmc">PMC7856574</ArticleId><ArticleId IdType="pubmed">33553852</ArticleId></ArticleIdList></Reference><Reference><Citation>Veljkovikj I., Ilbawi A.M., Roitberg F., Luciani S., Barango P., Corbex M., Dorji G., Gunawardena N., Johnson S., Juric A., et al. Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (impact reviews) Lancet Oncol. 2022;23:e459&#x2013;e468. doi: 10.1016/S1470-2045(22)00387-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(22)00387-4</ArticleId><ArticleId IdType="pubmed">36174632</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton D.R.S., Mmbaga B.T., Menya D., Dzamalala C., Nyakunga-Maro G., Finch P., Mlombe Y., Sch&#xfc;z J., McCormack V., Kigen N., et al. Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: Findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob. Health. 2022;10:e236&#x2013;e245. doi: 10.1016/S2214-109X(21)00506-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00506-4</ArticleId><ArticleId IdType="pmc">PMC8766315</ArticleId><ArticleId IdType="pubmed">34921758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagawa-Singer M. Providing resources for Asian Americans and Pacific Islanders. Cancer Pract. 2001;9:100&#x2013;103. doi: 10.1046/j.1523-5394.2001.009002100.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-5394.2001.009002100.x</ArticleId><ArticleId IdType="pubmed">11879286</ArticleId></ArticleIdList></Reference><Reference><Citation>Mwaka A.D. Global Perspectives in Cancer Care. Oxford University Press; Oxford, UK: 2022. Sociocultural Influences on Cancer Care in Sub-Saharan Africa; pp. 249&#x2013;260.</Citation></Reference><Reference><Citation>Enokida T., Moreira A., Bhardwaj N. Vaccines for immunoprevention of cancer. J. Clin. Investig. 2021;131:e146956. doi: 10.1172/JCI146956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146956</ArticleId><ArticleId IdType="pmc">PMC8087198</ArticleId><ArticleId IdType="pubmed">33938446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayinzoga F., Umulisa M.C., Sibomana H., Tenet V., Baussano I., Clifford G.M. Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort. Vaccine. 2020;38:4001&#x2013;4005. doi: 10.1016/j.vaccine.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7221340</ArticleId><ArticleId IdType="pubmed">32336599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed Y., Reynolds H.W., Waziri H., Attahiru A., Olowo-okere A., Kamateeka M., Waziri N.E., Garba A.M., Corr&#xea;a G.C., Garba R., et al. Exploring the landscape of routine immunization in Nigeria: A scoping review of barriers and facilitators. Vaccine X. 2024;20:100563. doi: 10.1016/j.jvacx.2024.100563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2024.100563</ArticleId><ArticleId IdType="pmc">PMC11488437</ArticleId><ArticleId IdType="pubmed">39430738</ArticleId></ArticleIdList></Reference><Reference><Citation>Abesig J., Chen Y., Wang H., Sompo F.M., Wu I.X.Y. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0234348. doi: 10.1371/journal.pone.0234348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234348</ArticleId><ArticleId IdType="pmc">PMC7292378</ArticleId><ArticleId IdType="pubmed">32530945</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Busafi S.A., Alwassief A. Global Perspectives on the Hepatitis B vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines. 2024;12:288. doi: 10.3390/vaccines12030288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12030288</ArticleId><ArticleId IdType="pmc">PMC10975970</ArticleId><ArticleId IdType="pubmed">38543922</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun V.C., Kazemiparkouhi F., Manjourides J., Suh H.H. Long-Term PM2.5 Exposure and Respiratory, Cancer, and Cardiovascular Mortality in Older US Adults. Am. J. Epidemiol. 2017;186:961&#x2013;969. doi: 10.1093/aje/kwx166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx166</ArticleId><ArticleId IdType="pmc">PMC6915823</ArticleId><ArticleId IdType="pubmed">28541385</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Zhang X., Yue J., Gao Y., Tillotson M.R., Zhao X. Nasal filter reveal exposure risks of inhalable particulates and heavy metals in urban women. Environ. Int. 2024;188:108743. doi: 10.1016/j.envint.2024.108743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2024.108743</ArticleId><ArticleId IdType="pubmed">38749121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bank A.D. Delivering Inclusive and Sustainable Infrastructure: Featured Infrastructure Projects and Initiatives. Inter-American Development Bank; Washington, DC, USA: 2017.</Citation></Reference><Reference><Citation>Ahoul&#xe9; D.G., Lalanne F., Mendret J., Brosillon S., Ma&#xef;ga A.H. Arsenic in African Waters: A Review. Water Air Soil Pollut. 2015;226:302. doi: 10.1007/s11270-015-2558-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11270-015-2558-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Irunde R., Ijumulana J., Ligate F., Maity J.P., Ahmad A., Mtamba J., Mtalo F., Bhattacharya P. Arsenic in Africa: Potential sources, spatial variability, and the state of the art for arsenic removal using locally available materials. Groundw. Sustain. Dev. 2022;18:100746. doi: 10.1016/j.gsd.2022.100746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gsd.2022.100746</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinh T.N.D., Tran N.K.S., Nguyen H.A., Chon N.M., Trinh K.T.L., Lee N.Y. Recent advances in portable devices for environmental monitoring applications. Biomicrofluidics. 2024;18:051501. doi: 10.1063/5.0224217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0224217</ArticleId><ArticleId IdType="pmc">PMC11377084</ArticleId><ArticleId IdType="pubmed">39247798</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D., Dahiya M., Kumar R., Nanda C. Sensors and systems for air quality assessment monitoring and management: A review. J. Environ. Manag. 2021;289:112510. doi: 10.1016/j.jenvman.2021.112510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jenvman.2021.112510</ArticleId><ArticleId IdType="pubmed">33827002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernecke B., Wright C. Commentary: Opportunities for the application of low-cost sensors in epidemiological studies to advance evidence of air pollution impacts on human health. Clean Air J. 2021;31:1&#x2013;4. doi: 10.17159/caj/2021/31/1.11219.</Citation><ArticleIdList><ArticleId IdType="doi">10.17159/caj/2021/31/1.11219</ArticleId></ArticleIdList></Reference><Reference><Citation>Luvhimbi N., Tshitangano T.G., Mabunda J.T., Olaniyi F.C., Edokpayi J.N. Water quality assessment and evaluation of human health risk of drinking water from source to point of use at Thulamela municipality, Limpopo Province. Sci. Rep. 2022;12:6059. doi: 10.1038/s41598-022-10092-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10092-4</ArticleId><ArticleId IdType="pmc">PMC9001720</ArticleId><ArticleId IdType="pubmed">35411067</ArticleId></ArticleIdList></Reference><Reference><Citation>Motlagh N.H., Zaidan M.A., Fung P.L., Lagerspetz E., Aula K., Varjonen S., Siekkinen M., Rebeiro-Hargrave A., Pet&#xe4;j&#xe4; T., Matsumi Y., et al. Transit pollution exposure monitoring using low-cost wearable sensors. Transp. Res. Part D Transp. Environ. 2021;98:102981. doi: 10.1016/j.trd.2021.102981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trd.2021.102981</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus P., Urquidi C., C&#xe1;rcamo M., Vidal V. Integrating the exposome and one health approach to national health surveillance: An opportunity for Latin American countries in health preventive management. Front. Public Health. 2024;12:1376609. doi: 10.3389/fpubh.2024.1376609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2024.1376609</ArticleId><ArticleId IdType="pmc">PMC11359557</ArticleId><ArticleId IdType="pubmed">39211902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirma A., Makita K., Grace Randolph D., Senerwa D., Lindahl J. Aflatoxin Exposure from Milk in Rural Kenya and the Contribution to the Risk of Liver Cancer. Toxins. 2019;11:469. doi: 10.3390/toxins11080469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins11080469</ArticleId><ArticleId IdType="pmc">PMC6722829</ArticleId><ArticleId IdType="pubmed">31405092</ArticleId></ArticleIdList></Reference><Reference><Citation>Okello N.O., Okello T.W., Zunckel M. Changes in health risk associated with air pollution and policy response effectiveness, Richards Bay, South Africa. Clean Air J. 2020;30:1&#x2013;10. doi: 10.17159/caj/2020/30/1.8012.</Citation><ArticleIdList><ArticleId IdType="doi">10.17159/caj/2020/30/1.8012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mwisongo A., Nabyonga-Orem J. Global health initiatives in Africa&#x2014;Governance, priorities, harmonisation and alignment. BMC Health Serv. Res. 2016;16:212. doi: 10.1186/s12913-016-1448-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-016-1448-9</ArticleId><ArticleId IdType="pmc">PMC4959383</ArticleId><ArticleId IdType="pubmed">27454542</ArticleId></ArticleIdList></Reference><Reference><Citation>Joubert B.R., Berhane K., Chevrier J., Collman G., Eskenazi B., Fobil J., Hoyo C., John C.C., Kumie A., Nicol M., et al. Integrating environmental health and genomics research in Africa: Challenges and opportunities identified during a human heredity and health in africa (h3africa) consortium workshop. AAS Open Res. 2019;2:159. doi: 10.12688/aasopenres.12983.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/aasopenres.12983.1</ArticleId><ArticleId IdType="pmc">PMC7194141</ArticleId><ArticleId IdType="pubmed">32382703</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch J.J., Salicrup L.A. Cancer Research and Clinical Trials in Developing Countries. Springer International Publishing; Berlin/Heidelberg, Germany: 2015. Funding for Cancer Research and Clinical Studies in Low- and Middle-Income Countries; pp. 137&#x2013;189.</Citation></Reference><Reference><Citation>Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 2018;68:394&#x2013;424. doi: 10.3322/caac.21492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21492</ArticleId><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman D.B., Young V.M., Freedman D.A., Adams S.A., Brandt H.M., Xirasagar S., Felder T.M., Ureda J.R., Hurley T., Khang L., et al. Reducing Cancer Disparities Through Innovative Partnerships: A Collaboration of the South Carolina Cancer Prevention and Control Research Network and Federally Qualified Health Centers. J. Cancer Educ. 2011;27:59&#x2013;61. doi: 10.1007/s13187-011-0272-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13187-011-0272-5</ArticleId><ArticleId IdType="pmc">PMC3272325</ArticleId><ArticleId IdType="pubmed">21932143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabanda R., Bikaitwoha Maniple E., Baluku J.B., Kiconco A. Utilisation of Community Audio Towers in Health Education for Prevention of Cervical Cancer by Health Workers in Kyotera District, Uganda: A Cross-Sectional Study. Risk Manag. Healthc. Policy. 2021;14:3667&#x2013;3673. doi: 10.2147/RMHP.S321200.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S321200</ArticleId><ArticleId IdType="pmc">PMC8420789</ArticleId><ArticleId IdType="pubmed">34512054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jatho A., Mugisha N.M., Kafeero J., Holoya G., Okuku F., Niyonzima N., Orem J. Capacity building for cancer prevention and early detection in the Ugandan primary healthcare facilities: Working toward reducing the unmet needs of cancer control services. Cancer Med. 2020;10:745&#x2013;756. doi: 10.1002/cam4.3659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.3659</ArticleId><ArticleId IdType="pmc">PMC7877353</ArticleId><ArticleId IdType="pubmed">33319508</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosser J.I., Njoroge B., Huchko M.J. Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. Patient Educ. Couns. 2015;98:884&#x2013;889. doi: 10.1016/j.pec.2015.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2015.03.017</ArticleId><ArticleId IdType="pmc">PMC4437717</ArticleId><ArticleId IdType="pubmed">25858634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbugua R.G., Karanja S., Oluchina S. Effectiveness of a Community Health Worker-Led Intervention on Knowledge, Perception, and Prostate Cancer Screening Among Men in Rural Kenya. Adv. Prev. Med. 2022;2022:4621446. doi: 10.1155/2022/4621446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4621446</ArticleId><ArticleId IdType="pmc">PMC9377835</ArticleId><ArticleId IdType="pubmed">35979267</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisson M., Kim J.J., Canfell K., Drolet M., Gingras G., Burger E.A., Martin D., Simms K.T., B&#xe9;nard &#xc9;., Boily M.-C., et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:575&#x2013;590. doi: 10.1016/S0140-6736(20)30068-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30068-4</ArticleId><ArticleId IdType="pmc">PMC7043009</ArticleId><ArticleId IdType="pubmed">32007141</ArticleId></ArticleIdList></Reference><Reference><Citation>Milondzo T., Meyer J.C., Dochez C., Burnett R.J. Human Papillomavirus Vaccine Hesitancy Highly Evident Among Caregivers of Girls Attending South African Private Schools. Vaccines. 2022;10:503. doi: 10.3390/vaccines10040503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040503</ArticleId><ArticleId IdType="pmc">PMC9033046</ArticleId><ArticleId IdType="pubmed">35455252</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S.S., Shedbalkar U.U., Truskewycz A., Chopade B.A., Ball A.S. Nanoparticles for environmental clean-up: A review of potential risks and emerging solutions. Environ. Technol. Innov. 2016;5:10&#x2013;21. doi: 10.1016/j.eti.2015.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eti.2015.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Adoga A.A., Kokong D.D., Nimkur T.L., Ma&#x2019;an N.D. Environmental and Life-Style Related Risk Factors for Sinonasal and Nasopharyngeal Malignancies Among a Prospective Cohort in Jos, Nigeria. Int. J. Otolaryngol. 2018;2018:8524861. doi: 10.1155/2018/8524861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8524861</ArticleId><ArticleId IdType="pmc">PMC6206526</ArticleId><ArticleId IdType="pubmed">30410543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2014;136:E359&#x2013;E386. doi: 10.1002/ijc.29210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.29210</ArticleId><ArticleId IdType="pubmed">25220842</ArticleId></ArticleIdList></Reference><Reference><Citation>Long X.-D., Deng Y., Huang X.-Y., Yao J.-G., Su Q.-Y., Wu X.-M., Wang J., Xu Q.-Q., Zhu X.-Y., Wang C., et al. Liver Research and Clinical Management. InTech; London, UK: 2018. Molecular Mechanisms of Hepatocellular Carcinoma Related to Aflatoxins: An Update.</Citation></Reference><Reference><Citation>Kristanto Y., Hartono A.R. Dietary management in colorectal cancer prevention: A review. Intisari Sains Medis. 2021;12:801&#x2013;804. doi: 10.15562/ism.v12i3.1020.</Citation><ArticleIdList><ArticleId IdType="doi">10.15562/ism.v12i3.1020</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy K.A., Fan Y., Wang R., Gao Y.-T., Yu M.C., Yuan J.-M. Alcohol and Tobacco Use in Relation to Gastric Cancer: A Prospective Study of Men in Shanghai, China. Cancer Epidemiol. Biomark. Prev. 2010;19:2287&#x2013;2297. doi: 10.1158/1055-9965.EPI-10-0362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-10-0362</ArticleId><ArticleId IdType="pmc">PMC2936659</ArticleId><ArticleId IdType="pubmed">20699372</ArticleId></ArticleIdList></Reference><Reference><Citation>Riaz I.B., Khan M.A., Haddad T.C. Potential application of artificial intelligence in cancer therapy. Curr. Opin. Oncol. 2024;36:437&#x2013;448. doi: 10.1097/CCO.0000000000001068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCO.0000000000001068</ArticleId><ArticleId IdType="pubmed">39007164</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari H., Bigdeli N. The Role and Application of Artificial Intelligence (AI) in Leveraging Big Data in the Healthcare Domain. Health Nexus. 2023;1:83&#x2013;86. doi: 10.61838/kman.hn.1.2.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.61838/kman.hn.1.2.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirillo D., N&#xfa;&#xf1;ez-Carpintero I., Valencia A. Artificial intelligence in cancer research: Learning at different levels of data granularity. Mol. Oncol. 2021;15:817&#x2013;829. doi: 10.1002/1878-0261.12920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1878-0261.12920</ArticleId><ArticleId IdType="pmc">PMC8024732</ArticleId><ArticleId IdType="pubmed">33533192</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy M. Integrating Artificial Intelligence and Big Data into Smart Healthcare Systems: A Comprehensive Review of Current Practices and Future Directions. Artif. Intell. Evol. 2023:133&#x2013;153. doi: 10.37256/aie.4220232980.</Citation><ArticleIdList><ArticleId IdType="doi">10.37256/aie.4220232980</ArticleId></ArticleIdList></Reference><Reference><Citation>Senkomago V., Joseph R., Sierra M., Van Dyne E., Endeshaw M., Duran D., Sugerman D.E., Saraiya M. CDC Activities to Enhance Training in Cancer Prevention and Control in Field Epidemiology Training Programs in Low- and Middle-Income Countries. J. Glob. Oncol. 2018;4:1&#x2013;9. doi: 10.1200/JGO.18.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JGO.18.00042</ArticleId><ArticleId IdType="pmc">PMC6223519</ArticleId><ArticleId IdType="pubmed">30084697</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel A.L., Morgan C., Duncan K., Williams M.J. Subsequent Cancer Prevention and Control Activities Among Low- and Middle-Income Country Participants in the US National Cancer Institute&#x2019;S Summer Curriculum in Cancer Prevention. J. Glob. Oncol. 2019;5:1&#x2013;9. doi: 10.1200/JGO.19.00231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JGO.19.00231</ArticleId><ArticleId IdType="pmc">PMC6825253</ArticleId><ArticleId IdType="pubmed">31626567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankaranarayanan R., Sauvaget C., Ramadas K., Ngoma T., Teguete I., Muwonge R., Naud P., Nessa A., Kuhaprema T., Qiao Y. Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Ann. Oncol. 2011;22:vii20&#x2013;vii28. doi: 10.1093/annonc/mdr422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdr422</ArticleId><ArticleId IdType="pubmed">22039141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndububa D.A. Liver cancer surveillance in people with hepatitis b in africa. Lancet Gastroenterol. Hepatol. 2024;9:491&#x2013;492. doi: 10.1016/S2468-1253(24)00087-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(24)00087-6</ArticleId><ArticleId IdType="pubmed">38588692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40760406</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-904X</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Pharmaceutical research</Title><ISOAbbreviation>Pharm Res</ISOAbbreviation></Journal><ArticleTitle>Cancer-specific Regulation of Metabolic and Epigenetic Pathways by Dietary Phytochemicals.</ArticleTitle><Pagination><StartPage>1443</StartPage><EndPage>1457</EndPage><MedlinePgn>1443-1457</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11095-025-03898-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cancer is a complex disease triggered by a combination of genetic mutations, metabolic reprogramming, epigenetic modifications, and environmental factors, and is one of the leading health burdens worldwide. Dietary phytochemical are effective in reducing the incidence of cancer by regulating epigenetic and metabolic pathways and possess great potential in cancer prevention and treatment.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This review aims to summarize the relevant metabolic and epigenetic changes in cancer, recent research progress in the mechanism study of dietary phytochemicals by regulating key pathways and provides new insights for further research.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched the relevant literature by searching through common databases, such as PubMed, Medline, ScienceDirect, Google Scholar and Web of Science, and summarized the anticancer effects of potential dietary phytochemicals regulating epigenetic and metabolic pathways in common cancers, such as colorectal cancer, prostate cancer, lung cancer, skin cancer, and breast cancer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Natural phytochemicals not only regulate key pathways, such as DNA methylation, histone modifications, oxidative stress, inflammation, and metabolic reprogramming, but also demonstrate multi-targeted intervention in tumor therapy by inducing apoptosis, inhibiting cell proliferation, angiogenesis, and metastasis. Additionally, the potential of dietary phytochemicals to reverse metabolic and epigenetic changes makes them promising as adjunctive or alternative therapies.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Phytochemicals exhibit significant effects in cancer prevention and treatment by targeting metabolic and epigenetic regulatory networks. Future research should further explore their mechanisms, clinical translational value, and synergistic effects with traditional therapies to provide theoretical foundations and practical guidance for developing new cancer intervention strategies.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mary Peter</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Pochung</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dave</LastName><ForeName>Parv Dushyant</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanner</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarwar</LastName><ForeName>Md Shahid</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, 3814, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Ah-Ng</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0002-9273-4217</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutics, Center for Phytochemical Epigenome Studies, Ernest Mario School of Pharmacy, The State University of New Jersey, Rutgers Piscataway, NJ, 08854, USA. kongt@pharmacy.rutgers.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Pharmaceutical Sciences, Ernest Mario School of Pharmacy, The State University of New Jersey, RutgersPiscataway, NJ, 08854, USA. kongt@pharmacy.rutgers.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES005022</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AT009152</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pharm Res</MedlineTA><NlmUniqueID>8406521</NlmUniqueID><ISSNLinking>0724-8741</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="Y">Phytochemicals</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053858" MajorTopicYN="Y">Metabolic Networks and Pathways</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000972" MajorTopicYN="Y">Antineoplastic Agents, Phytogenic</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Cancer prevention</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Dietary phytochemicals</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Lung cancer</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword><Keyword MajorTopicYN="N">Skin cancer</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>14</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>0</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40760406</ArticleId><ArticleId IdType="pmc">PMC12405319</ArticleId><ArticleId IdType="doi">10.1007/s11095-025-03898-0</ArticleId><ArticleId IdType="pii">10.1007/s11095-025-03898-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yu X, Zhao H, Wang R, Chen Y, Ouyang X, Li W, <i>et al</i>. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discovery. 2024;10(1):28.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10789753</ArticleId><ArticleId IdType="pubmed">38225241</ArticleId></ArticleIdList></Reference><Reference><Citation>Goker Bagca B, Biray Avci C. Epigenetic regulation of cancer by natural touch: phytochemicals and epigenetic regulation. In: Cancer research: an interdisciplinary approach.&#xa0;Cham: Springer Nature Switzerland; 2022. pp. 241&#x2013;262.</Citation></Reference><Reference><Citation>Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024;74(3):229&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">38572751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">34086348</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung KL, Kong A-N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010;12:87&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2811646</ArticleId><ArticleId IdType="pubmed">20013083</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu L, Cheung K-L, Khor TO, Chen C, Kong A-N. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev. 2010;29:483&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">20798979</ArticleId></ArticleIdList></Reference><Reference><Citation>Padma VV. An overview of targeted cancer therapy. Biomed. 2015;5:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662664</ArticleId><ArticleId IdType="pubmed">26613930</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandohee J, Kyereh E, Kulshrestha S, Xu B, Mahomoodally MF. Review of the recent developments in metabolomics-based phytochemical research. Crit Rev Food Sci Nutr. 2023;63(19):3734&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">34672234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zam W, Khadour A. Impact of phytochemicals and dietary patterns on epigenome and cancer. Nutr Cancer. 2017;69(2):184&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">28094554</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S, Meeran SM, Katiyar SK. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett. 2014;355(1):9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197101</ArticleId><ArticleId IdType="pubmed">25236912</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop S, Enciu AM, Tarcomnicu I, Gille E, Tanase C. Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation. Phytochem Rev. 2019;18:1005&#x2013;24.</Citation></Reference><Reference><Citation>Chou PJ, Peter RM, Shannar A, Pan Y, Dave PD, Xu J, <i>et al</i>. Epigenetics of Dietary Phytochemicals in Cancer Prevention: Fact or Fiction. The Cancer Journal. 2024;30(5):320&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11573353</ArticleId><ArticleId IdType="pubmed">39312452</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl T, Kumar K, Brisc C, Rus M, Nistor-Cseppento DC, Bustea C, <i>et al</i>. Exploring the multifocal role of phytochemicals as immunomodulators. Biomed Pharmacother. 2021;133:110959.
</Citation><ArticleIdList><ArticleId IdType="pubmed">33197758</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl T, Bungau S, Kumar K, Zengin G, Khan F, Kumar A, <i>et al</i>. Pleotropic effects of polyphenols in cardiovascular system. Biomed Pharmacother. 2020;130:110714.
</Citation><ArticleIdList><ArticleId IdType="pubmed">34321158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapinova A, Kubatka P, Golubnitschaja O, Kello M, Zubor P, Solar P, <i>et al</i>. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med. 2018;23:1&#x2013;18.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6085646</ArticleId><ArticleId IdType="pubmed">30092754</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol. 2020;10:1614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025531</ArticleId><ArticleId IdType="pubmed">32116665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li C-S, Dong Q. Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes. J Exp Clin Cancer Res. 2008;27:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2543009</ArticleId><ArticleId IdType="pubmed">18718024</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Zhang L, Hou X. Potential roles and molecular mechanisms of phytochemicals against cancer. Food Funct. 2022;13(18):9208&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">36047380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li G. Mechanisms and therapeutic regulation of pyroptosis in inflammatory diseases and cancer. Int J Mol Sci. 2020;21(4):1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7073143</ArticleId><ArticleId IdType="pubmed">32093389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou J-S, Zhao L-P, Huang Z-H, Chen X-Y, Xu J-T, Tai WC-S, <i>et al</i>. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomed. 2021;80:153370.</Citation><ArticleIdList><ArticleId IdType="pubmed">33113504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Gong L-S, Li N-F, Pan Y-F, Zhang L. Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-&#x3ba;B and Bcl-2/Bax signaling pathways. Biomed Pharmacother. 2018;97:213&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang SJ, Schmiech M, Hafner S, Paetz C, Werner K, El Gaafary M, <i>et al</i>. Chrysosplenol d, a flavonol from Artemisia annua, induces ERK1/2-mediated apoptosis in triple negative human breast cancer cells. Int J Mol Sci. 2020;21(11):4090.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7312517</ArticleId><ArticleId IdType="pubmed">32521698</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y, Du Q, Zhang Z, Ma J, Han L, Wang Y, <i>et al</i>. Curcumin promotes cancer-associated fibroblasts apoptosis via ROS-mediated endoplasmic reticulum stress. Arch Biochem Biophys. 2020;694:108613.
</Citation><ArticleIdList><ArticleId IdType="pubmed">33010228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma B, Zhang H, Wang Y, Zhao A, Zhu Z, Bao X, <i>et al</i>. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. J Exp Clin Cancer Res. 2018;37:1&#x2013;16.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6122202</ArticleId><ArticleId IdType="pubmed">30176898</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaheer K, Somashekarappa H, Lakshmanan MD. Piperine sensitizes radiation-resistant cancer cells towards radiation and promotes intrinsic pathway of apoptosis. J Food Sci. 2020;85(11):4070&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33089532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma E, Tewari M, Sati P, Sharma I, Attri DC, Rana S, <i>et al</i>. Serving up health: how phytochemicals transform food into medicine in the battle against cancer. Food Frontiers. 2024;5(5):1866&#x2013;908.</Citation></Reference><Reference><Citation>George BP, Chandran R, Abrahamse H. Role of phytochemicals in cancer chemoprevention: Insights. Antioxid. 2021;10(9):1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8466984</ArticleId><ArticleId IdType="pubmed">34573087</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannar A, Sarwar MS, Kong A-NT. A New Frontier in Studying Dietary Phytochemicals in Cancer and in Health: Metabolic and Epigenetic Reprogramming. Prevent Nutr Food Sci. 2022;27(4):335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843711</ArticleId><ArticleId IdType="pubmed">36721757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Li S, Hudlikar R, Wang L, Shannar A, Peter R, <i>et al</i>. Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals. Free Radical Biol Med. 2022;179:328&#x2013;36.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222414</ArticleId><ArticleId IdType="pubmed">33359432</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth Nanda C, Venkateswaran SV, Patani N, Yuneva M. Defining a metabolic landscape of tumours: genome meets metabolism. Br J Cancer. 2020;122(2):136&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051970</ArticleId><ArticleId IdType="pubmed">31819196</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Sui L. Metabolic reprogramming in cervical cancer and metabolomics perspectives. Nutr Metab. 2021;18:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525007</ArticleId><ArticleId IdType="pubmed">34666780</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Li Q, Chen Y, Yang Y. Recent metabolomics analysis in tumor metabolism reprogramming. Front Mol Biosci. 2021;8:763902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660977</ArticleId><ArticleId IdType="pubmed">34901157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge T, Gu X, Jia R, Ge S, Chai P, Zhuang A, <i>et al</i>. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Commun. 2022;42(11):1049&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9648395</ArticleId><ArticleId IdType="pubmed">36266736</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik AK, DeBerardinis RJ. Applications of metabolomics to study cancer metabolism. Biochimica et Biophysica Acta (BBA)-Rev Cancer. 1870;2018(1):2&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6193562</ArticleId><ArticleId IdType="pubmed">29702206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepali K, Liou J-P. Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends. J Biomed Sci. 2021;28:1&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040241</ArticleId><ArticleId IdType="pubmed">33840388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudlikar R, Wang L, Wu R, Li S, Peter R, Shannar A, <i>et al</i>. Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates. Cancer Prev Res. 2021;14(2):151&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044264</ArticleId><ArticleId IdType="pubmed">33055265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fardi M, Solali S, Hagh MF. Epigenetic mechanisms as a new approach in cancer treatment: An updated review. Genes &amp; diseases. 2018;5(4):304&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6303480</ArticleId><ArticleId IdType="pubmed">30591931</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos V, Esteller M. Cancer epigenetics in clinical practice. CA: A Cancer J Clin. 2023;73(4):376&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">36512337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L-H, Wu C-F, Rajasekaran N, Shin YK. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem. 2019;51(6):2647&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30562755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang F, Wei W. Targeting the acetylation signaling pathway in cancer therapy. In: Seminars in cancer biology. vol. 85.&#xa0;Academic Press; 2022. pp. 209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423867</ArticleId><ArticleId IdType="pubmed">33705871</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389(6649):349&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9311776</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer. 2001;1(3):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">11902574</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone modification in NSCLC: molecular mechanisms and therapeutic targets. Int J Mol Sci. 2021;22(21):11701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584007</ArticleId><ArticleId IdType="pubmed">34769131</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Bian J, Warrier S, <i>et al</i>. Correction: Role of novel histone modifications in cancer. Oncotarget. 2018;9(27):19460.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5922411</ArticleId><ArticleId IdType="pubmed">29722359</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcagno DQ, Wisnieski F, Mota ER, Maia de Sousa SB, Costa da Silva JM, Leal MF, <i>et al</i>. Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives. Epigenomics. 2019;11(3):349&#x2013;62.
</Citation><ArticleIdList><ArticleId IdType="pubmed">30672330</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber JJ, Geller B, Lipchik AM, Chen J, Salahudeen AA, Ram AN, <i>et al</i>. HAT1 coordinates histone production and acetylation via H4 promoter binding. Mol Cell. 2019;75(4):711-24.e5.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6707831</ArticleId><ArticleId IdType="pubmed">31278053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MK, Cai MY, Luo RZ, Tian X, Liao QM, Zhang XY, <i>et al</i>. Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma. Br J Dermatol. 2015;172(1):111&#x2013;9.
</Citation><ArticleIdList><ArticleId IdType="pubmed">24975674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin TK, Zhu JZ, Zhang G, Li Y-P. p300 mediates muscle wasting in Lewis lung carcinoma. Can Res. 2019;79(7):1331&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6445764</ArticleId><ArticleId IdType="pubmed">30705122</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Huang C, Xiong T, Zhuang C, Zhuang C, Li Y, <i>et al</i>. A CRISPR interference of CBP and p300 selectively induced synthetic lethality in bladder cancer cells in vitro. Int J Biol Sci. 2019;15(6):1276.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567804</ArticleId><ArticleId IdType="pubmed">31223286</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustachio LM, Roszik J, Farria AT, Guerra K, Dent SY. Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer. Am J Cancer Res. 2019;9(8):1830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726999</ArticleId><ArticleId IdType="pubmed">31497362</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Liu Z, Xu M, Xue Y, Yao B, Dou C, <i>et al</i>. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1. Cancer Lett. 2016;375(1):190&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pubmed">26945969</ArticleId></ArticleIdList></Reference><Reference><Citation>Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. In: Seminars in cancer biology.&#xa0;vol. 83. Academic Press; 2022. pp. 452&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">32814115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Zeng J, Liu H, Wang T, Yu Z, Chen J. Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs. Oncol Lett. 2019;17(3):3296&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6396103</ArticleId><ArticleId IdType="pubmed">30867763</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan H, Zhou K, Zhang Y, Yue P, Wang T, Li Y, <i>et al</i>. HDAC1 was involved in placental breast cancer resistance protein regulation in vitro: A preliminary study. J Cell Mol Med. 2019;23(8):5818.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6653152</ArticleId><ArticleId IdType="pubmed">31119861</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B, Laban M, Leung CH, Lee L, Lee C, Salto-Tellez M, <i>et al</i>. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 2005;12(4):395&#x2013;404.
</Citation><ArticleIdList><ArticleId IdType="pubmed">15665816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001;2(11):986&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1084129</ArticleId><ArticleId IdType="pubmed">11713189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Ao X, Jia Z, Li Y, Kuang S, Du C, <i>et al</i>. Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. Front Oncol. 2022;12: 951864.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428469</ArticleId><ArticleId IdType="pubmed">36059609</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Zhao L, Wu Y, Deng S, Cao P, Lei X, <i>et al</i>. The role of NcRNAs to regulate immune checkpoints in cancer. Front Immunol. 2022;13: 853480.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9019622</ArticleId><ArticleId IdType="pubmed">35464451</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Chen X, Yu F, Ding H, Zhang Y, Wang K. Extrachromosomal Circular DNAs: Origin, formation and emerging function in Cancer. Int J Biol Sci. 2021;17(4):1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040306</ArticleId><ArticleId IdType="pubmed">33867825</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Han T, Li B, Ma Q, Yang P, Li H. miR-552 promotes ovarian cancer progression by regulating PTEN pathway. Journal of ovarian research. 2019;12:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900846</ArticleId><ArticleId IdType="pubmed">31815639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564738</ArticleId><ArticleId IdType="pubmed">33860799</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirshev E, Oberg KC, Ioffe YJ, Unternaehrer JJ. Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. Clin Transl Med. 2019;8(1):24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715759</ArticleId><ArticleId IdType="pubmed">31468250</ArticleId></ArticleIdList></Reference><Reference><Citation>Devic S. Warburg effect-a consequence or the cause of carcinogenesis? J Cancer. 2016;7(7):817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860798</ArticleId><ArticleId IdType="pubmed">27162540</ArticleId></ArticleIdList></Reference><Reference><Citation>Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Sci. 2020;368(6487):eaaw5473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227780</ArticleId><ArticleId IdType="pubmed">32273439</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Sci. 2009;324(5930):1029&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849637</ArticleId><ArticleId IdType="pubmed">19460998</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang R, Zhou X, Wang W, Gao S, Mao Y, <i>et al.</i> Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis. Gut. 2020;69(7):1283&#x2013;93.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306982</ArticleId><ArticleId IdType="pubmed">31744909</ArticleId></ArticleIdList></Reference><Reference><Citation>Torresano L, Nuevo-Tapioles C, Santacatterina F, Cuezva JM. Metabolic reprogramming and disease progression in cancer patients. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis. 2020;1866(5):165721.</Citation><ArticleIdList><ArticleId IdType="pubmed">32057942</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C, Warmoes MO, Shen X, Locasale JW. Epigenetics and cancer metabolism. Cancer Lett. 2015;356(2):309&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984372</ArticleId><ArticleId IdType="pubmed">24125862</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Ma R, Wu Y, Zhai Y, Li S. Reciprocal regulation of metabolic reprogramming and epigenetic modifications in cancer. Front Genet. 2018;9:394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156463</ArticleId><ArticleId IdType="pubmed">30283496</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Shu L, Zhang C, Su Z-Y, Kong A-NT. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. Biochem Pharmacol. 2015;94(2):69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524742</ArticleId><ArticleId IdType="pubmed">25640947</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde ML, <i>et al</i>. Heterocyclic analogs of sulforaphane trigger DNA damage and impede DNA repair in colon cancer cells: interplay of HATs and HDACs. Mol Nutr Food Res. 2018;62(18):1800228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6553464</ArticleId><ArticleId IdType="pubmed">29924908</ArticleId></ArticleIdList></Reference><Reference><Citation>Altamemi I, Murphy EA, Catroppo JF, Zumbrun EE, Zhang J, McClellan JL, <i>et al</i>. Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in ApcMin/+ mice. J Pharmacol Exp Ther. 2014;350(1):99&#x2013;109.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056272</ArticleId><ArticleId IdType="pubmed">24817032</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X, Lin Q, Zhao N, Zeng J, Yang J, Liu Z, <i>et al</i>. Anti-colon cancer activity of dietary phytochemical Soyasaponin I and the induction of metabolic shifts in HCT116. Molecules. 2022;27(14):4382.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9316303</ArticleId><ArticleId IdType="pubmed">35889255</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhao L, Zhu LT, Wang Y, Pan D, Yao J, <i>et al</i>. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1&#x3b1; and glycolysis, by inhibiting PI3K/Akt signaling pathway. Mol Carcinog. 2014;53(S1):E107&#x2013;18.
</Citation><ArticleIdList><ArticleId IdType="pubmed">23761018</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunier E, Antonio S, Regazzetti A, Auzeil N, Lapr&#xe9;vote O, Shay JW, <i>et al</i>. Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells. Sci Rep. 2017;7(1):6945.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5537345</ArticleId><ArticleId IdType="pubmed">28761044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Mohd Tajuddin WNB, Lajis NH, Abas F, Othman I, Naidu R. Mechanistic understanding of curcumin&#x2019;s therapeutic effects in lung cancer. Nutr. 2019;11(12):2989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6950067</ArticleId><ArticleId IdType="pubmed">31817718</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Chen JX, Wang H, Lu G, Liu A, Li G, <i>et al</i>. NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (&#x2212;)-epigallocatechin-3-gallate. Nutr Cancer. 2015;67(1):167&#x2013;76.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4363938</ArticleId><ArticleId IdType="pubmed">25437343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam TK, Rotunno M, Lubin JH, Wacholder S, Consonni D, Pesatori AC, <i>et al</i>. Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinog. 2010;31(4):634&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847089</ArticleId><ArticleId IdType="pubmed">20044584</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandakumar V, Vaid M, Tollefsbol TO, Katiyar SK. RETRACTED: Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice. Carcinog. 2011;32(4):597&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066413</ArticleId><ArticleId IdType="pubmed">21186298</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandakumar V, Vaid M, Katiyar SK. (&#x2212;)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p 16 INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinog. 2011;32(4):537&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066414</ArticleId><ArticleId IdType="pubmed">21209038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal A, Piyathilake C, Hara Y, Katiyar SK. Exceptionally high protection of photocarcinogenesis by topical application of (-)-Epi gal locatechin-3-Gal late in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia. 2003;5(6):555&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1502572</ArticleId><ArticleId IdType="pubmed">14965448</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RP, Tyagi AK, Zhao J, Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinog. 2002;23(3):499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">11895866</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornel A, Nadile M, Retsidou MI, Sakellakis M, Gioti K, Beloukas A, <i>et al</i>. Ursolic acid against prostate and urogenital cancers: a review of in vitro and in vivo studies. Int J Mol Sci. 2023;24(8):7414.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10138876</ArticleId><ArticleId IdType="pubmed">37108576</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y. Phytochemicals for prostate cancer prevention: integrating redox signaling, epigenetics and genetics in vitro and in vivo (Doctoral dissertation, Rutgers University-Graduate School-New Brunswick);&#xa0;2015.</Citation></Reference><Reference><Citation>Sun X, Huang X, Liu L, Shen W, Zheng F, Liu M, <i>et al</i>. Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway. Transl Androl Urol. 2024;13(11):2358.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11650353</ArticleId><ArticleId IdType="pubmed">39698574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wu R, Sargsyan D, Su S, Kuo H-C, Li S, <i>et al.</i> Nfe2l2 regulates metabolic rewiring and epigenetic reprogramming in mediating cancer protective effect by fucoxanthin. AAPS J. 2022;24(1):30.
</Citation><ArticleIdList><ArticleId IdType="pubmed">35043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang H, Qin L, Lin S. Garlic-derived compounds: Epigenetic modulators and their antitumor effects. Phytother Res. 2024;38(3):1329&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">38194996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganai AA, Farooqi H. Bioactivity of genistein: A review of in vitro and in vivo studies. Biomed Pharmacother. 2015;76:30&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26653547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zan L, Chen Q, Zhang L, Li X. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25. Bioengineered. 2019;10(1):374&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738446</ArticleId><ArticleId IdType="pubmed">31431131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinog. 2006;27(4):856&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">16399773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R, Mao L, Xu P, Zheng X, Hackman RM, Mackenzie GG, <i>et al</i>. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models. Food Funct. 2018;9(11):5682&#x2013;96.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480214</ArticleId><ArticleId IdType="pubmed">30310905</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjanatha M, Shelton S, Bishop M, Lyn-Cook L, Aidoo A. Dietary effects of soy isoflavones daidzein and genistein on 7, 12-dimethylbenz [a] anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats. Carcinog. 2006;27(10):1970&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16709578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung EC, Lee P, Ceteci F, Nixon C, Blyth K, Sansom OJ, <i>et al</i>. Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestine. Genes Dev. 2016;30(1):52&#x2013;63.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4701978</ArticleId><ArticleId IdType="pubmed">26679840</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto M, Kawada K, Nakamoto Y, Itatani Y, Inamoto S, Toda K, <i>et al</i>. Regulation of <sup>18</sup>F-FDG Accumulation in Colorectal Cancer Cells with Mutated &lt;em&gt;KRAS&lt;/em&gt;. J Nucl Med. 2014;55(12):2038&#x2013;44.
</Citation><ArticleIdList><ArticleId IdType="pubmed">25453050</ArticleId></ArticleIdList></Reference><Reference><Citation>Toda K, Kawada K, Iwamoto M, Inamoto S, Sasazuki T, Shirasawa S, <i>et al</i>. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase. Neoplasia. 2016;18(11):654&#x2013;65.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5071549</ArticleId><ArticleId IdType="pubmed">27764698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou PJ, Peter RM, Shannar A, Pan Y, Dave PD, Xu J, <i>et al</i>. Epigenetics of Dietary Phytochemicals in Cancer Prevention: Fact or Fiction. Cancer J. 2024;30(5):320&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11573353</ArticleId><ArticleId IdType="pubmed">39312452</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Shu L, Zhang C, Su ZY, Kong AN. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. Biochem Pharmacol. 2015;94(2):69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524742</ArticleId><ArticleId IdType="pubmed">25640947</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Wu R, Gaspar JM, Sargsyan D, Su ZY, Zhang C, <i>et al</i>. DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. Carcinog. 2018;39(5):669&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248359</ArticleId><ArticleId IdType="pubmed">29547900</ArticleId></ArticleIdList></Reference><Reference><Citation>Altamemi I, Murphy EA, Catroppo JF, Zumbrun EE, Zhang J, McClellan JL, <i>et al</i>. Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice. J Pharmacol Exp Ther. 2014;350(1):99&#x2013;109.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056272</ArticleId><ArticleId IdType="pubmed">24817032</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde ML, <i>et al</i>. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs. Mol Nutr Food Res. 2018;62(18):e1800228.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6553464</ArticleId><ArticleId IdType="pubmed">29924908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou JW, Wang M, Sun NX, Qing Y, Yin TF, Li C, <i>et al</i>. Sulforaphane-induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco-2 cells. Oncol Lett. 2019;18(3):2639&#x2013;47.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676568</ArticleId><ArticleId IdType="pubmed">31452747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IA, Park YJ, Yeo HK, Han MJ, Kim DH. Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-&#x3ba;B pathway. J Agric Food Chem. 2010;58(20):10929&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">20923188</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung P-L, Wen K-C, Horng H-C, Chang C-M, Chen Y-J, Lee W-L, <i>et al</i>. The role of &#x3b1;2,3-linked sialylation on clear cell type epithelial ovarian cancer. Taiwan J Obstet Gynecol. 2018;57(2):255&#x2013;63.
</Citation><ArticleIdList><ArticleId IdType="pubmed">29673670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W-W, Yu C-Y, Lin T-W, Wang P-H, Tsai Y-C. Soyasaponin I decreases the expression of &#x3b1;2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells. Biochem Biophys Res Commun. 2006;341(2):614&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16427612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C-C, Lin T-W, Chang W-W, Wu C-Y, Lo W-H, Wang P-H, <i>et al</i>. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecol Oncol. 2005;96(2):415&#x2013;22.
</Citation><ArticleIdList><ArticleId IdType="pubmed">15661230</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila-Donat P, Fern&#xe1;ndez-Blanco C, Sagratini G, Font G, Ruiz M-J. Effects of soyasaponin I and soyasaponins-rich extract on the Alternariol-induced cytotoxicity on Caco-2 cells. Food Chem Toxicol. 2015;77:44&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25542527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Popovich DG. Group B Oleanane Triterpenoid Extract Containing Soyasaponins I and III from Soy Flour Induces Apoptosis in Hep-G2 Cells. J Agric Food Chem. 2010;58(9):5315&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20345167</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X, Lin Q, Zhao N, Zeng J, Yang J, Liu Z, Huang R. Anti-colon cancer activity of dietary phytochemical soyasaponin i and the induction of metabolic shifts in HCT116. Molecules. 2022;27(14):4382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9316303</ArticleId><ArticleId IdType="pubmed">35889255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L, Su F, Li Q, Wen Y, Wei F, He Z, <i>et al</i>. Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action. Front Pharmacol. 2023;14:1257450.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10484417</ArticleId><ArticleId IdType="pubmed">37693915</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanzaro D, Gabbia D, Cocetta V, Biagi M, Ragazzi E, Montopoli M, <i>et al</i>. Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression. Fitoterapia. 2018;124:42&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pubmed">29031537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing N, Song J, Liu Z, Wang L, Jiang G. Glycosylation of anthocyanins enhances the apoptosis of colon cancer cells by handicapping energy metabolism. BMC Complement Med Ther. 2020;20(1):312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566133</ArticleId><ArticleId IdType="pubmed">33059637</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Cui M, Li C, Li H, Dai Y, Cui K, <i>et al</i>. Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells. J Agric Food Chem. 2021;69(10):3060&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pubmed">33663206</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhao L, Zhu LT, Wang Y, Pan D, Yao J, <i>et al</i>. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1&#x3b1; and glycolysis, by inhibiting PI3K/Akt signaling pathway. Mol Carcinog. 2014;53(Suppl 1):E107&#x2013;18.
</Citation><ArticleIdList><ArticleId IdType="pubmed">23761018</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunier E, Antonio S, Regazzetti A, Auzeil N, Lapr&#xe9;vote O, Shay JW, <i>et al</i>. Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells. Sci Rep. 2017;7(1):6945.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5537345</ArticleId><ArticleId IdType="pubmed">28761044</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">38230766</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel S, Bhatia V, Biswas T, Ateeq B. Epigenetic reprogramming during prostate cancer progression: a perspective from development. In: Seminars in cancer biology.&#xa0;vol. 83.&#xa0;Academic Press; 2022. pp. 136&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612861</ArticleId><ArticleId IdType="pubmed">33545340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, <i>et al</i>. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet. 2008;40(6):741&#x2013;50.
</Citation><ArticleIdList><ArticleId IdType="pubmed">18488029</ArticleId></ArticleIdList></Reference><Reference><Citation>Varambally S, Cao Q, Mani R-S, Shankar S, Wang X, Ateeq B, <i>et al</i>. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Sci. 2008;322(5908):1695&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2684823</ArticleId><ArticleId IdType="pubmed">19008416</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyrta J, Augspach A, De Filippo MR, Prandi D, Thienger P, Benelli M, <i>et al.</i> Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity. Nat Commun. 2020;11(1):5549.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642293</ArticleId><ArticleId IdType="pubmed">33144576</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Pung D, Su Z-Y, Guo Y, Zhang C, Yang AY, <i>et al</i>. Epigenetics reactivation of Nrf2 in prostate TRAMP C1 cells by curcumin analogue FN1. Chem Res Toxicol. 2016;29(4):694&#x2013;703.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955590</ArticleId><ArticleId IdType="pubmed">26991801</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li M, Wang Y, Luo J. Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition. J Drug Target. 2017;25(7):645&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">28391715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Zhou X, Qi G, Guo Y. Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation. J Biochem Mol Toxicol. 2018;32(5):e22049.</Citation><ArticleIdList><ArticleId IdType="pubmed">29485738</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Huang X, Liu L, Shen W, Zheng F, Liu M, <i>et al</i>. Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway. Translat Androl Urol. 2024;13(11):2358375&#x2013;62375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11650353</ArticleId><ArticleId IdType="pubmed">39698574</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttari B, Arese M, Oberley-Deegan RE, Saso L, Chatterjee A. NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression. Front Physiol. 2022;13:989793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9540504</ArticleId><ArticleId IdType="pubmed">36213236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ide H, Lu Y, Noguchi T, Muto S, Okada H, Kawato S, <i>et al</i>. Modulation of AKR 1C2 by curcumin decreases testosterone production in prostate cancer. Cancer Sci. 2018;109(4):1230&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891173</ArticleId><ArticleId IdType="pubmed">29369461</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuorkey M. Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing. Intervent Med Appl Sci. 2014;6(4):139&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4274352</ArticleId><ArticleId IdType="pubmed">25598986</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas A, Hall JA, Patterson WL III, Ho E, Hsu A, Al-Mulla F, <i>et al</i>. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines. Biochem Cell Biol. 2016;94(1):71&#x2013;81.
</Citation><ArticleIdList><ArticleId IdType="pubmed">26458818</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutz J, Thaler S, Maxeiner S, Chun FK-H, Blaheta RA. Sulforaphane reduces prostate cancer cell growth and proliferation in vitro by modulating the Cdk-Cyclin axis and expression of the CD44 variants 4, 5, and 7. Int J Mol Sci. 2020;21(22):8724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7699211</ArticleId><ArticleId IdType="pubmed">33218199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Li S, Sargsyan D, Yin R, Kuo HC, Peter R, <i>et al</i>. DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice. Mol Carcinog. 2021;60(6):391&#x2013;402.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201649</ArticleId><ArticleId IdType="pubmed">33848375</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KB, Kim S-H, Hahm E-R, Pore SK, Jacobs BL, Singh SV. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Carcinog. 2018;39(6):826&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5972626</ArticleId><ArticleId IdType="pubmed">29668854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang C, Sarwar MS, Chou P, Wang Y, Su X, <i>et al</i>. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid. FASEB J: Off Publ Federat Am Soc Exp Biol. 2022;36(11):e22626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9703918</ArticleId><ArticleId IdType="pubmed">36305462</ArticleId></ArticleIdList></Reference><Reference><Citation>Du A, Wang Z, Huang T, Xue S, Jiang C, Qiu G, <i>et al.</i> Fatty acids in cancer: Metabolic functions and potential treatment. MedComm&#x2013;Oncol. 2023;2(1):e25.</Citation></Reference><Reference><Citation>Wang J, Chen J, Jiang Y, Shi Y, Zhu J, Xie C, <i>et al</i>. Wnt/&#x3b2;-catenin modulates chronic tobacco smoke exposure-induced acquisition of pulmonary cancer stem cell properties and diallyl trisulfide intervention. Toxicol Lett. 2018;291:70&#x2013;6.
</Citation><ArticleIdList><ArticleId IdType="pubmed">29626521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S-H, Bommareddy A, Singh SV. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res. 2011;4(6):897&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3107923</ArticleId><ArticleId IdType="pubmed">21411500</ArticleId></ArticleIdList></Reference><Reference><Citation>Samy ALPA, Shah D, Shahagadkar P, Shah H, Munirathinam G. Can diallyl trisulfide, a dietary garlic-derived compound, activate ferroptosis to overcome therapy resistance in prostate cancer? Nutr Health. 2022;28(2):207&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">34044656</ArticleId></ArticleIdList></Reference><Reference><Citation>Forde PM, Brahmer JR, Kelly RJ. New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer. Clin Cancer Res. 2014;20(9):2244&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4325981</ArticleId><ArticleId IdType="pubmed">24644000</ArticleId></ArticleIdList></Reference><Reference><Citation>Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, <i>et al</i>. Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci. 1998;95(20):11891&#x2013;6.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21736</ArticleId><ArticleId IdType="pubmed">9751761</ArticleId></ArticleIdList></Reference><Reference><Citation>Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, <i>et al</i>. Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res. 2005;11(18):6505&#x2013;11.
</Citation><ArticleIdList><ArticleId IdType="pubmed">16166426</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller G, Zielinski CC, Z&#xf6;chbauer-M&#xfc;ller S. Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev. 2010;29:95&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">20099008</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Broeck A, Brambilla E, Moro-Sibilot D, Lantuejoul S, Brambilla C, Eymin B, <i>et al.</i> Loss of histone h4k20 trimethylation occurs in preneoplasia and influences prognosis of non&#x2013;small cell lung cancer. Clin Cancer Res. 2008;14(22):7237&#x2013;45.
</Citation><ArticleIdList><ArticleId IdType="pubmed">18974389</ArticleId></ArticleIdList></Reference><Reference><Citation>Meynen J, Adriaensens P, Criel M, Louis E, Vanhove K, Thomeer M, <i>et al</i>. Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs. Int J Mol Sci. 2024;25(9):4690.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11083579</ArticleId><ArticleId IdType="pubmed">38731909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mari&#xeb;n H, Derveaux E, Vanhove K, Adriaensens P, Thomeer M, Mesotten L. Changes in metabolism as a diagnostic tool for lung cancer: systematic review. Metab. 2022;12(6):545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9229104</ArticleId><ArticleId IdType="pubmed">35736478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed N, Kidane B, Wang L, Nugent Z, Moldovan N, McElrea A, <i>et al</i>. Metabolic Changes in Early-Stage Non-Small Cell Lung Cancer Patients after Surgical Resection. Cancers. 2021;13(12):3012.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8234274</ArticleId><ArticleId IdType="pubmed">34208545</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie M, Yao K, Zhu X, Chen N, Xiao N, Wang Y, <i>et al</i>. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nat Commun. 2021;12(1):6479.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8580984</ArticleId><ArticleId IdType="pubmed">34759281</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi S-A, Wu Q, Chen Z, Zhang W, Zhou Y, Mao K, <i>et al</i>. High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis. Sci Rep. 2021;11(1):11805.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175557</ArticleId><ArticleId IdType="pubmed">34083687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z, Liang D, Deubler EL, Sarnat JA, Chow SS, Diver WR, <i>et al</i>. Lung cancer metabolomics: A pooled analysis in the Cancer Prevention Studies. BMC Med. 2024;22(1):262.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11197282</ArticleId><ArticleId IdType="pubmed">38915026</ArticleId></ArticleIdList></Reference><Reference><Citation>You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, <i>et al</i>. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):196.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10172373</ArticleId><ArticleId IdType="pubmed">37164974</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, <i>et al</i>. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy. Gut. 2022;71(4):734&#x2013;45.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8921579</ArticleId><ArticleId IdType="pubmed">34006584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong H, Baatar D, Hwang SG. Anticancer activities of ginsenosides, the main active components of ginseng. Evid-Based Complement Alternat Med. 2021;2021(1):8858006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875636</ArticleId><ArticleId IdType="pubmed">33623532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan T, Han D, Xu Y, Peng W, Bai L, Zhou X, <i>et al</i>. LC&#x2013;MS based metabolomics study of the effects of EGCG on A549 cells. Front Pharmacol. 2021;12:732716.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505700</ArticleId><ArticleId IdType="pubmed">34650434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng S-H, Lin S-M, Chen J-C, Su Y-H, Huang H-Y, Chen C-K, <i>et al.</i> Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res. 2004;10(6):2190&#x2013;202.
</Citation><ArticleIdList><ArticleId IdType="pubmed">15041740</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockmueller A, Sameri S, Liskova A, Zhai K, Varghese E, Samuel SM, <i>et al</i>. Resveratrol&#x2019;s anti-cancer effects through the modulation of tumor glucose metabolism. Cancers. 2021;13(2):188.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825813</ArticleId><ArticleId IdType="pubmed">33430318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J-H, Lai S-L, Chen W-S, Hung W-Y, Chow J-M, Hsiao M, <i>et al</i>. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways. Biochimica et Biophysica Acta (BBA)-Mol Cell Res. 2017;1864(10):1746&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">28648644</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrocini G, Triassi M, Mauriello MC, Torre G, Annunziata MC, De Vita V, <i>et al</i>. Epidemiology of skin cancer: role of some environmental factors. Cancers. 2010;2(4):1980&#x2013;9.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840456</ArticleId><ArticleId IdType="pubmed">24281212</ArticleId></ArticleIdList></Reference><Reference><Citation>Madronich S, Gruijl FR. Stratospheric ozone depletion between 1979 and 1992: implications for biologically active ultraviolet-B radiation and non-melanoma skin cancer incidence. Photochem Photobiol. 1994;59(5):541&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8041809</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard WF, Saxena V, Wenny B, DeLuisi J. Daily surface UV exposure and its relationship to surface pollutant measurements. J Air Waste Manag Assoc. 2003;53(2):237&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">12617297</ArticleId></ArticleIdList></Reference><Reference><Citation>Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Can Res. 2003;63(7):1639&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">12670917</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray SG. Epigenetic-based immune intervention for rheumatic diseases. Epigenomics. 2014;6(2):253&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">24811793</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements EG, Mohammad HP, Leadem BR, Easwaran H, Cai Y, Van Neste L, <i>et al</i>. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res. 2012;40(10):4334&#x2013;46.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378872</ArticleId><ArticleId IdType="pubmed">22278882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceol CJ, Houvras Y, Jane-Valbuena J, Bilodeau S, Orlando DA, Battisti V, <i>et al</i>. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011;471(7339):513&#x2013;7.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3348545</ArticleId><ArticleId IdType="pubmed">21430779</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Yang Y, Sargsyan D, Wu R, Yin R, Kuo H-CD, <i>et al</i>. Epigenome, transcriptome, and protection by sulforaphane at different stages of UVB-induced skin carcinogenesis. Cancer Prevent Res. 2020;13(6):551&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272261</ArticleId><ArticleId IdType="pubmed">32161072</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Yu S-W, Kong A-NT. Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J Biol Chem. 2006;281(37):27251&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">16790425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, <i>et al</i>. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer. 2008;99(4):647&#x2013;54.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527823</ArticleId><ArticleId IdType="pubmed">18665171</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M, Dhanalakshmi S, Singh RP, Agarwal R. Dietary feeding of silibinin prevents early biomarkers of UVB radiation&#x2013;induced carcinogenesis in SKH-1 hairless mouse epidermis. Cancer Epidemiol Biomark Prev. 2005;14(5):1344&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15894701</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yin R, Wu R, Ramirez CN, Sargsyan D, Li S, <i>et al</i>. DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice. Mol Carcinog. 2019;58(10):1738&#x2013;53.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6722003</ArticleId><ArticleId IdType="pubmed">31237383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar MS, Ramirez CN, Kuo H-CD, Chou P, Wu R, Sargsyan D, <i>et al</i>. Triterpenoid ursolic acid regulates the environmental carcinogen benzo [a] pyrene-driven epigenetic and metabolic alterations in SKH-1 hairless mice for skin cancer interception. Carcinog. 2024;45(5):288&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11102768</ArticleId><ArticleId IdType="pubmed">38466106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo H-CD, Wu R, Li S, Yang AY, Kong A-N. Anthocyanin delphinidin prevents neoplastic transformation of mouse skin JB6 P+ cells: Epigenetic re-activation of Nrf2-ARE pathway. AAPS J. 2019;21:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669902</ArticleId><ArticleId IdType="pubmed">31254216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Hall P, Smith M, Kirk M, Prasain JK, Barnes S, <i>et al</i>. Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J Nutr. 2004;134(12):3445S-S3452.
</Citation><ArticleIdList><ArticleId IdType="pubmed">15570052</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr. 2010;140(9):1607&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139234</ArticleId><ArticleId IdType="pubmed">20631324</ArticleId></ArticleIdList></Reference><Reference><Citation>deLima e Silva TC, da Silveira LT, Fragoso MF, da Silva FR, Martinez MF, Zapaterini JR, <i>et al</i>. Maternal resveratrol treatment reduces the risk of mammary carcinogenesis in female offspring prenatally exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Hormones Cancer. 2017;8:286&#x2013;97.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10355987</ArticleId><ArticleId IdType="pubmed">28786001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Dong J, Wang L-E, Ma H, Liu J, Zhao Y, <i>et al</i>. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Carcinog. 2012;33(4):828&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">22298638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GY, Suh J, Jang J-H, Kim D-H, Park OJ, Park SK, <i>et al</i>. Genistein inhibits proliferation of brca1 mutated breast cancer cells: The gpr30-akt axis as a potential target. J Cancer Prevent. 2019;24(4):197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6951321</ArticleId><ArticleId IdType="pubmed">31950019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, <i>et al</i>. High frequency of hypermethylation at the 14-3-3 &#x3c3; locus leads to gene silencing in breast cancer. Proc Natl Acad Sci. 2000;97(11):6049&#x2013;54.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18556</ArticleId><ArticleId IdType="pubmed">10811911</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem. 2010;17(20):2141&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904405</ArticleId><ArticleId IdType="pubmed">20423306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PA. DNA methylation and cancer. Oncogene. 2002;21(35):5358&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154398</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Q, Bai Q, Zou LY, Zhang QY, Zhou Y, Chang H, <i>et al</i>. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells. Genes Chromosom Cancer. 2014;53(5):422&#x2013;31.
</Citation><ArticleIdList><ArticleId IdType="pubmed">24532317</ArticleId></ArticleIdList></Reference><Reference><Citation>Mense SM, Hei TK, Ganju RK, Bhat HK. Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect. 2008;116(4):426&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2291001</ArticleId><ArticleId IdType="pubmed">18414622</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalesi E, Cipolletti M, Cracco P, Fiocchetti M, Marino M. Divergent effects of daidzein and its metabolites on estrogen-induced survival of breast cancer cells. Cancers. 2020;12(1):167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017042</ArticleId><ArticleId IdType="pubmed">31936631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40663150</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-6822</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Cell biology and toxicology</Title><ISOAbbreviation>Cell Biol Toxicol</ISOAbbreviation></Journal><ArticleTitle>Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights.</ArticleTitle><Pagination><StartPage>116</StartPage><MedlinePgn>116</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10565-025-10054-2</ELocationID><Abstract><AbstractText>The burgeoning field of epigenetics holds considerable potential in cancer prevention and management, as it targets mechanisms essential to regulating gene expression without altering DNA sequences. Epigenetic processes like DNA methylation, histone modifications, non-coding RNAs, and nucleosome remodelling-play an essential role in cellular differentiation and development, with dysfunction in these pathways often leading to malignancy. Targeting epigenetic regulators, including DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), can suppress cancer cell proliferation, making epigenetics a promising therapeutic frontier. Phytochemicals, natural bioactive compounds predominantly found in vegetables, fruits, and seeds, offer a complementary approach to traditional cancer therapies through their epigenetic influence. These compounds exhibit anti-inflammatory, anti-angiogenic, and antioxidant properties, which modulate pathways and proteins involved in chromatin remodeling and may influence the mammalian epigenome. A diverse spectrum of bioactive dietary ingredients, including curcumin, epigallocatechin-3-gallate (EGCG), genistein, quercetin, resveratrol, and sulforaphane, has gained significant interest for their ability to modulate gene expression and chromatin structure via epigenetic mechanisms. Their potential implications for cancer prevention and their role in regulating key epigenetic genes have been described in numerous investigations. This comprehensive review explores the molecular mechanisms by which dietary bioactive molecules may reverse epigenetic aberrations in cancer cells. It examines the influence of these compounds on DNA methylation, ten-eleven translocation (TET) enzymes, and histone modifications, while discussing their specific molecular targets in various cancer types. Additionally, we highlight the pathways through which these epi-nutrients may impact gene expression and enzyme activities associated with epigenetic regulation, which leads to innovative, diet-based anticancer strategies. Clinical trial number: not applicable.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bakrim</LastName><ForeName>Saad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geo-Bio-Environment Engineering and Innovation Laboratory, Molecular Engineering, Biotechnology and Innovation Team, Polydisciplinary Faculty of Taroudant, Ibn Zohr University, Agadir, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Omari</LastName><ForeName>Nasreddine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>High Institute of Nursing Professions and Health Techniques of Tetouan, Tetouan, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Yaagoubi</LastName><ForeName>Ouadie Mohamed</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Drug Science Laboratory - Faculty of Medicine, Pharmacy and Dentistry of Fez, Sidi Mohamed Ben Abdellah University, Fez, 30000, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Asaad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Research Center, Jazan University, P.O. Box: 114, Jazan, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, P. O. Box 2404, Khartoum, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdalla</LastName><ForeName>Ashraf N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. anabdrabo@uqu.edu.sa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamza</LastName><ForeName>Siddiqa M A</ForeName><Initials>SMA</Initials><AffiliationInfo><Affiliation>Department of Physiology, College of Medicine, Umm Al-Qura University, Alqunfudah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Salma Elhadi</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, Umm Al-Qura University, Alqunfudah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atifi</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biology, Immunology and Biodiversity Laboratory, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaid</LastName><ForeName>Younes</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouyahya</LastName><ForeName>Abdelhakim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Fessikh</LastName><ForeName>Meriem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ming</LastName><ForeName>Long Chiau</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Sawangi (M), Wardha, India. longchiauming@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medical and Life Sciences, Sunway University, Sunway City, Malaysia. longchiauming@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aanniz</LastName><ForeName>Tarik</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Biotechnology Laboratory, Rabat Medical &amp; Pharmacy School, Mohammed V University in Rabat, B.P. 6203, Rabat, Morocco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Biol Toxicol</MedlineTA><NlmUniqueID>8506639</NlmUniqueID><ISSNLinking>0742-2091</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>8R1V1STN48</RegistryNumber><NameOfSubstance UI="D002392">Catechin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="Y">Phytochemicals</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002392" MajorTopicYN="N">Catechin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer prevention</Keyword><Keyword MajorTopicYN="N">Epi-nutrients</Keyword><Keyword MajorTopicYN="N">Epigenetic cofactors</Keyword><Keyword MajorTopicYN="N">Epigenetic modulation</Keyword><Keyword MajorTopicYN="N">Molecular pathways</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: Not applicable. Conflicts of interest: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40663150</ArticleId><ArticleId IdType="pmc">PMC12263776</ArticleId><ArticleId IdType="doi">10.1007/s10565-025-10054-2</ArticleId><ArticleId IdType="pii">10.1007/s10565-025-10054-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aanniz T, Bouyahya A, Balahbib A, El Kadri K, Khalid A, Makeen HA, Alhazmi HA, El Omari N, Zaid Y, Wong RS-Y, Yeo CI, Goh BH, Bakrim S. Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: mechanisms insights and efficiencies. Chem Biol Interact. 2024;392:110907. 10.1016/j.cbi.2024.110907.</Citation><ArticleIdList><ArticleId IdType="pubmed">38395253</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi IHR, Abbasi F, Wang L, Abd El Hack ME, Swelum AA, Hao R, Yao J, Cao Y. Folate promotes S-adenosyl methionine reactions and the microbial methylation cycle and boosts ruminants production and reproduction. AMB Express. 2018;8:65. 10.1186/s13568-018-0592-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913057</ArticleId><ArticleId IdType="pubmed">29687201</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul QA, Yu BP, Chung HY, Jung HA, Choi JS. Epigenetic modifications of gene expression by lifestyle and environment. Arch Pharmacal Res. 2017;40(11):1219&#x2013;37. 10.1007/s12272-017-0973-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">29043603</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010;21(9):781&#x2013;92. 10.1016/j.jnutbio.2009.12.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">20382009</ArticleId></ArticleIdList></Reference><Reference><Citation>Addissouky T. Next generation of colorectal cancer management: integrating omics, targeted therapies, and smart technologies. Avicenna J Med Biochem. 2025;12:131&#x2013;43. 10.34172/ajmb.2530.</Citation></Reference><Reference><Citation>Allison J, Kaliszewska A, Uceda S, Reiriz M, Arias N. Targeting DNA Methylation in the Adult Brain through Diet. Nutrients. 2021;13(11):11. 10.3390/nu13113979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618930</ArticleId><ArticleId IdType="pubmed">34836233</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez MC, Maso V, Torello CO, Ferro KP, Saad STO. The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin Epigenetics. 2018;10(1):139. 10.1186/s13148-018-0563-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225654</ArticleId><ArticleId IdType="pubmed">30409182</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Yousef N, Shinwari Z, Al-Shahrani B, Al-Showimi M, Al-Moghrabi N. Curcumin induces re-expression of BRCA1 and suppression of &#x3b3; synuclein by modulating DNA promoter methylation in breast cancer cell lines. Oncol Rep. 2020;43(3):827&#x2013;38. 10.3892/or.2020.7473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7041105</ArticleId><ArticleId IdType="pubmed">32020216</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzeer J. Personalized health through epigenetics: the lifestylopathy approach. Med Res Arch. 2025;13(4). 10.18103/mra.v13i4.6435.</Citation></Reference><Reference><Citation>Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23(8):853&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3405985</ArticleId><ArticleId IdType="pubmed">22749138</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreescu, N., Puiu, M., &amp; Niculescu, M. (2018). Effects of Dietary Nutrients on Epigenetic Changes in Cancer. In R. G. Dumitrescu &amp; M. Verma (Eds.), Cancer Epigenetics for Precision Medicine (Vol. 1856, pp. 121&#x2013;139). Springer New York. 10.1007/978-1-4939-8751-1_7</Citation><ArticleIdList><ArticleId IdType="pubmed">30178249</ArticleId></ArticleIdList></Reference><Reference><Citation>Arand J, Chiang HR, Martin D, Snyder MP, Sage J, Reijo Pera RA, Wossidlo M. Tet enzymes are essential for early embryogenesis and completion of embryonic genome activation. EMBO Rep. 2022;23(2):e53968. 10.15252/embr.202153968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8811641</ArticleId><ArticleId IdType="pubmed">34866320</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V, Soofiyani SR, Kozhamzharova L, Sharifi-Rad J, Calina D, Cho WC. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int. 2022;22:257. 10.1186/s12935-022-02677-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9380290</ArticleId><ArticleId IdType="pubmed">35971151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayissi VBO, Ebrahimi A, Schluesenner H. Epigenetic effects of natural polyphenols: A focus on SIRT1-mediated mechanisms. Mol Nutr Food Res. 2014;58(1):22&#x2013;32. 10.1002/mnfr.201300195.</Citation><ArticleIdList><ArticleId IdType="pubmed">23881751</ArticleId></ArticleIdList></Reference><Reference><Citation>Babar Q, Saeed A, Tabish TA, Pricl S, Townley H, Thorat N. Novel epigenetic therapeutic strategies and targets in cancer. BBA-Mol Basis Dis. 2022;1868(12):166552. 10.1016/j.bbadis.2022.166552.</Citation><ArticleIdList><ArticleId IdType="pubmed">36126898</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek SH, Kim KI. Epigenetic Control of Autophagy: Nuclear Events Gain More Attention. Mol Cell. 2017;65(5):781&#x2013;5. 10.1016/j.molcel.2016.12.027.</Citation><ArticleIdList><ArticleId IdType="pubmed">28257699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakrim S, Aboulaghras S, Aanniz T, Benali T, El Omari N, El-Shazly M, Lee L-H, Mustafa SK, Sahib N, Rebezov M, Ali Shariati M, Lorenzo JM, Bouyahya A. Effects of Mediterranean diets and nutrigenomics on cardiovascular health. Crit Rev Food Sci Nutr. 2023;64(21):7589&#x2013;608. 10.1080/10408398.2023.2187622.</Citation><ArticleIdList><ArticleId IdType="pubmed">36908235</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannoura SF, Khan HY, Azmi AS. KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered? Front Oncol. 2022;12:1013902. 10.3389/fonc.2022.1013902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749787</ArticleId><ArticleId IdType="pubmed">36531078</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra S, Sahu RP, Kandala PK, Srivastava SK. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells. Mol Cancer Ther. 2010;9(6):1596&#x2013;608. 10.1158/1535-7163.MCT-09-1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2946330</ArticleId><ArticleId IdType="pubmed">20484017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekdash RA. Methyl donors, epigenetic alterations, and brain health: Understanding the connection. Int J Mol Sci. 2023;24(3):2346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917111</ArticleId><ArticleId IdType="pubmed">36768667</ArticleId></ArticleIdList></Reference><Reference><Citation>Beklemisheva AA, Fang Y, Feng J, Ma X, Dai W, Chiao JW. Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells. Anticancer Res. 2006;26(2A):1225&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16619528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat MI, Kapila R. Dietary metabolites derived from gut microbiota: Critical modulators of epigenetic changes in mammals. Nutr Rev. 2017;75(5):374&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">28444216</ArticleId></ArticleIdList></Reference><Reference><Citation>Biel M, Wascholowski V, Giannis A. Epigenetics&#x2014;An Epicenter of Gene Regulation: Histones and Histone-Modifying Enzymes. Angew Chem Int Ed. 2005;44(21):3186&#x2013;216. 10.1002/anie.200461346.</Citation><ArticleIdList><ArticleId IdType="pubmed">15898057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop K, Ferguson L. The Interaction between Epigenetics, Nutrition and the Development of Cancer. Nutrients. 2015;7(2):922&#x2013;47. 10.3390/nu7020922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344568</ArticleId><ArticleId IdType="pubmed">25647662</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco E, Gonz&#xe1;lez-Ram&#xed;rez M, Alcaine-Colet A, Aranda S, Di Croce L. The Bivalent Genome: Characterization, Structure, and Regulation. Trends in Genetics: TIG. 2020;36(2):118&#x2013;31. 10.1016/j.tig.2019.11.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">31818514</ArticleId></ArticleIdList></Reference><Reference><Citation>Block LG, Grier SA, Childers TL, Davis B, Ebert JEJ, Kumanyika S, Laczniak RN, Machin JE, Motley CM, Peracchio L, Pettigrew S, Scott M, Bieshaar MNGG. From Nutrients to Nurturance: A Conceptual Introduction to Food Well-Being. J Public Policy Mark. 2011;30(1):5&#x2013;13. 10.1509/jppm.30.1.5.</Citation></Reference><Reference><Citation>Bordoni L, Gabbianelli R. Primers on nutrigenetics and nutri(epi)genomics: Origins and development of precision nutrition. Biochimie. 2019;160:156&#x2013;71. 10.1016/j.biochi.2019.03.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">30878492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni L, Agostinho de Sousa J, Zhuo J, von Meyenn F. Evaluating the connection between diet quality, EpiNutrient intake and epigenetic age: An observational study. Am J Clin Nutr. 2024;120(5):1143&#x2013;55. 10.1016/j.ajcnut.2024.08.033.</Citation><ArticleIdList><ArticleId IdType="pubmed">39510725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouyahya A, Hachlafi NE, Aanniz T, Bourais I, Mechchate H, Benali T, Shariati MA, Burkov P, Lorenzo JM, Wilairatana P, Mubarak MS, Omari NE. Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates. Mol. 2022a;27(8):8. 10.3390/molecules27082568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9027183</ArticleId><ArticleId IdType="pubmed">35458763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouyahya A, Mechchate H, Oumeslakht L, Zeouk I, Aboulaghras S, Balahbib A, Zengin G, Kamal MA, Gallo M, Montesano D, El Omari N. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Biomolecules. 2022b;12(3):3. 10.3390/biom12030367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8945214</ArticleId><ArticleId IdType="pubmed">35327559</ArticleId></ArticleIdList></Reference><Reference><Citation>Calheiros J, Corbo V, Saraiva L. Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(4):188914.</Citation><ArticleIdList><ArticleId IdType="pubmed">37201730</ArticleId></ArticleIdList></Reference><Reference><Citation>Campit SE, Meliki A, Youngson NA, Chandrasekaran S. Nutrient Sensing by Histone Marks: Reading the Metabolic Histone Code Using Tracing, Omics, and Modeling. BioEssays. 2020;42(9):2000083. 10.1002/bies.202000083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11426192</ArticleId><ArticleId IdType="pubmed">32638413</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappuccilli M, Bergamini C, Giacomelli FA, Cianciolo G, Donati G, Conte D, Natali T, La Manna G, Capelli I. Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery. Nutrients. 2020;12(5):5. 10.3390/nu12051234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281987</ArticleId><ArticleId IdType="pubmed">32349312</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C. Nutrigenomics in the context of evolution. Redox Biol. 2023;62:102656. 10.1016/j.redox.2023.102656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10036735</ArticleId><ArticleId IdType="pubmed">36933390</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C, Ulven SM, Moln&#xe1;r F. Nutritional epigenetics. In: Carlberg C, Ulven SM, Moln&#xe1;r F, editors. Nutrigenomics: how science works. Springer International Publishing; 2020. p. 65&#x2013;79. 10.1007/978-3-030-36948-4_5.</Citation></Reference><Reference><Citation>Carlos-Reyes &#xc1;, L&#xf3;pez-Gonz&#xe1;lez JS, Meneses-Flores M, Gallardo-Rinc&#xf3;n D, Ru&#xed;z-Garc&#xed;a E, Marchat LA, Astudillo-De La Vega H, Hern&#xe1;ndez de la Cruz ON, L&#xf3;pez-Camarillo C. Dietary compounds as epigenetic modulating agents in cancer. Front Genet. 2019;10:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6406035</ArticleId><ArticleId IdType="pubmed">30881375</ArticleId></ArticleIdList></Reference><Reference><Citation>Casacuberta-Serra S, Gonz&#xe1;lez-Larreategui &#xcd;, Capit&#xe1;n-Leo D, Soucek L. MYC and KRAS cooperation: From historical challenges to therapeutic opportunities in cancer. Signal Transduct Target Ther. 2024;9(1):205. 10.1038/s41392-024-01907-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11336233</ArticleId><ArticleId IdType="pubmed">39164274</ArticleId></ArticleIdList></Reference><Reference><Citation>Casali C, Galgano L, Zannino L, Siciliani S, Cavallo M, Mazzini G, Biggiogera M. Impact of heat and cold shock on epigenetics and chromatin structure. Eur J Cell Biol. 2024;103(1):151373.</Citation><ArticleIdList><ArticleId IdType="pubmed">38016352</ArticleId></ArticleIdList></Reference><Reference><Citation>Casari G, Romaldi B, Scir&#xe8; A, Minnelli C, Marzioni D, Ferretti G, Armeni T. Epigenetic Properties of Compounds Contained in Functional Foods Against Cancer. Biomolecules. 2024;15(1):15. 10.3390/biom15010015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11762081</ArticleId><ArticleId IdType="pubmed">39858410</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassotta M, Forbes-Hernandez TY, Cianciosi D, Elexpuru Zabaleta M, Sumalla Cano S, Dominguez I, Bullon B, Regolo L, Alvarez-Suarez JM, Giampieri F, Battino M. Nutrition and Rheumatoid Arthritis in the &#x2018;Omics&#x2019; Era. Nutrients. 2021;13(3):3. 10.3390/nu13030763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996781</ArticleId><ArticleId IdType="pubmed">33652915</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B, Ghosh K, Kanade SR. Curcumin-mediated demethylation of the proximal promoter CpG island enhances the KLF4 recruitment that leads to increased expression of p21Cip1 in vitro. J Cell Biochem. 2019a;120(1):809&#x2013;20. 10.1002/jcb.27442.</Citation><ArticleIdList><ArticleId IdType="pubmed">30145810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B, Ghosh K, Kanade SR. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines. BioFactors (Oxford, England). 2019b;45(5):818&#x2013;29. 10.1002/biof.1544.</Citation><ArticleIdList><ArticleId IdType="pubmed">31317586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Huang Z-J, Duan Y-Q, Xiao X-R, Jiang J-Q, Zhang R. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention: APJCP. 2012;13(10):5303&#x2013;6. 10.7314/apjcp.2012.13.10.5303.</Citation><ArticleIdList><ArticleId IdType="pubmed">23244153</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Targeting epigenetic regulators for cancer therapy: Mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2019;4(1):62. 10.1038/s41392-019-0095-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6915746</ArticleId><ArticleId IdType="pubmed">31871779</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia N, Wang L, Lu X, Senut M-C, Brenner CA, Ruden DM. Hypothesis: Environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics. 2011;6(7):853&#x2013;6. 10.4161/epi.6.7.16461.</Citation><ArticleIdList><ArticleId IdType="pubmed">21617369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiacchiera F, Morey L, Mozzetta C. Epigenetic Regulation of Stem Cell Plasticity in Tissue Regeneration and Disease. Front Cell Dev Biol. 2020;8:82. 10.3389/fcell.2020.00082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042459</ArticleId><ArticleId IdType="pubmed">32140466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang Y-T, Chien Y-C, Lin Y-H, Wu H-H, Lee D-F, Yu Y-L. The Function of the Mutant p53&#x2013;R175H in Cancer. Cancers. 2021;13(16):4088. 10.3390/cancers13164088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391618</ArticleId><ArticleId IdType="pubmed">34439241</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S-W, Friso S. Epigenetics: A new bridge between nutrition and health. Adv Nutr. 2010;1(1):8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3042783</ArticleId><ArticleId IdType="pubmed">22043447</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Mart&#xed;n MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Aifantis I. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell. 2017;170(6):1079&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5755977</ArticleId><ArticleId IdType="pubmed">28823558</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;i&#x17e;auskait&#x117; A, &#x160;im&#x10d;ikas D, Schultze D, Kallifatidis G, Bruns H, &#x10c;ekauskas A, Herr I, Bau&#x161;ys A, Strupas K, Schemmer P. Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells. Oncol Rep. 2022;48(5):205. 10.3892/or.2022.8420.</Citation><ArticleIdList><ArticleId IdType="pubmed">36177901</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins HM, Abdelghany MK, Messmer M, Yue B, Deeves SE, Kindle KB, Mantelingu K, Aslam A, Winkler GS, Kundu TK, Heery DM. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer. 2013;13:37. 10.1186/1471-2407-13-37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3583671</ArticleId><ArticleId IdType="pubmed">23356739</ArticleId></ArticleIdList></Reference><Reference><Citation>Cropley JE, Suter CM, Beckman KB, Martin DIK. Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc Natl Acad Sci USA. 2006;103(46):17308&#x2013;12. 10.1073/pnas.0607090103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1838538</ArticleId><ArticleId IdType="pubmed">17101998</ArticleId></ArticleIdList></Reference><Reference><Citation>Das L, Vinayak M. Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer. PLoS ONE. 2015;10(4):e0124000. 10.1371/journal.pone.0124000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393109</ArticleId><ArticleId IdType="pubmed">25860911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauncey MJ. Nutrition, the brain and cognitive decline: Insights from epigenetics. Eur J Clin Nutr. 2014;68(11):1179&#x2013;85. 10.1038/ejcn.2014.173.</Citation><ArticleIdList><ArticleId IdType="pubmed">25182020</ArticleId></ArticleIdList></Reference><Reference><Citation>Davie JR, Sattarifard H, Sudhakar SRN, Roberts C-T, Beacon TH, Muker I, Shahib AK, Rastegar M. Basic Epigenetic Mechanisms. Sub-Cellular. Biochemistry. 2025;108:1&#x2013;49. 10.1007/978-3-031-75980-2_1.</Citation><ArticleIdList><ArticleId IdType="pubmed">39820859</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb M, Sengupta D, Kar S, Rath SK, Parbin S, Shilpi A, Roy S, Das G, Patra SK. Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators. Tumour Biol. 2014;35(12):12031&#x2013;47. 10.1007/s13277-014-2502-z.</Citation><ArticleIdList><ArticleId IdType="pubmed">25192721</ArticleId></ArticleIdList></Reference><Reference><Citation>Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Mass&#xe9; A, Kosmider O, Le Couedic J-P, Robert F, Alberdi A, L&#xe9;cluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Bernard OA. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360(22):2289&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">19474426</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng R, Shen N, Yang Y, Yu H, Xu S, Yang Y-W, Liu S, Meguellati K, Yan F. Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy. Biomaterials. 2018;167:80&#x2013;90. 10.1016/j.biomaterials.2018.03.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">29554483</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar S, Kumar A, Li K, Tzivion G, Levenson AS. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochem Biophys Acta. 2015;1853(2):265&#x2013;75. 10.1016/j.bbamcr.2014.11.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">25447541</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohoe DR, Bultman SJ. Metaboloepigenetics: Interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol. 2012;227(9):3169&#x2013;77. 10.1002/jcp.24054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338882</ArticleId><ArticleId IdType="pubmed">22261928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorna D, Grabowska A, Paluszczak J. Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: Targeting cancer cells. Br J Pharmacol. 2025;182(10):2137&#x2013;58. 10.1111/bph.16237.</Citation><ArticleIdList><ArticleId IdType="pubmed">37700551</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Xie Z, Wu L, Chiu M, Lin J, Chan KK, Liu S, Liu Z. Reactivation of RASSF1A in breast cancer cells by curcumin. Nutr Cancer. 2012;64(8):1228&#x2013;35. 10.1080/01635581.2012.717682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5082258</ArticleId><ArticleId IdType="pubmed">23145775</ArticleId></ArticleIdList></Reference><Reference><Citation>Duthie SJ. Epigenetic modifications and human pathologies: Cancer and CVD. Proc Nutr Soc. 2011a;70(1):47&#x2013;56. 10.1017/S0029665110003952.</Citation><ArticleIdList><ArticleId IdType="pubmed">21067630</ArticleId></ArticleIdList></Reference><Reference><Citation>Duthie SJ. Folate and cancer: How DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis. 2011b;34(1):101&#x2013;9. 10.1007/s10545-010-9128-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">20544289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich M. DNA Hypomethylation in Cancer Cells. Epigenomics. 2009;1(2):239&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873040</ArticleId><ArticleId IdType="pubmed">20495664</ArticleId></ArticleIdList></Reference><Reference><Citation>Eischen CM. Genome Stability Requires p53. Cold Spring Harb Perspect Med. 2016;6(6):a026096. 10.1101/cshperspect.a026096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888814</ArticleId><ArticleId IdType="pubmed">27252396</ArticleId></ArticleIdList></Reference><Reference><Citation>El Omari N, Bakha M, Imtara H, Guaouguaoua F-E, Balahbib A, Zengin G, Bouyahya A. Anticancer mechanisms of phytochemical compounds: Focusing on epigenetic targets. Environ Sci Pollut Res. 2021a;28(35):47869&#x2013;903. 10.1007/s11356-021-15594-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34308524</ArticleId></ArticleIdList></Reference><Reference><Citation>El Omari N, Bakrim S, Bakha M, Lorenzo JM, Rebezov M, Shariati MA, Aboulaghras S, Balahbib A, Khayrullin M, Bouyahya A. Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates. Nutrients. 2021b;13(11):11. 10.3390/nu13113714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621755</ArticleId><ArticleId IdType="pubmed">34835969</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahrner JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Can Res. 2002;62(24):7213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12499261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Can Res. 2003;63(22):7563&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">14633667</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res. 2005;11(19 Pt 1):7033&#x2013;41. 10.1158/1078-0432.CCR-05-0406.</Citation><ArticleIdList><ArticleId IdType="pubmed">16203797</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima N, Baqri SSR, Bhattacharya A, Koney NK-K, Husain K, Abbas A, Ansari RA. Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy. Front Genet. 2021;12:758733. 10.3389/fgene.2021.758733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8630677</ArticleId><ArticleId IdType="pubmed">34858475</ArticleId></ArticleIdList></Reference><Reference><Citation>Feil R, Fraga MF. Epigenetics and the environment: Emerging patterns and implications. Nat Rev Genet. 2012;13(2):97&#x2013;109. 10.1038/nrg3142.</Citation><ArticleIdList><ArticleId IdType="pubmed">22215131</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, De Carvalho DD. Clinical advances in targeting epigenetics for cancer therapy. FEBS J. 2022;289(5):1214&#x2013;39. 10.1111/febs.15750.</Citation><ArticleIdList><ArticleId IdType="pubmed">33545740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrone CK, Blydt-Hansen M, Rauh MJ. Age-associated TET2 mutations: common drivers of myeloid dysfunction, cancer and cardiovascular disease. Int J Mol Sci. 2020;21(2):626. 10.3390/ijms21020626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7014315</ArticleId><ArticleId IdType="pubmed">31963585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficz G, Gribben JG. Loss of 5-hydroxymethylcytosine in cancer: cause or consequence? Genomics. 2014;104(5):352&#x2013;7. 10.1016/j.ygeno.2014.08.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4566966</ArticleId><ArticleId IdType="pubmed">25179374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorito G, Guarrera S, Valle C, Ricceri F, Russo A, Grioni S, Mattiello A, Di Gaetano C, Rosa F, Modica F, Iacoviello L, Frasca G, Tumino R, Krogh V, Panico S, Vineis P, Sacerdote C, Matullo G. B-vitamins intake, DNA-methylation of One Carbon Metabolism and homocysteine pathway genes and myocardial infarction risk: The EPICOR study. Nutr Metab Cardiovasc Dis. 2014;24(5):483&#x2013;8. 10.1016/j.numecd.2013.10.026.</Citation><ArticleIdList><ArticleId IdType="pubmed">24418380</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Tollefsbol TO. Cancer Chemoprotection Through Nutrient-mediated Histone Modifications. Curr Med Chem. 2015;22(17):2051&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012963</ArticleId><ArticleId IdType="pubmed">25891109</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z, Xu Z, Hung M, Lin Y-C, Wang T, Gong M, Zhi X, Jablon DM, You L. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res. 2009;29:2025&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">19528461</ArticleId></ArticleIdList></Reference><Reference><Citation>Geissler F, Nesic K, Kondrashova O, Dobrovic A, Swisher EM, Scott CL, Wakefield JM. The role of aberrant DNA methylation in cancer initiation and clinical impacts. Ther Adv Med Oncol. 2024;16:17588359231220512. 10.1177/17588359231220511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10826407</ArticleId><ArticleId IdType="pubmed">38293277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerecke C, Egea Rodrigues C, Homann T, Kleuser B. The role of ten-eleven translocation proteins in inflammation. Front Immunol. 2022;13:861351. 10.3389/fimmu.2022.861351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977485</ArticleId><ArticleId IdType="pubmed">35386689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerh&#xe4;user C. Cancer cell metabolism, epigenetics and the potential influence of dietary components&#x2013;A perspective. Biomed Res. 2012;23(1):1&#x2013;21.</Citation></Reference><Reference><Citation>Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, Howard TP, Takeda DY, Ly SH, Kim E, Gannon HS, Hurhula B, Sharpe T, Goodale A, Fritchman B, Steelman S, Vazquez F, Tsherniak A, Aguirre AJ, Hahn WC. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat Genet. 2018;50(10):1381&#x2013;7. 10.1038/s41588-018-0204-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6168352</ArticleId><ArticleId IdType="pubmed">30224644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs A, Schwartzman J, Deng V, Alumkal J. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc Natl Acad Sci USA. 2009;106(39):16663&#x2013;8. 10.1073/pnas.0908908106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2757849</ArticleId><ArticleId IdType="pubmed">19805354</ArticleId></ArticleIdList></Reference><Reference><Citation>Grazioli E, Dimauro I, Mercatelli N, Wang G, Pitsiladis Y, Di Luigi L, Caporossi D. Physical activity in the prevention of human diseases: Role of epigenetic modifications. BMC Genomics. 2017;18(S8):802. 10.1186/s12864-017-4193-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688489</ArticleId><ArticleId IdType="pubmed">29143608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu&#xe9;ant J-L, Caillerez-Fofou M, Battaglia-Hsu S, Alberto J-M, Freund J-N, Dulluc I, Adjalla C, Maury F, Merle C, Nicolas J-P, Namour F, Daval J-L. Molecular and cellular effects of vitamin B12 in brain, myocardium and liver through its role as co-factor of methionine synthase. Biochimie. 2013;95(5):1033&#x2013;40. 10.1016/j.biochi.2013.01.020.</Citation><ArticleIdList><ArticleId IdType="pubmed">23415654</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilloteau P, Zabielski R, Hammon HM, Metges CC. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol. 2009;60(Suppl 3):17&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996479</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Shu L, Zhang C, Su Z-Y, Kong A-NT. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. Biochem Pharmacol. 2015;94(2):69&#x2013;78. 10.1016/j.bcp.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524742</ArticleId><ArticleId IdType="pubmed">25640947</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurugubelli KR, Ballambattu VB. Perspectives on folate with special reference to epigenetics and neural tube defects. Reprod Toxicol (Elmsford, NY). 2024;125:108576. 10.1016/j.reprotox.2024.108576.</Citation><ArticleIdList><ArticleId IdType="pubmed">38479591</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan, D., &amp; Weinberg, R. A. (2017). Biological Hallmarks of Cancer. In <i>Holland-Frei Cancer Medicine</i> (pp. 1&#x2013;10). John Wiley &amp; Sons, Ltd. 10.1002/9781119000822.hfcm002</Citation></Reference><Reference><Citation>Haro D, Marrero PF, Relat J. Nutritional Regulation of Gene Expression: Carbohydrate-, Fat- and Amino Acid-Dependent Modulation of Transcriptional Activity. Int J Mol Sci. 2019;20(6):1386. 10.3390/ijms20061386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6470599</ArticleId><ArticleId IdType="pubmed">30893897</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan F, Rehman MS, Khan MS, Ali MA, Javed A, Nawaz A, Yang C. Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. Front Genet. 2019;10:514. 10.3389/fgene.2019.00514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6557992</ArticleId><ArticleId IdType="pubmed">31214247</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y-F, Li B-Z, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song C-X, Zhang K, He C, Xu G-L. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333(6047):1303&#x2013;7. 10.1126/science.1210944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3462231</ArticleId><ArticleId IdType="pubmed">21817016</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. Oncogene. 2020;39(13):2658&#x2013;75. 10.1038/s41388-020-1181-z.</Citation><ArticleIdList><ArticleId IdType="pubmed">32005974</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez Borrero, L. J., &amp; El-Deiry, W. S. (2021). Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochimica et Biophysica Acta (BBA) Reviews on Cancer 18(1) 188556</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730328</ArticleId><ArticleId IdType="pubmed">33932560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho E, Beaver LM, Williams DE, Dashwood RH. Dietary Factors and Epigenetic Regulation for Prostate Cancer Prevention. Adv Nutr. 2011;2(6):497&#x2013;510. 10.3945/an.111.001032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226387</ArticleId><ArticleId IdType="pubmed">22332092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hore TA, von Meyenn F, Ravichandran M, Bachman M, Ficz G, Oxley D, Santos F, Balasubramanian S, Jurkowski TP, Reik W. Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to na&#xef;ve pluripotency by complementary mechanisms. Proc Natl Acad Sci USA. 2016;113(43):12202&#x2013;7. 10.1073/pnas.1608679113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5086989</ArticleId><ArticleId IdType="pubmed">27729528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh H-H, Kuo M-Z, Chen I-A, Lin C-J, Hsu V, HuangFu W-C, Wu T-Y. Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals. Pharm Res. 2025;42(1):69&#x2013;78. 10.1007/s11095-024-03810-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">39775615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A, Wong CP, Yu Z, Williams DE, Dashwood RH, Ho E. Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin Epigenetics. 2011;3(1):3. 10.1186/1868-7083-3-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257546</ArticleId><ArticleId IdType="pubmed">22303414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Lu J, Cheng J, Rao Q, Li Z, Hou H, Lou Z, Zhang L, Li W, Gong W, Liu M, Sun C, Yin X, Li J, Tan X, Wang P, Wang Y, Fang D, Cui Q, Xu Y. Structural insight into substrate preference for TET-mediated oxidation. Nature. 2015;527(7576):118&#x2013;22. 10.1038/nature15713.</Citation><ArticleIdList><ArticleId IdType="pubmed">26524525</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Jiang X, Li Z, Li Y, Song C-X, He C, Sun M, Chen P, Gurbuxani S, Wang J, Hong G-M, Elkahloun AG, Arnovitz S, Wang J, Szulwach K, Lin L, Street C, Wunderlich M, Dawlaty M, Chen J. <i>TET1</i> plays an essential oncogenic role in <i>MLL</i>-rearranged leukemia. Proc Natl Acad Sci. 2013;110(29):11994&#x2013;9. 10.1073/pnas.1310656110.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718141</ArticleId><ArticleId IdType="pubmed">23818607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J-Y, Aromolaran KA, Zukin RS. The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat Rev Neurosci. 2017;18(6):347&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380351</ArticleId><ArticleId IdType="pubmed">28515491</ArticleId></ArticleIdList></Reference><Reference><Citation>Imodoye SO, Adedokun KA, Bello IO. From complexity to clarity: Unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy. Histochem Cell Biol. 2024. 10.1007/s00418-023-02258-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">38189822</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo LT, Affronti HC, Wellen KE. The bidirectional relationship between cancer epigenetics and metabolism. Annu Rev Cancer Biol. 2021;5(1):235&#x2013;57. 10.1146/annurev-cancerbio-070820-035832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186467</ArticleId><ArticleId IdType="pubmed">34109280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazieh AR, Abuelgasim KA, Ardah HI, Alkaiyat M, OB, Da&#x2019;ar. The trends of complementary alternative medicine use among cancer patients. BMC Complement Med Ther. 2021;21(1):167. 10.1186/s12906-021-03338-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188662</ArticleId><ArticleId IdType="pubmed">34103037</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenke R, Re&#xdf;ing N, Hansen FK, Aigner A, B&#xfc;ch T. Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives. Cancers. 2021;13(4):634. 10.3390/cancers13040634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7915831</ArticleId><ArticleId IdType="pubmed">33562653</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S. Tet2 at the interface between cancer and immunity. Commun Biol. 2020;3(1):667. 10.1038/s42003-020-01391-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7661537</ArticleId><ArticleId IdType="pubmed">33184433</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Ma X, Huang Y, Xu Y, Zheng R, Chiao J-W. Reactivating aberrantly hypermethylated p15 gene in leukemic T cells by a phenylhexyl isothiocyanate mediated inter-active mechanism on DNA and chromatin. J Hematol Oncol. 2010;3:48. 10.1186/1756-8722-3-48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3009608</ArticleId><ArticleId IdType="pubmed">21114827</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang A, Wang X, Shan X, Li Y, Wang P, Jiang P, Feng Q. Curcumin Reactivates Silenced Tumor Suppressor Gene RAR&#x3b2; by Reducing DNA Methylation. Phytother Res. 2015;29(8):1237&#x2013;45. 10.1002/ptr.5373.</Citation><ArticleIdList><ArticleId IdType="pubmed">25981383</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Liu Y. DNA methylation in human diseases. Genes Dis. 2018;5(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6147084</ArticleId><ArticleId IdType="pubmed">30258928</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C, Burkhart DL, Haigis KM. Classification of KRAS -Activating Mutations and the Implications for Therapeutic Intervention. Cancer Discov. 2022;12(4):913&#x2013;23. 10.1158/2159-8290.CD-22-0035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988514</ArticleId><ArticleId IdType="pubmed">35373279</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph DB, Strand DW, Vezina CM. DNA methylation in development and disease: An overview for prostate researchers. Am J Clin Exp Urol. 2018;6(6):197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6334199</ArticleId><ArticleId IdType="pubmed">30697577</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi K, Liu S, Breslin SJP, Zhang J. Mechanisms that regulate the activities of TET proteins. Cellular and Molecular Life Sciences: CMLS. 2022a;79(7):363. 10.1007/s00018-022-04396-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9756640</ArticleId><ArticleId IdType="pubmed">35705880</ArticleId></ArticleIdList></Reference><Reference><Citation>Joven J, Micol V, Segura-Carretero A, Alonso-Villaverde C, Men&#xe9;ndez JA, For The Bioactive Food Components P. Polyphenols and the Modulation of Gene Expression Pathways: Can We Eat Our Way Out of the Danger of Chronic Disease? Crit Rev Food Sci Nutr. 2014;54(8):985&#x2013;1001. 10.1080/10408398.2011.621772.</Citation><ArticleIdList><ArticleId IdType="pubmed">24499117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kai L, Samuel SK, Levenson AS. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer. 2010;126(7):1538&#x2013;48. 10.1002/ijc.24928.</Citation><ArticleIdList><ArticleId IdType="pubmed">19810103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Chen J, Shi Y, Jia J, Zhang Y. Curcumin-induced histone hypoacetylation: The role of reactive oxygen species. Biochem Pharmacol. 2005;69(8):1205&#x2013;13. 10.1016/j.bcp.2005.01.014.</Citation><ArticleIdList><ArticleId IdType="pubmed">15794941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapl&#xe1;nek R, Kej&#xed;k Z, Hajduch J, Vesel&#xe1; K, Ku&#x10d;nirov&#xe1; K, Skali&#x10d;kov&#xe1; M, Venhauerov&#xe1; A, Hosnedlov&#xe1; B, Hrom&#xe1;dka R, Dytrych P, Novotn&#xfd; P, Abramenko N, Antonyov&#xe1; V, Hoskovec D, Babula P, Masa&#x159;&#xed;k M, Mart&#xe1;sek P, Jakubek M. TET protein inhibitors: potential and limitations. Biomed Pharmacother. 2023;166:115324. 10.1016/j.biopha.2023.115324.</Citation><ArticleIdList><ArticleId IdType="pubmed">37598475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H, Shibata T. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer. 2008;99(4):647&#x2013;54. 10.1038/sj.bjc.6604521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527823</ArticleId><ArticleId IdType="pubmed">18665171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedhari Sundaram M, Hussain A, Haque S, Raina R, Afroze N. Quercetin modifies 5&#x2019;CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells. J Cell Biochem. 2019;120(10):18357&#x2013;69. 10.1002/jcb.29147.</Citation><ArticleIdList><ArticleId IdType="pubmed">31172592</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MA, Hussain A, Sundaram MK, Alalami U, Gunasekera D, Ramesh L, Hamza A, Quraishi U. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncol Rep. 2015;33(4):1976&#x2013;84. 10.3892/or.2015.3802.</Citation><ArticleIdList><ArticleId IdType="pubmed">25682960</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H, Ullah H, Martorell M, Valdes SE, Belwal T, Tejada S, Sureda A, Kamal MA. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Semin Cancer Biol. 2021;69:200&#x2013;11. 10.1016/j.semcancer.2019.07.023.</Citation><ArticleIdList><ArticleId IdType="pubmed">31374244</ArticleId></ArticleIdList></Reference><Reference><Citation>Khor TO, Huang Y, Wu T-Y, Shu L, Lee J, Kong A-NT. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol. 2011;82(9):1073&#x2013;8. 10.1016/j.bcp.2011.07.065.</Citation><ArticleIdList><ArticleId IdType="pubmed">21787756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SO, Kim MR. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC-1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int J Oncol. 2013;42(1):349&#x2013;58. 10.3892/ijo.2012.1686.</Citation><ArticleIdList><ArticleId IdType="pubmed">23135610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnaird A, Zhao S, Wellen KE, Michelakis ED. Metabolic control of epigenetics in cancer. Nat Rev Cancer. 2016;16(11):694&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">27634449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari A, Bhawal S, Kapila S, Yadav H, Kapila R. Health-promoting role of dietary bioactive compounds through epigenetic modulations: A novel prophylactic and therapeutic approach. Crit Rev Food Sci Nutr. 2022;62(3):619&#x2013;39. 10.1080/10408398.2020.1825286.</Citation><ArticleIdList><ArticleId IdType="pubmed">33081489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutwin M, Sosnowska-&#x141;awnicka M, Nasi&#x142;owska B, Lange A, Wierzbicki M, Jaworski S. The Delivery of Mimic miRNA-7 into Glioblastoma Cells and Tumour Tissue by Graphene Oxide Nanosystems. Nanotechnol Sci Appl. 2024;17:167&#x2013;88. 10.2147/NSA.S469193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11402368</ArticleId><ArticleId IdType="pubmed">39280996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal MK, Sharma E, Tiwari RK, Devi R, Mishra UN, Thakur R, Gupta R, Dey A, Lal P, Kumar A. Nutrient-mediated perception and signalling in human metabolism: A perspective of nutrigenomics. Int J Mol Sci. 2022;23(19):11305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569568</ArticleId><ArticleId IdType="pubmed">36232603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam KK, Tang CL, Tan E, Wong SH, Cheah PY. KRAS mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancer. Mol Oncol. 2022;16(5):1171&#x2013;83. 10.1002/1878-0261.13163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8895447</ArticleId><ArticleId IdType="pubmed">34919787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarenkov A, Sardina JL. Dissecting TET2 regulatory networks in blood differentiation and cancer. Cancers. 2022;14(3):830. 10.3390/cancers14030830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8834528</ArticleId><ArticleId IdType="pubmed">35159097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-H. Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies. Cancer Treat Rev. 2024;129:102808. 10.1016/j.ctrv.2024.102808.</Citation><ArticleIdList><ArticleId IdType="pubmed">39106770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer. 2011;11:144. 10.1186/1471-2407-11-144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090367</ArticleId><ArticleId IdType="pubmed">21501498</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DSB, Forman SJ, Jove R, Riggs AD, Yu H. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci USA. 2012;109(20):7765&#x2013;9. 10.1073/pnas.1205132109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3356652</ArticleId><ArticleId IdType="pubmed">22547799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei I, Tian S, Gao W, Liu L, Guo Y, Tang P, Chen E, Wang Z. Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation. Elife. 2021;10:e60311. 10.7554/eLife.60311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8763402</ArticleId><ArticleId IdType="pubmed">34939931</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Tollefsbol TO. Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components. Curr Med Chem. 2010;17(20):2141&#x2013;51. 10.2174/092986710791299966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904405</ArticleId><ArticleId IdType="pubmed">20423306</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Meininger CJ, Kelly KA, Hawker JR, Morris SM, Wu G. Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regul Integr Com Physiol. 2002;282(1):R64-69. 10.1152/ajpregu.2002.282.1.R64.</Citation><ArticleIdList><ArticleId IdType="pubmed">11742824</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Rivas P, Bedolla R, Thapa D, Reddick RL, Ghosh R, Kumar AP. Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: Involvement of SIRT1/S6K axis. Cancer Prev Res. 2013;6(1):27&#x2013;39. 10.1158/1940-6207.CAPR-12-0349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536933</ArticleId><ArticleId IdType="pubmed">23248098</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Li Y, Yang S, Lu J, Jin X, Wu M. Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics. Biomed Pharmacother. 2022;153:113290. 10.1016/j.biopha.2022.113290.</Citation><ArticleIdList><ArticleId IdType="pubmed">35724509</ArticleId></ArticleIdList></Reference><Reference><Citation>Liga S, Paul C. Flavonoid-Based Nanogels: A Comprehensive Overview. Gels. 2025;11(4):267. 10.3390/gels11040267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12026979</ArticleId><ArticleId IdType="pubmed">40277705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillycrop KA, Burdge GC. Epigenetic mechanisms linking early nutrition to long term health. Best Pract Res Clin Endocrinol Metab. 2012;26(5):667&#x2013;76. 10.1016/j.beem.2012.03.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">22980048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim W-J, Kim KH, Kim J-Y, Jeong S, Kim N. Identification of DNA-Methylated CpG Islands Associated With Gene Silencing in the Adult Body Tissues of the Ogye Chicken Using RNA-Seq and Reduced Representation Bisulfite Sequencing. Front Genet. 2019;10:346. 10.3389/fgene.2019.00346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6476954</ArticleId><ArticleId IdType="pubmed">31040866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H-Y, Chen C-S, Lin S-P, Weng J-R, Chen C-S. Targeting histone deacetylase in cancer therapy. Med Res Rev. 2006;26(4):397&#x2013;413. 10.1002/med.20056.</Citation><ArticleIdList><ArticleId IdType="pubmed">16450343</ArticleId></ArticleIdList></Reference><Reference><Citation>Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem Pharmacol. 2010;80(12):1771&#x2013;92. 10.1016/j.bcp.2010.06.036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2974019</ArticleId><ArticleId IdType="pubmed">20599773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lio C-WJ, Yuita H, Rao A. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies. Blood. 2019;134(18):1487&#x2013;97. 10.1182/blood.2019791475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839946</ArticleId><ArticleId IdType="pubmed">31467060</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JJ, Ward RL. Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer. Adv Genet. 2010;71:79&#x2013;121. 10.1016/B978-0-12-380864-6.00004-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">20933127</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DP, Song H, Xu Y. A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene. 2010;29(7):949&#x2013;56. 10.1038/onc.2009.376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837937</ArticleId><ArticleId IdType="pubmed">19881536</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, Li P, Lin J, Fuchs JR, Marcucci G, Li C, Chan KK. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett. 2009;19(3):706&#x2013;9. 10.1016/j.bmcl.2008.12.041.</Citation><ArticleIdList><ArticleId IdType="pubmed">19112019</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Chen C, Wang X, Sun Y, Zhang J, Chen J, Shi Y. An epigenetic role of mitochondria in cancer. Cells. 2022;11(16):2518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9406960</ArticleId><ArticleId IdType="pubmed">36010594</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Moyado IF, Ko M, Hogan PG, Rao A. TET enzymes in the immune system: from DNA demethylation to immunotherapy, inflammation, and cancer. Annu Rev Immunol. 2024;42(1):455&#x2013;88. 10.1146/annurev-immunol-080223-044610.</Citation><ArticleIdList><ArticleId IdType="pubmed">38360546</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Lin X, Feng J, Zhao X, Gallagher R, Lee MY, Chiao J-W, Liu D. Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways. J Hematol Oncol. 2008;1:6. 10.1186/1756-8722-1-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2438442</ArticleId><ArticleId IdType="pubmed">18577263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Chan Y-T, Tan H-Y, Li S, Wang N, Feng Y. Epigenetic regulation in human cancer: The potential role of epi-drug in cancer therapy. Mol Cancer. 2020;19(1):79. 10.1186/s12943-020-01197-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184703</ArticleId><ArticleId IdType="pubmed">32340605</ArticleId></ArticleIdList></Reference><Reference><Citation>Luebben WR, Sharma N, Nyborg JK. Nucleosome eviction and activated transcription require p300 acetylation of histone H3 lysine 14. Proc Natl Acad Sci. 2010;107(45):19254&#x2013;9. 10.1073/pnas.1009650107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2984149</ArticleId><ArticleId IdType="pubmed">20974913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma B, Wang S, Wu W, Shan P, Chen Y, Meng J, Xing L, Yun J, Hao L, Wang X, Li S, Guo Y. Mechanisms of circRNA/lncRNA-miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162:114672. 10.1016/j.biopha.2023.114672.</Citation><ArticleIdList><ArticleId IdType="pubmed">37060662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Field NR, Xie T, Briscas S, Kokinogoulis EG, Skipper TS, Alghalayini A, Sarker FA, Tran N, Bowden NA, Dickson K-A, Marsh DJ. Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies&#x2014;Therapeutic Vulnerabilities in Treatment-Resistant Subtypes. Cancers. 2024;16(17):3068. 10.3390/cancers16173068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11393890</ArticleId><ArticleId IdType="pubmed">39272926</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddocks ODK, Labuschagne CF, Adams PD, Vousden KH. Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells. Mol Cell. 2016;61(2):210&#x2013;21. 10.1016/j.molcel.2015.12.014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728077</ArticleId><ArticleId IdType="pubmed">26774282</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhusudana Rao K, Krishna Rao KSV, Ramanjaneyulu G, Ha C-S. Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery. Int J Pharm. 2015;478(2):788&#x2013;95. 10.1016/j.ijpharm.2014.12.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">25528297</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboobnia K, Beveridge DJ, Yeoh GC, Kabir TD, Leedman PJ. MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities. Int J Mol Sci. 2024;25(17):9393. 10.3390/ijms25179393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11395074</ArticleId><ArticleId IdType="pubmed">39273339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud AM, Ali MM. Methyl Donor Micronutrients that Modify DNA Methylation and Cancer Outcome. Nutrients. 2019;11(3):608. 10.3390/nu11030608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6471069</ArticleId><ArticleId IdType="pubmed">30871166</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiti A, Drohat AC. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine. J Biol Chem. 2011;286(41):35334&#x2013;8. 10.1074/jbc.C111.284620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3195571</ArticleId><ArticleId IdType="pubmed">21862836</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, Hirata H, Li LC, Zhao H, Okino ST, Place RF, Pookot D, Dahiya R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Can Res. 2008;68(8):2736&#x2013;44. 10.1158/0008-5472.can-07-2290.</Citation><ArticleIdList><ArticleId IdType="pubmed">18413741</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 2010;116(1):66&#x2013;76. 10.1002/cncr.24662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954042</ArticleId><ArticleId IdType="pubmed">19885928</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra J, Nguyen D, Tan T, Semeniuk Iii GB. Management of KRAS-mutated non-small cell lung cancer. Clin Adv Hematol Oncol. 2024;22(2):67&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">38446474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancarella D, Plass C. Epigenetic signatures in cancer: Proper controls, current challenges and the potential for clinical translation. Genome Med. 2021;13(1):23. 10.1186/s13073-021-00837-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874645</ArticleId><ArticleId IdType="pubmed">33568205</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Davie JR. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells. J Cell Physiol. 2010;224(1):28&#x2013;32. 10.1002/jcp.22078.</Citation><ArticleIdList><ArticleId IdType="pubmed">20301197</ArticleId></ArticleIdList></Reference><Reference><Citation>Marechal A, Zou L. DNA Damage Sensing by the ATM and ATR Kinases. Cold Spring Harb Perspect Biol. 2013;5(9):a012716&#x2013;a012716. 10.1101/cshperspect.a012716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3753707</ArticleId><ArticleId IdType="pubmed">24003211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n-Garc&#xed;a PJ, Llobat L. How does protein nutrition affect the epigenetic changes in pig? A Review. Animals. 2021;11(2):544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923233</ArticleId><ArticleId IdType="pubmed">33669864</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino E, D&#x2019;Onofrio N, Balestrieri A, Colloca A, Anastasio C, Sardu C, Marfella R, Campanile G, Balestrieri ML. Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease. Nutrients. 2024;16(1):160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10780859</ArticleId><ArticleId IdType="pubmed">38201989</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk123. Am J Clin Nutr. 2009;89(2):624&#x2013;33. 10.3945/ajcn.2008.26568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2647765</ArticleId><ArticleId IdType="pubmed">19116331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangelo D, Pelosi E, Castelli G, Lo-Coco F, Testa U. Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation. Blood Cells Mol Dis. 2018;69:57&#x2013;64. 10.1016/j.bcmd.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">28954710</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavioglu N, Ramo-Fern&#xe1;ndez L, Gumpp A, Kolassa I-T, Karabatsiakis A. A history of childhood maltreatment is associated with altered DNA methylation levels of DNA methyltransferase 1 in maternal but not neonatal mononuclear immune cells. Front Psych. 2022. 10.3389/fpsyt.2022.945343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9685310</ArticleId><ArticleId IdType="pubmed">36440389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzio EA, Soliman KFA. Epigenetics and Nutritional Environmental Signals. Integr Comp Biol. 2014;54(1):21&#x2013;30. 10.1093/icb/icu049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4072902</ArticleId><ArticleId IdType="pubmed">24861811</ArticleId></ArticleIdList></Reference><Reference><Citation>Meadows, A. (2021). Nutrient<i> Sensing in Immune Function: A Systems Biology Approach</i> [PhD Thesis]. University of Cambridge.</Citation></Reference><Reference><Citation>Meeran SM, Patel SN, Tollefsbol TO. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS ONE. 2010;5(7):e11457. 10.1371/journal.pone.0011457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897894</ArticleId><ArticleId IdType="pubmed">20625516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehedint MG, Zeisel SH. Choline&#x2019;s role in maintaining liver function: New evidence for epigenetic mechanisms. Curr Opin Clin Nutr Metab Care. 2013;16(3):339&#x2013;45. 10.1097/MCO.0b013e3283600d46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729018</ArticleId><ArticleId IdType="pubmed">23493015</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier JL. Metabolic Mechanisms of Epigenetic Regulation. ACS Chem Biol. 2013;8(12):2607&#x2013;21. 10.1021/cb400689r.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918459</ArticleId><ArticleId IdType="pubmed">24228614</ArticleId></ArticleIdList></Reference><Reference><Citation>Mierziak J, Kostyn K, Boba A, Czemplik M, Kulma A, Wojtasik W. Influence of the Bioactive Diet Components on the Gene Expression Regulation. Nutrients. 2021;13(11):3673. 10.3390/nu13113673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619229</ArticleId><ArticleId IdType="pubmed">34835928</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen SU, Gillberg L, Lykkesfeldt J, Gr&#xf8;nb&#xe6;k K. The role of vitamin C in epigenetic cancer therapy. Free Radical Biol Med. 2021;170:179&#x2013;93. 10.1016/j.freeradbiomed.2021.03.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingay M, Chaturvedi A, Bilenky M, Cao Q, Jackson L, Hui T, Moksa M, Heravi-Moussavi A, Humphries RK, Heuser M, Hirst M. Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia. Leukemia. 2018;32(1):11&#x2013;20. 10.1038/leu.2017.171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770587</ArticleId><ArticleId IdType="pubmed">28663574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R. Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins. J Breast Cancer. 2013;16(1):23. 10.4048/jbc.2013.16.1.23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3625766</ArticleId><ArticleId IdType="pubmed">23593078</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett JR, Puthillathu N, Vengilote R, Jaworski DM, Namboodiri AM. Acetate revisited: A key biomolecule at the nexus of metabolism, epigenetics and oncogenesis&#x2014;Part 1: Acetyl-CoA, acetogenesis and acyl-CoA short-chain synthetases. Front Physiol. 2020;11:580167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689297</ArticleId><ArticleId IdType="pubmed">33281616</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongio&#xec; LM, La Vignera S, Cannarella R, Cimino L, Compagnone M, Condorelli RA, Calogero AE. The Role of Resveratrol Administration in Human Obesity. Int J Mol Sci. 2021;22(9):4362. 10.3390/ijms22094362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8122246</ArticleId><ArticleId IdType="pubmed">33921991</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers. 2021;13(3):514. 10.3390/cancers13030514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7866004</ArticleId><ArticleId IdType="pubmed">33572780</ArticleId></ArticleIdList></Reference><Reference><Citation>Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis. 2006;27(4):811&#x2013;9. 10.1093/carcin/bgi265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2276576</ArticleId><ArticleId IdType="pubmed">16280330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandakumar V, Vaid M, Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 2011;32(4):537&#x2013;44. 10.1093/carcin/bgq285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066414</ArticleId><ArticleId IdType="pubmed">21209038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LT, Lee Y-H, Sharma AR, Park J-B, Jagga S, Sharma G, Lee S-S, Nam J-S. Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity. Korean J Physiol Pharmacol. 2017;21(2):205&#x2013;13. 10.4196/kjpp.2017.21.2.205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5343054</ArticleId><ArticleId IdType="pubmed">28280414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson ML, Das S, Im KM, Turan S, Berndt SI, Li H, Lou H, Brodie SA, Billaud JN, Zhang T, Bouk AJ, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang WY, et al. TET2 binds the androgen receptor and loss is associated with prostate cancer. Oncogene. 2017;36(15):2172&#x2013;83. 10.1038/onc.2016.376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5391277</ArticleId><ArticleId IdType="pubmed">27819678</ArticleId></ArticleIdList></Reference><Reference><Citation>Niculescu MD, Lupu DS. Nutritional influence on epigenetics and effects on longevity. Curr Opin Clin Nutr Metab Care. 2011;14(1):35&#x2013;40. 10.1097/MCO.0b013e328340ff7c.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088573</ArticleId></ArticleIdList></Reference><Reference><Citation>Oommen AM, Griffin JB, Sarath G, Zempleni J. Roles for nutrients in epigenetic events. J Nutr Biochem. 2005;16(2):74&#x2013;7. 10.1016/j.jnutbio.2004.08.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">15681164</ArticleId></ArticleIdList></Reference><Reference><Citation>Opara JK, Sanchez S, Thomas SM, Anant S. Natural products targeting cancer stem cells: A promising therapeutic approach. Explor Drug Sci. 2025;3:1008106. 10.37349/eds.2025.1008106.</Citation></Reference><Reference><Citation>Palit D, Kundu S, Pain PK, Sarma R, Manna D. A chemical model of a TET enzyme for selective oxidation of hydroxymethyl cytosine to formyl cytosine. Inorg Chem. 2023;62(26):10039&#x2013;43. 10.1021/acs.inorgchem.3c00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">37339080</ArticleId></ArticleIdList></Reference><Reference><Citation>Paluszczak J, Krajka-Ku&#x17a;niak V, Baer-Dubowska W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett. 2010;192(2):119&#x2013;25. 10.1016/j.toxlet.2009.10.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">19840838</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M, Kaur P, Shukla S, Abbas A, Fu P, Gupta S. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study. Mol Carcinog. 2012;51(12):952&#x2013;62. 10.1002/mc.20866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019962</ArticleId><ArticleId IdType="pubmed">22006862</ArticleId></ArticleIdList></Reference><Reference><Citation>Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr. 2010;140(9):1607&#x2013;14. 10.3945/jn.110.123422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139234</ArticleId><ArticleId IdType="pubmed">20631324</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra S, Nayak R, Patro S, Pradhan B, Sahu B, Behera C, Bhutia SK, Jena M. Chemical diversity of dietary phytochemicals and their mode of chemoprevention. Biotechnol Rep. 2021;30:e00633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8167155</ArticleId><ArticleId IdType="pubmed">34094892</ArticleId></ArticleIdList></Reference><Reference><Citation>Pembrey M, Saffery R, Bygren LO, Network in Epigenetic Epidemiology, &amp; Network in Epigenetic Epidemiology. Human transgenerational responses to early-life experience: Potential impact on development, health and biomedical research. J Med Genet. 2014;51(9):563&#x2013;72. 10.1136/jmedgenet-2014-102577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157403</ArticleId><ArticleId IdType="pubmed">25062846</ArticleId></ArticleIdList></Reference><Reference><Citation>Perri F, Longo F, Giuliano M, Sabbatino F, Favia G, Ionna F, Addeo R, Scarpati GD, Di Lorenzo G, Pisconti S. Epigenetic control of gene expression: Potential implications for cancer treatment. Crit Rev Oncol Hematol. 2017;111(166):172. 10.1016/j.critrevonc.2017.01.020.</Citation><ArticleIdList><ArticleId IdType="pubmed">28259291</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran R, Thamarai R, Sivasamy S, Dhandayuthapani S, Batra J, Kamaraj C, Karthik K, Shah MA, Mallik S. Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy. Epigenetics Chromatin. 2024;17(1):31. 10.1186/s13072-024-00554-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11484394</ArticleId><ArticleId IdType="pubmed">39415281</ArticleId></ArticleIdList></Reference><Reference><Citation>Prachayasittikul V, Prathipati P, Pratiwi R, Phanus-umporn C, Malik AA, Schaduangrat N, Seenprachawong K, Wongchitrat P, Supokawej A, Prachayasittikul V, Wikberg JES, Nantasenamat C. Exploring the epigenetic drug discovery landscape. Expert Opin Drug Discov. 2017;12(4):345&#x2013;62. 10.1080/17460441.2017.1295954.</Citation><ArticleIdList><ArticleId IdType="pubmed">28276705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratheeshkumar P, Son Y-O, Divya SP, Wang L, Turcios L, Roy RV, Hitron JA, Kim D, Dai J, Asha P, Zhang Z, Shi X. Quercetin inhibits Cr(VI)-induced malignant cell transformation by targeting miR-21-PDCD4 signaling pathway. Oncotarget. 2017;8(32):52118&#x2013;31. 10.18632/oncotarget.10130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5581017</ArticleId><ArticleId IdType="pubmed">28881718</ArticleId></ArticleIdList></Reference><Reference><Citation>Pudenz M, Roth K, Gerhauser C. Impact of Soy Isoflavones on the Epigenome in Cancer Prevention. Nutrients. 2014;6(10):4218&#x2013;72. 10.3390/nu6104218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210915</ArticleId><ArticleId IdType="pubmed">25322458</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Q, Hu B, Jiang W, Wang Y, Yan J, Ma F, Guan Q, Xu J. Advances in Plant Epigenome Editing Research and Its Application in Plants. Int J Mol Sci. 2023;24(4):4. 10.3390/ijms24043442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9961165</ArticleId><ArticleId IdType="pubmed">36834852</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Zhu W, Shi H, Hewett JE, Ruhlen RL, MacDonald RS, Rottinghaus GE, Chen Y-C, Sauter ER. Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutr Cancer. 2009;61(2):238&#x2013;44. 10.1080/01635580802404196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3390914</ArticleId><ArticleId IdType="pubmed">19235040</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Zhang K, Clarke K, Weiland T, Sauter ER. Methylation and miRNA effects of resveratrol on mammary tumors vs Normal Tissue. Nutr Cancer. 2014;66(2):270&#x2013;7. 10.1080/01635581.2014.868910.</Citation><ArticleIdList><ArticleId IdType="pubmed">24447120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaiah MJ, Tangutur AD, Manyam RR. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Life Sci. 2021;277:119504. 10.1016/j.lfs.2021.119504.</Citation><ArticleIdList><ArticleId IdType="pubmed">33872660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramalho MJ, Alves B, Andrade S, Lima J, Loureiro JA, Pereira MC. Folic-Acid-Conjugated Poly (Lactic-Co-Glycolic Acid) Nanoparticles Loaded with Gallic Acid Induce Glioblastoma Cell Death by Reactive-Oxygen-Species-Induced Stress. Polymers. 2024;16(15):2161. 10.3390/polym16152161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11313823</ArticleId><ArticleId IdType="pubmed">39125187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramazi S, Allahverdi A, Zahiri J. Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders. J Biosci. 2020;45:135. 10.1007/s12038-020-00099-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33184251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramazi S, Dadzadi M, Sahafnejad Z, Allahverdi A. Epigenetic Regulation in Lung Cancer. Medcomm. 2023;4(6):e401. 10.1002/mco2.401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10600507</ArticleId><ArticleId IdType="pubmed">37901797</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid MA, Dai Z, Locasale JW. The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat Cell Biol. 2017;19(11):11. 10.1038/ncb3629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886854</ArticleId><ArticleId IdType="pubmed">29058720</ArticleId></ArticleIdList></Reference><Reference><Citation>Remely M, Lovrecic L, De La Garza AL, Migliore L, Peterlin B, Milagro FI, Martinez AJ, Haslberger AG. Therapeutic perspectives of epigenetically active nutrients. Br J Pharmacol. 2015;172(11):2756&#x2013;68. 10.1111/bph.12854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4439873</ArticleId><ArticleId IdType="pubmed">25046997</ArticleId></ArticleIdList></Reference><Reference><Citation>Reva K, Laranjinha J, Rocha BS. Epigenetic Modifications Induced by the Gut Microbiota May Result from What We Eat: Should We Talk about Precision Diet in Health and Disease? Metabolites. 2023;13(3):3. 10.3390/metabo13030375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10051796</ArticleId><ArticleId IdType="pubmed">36984815</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi G, Rossi M, Fendt S. Metabolic interactions in cancer: Cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape. Wires Syst Biol Med. 2018;10(1):e1397. 10.1002/wsbm.1397.</Citation><ArticleIdList><ArticleId IdType="pubmed">28857478</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberti A, Fern&#xe1;ndez AF, Fraga MF. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation. Mol Metab. 2021;45:101165. 10.1016/j.molmet.2021.101165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7868988</ArticleId><ArticleId IdType="pubmed">33453420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 2007;1(1):19&#x2013;25. 10.1016/j.molonc.2007.01.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543853</ArticleId><ArticleId IdType="pubmed">19383284</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy M, Mukherjee S. Reversal of resistance towards cisplatin by curcumin in cervical cancer cells. Asian Pac J Cancer Prev. 2014;15(3):1403&#x2013;10. 10.7314/apjcp.2014.15.3.1403.</Citation><ArticleIdList><ArticleId IdType="pubmed">24606473</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S, Deka D, Kondaveeti SB, Ayyadurai P, Siripragada S, Philip N, Pathak S, Duttaroy AK, Banerjee A. An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update. Epigenetics. 2025;20(1):2491316. 10.1080/15592294.2025.2491316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12005453</ArticleId><ArticleId IdType="pubmed">40239010</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo GL, Vastolo V, Ciccarelli M, Albano L, Macchia PE, Ungaro P. Dietary polyphenols and chromatin remodeling. Crit Rev Food Sci Nutr. 2017;57(12):2589&#x2013;99. 10.1080/10408398.2015.1062353.</Citation><ArticleIdList><ArticleId IdType="pubmed">26357880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sailo BL, Liu L, Chauhan S, Girisa S, Hegde M, Liang L, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review. Cancers. 2024;16(2):244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10814109</ArticleId><ArticleId IdType="pubmed">38254735</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J. Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines. 2018;6(3):91. 10.3390/biomedicines6030091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6164842</ArticleId><ArticleId IdType="pubmed">30205595</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmer&#xf3;n-B&#xe1;rcenas EG, Zacapala-G&#xf3;mez AE, Torres-Rojas FI, Antonio-V&#xe9;jar V, &#xc1;vila-L&#xf3;pez PA, Ba&#xf1;os-Hern&#xe1;ndez CJ, N&#xfa;&#xf1;ez-Mart&#xed;nez HN, Dircio-Maldonado R, Mart&#xed;nez-Carrillo DN, Ortiz-Ortiz J, Jim&#xe9;nez-Wences H. TET enzymes and 5hmC levels in carcinogenesis and progression of breast cancer: potential therapeutic targets. Int J Mol Sci. 2023;25(1):272. 10.3390/ijms25010272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10779134</ArticleId><ArticleId IdType="pubmed">38203443</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez H, Hossain MB, Lera L, Hirsch S, Albala C, Uauy R, Broberg K, Ronco AM. High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes p16, MLH1, and MGMT in elderly Chileans. Clin Epigenetics. 2017;9:74. 10.1186/s13148-017-0374-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5525256</ArticleId><ArticleId IdType="pubmed">28748002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasidharan Nair V, El Salhat H, Taha RZ, John A, Ali BR, Elkord E. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer. Clin Epigenetics. 2018;10:78. 10.1186/s13148-018-0512-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003083</ArticleId><ArticleId IdType="pubmed">29983831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry NG, Wan X, Huang T, Alvarez AA, Pangeni RP, Song X, James CD, Horbinski CM, Brennan CW, Nakano I, Hu B, Cheng S-Y. LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement. Neuro Oncol. 2020;22(9):1315&#x2013;26. 10.1093/neuonc/noaa032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523463</ArticleId><ArticleId IdType="pubmed">32055849</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz W, &amp; Hoffmann MJ (2025). DNA Methylation and Chromatin Regulators in Bladder Cancer (pp. 181&#x2013;217). 10.1007/978-3-031-68505-7_10</Citation></Reference><Reference><Citation>Schulz WA (2023). Cancer Genetics. In W. A. Schulz, <i>Molecular Biology of Human Cancers</i> (pp. 29&#x2013;49). Springer International Publishing. 10.1007/978-3-031-16286-2_2</Citation></Reference><Reference><Citation>Scuto A, Kirschbaum M, Buettner R, Kujawski M, Cermak JM, Atadja P, Jove R. SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-&#x3ba;B/STAT3 complex to its promoter in malignant lymphoid cells. Cell Death Dis. 2013;4(5):e635. 10.1038/cddis.2013.159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3674366</ArticleId><ArticleId IdType="pubmed">23681230</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidel C, Schnekenburger M, Dicato M, Diederich M. Histone deacetylase modulators provided by Mother Nature. Genes Nutr. 2012;7(3):3. 10.1007/s12263-012-0283-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380189</ArticleId><ArticleId IdType="pubmed">22328271</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafabakhsh R, Aghadavod E, Ghayour-Mobarhan M, Ferns G, Asemi Z. Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy. J Cell Physiol. 2019;234(6):7839&#x2013;46. 10.1002/jcp.27844.</Citation><ArticleIdList><ArticleId IdType="pubmed">30515789</ArticleId></ArticleIdList></Reference><Reference><Citation>Shechter D, Dormann HL, Allis CD, Hake SB. Extraction, purification and analysis of histones. Nat Protoc. 2007;2(6):1445&#x2013;57. 10.1038/nprot.2007.202.</Citation><ArticleIdList><ArticleId IdType="pubmed">17545981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J, Shi W, Guo H, Long W, Wang Y, Qi J, Liu J, Xu Y. The Inhibitory Effect of (-)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing SCUBE2 Methylation and DNMT Activity. Molecules. 2019;24(16):2899. 10.3390/molecules24162899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6719997</ArticleId><ArticleId IdType="pubmed">31404982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy N, Bhagat T, Nieves E, Stenson M, Lawson J, Choudhary GS, Habermann T, Nowakowski G, Singh R, Wu X, Verma A, Witzig TE. Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells. Blood Cancer J. 2017;7(7):e587. 10.1038/bcj.2017.65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549257</ArticleId><ArticleId IdType="pubmed">28731456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, Thurston A, Huntley JF, Rees WD, Maloney CA, Lea RG, Craigon J, McEvoy TG, Young LE. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci USA. 2007;104(49):19351&#x2013;6. 10.1073/pnas.0707258104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2148293</ArticleId><ArticleId IdType="pubmed">18042717</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem Pharmacol. 2011;82(12):1807&#x2013;21. 10.1016/j.bcp.2011.07.093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4082721</ArticleId><ArticleId IdType="pubmed">21827739</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh C, Sharma A, Bishnoi M, Kondepudi KK, &amp; Singh RP (2020). Nutrigenomics Approaches to Control Metabolic Diseases and Challenges to Personalized Nutritional Intervention. In T. R. Sharma, R. Deshmukh, &amp; H. Sonah (Eds.), <i>Advances in Agri-Food Biotechnology</i> (pp. 287&#x2013;332). Springer Singapore. 10.1007/978-981-15-2874-3_12</Citation></Reference><Reference><Citation>Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14(3):204&#x2013;20. 10.1038/nrg3354.</Citation><ArticleIdList><ArticleId IdType="pubmed">23400093</ArticleId></ArticleIdList></Reference><Reference><Citation>Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W. The ten-eleven translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia. 2014;28(3):485&#x2013;96. 10.1038/leu.2013.337.</Citation><ArticleIdList><ArticleId IdType="pubmed">24220273</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K, Haslberger A. Epigenetic mechanisms in anti-cancer actions of bioactive food components&#x2014;The implications in cancer prevention. Br J Pharmacol. 2012;167(2):279&#x2013;97. 10.1111/j.1476-5381.2012.02002.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3481038</ArticleId><ArticleId IdType="pubmed">22536923</ArticleId></ArticleIdList></Reference><Reference><Citation>Steluti J, Palchetti CZ, Miranda AM, Fisberg RM, Marchioni DM. DNA methylation and one-carbon metabolism related nutrients and polymorphisms: Analysis after mandatory flour fortification with folic acid. Br J Nutr. 2020;123(1):23&#x2013;9. 10.1017/S0007114519002526.</Citation><ArticleIdList><ArticleId IdType="pubmed">31583988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagde P, Kulkarni GT, Mishra DK, Kesharwani P. Recent advances in folic acid engineered nanocarriers for treatment of breast cancer. J Drug Deliv Sci Technol. 2020;56:101613. 10.1016/j.jddst.2020.101613.</Citation></Reference><Reference><Citation>Tan S, Wang C, Lu C, Zhao B, Cui Y, Shi X, Ma X. Quercetin is able to demethylate the p16INK4a gene promoter. Chemotherapy. 2009;55(1):6&#x2013;10. 10.1159/000166383.</Citation><ArticleIdList><ArticleId IdType="pubmed">18974642</ArticleId></ArticleIdList></Reference><Reference><Citation>Teegarden D, Romieu I, Leli&#xe8;vre SA. Redefining the impact of nutrition on breast cancer incidence: Is epigenetics involved? Nutr Res Rev. 2012;25(1):68&#x2013;95. 10.1017/S0954422411000199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090752</ArticleId><ArticleId IdType="pubmed">22853843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiffon C. The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease. Int J Mol Sci. 2018;19(11):3425. 10.3390/ijms19113425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6275017</ArticleId><ArticleId IdType="pubmed">30388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Toufektchan E, Toledo F. The Guardian of the Genome Revisited: P53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure. Cancers. 2018;10(5):135. 10.3390/cancers10050135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977108</ArticleId><ArticleId IdType="pubmed">29734785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuli HS, Garg VK, Bhushan S, Uttam V, Sharma U, Jain A, Sak K, Yadav V, Lorenzo JM, Dhama K, Behl T, Sethi G. Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection. Transl Oncol. 2023;27:101596. 10.1016/j.tranon.2022.101596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9727168</ArticleId><ArticleId IdType="pubmed">36473401</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tongelen A, Loriot A, De Smet C. Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Lett. 2017;396:130&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28342986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ur Rehman S, Abdullah M, Shurovi M. The role of DNA methylation and histone modifications in the pathogenesis of hematological malignancies and solid cancers: mechanisms, clinical implications, and therapeutic potential. Asian J Med Biol Res. 2025;11:23&#x2013;36. 10.3329/ajmbr.v11i2.79668.</Citation></Reference><Reference><Citation>Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, Boiteux J-P, Fontana L, Bignon Y-J, Guy L, Bernard-Gallon DJ. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo. 2010;24(4):393&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">20668305</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasanthakumar A, Godley LA. 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy. Cancer Genet. 2015;208(5):167&#x2013;77. 10.1016/j.cancergen.2015.02.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">25892122</ArticleId></ArticleIdList></Reference><Reference><Citation>vel Szic KS, Declerck K, Vidakovi&#x107; M, &amp; Vanden Berghe W 2015 From inflammaging to healthy aging by dietary lifestyle choices: Is epigenetics the key to personalized nutrition? Clin Epigenetics 7 1 33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4389409</ArticleId><ArticleId IdType="pubmed">25861393</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Berger A, B&#xf6;cker A, Busch C, Weiland T, Noor S, Leischner C, Schleicher S, Mayer M, Weiss TS, Bischoff SC, Lauer UM, Bitzer M. Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells. PLoS ONE. 2013;8(8):e73097. 10.1371/journal.pone.0073097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3758278</ArticleId><ArticleId IdType="pubmed">24023672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: Mechanisms, structures and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92. 10.1038/s41392-023-01347-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9977964</ArticleId><ArticleId IdType="pubmed">36859359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wettergren Y, Rolny P, Lindegren H, Odin E, Rotter Sopasakis V, Keane S, Ejesk&#xe4;r K. Increased MLH1, MGMT, and p16INK4a methylation levels in colon mucosa potentially useful as early risk marker of colon cancer. Mol Cell Oncol. 2025;12(1):2503069. 10.1080/23723556.2025.2503069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12068326</ArticleId><ArticleId IdType="pubmed">40357388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G. Functional Amino Acids in Growth, Reproduction, and Health. Adv Nutr. 2010;1(1):31&#x2013;7. 10.3945/an.110.1008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3042786</ArticleId><ArticleId IdType="pubmed">22043449</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, Bazer FW, Wallace JM, Spencer TE. Board-invited review: Intrauterine growth retardation: implications for the animal sciences. J Anim Sci. 2006;84(9):2316&#x2013;37. 10.2527/jas.2006-156.</Citation><ArticleIdList><ArticleId IdType="pubmed">16908634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Gao Z-J, Yu X, Wang P. Dietary regulation in health and disease. Signal Transduct Target Ther. 2022;7(1):252. 10.1038/s41392-022-01104-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308782</ArticleId><ArticleId IdType="pubmed">35871218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-L, Lin Z-J, Li C-C, Lin X, Shan S-K, Guo B, Zheng M-H, Li F, Yuan L-Q, Li Z. Epigenetic regulation in metabolic diseases: Mechanisms and advances in clinical study. Signal Transduct Target Ther. 2023;8(1):1. 10.1038/s41392-023-01333-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981733</ArticleId><ArticleId IdType="pubmed">36864020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Huang D, Wang J, Zhao Y, Sun W, Shen X. Engineering Heterogeneous Tumor Models for Biomedical Applications. Adv Sci. 2024;11(1):2304160. 10.1002/advs.202304160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10767453</ArticleId><ArticleId IdType="pubmed">37946674</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Wu G, Zhou Z, Zhang X, Wang Y, Song G, Ding E, Sun X, Zhong L, Li S, Weng J, Zhu Z, Chen J, Wang X. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial&#x2013;mesenchymal transition and promotes metastasis of colorectal cancer. Cell Death Dis. 2019;10(11):11. 10.1038/s41419-019-2070-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6828677</ArticleId><ArticleId IdType="pubmed">31685801</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Liu Y, Bai F, Zhang J-Y, Ma S-H, Liu J, Xu Z-D, Zhu H-G, Ling Z-Q, Ye D, Guan K-L, Xiong Y. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663&#x2013;9. 10.1038/onc.2012.67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3897214</ArticleId><ArticleId IdType="pubmed">22391558</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AY, Kim H, Li W, Kong A-NT. Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers. Curr Top Med Chem. 2016;16(7):697&#x2013;713. 10.2174/1568026615666150826114359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955582</ArticleId><ArticleId IdType="pubmed">26306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zhang M, Wang Y. The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy. J Natl Cancer Center. 2022;2(4):277&#x2013;90. 10.1016/j.jncc.2022.09.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11256729</ArticleId><ArticleId IdType="pubmed">39036551</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Hu L, Xu Y. Structure and function of TET enzymes. Adv Exp Med Biol. 2022;1389:239&#x2013;67. 10.1007/978-3-031-11454-0_10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36350513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Hon GC, Szulwach KE, Song C-X, Zhang L, Kim A, Li X, Dai Q, Shen Y, Park B, Min J-H, Jin P, Ren B, He C. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. 2012;149(6):1368&#x2013;80. 10.1016/j.cell.2012.04.027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3589129</ArticleId><ArticleId IdType="pubmed">22608086</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Zhao H, Wang R, Chen Y, Ouyang X, Li W, Sun Y, Peng A. Cancer epigenetics: From laboratory studies and clinical trials to precision medicine. Cell Death Discov. 2024;10(1):28. 10.1038/s41420-024-01803-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10789753</ArticleId><ArticleId IdType="pubmed">38225241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacapala-G&#xf3;mez AE, Mendoza-Catal&#xe1;n MA, Antonio-V&#xe9;jar V, Jim&#xe9;nez-Wences H, Ort&#xed;z-Ort&#xed;z J, &#xc1;vila-L&#xf3;pez PA, Ba&#xf1;os-Hern&#xe1;ndez CJ, Salmer&#xf3;n-B&#xe1;rcenas EG. TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers. Eur Rev Med Pharmacol Sci. 2024;28(3):1123&#x2013;34. 10.26355/eurrev_202402_35349.</Citation><ArticleIdList><ArticleId IdType="pubmed">38375718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadi Heydarabad M, Nikasa M, Vatanmakanian M, Azimi A, Farshdousti Hagh M. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective. J Cell Biochem. 2018;119(6):4890&#x2013;6. 10.1002/jcb.26709.</Citation><ArticleIdList><ArticleId IdType="pubmed">29377275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaiou M, Amrani R, Rihn B, Hajri T. Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. Biomedicines. 2021;9(9):1256. 10.3390/biomedicines9091256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8468830</ArticleId><ArticleId IdType="pubmed">34572442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel SH. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr. 2009;89(5):1488S-1493S. 10.3945/ajcn.2009.27113B.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677001</ArticleId><ArticleId IdType="pubmed">19261726</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N. Epigenetic modulation of DNA methylation by nutrition and its mechanisms in animals. Anim Nutr. 2015;1(3):144&#x2013;51. 10.1016/j.aninu.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5945948</ArticleId><ArticleId IdType="pubmed">29767106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE. Plasma Folate, Vitamin B6, Vitamin B12, Homocysteine, and Risk of Breast Cancer. J Natl Cancer Inst. 2003;95(5):373&#x2013;80. 10.1093/jnci/95.5.373.</Citation><ArticleIdList><ArticleId IdType="pubmed">12618502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Su Z-Y, Khor TO, Shu L, Kong A-NT. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem Pharmacol. 2013;85(9):1398&#x2013;404. 10.1016/j.bcp.2013.02.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4123317</ArticleId><ArticleId IdType="pubmed">23416117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, An X, Li Z, Zhang S. Role of gene promoter methylation regulated by TETs and DNMTs in the overexpression of HLA-G in MCF-7 cells. Exp Ther Med. 2019;17(6):4709&#x2013;14. 10.3892/etm.2019.7481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6489065</ArticleId><ArticleId IdType="pubmed">31086605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang Y, Wang C, Wang X. TET (ten-eleven translocation) family proteins: structure, biological functions and applications. Signal Transduct Target Ther. 2023;8(1):297. 10.1038/s41392-023-01537-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10415333</ArticleId><ArticleId IdType="pubmed">37563110</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li S, Shi J, Guo H, Wang B, Geng C. The LncRNA RMST-miR-4295-ITPR1 axis: A key mechanism in regulating autophagy in triple-negative breast cancer cells. BMC Cancer. 2025;25(1):782. 10.1186/s12885-025-14189-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12034165</ArticleId><ArticleId IdType="pubmed">40287640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Zhao H, Zhao Y, Sui M, Liu J, Li P, Liu N, Zhang K. Role of ginseng, quercetin, and tea in enhancing chemotherapeutic efficacy of colorectal cancer. Front Med. 2022;9:939424. 10.3389/fmed.2022.939424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252166</ArticleId><ArticleId IdType="pubmed">35795631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Hao Q, Lu H. Mutant p53 in cancer therapy&#x2014;The barrier or the path. J Mol Cell Biol. 2019;11(4):293&#x2013;305. 10.1093/jmcb/mjy072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487791</ArticleId><ArticleId IdType="pubmed">30508182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Jiao D, Dou M, Zhang W, Lv L, Chen J, Li L, Wang L, Han X. Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression. J Cell Mol Med. 2020;24(18):10648&#x2013;62. 10.1111/jcmm.15683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521266</ArticleId><ArticleId IdType="pubmed">32725802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D-D, Luo M, Huang S-Y, Saimaiti A, Shang A, Gan R-Y, Li H-B. Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases. Oxid Med Cell Longev. 2021;2021:9932218. 10.1155/2021/9932218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8289612</ArticleId><ArticleId IdType="pubmed">34336123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20(1):143. 10.1186/s12943-021-01441-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8571891</ArticleId><ArticleId IdType="pubmed">34742312</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40647494</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>13</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>Ultra-Processed Diets and Endocrine Disruption, Explanation of Missing Link in Rising Cancer Incidence Among Young Adults.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2196</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers17132196</ELocationID><Abstract><AbstractText>The global increase in early-onset cancers among adolescents and young adults has happened at the same time as the rise in the consumption of ultra-processed foods (UPFs). Far beyond their poor nutritional quality, UPFs are increasingly seen as Trojan horses, complex biological agents that interfere with many functions of the human organism. In this review, we utilise the Trojan horse model to explain the quiet and building health risks from UPFs as foods that seem harmless, convenient, and affordable while secretly delivering endocrine-disrupting chemicals (EDCs), causing chronic low-grade inflammation, altering the microbiome, and producing epigenetic alterations. We bring together new proof showing that UPFs mess up hormonal signals, harm the body's ability to fight off harmful germs, lead to an imbalance of microbes, and cause detrimental changes linked to cancer. Important components, such as bisphenols and phthalates, can migrate from containers into food, while additional ingredients and effects from cooking disrupt the normal balance of cells. These exposures are especially harmful during vulnerable developmental periods and may lay the groundwork for disease many years later. The Trojan horse model illustrates the hidden nature of UPF-related damage, not through a sudden toxin but via chronic dysregulation of metabolic, hormonal, and genetic control. This model changes focus from usual diet worries to a bigger-picture view of UPFs as causes of life-disrupting damage. Ultimately, this review aims to identify gaps in current knowledge and epidemiological approaches and highlight the need for multi-omics, long-term studies and personalised nutrition plans to assess and reduce the cancer risk associated with UPFs. Recognising UPFs as a silent disruptor is crucial in shaping public health policies and cancer prevention programs targeting younger people.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fajki&#x107;</LastName><ForeName>Almir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3722-9701</Identifier><AffiliationInfo><Affiliation>Department of Pathophysiology, Faculty of Medicine, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepara</LastName><ForeName>Orhan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Human Physiology, Faculty of Medicine, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahi&#x107;</LastName><ForeName>Rijad</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Clinical Center Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Had&#x17e;ovi&#x107;-D&#x17e;uvo</LastName><ForeName>Almira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human Physiology, Faculty of Medicine, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belan&#x10d;i&#x107;</LastName><ForeName>Andrej</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7848-6600</Identifier><AffiliationInfo><Affiliation>Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, Brace Branchetta 20, 51000 Rijeka, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chupin</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0804-8039</Identifier><AffiliationInfo><Affiliation>Peoples' Friendship University of Russia (RUDN University), Moscow 117198, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavkovi&#x107;</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>International Society of Engineering Science and Technology, Nottingham NG11 8NE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sher</LastName><ForeName>Emina Karahmet</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0002-0913-5759</Identifier><AffiliationInfo><Affiliation>International Society of Engineering Science and Technology, Nottingham NG11 8NE, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Trojan horse model</Keyword><Keyword MajorTopicYN="N">early-onset cancer</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">ultra-processed foods: endocrine-disrupting chemicals</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40647494</ArticleId><ArticleId IdType="pmc">PMC12249071</ArticleId><ArticleId IdType="doi">10.3390/cancers17132196</ArticleId><ArticleId IdType="pii">cancers17132196</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gibney M.J. Ultra-processed foods: Definitions and policy issues. Curr. Dev. Nutr. 2018;3:nzy077. doi: 10.1093/cdn/nzy077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cdn/nzy077</ArticleId><ArticleId IdType="pmc">PMC6389637</ArticleId><ArticleId IdType="pubmed">30820487</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzi F., Magkos F., Fava F., Milani G.P., Agostoni C., Astrup A., Saguy I.S. A multidisciplinary perspective of ultra-processed foods and associated food processing technologies: A view of the sustainable road ahead. Nutrients. 2021;13:3948. doi: 10.3390/nu13113948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113948</ArticleId><ArticleId IdType="pmc">PMC8619086</ArticleId><ArticleId IdType="pubmed">34836203</ArticleId></ArticleIdList></Reference><Reference><Citation>Henney A.E., Gillespie C.S., Alam U., Hydes T.J., Boyland E., Cuthbertson D.J. Ultra-processed food and non-communicable diseases in the United Kingdom: A narrative review and thematic synthesis of literature. Obes. Rev. 2024;25:e13682. doi: 10.1111/obr.13682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13682</ArticleId><ArticleId IdType="pubmed">38204299</ArticleId></ArticleIdList></Reference><Reference><Citation>Paramasivam A., Murugan R., Jeraud M., Dakkumadugula A., Periyasamy R., Arjunan S. Additives in processed foods as a potential source of endocrine-disrupting chemicals: A review. J. Xenobiot. 2024;14:1697&#x2013;1710. doi: 10.3390/jox14040090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jox14040090</ArticleId><ArticleId IdType="pmc">PMC11587131</ArticleId><ArticleId IdType="pubmed">39584955</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondinella D., Raoul P.C., Valeriani E., Proietti S., Scazzocchio B., Masella R. The detrimental impact of ultra-processed foods on the human gut microbiome and gut barrier. Nutrients. 2025;17:859. doi: 10.3390/nu17050859.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu17050859</ArticleId><ArticleId IdType="pmc">PMC11901572</ArticleId><ArticleId IdType="pubmed">40077728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia S., Pappo A.S., Acquazzino M., Allen-Rhoades W.A., Barnett M., Borinstein S.C., Casey R., Choo S., Chugh R., Dinner S., et al. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2023;21:851&#x2013;880. doi: 10.6004/jnccn.2023.0040.</Citation><ArticleIdList><ArticleId IdType="doi">10.6004/jnccn.2023.0040</ArticleId><ArticleId IdType="pubmed">37549914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes T., Harper A., Gupta S., Frazier A.L., van der Graaf W.T.A., Moreno F., Joseph A., Fidler-Benaoudia M.M. The current and future global burden of cancer among adolescents and young adults: A population-based study. Lancet Oncol. 2024;25:1614&#x2013;1624. doi: 10.1016/S1470-2045(24)00523-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(24)00523-0</ArticleId><ArticleId IdType="pubmed">39557059</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Kuang X. Global cancer statistics of young adults and its changes in the past decade: Incidence and mortality from GLOBOCAN 2022. Public Health. 2024;237:336&#x2013;343. doi: 10.1016/j.puhe.2024.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2024.10.033</ArticleId><ArticleId IdType="pubmed">39515218</ArticleId></ArticleIdList></Reference><Reference><Citation>di Martino E., Smith L., Bradley S.H., Hemphill S., Wright J., Renzi C., Bergin R., Emery J., Neal R.D. Incidence trends for twelve cancers in younger adults&#x2014;A rapid review. Br. J. Cancer. 2022;126:1374&#x2013;1386. doi: 10.1038/s41416-022-01704-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-022-01704-x</ArticleId><ArticleId IdType="pmc">PMC9090760</ArticleId><ArticleId IdType="pubmed">35132237</ArticleId></ArticleIdList></Reference><Reference><Citation>Toss A., Piombino C., Quarello P., Trama A., Mascarin M., Lambertini M., Canesi M., Incorvaia L., Milano G.M., Maruzzo M., et al. Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working Group. Eur. J. Cancer. 2024;212:115042. doi: 10.1016/j.ejca.2024.115042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2024.115042</ArticleId><ArticleId IdType="pubmed">39362174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord S.R., Harris A.L. Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? Br. J. Cancer. 2023;128:958&#x2013;966. doi: 10.1038/s41416-023-02204-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-023-02204-2</ArticleId><ArticleId IdType="pmc">PMC10006178</ArticleId><ArticleId IdType="pubmed">36823364</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.T., Pham Y.T.-H., Le L.T., Dao H.V., Koriyama C., Ha T.H., Lichtveld M., Kuchipudi S.V., Huynh N.Y.-N., Nguyen D.D., et al. Factors affecting cancer mortality in young adults: Findings from a prospective cohort study. Cancers. 2024;16:3853. doi: 10.3390/cancers16223853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16223853</ArticleId><ArticleId IdType="pmc">PMC11593055</ArticleId><ArticleId IdType="pubmed">39594808</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha L.L., Grat&#xe3;o L.H.A., do Carmo A.S., Costa A.B.P., de Freitas Cunha C., de Oliveira T.R.P.R., Mendes L.L. School Type, Eating Habits, and Screen Time are Associated with Ultra-Processed Food Consumption among Brazilian Adolescents. J. Acad. Nutr. Diet. 2021;121:1136&#x2013;1142. doi: 10.1016/j.jand.2020.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jand.2020.12.010</ArticleId><ArticleId IdType="pubmed">33516640</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira R.R., Peter N.B., Muniz L.C. Food consumption according to the level of processing among adolescents from the rural area of a municipality in the south of Brazil. Cienc. Saude Coletiva. 2021;26:1105&#x2013;1114. doi: 10.1590/1413-81232021263.06502019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1413-81232021263.06502019</ArticleId><ArticleId IdType="pubmed">33729363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez Steele E., Khandpur N., da Costa Louzada M.L., Monteiro C.A. Association between dietary contribution of ultra-processed foods and urinary concentrations of phthalates and bisphenol in a nationally representative sample of the US population aged 6 years and older. PLoS ONE. 2020;15:e0236738. doi: 10.1371/journal.pone.0236738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236738</ArticleId><ArticleId IdType="pmc">PMC7394369</ArticleId><ArticleId IdType="pubmed">32735599</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa R.D.S., Bragan&#xe7;a M.L.B.M., Oliveira B.R.D., Coelho C.C.N.D.S., Silva A.A.M.D. Association between the Degree of Processing of Consumed Foods and Sleep Quality in Adolescents. Nutrients. 2020;12:462. doi: 10.3390/nu12020462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020462</ArticleId><ArticleId IdType="pmc">PMC7071336</ArticleId><ArticleId IdType="pubmed">32059416</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola P.C.D.A.F., de Carvalho C.A., Bragan&#xe7;a M.L.B.M., da Cunha Fran&#xe7;a A.K.T., de Britto M.T.S.S., da Silva A.A.M. High consumption of ultra-processed foods is associated with lower muscle mass in Brazilian adolescents in the RPS birth cohort. Nutrition. 2020;79&#x2013;80:110983. doi: 10.1016/j.nut.2020.110983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.110983</ArticleId><ArticleId IdType="pubmed">32942129</ArticleId></ArticleIdList></Reference><Reference><Citation>Enes C.C., Camargo C.M.D., Justino M.I.C. Ultra-processed food consumption and obesity in adolescents. Rev. Nutr. 2019;32:e18170. doi: 10.1590/1678-9865201932e180170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-9865201932e180170</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo A.S., Neves F.S., Batista A.P., Machado-Coelho G.L.L., Sartorelli D.S., de Faria E.R., Netto M.P., Oliveira R.M., Fontes V.S., C&#xe2;ndido A.P.C. Percentage of energy contribution according to the degree of industrial food processing and associated factors in adolescents (EVA-JF study, Brazil) Public Health Nutr. 2021;24:4220&#x2013;4229. doi: 10.1017/S1368980021000100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980021000100</ArticleId><ArticleId IdType="pmc">PMC10195385</ArticleId><ArticleId IdType="pubmed">33436138</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;avila H.F., Kirsten V.R. Energy intake from ultra-processed foods among adolescents. Rev. Paul. Pediatr. 2017;35:54&#x2013;60. doi: 10.1590/1984-0462/;2017;35;1;00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1984-0462/;2017;35;1;00001</ArticleId><ArticleId IdType="pmc">PMC5417810</ArticleId><ArticleId IdType="pubmed">28977317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauber F., Martins C.A., Azeredo C.M., Leffa P.S., da Costa Louzada M.L., Levy R.B. Eating context and ultraprocessed food consumption among UK adolescents. Br. J. Nutr. 2022;127:112&#x2013;122. doi: 10.1017/S0007114521000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114521000854</ArticleId><ArticleId IdType="pubmed">33691816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanjohi M.N., Asiki G., Wilunda C., Holdsworth M., Pradeilles R., Paulo L.S., Langat N., Amugsi D.A., Kimenju S., Kimani-Murage E.W., et al. Ultra-processed food consumption is associated with poor diet quality and nutrient intake among adolescents in urban slums, Kenya. Int. J. Public Health. 2025;69:1607891. doi: 10.3389/ijph.2024.1607891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2024.1607891</ArticleId><ArticleId IdType="pmc">PMC11919627</ArticleId><ArticleId IdType="pubmed">40110341</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K., Gunter M.J., Rauber F., Millett C., Imamura F., Shi Z., Scarborough P., Monteiro C.A., Forouhi N.G. Ultra-processed food consumption, cancer risk and cancer mortality: A large-scale prospective analysis within the UK Biobank. EClinicalMedicine. 2023;56:101840. doi: 10.1016/j.eclinm.2023.101840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101840</ArticleId><ArticleId IdType="pmc">PMC9985039</ArticleId><ArticleId IdType="pubmed">36880051</ArticleId></ArticleIdList></Reference><Reference><Citation>Aramburu A., Alvarado-Gamarra G., Cornejo R., Curi-Quinto K., D&#xed;az-Parra C.D.P., Rojas- Limache G., Lanata C.F. Ultra-processed foods consumption and health-related outcomes: A systematic review of randomised controlled trials. Front. Nutr. 2024;11:1421728. doi: 10.3389/fnut.2024.1421728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2024.1421728</ArticleId><ArticleId IdType="pmc">PMC11233771</ArticleId><ArticleId IdType="pubmed">38988861</ArticleId></ArticleIdList></Reference><Reference><Citation>Fardet A. Ultra-processing should be understood as a holistic issue, from food matrix, to dietary patterns, food scoring, and food systems. J. Food Sci. 2024;89:4563&#x2013;4573. doi: 10.1111/1750-3841.17139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1750-3841.17139</ArticleId><ArticleId IdType="pubmed">38829743</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro C.A., Cannon G., Levy R.B., Moubarac J.-C., Louzada M.L.C., Rauber F., Khandpur N., Cediel G., Neri D., Martinez-Steele E., et al. Ultra-processed foods: What they are and how to identify them. Public Health Nutr. 2019;22:936&#x2013;941. doi: 10.1017/S1368980018003762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980018003762</ArticleId><ArticleId IdType="pmc">PMC10260459</ArticleId><ArticleId IdType="pubmed">30744710</ArticleId></ArticleIdList></Reference><Reference><Citation>Braesco V., Souchon I., Sauvant P., Haurogn&#xe9; T., Maillot M., F&#xe9;art C., Darmon N. Ultra-processed foods: How functional is the NOVA system? Eur. J. Clin. Nutr. 2022;76:1245&#x2013;1253. doi: 10.1038/s41430-022-01099-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-022-01099-1</ArticleId><ArticleId IdType="pmc">PMC9436773</ArticleId><ArticleId IdType="pubmed">35314769</ArticleId></ArticleIdList></Reference><Reference><Citation>Egnell M., Kesse-Guyot E., Galan P., Touvier M., Rayner M., Jewell J., Breda J., Hercberg S., Julia C. Impact of Front-of-Pack Nutrition Labels on Portion Size Selection: An Experimental Study in a French Cohort. Nutrients. 2018;10:1268. doi: 10.3390/nu10091268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10091268</ArticleId><ArticleId IdType="pmc">PMC6165438</ArticleId><ArticleId IdType="pubmed">30205548</ArticleId></ArticleIdList></Reference><Reference><Citation>McClements D.J. Ultraprocessed plant-based foods: Designing the next generation of healthy and sustainable alternatives to animal-based foods. Compr. Rev. Food Sci. Food Saf. 2023;22:3531&#x2013;3559. doi: 10.1111/1541-4337.13204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1541-4337.13204</ArticleId><ArticleId IdType="pubmed">37350040</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy R.B., Barata M.F., Leite M.A., Andrade G.C. How and why ultra-processed foods harm human health. Proc. Nutr. Soc. 2024;83:1&#x2013;8. doi: 10.1017/S0029665123003567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665123003567</ArticleId><ArticleId IdType="pubmed">37424296</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafner E., Hribar M., Pravst I. Ultra-Processed Foods in the Food Supply: Prevalence, Nutritional Composition and Use of Voluntary Labelling Schemes. Nutrients. 2025;17:1731. doi: 10.3390/nu17101731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu17101731</ArticleId><ArticleId IdType="pmc">PMC12113896</ArticleId><ArticleId IdType="pubmed">40431470</ArticleId></ArticleIdList></Reference><Reference><Citation>Viennois E., Merlin D., Gewirtz A.T., Chassaing B. Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Res. 2017;77:27&#x2013;40. doi: 10.1158/0008-5472.CAN-16-1359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-16-1359</ArticleId><ArticleId IdType="pmc">PMC5214513</ArticleId><ArticleId IdType="pubmed">27821485</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai S., Wellens J., Yang N., Li D., Wang J., Wang L., Yuan S., He Y., Song P., Munger R., et al. Ultra-processed foods and human health: An umbrella review and updated meta-analyses of observational evidence. Clin. Nutr. 2024;43:1386&#x2013;1394. doi: 10.1016/j.clnu.2024.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2024.04.016</ArticleId><ArticleId IdType="pubmed">38688162</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson E., Cummings J.R., Gough T., Jones A., Evans R. Consumer Awareness, Perceptions and Avoidance of Ultra-Processed Foods: A Study of UK Adults in 2024. Foods. 2024;13:2317. doi: 10.3390/foods13152317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods13152317</ArticleId><ArticleId IdType="pmc">PMC11311829</ArticleId><ArticleId IdType="pubmed">39123509</ArticleId></ArticleIdList></Reference><Reference><Citation>Juul F., Bere E. Ultra-processed foods&#x2014;A scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2024;68:10&#x2013;29219. doi: 10.29219/fnr.v68.10616.</Citation><ArticleIdList><ArticleId IdType="doi">10.29219/fnr.v68.10616</ArticleId><ArticleId IdType="pmc">PMC11077402</ArticleId><ArticleId IdType="pubmed">38720949</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignesh A., Amal T.C., Vasanth K. Food contaminants: Impact of food processing, challenges and mitigation strategies for food security. Food Res. Int. 2024;191:114739. doi: 10.1016/j.foodres.2024.114739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2024.114739</ArticleId><ArticleId IdType="pubmed">39059927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubbink J., Levine A.S. From Processed Foods to Ultraprocessed Foods: Evolution of an Industry Model and Impact on Dietary Quality, Health, and Society. Annu. Rev. Food Sci. Technol. 2025;16:1&#x2013;24. doi: 10.1146/annurev-food-111523-122028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-food-111523-122028</ArticleId><ArticleId IdType="pubmed">39536090</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Gialluisi A., Di Castelnuovo A., Costanzo S., Pepe A., Ruggiero E., De Curtis A., Persichillo M., Cerletti C., Donati M.B., et al. Ultra-processed food consumption is associated with the acceleration of biological aging in the Moli-sani Study. Am. J. Clin. Nutr. 2024;120:1432&#x2013;1440. doi: 10.1016/j.ajcnut.2024.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajcnut.2024.10.006</ArticleId><ArticleId IdType="pubmed">39500680</ArticleId></ArticleIdList></Reference><Reference><Citation>Melough M.M., Maffini M.V., Otten J.J., Sathyanarayana S. Diet quality and exposure to endocrine-disrupting chemicals among US adults. Env. Res. 2022;211:113049. doi: 10.1016/j.envres.2022.113049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2022.113049</ArticleId><ArticleId IdType="pubmed">35240113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Gui W., Liu S., Zhao F., Fan W., Jing F., Sun C. Ultra-processed foods intake and sex hormone levels among children and adolescents aged 6&#x2013;19&#x2009;years: A cross-sectional study. Front. Nutr. 2024;11:1451481. doi: 10.3389/fnut.2024.1451481.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2024.1451481</ArticleId><ArticleId IdType="pmc">PMC11412839</ArticleId><ArticleId IdType="pubmed">39309139</ArticleId></ArticleIdList></Reference><Reference><Citation>Oviedo-Sol&#xed;s C.I., Monterrubio-Flores E.A., Cediel G., Denova-Guti&#xe9;rrez E., Barquera S. Trend of Ultraprocessed Product Intake Is Associated with the Double Burden of Malnutrition in Mexican Children and Adolescents. Nutrients. 2022;14:4347. doi: 10.3390/nu14204347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14204347</ArticleId><ArticleId IdType="pmc">PMC9607204</ArticleId><ArticleId IdType="pubmed">36297032</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce E.N. Endocrine Disruptors and Thyroid Health. Endocr. Pract. 2024;30:172&#x2013;176. doi: 10.1016/j.eprac.2023.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2023.11.002</ArticleId><ArticleId IdType="pubmed">37956907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagarde F., Beausoleil C., Belcher S.M., Belzunces L.P., Emond C., Guerbet M., Rousselle C. Non-monotonic dose-response relationships and endocrine disruptors: A qualitative method of assessment. Environ. Health. 2015;14:13. doi: 10.1186/1476-069X-14-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-069X-14-13</ArticleId><ArticleId IdType="pmc">PMC4429934</ArticleId><ArticleId IdType="pubmed">25971433</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz B., Terekeci H., Sandal S., Kelestimur F. Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev. Endocr. Metab. Disord. 2020;21:127&#x2013;147. doi: 10.1007/s11154-019-09521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-019-09521-z</ArticleId><ArticleId IdType="pubmed">31792807</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel M.C., Rosenberg A.M., Kinkade C.W., Capurro C., Rivera-N&#xfa;&#xf1;ez Z., Barrett E.S. Exposure to synthetic endocrine-disrupting chemicals in relation to maternal and fetal sex steroid hormones: A scoping review. Curr. Environ. Health Rep. 2024;11:356&#x2013;379. doi: 10.1007/s40572-024-00455-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40572-024-00455-6</ArticleId><ArticleId IdType="pmc">PMC11324767</ArticleId><ArticleId IdType="pubmed">39037689</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalal N., Surendranath A.R., Pathak J.L., Yu S., Chung C.Y. Bisphenol A (BPA) the mighty and the mutagenic. Toxicol. Rep. 2017;5:76&#x2013;84. doi: 10.1016/j.toxrep.2017.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxrep.2017.12.013</ArticleId><ArticleId IdType="pmc">PMC5977157</ArticleId><ArticleId IdType="pubmed">29854579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kur&#x15f;uno&#x11f;lu N.E., Sarer Yurekli B.P. Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence. World J. Clin. Cases. 2022;10:11226&#x2013;11239. doi: 10.12998/wjcc.v10.i31.11226.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i31.11226</ArticleId><ArticleId IdType="pmc">PMC9649566</ArticleId><ArticleId IdType="pubmed">36387809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugnier C., Meyer A., Charloux A., Andr&#xe8;s E., G&#xe9;ny B., Talha S. The endocrine function of the heart: Physiology and involvements of natriuretic peptides and cyclic nucleotide phosphodiesterases in heart failure. J. Clin. Med. 2019;8:1746. doi: 10.3390/jcm8101746.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8101746</ArticleId><ArticleId IdType="pmc">PMC6832599</ArticleId><ArticleId IdType="pubmed">31640161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng B., Wu Y., Huang Y., Zhang Y., Li X., Liu Y., Wang Y., Chen L., Zhou Y., Tang S. Carcinogenic health outcomes associated with endocrine disrupting chemicals exposure in humans: A wide-scope analysis. J. Hazard. Mater. 2024;476:135067. doi: 10.1016/j.jhazmat.2024.135067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhazmat.2024.135067</ArticleId><ArticleId IdType="pubmed">38964039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassotis C.D., Vandenberg L.N., Demeneix B.A., Porta M., Slama R., Trasande L. Endocrine-disrupting chemicals: Economic, regulatory, and policy implications. Lancet Diabetes Endocrinol. 2020;8:719&#x2013;730. doi: 10.1016/S2213-8587(20)30128-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30128-5</ArticleId><ArticleId IdType="pmc">PMC7437819</ArticleId><ArticleId IdType="pubmed">32707119</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoso E., Masi M., Racchi M., Corsini E. Endocrine-disrupting chemicals&#x2019; (EDCs) effects on tumour microenvironment and cancer progression: Emerging contribution of RACK1. Int. J. Mol. Sci. 2020;21:9229. doi: 10.3390/ijms21239229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21239229</ArticleId><ArticleId IdType="pmc">PMC7729595</ArticleId><ArticleId IdType="pubmed">33287384</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W.P., Wang Y.F., Gao J., Yu M.L., Yu Y.Y., Yao Y.Q. In vitro evidence for endocrine-disrupting chemical (EDC)'s inhibition of drug metabolism. Afr. Health Sci. 2014;14:185&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4449052</ArticleId><ArticleId IdType="pubmed">26060477</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneha S., Baker S.C., Green A., Storr S., Aiyappa R., Martin S., Pors K. Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies. Biomedicines. 2021;9:290. doi: 10.3390/biomedicines9030290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030290</ArticleId><ArticleId IdType="pmc">PMC7998590</ArticleId><ArticleId IdType="pubmed">33809117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebert D.W. Aryl hydrocarbon receptor (AHR): &#x201c;Pioneer member&#x201d; of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of &#x201c;sensors&#x201d; of foreign and endogenous signals. Prog. Lipid Res. 2017;67:38&#x2013;57. doi: 10.1016/j.plipres.2017.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2017.06.001</ArticleId><ArticleId IdType="pmc">PMC5568781</ArticleId><ArticleId IdType="pubmed">28606467</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho N.R., Pimp&#xe3;o A.B., Correia M.J., Rodrigues T.C., Monteiro E.C., Morello J., Pereira S.A. Pharmacological blockage of the AHR-CYP1A1 axis: A call for in vivo evidence. J. Mol. Med. 2022;100:215&#x2013;243. doi: 10.1007/s00109-021-02163-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-021-02163-2</ArticleId><ArticleId IdType="pmc">PMC8605459</ArticleId><ArticleId IdType="pubmed">34800164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Kwon J.S., Ahn C., Jeung E.B. Endocrine-Disrupting Chemicals and Their Adverse Effects on the Endoplasmic Reticulum. Int. J. Mol. Sci. 2022;23:1581. doi: 10.3390/ijms23031581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031581</ArticleId><ArticleId IdType="pmc">PMC8836273</ArticleId><ArticleId IdType="pubmed">35163501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazzaz S.A., Tawil J., Harhaj E.W. The aryl hydrocarbon receptor-interacting protein in cancer and immunity: Beyond a chaperone protein for the dioxin receptor. J. Biol. Chem. 2024;300:107157. doi: 10.1016/j.jbc.2024.107157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2024.107157</ArticleId><ArticleId IdType="pmc">PMC11002312</ArticleId><ArticleId IdType="pubmed">38479600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas B., Yang Y., Wang Y., Kim K., Chung H.J., Cheung M., Ngo K., Shinn A., Chan W.K. p23 protects the human aryl hydrocarbon receptor from degradation via a heat shock protein 90-independent mechanism. Biochem. Pharmacol. 2018;152:34&#x2013;44. doi: 10.1016/j.bcp.2018.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2018.03.015</ArticleId><ArticleId IdType="pmc">PMC5960609</ArticleId><ArticleId IdType="pubmed">29555469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Qian H. Phthalates and Their Impacts on Human Health. Healthcare. 2021;9:603. doi: 10.3390/healthcare9050603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9050603</ArticleId><ArticleId IdType="pmc">PMC8157593</ArticleId><ArticleId IdType="pubmed">34069956</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker B.H., Melough M.M., Paquette A.G., Barrett E.S., Day D.B., Kannan K., Nguyen R.H., Bush N.R., LeWinn K.Z., Carroll K.N., et al. Ultra-processed and fast food consumption, exposure to phthalates during pregnancy, and socioeconomic disparities in phthalate exposures. Environ. Int. 2024;183:108427. doi: 10.1016/j.envint.2024.108427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2024.108427</ArticleId><ArticleId IdType="pmc">PMC10834835</ArticleId><ArticleId IdType="pubmed">38194756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagne-Fotso R., Riou M., Saoudi A., Zeghnoun A., Frederiksen H., Berman T., Montazeri P., Andersson A.-M., Rodriguez-Martin L., Akesson A., et al. Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data-The European Joint Programme HBM4EU. Environ. Int. 2024;190:108912. doi: 10.1016/j.envint.2024.108912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2024.108912</ArticleId><ArticleId IdType="pubmed">39116556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Kounatidis D., Tsilingiris D., Vallianou N.G., Karampela I., Psallida S., Papavassiliou A.G. The role of endocrine disruptors bisphenols and phthalates in obesity: Current evidence, perspectives and controversies. Int. J. Mol. Sci. 2024;25:675. doi: 10.3390/ijms25010675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25010675</ArticleId><ArticleId IdType="pmc">PMC10779569</ArticleId><ArticleId IdType="pubmed">38203845</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Casanova J.E., Berm&#xfa;dez V., Caro Fuentes N.J., Angarita L.C., Caicedo N.H., Rivas Mu&#xf1;oz J., Rojas-G&#xf3;mez D.M. New evidence on BPA&#x2019;s role in adipose tissue development of proinflammatory processes and its relationship with obesity. Int. J. Mol. Sci. 2023;24:8231. doi: 10.3390/ijms24098231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098231</ArticleId><ArticleId IdType="pmc">PMC10179730</ArticleId><ArticleId IdType="pubmed">37175934</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z., He L., Wu J., Xie C., Geng S., Wu J., Zhong C., Li X. Bisphenol A-Induced Cancer-Associated Adipocytes Promotes Breast Carcinogenesis via CXCL12/AKT Signaling. Mol. Cell. Endocrinol. 2025;599:112473. doi: 10.1016/j.mce.2025.112473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2025.112473</ArticleId><ArticleId IdType="pubmed">39863150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokobza E., Hinault C., Tiroille V., Clavel S., Bost F., Chevalier N. The adipose tissue at the crosstalk between EDCs and cancer development. Front. Endocrinol. 2021;12:691658. doi: 10.3389/fendo.2021.691658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.691658</ArticleId><ArticleId IdType="pmc">PMC8329539</ArticleId><ArticleId IdType="pubmed">34354670</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee O., Paul T., Singh S., Maji B.K., Mukherjee S. Individual and combined antagonism of aryl hydrocarbon receptor (AhR) and estrogen receptors (ERs) offers distinct level of protection against Bisphenol A (BPA)-induced pancreatic islet cell toxicity in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2025;398:3939&#x2013;3954. doi: 10.1007/s00210-024-03506-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-024-03506-9</ArticleId><ArticleId IdType="pubmed">39377923</ArticleId></ArticleIdList></Reference><Reference><Citation>Szaefer H., Licznerska B., Baer-Dubowska W. The Aryl Hydrocarbon Receptor and Its Crosstalk: A Chemopreventive Target of Naturally Occurring and Modified Phytochemicals. Molecules. 2024;29:4283. doi: 10.3390/molecules29184283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules29184283</ArticleId><ArticleId IdType="pmc">PMC11433792</ArticleId><ArticleId IdType="pubmed">39339278</ArticleId></ArticleIdList></Reference><Reference><Citation>Donini C.F., El Helou M., Wierinckx A., Gy&#x151;rffy B., Aires S., Escande A., Croze S., Clezardin P., Lachuer J., Diab-Assaf M., et al. Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay. Front. Oncol. 2020;10:712. doi: 10.3389/fonc.2020.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.00712</ArticleId><ArticleId IdType="pmc">PMC7326103</ArticleId><ArticleId IdType="pubmed">32670863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodila A., Franko N., Sollner Dolenc M. A review on immunomodulatory effects of BPA analogues. Arch. Toxicol. 2023;97:1831&#x2013;1846. doi: 10.1007/s00204-023-03519-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-023-03519-y</ArticleId><ArticleId IdType="pmc">PMC10256647</ArticleId><ArticleId IdType="pubmed">37204436</ArticleId></ArticleIdList></Reference><Reference><Citation>Primost M.A., Chierichetti M.A., Casta&#xf1;os C., Bigatti G., Miglioranza K.S.B. Persistent Organic Pollutants (POPs), Current Use Pesticides (CUPs) and Polycyclic Aromatic Hydrocarbons (PAHs) in edible marine invertebrates from a Patagonian harbor. Mar. Pollut. Bull. 2024;207:116940. doi: 10.1016/j.marpolbul.2024.116940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.marpolbul.2024.116940</ArticleId><ArticleId IdType="pubmed">39244891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditchfield C., Kushida M.M., Mazalli M.R., Sobral P.J.A. Can Chocolate Be Classified as an Ultra-Processed Food? A Short Review on Processing and Health Aspects to Help Answer This Question. Foods. 2023;12:3070. doi: 10.3390/foods12163070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods12163070</ArticleId><ArticleId IdType="pmc">PMC10453203</ArticleId><ArticleId IdType="pubmed">37628068</ArticleId></ArticleIdList></Reference><Reference><Citation>Muncke J., Touvier M., Trasande L., Scheringer M. Health impacts of exposure to synthetic chemicals in food. Nat. Med. 2025;31:1431&#x2013;1443. doi: 10.1038/s41591-025-03697-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-025-03697-5</ArticleId><ArticleId IdType="pubmed">40379996</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Z., Chen S., Shi Y., Wang P., Wu Y., Li G. Dietary advanced glycation end products (dAGEs): An insight between modern diet and health. Food Chem. 2023;415:135735. doi: 10.1016/j.foodchem.2023.135735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2023.135735</ArticleId><ArticleId IdType="pubmed">36863235</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X., Nie C., Liu H., Ma Q., Peng B., Zhang M., Chen Z., Li J. Comparison of metabolic fate, target organs, and microbiota interactions of free and bound dietary advanced glycation end products. Crit. Rev. Food Sci. Nutr. 2023;63:3612&#x2013;3633. doi: 10.1080/10408398.2021.1991265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2021.1991265</ArticleId><ArticleId IdType="pubmed">34698575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zin&#xf6;cker M.K., Lindseth I.A. The Western diet&#x2013;microbiome&#x2013;host interaction and its role in metabolic disease. Nutrients. 2018;10:365. doi: 10.3390/nu10030365.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10030365</ArticleId><ArticleId IdType="pmc">PMC5872783</ArticleId><ArticleId IdType="pubmed">29562591</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada Venegas D., De la Fuente M.K., Landskron G., Gonz&#xe1;lez M.J., Quera R., Dijkstra G., Harmsen H.J.M., Faber K.N., Hermoso M.A. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 2019;10:277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421268</ArticleId><ArticleId IdType="pubmed">30915065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmora N., Suez J., Elinav E. You are what you eat: Diet, health and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 2019;16:35&#x2013;56. doi: 10.1038/s41575-018-0061-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-018-0061-2</ArticleId><ArticleId IdType="pubmed">30262901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chassaing B., Koren O., Goodrich J.K., Poole A.C., Srinivasan S., Ley R.E., Gewirtz A.T. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92&#x2013;96. doi: 10.1038/nature14232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14232</ArticleId><ArticleId IdType="pmc">PMC4910713</ArticleId><ArticleId IdType="pubmed">25731162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirbel J., Pyl P.T., Kartal E., Zych K., Kashani A., Milanese A., Fleck J.S., Voigt A.Y., Palleja A., Ponnudurai R., et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 2019;25:679&#x2013;689. doi: 10.1038/s41591-019-0406-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0406-6</ArticleId><ArticleId IdType="pmc">PMC7984229</ArticleId><ArticleId IdType="pubmed">30936547</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera M., G&#xe1;lvez-Ontiveros Y., Rivas A. Endobolome, a new concept for determining the influence of microbiota disrupting chemicals (MDC) in relation to specific endocrine pathogenesis. Front. Microbiol. 2020;11:578007. doi: 10.3389/fmicb.2020.578007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.578007</ArticleId><ArticleId IdType="pmc">PMC7733930</ArticleId><ArticleId IdType="pubmed">33329442</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalakrishnan V., Helmink B.A., Spencer C.N., Reuben A., Wargo J.A. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018;33:570&#x2013;580. doi: 10.1016/j.ccell.2018.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2018.03.015</ArticleId><ArticleId IdType="pmc">PMC6529202</ArticleId><ArticleId IdType="pubmed">29634945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G., Zheng Y., Zhang N., Huang G., Zhang W., Li Q., Ren X. Desulfovibrio vulgaris caused gut inflammation and aggravated DSS-induced colitis in C57BL/6 mice model. Gut Pathog. 2024;16:39. doi: 10.1186/s13099-024-00632-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-024-00632-w</ArticleId><ArticleId IdType="pmc">PMC11282857</ArticleId><ArticleId IdType="pubmed">39060944</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang S., Zhou W., Hu D., Xu H., Ji G. Secondary bile acids and tumorigenesis in colorectal cancer. Front. Oncol. 2022;12:813745. doi: 10.3389/fonc.2022.813745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.813745</ArticleId><ArticleId IdType="pmc">PMC9097900</ArticleId><ArticleId IdType="pubmed">35574393</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Dai H., Lu Y., Li R., Gao C., Pan S. Trimethylamine N-oxide promotes cell proliferation and angiogenesis in colorectal cancer. J. Immunol. Res. 2022;2022:7043856. doi: 10.1155/2022/7043856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7043856</ArticleId><ArticleId IdType="pmc">PMC9273394</ArticleId><ArticleId IdType="pubmed">35832644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubatan J., Boye T.L., Temby M., Sojwal R.S., Holman D.R., Sinha S.R., Rogalla S.R., Nielsen O.H. Gut microbiome in inflammatory bowel disease: Role in pathogenesis, dietary modulation, and colitis-associated colon cancer. Microorganisms. 2022;10:1371. doi: 10.3390/microorganisms10071371.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10071371</ArticleId><ArticleId IdType="pmc">PMC9316834</ArticleId><ArticleId IdType="pubmed">35889090</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Toole P.W., Marchesi J.R., Hill C. Next-generation probiotics: The spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2017;2:17057. doi: 10.1038/nmicrobiol.2017.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2017.57</ArticleId><ArticleId IdType="pubmed">28440276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevilacqua A., Speranza B., Racioppo A., Santillo A., Albenzio M., Derossi A., Caporizzi R., Francavilla M., Racca D., Flagella Z., et al. Ultra-Processed Food and Gut Microbiota: Do Additives Affect Eubiosis? A Narrative Review. Nutrients. 2024;17:2. doi: 10.3390/nu17010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu17010002</ArticleId><ArticleId IdType="pmc">PMC11723215</ArticleId><ArticleId IdType="pubmed">39796436</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcaire F., Gim&#xe9;nez A., Ares G. Food Additives Associated with Gut Dysbiosis in Processed and Ultra-Processed Products Commercialized in the Uruguayan Market. Food Res. Int. 2024;191:114721. doi: 10.1016/j.foodres.2024.114721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2024.114721</ArticleId><ArticleId IdType="pubmed">39059917</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonza I., Goya-Jorge E., Douny C., Boutaleb S., Taminiau B., Daube G., Scippo M., Louis E., Delcenserie V. Food Additives Impair Gut Microbiota from Healthy Individuals and IBD Patients in a Colonic In Vitro Fermentation Model. Food Res. Int. 2024;182:114157. doi: 10.1016/j.foodres.2024.114157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2024.114157</ArticleId><ArticleId IdType="pubmed">38519184</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Qu R., Li M., Sheng P., Jin L., Huang X., Xu Z.Z. Impacts of Food Additives on Gut Microbiota and Host Health. Food Res. Int. 2024;196:114998. doi: 10.1016/j.foodres.2024.114998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2024.114998</ArticleId><ArticleId IdType="pubmed">39614468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chassaing B., Compher C., Bonhomme B., Liu Q., Tian Y., Walters W., Nessel L., Delaroque C., Hao F., Gershuni V., et al. Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome. Gastroenterology. 2022;162:743&#x2013;756. doi: 10.1053/j.gastro.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC9639366</ArticleId><ArticleId IdType="pubmed">34774538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros&#xe9;s C., Nieto J.A., Viadel B., Gallego E., Romo-Hualde A., Streitenberger S., Milagro F.I., Barcel&#xf3; A. An In Vitro Protocol to Study the Modulatory Effects of a Food or Biocompound on Human Gut Microbiome and Metabolome. Foods. 2021;10:3020. doi: 10.3390/foods10123020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods10123020</ArticleId><ArticleId IdType="pmc">PMC8701939</ArticleId><ArticleId IdType="pubmed">34945571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerma-Aguilera A.M., P&#xe9;rez-Burillo S., Navajas-Porras B., Le&#xf3;n E.D., Ru&#xed;z-P&#xe9;rez S., Pastoriza S., Jim&#xe9;nez-Hern&#xe1;ndez N., C&#xe4;mmerer B.-M., Rufi&#xe1;n-Henares J.&#xc1;., Gosalbes M.J., et al. Effects of Different Foods and Cooking Methods on the Gut Microbiota: An In Vitro Approach. Front. Microbiol. 2024;14:1334623. doi: 10.3389/fmicb.2023.1334623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1334623</ArticleId><ArticleId IdType="pmc">PMC10800916</ArticleId><ArticleId IdType="pubmed">38260868</ArticleId></ArticleIdList></Reference><Reference><Citation>Karl J.P., Armstrong N.J., Player R.A., Rood J.C., Soares J.W., McClung H.L. The Fecal Metabolome Links Diet Composition, Foacidic Positive Ion Conditions, Chromatographicallyod Processing, and the Gut Microbiota to Gastrointestinal Health in a Randomized Trial of Adults Consuming a Processed Diet. J. Nutr. 2022;152:2343&#x2013;2357. doi: 10.1093/jn/nxac161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxac161</ArticleId><ArticleId IdType="pubmed">36774101</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeming E.R., Johnson A.J., Spector T.D., Le Roy C.I. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients. 2019;11:2862. doi: 10.3390/nu11122862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11122862</ArticleId><ArticleId IdType="pmc">PMC6950569</ArticleId><ArticleId IdType="pubmed">31766592</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerasimidis K., Bryden K., Chen X., Papachristou E., Verney A., Roig M., Hansen R., Nichols B., Papadopoulou R., Parrett A. The Impact of Food Additives, Artificial Sweeteners and Domestic Hygiene Products on the Human Gut Microbiome and Its Fibre Fermentation Capacity. Eur. J. Nutr. 2020;59:3213&#x2013;3230. doi: 10.1007/s00394-019-02161-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-019-02161-8</ArticleId><ArticleId IdType="pmc">PMC7501109</ArticleId><ArticleId IdType="pubmed">31853641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain S., Tulsyan S., Dar S.A., Sisodiya S., Abiha U., Kumar R., Mishra B.N., Haque S. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy. Semin. Cancer Biol. 2022;83:441&#x2013;451. doi: 10.1016/j.semcancer.2021.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2021.06.023</ArticleId><ArticleId IdType="pubmed">34182144</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrero M.J., Cejas P., Long H.W., Ramirez de Molina A. Nutritional epigenetics in cancer. Adv. Nutr. 2022;13:1748&#x2013;1761. doi: 10.1093/advances/nmac039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmac039</ArticleId><ArticleId IdType="pmc">PMC9526851</ArticleId><ArticleId IdType="pubmed">35421212</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan K., Bancil A.S., Lindsay J.O., Chassaing B. Ultra-processed foods and food additives in gut health and disease. Nat. Rev. Gastroenterol. Hepatol. 2024;21:406&#x2013;427. doi: 10.1038/s41575-024-00893-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-024-00893-5</ArticleId><ArticleId IdType="pubmed">38388570</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaksen I.M., Dankel S.N. Ultra-processed food consumption and cancer risk: A systematic review and meta-analysis. Clin. Nutr. 2023;42:919&#x2013;928. doi: 10.1016/j.clnu.2023.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2023.03.018</ArticleId><ArticleId IdType="pubmed">37087831</ArticleId></ArticleIdList></Reference><Reference><Citation>Srour B., Kordahi M.C., Bonazzi E., Deschasaux-Tanguy M., Touvier M., Chassaing B. Ultra-processed foods and human health: From epidemiological evidence to mechanistic insights. Lancet Gastroenterol. Hepatol. 2022;7:1128&#x2013;1140. doi: 10.1016/S2468-1253(22)00169-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(22)00169-8</ArticleId><ArticleId IdType="pubmed">35952706</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rtille F., Da Silva V.H., Johansson A.M., Lindstr&#xf6;m T., Wright D., Coutinho L.L., Jensen P., Guerrero-Bosagna C. Mutation dynamics of CpG dinucleotides during a recent event of vertebrate diversification. Epigenetics. 2019;14:685&#x2013;707. doi: 10.1080/15592294.2019.1609868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2019.1609868</ArticleId><ArticleId IdType="pmc">PMC6557589</ArticleId><ArticleId IdType="pubmed">31070073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop K.S., Ferguson L.R. The interaction between epigenetics, nutrition and the development of cancer. Nutrients. 2015;7:922&#x2013;947. doi: 10.3390/nu7020922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7020922</ArticleId><ArticleId IdType="pmc">PMC4344568</ArticleId><ArticleId IdType="pubmed">25647662</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong F., Lin Y., Zhao L., Yang C., Ye Y., Shen Z. Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: From mechanisms to therapeutics. Br. J. Cancer. 2023;129:24&#x2013;37. doi: 10.1038/s41416-023-02292-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-023-02292-0</ArticleId><ArticleId IdType="pmc">PMC10307880</ArticleId><ArticleId IdType="pubmed">37117649</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhootra S., Jill N., Shanmugam G., Rakshit S., Sarkar K. DNA methylation and cancer: Transcriptional regulation, prognostic, and therapeutic perspective. Med. Oncol. 2023;40:71. doi: 10.1007/s12032-022-01943-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12032-022-01943-1</ArticleId><ArticleId IdType="pubmed">36602616</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Song K., Chen H., Dai M. Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection. J. Natl. Cancer Cent. 2025;5:108&#x2013;112. doi: 10.1016/j.jncc.2024.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jncc.2024.12.007</ArticleId><ArticleId IdType="pmc">PMC12010373</ArticleId><ArticleId IdType="pubmed">40265091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaib S., Rana N., Khan I. Histone modifications and their role in epigenetics of cancer. Curr. Med. Chem. 2022;29:2399&#x2013;2411. doi: 10.2174/0929867328666211108105214.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867328666211108105214</ArticleId><ArticleId IdType="pubmed">34749606</ArticleId></ArticleIdList></Reference><Reference><Citation>Neganova M.E., Klochkov S.G., Aleksandrova Y.R., Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. Semin. Cancer Biol. 2022;83:452&#x2013;471. doi: 10.1016/j.semcancer.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2020.07.015</ArticleId><ArticleId IdType="pubmed">32814115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Sun Z., Jia J., Du T., Zhang N., Tang Y., Fang Y., Fang D. Overview of histone modification. Adv. Exp. Med. Biol. 2021;1283:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">33155134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhang J., Diao L., Han L. Small non-coding RNAs in human cancer: Function, clinical utility, and characterisation. Oncogene. 2021;40:1570&#x2013;1577. doi: 10.1038/s41388-020-01630-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-020-01630-3</ArticleId><ArticleId IdType="pubmed">33452456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Xu X., Song J., Xu Y., Qian H., Jin J., Liang Z.F. Non-coding RNAs&#x2019; function in cancer development, diagnosis and therapy. Biomed. Pharmacother. 2023;167:115527. doi: 10.1016/j.biopha.2023.115527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.115527</ArticleId><ArticleId IdType="pubmed">37751642</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Veneziano D., Acunzo M., Croce C.M. Small non-coding RNA and cancer. Carcinogenesis. 2017;38:485&#x2013;491. doi: 10.1093/carcin/bgx026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgx026</ArticleId><ArticleId IdType="pmc">PMC6248440</ArticleId><ArticleId IdType="pubmed">28449079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante M., Cristaldi A., Oliveri Conti G. Oncogenic role of miRNA in environmental exposure to plasticisers: A systematic review. J. Pers. Med. 2021;11:500. doi: 10.3390/jpm11060500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11060500</ArticleId><ArticleId IdType="pmc">PMC8229109</ArticleId><ArticleId IdType="pubmed">34199666</ArticleId></ArticleIdList></Reference><Reference><Citation>Llaurad&#xf3;-Pont J., Stratakis N., Fiorito G., Handakas E., Neumann A., Barros H., Brants&#xe6;ter A.L., Chang K., Chatzi L., Felix J.F., et al. A Meta-Analysis of Epigenome-Wide Association Studies of Ultra-Processed Food Consumption with DNA Methylation in European Children. Clin. Epigenetics. 2025;17:3. doi: 10.1186/s13148-024-01782-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-024-01782-z</ArticleId><ArticleId IdType="pmc">PMC11706074</ArticleId><ArticleId IdType="pubmed">39773758</ArticleId></ArticleIdList></Reference><Reference><Citation>Edalati S., Bagherzadeh F., Asghari Jafarabadi M., Ebrahimi-Mamaghani M. Higher Ultra-Processed Food Intake Is Associated with Higher DNA Damage in Healthy Adolescents. Br. J. Nutr. 2021;125:568&#x2013;576. doi: 10.1017/S0007114520001981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114520001981</ArticleId><ArticleId IdType="pubmed">32513316</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas R.D.S., da Silva J. Impact of Ultra-Processed Foods on Human Health: A Comprehensive Review of Genomic Instability and Molecular Mechanisms. Nutrition. 2025;137:112800. doi: 10.1016/j.nut.2025.112800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2025.112800</ArticleId><ArticleId IdType="pubmed">40393283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhauser C. Impact of Dietary Gut Microbial Metabolites on the Epigenome. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2018;373:20170359. doi: 10.1098/rstb.2017.0359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2017.0359</ArticleId><ArticleId IdType="pmc">PMC5915727</ArticleId><ArticleId IdType="pubmed">29685968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Giovannucci E.L. Ultra-Processed Foods and Health: A Comprehensive Review. Crit. Rev. Food Sci. Nutr. 2023;63:10836&#x2013;10848. doi: 10.1080/10408398.2022.2084359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2084359</ArticleId><ArticleId IdType="pubmed">35658669</ArticleId></ArticleIdList></Reference><Reference><Citation>Milagro F.I., Mansego M.L., De Miguel C., Mart&#xed;nez J.A. Dietary Factors, Epigenetic Modifications and Obesity Outcomes: Progresses and Perspectives. Mol. Asp. Med. 2013;34:782&#x2013;812. doi: 10.1016/j.mam.2012.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2012.06.010</ArticleId><ArticleId IdType="pubmed">22771541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Deng Y., Li Z., Chen Y., Zhu X., Tan X., Cao G. Cancer Evo-Dev: A theory of inflammation-induced oncogenesis. Front. Immunol. 2021;12:768098. doi: 10.3389/fimmu.2021.768098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.768098</ArticleId><ArticleId IdType="pmc">PMC8645856</ArticleId><ArticleId IdType="pubmed">34880864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mella C., Tsarouhas P., Brockwell M., Ball H.C. The role of chronic inflammation in pediatric cancer. Cancers. 2025;17:154. doi: 10.3390/cancers17010154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers17010154</ArticleId><ArticleId IdType="pmc">PMC11719864</ArticleId><ArticleId IdType="pubmed">39796780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed D.M., Abdelgawad M.A., Ghoneim M.M., Alhossan A., Al-Serwi R.H., Farouk A. Impact of some natural and artificial sweeteners consumption on different hormonal levels and inflammatory cytokines in male rats: In vivo and in silico studies. ACS Omega. 2024;9:30364&#x2013;30380. doi: 10.1021/acsomega.4c01250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.4c01250</ArticleId><ArticleId IdType="pmc">PMC11256323</ArticleId><ArticleId IdType="pubmed">39035958</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Wang S., Jin J., Wang J., Chen W., Xue Y., Sheng L., Zhai Y., Yao W. Sucralose triggers insulin resistance leading to follicular dysplasia in mice. Reprod. Toxicol. 2024;128:108644. doi: 10.1016/j.reprotox.2024.108644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reprotox.2024.108644</ArticleId><ArticleId IdType="pubmed">38880404</ArticleId></ArticleIdList></Reference><Reference><Citation>Tristan Asensi M., Napoletano A., Sofi F., Dinu M. Low-grade inflammation and ultra-processed foods consumption: A review. Nutrients. 2023;15:1546. doi: 10.3390/nu15061546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15061546</ArticleId><ArticleId IdType="pmc">PMC10058108</ArticleId><ArticleId IdType="pubmed">36986276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvetsky A.C., Wang Y., Reddy A.G., Um C.Y., Hodge R.A., Lichtman C., Mitchell D., Nanavati A., Pollak M., Wang Y., et al. Nonnutritive sweetener consumption, metabolic risk factors, and inflammatory biomarkers among adults in the Cancer Prevention Study-3 Diet Assessment Sub-Study. J. Nutr. 2025;155:1952&#x2013;1961. doi: 10.1016/j.tjnut.2025.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tjnut.2025.03.020</ArticleId><ArticleId IdType="pubmed">40127735</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Tapia M., Miller A.W., Granados-Portillo O., Tovar A.R., Torres N. The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet. Gut Microbes. 2020;12:1801301. doi: 10.1080/19490976.2020.1801301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1801301</ArticleId><ArticleId IdType="pmc">PMC7524302</ArticleId><ArticleId IdType="pubmed">32804018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bujtor M. Can dietary intake protect against low-grade inflammation in children and adolescents? Brain Behav. Immun. Health. 2021;18:100369. doi: 10.1016/j.bbih.2021.100369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100369</ArticleId><ArticleId IdType="pmc">PMC8604686</ArticleId><ArticleId IdType="pubmed">34825233</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavez-Dominguez R., Perez-Medina M., Aguilar-Cazares D., Galicia-Velasco M., Meneses-Flores M., Islas-Vazquez L., Camarena A., Lopez-Gonzalez J.S. Old and new players of inflammation and their relationship with cancer development. Front. Oncol. 2021;11:722999. doi: 10.3389/fonc.2021.722999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.722999</ArticleId><ArticleId IdType="pmc">PMC8645998</ArticleId><ArticleId IdType="pubmed">34881173</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris H.R., Willett W.C., Vaidya R.L., Michels K.B. An adolescent and early adulthood dietary pattern associated with inflammation and the incidence of breast cancer. Cancer Res. 2017;77:1179&#x2013;1187. doi: 10.1158/0008-5472.CAN-16-2273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-16-2273</ArticleId><ArticleId IdType="pmc">PMC5335878</ArticleId><ArticleId IdType="pubmed">28249935</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S., Katagiri R., Yamaji T., Sawada N., Imatoh T., Ihira H., Inoue M., Tsugane S., Iwasaki M., Japan Public Health Center-Based Prospective Study Group Association between C-reactive protein and risk of overall and 18 site-specific cancers in a Japanese case-cohort. Br. J. Cancer. 2022;126:1481&#x2013;1489. doi: 10.1038/s41416-022-01715-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-022-01715-8</ArticleId><ArticleId IdType="pmc">PMC9091208</ArticleId><ArticleId IdType="pubmed">35140343</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K., Song X., Cheng C., Shi Q., Li X., Long J., Yang H., Chen S. Association between dietary inflammatory potential and liver cancer risk: A systematic review and dose-response meta-analysis. Nutr. Cancer. 2025;77:433&#x2013;443. doi: 10.1080/01635581.2025.2471619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2025.2471619</ArticleId><ArticleId IdType="pubmed">40009789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramal-Sanchez M., Bravo-Trippetta C., D&#x2019;aNtonio V., Corvaglia E., K&#xe4;mpfer A.A.M., Schins R.P.F., Serafini M., Angelino D. Development and Assessment of an Intestinal Tri-Cellular Model to Investigate the Pro/Anti-Inflammatory Potential of Digested Foods. Front. Immunol. 2025;16:1545261. doi: 10.3389/fimmu.2025.1545261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2025.1545261</ArticleId><ArticleId IdType="pmc">PMC11835836</ArticleId><ArticleId IdType="pubmed">39975553</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahid F., Krischler P., Leners B., Bohn T. Effect of Digested Selected Food Items on Markers of Oxidative Stress and Inflammation in a Caco-2-Based Human Gut Epithelial Model. Antioxidants. 2024;13:150. doi: 10.3390/antiox13020150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox13020150</ArticleId><ArticleId IdType="pmc">PMC10885899</ArticleId><ArticleId IdType="pubmed">38397747</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.P.K., Altenburger M.J., Lamy E. Development of an Inflammation-Triggered In Vitro &#x201c;Leaky Gut&#x201d; Model Using Caco-2/HT29-MTX-E12 Combined with Macrophage-like THP-1 Cells or Primary Human-Derived Macrophages. Int. J. Mol. Sci. 2023;24:7427. doi: 10.3390/ijms24087427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24087427</ArticleId><ArticleId IdType="pmc">PMC10139037</ArticleId><ArticleId IdType="pubmed">37108590</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira S., Barbosa J., Faria J., S&#xe1; S.I., Cardoso A., Soares R., Fonseca B.M., Leal S. Unhealthy Diets Induce Distinct and Regional Effects on Intestinal Inflammatory Signalling Pathways and Long-Lasting Metabolic Dysfunction in Rats. Int. J. Mol. Sci. 2022;23:10984. doi: 10.3390/ijms231810984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810984</ArticleId><ArticleId IdType="pmc">PMC9503261</ArticleId><ArticleId IdType="pubmed">36142897</ArticleId></ArticleIdList></Reference><Reference><Citation>Viennois E., Bretin A., Dub&#xe9; P.E., Maue A.C., Dauriat C.J.G., Barnich N., Gewirtz A.T., Chassaing B. Dietary Emulsifiers Directly Impact Adherent-Invasive E. coli Gene Expression to Drive Chronic Intestinal Inflammation. Cell Rep. 2020;33:108229. doi: 10.1016/j.celrep.2020.108229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108229</ArticleId><ArticleId IdType="pmc">PMC7539532</ArticleId><ArticleId IdType="pubmed">33027647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignogna C., Costanzo S., Di Castelnuovo A., Ruggiero E., Shivappa N., Hebert J.R., Esposito S., De Curtis A., Persichillo M., Cerletti C., et al. The Inflammatory Potential of the Diet as a Link between Food Processing and Low-Grade Inflammation: An Analysis on 21,315 Participants to the Moli-sani Study. Clin. Nutr. 2022;41:2226&#x2013;2234. doi: 10.1016/j.clnu.2022.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2022.08.020</ArticleId><ArticleId IdType="pubmed">36081297</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale M., Costabile G., Testa R., D&#x2019;Abbronzo G., Nettore I.C., Macchia P.E., Giacco R. Ultra-processed foods and human health: A systematic review and meta-analysis of prospective cohort studies. Adv. Nutr. 2024;15:100121. doi: 10.1016/j.advnut.2023.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advnut.2023.09.009</ArticleId><ArticleId IdType="pmc">PMC10831891</ArticleId><ArticleId IdType="pubmed">38245358</ArticleId></ArticleIdList></Reference><Reference><Citation>Forde C.G. Beyond ultra-processed: Considering the future role of food processing in human health. Proc. Nutr. Soc. 2023;82:406&#x2013;418. doi: 10.1017/S0029665123003014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665123003014</ArticleId><ArticleId IdType="pubmed">37654079</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasiou I.A., Kounatidis D., Vallianou N.G., Skourtis A., Dimitriou K., Tzivaki I., Tsioulos G., Rigatou A., Karampela I., Dalamaga M. Beneath the surface: The emerging role of ultra-processed foods in obesity-related cancer. Curr. Oncol. Rep. 2025;27:390&#x2013;414. doi: 10.1007/s11912-025-01654-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11912-025-01654-6</ArticleId><ArticleId IdType="pmc">PMC11976848</ArticleId><ArticleId IdType="pubmed">40014232</ArticleId></ArticleIdList></Reference><Reference><Citation>Morys F., Kanyamibwa A., F&#xe4;ngstr&#xf6;m D., Tweedale M., Pastor-Bernier A., Azizi H., Liu L., Horstmann A., Dagher A. Ultra-processed food consumption affects structural integrity of feeding-related brain regions independent of and via adiposity. NPJ Metab. Health Dis. 2025;3:13. doi: 10.1038/s44324-025-00056-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44324-025-00056-3</ArticleId><ArticleId IdType="pmc">PMC11978510</ArticleId><ArticleId IdType="pubmed">40213086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez Leo E.E., Pe&#xf1;afiel A.M., Hern&#xe1;ndez Escalante V.M., Cabrera Araujo Z.M. Ultra-processed diet, systemic oxidative stress, and breach of immunologic tolerance. Nutrition. 2021;91&#x2013;92:111419. doi: 10.1016/j.nut.2021.111419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111419</ArticleId><ArticleId IdType="pubmed">34399404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lustig R.H. Ultraprocessed food: Addictive, toxic, and ready for regulation. Nutrients. 2020;12:3401. doi: 10.3390/nu12113401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12113401</ArticleId><ArticleId IdType="pmc">PMC7694501</ArticleId><ArticleId IdType="pubmed">33167515</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghy K., Lad&#xe1;nyi A., Reszegi A., Kovalszky I. Insights into the tumor microenvironment&#x2014;Components, functions and therapeutics. Int. J. Mol. Sci. 2023;24:17536. doi: 10.3390/ijms242417536.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms242417536</ArticleId><ArticleId IdType="pmc">PMC10743805</ArticleId><ArticleId IdType="pubmed">38139365</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhang Z., Yang H., Qiu P., Wang H., Wang F., Zhao Q., Fang J., Nie J. Consumption of ultra-processed foods and health outcomes: A systematic review of epidemiological studies. Nutr. J. 2020;19:86. doi: 10.1186/s12937-020-00604-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-020-00604-1</ArticleId><ArticleId IdType="pmc">PMC7441617</ArticleId><ArticleId IdType="pubmed">32819372</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E. Ultraprocessed foods linked with 32 types of health problems. JAMA. 2024;331:1265. doi: 10.1001/jama.2024.2088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.2088</ArticleId><ArticleId IdType="pubmed">38517450</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paula L.C.P., Alves C. Food packaging and endocrine disruptors. J. Pediatr. 2024;100((Suppl. S1)):S40&#x2013;S47. doi: 10.1016/j.jped.2023.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2023.09.010</ArticleId><ArticleId IdType="pmc">PMC10960186</ArticleId><ArticleId IdType="pubmed">37913820</ArticleId></ArticleIdList></Reference><Reference><Citation>Valicente V.M., Peng C.H., Pacheco K.N., Lin L., Kielb E.I., Dawoodani E., Abdollahi A., Mattes R.D. Ultraprocessed foods and obesity risk: A critical review of reported mechanisms. Adv. Nutr. 2023;14:718&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10334162</ArticleId><ArticleId IdType="pubmed">37080461</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobias D.K., Hall K.D. Eliminate or reformulate ultra-processed foods? Biological mechanisms matter. Cell Metab. 2021;33:2314&#x2013;2315. doi: 10.1016/j.cmet.2021.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.10.005</ArticleId><ArticleId IdType="pubmed">34699743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Du M., Wang K., Shen W., Lu D., Zheng Y., Song M., Cao Y., Smith-Warner S.A., Ogino S., et al. Association of ultra-processed food consumption with colorectal cancer risk among men and women: Results from three prospective US cohort studies. BMJ. 2022;378:e068921. doi: 10.1136/bmj-2021-068921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068921</ArticleId><ArticleId IdType="pmc">PMC9430376</ArticleId><ArticleId IdType="pubmed">38752573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari F., Yarmand S., Nouri M., Akbari M.E., Hadaegh F., Azizi F., Mirmiran P. Ultra-processed food intake and risk of colorectal cancer: A matched case-control study. Nutr. Cancer. 2023;75:532&#x2013;541. doi: 10.1080/01635581.2022.2125990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2022.2125990</ArticleId><ArticleId IdType="pubmed">36190723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong G.C., Gu H.T., Peng Y., Wang K., Wu Y.Q., Hu T.Y., Jing F.C., Hao F.B. Association of ultra-processed food consumption with cardiovascular mortality in the US population: Long-term results from a large prospective multicenter study. Int. J. Behav. Nutr. Phys. Act. 2021;18:21. doi: 10.1186/s12966-021-01081-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12966-021-01081-3</ArticleId><ArticleId IdType="pmc">PMC7860226</ArticleId><ArticleId IdType="pubmed">33536027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40545531</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1475-2867</ISSN><JournalIssue CitedMedium="Print"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>22</Day></PubDate></JournalIssue><Title>Cancer cell international</Title><ISOAbbreviation>Cancer Cell Int</ISOAbbreviation></Journal><ArticleTitle>The role of physical activity and epigenetic changes in colorectal cancer prevention.</ArticleTitle><Pagination><StartPage>227</StartPage><MedlinePgn>227</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">227</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12935-025-03872-1</ELocationID><Abstract><AbstractText>Regular and consistent physical activity significantly reduces the risk of colorectal cancer (CRC) by approximately 24% in men and 23% in women. There are several mechanisms through which exercise can help protect against CRC. For example, it can reduce chronic inflammation, boost the immune system, and cause positive epigenetic changes like DNA methylation and histone modifications. It increases the activity of immune cells like natural killer cells and cytotoxic T lymphocytes, shifts macrophages to an anti-tumor state, and promotes a tumor-suppressive microenvironment. Exercise also positively affects the gut microbiome, increasing beneficial bacteria that produce anti-inflammatory short-chain fatty acids like butyrate, which strengthen gut health and support epigenetic regulation. Additionally, physical activity lowers oxidative stress, enhances DNA repair, and regulates hormones like insulin and IGF-1, which are associated with cancer progression. Although exercise benefits vary among individuals, especially between genders, it is still a powerful preventive and therapeutic tool for CRC. For patients and survivors, personalized exercise programs improve physical function, decrease fatigue, and improve overall quality of life. Overall, exercise offers a multifaceted approach to CRC prevention and management by targeting inflammation, immunity, epigenetics, and gut health, as this review explores.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Basic Science Department, Wuchang Shouyi University, Wuhan, 430064, Hubei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keat</LastName><ForeName>Ooi Boon</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Postgraduate Center, Management and Science University, Selangor Darul Ehsan, 40100, Shah Alam,, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajabi</LastName><ForeName>Sogand</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Biology, Sirjan Branch, Islamic Azad University, Sirjan, Iran. Sogand.rajabi1381@outlook.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cancer Cell Int</MedlineTA><NlmUniqueID>101139795</NlmUniqueID><ISSNLinking>1475-2867</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Epigenetic changes</Keyword><Keyword MajorTopicYN="N">Immunity</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Physical activity</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: NA. Consent for publication: NA. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>22</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40545531</ArticleId><ArticleId IdType="pmc">PMC12183916</ArticleId><ArticleId IdType="doi">10.1186/s12935-025-03872-1</ArticleId><ArticleId IdType="pii">10.1186/s12935-025-03872-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vallis J, Wang PP. The role of diet and lifestyle in colorectal cancer incidence and survival. Exon Publications. 2022:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">36343149</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Ca. 2025;75:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11745215</ArticleId><ArticleId IdType="pubmed">39817679</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirsasan R, Akbarzadeh M, Akbarzadeh S. Exercise and colorectal cancer: prevention and molecular mechanisms. Cancer Cell Int. 2022;22:247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9361674</ArticleId><ArticleId IdType="pubmed">35945569</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurdana M. Physical activity and cancer risk. Actual knowledge and possible biological mechanisms. Radiol Oncol. 2021;55:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877262</ArticleId><ArticleId IdType="pubmed">33885236</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards ES, Sackett SC. Psychosocial variables related to why women are less active than men and related health implications: supplementary issue: health disparities in women. Clin Med Insights: Women&#x2019;s Health. 2016;9:CMWH.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933535</ArticleId><ArticleId IdType="pubmed">27398045</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese S, Rao S, Khattak A, Zamir F, Chaari A. Physical exercise and the gut microbiome: a bidirectional relationship influencing health and performance. Nutrients. 2024;16:3663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11547208</ArticleId><ArticleId IdType="pubmed">39519496</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauss M, G&#xe9;rard P, Mosca A, Leclerc M. Interplay between exercise and gut Microbiome in the context of human health and performance. Front Nutr. 2021;8:637010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222532</ArticleId><ArticleId IdType="pubmed">34179053</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautala AJ, Kiviniemi AM, M&#xe4;kikallio TH, Kinnunen H, Nissil&#xe4; S, Huikuri HV, et al. Individual differences in the responses to endurance and resistance training. Eur J Appl Physiol. 2006;96:535&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">16369817</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaza-Diaz J, Izquierdo D, Torres-Martos &#xc1;, Baig AT, Aguilera CM, Ruiz-Ojeda FJ. Impact of physical activity and exercise on the epigenome in skeletal muscle and effects on systemic metabolism. Biomedicines. 2022;10:126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8773693</ArticleId><ArticleId IdType="pubmed">35052805</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiger C, Needhamsen M, Emanuelsson EB, Norrbom J, Steindorf K, Sundberg CJ, et al. DNA methylation of exercise-responsive genes differs between trained and untrained men. BMC Biol. 2024;22:147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11225400</ArticleId><ArticleId IdType="pubmed">38965555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizuayehu HM, Ahmed KY, Kibret GD, Dadi AF, Belachew SA, Bagade T, et al. Global disparities of cancer and its projected burden in 2050. JAMA Netw Open. 2024;7:e2443198&#x2013;e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11539015</ArticleId><ArticleId IdType="pubmed">39499513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah F, Pillai AB, Omar N, Dima D, Harichand S. Early-onset colorectal cancer: current insights. Cancers. 2023;15:3202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10296149</ArticleId><ArticleId IdType="pubmed">37370811</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers. 2024;16:1530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11049480</ArticleId><ArticleId IdType="pubmed">38672612</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksandrova K, Pischon T, Jenab M, Bueno-de-Mesquita HB, Fedirko V, Norat T, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 2014;12:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192278</ArticleId><ArticleId IdType="pubmed">25319089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehl R, Scharhag-Rosenberger F, Schommer K, Schmidt ME, Dreger P, Huber G, et al. Exercise intensity classification in cancer patients undergoing allogeneic HCT. Fac Behav Cult Stud Heidelberg Univ. 2015;35:1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">25202849</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YJ. An overview of current physical activity recommendations in primary care. Korean J Family Med. 2019;40:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536904</ArticleId><ArticleId IdType="pubmed">31122003</ArticleId></ArticleIdList></Reference><Reference><Citation>McTiernan A. Dose finding in physical activity and cancer risk reduction. J Clin Oncol. 2020;38:657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7048165</ArticleId><ArticleId IdType="pubmed">31951491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wele P, Wu X, Shi H. Sex-dependent differences in colorectal cancer: with a focus on obesity. Cells. 2022;11:3688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9688265</ArticleId><ArticleId IdType="pubmed">36429114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Huang Y, Zhang R, Zheng C, You F, Wang M, et al. Sex differences in colorectal cancer: with a focus on sex hormone&#x2013;gut Microbiome axis. Cell Communication Signal. 2024;22:167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10921775</ArticleId><ArticleId IdType="pubmed">38454453</ArticleId></ArticleIdList></Reference><Reference><Citation>Papier K, Bradbury KE, Balkwill A, Barnes I, Smith-Byrne K, Gunter MJ, et al. Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK. Nat Commun. 2025;16:375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11711514</ArticleId><ArticleId IdType="pubmed">39779669</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin D, Lu Y, Wu W, Jiang F, Li Z, Xu L, et al. Diet-wide association, genetic susceptibility and colorectal cancer risk: a prospective cohort study. Nutrients. 2023;15:4801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10674290</ArticleId><ArticleId IdType="pubmed">38004195</ArticleId></ArticleIdList></Reference><Reference><Citation>Veettil SK, Wong TY, Loo YS, Playdon MC, Lai NM, Giovannucci EL, et al. Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies. JAMA Netw Open. 2021;4:e2037341&#x2013;e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887658</ArticleId><ArticleId IdType="pubmed">33591366</ArticleId></ArticleIdList></Reference><Reference><Citation>Diakit&#xe9; MT, Diakit&#xe9; B, Kon&#xe9; A, Balam S, Fofana D, Diallo D, et al. Relationships between gut microbiota, red meat consumption and colorectal cancer. J Carcinog Mutagen. 2022;13:1000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10194058</ArticleId><ArticleId IdType="pubmed">37206892</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulanda S, Janoszka B. Consumption of thermally processed meat containing carcinogenic compounds (polycyclic aromatic hydrocarbons and heterocyclic aromatic amines) versus a risk of some cancers in humans and the possibility of reducing their formation by natural food additives&#x2014;a literature review. Int J Environ Res Public Health. 2022;19:4781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9024867</ArticleId><ArticleId IdType="pubmed">35457645</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe W, Elliott CT, Green BD. A review of the in vivo evidence investigating the role of nitrite exposure from processed meat consumption in the development of colorectal cancer. Nutrients. 2019;11:2673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893523</ArticleId><ArticleId IdType="pubmed">31694233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Fekete M, Varga P, Lehoczki A, Fekete JT, Ungvari A et al. Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25&#x2013;57% elevation in risk. GeroScience. 2024:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12181496</ArticleId><ArticleId IdType="pubmed">39379738</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Z, Huang J, Huang M, Yao Z, Huang J, Chen J, et al. Risk factors for early-onset colorectal cancer: A large-scale Chinese cohort study. J Natl Cancer Cent. 2023;3:28&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11256612</ArticleId><ArticleId IdType="pubmed">39036307</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P, Tao Z, Yang H, Zhang C. Obesity and early-onset colorectal cancer risk: emerging clinical evidence and biological mechanisms. Front Oncol. 2024;14:1366544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11100318</ArticleId><ArticleId IdType="pubmed">38764574</ArticleId></ArticleIdList></Reference><Reference><Citation>Adnan D, Trinh JQ, Sharma D, Alsayid M, Bishehsari F. Early-onset colon cancer shows a distinct intestinal Microbiome and a host&#x2013;microbe interaction. Cancer Prev Res. 2024;17:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10842926</ArticleId><ArticleId IdType="pubmed">37967575</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R, Kelly BN, Ike A, Berger D, Chan A, Drew DA, et al. The impact of the gut microbiome, environment, and diet in early-onset colorectal cancer development. Cancers. 2024;16:676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10854951</ArticleId><ArticleId IdType="pubmed">38339427</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx O, Mankarious M, Yochum G. Molecular genetics of early-onset colorectal cancer. World J Biol Chem. 2023;14:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10080548</ArticleId><ArticleId IdType="pubmed">37034132</ArticleId></ArticleIdList></Reference><Reference><Citation>Daca Alvarez M, Quintana I, Terradas M, Mur P, Balaguer F, Valle L. The inherited and Familial component of early-onset colorectal cancer. Cells. 2021;10:710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005051</ArticleId><ArticleId IdType="pubmed">33806975</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly M, Linehan A, Krstic A, Kolch W, Sheahan K, Winter DC, et al. Oncotherapeutic strategies in early onset colorectal cancer. Cancers. 2023;15:552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9856676</ArticleId><ArticleId IdType="pubmed">36672501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, et al. Early-onset colorectal cancer: initial clues and current views. Nat Reviews Gastroenterol Hepatol. 2020;17:352&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10711686</ArticleId><ArticleId IdType="pubmed">32086499</ArticleId></ArticleIdList></Reference><Reference><Citation>Screening P, Board PE. Colorectal Cancer Screening (PDQ<sup>&#xae;</sup>). National Cancer Institute (US); 2024. PDQ Cancer Information Summaries [Internet].</Citation></Reference><Reference><Citation>Zhu L-H, Dong J, Li W-L, Kou Z-Y, Yang J. Genotype&#x2013;Phenotype correlations in autosomal dominant and recessive APC Mutation-Negative colorectal adenomatous polyposis. Dig Dis Sci. 2023;68:2799&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10293350</ArticleId><ArticleId IdType="pubmed">36862359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wang X, Yu J, Zhan Z, Guo Z. IL-6, TNF-&#x3b1; and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy. Front Oncol. 2022;12:997665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9549173</ArticleId><ArticleId IdType="pubmed">36226059</ArticleId></ArticleIdList></Reference><Reference><Citation>Florescu DN, Boldeanu M-V, &#x218;erban R-E, Florescu LM, Serbanescu M-S, Ionescu M, et al. Correlation of the pro-inflammatory cytokines IL-1&#x3b2;, IL-6, and TNF-&#x3b1;, inflammatory markers, and tumor markers with the diagnosis and prognosis of colorectal cancer. Life. 2023;13:2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10744550</ArticleId><ArticleId IdType="pubmed">38137862</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M, Chan AT. The potential role of exercise and nutrition in Harnessing the immune system to improve colorectal cancer survival. Gastroenterology. 2018;155:596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6571501</ArticleId><ArticleId IdType="pubmed">30076837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman-Goetz L, Husted J. Exercise, immunity, and colon cancer. Exercise and immune function. CRC; 2024. pp. 179&#x2013;98.</Citation></Reference><Reference><Citation>Daou HN. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation. Am J Physiology-Regulatory Integr Comp Physiol. 2020;318:R296&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">31823669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D-W, Christopher CN, Normann AJ, Norris MK, Dieli-Conwright CM, editors. A 16-week circuit interval-based exercise intervention reduces systemic inflammation in obese, sedentary cancer survivors. PHILADELPHIA, PA&#x2026;: CANCER RESEARCH; 2022. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR.</Citation><ArticleIdList><ArticleId IdType="pubmed">35775225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Shanmugan S. A review article: the relationship between obesity and colorectal Cancer. Curr Diab Rep. 2025;25:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11611961</ArticleId><ArticleId IdType="pubmed">39621160</ArticleId></ArticleIdList></Reference><Reference><Citation>Orange ST, Leslie J, Ross M, Mann DA, Wackerhage H. The exercise IL-6 enigma in cancer. Trends Endocrinol Metabolism. 2023;34:749&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">37633799</ArticleId></ArticleIdList></Reference><Reference><Citation>Devin JL, Hill MM, Mourtzakis M, Quadrilatero J, Jenkins DG, Skinner TL. Acute high intensity interval exercise reduces colon cancer cell growth. J Physiol. 2019;597:2177&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6462486</ArticleId><ArticleId IdType="pubmed">30812059</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng N, Reyes-Uribe L, Fahrmann JF, Thoman WS, Munsell MF, Dennison JB, et al. Exercise training reduces the inflammatory response and promotes intestinal mucosa-associated immunity in Lynch syndrome. Clin Cancer Res. 2023;29:4361&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10618653</ArticleId><ArticleId IdType="pubmed">37724990</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Chen M, Deng K. Blocking the Wnt/&#x3b2;-catenin signaling pathway to treat colorectal cancer: strategies to improve current therapies. Int J Oncol. 2022;62:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9854240</ArticleId><ArticleId IdType="pubmed">36579676</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ara&#xfa;jo WM, Tanaka MN, Lima PH, de Moraes CF, Leve F, Bastos LG, et al. TGF-&#x3b2; acts as a dual regulator of COX&#x2010;2/PGE2 tumor promotion depending of its cross&#x2010;interaction with H&#x2010;Ras and Wnt/&#x3b2;&#x2010;catenin pathways in colorectal cancer cells. Cell Biol Int. 2021;45:662&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">33300198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Zhang J, Wang D, Cen B, Lang JD, DuBois RN. The COX-2&#x2013;PGE2 pathway promotes tumor evasion in colorectal adenomas. Cancer Prev Res. 2022;15:285&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9064954</ArticleId><ArticleId IdType="pubmed">35121582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasha A, Kumar K, Heena S, Arnold Emerson I, Pawar SC. Inhibition of NF-kB and COX-2 by Andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway. Sci Rep. 2024;14:12020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11128455</ArticleId><ArticleId IdType="pubmed">38797813</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin K, Qian C, Lin J, Liu B. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. Front Oncol. 2023;13:1099811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9911818</ArticleId><ArticleId IdType="pubmed">36776289</ArticleId></ArticleIdList></Reference><Reference><Citation>Oru&#xe7; Z, Kaplan MA. Effect of exercise on colorectal cancer prevention and treatment. World J Gastrointest Oncol. 2019;11:348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522766</ArticleId><ArticleId IdType="pubmed">31139306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J, Sun H, Yu F-B, Li B, Zhang Y, Zhu Y-T. The role of cyclooxygenase-2 in colorectal cancer. Int J Med Sci. 2020;17:1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211146</ArticleId><ArticleId IdType="pubmed">32410839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metabol. 2018;27:10&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29056514</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazanin M, Razi M, Tolouei-Azar J. Effect of running exercise training on inflammatory mediators and cytokines expression in testicular tissue; effect of exercise intensity. Life Sci. 2024;339:122397.</Citation><ArticleIdList><ArticleId IdType="pubmed">38185243</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaulding HR, Yan Z. AMPK and the adaptation to exercise. Annu Rev Physiol. 2022;84:209&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8919726</ArticleId><ArticleId IdType="pubmed">35143330</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Chen J, Zhang Z, Shi H, Sun W, Yi Q. The role of AMPK in macrophage metabolism, function and polarisation. J Translational Med. 2023;21:892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10709986</ArticleId><ArticleId IdType="pubmed">38066566</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Wang Y, Zhang D, Wang H, Cui X, Zhang C, et al. Gliclazide reduces Colitis-Associated colorectal Cancer formation by deceasing colonic inflammation and regulating AMPK-NF-&#x3ba;B signaling pathway. Dig Dis Sci. 2024;69:453&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10861754</ArticleId><ArticleId IdType="pubmed">38103106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos JAC, Veras ASC, Batista VRG, Tavares MEA, Correia RR, Suggett CB, et al. Physical exercise and the functions of MicroRNAs. Life Sci. 2022;304:120723.</Citation><ArticleIdList><ArticleId IdType="pubmed">35718233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno A, Dovizio M, Patrignani P. Molecular and experimental basis for COX Inhibition in cancer. NSAIDs and aspirin: recent advances and implications for clinical management. 2016:175&#x2013;201.</Citation></Reference><Reference><Citation>Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, et al. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res. 2009;315:1439&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">19133256</ArticleId></ArticleIdList></Reference><Reference><Citation>Haydon AM, MacInnis RJ, English DR, Morris H, Giles GG. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut. 2006;55:689&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1856138</ArticleId><ArticleId IdType="pubmed">16299029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasprzak A. Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. Int J Mol Sci. 2021;22:6434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8234711</ArticleId><ArticleId IdType="pubmed">34208601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gligorijevi&#x107; N, Dobrijevi&#x107; Z, &#x160;underi&#x107; M, Robajac D, &#x10c;eti&#x107; D, Penezi&#x107; A, et al. The insulin-like growth factor system and colorectal cancer. Life. 2022;12:1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9410426</ArticleId><ArticleId IdType="pubmed">36013453</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaka M, Ou S-HI. NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis. Trends cancer. 2022;8:242&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">34996744</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95:727&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491542</ArticleId><ArticleId IdType="pubmed">26084689</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrad S, Dezfuli SAT, Yazdani R, Hayati S, Shanjani SM. The effect of physical exercise on Circulating neurotrophic factors in healthy aged subjects: A meta-analysis and meta-regression. Exp Gerontol. 2024;196:112579.</Citation><ArticleIdList><ArticleId IdType="pubmed">39260585</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C-L, Gao T-Q, Wang Z, Li D-D. Role of insulin/insulin-like growth factor 1 signaling pathway in longevity. World J Gastroenterology: WJG. 2005;11:1891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4305707</ArticleId><ArticleId IdType="pubmed">15800976</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P-y, Zhuang J, Hwang PM. p53: exercise capacity and metabolism. Curr Opin Oncol. 2012;24:76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4153442</ArticleId><ArticleId IdType="pubmed">22123233</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebl MC, Hofmann TG. The role of p53 signaling in colorectal cancer. Cancers. 2021;13:2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8125348</ArticleId><ArticleId IdType="pubmed">33924934</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Chico C, L&#xf3;pez-Ortiz S, Pe&#xf1;&#xed;n-Grandes S, Pinto-Fraga J, Valenzuela PL, Emanuele E, et al. Physical exercise and the hallmarks of breast cancer: a narrative review. Cancers. 2023;15:324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9818971</ArticleId><ArticleId IdType="pubmed">36612320</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukama T, Srour B, Johnson T, Katzke V, Kaaks R. IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all causes in EPIC-Heidelberg. J Clin Endocrinol Metabolism. 2023;108:e1092&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10505533</ArticleId><ArticleId IdType="pubmed">37066827</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimberg A. Mechanisms by which IGF-I May promote cancer. Cancer Biol Ther. 2003;2:630&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4164051</ArticleId><ArticleId IdType="pubmed">14688466</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanoudaki M, Giaginis C, Karafyllaki D, Papadopoulos K, Solovos E, Antasouras G, et al. Exercise as a promising agent against cancer: evaluating its anti-cancer molecular mechanisms. Cancers. 2023;15:5135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10648074</ArticleId><ArticleId IdType="pubmed">37958310</ArticleId></ArticleIdList></Reference><Reference><Citation>Amemori S, Ootani A, Aoki S, Fujise T, Shimoda R, Kakimoto T, et al. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiology-Gastrointestinal Liver Physiol. 2007;292:G923&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17170030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes C, Carvalho M, Bravo J, Martins S, Raimundo A. Possible interaction between physical exercise and leptin and Ghrelin changes following Roux-en-Y gastric bypass in sarcopenic obesity Patients&#x2014;A pilot study. Nutrients. 2024;16:3913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11597895</ArticleId><ArticleId IdType="pubmed">39599699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasprzak A. Role of the Ghrelin system in colorectal cancer. Int J Mol Sci. 2022;23:5380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9141034</ArticleId><ArticleId IdType="pubmed">35628187</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuri R, Moghaddasi M, Darvishi H, Izadpanah A. Effect of aerobic exercise on leptin and Ghrelin in patients with colorectal cancer. J Cancer Res Ther. 2016;12:169&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">27072232</ArticleId></ArticleIdList></Reference><Reference><Citation>Piringer G, Fridrik M, Fridrik A, Leiherer A, Zabernigg A, Greil R, et al. A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients. Support Care Cancer. 2018;26:1345&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">29168033</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R, Kenfield SA, Yanagisawa Y, Newton RU. Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes. Br Med Bull. 2021;139:100&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8431973</ArticleId><ArticleId IdType="pubmed">34426823</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers SK, Deminice R, Ozdemir M, Yoshihara T, Bomkamp MP, Hyatt H. Exercise-induced oxidative stress: friend or foe? J Sport Health Sci. 2020;9:415&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498668</ArticleId><ArticleId IdType="pubmed">32380253</ArticleId></ArticleIdList></Reference><Reference><Citation>Per&#x161;e M. Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? Biomed Res Int. 2013;2013:725710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3666330</ArticleId><ArticleId IdType="pubmed">23762854</ArticleId></ArticleIdList></Reference><Reference><Citation>Per&#x161;e M, Injac R, &#x160;trukelj B, Cerar A. High fat mixed lipid diet modifies protective effects of exercise on 1, 2 dimethylhydrazine induced colon cancer in rats. Technol Cancer Res Treat. 2012;11:289&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">22417061</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimian A, Mir SM, Parsian H, Refieyan S, Mirza-Aghazadeh&#x2010;Attari M, Yousefi B, et al. Crosstalk between phosphoinositide 3&#x2010;kinase/Akt signaling pathway with DNA damage response and oxidative stress in cancer. J Cell Biochem. 2019;120:10248&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">30592328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazizadeh Darband S, Saboory E, Sadighparvar S, Kaviani M, Mobaraki K, Jabbari N, et al. The modulatory effects of exercise on the inflammatory and apoptotic markers in rats with 1, 2-dimethylhydrazine-induced colorectal cancer. Can J Physiol Pharmacol. 2020;98:147&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">31614098</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltgalvis KA, Berger FG, Pena MMO, Davis JM, Carson JA. Effect of exercise on biological pathways in apc min/++ mouse intestinal polyps. J Appl Physiol. 2008;104:1137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">18239078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y-H, Ma S, Zhang X-N, Zhang Z-Y, Zhu H-F, Ji Y-H et al. Hypermethylation of ADHFE1 promotes the proliferation of colorectal cancer cell via modulating cell cycle progression. OncoTargets Therapy. 2019:8105&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782030</ArticleId><ArticleId IdType="pubmed">31632063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang C, Zhong R, Wang L, Sun L. Research progress of DNA methylation in colorectal cancer. Mol Med Rep. 2024;30:154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11240861</ArticleId><ArticleId IdType="pubmed">38963030</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman R, Mohtarrudin N, Zubir NMA, Seow HF, Ngan KW, Osman M. HER3 overexpression and hypomethylation in colorectal adenocarcinoma. Malays J Pathol. 2022;44:67&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">35484888</ArticleId></ArticleIdList></Reference><Reference><Citation>Debernardi C, Libera L, Berrino E, Sahnane N, Chiaravalli AM, Laudi C, et al. Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction. Clin Epigenetics. 2021;13:154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8351348</ArticleId><ArticleId IdType="pubmed">34372923</ArticleId></ArticleIdList></Reference><Reference><Citation>Timar J, Kashofer K. Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev. 2020;39:1029&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680318</ArticleId><ArticleId IdType="pubmed">32725342</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CC, Xu J, Bian X, Wu J-L, Kang W, Qian Y, et al. In colorectal cancer cells with mutant KRAS, SLC25A22-mediated Glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and drug resistance. Gastroenterology. 2020;159:2163&#x2013;80. e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32814111</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami M, Sadrifar S, Karbalaei M, Keikha M, Kobyliak NM, Yousefi B. Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal cancer cells. J Gastrointest cancer. 2020;51:738&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">31735976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer M, Berger A, Leischner C, Renner O, Burkard M, B&#xf6;cker A, et al. Preclinical efficacy and toxicity analysis of the pan-histone deacetylase inhibitor gossypol for the therapy of colorectal cancer or hepatocellular carcinoma. Pharmaceuticals. 2022;15:438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9028974</ArticleId><ArticleId IdType="pubmed">35455435</ArticleId></ArticleIdList></Reference><Reference><Citation>An X, Lan X, Feng Z, Li X, Su Q. Histone modification: biomarkers and potential therapies in colorectal cancer. Ann Hum Genet. 2023;87:274&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">37712180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C, Shimizu J, Kawano F, Kim HJ, Kim CK. Adaptive responses of histone modifications to resistance exercise in human skeletal muscle. PLoS ONE. 2020;15:e0231321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145008</ArticleId><ArticleId IdType="pubmed">32271843</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yang Z, Feng J, Duan T, Pan T, Yan L, et al. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer. Cancer Med. 2021;10:317&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826484</ArticleId><ArticleId IdType="pubmed">33174323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Miao R-r, Li Y-n, Pan T, Wu S-h, Qu X-j, et al. Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting &#x3b2;-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis. Acta Pharmacol Sin. 2022;43:2967&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9622750</ArticleId><ArticleId IdType="pubmed">35365782</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyne DJ, O&#x2019;Sullivan DE, Olij BF, King WD, Friedenreich CM, Brenner DR. Physical activity, global DNA methylation, and breast cancer risk: a systematic literature review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2018;27:1320&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">29991518</ArticleId></ArticleIdList></Reference><Reference><Citation>Etayo-Urtasun P, S&#xe1;ez de Asteasu ML, Izquierdo M. Effects of exercise on DNA methylation: A systematic review of randomized controlled trials. Sports Med. 2024;54:2059&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11329527</ArticleId><ArticleId IdType="pubmed">38839665</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Yang L, Zhong C, Zhou L, Retracted. EZH2 regulates H2B phosphorylation and elevates colon cancer cell autophagy. Wiley Online Library; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">31283006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, Shan L, Wang J, Hu J, Zheng W, Lv Y, et al. Small molecule 2, 3-DCPE induces S phase arrest by activating the ATM/ATR-Chk1-Cdc25A signaling pathway in DLD-1 colon cancer cells. Oncol Lett. 2020;20:294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7576987</ArticleId><ArticleId IdType="pubmed">33101488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghate NB, Kim S, Spiller E, Kim S, Shin Y, Rhie SK, et al. VprBP directs epigenetic gene Silencing through histone H2A phosphorylation in colon cancer. Mol Oncol. 2021;15:2801&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486565</ArticleId><ArticleId IdType="pubmed">34312968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman NJ, Parker BL, Chaudhuri R, Fisher-Wellman KH, Kleinert M, Humphrey SJ, et al. Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates. Cell Metabol. 2015;22:922&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4635038</ArticleId><ArticleId IdType="pubmed">26437602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo W-S, Trievel RC, Rojas JR, Duggan L, Hsu J-Y, Allis CD, et al. Phosphorylation of Serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell. 2000;5:917&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">10911986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YR, Kim G, Tak WY, Jang SY, Kweon YO, Park JG, et al. Circulating Exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. Int J Cancer. 2019;144:1444&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">30338850</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhoulideh Y. Non-coding RNAs and Exosomal NcRNAs in colorectal cancer. Egypt J Med Hum Genet. 2025;26:19.</Citation></Reference><Reference><Citation>Moridikia A, Mirzaei H, Sahebkar A, Salimian J. MicroRNAs: potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol. 2018;233:901&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">28092102</ArticleId></ArticleIdList></Reference><Reference><Citation>Prossomariti A, Piazzi G, Alquati C, Ricciardiello L. Are Wnt/&#x3b2;-catenin and PI3K/AKT/mTORC1 distinct pathways in colorectal cancer? Cell Mol Gastroenterol Hepatol. 2020;10:491&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7369353</ArticleId><ArticleId IdType="pubmed">32334125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Yu X, Zhang S, He Y, Guo W. Mechanism underlying circrna dysregulation in the TME of digestive system cancer. Front Immunol. 2022;13:951561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9550895</ArticleId><ArticleId IdType="pubmed">36238299</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J, Tai JW, Lu L-F. miRNA&#x2013;Microbiota interaction in gut homeostasis and colorectal cancer. Trends cancer. 2019;5:666&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8480531</ArticleId><ArticleId IdType="pubmed">31735285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Jia H, Bao X, Wu Y, Zhu T, Li R, et al. Tumor exosome promotes Th17 cell differentiation by transmitting the LncRNA CRNDE-h in colorectal cancer. Cell Death Dis. 2021;12:123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835218</ArticleId><ArticleId IdType="pubmed">33495437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20:5758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6888455</ArticleId><ArticleId IdType="pubmed">31744051</ArticleId></ArticleIdList></Reference><Reference><Citation>Liau XL, Salvamani S, Gunasekaran B, Chellappan DK, Rhodes A, Ulaganathan V, et al. CCAT 1-a pivotal oncogenic long non-coding RNA in colorectal cancer. Br J Biomed Sci. 2023;80:11103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10070472</ArticleId><ArticleId IdType="pubmed">37025163</ArticleId></ArticleIdList></Reference><Reference><Citation>Danac JMC, Garcia RL. CircPVT1 attenuates negative regulation of NRAS by let-7 and drives cancer cells towards oncogenicity. Sci Rep. 2021;11:9021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8079436</ArticleId><ArticleId IdType="pubmed">33907219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu D-w. Immunomodulatory effects of exercise in cancer prevention and adjuvant therapy: a narrative review. Front Physiol. 2024;14:1292580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10794543</ArticleId><ArticleId IdType="pubmed">38239881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-K, Oh J. Patient-reported outcomes of regular aerobic exercise in gastric cancer. Cancers. 2021;13:2080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8123334</ArticleId><ArticleId IdType="pubmed">33923080</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzaglo GB, Telles GD, Ara&#xfa;jo RB, Junior GD, Ruberti OM, Ferreira ML, et al. The therapeutic potential of physical exercise in cancer: the role of chemokines. Int J Mol Sci. 2024;25:13740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11678861</ArticleId><ArticleId IdType="pubmed">39769501</ArticleId></ArticleIdList></Reference><Reference><Citation>Moein S, Vaghari-Tabari M, Qujeq D, Majidinia M, Nabavi SM, Yousefi B. MiRNAs and inflammatory bowel disease: an interesting new story. J Cell Physiol. 2019;234:3277&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30417350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JM-K, Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci. 2015;16:2472&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4346847</ArticleId><ArticleId IdType="pubmed">25622259</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima K, Takeoka M, Mori M, Hashimoto S, Sakurai A, Nose H, et al. Exercise effects on methylation of ASC gene. Int J Sports Med. 2010;31:671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20200803</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons CC, van den Brandt PA, Stehouwer CD, van Engeland M, Weijenberg MP. Body size, physical activity, early-Life energy restriction, and associations with methylated insulin-like growth factor&#x2013;binding protein genes in colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2014;23:1852&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">24972776</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonevitsky AG, Maltseva DV, Abbasi A, Samatov TR, Sakharov DA, Shkurnikov MU, et al. Dynamically regulated miRNA-mRNA networks revealed by exercise. BMC Physiol. 2013;13:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681679</ArticleId><ArticleId IdType="pubmed">24219008</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen S, &#xc5;kerstr&#xf6;m T, Rinnov A, Yfanti C, Scheele C, Pedersen BK, et al. The MiRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS ONE. 2014;9:e87308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929352</ArticleId><ArticleId IdType="pubmed">24586268</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23:1&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11580516</ArticleId><ArticleId IdType="pubmed">39574178</ArticleId></ArticleIdList></Reference><Reference><Citation>Boytar AN, Nitert MD, Morrision M, Skinner TL, Jenkins DG. Exercise-induced changes to the human gut microbiota and implications for colorectal cancer: a narrative review. J Physiol. 2022;600:5189&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10099575</ArticleId><ArticleId IdType="pubmed">36369926</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Ren Q, Zhong Z, Li Q, Huang Z, Zhang C, et al. Exploring the gut microbiome&#x2019;s role in colorectal cancer: diagnostic and prognostic implications. Front Immunol. 2024;15:1431747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11524876</ArticleId><ArticleId IdType="pubmed">39483461</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco W, Bricca L, Kaitsas F, Tartaglia MF, Venturini I, Rugge M et al. Gut microbiota in colorectal cancer: from pathogenesis to clinic. Best Pract Res Clin Gastroenterol. 2024:101941.</Citation><ArticleIdList><ArticleId IdType="pubmed">39645279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley JA, Forster SC, Giles EM, Exercise. Gut Microbiome, and Gastrointestinal Diseases: Therapeutic Impact and Molecular Mechanisms. Gastroenterology. 2025.</Citation><ArticleIdList><ArticleId IdType="pubmed">39978410</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui R, Boghossian A, Alharbi AM, Alfahemi H, Khan NA. The pivotal role of the gut Microbiome in colorectal cancer. Biology. 2022;11:1642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9687647</ArticleId><ArticleId IdType="pubmed">36358343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, et al. American Cancer society guideline for diet and physical activity for cancer prevention. Cancer J Clin. 2020;70:245&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">32515498</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell KL, Winters-Stone K, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51:2375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576825</ArticleId><ArticleId IdType="pubmed">31626055</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore SC, Lee I-M, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176:816&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5812009</ArticleId><ArticleId IdType="pubmed">27183032</ArticleId></ArticleIdList></Reference><Reference><Citation>Durko L, Malecka-Panas E. Lifestyle modifications and colorectal cancer. Curr Colorectal cancer Rep. 2014;10:45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950624</ArticleId><ArticleId IdType="pubmed">24659930</ArticleId></ArticleIdList></Reference><Reference><Citation>Severo JS, Silva ACAd S, BLBd, Reinaldo TS, Oliveira AMd, Lima RSP, et al. Physical exercise as a therapeutic approach in Gastrointestinal diseases. J Clin Med. 2025;14:1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11899784</ArticleId><ArticleId IdType="pubmed">40095789</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Global strategy on diet, physical activity and health. 2004.</Citation></Reference><Reference><Citation>Lund CM, Dolin TG, Mikkelsen MK, Juhl CB, Vinther A, Nielsen DL. Effect of exercise on physical function and psychological well-being in older patients with colorectal cancer receiving chemotherapy&#x2014;a systematic review. Clin Colorectal Cancer. 2020;19:e243&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">32828706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zopf EM, Schulz H, Poeschko J, Aschenbroich K, Wilhelm T, Eypasch E et al. Effects of supervised aerobic exercise on cardiorespiratory fitness and patient-reported health outcomes in colorectal cancer patients undergoing adjuvant chemotherapy&#x2014;a pilot study. Support Care Cancer. 2022:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8795052</ArticleId><ArticleId IdType="pubmed">34623488</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control. 1996;7:253&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">8740738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolin KY, Yan Y, Colditz GA, Lee I. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009;100:611&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2653744</ArticleId><ArticleId IdType="pubmed">19209175</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, et al. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009;169:2102&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852183</ArticleId><ArticleId IdType="pubmed">20008694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML, et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control. 2012;23:1939&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3499635</ArticleId><ArticleId IdType="pubmed">23053793</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle T, Fritschi L, Platell C, Heyworth J. Lifestyle factors associated with survival after colorectal cancer diagnosis. Br J Cancer. 2013;109:814&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738138</ArticleId><ArticleId IdType="pubmed">23787918</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood S, MacInnis RJ, English DR, Karahalios A, Lynch BM. Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysis. Int J Epidemiol. 2017;46:1797&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pubmed">29025130</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Lee MK, Lee DH, Kang DW, Min JH, Lee JW, et al. Effects of a 12-week home-based exercise program on quality of life, psychological health, and the level of physical activity in colorectal cancer survivors: a randomized controlled trial. Support Care Cancer. 2019;27:2933&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30564936</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy KT, Lam K, Kong JC. Exercise and colorectal cancer survival: an updated systematic review and meta-analysis. Int J Colorectal Dis. 2022;37:1751&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388423</ArticleId><ArticleId IdType="pubmed">35882678</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JC, Ma C, Shi Q, Niedzwiecki D, Zemla T, Couture F, et al. Association between physical activity and the time course of cancer recurrence in stage III colon cancer. Br J Sports Med. 2023;57:965&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10423490</ArticleId><ArticleId IdType="pubmed">36878665</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao X, Ling Y, Zeng Y, Wu Y, Guo C, Jin Y, et al. Physical activity and cancer risk: A dose-response analysis for the global burden of disease study 2019. Cancer Commun. 2023;43:1229&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10631483</ArticleId><ArticleId IdType="pubmed">37743572</ArticleId></ArticleIdList></Reference><Reference><Citation>Himbert C, Ose J, Gigic B, Viskochil R, Santuci K, Lin T, et al. Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes. BMC Cancer. 2023;23:300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10069054</ArticleId><ArticleId IdType="pubmed">37013476</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein MJ, Baurecht H, Bohmann P, Fervers B, Fontvieille E, Freisling H, et al. Diurnal timing of physical activity and risk of colorectal cancer in the UK biobank. BMC Med. 2024;22:399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11409794</ArticleId><ArticleId IdType="pubmed">39289682</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit KC, Derksen JW, Stellato RK, Lanen AV, Wesselink E, Belt EJ et al. Determinants of physical activity among patients with colorectal cancer: from diagnosis to 5 years after diagnosis. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38079324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou D, Xin X, Xu Y, Xu H, Xu T. A cross-sectional study on the association between physical activity and the risk of colon cancer based on NHANES 2007&#x2013;2018. Sci Rep. 2025;15:3297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11770084</ArticleId><ArticleId IdType="pubmed">39865142</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuebel KE, Chen W, Cope L, Gl&#xf6;ckner SC, Suzuki H, Yi J-M, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007;3:e157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1988850</ArticleId><ArticleId IdType="pubmed">17892325</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, et al. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol. 2009;20:1216&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19164452</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene. 2009;28:1385&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">19137007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa T, Kondo T, Ma D, Niu D, Mochizuki K, Kawasaki T, et al. Global histone modification of histone H3 in colorectal cancer and its precursor lesions. Hum Pathol. 2012;43:834&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">21917293</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng L, Hu J, Li S, Wang Z, Xia B, Jiang B, et al. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci. Int J Cancer. 2013;132:E18&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22945423</ArticleId></ArticleIdList></Reference><Reference><Citation>Benard A, Zeestraten EC, Goossens-Beumer IJ, Putter H, van de Velde CJ, Hoon DS, et al. DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence. Apoptosis. 2014;19:1581&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362525</ArticleId><ArticleId IdType="pubmed">25064172</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang T-J, Wang H-X, Zheng Y-Y, Cao Y-Q, Wu X, Zhou X, et al. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review. Oncotarget. 2017;8:46468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542282</ArticleId><ArticleId IdType="pubmed">28515349</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Zhao Q, Zhou J, Shi R. miR-429 mediates tumor growth and metastasis in colorectal cancer. Am J cancer Res. 2017;7:218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5336497</ArticleId><ArticleId IdType="pubmed">28337372</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. M 6 A-dependent Glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118901</ArticleId><ArticleId IdType="pubmed">32245489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298962</ArticleId><ArticleId IdType="pubmed">32552762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X-t, Xing W, Zhao R-s, Tan Y, Wu X-f, Ao L-q, et al. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer. J Experimental Clin Cancer Res. 2020;39:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7709355</ArticleId><ArticleId IdType="pubmed">33267897</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang AC, Buckingham L, Bishehsari F, Sutherland S, Ma K, Melson JE. Correlation of LINE-1 hypomethylation with size and pathologic extent of dysplasia in colorectal tubular adenomas. Clin Translational Gastroenterol. 2021;12:e00369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8162511</ArticleId><ArticleId IdType="pubmed">34060495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Gao Y, Yu Z, Su H. Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer. Bioengineered. 2022;13:8526&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9161846</ArticleId><ArticleId IdType="pubmed">35287563</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvandi E, Wong WK, Joglekar MV, Spring KJ, Hardikar AA. Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis. BMC Med. 2022;20:323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9528142</ArticleId><ArticleId IdType="pubmed">36184594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F, Zhao J, Sun J, Chen W, Zhao Y, Zhou S et al. Impact of ambient air pollution on colorectal cancer risk and survival: insights from a prospective cohort and epigenetic Mendelian randomization study. EBioMedicine. 2024;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11035091</ArticleId><ArticleId IdType="pubmed">38631091</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian Z, Yang F, Xu P, Gao G, Yang C, Cao Y, et al. LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM. Mol Cancer. 2024;23:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10807094</ArticleId><ArticleId IdType="pubmed">38263157</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Xie K, Li L, Li Z, Lu Q, Feng J. FOXN3 downregulation in colorectal Cancer enhances tumor cell stemness by promoting EP300-Mediated epigenetic upregulation of SOX12. Mol Carcinog. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39607349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Li H, Long Y, Zhang Z, Zhang F, Pan R et al. Epigenetic suppression of miR-137 induces RNF4 expression, facilitating Wnt signaling in colorectal Cancer. Mol Carcinog. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39630054</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40183455</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1573</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>Phytotherapy research : PTR</Title><ISOAbbreviation>Phytother Res</ISOAbbreviation></Journal><ArticleTitle>The Role of Medicinal Plants in Modulating Epigenetic Mechanisms: Implications for Cancer Prevention and Therapy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ptr.8481</ELocationID><Abstract><AbstractText>Cancer remains a significant global health challenge, with its progression driven by both genetic mutations and reversible epigenetic modifications. This review highlights the potential of phytochemicals to modulate epigenetic mechanisms for cancer prevention and treatment. Natural compounds such as quercetin, EGCG, genistein, and &#x3b2;-elemene interact with key processes such as DNA methylation, histone modifications, and non-coding RNA regulation. These mechanisms enable the reactivation of tumor suppressor genes, increased sensitivity to conventional therapy and mitigation of drug resistance. For instance, EGCG improves the efficacy of cisplatin by altering DNA methylation patterns, while genistein influences breast cancer progression through HER2 pathway regulation. However, challenges such as low bioavailability, variability in compound composition, and the need for robust clinical validation remain. Further high-quality clinical trials are required to confirm the efficacy and safety of these compounds in cancer prevention and therapy.</AbstractText><CopyrightInformation>&#xa9; 2025 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bendrihem</LastName><ForeName>Khadra Afaf</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Biotechnology, Water, Environment and Health Laboratory, Faculty of Natural and Life Sciences, University of Abbes Laghrour, Khenchela, Algeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouane</LastName><ForeName>Aicha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, Faculty of Natural Science and Life, El-Oued University, Algeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azzi</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Biology, Faculty of Natural Science and Life, El-Oued University, Algeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihoubi</LastName><ForeName>Mohamed Aimene</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Laboratory of Biotechnology of Bioactive Molecules and Cellular Physiopathology, Faculty of Science and Nature's Life, University of Batna 2, Batna, Algeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atanassova</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Scientific Consulting, Chemical Engineering, University of Chemical Technology and Metallurgy, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawicka</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Plant Production Technology and Commoditties Science, University of Life Sciences in Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahnit</LastName><ForeName>Wafa</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Faculty of Sciences, University of Ferhat ABBAS Setif 1, Algeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messaoudi</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3536-6358</Identifier><AffiliationInfo><Affiliation>Nuclear Research Centre of Birine, Djelfa, Algeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Phytother Res</MedlineTA><NlmUniqueID>8904486</NlmUniqueID><ISSNLinking>0951-418X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Terpenoids</Keyword><Keyword MajorTopicYN="N">cancer epigenetics</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">epigenetic therapy</Keyword><Keyword MajorTopicYN="N">medicinal plants</Keyword><Keyword MajorTopicYN="N">phytochemicals</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40183455</ArticleId><ArticleId IdType="doi">10.1002/ptr.8481</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Abdelaty, N. A., E. Z. Attia, A. Hamed, and S. Y. Desoukey. 2021. &#x201c;A Review on Various Classes of Secondary Metabolites and Biological Activities of Lamiaceae (Labiatae) (2002&#x2013;2018).&#x201d;</Citation></Reference><Reference><Citation>Aanniz, T., A. Bouyahya, A. Balahbib, et&#xa0;al. 2024. &#x201c;Natural Bioactive Compounds Targeting DNA Methyltransferase Enzymes in Cancer: Mechanisms Insights and Efficiencies.&#x201d; Chemico&#x2010;Biological Interactions 392: 110907. https://doi.org/10.1016/j.cbi.2024.110907.</Citation></Reference><Reference><Citation>Abbas, A., J. A. Hall, W. L. Patterson, et&#xa0;al. 2016. &#x201c;Sulforaphane Modulates Telomerase Activity via Epigenetic Regulation in Prostate Cancer Cell Lines.&#x201d; Biochemistry and Cell Biology 94: 71&#x2013;81. https://doi.org/10.1139/bcb&#x2010;2015&#x2010;0038.</Citation></Reference><Reference><Citation>Abbas, M. N., S. Kausar, and H. Cui. 2020. &#x201c;Therapeutic Potential of Natural Products in Glioblastoma Treatment: Targeting Key Glioblastoma Signaling Pathways and Epigenetic Alterations.&#x201d; Clinical &amp; Translational Oncology 22: 963&#x2013;977. https://doi.org/10.1007/s12094&#x2010;019&#x2010;02227&#x2010;3.</Citation></Reference><Reference><Citation>Agarwal, A., V. Kansal, H. Farooqi, R. Prasad, and V. K. Singh. 2023. &#x201c;Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.&#x201d; Biomedicine 11, no. 3: 789. https://doi.org/10.3390/biomedicines11030789.</Citation></Reference><Reference><Citation>Aggarwal, V., H. S. Tuli, J. Kaur, et&#xa0;al. 2020. &#x201c;Garcinol Exhibits Anti&#x2010;Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells.&#x201d; Biomedicine 8, no. 5: 103. https://doi.org/10.3390/biomedicines8050103.</Citation></Reference><Reference><Citation>Alatawi, F. S., A. M. E. Omran, M. S. Alatawi, E. Rashad, N. A. E. Yasin, and A. F. Soliman. 2024. &#x201c;Network Pharmacology Prediction and Experimental Validation of Ferulic Acid's Protective Effects Against Diclofenac&#x2010;Induced Liver Injury.&#x201d; Journal of Food Biochemistry 2024: 5592390. https://doi.org/10.1155/2024/5592390.</Citation></Reference><Reference><Citation>Al&#x2010;Semelawy, A. E.&#x2010;S., S. A. Aziza, H. Abd El&#x2010;Maksoud, Y. A. EL&#x2010;Senosi, and A. D. Abel Magid. 2024. &#x201c;A Potential Therapeutic Impact of Gallic Acid in a Rat Model of Hepatocarcinogenesis Through Inhibition of Cell Proliferation and Oncogenic miRNA&#x2010;221 and Induction of Apoptosis by Nrf&#x2010;2 /Bcl&#x2010;2/TGF&#x2010; &#x392;1 Signaling Pathways.&#x201d; Benha Veterinary Medical Journal 46, no. 2: 13&#x2013;18. https://doi.org/10.21608/bvmj.2024.279991.1802.</Citation></Reference><Reference><Citation>Alvarez, M. C., V. Maso, C. O. Torello, K. P. Ferro, and S. T. O. Saad. 2018. &#x201c;The Polyphenol Quercetin Induces Cell Death in Leukemia by Targeting Epigenetic Regulators of pro&#x2010;Apoptotic Genes.&#x201d; Clinical Epigenetics 10: 139. https://doi.org/10.1186/s13148&#x2010;018&#x2010;0563&#x2010;3.</Citation></Reference><Reference><Citation>Anand, P., A. B. Kunnumakkara, C. Sundaram, et&#xa0;al. 2008. &#x201c;Cancer Is a Preventable Disease That Requires Major Lifestyle Changes.&#x201d; Pharmaceutical Research 25: 2097&#x2013;2116. https://doi.org/10.1007/s11095&#x2010;008&#x2010;9661&#x2010;9.</Citation></Reference><Reference><Citation>Aravindaram, K., and N.&#x2010;S. Yang. 2010. &#x201c;Anti&#x2010;Inflammatory Plant Natural Products for Cancer Therapy.&#x201d; Planta Medica 76: 1103&#x2013;1117. https://doi.org/10.1055/s&#x2010;0030&#x2010;1249859.</Citation></Reference><Reference><Citation>Arif, K. M. T., E. K. Elliott, L. M. Haupt, and L. R. Griffiths. 2020. &#x201c;Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.&#x201d; Cancers 12: 2922. https://doi.org/10.3390/cancers12102922.</Citation></Reference><Reference><Citation>Asma, S. T., U. Acaroz, K. Imre, et&#xa0;al. 2022. &#x201c;Natural Products/Bioactive Compounds as a Source of Anticancer Drugs.&#x201d; Cancers 14: 6203. https://doi.org/10.3390/cancers14246203.</Citation></Reference><Reference><Citation>Babaeenezhad, E., M. Rashidipour, Z. Jangravi, M. Moradi Sarabi, and A. Shahriary. 2024. &#x201c;Cytotoxic and Epigenetic Effects of Berberine&#x2010;Loaded Chitosan/Pectin Nanoparticles on AGS Gastric Cancer Cells: Role of the miR&#x2010;185&#x2010;5p/KLF7 Axis, DNMTs, and Global DNA Methylation.&#x201d; International Journal of Biological Macromolecules 260: 129618. https://doi.org/10.1016/j.ijbiomac.2024.129618.</Citation></Reference><Reference><Citation>Baharuddin, P., N. Satar, K. S. Fakiruddin, et&#xa0;al. 2016. &#x201c;Curcumin Improves the Efficacy of Cisplatin by Targeting Cancer Stem&#x2010;Like Cells Through P21 and Cyclin D1&#x2010;Mediated Tumour Cell Inhibition in Non&#x2010;Small Cell Lung Cancer Cell Lines.&#x201d; Oncology Reports 35: 13&#x2013;25. https://doi.org/10.3892/or.2015.4371.</Citation></Reference><Reference><Citation>Bahmei, A., S. Namdari, M. Yaghoubzad&#x2010;Maleki, A. Emami, R. Ranjbaran, and G. Tamaddon. 2024. &#x201c;Bioinformatics&#x2010;Guided Discovery of miRNAs Involved in Apoptosis Modulated by Parthenolide Combined With Vincristine in the NALM6 Cell Line.&#x201d; Cell Journal (Yakhteh) 26: 139. https://doi.org/10.22074/CELLJ.2024.2013673.1428.</Citation></Reference><Reference><Citation>Balasubramanyam, K., R. A. Varier, M. Altaf, et&#xa0;al. 2004. &#x201c;Curcumin, a Novel P300/CREB&#x2010;Binding Protein&#x2010;Specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase&#x2010;Dependent Chromatin Transcription.&#x201d; Journal of Biological Chemistry 279: 51163&#x2013;51171. https://doi.org/10.1074/jbc.M409024200.</Citation></Reference><Reference><Citation>Bao, C., T. Liu, L. Qian, et&#xa0;al. 2021. &#x201c;Shikonin Inhibits Migration and Invasion of Triple&#x2010;Negative Breast Cancer Cells by Suppressing Epithelial&#x2010;Mesenchymal Transition via miR&#x2010;17&#x2010;5p/PTEN/Akt Pathway.&#x201d; Journal of Cancer 12: 76&#x2013;88. https://doi.org/10.7150/jca.47553.</Citation></Reference><Reference><Citation>Batiha, G. E.&#x2010;S., A. M. Beshbishy, M. Ikram, et&#xa0;al. 2020. &#x201c;The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin.&#x201d; Food 9: 374. https://doi.org/10.3390/foods9030374.</Citation></Reference><Reference><Citation>Biersack, B. 2016. &#x201c;Non&#x2010;Coding RNA/microRNA&#x2010;Modulatory Dietary Factors and Natural Products for Improved Cancer Therapy and Prevention: Alkaloids, Organosulfur Compounds, Aliphatic Carboxylic Acids and Water&#x2010;Soluble Vitamins.&#x201d; Noncoding RNA Res 1: 51&#x2013;63. https://doi.org/10.1016/j.ncrna.2016.09.001.</Citation></Reference><Reference><Citation>Bintu, L., J. Yong, Y. E. Antebi, et&#xa0;al. 2016. &#x201c;Dynamics of Epigenetic Regulation at the Single&#x2010;Cell Level.&#x201d; Science 351: 720&#x2013;724. https://doi.org/10.1126/science.aab2956.</Citation></Reference><Reference><Citation>Borutinskait&#x117;, V., A. Virk&#x161;ait&#x117;, G. Gudelyt&#x117;, and R. Navakauskien&#x117;. 2018. &#x201c;Green Tea Polyphenol EGCG Causes Anti&#x2010;Cancerous Epigenetic Modulations in Acute Promyelocytic Leukemia Cells.&#x201d; Leukemia &amp; Lymphoma 59: 469&#x2013;478. https://doi.org/10.1080/10428194.2017.1339881.</Citation></Reference><Reference><Citation>Bouyahya, A., H. Mechchate, L. Oumeslakht, et&#xa0;al. 2022. &#x201c;The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.&#x201d; Biomolecules 12: 367. https://doi.org/10.3390/biom12030367.</Citation></Reference><Reference><Citation>Bray, F., M. Laversanne, H. Sung, et&#xa0;al. 2024. &#x201c;Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.&#x201d; CA: A Cancer Journal for Clinicians 74: 229&#x2013;263. https://doi.org/10.3322/caac.21834.</Citation></Reference><Reference><Citation>Brown, J. S., S. R. Amend, R. H. Austin, R. A. Gatenby, E. U. Hammarlund, and K. J. Pienta. 2023. &#x201c;Updating the Definition of Cancer.&#x201d; Molecular Cancer Research 21: 1142&#x2013;1147. https://doi.org/10.1158/1541&#x2010;7786.MCR&#x2010;23&#x2010;0411.</Citation></Reference><Reference><Citation>Carlos&#x2010;Reyes, &#xc1;., J. S. L&#xf3;pez&#x2010;Gonz&#xe1;lez, M. Meneses&#x2010;Flores, et&#xa0;al. 2019. &#x201c;Dietary Compounds as Epigenetic Modulating Agents in Cancer.&#x201d; Frontiers in Genetics 10: 79. https://doi.org/10.3389/fgene.2019.00079.</Citation></Reference><Reference><Citation>Castro&#x2010;Mu&#xf1;oz, L., E. Ulloa, C. Sahlgren, M. Lizano, E. De La Cruz&#x2010;Hern&#xe1;ndez, and A. Contreras&#x2010;Paredes. 2023. &#x201c;Modulating Epigenetic Modifications for Cancer Therapy (Review).&#x201d; Oncology Reports 49: 59. https://doi.org/10.3892/or.2023.8496.</Citation></Reference><Reference><Citation>Cavalieri, V. 2021. &#x201c;The Expanding Constellation of Histone Post&#x2010;Translational Modifications in the Epigenetic Landscape.&#x201d; Genes 12, no. 10: 1596. https://doi.org/10.3390/genes12101596.</Citation></Reference><Reference><Citation>Cecerska&#x2010;Hery&#x107;, E., Z. Wi&#x15b;niewska, N. Serwin, et&#xa0;al. 2024. &#x201c;Can Compounds of Natural Origin be Important in Chemoprevention? Anticancer Properties of Quercetin, Resveratrol, and Curcumin&#x2014;A Comprehensive Review.&#x201d; International Journal of Molecular Sciences 25: 4505. https://doi.org/10.3390/ijms25084505.</Citation></Reference><Reference><Citation>Chakrabortty, A., D. J. Patton, B. F. Smith, and P. Agarwal. 2023. &#x201c;miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.&#x201d; Genes 14, no. 7: 1375. https://doi.org/10.3390/genes14071375.</Citation></Reference><Reference><Citation>Chan, M. M., and D. Fong. 2009. &#x201c;Overcoming Drug Resistance by Phytochemicals.&#x201d; In Drug Resistance in Cancer Cells, edited by Z. H. Siddik and K. Mehta, 315&#x2013;342. Springer US. 978&#x2013;0&#x2013;387&#x2010;89445&#x2010;4.</Citation></Reference><Reference><Citation>Chawra, H. S., M. Agarwal, A. Mishra, et&#xa0;al. 2024. &#x201c;MicroRNA&#x2010;21's Role in PTEN Suppression and PI3K/AKT Activation: Implications for Cancer Biology.&#x201d; Pathology, Research and Practice 254: 155091. https://doi.org/10.1016/j.prp.2024.155091.</Citation></Reference><Reference><Citation>Chen, J., Y. Ying, H. Zhu, et&#xa0;al. 2019. &#x201c;Curcumin&#x2010;Induced Promoter Hypermethylation of the Mammalian Target of Rapamycin Gene in Multiple Myeloma Cells.&#x201d; Oncology Letters 17: 1108&#x2013;1114. https://doi.org/10.3892/ol.2018.9662.</Citation></Reference><Reference><Citation>Chen, N., G. Zhao, X. Yan, et&#xa0;al. 2018. &#x201c;A Novel FLI1 Exonic Circular RNA Promotes Metastasis in Breast Cancer by Coordinately Regulating TET1 and DNMT1.&#x201d; Genome Biology 19: 218. https://doi.org/10.1186/s13059&#x2010;018&#x2010;1594&#x2010;y.</Citation></Reference><Reference><Citation>Chen, T.&#x2010;C., J.&#x2010;Y. Chuang, C.&#x2010;Y. Ko, et&#xa0;al. 2020. &#x201c;AR Ubiquitination Induced by the Curcumin Analog Suppresses Growth of Temozolomide&#x2010;Resistant Glioblastoma Through Disrupting GPX4&#x2010;Mediated Redox Homeostasis.&#x201d; Redox Biology 30: 101413. https://doi.org/10.1016/j.redox.2019.101413.</Citation></Reference><Reference><Citation>Chen, X., X. Ren, J. E, Y. Zhou, and R. Bian. 2023. &#x201c;Exosome&#x2010;Transmitted Circ IFNGR2 Modulates Ovarian Cancer Metastasis via miR&#x2010;378/ST5 Axis.&#x201d; Molecular and Cellular Biology 43: 22&#x2013;42. https://doi.org/10.1080/10985549.2022.2160605.</Citation></Reference><Reference><Citation>Cheng, Y., C. Yu, W. Li, Y. He, and Y. Bao. 2022. &#x201c;Matrine Inhibits Proliferation, Invasion, and Migration and Induces Apoptosis of Colorectal Cancer Cells via miR&#x2010;10b/PTEN Pathway.&#x201d; Cancer Biotherapy and Radiopharmaceuticals 37: 871&#x2013;881. https://doi.org/10.1089/cbr.2020.3800.</Citation></Reference><Reference><Citation>Cho, C.&#x2010;C., C.&#x2010;J. Lin, H.&#x2010;H. Huang, et&#xa0;al. 2023. &#x201c;Mechanistic Insights Into Harmine&#x2010;Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.&#x201d; ACS Chemical Biology 18: 1335&#x2013;1350. https://doi.org/10.1021/acschembio.3c00065.</Citation></Reference><Reference><Citation>Choi, K.&#x2010;C., Y.&#x2010;H. Lee, M. G. Jung, et&#xa0;al. 2009. &#x201c;Gallic Acid Suppresses Lipopolysaccharide&#x2010;Induced Nuclear Factor&#x2010;kappaB Signaling by Preventing RelA Acetylation in A549 Lung Cancer Cells.&#x201d; Molecular Cancer Research 7: 2011&#x2013;2021. https://doi.org/10.1158/1541&#x2010;7786.MCR&#x2010;09&#x2010;0239.</Citation></Reference><Reference><Citation>Chu, Y. C., S.&#x2010;T. Lin, S. A. Setiawan, et&#xa0;al. 2023. &#x201c;Phenethyl Isothiocyanate Inhibits CD133+/CD90+ Liver Cancer Stem Cells by Modulation of microRNA&#x2010;214&#x2010;&#x3b2;&#x2010;Catenin Epigenome Axis.&#x201d; Advances in Digestive Medicine 10: 215&#x2013;225. https://doi.org/10.1002/aid2.13352.</Citation></Reference><Reference><Citation>Ciesielski, O., M. Biesiekierska, and A. Balcerczyk. 2020. &#x201c;Epigallocatechin&#x2010;3&#x2010;Gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.&#x201d; Molecules 25: 2326. https://doi.org/10.3390/molecules25102326.</Citation></Reference><Reference><Citation>Cortez, N., C. Villegas, V. Burgos, et&#xa0;al. 2024. &#x201c;Adjuvant Properties of Caffeic Acid in Cancer Treatment.&#x201d; International Journal of Molecular Sciences 25: 7631. https://doi.org/10.3390/ijms25147631.</Citation></Reference><Reference><Citation>Curti, V., A. Di Lorenzo, D. Rossi, et&#xa0;al. 2017. &#x201c;Enantioselective Modulatory Effects of Naringenin Enantiomers on the Expression Levels of miR&#x2010;17&#x2010;3p Involved in Endogenous Antioxidant Defenses.&#x201d; Nutrients 9, no. 3: 215. https://doi.org/10.3390/nu9030215.</Citation></Reference><Reference><Citation>Das, D. D., N. Sharma, V. Chawla, and P. A. Chawla. 2023. &#x201c;Current Trends of Analytical Techniques for Bioactive Terpenoids: A Review.&#x201d; Critical Reviews in Analytical Chemistry 0: 1&#x2013;17. https://doi.org/10.1080/10408347.2023.2219757.</Citation></Reference><Reference><Citation>Deng, H., S. Chen, X. Yuan, and J. Zhang. 2022. &#x201c;Transcriptome Sequencing Analysis of the Effect of &#x3b2;&#x2010;Elemene on Colorectal Cancer From the lncRNA&#x2010;miRNA&#x2010;mRNA Perspective.&#x201d; Genetics Research 2022: 5896296. https://doi.org/10.1155/2022/5896296.</Citation></Reference><Reference><Citation>Ding, L., Y. Zhao, S. Dang, et&#xa0;al. 2019. &#x201c;Circular RNA Circ&#x2010;DONSON Facilitates Gastric Cancer Growth and Invasion via NURF Complex Dependent Activation of Transcription Factor SOX4.&#x201d; Molecular Cancer 18: 45. https://doi.org/10.1186/s12943&#x2010;019&#x2010;1006&#x2010;2.</Citation></Reference><Reference><Citation>Ding, X., Y. Li, J. L&#xfc;, et&#xa0;al. 2021. &#x201c;piRNA&#x2010;823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer.&#x201d; Frontiers in Cell and Development Biology 9: 641052. https://doi.org/10.3389/fcell.2021.641052.</Citation></Reference><Reference><Citation>Dong, A., Y. Fang, L. Zhang, et&#xa0;al. 2011. &#x201c;Caffeic Acid 3,4&#x2010;Dihydroxy&#x2010;Phenethyl Ester Induces Cancer Cell Senescence by Suppressing Twist Expression.&#x201d; Journal of Pharmacology and Experimental Therapeutics 339: 238&#x2013;247. https://doi.org/10.1124/jpet.111.181081.</Citation></Reference><Reference><Citation>Du, F., Y. Feng, J. Fang, and M. Yang. 2015. &#x201c;MicroRNA&#x2010;143 Enhances Chemosensitivity of Quercetin Through Autophagy Inhibition via Target GABARAPL1 in Gastric Cancer Cells.&#x201d; Biomedicine &amp; Pharmacotherapy 74: 169&#x2013;177. https://doi.org/10.1016/j.biopha.2015.08.005.</Citation></Reference><Reference><Citation>Du, K., Z. Li, X. Fang, T. Cao, and Y. Xu. 2017. &#x201c;Ferulic Acid Promotes Osteogenesis of Bone Marrow&#x2010;Derived Mesenchymal Stem Cells by Inhibiting microRNA&#x2010;340 to Induce &#x3b2;&#x2010;Catenin Expression Through Hypoxia.&#x201d; European Journal of Cell Biology 96: 496&#x2013;503. https://doi.org/10.1016/j.ejcb.2017.07.002.</Citation></Reference><Reference><Citation>El Omari, N., S. Bakrim, M. Bakha, et&#xa0;al. 2021. &#x201c;Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.&#x201d; Nutrients 13: 3714. https://doi.org/10.3390/nu13113714.</Citation></Reference><Reference><Citation>Elbasyouni, A., L. Saadi, and A. Baha. 2022. &#x201c;Dietary Curcuma, a Powerful Epigenome Modulator in Breast Cancer: An in Silico Study.&#x201d; Indonesian Journal of Cancer Chemoprevention 13: 61&#x2013;70. https://doi.org/10.14499/indonesianjcanchemoprev13iss1pp61&#x2010;70.</Citation></Reference><Reference><Citation>El&#x2010;Readi, M. Z., A. M. Al&#x2010;Abd, M. A. Althubiti, et&#xa0;al. 2021. &#x201c;Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites.&#x201d; Frontiers in Pharmacology 12: 658513. https://doi.org/10.3389/fphar.2021.658513.</Citation></Reference><Reference><Citation>Ery&#x131;lmaz Pehlivan, F. 2022. &#x201c;Diet&#x2010;Epigenome Interactions: Epi&#x2010;Drugs Modulating the Epigenetic Machinery During Cancer Prevention.&#x201d; In Biochemistry, edited by Anwar, M., Farooq, Z., Ahmad Rather, R., Tauseef, M., and Heinbockel, T., IntechOpen, Vol. 35 978&#x2013;1&#x2013;83880&#x2010;993&#x2010;5.</Citation></Reference><Reference><Citation>Fabiani, R., N. Vella, and P. Rosignoli. 2021. &#x201c;Epigenetic Modifications Induced by Olive Oil and Its Phenolic Compounds: A Systematic Review.&#x201d; Molecules 26, no. 2: 273. https://doi.org/10.3390/molecules26020273.</Citation></Reference><Reference><Citation>Fan, M., M. Shan, X. Lan, et&#xa0;al. 2022. &#x201c;Anti&#x2010;Cancer Effect and Potential microRNAs Targets of Ginsenosides Against Breast Cancer.&#x201d; Frontiers in Pharmacology 13: 1033017. https://doi.org/10.3389/fphar.2022.1033017.</Citation></Reference><Reference><Citation>Farasati Far, B., K. Vakili, M. Fathi, S. Yaghoobpoor, M. Bhia, and M. R. Naimi&#x2010;Jamal. 2023. &#x201c;The Role of microRNA&#x2010;21 (miR&#x2010;21) in Pathogenesis, Diagnosis, and Prognosis of Gastrointestinal Cancers: A Review.&#x201d; Life Sciences 316: 121340. https://doi.org/10.1016/j.lfs.2022.121340.</Citation></Reference><Reference><Citation>Fatima, N., S. S. R. Baqri, A. Bhattacharya, et&#xa0;al. 2021. &#x201c;Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy.&#x201d; Frontiers in Genetics 12: 758733. https://doi.org/10.3389/fgene.2021.758733.</Citation></Reference><Reference><Citation>Feng, M., X. Fan, J. Shi, et&#xa0;al. 2024. &#x201c;Terpenoids From Quinoa Reverse Drug Resistance of Colon Cancer by Upregulating miR&#x2010;495&#x2010;3p.&#x201d; Journal of the Science of Food and Agriculture 104: 8916&#x2013;8927. https://doi.org/10.1002/jsfa.13718.</Citation></Reference><Reference><Citation>Frick, C., H. Rumgay, J. Vignat, et&#xa0;al. 2023. &#x201c;Quantitative Estimates of Preventable and Treatable Deaths From 36 Cancers Worldwide: A Population&#x2010;Based Study.&#x201d; Lancet Global Health 11: e1700&#x2013;e1712. https://doi.org/10.1016/S2214&#x2010;109X(23)00406&#x2010;0.</Citation></Reference><Reference><Citation>Ganesan, A., P. B. Arimondo, M. G. Rots, C. Jeronimo, and M. Berdasco. 2019. &#x201c;The Timeline of Epigenetic Drug Discovery: From Reality to Dreams.&#x201d; Clinical Epigenetics 11: 174. https://doi.org/10.1186/s13148&#x2010;019&#x2010;0776&#x2010;0.</Citation></Reference><Reference><Citation>Gao, L., J. Guo, Y. Fan, et&#xa0;al. 2018. &#x201c;Module and Individual Domain Deletions of NRPS to Produce Plipastatin Derivatives in Bacillus Subtilis.&#x201d; Microbial Cell Factories 17: 84. https://doi.org/10.1186/s12934&#x2010;018&#x2010;0929&#x2010;4.</Citation></Reference><Reference><Citation>Gao, L., F. Meng, Z. Yang, et&#xa0;al. 2024. &#x201c;Nano&#x2010;Drug Delivery System for the Treatment of Multidrug&#x2010;Resistant Breast Cancer: Current Status and Future Perspectives.&#x201d; Biomedicine &amp; Pharmacotherapy 179: 117327. https://doi.org/10.1016/j.biopha.2024.117327.</Citation></Reference><Reference><Citation>Gao, Y., J. Duan, X. Dang, et&#xa0;al. 2023. &#x201c;Design, Synthesis and Biological Evaluation of Novel Histone Deacetylase (HDAC) Inhibitors Derived From &#x3b2;&#x2010;Elemene Scaffold.&#x201d; Journal of Enzyme Inhibition and Medicinal Chemistry 38: 2195991. https://doi.org/10.1080/14756366.2023.2195991.</Citation></Reference><Reference><Citation>George, B. P., R. Chandran, and H. Abrahamse. 2021. &#x201c;Role of Phytochemicals in Cancer Chemoprevention: Insights.&#x201d; Antioxidants (Basel, Switzerland) 10, no. 9: 1455. https://doi.org/10.3390/antiox10091455.</Citation></Reference><Reference><Citation>Gonz&#xe1;lez&#x2010;Iriarte, M., R. Carmona, J. M. P&#xe9;rez&#x2010;Pomares, et&#xa0;al. 2003. &#x201c;A Modified Chorioallantoic Membrane Assay Allows for Specific Detection of Endothelial Apoptosis Induced by Antiangiogenic Substances.&#x201d; Angiogenesis 6: 251&#x2013;254. https://doi.org/10.1023/B:AGEN.0000021388.59617.6b.</Citation></Reference><Reference><Citation>Good, C. R., S. Panjarian, A. D. Kelly, et&#xa0;al. 2018. &#x201c;TET1&#x2010;Mediated Hypomethylation Activates Oncogenic Signaling in Triple&#x2010;Negative Breast Cancer.&#x201d; Cancer Research 78: 4126&#x2013;4137. https://doi.org/10.1158/0008&#x2010;5472.CAN&#x2010;17&#x2010;2082.</Citation></Reference><Reference><Citation>Griffith, D. R., L. Botta, T. G. St. Denis, and S. A. Snyder. 2014. &#x201c;Explorations of Caffeic Acid Derivatives: Total Syntheses of Rufescenolide, Yunnaneic Acids C and D, and Studies Toward Yunnaneic Acids A and B.&#x201d; Journal of Organic Chemistry 79: 88&#x2013;105. https://doi.org/10.1021/jo4023167.</Citation></Reference><Reference><Citation>Gujral, P., V. Mahajan, A. C. Lissaman, and A. P. Ponnampalam. 2020. &#x201c;Histone Acetylation and the Role of Histone Deacetylases in Normal Cyclic Endometrium.&#x201d; Reproductive Biology and Endocrinology 18: 84. https://doi.org/10.1186/s12958&#x2010;020&#x2010;00637&#x2010;5.</Citation></Reference><Reference><Citation>Guo, L., Y.&#x2010;T. Lee, Y. Zhou, and Y. Huang. 2022b. &#x201c;Targeting Epigenetic Regulatory Machinery to Overcome Cancer Therapy Resistance.&#x201d; Seminars in Cancer Biology 83: 487&#x2013;502. https://doi.org/10.1016/j.semcancer.2020.12.022.</Citation></Reference><Reference><Citation>Guo, Y., Z.&#x2010;Y. Su, and A.&#x2010;N. T. Kong. 2015. &#x201c;Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals.&#x201d; Current Pharmacology Reports 1: 245&#x2013;257. https://doi.org/10.1007/s40495&#x2010;015&#x2010;0023&#x2010;0.</Citation></Reference><Reference><Citation>Guo, Z., Y. Zhang, W. Xu, X. Zhang, and J. Jiang. 2022a. &#x201c;Engineered Exosome&#x2010;Mediated Delivery of circDIDO1 Inhibits Gastric Cancer Progression via Regulation of MiR&#x2010;1307&#x2010;3p/SOCS2 Axis.&#x201d; Journal of Translational Medicine 20: 326. https://doi.org/10.1186/s12967&#x2010;022&#x2010;03527&#x2010;z.</Citation></Reference><Reference><Citation>Haque, S., and S. R. Vaiselbuh. 2020. &#x201c;Vincristine and Prednisone Regulates Cellular and Exosomal miR&#x2010;181a Expression Differently Within the First Time Diagnosed and the Relapsed Leukemia B Cells.&#x201d; Leukemia Research Reports 14: 100221. https://doi.org/10.1016/j.lrr.2020.100221.</Citation></Reference><Reference><Citation>Hardy, T. M., and T. O. Tollefsbol. 2011. &#x201c;Epigenetic Diet: Impact on the Epigenome and Cancer.&#x201d; Epigenomics 3: 503&#x2013;518. https://doi.org/10.2217/epi.11.71.</Citation></Reference><Reference><Citation>Hart, S. N., E. C. Polley, A. Yussuf, et&#xa0;al. 2020. &#x201c;Mutation Prevalence Tables for Hereditary Cancer Derived From Multigene Panel Testing.&#x201d; Human Mutation 41, no. 8: e1. https://doi.org/10.1002/humu.24053.</Citation></Reference><Reference><Citation>Havas, A. P., K. B. Rodrigues, A. Bhakta, et&#xa0;al. 2016. &#x201c;Belinostat and Vincristine Demonstrate Mutually Synergistic Cytotoxicity Associated With Mitotic Arrest and Inhibition of Polyploidy in a Preclinical Model of Aggressive Diffuse Large B Cell Lymphoma.&#x201d; Cancer Biology &amp; Therapy 17: 1240&#x2013;1252. https://doi.org/10.1080/15384047.2016.1250046.</Citation></Reference><Reference><Citation>He, F., C. J. Chou, M. Scheiner, et&#xa0;al. 2021. &#x201c;Melatonin&#x2010; and Ferulic Acid&#x2010;Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model.&#x201d; Journal of Medicinal Chemistry 64: 3794&#x2013;3812. https://doi.org/10.1021/acs.jmedchem.0c01940.</Citation></Reference><Reference><Citation>Hewlings, S. J., and D. S. Kalman. 2017. &#x201c;Curcumin: A Review of Its' Effects on Human Health.&#x201d; Food 6, no. 10: 92. https://doi.org/10.3390/foods6100092.</Citation></Reference><Reference><Citation>Heydari, Z., F. Moeinvaziri, S. M. A. Mirazimi, et&#xa0;al. 2024. &#x201c;Alteration in DNA Methylation Patterns: Epigenetic Signatures in Gastrointestinal Cancers.&#x201d; European Journal of Pharmacology 973: 176563. https://doi.org/10.1016/j.ejphar.2024.176563.</Citation></Reference><Reference><Citation>Hogg, S. J., P. A. Beavis, M. A. Dawson, and R. W. Johnstone. 2020. &#x201c;Targeting the Epigenetic Regulation of Antitumour Immunity.&#x201d; Nature Reviews. Drug Discovery 19: 776&#x2013;800. https://doi.org/10.1038/s41573&#x2010;020&#x2010;0077&#x2010;5.</Citation></Reference><Reference><Citation>Hu, C., M. Wang, M. Hu, et&#xa0;al. 2023. &#x201c;Genistein Induces Endocrine Resistance in Human Breast Cancer by Suppressing H3K27 Trimethylation.&#x201d; Endocrine&#x2010;Related Cancer 30: e220191. https://doi.org/10.1530/ERC&#x2010;22&#x2010;0191.</Citation></Reference><Reference><Citation>Hu, J., S. Cao, Z. Zhang, et&#xa0;al. 2020. &#x201c;Effects of Caffeic Acid on Epigenetics in the Brain of Rats With Chronic Unpredictable Mild Stress.&#x201d; Molecular Medicine Reports 22: 5358&#x2013;5368. https://doi.org/10.3892/mmr.2020.11609.</Citation></Reference><Reference><Citation>Hu, Y., Z. Lang, X. Li, et&#xa0;al. 2024. &#x201c;Ginsenoside Rg3 Promotes Hepatic Stellate Cell Ferroptosis by Epigenetically Regulating ACSL4 to Suppress Liver Fibrosis Progression.&#x201d; Phytomedicine 124: 155289. https://doi.org/10.1016/j.phymed.2023.155289.</Citation></Reference><Reference><Citation>Huang, C., H. Liu, X.&#x2010;L. Gong, L.&#x2010;Y. Wu, and B. Wen. 2017. &#x201c;Effect of Evodiamine and Berberine on the Interaction Between DNMTs and Target microRNAs During Malignant Transformation of the Colon by TGF&#x2010;&#x392;1.&#x201d; Oncology Reports 37: 1637&#x2013;1645. https://doi.org/10.3892/or.2017.5379.</Citation></Reference><Reference><Citation>Huang, J., T. Weng, J. Ko, et&#xa0;al. 2018. &#x201c;Suppression of Cleavage Factor Im 25 Promotes the Proliferation of Lung Cancer Cells Through Alternative Polyadenylation.&#x201d; Biochemical and Biophysical Research Communications 503: 856&#x2013;862. https://doi.org/10.1016/j.bbrc.2018.06.087.</Citation></Reference><Reference><Citation>Huang, T. H.&#x2010;M. 2023. &#x201c;Data From Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer.&#x201d; https://doi.org/10.1158/0008&#x2010;5472.c.6502631.v1.</Citation></Reference><Reference><Citation>Huang, X., P. Yan, W. Ding, et&#xa0;al. 2022. &#x201c;&#x3b1;&#x2010;Pinene Inhibits the Growth of Cervical Cancer Cells Through Its Proapoptotic Activity by Regulating the miR&#x2010;34a&#x2010;5p/Bcl&#x2010;2 Signaling Axis.&#x201d; Drug Development Research 83: 1766&#x2013;1776. https://doi.org/10.1002/ddr.21994.</Citation></Reference><Reference><Citation>Huang, Y., S. Chen, S. Wu, G. Dong, and C. Sheng. 2020. &#x201c;Evodiamine&#x2010;Inspired Dual Inhibitors of Histone Deacetylase 1 (HDAC1) and Topoisomerase 2 (TOP2) With Potent Antitumor Activity.&#x201d; Acta Pharmaceutica Sinica B 10: 1294&#x2013;1308.</Citation></Reference><Reference><Citation>Huang, Y.&#x2010;H., K. Cai, P.&#x2010;P. Xu, et&#xa0;al. 2021. &#x201c;CREBBP/EP300 Mutations Promoted Tumor Progression in Diffuse Large B&#x2010;Cell Lymphoma Through Altering Tumor&#x2010;Associated Macrophage Polarization via FBXW7&#x2010;NOTCH&#x2010;CCL2/CSF1 Axis.&#x201d; Signal Transduction and Targeted Therapy 6: 10. https://doi.org/10.1038/s41392&#x2010;020&#x2010;00437&#x2010;8.</Citation></Reference><Reference><Citation>Huminiecki, L. 2022. &#x201c;Evidence for Multilevel Chemopreventive Activities of Natural Phenols From Functional Genomic Studies of Curcumin, Resveratrol, Genistein, Quercetin, and Luteolin.&#x201d; International Journal of Molecular Sciences 23: 14957. https://doi.org/10.3390/ijms232314957.</Citation></Reference><Reference><Citation>Imai&#x2010;Sumida, M., P. Dasgupta, P. Kulkarni, et&#xa0;al. 2020. &#x201c;Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney Cancer.&#x201d; Cellular Physiology and Biochemistry 54: 53&#x2013;70. https://doi.org/10.33594/000000205.</Citation></Reference><Reference><Citation>Iravani Saadi, M., J. Moayedi, F. Hosseini, et&#xa0;al. 2024. &#x201c;The Effects of Resveratrol, Gallic Acid, and Piperine on the Expression of miR&#x2010;17, miR&#x2010;92b, miR&#x2010;181a, miR&#x2010;222, BAX, BCL&#x2010;2, MCL&#x2010;1, WT1, c&#x2010;Kit, and CEBPA in Human Acute Myeloid Leukemia Cells and Their Roles in Apoptosis.&#x201d; Biochemical Genetics 62: 2958&#x2013;2974. https://doi.org/10.1007/s10528&#x2010;023&#x2010;10582&#x2010;8.</Citation></Reference><Reference><Citation>Islam, M. T., and M. A. Uddin. 2017. &#x201c;Phytochemicals Are the Promising Tools Towards Drug&#x2010;Resistant Cancers.&#x201d; Boletim Informativo Geum 8: 26.</Citation></Reference><Reference><Citation>Ito, M., Y. Miyata, and M. Okada. 2023. &#x201c;Current Clinical Trials With Non&#x2010;Coding RNA&#x2010;Based Therapeutics in Malignant Diseases: A Systematic Review.&#x201d; Translational Oncology 31: 101634. https://doi.org/10.1016/j.tranon.2023.101634.</Citation></Reference><Reference><Citation>Izzo, A. A., S. Hoon&#x2010;Kim, R. Radhakrishnan, and E. M. Williamson. 2016. &#x201c;A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies.&#x201d; Phytotherapy Research 30: 691&#x2013;700. https://doi.org/10.1002/ptr.5591.</Citation></Reference><Reference><Citation>Jabbari, N., M. Feghhi, O. Esnaashari, H. Soraya, and J. Rezaie. 2022. &#x201c;Inhibitory Effects of Gallic Acid on the Activity of Exosomal Secretory Pathway in Breast Cancer Cell Lines: A Possible Anticancer Impact.&#x201d; BioImpacts: BI 12: 549&#x2013;559. https://doi.org/10.34172/bi.2022.23489.</Citation></Reference><Reference><Citation>Jamshidi&#x2010;adegani, F., S. Ghaemi, S. Al&#x2010;Hashmi, et&#xa0;al. 2022. &#x201c;Comparative Study of the Cytotoxicity, Apoptotic, and Epigenetic Effects of Boswellic Acid Derivatives on Breast Cancer.&#x201d; Scientific Reports 12: 19979. https://doi.org/10.1038/s41598&#x2010;022&#x2010;24229&#x2010;y.</Citation></Reference><Reference><Citation>Jang, S. Y., D. Hong, S. Y. Jeong, and J.&#x2010;H. Kim. 2015. &#x201c;Shikonin Causes Apoptosis by up&#x2010;Regulating P73 and Down&#x2010;Regulating ICBP90 in Human Cancer Cells.&#x201d; Biochemical and Biophysical Research Communications 1: 71&#x2013;76. https://doi.org/10.1016/j.bbrc.2015.07.131.</Citation></Reference><Reference><Citation>Jang, Y.&#x2010;G., E.&#x2010;B. Ko, and K.&#x2010;C. Choi. 2020. &#x201c;Gallic Acid, a Phenolic Acid, Hinders the Progression of Prostate Cancer by Inhibition of Histone Deacetylase 1 and 2 Expression.&#x201d; Journal of Nutritional Biochemistry 84: 108444. https://doi.org/10.1016/j.jnutbio.2020.108444.</Citation></Reference><Reference><Citation>Jen&#x10d;a, A., D. K. Mills, H. Ghasemi, et&#xa0;al. 2024. &#x201c;Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy.&#x201d; Biologics: Targets and Therapy 18: 229&#x2013;255. https://doi.org/10.2147/BTT.S484068.</Citation></Reference><Reference><Citation>Jeong, D., J. Ham, S. Park, et&#xa0;al. 2019. &#x201c;Ginsenoside Rh2 Suppresses Breast Cancer Cell Proliferation by Epigenetically Regulating the Long Noncoding RNA C3orf67&#x2010;AS1.&#x201d; American Journal of Chinese Medicine 47: 1643&#x2013;1658. https://doi.org/10.1142/S0192415X19500848.</Citation></Reference><Reference><Citation>Jiang, Y., J. Pei, Y. Zheng, Y. Miao, B. Duan, and L. Huang. 2022. &#x201c;Gallic Acid: A Potential Anti&#x2010;Cancer Agent.&#x201d; Chinese Journal of Integrative Medicine 28: 661&#x2013;671. https://doi.org/10.1007/s11655&#x2010;021&#x2010;3345&#x2010;2.</Citation></Reference><Reference><Citation>Kaikkonen, M. U., M. T. Y. Lam, and C. K. Glass. 2011. &#x201c;Non&#x2010;Coding RNAs as Regulators of Gene Expression and Epigenetics.&#x201d; Cardiovascular Research 90: 430&#x2013;440. https://doi.org/10.1093/cvr/cvr097.</Citation></Reference><Reference><Citation>Kang, K. A., H. S. Kim, D. H. Kim, and J. W. Hyun. 2013. &#x201c;The Role of a Ginseng Saponin Metabolite as a DNA Methyltransferase Inhibitor in Colorectal Cancer Cells.&#x201d; International Journal of Oncology 43: 228&#x2013;236. https://doi.org/10.3892/ijo.2013.1931.</Citation></Reference><Reference><Citation>Karam, L., S. Abou Staiteieh, R. Chaaban, et&#xa0;al. 2021. &#x201c;Anticancer Activities of Parthenolide in Primary Effusion Lymphoma Preclinical Models.&#x201d; Molecular Carcinogenesis 60: 567&#x2013;581. https://doi.org/10.1002/mc.23324.</Citation></Reference><Reference><Citation>Kedhari Sundaram, M., A. Hussain, S. Haque, R. Raina, and N. Afroze. 2019. &#x201c;Quercetin Modifies 5&#x2032;CpG Promoter Methylation and Reactivates Various Tumor Suppressor Genes by Modulating Epigenetic Marks in Human Cervical Cancer Cells.&#x201d; Journal of Cellular Biochemistry 120: 18357&#x2013;18369. https://doi.org/10.1002/jcb.29147.</Citation></Reference><Reference><Citation>Khan, A., A. Khan, M. A. Khan, et&#xa0;al. 2023. &#x201c;Phytocompounds Targeting Epigenetic Modulations: An Assessment in Cancer.&#x201d; Frontiers in Pharmacology 14: 1273993. https://doi.org/10.3389/fphar.2023.1273993.</Citation></Reference><Reference><Citation>Khan, K., C. Quispe, Z. Javed, et&#xa0;al. 2020. &#x201c;Resveratrol, Curcumin, Paclitaxel and miRNAs Mediated Regulation of PI3K/Akt/mTOR Pathway: Go Four Better to Treat Bladder Cancer.&#x201d; Cancer Cell International 20: 560. https://doi.org/10.1186/s12935&#x2010;020&#x2010;01660&#x2010;7.</Citation></Reference><Reference><Citation>Kim, D.&#x2010;Y., S.&#x2010;H. Kim, H.&#x2010;T. Cheong, C.&#x2010;S. Ra, K.&#x2010;J. Rhee, and B. D. Jung. 2020. &#x201c;Berberine Induces P53&#x2010;Dependent Apoptosis Through Inhibition of DNA Methyltransferase3b in Hep3B Cells.&#x201d; Korean Journal of Clinical Laboratory Science 52: 69&#x2013;77. https://doi.org/10.15324/kjcls.2020.52.1.69.</Citation></Reference><Reference><Citation>Kim, H., C. N. Ramirez, Z.&#x2010;Y. Su, and A.&#x2010;N. T. Kong. 2015. &#x201c;Epigenetic Modifications of Triterpenoid Ursolic Acid in Activating Nrf2 and Blocking Cellular Transformation of Mouse Epidermal Cells.&#x201d; Journal of Nutritional Biochemistry 33: 54. https://doi.org/10.1016/j.jnutbio.2015.09.014.</Citation></Reference><Reference><Citation>Kour, S., I. Biswas, S. Sheoran, et&#xa0;al. 2024. &#x201c;Betulin: A Novel Triterpenoid Anti&#x2010;Cancerous Agent Targeting Cervical Cancer Through Epigenetic Proteins.&#x201d; Molecular Diversity 29, no. 2: 1507&#x2013;1524. https://doi.org/10.1007/s11030&#x2010;024&#x2010;10930&#x2010;9.</Citation></Reference><Reference><Citation>Krajka&#x2010;Ku&#x17a;niak, V., and W. Baer&#x2010;Dubowska. 2021. &#x201c;Modulation of Nrf2 and NF&#x2010;&#x3ba;B Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?&#x201d; International Journal of Molecular Sciences 22, no. 15: 8223. https://doi.org/10.3390/ijms22158223.</Citation></Reference><Reference><Citation>Kuai, J., and N. Zhang. 2022. &#x201c;Upregulation of SIRT1 by Evodiamine Activates PI3K/AKT Pathway and Blocks Intervertebral Disc Degeneration.&#x201d; Molecular Medicine Reports 26: 1&#x2013;8. https://doi.org/10.3892/mmr.2022.12781.</Citation></Reference><Reference><Citation>Kuete, V., B. Ngameni, B. Wiench, et&#xa0;al. 2011. &#x201c;Cytotoxicity and Mode of Action of Four Naturally Occuring Flavonoids From the Genus Dorstenia: Gancaonin Q, 4&#x2010;Hydroxylonchocarpin, 6&#x2010;Prenylapigenin, and 6,8&#x2010;Diprenyleriodictyol.&#x201d; Planta Medica 77: 1984&#x2013;1989. https://doi.org/10.1055/s&#x2010;0031&#x2010;1280023.</Citation></Reference><Reference><Citation>Kuete, V., L. P. Sandjo, G. M. N. Kwamou, B. Wiench, A. E. Nkengfack, and T. Efferth. 2014. &#x201c;Activity of Three Cytotoxic Isoflavonoids From Erythrina Excelsa and Erythrina Senegalensis (Neobavaisoflavone, Sigmoidin H and Isoneorautenol) Toward Multi&#x2010;Factorial Drug Resistant Cancer Cells.&#x201d; Phytomedicine 21: 682&#x2013;688. https://doi.org/10.1016/j.phymed.2013.10.017.</Citation></Reference><Reference><Citation>Kumar, N., and N. Goel. 2019. &#x201c;Phenolic Acids: Natural Versatile Molecules With Promising Therapeutic Applications.&#x201d; Biotechnology Reports 24: e00370. https://doi.org/10.1016/j.btre.2019.e00370.</Citation></Reference><Reference><Citation>Kumar, S., and A. K. Pandey. 2013. &#x201c;Chemistry and Biological Activities of Flavonoids: An Overview.&#x201d; Scientific World Journal 2013: 162750. https://doi.org/10.1155/2013/162750.</Citation></Reference><Reference><Citation>Kumar, V., J. K. Dhanjal, A. N. Sari, et&#xa0;al. 2024. &#x201c;Effect of Withaferin&#x2010;A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer Therapy.&#x201d; Current Topics in Medicinal Chemistry 24: 379&#x2013;391. https://doi.org/10.2174/1568026623666230726105017.</Citation></Reference><Reference><Citation>Kumari, K., S. Keshari, D. Sengupta, S. C. Sabat, and S. K. Mishra. 2017. &#x201c;Transcriptome Analysis of Genes Associated With Breast Cancer Cell Motility in Response to Artemisinin Treatment.&#x201d; BMC Cancer 17: 858. https://doi.org/10.1186/s12885&#x2010;017&#x2010;3863&#x2010;7.</Citation></Reference><Reference><Citation>Lai, A. Y., and P. A. Wade. 2011. &#x201c;Cancer Biology and NuRD: A Multifaceted Chromatin Remodelling Complex.&#x201d; Nature Reviews. Cancer 11: 588&#x2013;596. https://doi.org/10.1038/nrc3091.</Citation></Reference><Reference><Citation>Lai, R., Z. Lin, C. Yang, et&#xa0;al. 2024. &#x201c;Novel Berberine Derivatives as P300 Histone Acetyltransferase Inhibitors in Combination Treatment for Breast Cancer.&#x201d; European Journal of Medicinal Chemistry 266: 116116. https://doi.org/10.1016/j.ejmech.2023.116116.</Citation></Reference><Reference><Citation>Lam, T. K., S. Shao, Y. Zhao, et&#xa0;al. 2012. &#x201c;Influence of Quercetin&#x2010;Rich Food Intake on microRNA Expression in Lung Cancer Tissues.&#x201d; Cancer Epidemiology, Biomarkers &amp; Prevention 21: 2176&#x2013;2184. https://doi.org/10.1158/1055&#x2010;9965.EPI&#x2010;12&#x2010;0745.</Citation></Reference><Reference><Citation>Lee, H., P. Zhang, A. Herrmann, et&#xa0;al. 2012. &#x201c;Acetylated STAT3 Is Crucial for Methylation of Tumor&#x2010;Suppressor Gene Promoters and Inhibition by Resveratrol Results in Demethylation.&#x201d; Proceedings of the National Academy of Sciences of the United States of America 109: 7765&#x2013;7769. https://doi.org/10.1073/pnas.1205132109.</Citation></Reference><Reference><Citation>Lee, W.&#x2010;J., Y.&#x2010;R. Chen, and T.&#x2010;H. Tseng. 2011. &#x201c;Quercetin Induces FasL&#x2010;Related Apoptosis, in Part, Through Promotion of Histone H3 Acetylation in Human Leukemia HL&#x2010;60 Cells.&#x201d; Oncology Reports 25: 583&#x2013;591. https://doi.org/10.3892/or.2010.1097.</Citation></Reference><Reference><Citation>Li, C., and X. Li. 2022. &#x201c;Exosome&#x2010;Derived Circ_0094343 Promotes Chemosensitivity of Colorectal Cancer Cells by Regulating Glycolysis via the miR&#x2010;766&#x2010;5p/TRIM67 Axis.&#x201d; Contrast Media &amp; Molecular Imaging 2022: 2878557. https://doi.org/10.1155/2022/2878557.</Citation></Reference><Reference><Citation>Li, C.&#x2010;Y., W. Wang, C.&#x2010;H. Leung, G.&#x2010;J. Yang, and J. Chen. 2024. &#x201c;KDM5 Family as Therapeutic Targets in Breast Cancer: Pathogenesis and Therapeutic Opportunities and Challenges.&#x201d; Molecular Cancer 23, no. 1: 109. https://doi.org/10.1186/s12943&#x2010;024&#x2010;02011&#x2010;0.</Citation></Reference><Reference><Citation>Li, G., C. Zhang, W. Liang, Y. Zhang, Y. Shen, and X. Tian. 2021b. &#x201c;Berberine Regulates the Notch1/PTEN/PI3K/AKT/mTOR Pathway and Acts Synergistically With 17&#x2010;AAG and SAHA in SW480 Colon Cancer Cells.&#x201d; Pharmaceutical Biology 59: 21&#x2013;30. https://doi.org/10.1080/13880209.2020.1865407.</Citation></Reference><Reference><Citation>Li, Q., S. Zhang, M. Wang, et&#xa0;al. 2019. &#x201c;Downregulated miR&#x2010;21 Mediates Matrine&#x2010;Induced Apoptosis via the PTEN/Akt Signaling Pathway in FTC&#x2010;133 Human Follicular Thyroid Cancer Cells.&#x201d; Oncology Letters 18: 3553&#x2013;3560. https://doi.org/10.3892/ol.2019.10693.</Citation></Reference><Reference><Citation>Li, S., W. Han, Q. He, Y. Wang, G. Jin, and Y. Zhang. 2023b. &#x201c;Ginsenoside Rh2 Suppresses Colon Cancer Growth by Targeting the miR&#x2010;150&#x2010;3p/SRCIN1/Wnt Axis.&#x201d; Acta Biochimica et Biophysica Sinica Shanghai 55: 633&#x2013;648. https://doi.org/10.3724/abbs.2023032.</Citation></Reference><Reference><Citation>Li, S., C. Shi, W. Fu, and J. Zhang. 2023a. &#x201c;Berberine Inhibits Tumour Growth In&#xa0;Vivo and In&#xa0;Vitro Through Suppressing the lincROR&#x2010;Wnt/&#x3b2;&#x2010;Catenin Regulatory Axis in Colorectal Cancer.&#x201d; Journal of Pharmacy and Pharmacology 75: 129&#x2013;138. https://doi.org/10.1093/jpp/rgac067.</Citation></Reference><Reference><Citation>Li, S., R. Wu, L. Wang, et&#xa0;al. 2022a. &#x201c;Triterpenoid Ursolic Acid Drives Metabolic Rewiring and Epigenetic Reprogramming in Treatment/Prevention of Human Prostate Cancer.&#x201d; Molecular Carcinogenesis 61: 111&#x2013;121. https://doi.org/10.1002/mc.23365.</Citation></Reference><Reference><Citation>Li, X., R. Chen, X. Lei, et&#xa0;al. 2021a. &#x201c;Quercetin Regulates ER&#x3b1; Mediated Differentiation of BMSCs Through Circular RNA.&#x201d; Gene 769: 145172. https://doi.org/10.1016/j.gene.2020.145172.</Citation></Reference><Reference><Citation>Li, X., S. Wang, W. Mu, et&#xa0;al. 2022b. &#x201c;Reactive Oxygen Species Reprogram Macrophages to Suppress Antitumor Immune Response Through the Exosomal miR&#x2010;155&#x2010;5p/PD&#x2010;L1 Pathway.&#x201d; Journal of Experimental &amp; Clinical Cancer Research 41: 41. https://doi.org/10.1186/s13046&#x2010;022&#x2010;02244&#x2010;1.</Citation></Reference><Reference><Citation>Li, Y., F. Jiang, L. Chen, et&#xa0;al. 2015. &#x201c;Blockage of TGF&#x3b2;&#x2010;SMAD2 by Demethylation&#x2010;Activated miR&#x2010;148a Is Involved in Caffeic Acid&#x2010;Induced Inhibition of Cancer Stem Cell&#x2010;Like Properties In&#xa0;Vitro and In&#xa0;Vivo.&#x201d; FEBS Open Bio 5: 466&#x2013;475. https://doi.org/10.1016/j.fob.2015.05.009.</Citation></Reference><Reference><Citation>Liao, M., W. Chu, X. Sun, et&#xa0;al. 2022. &#x201c;Reduction of H3K27cr Modification During DNA Damage in Colon Cancer.&#x201d; Frontiers in Oncology 12: 924061. https://doi.org/10.3389/fonc.2022.924061.</Citation></Reference><Reference><Citation>Lin, S., S.&#x2010;C. Tsai, C.&#x2010;C. Lee, B.&#x2010;W. Wang, J.&#x2010;Y. Liou, and K.&#x2010;G. Shyu. 2004. &#x201c;Berberine Inhibits HIF&#x2010;1alpha Expression via Enhanced Proteolysis.&#x201d; Molecular Pharmacology 66: 612&#x2013;619.</Citation></Reference><Reference><Citation>Lister, R., M. Pelizzola, R. H. Dowen, et&#xa0;al. 2009. &#x201c;Human DNA Methylomes at Base Resolution Show Widespread Epigenomic Differences.&#x201d; Nature 462, no. 7271: 315&#x2013;322. https://doi.org/10.1038/nature08514.</Citation></Reference><Reference><Citation>Liu, D., X. Meng, D. Wu, Z. Qiu, and H. Luo. 2019. &#x201c;A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine.&#x201d; Frontiers in Pharmacology 10: 9. https://doi.org/10.3389/fphar.2019.00009.</Citation></Reference><Reference><Citation>Liu, K., J. Huang, M. Xie, et&#xa0;al. 2014a. &#x201c;MIR34A Regulates Autophagy and Apoptosis by Targeting HMGB1 in the Retinoblastoma Cell.&#x201d; Autophagy 10: 442&#x2013;452. https://doi.org/10.4161/auto.27418.</Citation></Reference><Reference><Citation>Liu, X., Y. Chen, and Z. Jiang. 2020b. &#x201c;Grifolin Inhibits Proliferation, Migration, and Invasion of Lung Cancer A549 Cells by Regulating miRNA&#x2010;1251&#x2010;5p.&#x201d; Nanoscience and Nanotechnology Letters 12: 376&#x2013;382. https://doi.org/10.1166/nnl.2020.3114.</Citation></Reference><Reference><Citation>Liu, X., D. Papukashvili, Z. Wang, et&#xa0;al. 2022. &#x201c;Potential Utility of miRNAs for Liquid Biopsy in Breast Cancer.&#x201d; Frontiers in Oncology 12: 940314. https://doi.org/10.3389/fonc.2022.940314.</Citation></Reference><Reference><Citation>Liu, Y., Y. Feng, Y. Li, et&#xa0;al. 2020a. &#x201c;Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 Expression.&#x201d; Frontiers in Pharmacology 11: 867. https://doi.org/10.3389/fphar.2020.00867.</Citation></Reference><Reference><Citation>Liu, Y.&#x2010;Q., Y. Li, J. Qin, et&#xa0;al. 2014b. &#x201c;Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing miRNA Expression Profiles.&#x201d; Asian Pacific Journal of Cancer Prevention 15: 2169&#x2013;2177. https://doi.org/10.7314/APJCP.2014.15.5.2169.</Citation></Reference><Reference><Citation>Lu, X., D. Chen, F. Yang, and N. Xing. 2020. &#x201c;Quercetin Inhibits Epithelial&#x2010;To&#x2010;Mesenchymal Transition (EMT) Process and Promotes Apoptosis in Prostate Cancer via Downregulating lncRNA MALAT1.&#x201d; Cancer Management and Research 12: 1741&#x2013;1750. https://doi.org/10.2147/CMAR.S241093.</Citation></Reference><Reference><Citation>L&#xfc;, Y., B. Han, H. Yu, Z. Cui, Z. Li, and J. Wang. 2018. &#x201c;Berberine Regulates the microRNA&#x2010;21&#x2010;ITG&#x392;4&#x2010;PDCD4 Axis and Inhibits Colon Cancer Viability.&#x201d; Oncology Letters 15: 5971&#x2013;5976. https://doi.org/10.3892/ol.2018.7997.</Citation></Reference><Reference><Citation>Ma, J., and F. Liu. 2022. &#x201c;Study of tRNA&#x2010;Derived Fragment tRF&#x2010;20&#x2010;S998LO9D in Pan&#x2010;Cancer.&#x201d; Disease Markers 2022: 8799319. https://doi.org/10.1155/2022/8799319.</Citation></Reference><Reference><Citation>Ma, L., J. M. Feugang, P. Konarski, et&#xa0;al. 2006. &#x201c;Growth Inhibitory Effects of Quercetin on Bladder Cancer Cell.&#x201d; FBL 11: 2275&#x2013;2285. https://doi.org/10.2741/1970.</Citation></Reference><Reference><Citation>Ma, Z., Y. Zuo, and W. Wang. 2023. &#x201c;Ginsenoside Rg3 Inhibits Renal Cell Carcinoma Cell Migration, Invasion, Colony Formation, and Tube Formation and Enhances Apoptosis Through Promoting the DNA Demethylation and Histone Acetylation.&#x201d; Journal of Pharmacy and Pharmacology 75: 76&#x2013;86. https://doi.org/10.1093/jpp/rgac072.</Citation></Reference><Reference><Citation>MacKenzie, T. N., N. Mujumdar, S. Banerjee, et&#xa0;al. 2013. &#x201c;Triptolide Induces the Expression of miR&#x2010;142&#x2010;3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation.&#x201d; Molecular Cancer Therapeutics 12: 1266&#x2013;1275. https://doi.org/10.1158/1535&#x2010;7163.MCT&#x2010;12&#x2010;1231.</Citation></Reference><Reference><Citation>Mai, D., P. Ding, L. Tan, et&#xa0;al. 2018. &#x201c;PIWI&#x2010;Interacting RNA&#x2010;54265 Is Oncogenic and a Potential Therapeutic Target in Colorectal Adenocarcinoma.&#x201d; Theranostics 8: 5213&#x2013;5230. https://doi.org/10.7150/thno.28001.</Citation></Reference><Reference><Citation>Mai, D., Y. Zheng, H. Guo, et&#xa0;al. 2020. &#x201c;Serum piRNA&#x2010;54265 Is a New Biomarker for Early Detection and Clinical Surveillance of Human Colorectal Cancer.&#x201d; Theranostics 10: 8468&#x2013;8478. https://doi.org/10.7150/thno.46241.</Citation></Reference><Reference><Citation>Marin, I., E. Ofek, J. Bar, et&#xa0;al. 2020. &#x201c;MiR&#x2010;21, EGFR and PTEN in Non&#x2010;Small Cell Lung Cancer: An In&#xa0;Situ Hybridisation and Immunohistochemistry Study.&#x201d; Journal of Clinical Pathology 73: 636&#x2013;641. https://doi.org/10.1136/jclinpath&#x2010;2019&#x2010;206420.</Citation></Reference><Reference><Citation>Mavrogiannis, A. V., I. Kokkinopoulou, C. K. Kontos, and D. C. Sideris. 2018. &#x201c;Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis&#x2010;Related Genes in Breast Cancer Cell Lines.&#x201d; Current Pharmaceutical Biotechnology 19: 1076&#x2013;1086. https://doi.org/10.2174/1389201019666181112103204.</Citation></Reference><Reference><Citation>Meeran, S. M., A. Ahmed, and T. O. Tollefsbol. 2010. &#x201c;Epigenetic Targets of Bioactive Dietary Components for Cancer Prevention and Therapy.&#x201d; Clinical Epigenetics 1: 101&#x2013;116. https://doi.org/10.1007/s13148&#x2010;010&#x2010;0011&#x2010;5.</Citation></Reference><Reference><Citation>Mirzaei, S., M. H. Gholami, H. L. Ang, et&#xa0;al. 2021. &#x201c;Pre&#x2010;Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and co&#x2010;Delivery Systems for Pancreatic Cancer Therapy.&#x201d; Cells 10: 3348. https://doi.org/10.3390/cells10123348.</Citation></Reference><Reference><Citation>Mo, D., F. He, J. Zheng, H. Chen, L. Tang, and F. Yan. 2021. &#x201c;tRNA&#x2010;Derived Fragment tRF&#x2010;17&#x2010;79MP9PP Attenuates Cell Invasion and Migration via THBS1/TGF&#x2010;&#x392;1/Smad3 Axis in Breast Cancer.&#x201d; Frontiers in Oncology 11: 656078. https://doi.org/10.3389/fonc.2021.656078.</Citation></Reference><Reference><Citation>Mollanoori, H., Y. Ghelmani, B. Hassani, and M. Dehghani. 2024. &#x201c;Integrated Whole Transcriptome Profiling Revealed a Convoluted Circular RNA&#x2010;Based Competing Endogenous RNAs Regulatory Network in Colorectal Cancer.&#x201d; Scientific Reports 14, no. 1: 91. https://doi.org/10.1038/s41598&#x2010;023&#x2010;50230&#x2010;0.</Citation></Reference><Reference><Citation>Mondal, A., A. Gandhi, C. Fimognari, A. G. Atanasov, and A. Bishayee. 2019. &#x201c;Alkaloids for Cancer Prevention and Therapy: Current Progress and Future Perspectives.&#x201d; European Journal of Pharmacology 858: 172472. https://doi.org/10.1016/j.ejphar.2019.172472.</Citation></Reference><Reference><Citation>Morschhauser, F., H. Tilly, A. Chaidos, et&#xa0;al. 2020. &#x201c;Tazemetostat for Patients With Relapsed or Refractory Follicular Lymphoma: An Open&#x2010;Label, Single&#x2010;Arm, Multicentre, Phase 2 Trial.&#x201d; Lancet Oncology 21, no. 11: 1433&#x2013;1442. https://doi.org/10.1016/S1470&#x2010;2045(20)30441&#x2010;1.</Citation></Reference><Reference><Citation>Mou, L., L. Liao, Y. Zhang, D. Ming, and J. Jiang. 2021. &#x201c;Ursolic Acid Ameliorates Nthy&#x2010;Ori 3&#x2010;1 Cells Injury Induced by IL&#x2010;1&#x3b2; Through Limiting MALAT1/miR&#x2010;206/PTGS1 ceRNA Network and NF&#x2010;&#x3ba;B Signaling Pathway.&#x201d; Psychopharmacology 238: 1141&#x2013;1156. https://doi.org/10.1007/s00213&#x2010;021&#x2010;05761&#x2010;7.</Citation></Reference><Reference><Citation>Murthy, S. S., D. Trapani, B. Cao, et&#xa0;al. 2024. &#x201c;Premature Mortality Trends in 183 Countries by Cancer Type, Sex, WHO Region, and World Bank Income Level in 2000&#x2013;19: A Retrospective, Cross&#x2010;Sectional, Population&#x2010;Based Study.&#x201d; Lancet Oncology 25: 969&#x2013;978. https://doi.org/10.1016/S1470&#x2010;2045(24)00274&#x2010;2.</Citation></Reference><Reference><Citation>Mutlu, D., N. K. Dikici, N. N. B. Kart, and &#x15e;. Arslan. 2024. &#x201c;Phenolic Acids Modulating Epigenetic Mechanisms in HepG2 Human Hepatoma Cells.&#x201d; Journal of the Institute of Science and Technology 14: 604&#x2013;615. https://doi.org/10.21597/jist.1427824.</Citation></Reference><Reference><Citation>Nettore, I. C., C. Rocca, G. Mancino, et&#xa0;al. 2019. &#x201c;Quercetin and Its Derivative Q2 Modulate Chromatin Dynamics in Adipogenesis and Q2 Prevents Obesity and Metabolic Disorders in Rats.&#x201d; Journal of Nutritional Biochemistry 69: 151&#x2013;162. https://doi.org/10.1016/j.jnutbio.2019.03.019.</Citation></Reference><Reference><Citation>Nimal, S., N. Kumbhar, S., et&#xa0;al. 2024. &#x201c;Apigenin and Its Combination With Vorinostat Induces Apoptotic&#x2010;Mediated Cell Death in TNBC by Modulating the Epigenetic and Apoptotic Regulators and Related miRNAs.&#x201d; Scientific Reports 14: 9540. https://doi.org/10.1038/s41598&#x2010;024&#x2010;60395&#x2010;x.</Citation></Reference><Reference><Citation>Nobili, S., I. Landini, T. Mazzei, and E. Mini. 2012. &#x201c;Overcoming Tumor Multidrug Resistance Using Drugs Able to Evade P&#x2010;Glycoprotein or to Exploit Its Expression.&#x201d; Medicinal Research Reviews 32: 1220&#x2013;1262. https://doi.org/10.1002/med.20239.</Citation></Reference><Reference><Citation>Nowrasteh, G., A. Zand, L. B. Raposa, et&#xa0;al. 2023. &#x201c;Fruit Extract, Rich in Polyphenols and Flavonoids, Modifies the Expression of DNMT and HDAC Genes Involved in Epigenetic Processes.&#x201d; Nutrients 15, no. 8: 1867. https://doi.org/10.3390/nu15081867.</Citation></Reference><Reference><Citation>Olofinsan, K., H. Abrahamse, and B. P. George. 2023. &#x201c;Therapeutic Role of Alkaloids and Alkaloid Derivatives in Cancer Management.&#x201d; Molecules 28: 5578. https://doi.org/10.3390/molecules28145578.</Citation></Reference><Reference><Citation>Oodi, A., H. Norouzi, N. Amirizadeh, M. Nikougoftar, and Z. Vafaie. 2017. &#x201c;Harmine, a Novel DNA Methyltransferase 1 Inhibitor in the Leukemia Cell Line.&#x201d; Indian Journal of Hematology and Blood Transfusion 33: 509&#x2013;515. https://doi.org/10.1007/s12288&#x2010;016&#x2010;0770&#x2010;z.</Citation></Reference><Reference><Citation>Paccez, J. D., K. Duncan, D. Sekar, et&#xa0;al. 2019. &#x201c;Dihydroartemisinin Inhibits Prostate Cancer via JARID2/miR&#x2010;7/miR&#x2010;34a&#x2010;Dependent Downregulation of Axl.&#x201d; Oncogene 8: 1&#x2013;14. https://doi.org/10.1038/s41389&#x2010;019&#x2010;0122&#x2010;6.</Citation></Reference><Reference><Citation>Panda, M., S. K. Tripathi, G. Zengin, and B. K. Biswal. 2023. &#x201c;Evodiamine as an Anticancer Agent: A Comprehensive Review on Its Therapeutic Application, Pharmacokinetic, Toxicity, and Metabolism in Various Cancers.&#x201d; Cell Biology and Toxicology 39: 1&#x2013;31. https://doi.org/10.1007/s10565&#x2010;022&#x2010;09772&#x2010;8.</Citation></Reference><Reference><Citation>Pang, F., S. Ding, N. Li, et&#xa0;al. 2023. &#x201c;Gallic Acid Mediates Tumor&#x2010;Suppressive Effects on Osteosarcoma Through the H19&#x2010;Wnt/&#x3b2;&#x2010;Catenin Regulatory Axis.&#x201d; Journal of Orthopaedic Translation 39: 34. https://doi.org/10.1016/j.jot.2022.12.003.</Citation></Reference><Reference><Citation>Paolini, A., V. Curti, F. Pasi, G. Mazzini, R. Nano, and E. Capelli. 2015. &#x201c;Gallic Acid Exerts a Protective or an Anti&#x2010;Proliferative Effect on Glioma T98G Cells via Dose&#x2010;Dependent Epigenetic Regulation Mediated by miRNAs.&#x201d; International Journal of Oncology 46: 1491&#x2013;1497. https://doi.org/10.3892/ijo.2015.2864.</Citation></Reference><Reference><Citation>Parashar, N. C., G. Parashar, H. Nayyar, and R. Sandhir. 2021. &#x201c;Differential DNA Methylation in Regulation of Deacetylvindoline&#x2010;4&#x2010;O&#x2010;Acetyl Transferase (DAT) Gene in Catharanthus Roseus.&#x201d; Journal of Plant Biochemistry and Biotechnology 30: 326&#x2013;335. https://doi.org/10.1007/s13562&#x2010;020&#x2010;00592&#x2010;7.</Citation></Reference><Reference><Citation>Pauli, C., D. Heid, C. Rohde, et&#xa0;al. 2024. &#x201c;Abstract 2763: A Specific Ribomethylome Pattern in Lung Cancer Is Associated With Increased Risk of Metastasis.&#x201d; Cancer Research 84: 2763. https://doi.org/10.1158/1538&#x2010;7445.AM2024&#x2010;2763.</Citation></Reference><Reference><Citation>Peng, Y., and H. Pei. 2021. &#x201c;DNA Alkylation Lesion Repair: Outcomes and Implications in Cancer Chemotherapy.&#x201d; Journal of Zhejiang University. Science. B 22: 47&#x2013;62. https://doi.org/10.1631/jzus.B2000344.</Citation></Reference><Reference><Citation>Pengnam, S., S. Plianwong, B.&#x2010;E. Yingyongnarongkul, P. Patrojanasophon, and P. Opanasopit. 2022. &#x201c;Delivery of Small Interfering RNAs by Nanovesicles for Cancer Therapy.&#x201d; Drug Metabolism and Pharmacokinetics 42: 100425. https://doi.org/10.1016/j.dmpk.2021.100425.</Citation></Reference><Reference><Citation>Tabrez, S., and M. Imran Khan, eds. 2021. Polyphenols&#x2010;Based Nanotherapeutics for Cancer Management. Springer Singapore. ISBN 9789811649349.</Citation></Reference><Reference><Citation>Pop, S., A. M. Enciu, I. Tarcomnicu, E. Gille, and C. Tanase. 2019. &#x201c;Phytochemicals in Cancer Prevention: Modulating Epigenetic Alterations of DNA Methylation.&#x201d; Phytochemistry Reviews 18: 1005&#x2013;1024. https://doi.org/10.1007/s11101&#x2010;019&#x2010;09627&#x2010;x.</Citation></Reference><Reference><Citation>Qian, L., H. Xie, L. Zhang, Q. Zhao, J. L&#xfc;, and Z. Yu. 2021. &#x201c;Piwi&#x2010;Interacting RNAs: A New Class of Regulator in Human Breast Cancer.&#x201d; Frontiers in Oncology 11: 695077. https://doi.org/10.3389/fonc.2021.695077.</Citation></Reference><Reference><Citation>Qian, M., S. Wang, X. Guo, et&#xa0;al. 2020. &#x201c;Hypoxic Glioma&#x2010;Derived Exosomes Deliver microRNA&#x2010;1246 to Induce M2 Macrophage Polarization by Targeting TERF2IP via the STAT3 and NF&#x2010;&#x3ba;B Pathways.&#x201d; Oncogene 39: 428&#x2013;442. https://doi.org/10.1038/s41388&#x2010;019&#x2010;0996&#x2010;y.</Citation></Reference><Reference><Citation>Qian, T., T. Wenxian, and H. Anbing. 2024. &#x201c;&#x3b2;&#x2010;Elemene Enhances Cisplatin Sensitivity of Non&#x2010;Small Cell Lung Cancer Cells via the miR&#x2010;17&#x2010;5p/STAT3 Axis.&#x201d; Chemical Biology &amp; Drug Design 103: e14395. https://doi.org/10.1111/cbdd.14395.</Citation></Reference><Reference><Citation>Qian, X., L. Zhu, M. Xu, et&#xa0;al. 2023. &#x201c;Shikonin Suppresses Small Cell Lung Cancer Growth via Inducing ATF3&#x2010;Mediated Ferroptosis to Promote ROS Accumulation.&#x201d; Chemico&#x2010;Biological Interactions 382: 110588. https://doi.org/10.1016/j.cbi.2023.110588.</Citation></Reference><Reference><Citation>Qiu, J., X. Liu, G. Yang, Z. Gui, and S. Ding. 2023. &#x201c;MiR&#x2010;29b Level&#x2010;Mediated Regulation of Klotho Methylation via DNMT3A Targeting in Chronic Obstructive Pulmonary Disease.&#x201d; Cells and Development 174: 203827. https://doi.org/10.1016/j.cdev.2023.203827.</Citation></Reference><Reference><Citation>Rajabinasab, F., P. Hajimirzaei, F. Ramezani, et&#xa0;al. 2024. Lung Protective Effect of Apigenin Against X&#x2010;Ray Radiation: An Experimental Study. Research Square [Preprint]. 2023. https://doi.org/10.21203/rs.3.rs&#x2010;4011444/v1.</Citation></Reference><Reference><Citation>Ramachandran, C., G. Portalatin, K.&#x2010;W. Quirin, E. Escalon, Z. Khatib, and S. J. Melnick. 2015. &#x201c;Inhibition of AKT Signaling by Supercritical CO2 Extract of Mango Ginger (Curcuma Amada Roxb.) in Human Glioblastoma Cells.&#x201d; J Complement Integr Med 12: 307&#x2013;315. https://doi.org/10.1515/jcim&#x2010;2015&#x2010;0005.</Citation></Reference><Reference><Citation>Ramazi, S., A. Allahverdi, and J. Zahiri. 2020. &#x201c;Evaluation of Post&#x2010;Translational Modifications in Histone Proteins: A Review on Histone Modification Defects in Developmental and Neurological Disorders.&#x201d; Journal of Biosciences 45: 135. https://doi.org/10.1007/s12038&#x2010;020&#x2010;00099&#x2010;2.</Citation></Reference><Reference><Citation>Rezaie, F., M. J. Mokhtari, and M. Kalani. 2021. &#x201c;Quercetin Arrests in G2 Phase, Upregulates INXS LncRNA and Downregulates UCA1 LncRNA in MCF&#x2010;7 Cells.&#x201d; International Journal of Molecular and Cellular Medicine 10: 208&#x2013;216. https://doi.org/10.22088/IJMCM.BUMS.10.3.207.</Citation></Reference><Reference><Citation>Rodrigues, A. C., X. Li, L. Radecki, et&#xa0;al. 2011. &#x201c;MicroRNA Expression Is Differentially Altered by Xenobiotic Drugs in Different Human Cell Lines.&#x201d; Biopharmaceutics &amp; Drug Disposition 32: 355&#x2013;367. https://doi.org/10.1002/bdd.764.</Citation></Reference><Reference><Citation>Saenglee, S., S. Jogloy, A. Patanothai, and T. Senawong. 2016. &#x201c;Cytotoxic Effects of Peanut Phenolic Compounds Possessing Histone Deacetylase Inhibitory Activity on Human Colon Cancer Cell Lines.&#x201d; Turkish Journal of Biology 40: 1258&#x2013;1271. https://doi.org/10.3906/biy&#x2010;1601&#x2010;23.</Citation></Reference><Reference><Citation>Sanaei, M., and F. Kavoosi. 2020. &#x201c;Effect of 5&#x2010;Aza&#x2010;2&#x2032;&#x2010;Deoxycytidine on Estrogen Receptor Alpha/Beta and DNA Methyltransferase 1 Genes Expression, Apoptosis Induction, and Cell Growth Prevention of the Colon Cancer HT 29 Cell Line.&#x201d; International Journal of Preventive Medicine 11: 147. https://doi.org/10.4103/ijpvm.IJPVM_140_19.</Citation></Reference><Reference><Citation>Sarwar, M. S., C. N. Ramirez, H.&#x2010;C. D. Kuo, et&#xa0;al. 2024. &#x201c;Triterpenoid Ursolic Acid Regulates the Environmental Carcinogen Benzo[a]Pyrene&#x2010;Driven Epigenetic and Metabolic Alterations in SKH&#x2010;1 Hairless Mice for Skin Cancer Interception.&#x201d; Carcinogenesis 45: 288&#x2013;299. https://doi.org/10.1093/carcin/bgae009.</Citation></Reference><Reference><Citation>Saviana, M., P. Le, L. Micalo, et&#xa0;al. 2023. &#x201c;Crosstalk Between miRNAs and DNA Methylation in Cancer.&#x201d; Genes 14, no. 5: 1075. https://doi.org/10.3390/genes14051075.</Citation></Reference><Reference><Citation>Sawesi, S., S. A. Malkaram, Z. Y. Abd Elmageed, and T. E. Fandy. 2022. &#x201c;Modulation of the Activity of Histone Lysine Methyltransferases and Demethylases by Curcumin Analog in Leukaemia Cells.&#x201d; Journal of Cellular and Molecular Medicine 26: 5624&#x2013;5633. https://doi.org/10.1111/jcmm.17589.</Citation></Reference><Reference><Citation>Secme, M., D. Mutlu, L. Elmas, and S. Arslan. 2023. &#x201c;Assessing Effects of Caffeic Acid on Cytotoxicity, Apoptosis, Invasion, GST Enzyme Activity, Oxidant, Antioxidant Status and Micro&#x2010;RNA Expressions in HCT116 Colorectal Cancer Cells.&#x201d; South African Journal of Botany 157: 19&#x2013;26. https://doi.org/10.1016/j.sajb.2023.03.046.</Citation></Reference><Reference><Citation>Sehgal, A., M. A. Bhat, D. Dogra, S. Rawat, and S. K. Dhatwalia. 2023. &#x201c;EGCG: The Antioxidant Powerhouse in Lung Cancer Management and Chemotherapy Enhancement.&#x201d; Advances in Redox Research 9: 100085. https://doi.org/10.1016/j.arres.2023.100085.</Citation></Reference><Reference><Citation>Sergeeva, A., K. Davydova, A. Perenkov, and M. Vedunova. 2023. &#x201c;Mechanisms of Human DNA Methylation, Alteration of Methylation Patterns in Physiological Processes and Oncology.&#x201d; Gene 875: 147487. https://doi.org/10.1016/j.gene.2023.147487.</Citation></Reference><Reference><Citation>Shan, S., Y. Lu, X. Zhang, J. Shi, H. Li, and Z. Li. 2021. &#x201c;Inhibitory Effect of Bound Polyphenol From Foxtail Millet Bran on miR&#x2010;149 Methylation Increases the Chemosensitivity of Human Colorectal Cancer HCT&#x2010;8/Fu Cells.&#x201d; Molecular and Cellular Biochemistry 476: 513&#x2013;523. https://doi.org/10.1007/s11010&#x2010;020&#x2010;03906&#x2010;4.</Citation></Reference><Reference><Citation>Sharma, A. K., and M. J. Hendzel. 2019. &#x201c;The Relationship Between Histone Posttranslational Modification and DNA Damage Signaling and Repair.&#x201d; International Journal of Radiation Biology 95: 382&#x2013;393. https://doi.org/10.1080/09553002.2018.1516911.</Citation></Reference><Reference><Citation>Sharma, D., C. G. Hager, L. Shang, et&#xa0;al. 2023. &#x201c;The BET Degrader ZBC260 Suppresses Stemness and Tumorigenesis and Promotes Differentiation in Triple&#x2010;Negative Breast Cancer by Disrupting Inflammatory Signaling.&#x201d; Breast Cancer Research 25: 144. https://doi.org/10.1186/s13058&#x2010;023&#x2010;01715&#x2010;3.</Citation></Reference><Reference><Citation>Shen, Y., M. Takahashi, H.&#x2010;M. Byun, et&#xa0;al. 2012. &#x201c;Boswellic Acid Induces Epigenetic Alterations by Modulating DNA Methylation in Colorectal Cancer Cells.&#x201d; Cancer Biology &amp; Therapy 13: 542&#x2013;552. https://doi.org/10.4161/cbt.19604.</Citation></Reference><Reference><Citation>Shirazi&#x2010;Tehrani, E., A. Vafadar, M. Keshavarzi, and N. Firouzabadi. 2022. &#x201c;Anticancer Properties of Vincristine Is Modulated by microRNAs in Acute Lymphoblastic Leukemia Nalm6 Cell Line.&#x201d; Anti&#x2010;Cancer Drugs 33: e680. https://doi.org/10.1097/CAD.0000000000001234.</Citation></Reference><Reference><Citation>Si, L., L. Zhang, S. Xing, et&#xa0;al. 2023. &#x201c;Curcumin as a Therapeutic Agent in Cancer Therapy: Focusing on Its Modulatory Effects on Circular RNAs.&#x201d; Phytotherapy Research 37: 3121&#x2013;3134. https://doi.org/10.1002/ptr.7863.</Citation></Reference><Reference><Citation>Singh, S. K., C. Hawkins, I. D. Clarke, et&#xa0;al. 2004. &#x201c;Identification of Human Brain Tumour Initiating Cells.&#x201d; Nature 432: 396&#x2013;401. https://doi.org/10.1038/nature03128.</Citation></Reference><Reference><Citation>Singh, V., E. Shirbhate, R. Kore, et&#xa0;al. 2024. &#x201c;Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer.&#x201d; Mini&#x2010;Reviews in Medicinal Chemistry 24: 1409&#x2013;1426. https://doi.org/10.2174/0113895575283895240207065454.</Citation></Reference><Reference><Citation>Ska&#x142;a, E., M. Toma, T. Kowalczyk, T. &#x15a;liwi&#x144;ski, and P. Sitarek. 2018. &#x201c;Rhaponticum Carthamoides Transformed Root Extract Inhibits Human Glioma Cells Viability, Induces Double Strand DNA Damage, H2A.X Phosphorylation, and PARP1 Cleavage.&#x201d; Cytotechnology 70: 1585&#x2013;1594. https://doi.org/10.1007/s10616&#x2010;018&#x2010;0251&#x2010;3.</Citation></Reference><Reference><Citation>Soerjomataram, I., and F. Bray. 2021. &#x201c;Planning for Tomorrow: Global Cancer Incidence and the Role of Prevention 2020&#x2013;2070.&#x201d; Nature Reviews. Clinical Oncology 18: 663&#x2013;672. https://doi.org/10.1038/s41571&#x2010;021&#x2010;00514&#x2010;z.</Citation></Reference><Reference><Citation>Solanki, R., and S. Patel. 2024. &#x201c;Evodiamine and Its Nano&#x2010;Based Approaches for Enhanced Cancer Therapy: Recent Advances and Challenges.&#x201d; Journal of the Science of Food and Agriculture 104: 8430&#x2013;8444. https://doi.org/10.1002/jsfa.13612.</Citation></Reference><Reference><Citation>Sonar, S., S. Nyahatkar, K. Kalele, and M. D. Adhikari. 2024. &#x201c;Role of DNA Methylation in Cancer Development and Its Clinical Applications.&#x201d; Clinical and Translational Discovery 4: e279. https://doi.org/10.1002/ctd2.279.</Citation></Reference><Reference><Citation>Stefanska, B., H. Karlic, F. Varga, K. Fabianowska&#x2010;Majewska, and A. Haslberger. 2012. &#x201c;Epigenetic Mechanisms in Anti&#x2010;Cancer Actions of Bioactive Food Components &#x2013; The Implications in Cancer Prevention.&#x201d; British J Pharmacology 167: 279&#x2013;297. https://doi.org/10.1111/j.1476&#x2010;5381.2012.02002.x.</Citation></Reference><Reference><Citation>Stefansson, O. A., B. D. Sigurpalsdottir, S. Rognvaldsson, et&#xa0;al. 2024. &#x201c;The Correlation Between CpG Methylation and Gene Expression Is Driven by Sequence Variants.&#x201d; Nature Genetics 56: 1624&#x2013;1631. https://doi.org/10.1038/s41588&#x2010;024&#x2010;01851&#x2010;2.</Citation></Reference><Reference><Citation>Stompor&#x2010;Gor&#x105;cy, M., and M. Machaczka. 2021. &#x201c;Recent Advances in Biological Activity, New Formulations and Prodrugs of Ferulic Acid.&#x201d; International Journal of Molecular Sciences 22: 12889. https://doi.org/10.3390/ijms222312889.</Citation></Reference><Reference><Citation>Su, T., X. Yang, J.&#x2010;H. Deng, et&#xa0;al. 2018. &#x201c;Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis In&#xa0;Vitro and In&#xa0;Vivo.&#x201d; Frontiers in Pharmacology 9: 434. https://doi.org/10.3389/fphar.2018.00434.</Citation></Reference><Reference><Citation>Sun, G., W. Yuan, W. Zhu, and J. Chen. 2022. &#x201c;WZY&#x2010;321 Triggers Glioma Cell Apoptosis via XAF1 Up&#x2010;Regulation Caused by MTM&#x2010;Mediated miR&#x2010;873 Down&#x2010;Regulation.&#x201d; Journal of Cancer 13: 2312&#x2013;2321. https://doi.org/10.7150/jca.68775.</Citation></Reference><Reference><Citation>Sun, Q.&#x2010;L., C.&#x2010;P. Zhao, T.&#x2010;Y. Wang, et&#xa0;al. 2015. &#x201c;Expression Profile Analysis of Long Non&#x2010;Coding RNA Associated With Vincristine Resistance in Colon Cancer Cells by Next&#x2010;Generation Sequencing.&#x201d; Gene 572: 79&#x2013;86. https://doi.org/10.1016/j.gene.2015.06.087.</Citation></Reference><Reference><Citation>Tabernero, J., G. I. Shapiro, P. M. LoRusso, et&#xa0;al. 2013. &#x201c;First&#x2010;In&#x2010;Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients With Liver Involvement.&#x201d; Cancer Discovery 3: 406&#x2013;417. https://doi.org/10.1158/2159&#x2010;8290.CD&#x2010;12&#x2010;0429.</Citation></Reference><Reference><Citation>Tamaddon, M., G. Shokri, S. M. A. Hosseini Rad, I. Rad, &#xc0;. Emami Razavi, and F. Kouhkan. 2020. &#x201c;Involved microRNAs in Alternative Polyadenylation Intervene in Breast Cancer via Regulation of Cleavage Factor &#x201c;CFIm25.&#x201d;.&#x201d; Scientific Reports 10: 11608. https://doi.org/10.1038/s41598&#x2010;020&#x2010;68406&#x2010;3.</Citation></Reference><Reference><Citation>Tan, S., F. Yan, Q. Li, et&#xa0;al. 2020. &#x201c;Chlorogenic Acid Promotes Autophagy and Alleviates Salmonella Typhimurium Infection Through the lncRNAGAS5/miR&#x2010;23a/PTEN Axis and the P38 MAPK Pathway.&#x201d; Frontiers in Cell and Development Biology 8: 552020. https://doi.org/10.3389/fcell.2020.552020.</Citation></Reference><Reference><Citation>Tang, Q., and S. S. Hann. 2020. Biological Roles and Mechanisms of Circular RNA in Human Cancers. Vol. 13, 2067&#x2013;2092. OTT. https://doi.org/10.2147/OTT.S233672.</Citation></Reference><Reference><Citation>Tao, S.&#x2010;F., H.&#x2010;F. He, and Q. Chen. 2015. &#x201c;Quercetin Inhibits Proliferation and Invasion Acts by up&#x2010;Regulating miR&#x2010;146a in Human Breast Cancer Cells.&#x201d; Molecular and Cellular Biochemistry 402: 93&#x2013;100. https://doi.org/10.1007/s11010&#x2010;014&#x2010;2317&#x2010;7.</Citation></Reference><Reference><Citation>Taub, J. W., S. A. Buck, A. C. Xavier, H. Edwards, L. H. Matherly, and Y. Ge. 2024. &#x201c;The Evolution and History of Vinca Alkaloids: From the Big Bang to the Treatment of Pediatric Acute Leukemia.&#x201d; Pediatric Blood &amp; Cancer 71: e31247. https://doi.org/10.1002/pbc.31247.</Citation></Reference><Reference><Citation>Tu, H.&#x2010;J., Y.&#x2010;J. Lin, M.&#x2010;W. Chao, et&#xa0;al. 2018. &#x201c;The Anticancer Effects of MPT0G211, a Novel HDAC6 Inhibitor, Combined With Chemotherapeutic Agents in Human Acute Leukemia Cells.&#x201d; Clinical Epigenetics 10: 162. https://doi.org/10.1186/s13148&#x2010;018&#x2010;0595&#x2010;8.</Citation></Reference><Reference><Citation>Tunca, B., G. Tezcan, G. Cecener, et&#xa0;al. 2012. &#x201c;Olea Europaea Leaf Extract Alters microRNA Expression in Human Glioblastoma Cells.&#x201d; Journal of Cancer Research and Clinical Oncology 138: 1831&#x2013;1844. https://doi.org/10.1007/s00432&#x2010;012&#x2010;1261&#x2010;8.</Citation></Reference><Reference><Citation>Ullah, A., N. Ullah, T. Nawaz, and T. Aziz. 2023. &#x201c;Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment.&#x201d; Anti&#x2010;Cancer Agents in Medicinal Chemistry&#x2010; Anti&#x2010;Cancer Agents 23: 765&#x2013;778. https://doi.org/10.2174/1871520622666220831124321.</Citation></Reference><Reference><Citation>Uramova, S., P. Kubatka, Z. Dankova, et&#xa0;al. 2018. &#x201c;Plant Natural Modulators in Breast Cancer Prevention: Status Quo and Future Perspectives Reinforced by Predictive, Preventive, and Personalized Medical Approach.&#x201d; EPMA Journal 9: 403&#x2013;419. https://doi.org/10.1007/s13167&#x2010;018&#x2010;0154&#x2010;6.</Citation></Reference><Reference><Citation>Vanzan, L., A. Sklias, M. Boskovic, Z. Herceg, R. Murr, and D. M. Suter. 2023. &#x201c;Chapter&#xa0;3 &#x2010; Mechanisms of Histone Modifications.&#x201d; In Handbook of Epigenetics (Third Edition), edited by T. O. Tollefsbol, 27&#x2013;54. Academic Press. 978&#x2013;0&#x2013;323&#x2010;91909&#x2010;8.</Citation></Reference><Reference><Citation>Vasan, N., J. Baselga, and D. M. Hyman. 2019. &#x201c;A View on Drug Resistance in Cancer.&#x201d; Nature 575: 299&#x2013;309. https://doi.org/10.1038/s41586&#x2010;019&#x2010;1730&#x2010;1.</Citation></Reference><Reference><Citation>Venturelli, S., A. Berger, A. B&#xf6;cker, et&#xa0;al. 2013. &#x201c;Resveratrol as a Pan&#x2010;HDAC Inhibitor Alters the Acetylation Status of Histone [Corrected] Proteins in Human&#x2010;Derived Hepatoblastoma Cells.&#x201d; PLoS One 8, no. 8: e73097. https://doi.org/10.1371/journal.pone.0073097.</Citation></Reference><Reference><Citation>Vollmer, M., D. Schr&#xf6;ter, S. Esders, et&#xa0;al. 2017. &#x201c;Chlorogenic Acid Versus Amaranth's Caffeoylisocitric Acid &#x2010; Gut Microbial Degradation of Caffeic Acid Derivatives.&#x201d; Food Research International 100: 375&#x2013;384. https://doi.org/10.1016/j.foodres.2017.06.013.</Citation></Reference><Reference><Citation>Wang, F., C.&#x2010;H. Lu, and I. Willner. 2014. &#x201c;From Cascaded Catalytic Nucleic Acids to Enzyme&#x2010;DNA Nanostructures: Controlling Reactivity, Sensing, Logic Operations, and Assembly of Complex Structures.&#x201d; Chemical Reviews 114: 2881&#x2013;2941. https://doi.org/10.1021/cr400354z.</Citation></Reference><Reference><Citation>Wang, F., W. Lu, T. Zhang, et&#xa0;al. 2013. &#x201c;Development of Novel Ferulic Acid Derivatives as Potent Histone Deacetylase Inhibitors.&#x201d; Bioorganic &amp; Medicinal Chemistry 21: 6973&#x2013;6980. https://doi.org/10.1016/j.bmc.2013.09.021.</Citation></Reference><Reference><Citation>Wang, H., and K. Helin. 2025. &#x201c;Roles of H3K4 Methylation in Biology and Disease.&#x201d; Trends in Cell Biology 35, no. 2: 115&#x2013;128. https://doi.org/10.1016/j.tcb.2024.06.001.</Citation></Reference><Reference><Citation>Wang, H., Y. Sun, Y. Wu, et&#xa0;al. 2022b. &#x201c;MiR&#x2010;30d Participates in Vincristine&#x2010;Induced Neuropathic Pain by Down&#x2010;Regulating GAD67.&#x201d; Neurochemical Research 47: 481&#x2013;492. https://doi.org/10.1007/s11064&#x2010;021&#x2010;03462&#x2010;3.</Citation></Reference><Reference><Citation>Wang, J., G. Ma, M. Li, et&#xa0;al. 2020. &#x201c;Plasma tRNA Fragments Derived From 5&#x2032; Ends as Novel Diagnostic Biomarkers for Early&#x2010;Stage Breast Cancer.&#x201d; Molecular Therapy &#x2010; Nucleic Acids 21: 954&#x2013;964. https://doi.org/10.1016/j.omtn.2020.07.026.</Citation></Reference><Reference><Citation>Wang, K., X. Jiang, Y. Jiang, et&#xa0;al. 2023a. &#x201c;EZH2&#x2010;H3K27me3&#x2010;Mediated Silencing of Mir&#x2010;139&#x2010;5p Inhibits Cellular Senescence in Hepatocellular Carcinoma by Activating TOP2A.&#x201d; Journal of Experimental &amp; Clinical Cancer Research 42: 320. https://doi.org/10.1186/s13046&#x2010;023&#x2010;02855&#x2010;2.</Citation></Reference><Reference><Citation>Wang, K.&#x2010;D., M.&#x2010;L. Zhu, C.&#x2010;J. Qin, et&#xa0;al. 2023d. &#x201c;Sanguinarine Induces Apoptosis in Osteosarcoma by Attenuating the Binding of STAT3 to the Single&#x2010;Stranded DNA&#x2010;Binding Protein 1 (SSBP1) Promoter Region.&#x201d; British Journal of Pharmacology 180: 3175&#x2013;3193. https://doi.org/10.1111/bph.16202.</Citation></Reference><Reference><Citation>Wang, X., T. Chen, C. Li, et&#xa0;al. 2022a. &#x201c;CircRNA&#x2010;CREIT Inhibits Stress Granule Assembly and Overcomes Doxorubicin Resistance in TNBC by Destabilizing PKR.&#x201d; Journal of Hematology &amp; Oncology 15: 122. https://doi.org/10.1186/s13045&#x2010;022&#x2010;01345&#x2010;w.</Citation></Reference><Reference><Citation>Wang, X., P. Jiang, P. Wang, C. S. Yang, X. Wang, and Q. Feng. 2015. &#x201c;EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer.&#x201d; PLoS One 10: e0125402. https://doi.org/10.1371/journal.pone.0125402.</Citation></Reference><Reference><Citation>Wang, X., A. Peng, and C. Huang. 2024. &#x201c;Suppression of Colon Cancer Growth by Berberine Mediated by the Intestinal Microbiota and the Suppression of DNA Methyltransferases (DNMTs).&#x201d; Molecular and Cellular Biochemistry 479: 2131&#x2013;2141. https://doi.org/10.1007/s11010&#x2010;023&#x2010;04836&#x2010;7.</Citation></Reference><Reference><Citation>Wang, Z., H. Deng, Y. Jin, et&#xa0;al. 2023b. &#x201c;Circular RNAs: Biology and Clinical Significance of Breast Cancer.&#x201d; RNA Biology 20: 859&#x2013;874. https://doi.org/10.1080/15476286.2023.2272468.</Citation></Reference><Reference><Citation>Wang, Z., Y. Xiong, Y. Peng, et&#xa0;al. 2023c. &#x201c;Natural Product Evodiamine&#x2010;Inspired Medicinal Chemistry: Anticancer Activity, Structural Optimization and Structure&#x2010;Activity Relationship.&#x201d; European Journal of Medicinal Chemistry 247: 115031. https://doi.org/10.1016/j.ejmech.2022.115031.</Citation></Reference><Reference><Citation>Wei, Y. P., X. H. Wang, G. Liu, et&#xa0;al. 2018. &#x201c;Matrine Exerts Inhibitory Effects in Melanoma Through the Regulation of miR&#x2010;19b&#x2010;3p/PTEN.&#x201d; International Journal of Oncology 53: 791&#x2013;800. https://doi.org/10.3892/ijo.2018.4414.</Citation></Reference><Reference><Citation>Wei, Z., Y. Shi, C. Xue, et&#xa0;al. 2022. &#x201c;Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression.&#x201d; Journal of Cancer 13: 3674&#x2013;3686. https://doi.org/10.7150/jca.78090.</Citation></Reference><Reference><Citation>Weng, Y.&#x2010;P., P.&#x2010;F. Hung, W.&#x2010;Y. Ku, et&#xa0;al. 2017. &#x201c;The Inhibitory Activity of Gallic Acid Against DNA Methylation: Application of Gallic Acid on Epigenetic Therapy of Human Cancers.&#x201d; Oncotarget 9: 361&#x2013;374. https://doi.org/10.18632/oncotarget.23015.</Citation></Reference><Reference><Citation>Williamson, E. M., X. Liu, and A. A. Izzo. 2020. &#x201c;Trends in Use, Pharmacology, and Clinical Applications of Emerging Herbal Nutraceuticals.&#x201d; British J Pharmacology 177: 1227&#x2013;1240. https://doi.org/10.1111/bph.14943.</Citation></Reference><Reference><Citation>Wink, M. 2007. &#x201c;Molecular Modes of Action of Cytotoxic Alkaloids: From DNA Intercalation, Spindle Poisoning, Topoisomerase Inhibition to Apoptosis and Multiple Drug Resistance.&#x201d; Alkaloids. Chemistry and Biology 64: 1&#x2013;47. https://doi.org/10.1016/s1099&#x2010;4831(07)64001&#x2010;2.</Citation></Reference><Reference><Citation>Wink, M. 2015. &#x201c;Modes of Action of Herbal Medicines and Plant Secondary Metabolites.&#x201d; Medicine 2: 251&#x2013;286. https://doi.org/10.3390/medicines2030251.</Citation></Reference><Reference><Citation>Wink, M. 2020. &#x201c;Potential of DNA Intercalating Alkaloids and Other Plant Secondary Metabolites Against SARS&#x2010;CoV&#x2010;2 Causing COVID&#x2010;19.&#x201d; Diversity 12, no. 5: 175. https://doi.org/10.3390/d12050175.</Citation></Reference><Reference><Citation>Wu, J., Q. Tang, L. Yang, Y. Chen, F. Zheng, and S. S. Hann. 2017. &#x201c;Interplay of DNA Methyltransferase 1 and EZH2 Through Inactivation of Stat3 Contributes to &#x3b2;&#x2010;Elemene&#x2010;Inhibited Growth of Nasopharyngeal Carcinoma Cells.&#x201d; Scientific Reports 7: 509. https://doi.org/10.1038/s41598&#x2010;017&#x2010;00626&#x2010;6.</Citation></Reference><Reference><Citation>Wu, J., X. Tang, Y. Shi, et&#xa0;al. 2022a. &#x201c;Crosstalk of LncRNA HOTAIR and SP1&#x2010;Mediated Repression of PDK1 Contributes to &#x3b2;&#x2010;Elemene&#x2010;Inhibited Proliferation of Hepatocellular Carcinoma Cells.&#x201d; Journal of Ethnopharmacology 283: 114456. https://doi.org/10.1016/j.jep.2021.114456.</Citation></Reference><Reference><Citation>Wu, S., Y. Huang, T. Wang, et&#xa0;al. 2022b. &#x201c;Evodiamine&#x2010;Inspired Topoisomerase&#x2010;Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy.&#x201d; Journal of Medicinal Chemistry 65: 4818&#x2013;4831. https://doi.org/10.1021/acs.jmedchem.1c02026.</Citation></Reference><Reference><Citation>Wu, T. P., T. Wang, M. G. Seetin, et&#xa0;al. 2016. &#x201c;DNA Methylation on N6&#x2010;Adenine in Mammalian Embryonic Stem Cells.&#x201d; Nature 532, no. 7599: 329&#x2013;333. https://doi.org/10.1038/nature17640.</Citation></Reference><Reference><Citation>Wu, Y.&#x2010;Y., Y.&#x2010;M. Xu, and A. T. Y. Lau. 2023. &#x201c;Epigenetic Effects of Herbal Medicine.&#x201d; Clinical Epigenetics 15: 85. https://doi.org/10.1186/s13148&#x2010;023&#x2010;01481&#x2010;1.</Citation></Reference><Reference><Citation>Xia, D., D. Wang, S.&#x2010;H. Kim, H. Katoh, and R. N. DuBois. 2012. &#x201c;Prostaglandin E2 Promotes Intestinal Tumor Growth via DNA Methylation.&#x201d; Nature Medicine 18: 224&#x2013;226. https://doi.org/10.1038/nm.2608.</Citation></Reference><Reference><Citation>Xiang, F., Y. Fan, Z. Ni, et&#xa0;al. 2019. &#x201c;Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA&#x2010;149&#x2010;5p/MyD88.&#x201d; Frontiers in Oncology 9: 501. https://doi.org/10.3389/fonc.2019.00501.</Citation></Reference><Reference><Citation>Xiao, C.&#x2010;L., S. Zhu, M. He, et&#xa0;al. 2018. &#x201c;N6&#x2010;Methyladenine DNA Modification in the Human Genome.&#x201d; Molecular Cell 71: 306&#x2013;318.e7. https://doi.org/10.1016/j.molcel.2018.06.015.</Citation></Reference><Reference><Citation>Xiao, X., D. Shi, L. Liu, et&#xa0;al. 2011. &#x201c;Quercetin Suppresses Cyclooxygenase&#x2010;2 Expression and Angiogenesis Through Inactivation of P300 Signaling.&#x201d; PLoS One 6: e22934. https://doi.org/10.1371/journal.pone.0022934.</Citation></Reference><Reference><Citation>Xie, J., W. Zhang, X. Liang, et&#xa0;al. 2020. &#x201c;RPL32 Promotes Lung Cancer Progression by Facilitating P53 Degradation.&#x201d; Molecular Therapy &#x2010; Nucleic Acids 21: 75&#x2013;85. https://doi.org/10.1016/j.omtn.2020.05.019.</Citation></Reference><Reference><Citation>Xu, C., Z.&#x2010;B. Jiang, L. Shao, et&#xa0;al. 2023. &#x201c;&#x3b2;&#x2010;Elemene Enhances Erlotinib Sensitivity Through Induction of Ferroptosis by Upregulating lncRNA H19 in EGFR&#x2010;Mutant Non&#x2010;Small Cell Lung Cancer.&#x201d; Pharmacological Research 191: 106739. https://doi.org/10.1016/j.phrs.2023.106739.</Citation></Reference><Reference><Citation>Xu, G., W. Zhang, Z. Wang, M. Chen, and B. Shi. 2020. &#x201c;Matrine Regulates H2O2&#x2010;Induced Oxidative Stress Through Long Non&#x2010;Coding RNA HOTAIR/miR&#x2010;106b&#x2010;5p Axis via AKT and STAT3 Pathways.&#x201d; Bioscience Reports 40, no. 5: BSR20192560. https://doi.org/10.1042/BSR20192560.</Citation></Reference><Reference><Citation>Xu, Q., M. Li, M. Yang, et&#xa0;al. 2018. &#x201c;&#x3b1;&#x2010;Pinene Regulates miR&#x2010;221 and Induces G2/M Phase Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.&#x201d; Bioscience Reports 38, no. 6: BSR20180980. https://doi.org/10.1042/BSR20180980.</Citation></Reference><Reference><Citation>Yan, W., T. H. Y. Wu, S. S. Y. Leung, and K. K. W. To. 2020. &#x201c;Flavonoids Potentiated Anticancer Activity of Cisplatin in Non&#x2010;Small Cell Lung Cancer Cells In&#xa0;Vitro by Inhibiting Histone Deacetylases.&#x201d; Life Sciences 258: 118211. https://doi.org/10.1016/j.lfs.2020.118211.</Citation></Reference><Reference><Citation>Yan, X., C. Yuan, Z. Wang, et&#xa0;al. 2024. &#x201c;Berberine Modulates Ovarian Cancer Autophagy and Glycolysis Through the LINC01123/P65/MAPK10 Signaling Axis.&#x201d; Phytomedicine 135: 156121. https://doi.org/10.1016/j.phymed.2024.156121.</Citation></Reference><Reference><Citation>Yang, T., Y. Li, F. Zhao, L. Zhou, and R. Jia. 2021. &#x201c;Circular RNA Foxo3: A Promising Cancer&#x2010;Associated Biomarker.&#x201d; Frontiers in Genetics 12: 652995. https://doi.org/10.3389/fgene.2021.652995.</Citation></Reference><Reference><Citation>Yang, X., M. Liu, M. Li, et&#xa0;al. 2020. &#x201c;Epigenetic Modulations of Noncoding RNA: A Novel Dimension of Cancer Biology.&#x201d; Molecular Cancer 19: 64. https://doi.org/10.1186/s12943&#x2010;020&#x2010;01159&#x2010;9.</Citation></Reference><Reference><Citation>Yang, Y., M. B. Ishak Gabra, E. A. Hanse, et&#xa0;al. 2019. &#x201c;MiR&#x2010;135 Suppresses Glycolysis and Promotes Pancreatic Cancer Cell Adaptation to Metabolic Stress by Targeting Phosphofructokinase&#x2010;1.&#x201d; Nature Communications 10: 809. https://doi.org/10.1038/s41467&#x2010;019&#x2010;08759&#x2010;0.</Citation></Reference><Reference><Citation>Yao, L., L. Yang, H. Song, T.&#x2010;G. Liu, and H. Yan. 2020. &#x201c;Silencing of lncRNA XIST Suppresses Proliferation and Autophagy and Enhances Vincristine Sensitivity in Retinoblastoma Cells by Sponging miR&#x2010;204&#x2010;5p.&#x201d; European Review for Medical and Pharmacological Sciences 24: 3526&#x2013;3537. https://doi.org/10.26355/eurrev_202004_20812.</Citation></Reference><Reference><Citation>Yen, H.&#x2010;R., W.&#x2010;Y. Lai, C.&#x2010;H. Muo, and M.&#x2010;F. Sun. 2016. &#x201c;Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese&#x2010;Registry, Population&#x2010;Based Study.&#x201d; Integrative Cancer Therapies 16: 147. https://doi.org/10.1177/1534735416659357.</Citation></Reference><Reference><Citation>Ying, H., Y. Jin, Y. Guo, et&#xa0;al. 2022. &#x201c;Long Non&#x2010;Coding RNA NUT Family Member 2A&#x2010;Antisense RNA 1 Sponges microRNA&#x2010;613 to Increase the Resistance of Gastric Cancer Cells to Matrine Through Regulating Oxidative Stress and Vascular Endothelial Growth Factor A.&#x201d; Aging (Albany NY) 14: 5153&#x2013;5162. https://doi.org/10.18632/aging.204135.</Citation></Reference><Reference><Citation>Yu, C., D.&#x2010;Q. Chen, H.&#x2010;X. Liu, W.&#x2010;B. Li, J.&#x2010;W. Lu, and J.&#x2010;F. Feng. 2019. &#x201c;Rosmarinic Acid Reduces the Resistance of Gastric Carcinoma Cells to 5&#x2010;Fluorouracil by Downregulating FOXO4&#x2010;Targeting miR&#x2010;6785&#x2010;5p.&#x201d; Biomedicine &amp; Pharmacotherapy 109: 2327&#x2013;2334. https://doi.org/10.1016/j.biopha.2018.10.061.</Citation></Reference><Reference><Citation>Yu, Y., Y. Xing, Q. Zhang, et&#xa0;al. 2021. &#x201c;Soy Isoflavone Genistein Inhibits Hsa_circ_0031250/miR&#x2010;873&#x2010;5p/FOXM1 Axis to Suppress Non&#x2010;Small&#x2010;Cell Lung Cancer Progression.&#x201d; IUBMB Life 73: 92&#x2013;107. https://doi.org/10.1002/iub.2404.</Citation></Reference><Reference><Citation>Zhang, C., L. Shu, H. Kim, et&#xa0;al. 2016. &#x201c;Phenethyl Isothiocyanate (PEITC) Suppresses Prostate Cancer Cell Invasion Epigenetically Through Regulating microRNA&#x2010;194.&#x201d; Molecular Nutrition &amp; Food Research 60: 1427&#x2013;1436. https://doi.org/10.1002/mnfr.201500918.</Citation></Reference><Reference><Citation>Zhang, D.&#x2010;S., Y.&#x2010;Y. Li, X.&#x2010;J. Chen, et&#xa0;al. 2015a. &#x201c;BCL2 Promotor Methylation and miR&#x2010;15a/16&#x2010;1 Upregulation Is Associated With Sanguinarine&#x2010;Induced Apoptotic Death in Rat HSC&#x2010;T6 Cells.&#x201d; Journal of Pharmacological Sciences 127: 135&#x2013;144. https://doi.org/10.1016/j.jphs.2014.11.012.</Citation></Reference><Reference><Citation>Zhang, F., J. Jiang, H. Qian, Y. Yan, and W. Xu. 2023b. &#x201c;Exosomal circRNA: Emerging Insights Into Cancer Progression and Clinical Application Potential.&#x201d; Journal of Hematology &amp; Oncology 16: 67. https://doi.org/10.1186/s13045&#x2010;023&#x2010;01452&#x2010;2.</Citation></Reference><Reference><Citation>Zhang, G., C. Xue, and Y. Zeng. 2021b. &#x201c;&#x3b2;&#x2010;Elemene Alleviates Airway Stenosis via the ILK/Akt Pathway Modulated by MIR143HG Sponging miR&#x2010;1275.&#x201d; Cellular &amp; Molecular Biology Letters 26: 28. https://doi.org/10.1186/s11658&#x2010;021&#x2010;00261&#x2010;0.</Citation></Reference><Reference><Citation>Zhang, H., S. Park, H. Huang, et&#xa0;al. 2021c. &#x201c;Anticancer Effects and Potential Mechanisms of Ginsenoside Rh2 in Various Cancer Types (Review).&#x201d; Oncology Reports 45: 33. https://doi.org/10.3892/or.2021.7984.</Citation></Reference><Reference><Citation>Zhang, L., Q.&#x2010;Y. Cai, J. Liu, et&#xa0;al. 2019a. &#x201c;Ursolic Acid Suppresses the Invasive Potential of Colorectal Cancer Cells by Regulating the TGF&#x2010;&#x3b2;1/ZEB1/miR&#x2010;200c Signaling Pathway.&#x201d; Oncology Letters 18: 3274&#x2013;3282. https://doi.org/10.3892/ol.2019.10604.</Citation></Reference><Reference><Citation>Zhang, L., Y. Wang, Y. Zhang, Y. Zhao, and P. Li. 2021a. &#x201c;Pathogenic Mechanisms and the Potential Clinical Value of circFoxo3 in Cancers.&#x201d; Molecular Therapy &#x2010; Nucleic Acids 23: 908&#x2013;917. https://doi.org/10.1016/j.omtn.2021.01.010.</Citation></Reference><Reference><Citation>Zhang, M., N. Huang, X. Yang, et&#xa0;al. 2018. &#x201c;A Novel Protein Encoded by the Circular Form of the SHPRH Gene Suppresses Glioma Tumorigenesis.&#x201d; Oncogene 37: 1805&#x2013;1814. https://doi.org/10.1038/s41388&#x2010;017&#x2010;0019&#x2010;9.</Citation></Reference><Reference><Citation>Zhang, R., J. Feng, Y. Zheng, et&#xa0;al. 2024. &#x201c;Beta&#x2010;Elemene Inhibits the Growth of KDM6A&#x2010;Null Bladder Cancer Cells by Suppressing the Epithelial&#x2010;Mesenchymal Transition.&#x201d; Clinical Traditional Medicine and Pharmacology 5: 200130. https://doi.org/10.1016/j.ctmp.2024.200130.</Citation></Reference><Reference><Citation>Zhang, R., X. Li, Y. Gao, et&#xa0;al. 2022b. &#x201c;Ginsenoside Rg1 Epigenetically Modulates Smad7 Expression in Liver Fibrosis via MicroRNA&#x2010;152.&#x201d; Journal of Ginseng Research 47: 534. https://doi.org/10.1016/j.jgr.2022.12.005.</Citation></Reference><Reference><Citation>Zhang, T., W. Zhang, and M. Hao. 2021d. &#x201c;Phenethyl Isothiocyanate Reduces Breast Cancer Stem Cell&#x2010;Like Properties by Epigenetic Reactivation of CDH1.&#x201d; Oncology Reports 45: 337&#x2013;348. https://doi.org/10.3892/or.2020.7860.</Citation></Reference><Reference><Citation>Zhang, X., Q. Guo, J. Chen, and Z. Chen. 2015b. &#x201c;Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA&#x2010;217&#x2010;KRAS Axis.&#x201d; Molecules and Cells 38: 638&#x2013;642. https://doi.org/10.14348/molcells.2015.0037.</Citation></Reference><Reference><Citation>Zhang, Y., Y. Hu, and F. Guo. 2023a. &#x201c;miR&#x2010;21 Inhibits Non&#x2010;Small Cell Lung Cancer Cell Proliferation and Promotes Apoptosis.&#x201d; Journal of Biomaterials and Tissue Engineering 13: 18&#x2013;23. https://doi.org/10.1166/jbt.2023.3214.</Citation></Reference><Reference><Citation>Zhang, Y., Q. Li, and H. Chen. 2013. &#x201c;DNA Methylation and Histone Modifications of Wnt Genes by Genistein During Colon Cancer Development.&#x201d; Carcinogenesis 34: 1756&#x2013;1763. https://doi.org/10.1093/carcin/bgt129.</Citation></Reference><Reference><Citation>Zhang, Y., J. Lu, Y.&#x2010;J. Zhong, et&#xa0;al. 2022a. &#x201c;Methyl Ferulic Acid Ameliorates Alcohol&#x2010;Induced Hepatic Insulin Resistance via miR&#x2010;378b&#x2010;Mediated Activation of PI3K&#x2010;AKT Pathway.&#x201d; Biomedicine &amp; Pharmacotherapy 145: 112462. https://doi.org/10.1016/j.biopha.2021.112462.</Citation></Reference><Reference><Citation>Zhang, Z., B. Li, P. Xu, and B. Yang. 2019b. &#x201c;Integrated Whole Transcriptome Profiling and Bioinformatics Analysis for Revealing Regulatory Pathways Associated With Quercetin&#x2010;Induced Apoptosis in HCT&#x2010;116 Cells.&#x201d; Frontiers in Pharmacology 10: 798. https://doi.org/10.3389/fphar.2019.00798.</Citation></Reference><Reference><Citation>Zhao, Y., X. Chen, J. Jiang, X. Wan, Y. Wang, and P. Xu. 2020. &#x201c;Epigallocatechin Gallate Reverses Gastric Cancer by Regulating the Long Noncoding RNA LINC00511/miR&#x2010;29b/KDM2A Axis.&#x201d; Biochimica et Biophysica Acta &#x2010; Molecular Basis of Disease 1866: 165856. https://doi.org/10.1016/j.bbadis.2020.165856.</Citation></Reference><Reference><Citation>Zhao, Z., and A. Shilatifard. 2019. &#x201c;Epigenetic Modifications of Histones in Cancer.&#x201d; Genome Biology 20: 245. https://doi.org/10.1186/s13059&#x2010;019&#x2010;1870&#x2010;5.</Citation></Reference><Reference><Citation>Zhong, S., X. Chen, D. Wang, et&#xa0;al. 2016. &#x201c;MicroRNA Expression Profiles of Drug&#x2010;Resistance Breast Cancer Cells and Their Exosomes.&#x201d; Oncotarget 7: 19601&#x2013;19609. https://doi.org/10.18632/oncotarget.7481.</Citation></Reference><Reference><Citation>Zhong, S., T. Ma, X. Zhang, et&#xa0;al. 2015. &#x201c;MicroRNA Expression Profiling and Bioinformatics Analysis of Dysregulated microRNAs in Vinorelbine&#x2010;Resistant Breast Cancer Cells.&#x201d; Gene 556: 113&#x2013;118. https://doi.org/10.1016/j.gene.2014.11.046.</Citation></Reference><Reference><Citation>Zhong, X., H. Deng, M. Long, et&#xa0;al. 2023. &#x201c;Discovery of Berberine Analogs as Potent and Highly Selective P300/CBP HAT Inhibitors.&#x201d; Bioorganic Chemistry 138: 106597. https://doi.org/10.1016/j.bioorg.2023.106597.</Citation></Reference><Reference><Citation>Zhou, S. H., Y. F. Deng, Z. W. Weng, H. W. Weng, and Z. D. Liu. 2019. &#x201c;Traditional Chinese Medicine as a Remedy for Male Infertility: A Review.&#x201d; World J Mens Health 37: 175&#x2013;185. https://doi.org/10.5534/wjmh.180069.</Citation></Reference><Reference><Citation>Zhou, X., D. Jiao, M. Dou, et&#xa0;al. 2020. &#x201c;Curcumin Inhibits the Growth of Triple&#x2010;Negative Breast Cancer Cells by Silencing EZH2 and Restoring DLC1 Expression.&#x201d; Journal of Cellular and Molecular Medicine 24: 10648&#x2013;10662. https://doi.org/10.1111/jcmm.15683.</Citation></Reference><Reference><Citation>Zhu, F., X. Meng, H. Liang, et&#xa0;al. 2022. &#x201c;Design, Synthesis, and Structure&#x2010;Activity Relationships of Evodiamine&#x2010;Based Topoisomerase (Top)/histone Deacetylase (HDAC) Dual Inhibitors.&#x201d; Bioorganic Chemistry 122: 105702. https://doi.org/10.1016/j.bioorg.2022.105702.</Citation></Reference><Reference><Citation>Zhu, H., H. Wu, X. Liu, et&#xa0;al. 2008. &#x201c;Role of MicroRNA miR&#x2010;27a and miR&#x2010;451 in the Regulation of MDR1/P&#x2010;Glycoprotein Expression in Human Cancer Cells.&#x201d; Biochemical Pharmacology 76: 582&#x2013;588. https://doi.org/10.1016/j.bcp.2008.06.007.</Citation></Reference><Reference><Citation>Zhu, H.&#x2010;B., K. Yang, Y.&#x2010;Q. Xie, Y.&#x2010;W. Lin, Q.&#x2010;Q. Mao, and L.&#x2010;P. Xie. 2013. &#x201c;Silencing of Mutant P53 by siRNA Induces Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells.&#x201d; World Journal of Surgical Oncology 11, no. 22: 22. https://doi.org/10.1186/1477&#x2010;7819&#x2010;11&#x2010;22.</Citation></Reference><Reference><Citation>Zhu, J., X. Cheng, N. Naumovski, L. Hu, and K. Wang. 2023. &#x201c;Epigenetic Regulation by Quercetin: A Comprehensive Review Focused on Its Biological Mechanisms.&#x201d; Critical Reviews in Food Science and Nutrition 65, no. 4: 627&#x2013;646. https://doi.org/10.1080/10408398.2023.2278760.</Citation></Reference><Reference><Citation>Zou, J.&#x2010;Y., Q.&#x2010;L. Chen, X.&#x2010;C. Luo, et&#xa0;al. 2024b. &#x201c;Natural Products Reverse Cancer Multidrug Resistance.&#x201d; Frontiers in Pharmacology 15: 1348076. https://doi.org/10.3389/fphar.2024.1348076.</Citation></Reference><Reference><Citation>Zou, R., Y. Wang, Y. Cai, et&#xa0;al. 2024a. &#x201c;Nanofiber&#x2010;Based Delivery of Evodiamine Impedes Malignant Properties of Intrahepatic Cholangiocarcinoma Cells by Targeting HDAC4 and Restoring TPM1 Transcription.&#x201d; Human Cell 37: 1505&#x2013;1521. https://doi.org/10.1007/s13577&#x2010;024&#x2010;01105&#x2010;7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40062208</PMID><DateRevised><Year>2025</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2198-641X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Current pharmacology reports</Title><ISOAbbreviation>Curr Pharmacol Rep</ISOAbbreviation></Journal><ArticleTitle>Application of Metabolomics in Carcinogenesis and Cancer Prevention by Dietary Phytochemicals.</ArticleTitle><Pagination><StartPage>12</StartPage><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40495-025-00396-0</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="UNASSIGNED">In this review article, specific emphasis is on evolution of metabolomics in cancer research, metabolomics workflow, general understanding of liquid chromatography - mass spectrometry (LC-MS) based platform for quantitation of metabolites, their biological interpretation and the application in carcinogenesis and cancer prevention by dietary phytochemicals.</AbstractText><AbstractText Label="RECENT&#xa0;FINDINGS" NlmCategory="UNASSIGNED">Metabolomics is increasingly becoming a preferred approach for next generation metabolic screening and has profound impact on medical practice. Metabolomics describes the end products of biochemical processes which are greatly influenced by genetic and environmental factors. Metabolic alterations can be linked to potential biochemical reactions/enzymes and their corresponding genes. Thus, these results can be further validated via multi-omics approach including genomics, transcriptomics and proteomics. However, challenges exist within and between omic-domain data integration considering complex biochemical regulation including organism versus tissue versus cellular level processes, epigenetics, transcriptional and post translational modifications. Metabolomics can reflect the steady state or dynamic state of metabolism because metabolites are highly dynamic in space and time.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="UNASSIGNED">Metabolomic analysis of biological samples exhibit the possibility to determine mechanism of action of anti-cancer agents, biomarker discovery and impact of genetic alterations.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025, corrected publication 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peter</LastName><ForeName>Rebecca Mary</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854 USA.</Affiliation><Identifier Source="ROR">https://ror.org/05vt9qd57</Identifier><Identifier Source="GRID">grid.430387.b</Identifier><Identifier Source="ISNI">0000 0004 1936 8796</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854 USA.</Affiliation><Identifier Source="ROR">https://ror.org/05vt9qd57</Identifier><Identifier Source="GRID">grid.430387.b</Identifier><Identifier Source="ISNI">0000 0004 1936 8796</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Xiaoyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Metabolomics Shared Resource, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903 USA.</Affiliation><Identifier Source="ROR">https://ror.org/0060x3y55</Identifier><Identifier Source="ISNI">0000 0004 0405 0718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Ah-Ng</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854 USA.</Affiliation><Identifier Source="ROR">https://ror.org/05vt9qd57</Identifier><Identifier Source="GRID">grid.430387.b</Identifier><Identifier Source="ISNI">0000 0004 1936 8796</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Pharmacol Rep</MedlineTA><NlmUniqueID>101649562</NlmUniqueID><ISSNLinking>2198-641X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer prevention</Keyword><Keyword MajorTopicYN="N">Liquid chromatography &#x2013; mass spectrometry</Keyword><Keyword MajorTopicYN="N">Metabolic alterations</Keyword><Keyword MajorTopicYN="N">Metabolomic workflow</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword><Keyword MajorTopicYN="N">Phytochemicals</Keyword></KeywordList><CoiStatement>Competing InterestsThe authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>10</Day><Hour>17</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>10</Day><Hour>17</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40062208</ArticleId><ArticleId IdType="pmc">PMC11889054</ArticleId><ArticleId IdType="doi">10.1007/s40495-025-00396-0</ArticleId><ArticleId IdType="pii">396</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tomita M, Kami K. Cancer. Systems biology, metabolomics, and cancer metabolism. Science. 2012;336(6084):990&#x2013;1. 10.1126/science.1223066.</Citation><ArticleIdList><ArticleId IdType="pubmed">22628644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A, Sun H, Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol. 2012;168(6):1718&#x2013;27. 10.1007/s12010-012-9891-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22971835</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M, Brennan L, Wishart DS, Oresic M, Hankemeier T, Broadhurst DI, Lane AN, Suhre K, Kastenmuller G, Sumner SJ, Thiele I, Fiehn O, Kaddurah-Daouk R, for &#x201c;Precision M, Pharmacometabolomics Task Group&#x201d;-Metabolomics Society I. Metabolomics enables precision medicine: &#x201c;a white paper, community perspective.&#x201d; Metabolomics. 2016;12(10):149. 10.1007/s11306-016-1094-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009152</ArticleId><ArticleId IdType="pubmed">27642271</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivedi DK, Hollywood KA, Goodacre R. Metabolomics for the masses: The future of metabolomics in a personalized world. New Horiz Transl Med. 2017;3(6):294&#x2013;305. 10.1016/j.nhtm.2017.06.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5653644</ArticleId><ArticleId IdType="pubmed">29094062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiehn O. Metabolomics&#x2013;the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1&#x2013;2):155&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">11860207</ArticleId></ArticleIdList></Reference><Reference><Citation>Macel M, Van Dam NM, Keurentjes JJ. Metabolomics: the chemistry between ecology and genetics. Mol Ecol Resour. 2010;10(4):583&#x2013;93. 10.1111/j.1755-0998.2010.02854.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">21565063</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifonova OP, Maslov DL, Balashova EE, Lokhov PG. Current State and Future Perspectives on Personalized Metabolomics. Metabolites. 2023;13(1). 10.3390/metabo13010067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9863827</ArticleId><ArticleId IdType="pubmed">36676992</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998;16(9):373&#x2013;8. 10.1016/s0167-7799(98)01214-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">9744112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Oliver SG. The metabolome 18 years on: a concept comes of age. Metabolomics. 2016;12(9):148. 10.1007/s11306-016-1108-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009154</ArticleId><ArticleId IdType="pubmed">27695392</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Li Q, Chen Y, Yang Y. Recent metabolomics analysis in tumor metabolism reprogramming. Front Mol Biosci. 2021;8:763902. 10.3389/fmolb.2021.763902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660977</ArticleId><ArticleId IdType="pubmed">34901157</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021;71(4):333&#x2013;58. 10.3322/caac.21670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298088</ArticleId><ArticleId IdType="pubmed">33982817</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309&#x2013;14. 10.1126/science.123.3191.309.</Citation><ArticleIdList><ArticleId IdType="pubmed">13298683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Rhee JK, Yoo HJ, Lee HJ, Lee EJ, Lee JW, Yu JH, Son BH, Gong G, Kim SB, Singh SR, Ahn SH, Chang S. Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett. 2015;357(2):488&#x2013;97. 10.1016/j.canlet.2014.11.058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750883</ArticleId><ArticleId IdType="pubmed">25484137</ArticleId></ArticleIdList></Reference><Reference><Citation>Danzi F, Pacchiana R, Mafficini A, Scupoli MT, Scarpa A, Donadelli M, Fiore A. To metabolomics and beyond: a technological portfolio to investigate cancer metabolism. Signal Transduct Target Ther. 2023;8(1):137. 10.1038/s41392-023-01380-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10033890</ArticleId><ArticleId IdType="pubmed">36949046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Nishiumi S, Ikeda A, Yoshie T, Sakai A, Matsubara A, Izumi Y, Tsumura H, Tsuda M, Nishisaki H, Hayashi N, Kawano S, Fujiwara Y, Minami H, Takenawa T, Azuma T, Yoshida M. A novel serum metabolomics-based diagnostic approach to pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(4):571&#x2013;9. 10.1158/1055-9965.EPI-12-1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">23542803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012;26(5):548&#x2013;58. 10.1002/bmc.1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">21773981</ArticleId></ArticleIdList></Reference><Reference><Citation>Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer. 2005;113(5):782&#x2013;8. 10.1002/ijc.20651.</Citation><ArticleIdList><ArticleId IdType="pubmed">15499633</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu XL, Li WZ, Zhang Q, Wang XM, Zhou YR, Wu CG, Xiong SM, Le AP, Zhang ZL. Analysis of Plasma Metabolic Profile in Children with Transfusion-Dependent Thalassemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024;32(2):525&#x2013;31. 10.19746/j.cnki.issn.1009-2137.2024.02.031.</Citation><ArticleIdList><ArticleId IdType="pubmed">38660862</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan SK, Wei BJ, Lin ZY, Yang Y, Zhou ZT, Zhang WD. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol. 2008;44(5):477&#x2013;83. 10.1016/j.oraloncology.2007.06.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17936673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009;69(2):700&#x2013;8. 10.1158/0008-5472.CAN-08-3157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2629384</ArticleId><ArticleId IdType="pubmed">19147587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam H, Chung BC, Kim Y, Lee K, Lee D. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009;25(23):3151&#x2013;7. 10.1093/bioinformatics/btp558.</Citation><ArticleIdList><ArticleId IdType="pubmed">19783829</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, Bianchi L, Rusca M, Mutti A. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res. 2005;6(1):71. 10.1186/1465-9921-6-71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1185565</ArticleId><ArticleId IdType="pubmed">16018807</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindle K. New approaches for imaging tumour responses to treatment. Nat Rev Cancer. 2008;8(2):94&#x2013;107. 10.1038/nrc2289.</Citation><ArticleIdList><ArticleId IdType="pubmed">18202697</ArticleId></ArticleIdList></Reference><Reference><Citation>Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, Buchler MW. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut. 1995;36(5):771&#x2013;7. 10.1136/gut.36.5.771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1382685</ArticleId><ArticleId IdType="pubmed">7797130</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottgen C, Levegrun S, Theegarten D, Marnitz S, Grehl S, Pink R, Eberhardt W, Stamatis G, Gauler T, Antoch G, Bockisch A, Stuschke M. Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res. 2006;12(1):97&#x2013;106. 10.1158/1078-0432.CCR-05-0510.</Citation><ArticleIdList><ArticleId IdType="pubmed">16397030</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri GS, Kaur G, Carbone GM, Shinde D. Metabolomics in oncology. Cancer Rep (Hoboken). 2023;6(3):e1795. 10.1002/cnr2.1795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10026298</ArticleId><ArticleId IdType="pubmed">36811317</ArticleId></ArticleIdList></Reference><Reference><Citation>Beger RD. A review of applications of metabolomics in cancer. Metabolites. 2013;3(3):552&#x2013;74. 10.3390/metabo3030552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3901293</ArticleId><ArticleId IdType="pubmed">24958139</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzone L, Salomone S, Libra M. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front Pharmacol. 2018;9:1300. 10.3389/fphar.2018.01300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243123</ArticleId><ArticleId IdType="pubmed">30483135</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Li L. Sample normalization methods in quantitative metabolomics. J Chromatogr A. 2016;1430:80&#x2013;95. 10.1016/j.chroma.2015.12.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">26763302</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Li EM, Xu LY. Guide to metabolomics analysis: a bioinformatics workflow. Metabolites. 2022;12(4). 10.3390/metabo12040357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9032224</ArticleId><ArticleId IdType="pubmed">35448542</ArticleId></ArticleIdList></Reference><Reference><Citation>Beisken S, Eiden M, Salek RM. Getting the right answers: understanding metabolomics challenges. Expert Rev Mol Diagn. 2015;15(1):97&#x2013;109. 10.1586/14737159.2015.974562.</Citation><ArticleIdList><ArticleId IdType="pubmed">25354566</ArticleId></ArticleIdList></Reference><Reference><Citation>Martias C, Baroukh N, Mavel S, Blasco H, Lefevre A, Roch L, Montigny F, Gatien J, Schibler L, Dufour-Rainfray D, Nadal-Desbarats L, Emond P. Optimization of sample preparation for metabolomics exploration of urine, feces, blood and saliva in humans using combined NMR and UHPLC-HRMS Platforms. Molecules. 2021;26(14). 10.3390/molecules26144111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305469</ArticleId><ArticleId IdType="pubmed">34299389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Xiao JF, Tuli L, Ressom HW. LC-MS-based metabolomics. Mol Biosyst. 2012;8(2):470&#x2013;81. 10.1039/c1mb05350g.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699692</ArticleId><ArticleId IdType="pubmed">22041788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L, Wang J, Page D, Asthana S, Zetterberg H, Carlsson C, Okonkwo OC, Li L. Comparative evaluation of MS-based metabolomics software and its application to preclinical alzheimer&#x2019;s disease. Sci Rep. 2018;8(1):9291. 10.1038/s41598-018-27031-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006240</ArticleId><ArticleId IdType="pubmed">29915347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Hou J, Tanner JJ, Cheng J. Bioinformatics methods for mass spectrometry-based proteomics data analysis. Int J Mol Sci. 2020;21(8). 10.3390/ijms21082873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7216093</ArticleId><ArticleId IdType="pubmed">32326049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37(Web Server issue):W652-60. 10.1093/nar/gkp356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703878</ArticleId><ArticleId IdType="pubmed">19429898</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37(Database issue):D603-10. 10.1093/nar/gkn810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2686599</ArticleId><ArticleId IdType="pubmed">18953024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL. Metabolite identification via the madison metabolomics consortium database. Nat Biotechnol. 2008;26(2):162&#x2013;4. 10.1038/nbt0208-162.</Citation><ArticleIdList><ArticleId IdType="pubmed">18259166</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CA, O&#x2019;Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27(6):747&#x2013;51. 10.1097/01.ftd.0000179845.53213.39.</Citation><ArticleIdList><ArticleId IdType="pubmed">16404815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kind T, Fiehn O. Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics. 2006;7:234. 10.1186/1471-2105-7-234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464138</ArticleId><ArticleId IdType="pubmed">16646969</ArticleId></ArticleIdList></Reference><Reference><Citation>Giavalisco P, Kohl K, Hummel J, Seiwert B, Willmitzer L. 13C isotope-labeled metabolomes allowing for improved compound annotation and relative quantification in liquid chromatography-mass spectrometry-based metabolomic research. Anal Chem. 2009;81(15):6546&#x2013;51. 10.1021/ac900979e.</Citation><ArticleIdList><ArticleId IdType="pubmed">19588932</ArticleId></ArticleIdList></Reference><Reference><Citation>Baty JD, Robinson PR. Single and multiple ion recording techniques for the analysis of diphenylhydantoin and its major metabolite in plasma. Biomed Mass Spectrom. 1977;4(1):36&#x2013;41. 10.1002/bms.1200040104.</Citation><ArticleIdList><ArticleId IdType="pubmed">836941</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Wishart DS. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 2010;38(Web Server issue):W71-7. 10.1093/nar/gkq329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896187</ArticleId><ArticleId IdType="pubmed">20457745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankainen M, Gopalacharyulu P, Holm L, Oresic M. MPEA&#x2013;metabolite pathway enrichment analysis. Bioinformatics. 2011;27(13):1878&#x2013;9. 10.1093/bioinformatics/btr278.</Citation><ArticleIdList><ArticleId IdType="pubmed">21551139</ArticleId></ArticleIdList></Reference><Reference><Citation>Su ZY, Zhang C, Lee JH, Shu L, Wu TY, Khor TO, Conney AH, Lu YP, Kong AN. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane. Cancer Prev Res (Phila). 2014;7(3):319&#x2013;29. 10.1158/1940-6207.CAPR-13-0313-T.</Citation><ArticleIdList><ArticleId IdType="pubmed">24441674</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-Gonzalez X, Fuentes F, Su Z-Y. Apigenin Reactivates Nrf2 Anti-oxidative Stress Signaling in Mouse Skin Epidermal JB6 P&#x2009;+&#x2009;Cells Through Epigenetics Modifications. AAPS J. 2014;16(4):727&#x2013;35. 10.1208/s12248-014-9613-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4070251</ArticleId><ArticleId IdType="pubmed">24830944</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AY, Lee JH, Shu L, Zhang C, Su Z-Y, Lu Y, Huang M-T, Ramirez C, Pung D, Huang Y, Verzi M, Hart RP, Kong A-NT. Genome-wide analysis of DNA methylation in UVB- and DMBA/TPA-induced mouse skin cancer models. Life Sci. 2014;113(1):45&#x2013;54. 10.1016/j.lfs.2014.07.031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5897904</ArticleId><ArticleId IdType="pubmed">25093921</ArticleId></ArticleIdList></Reference><Reference><Citation>Khor TO, Fuentes F, Shu L, Paredes-Gonzalez X, Yang AY, Liu Y, Smiraglia DJ, Yegnasubramanian S, Nelson WG, Kong AN. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer. Cancer Prev Res (Phila). 2014;7(12):1186&#x2013;97. 10.1158/1940-6207.CAPR-14-0127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4256109</ArticleId><ArticleId IdType="pubmed">25266896</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AY, Kim H, Li W, Kong AN. Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers. Curr Top Med Chem. 2016;16(7):697&#x2013;713. 10.2174/1568026615666150826114359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955582</ArticleId><ArticleId IdType="pubmed">26306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Q, Wu R, Xiao X, Yang C, Yang Y, Wang C, Lin L, Kong AN. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. J Cell Biochem. 2018;119(11):9573&#x2013;82. 10.1002/jcb.27275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195448</ArticleId><ArticleId IdType="pubmed">30129150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudlikar RR, Sargsyan D, Li W, Wu R, Zheng M, Kong A-N. Epigenomic, transcriptomic, and protective effect of carotenoid fucoxanthin in high glucose-induced oxidative stress in Mes13 Kidney mesangial cells. Chem Res Toxicol. 2021;34(3):713&#x2013;22. 10.1021/acs.chemrestox.0c00235.</Citation><ArticleIdList><ArticleId IdType="pubmed">33448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Janke R, Dodson AE, Rine J. Metabolism and epigenetics. Annu Rev Cell Dev Biol. 2015;31:473&#x2013;96. 10.1146/annurev-cellbio-100814-125544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5091661</ArticleId><ArticleId IdType="pubmed">26359776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DC, Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion. 2010;10(1):12&#x2013;31. 10.1016/j.mito.2009.09.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245717</ArticleId><ArticleId IdType="pubmed">19796712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannar A, Sarwar MS, Kong AT. A new frontier in studying dietary phytochemicals in cancer and in health: metabolic and epigenetic reprogramming. Prev Nutr Food Sci. 2022;27(4):335&#x2013;46. 10.3746/pnf.2022.27.4.335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843711</ArticleId><ArticleId IdType="pubmed">36721757</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Wu R, Wang L, Dina Kuo HC, Sargsyan D, Zheng X, Wang Y, Su X, Kong AN. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer. Mol Carcinog. 2022;61(1):111&#x2013;21. 10.1002/mc.23365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8665082</ArticleId><ArticleId IdType="pubmed">34727410</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang C, Sarwar MS, Chou P, Wang Y, Su X, Kong AT. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid. FASEB J. 2022;36(11):e22626. 10.1096/fj.202201195R.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9703918</ArticleId><ArticleId IdType="pubmed">36305462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar MS, Ramirez CN, Kuo HD, Chou P, Wu R, Sargsyan D, Yang Y, Shannar A, Peter RM, Yin R, Wang Y, Su X, Kong AN. Triterpenoid ursolic acid regulates the environmental carcinogen benzo[a]pyrene-driven epigenetic and metabolic alterations in SKH-1 hairless mice for skin cancer interception. Carcinogenesis. 2024;45(5):288&#x2013;99. 10.1093/carcin/bgae009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11102768</ArticleId><ArticleId IdType="pubmed">38466106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar MS, Ramirez CN, Dina Kuo HC, Chou P, Wu R, Sargsyan D, Yang Y, Shannar A, Mary Peter R, Yin R, Wang Y, Su X, Kong AN. The environmental carcinogen benzo[a]pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model. Carcinogenesis. 2023;44(5):436&#x2013;49. 10.1093/carcin/bgad024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10414144</ArticleId><ArticleId IdType="pubmed">37100755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudlikar RR, Sargsyan D, Cheng D, Kuo HD, Wu R, Su X, Kong AN. Tobacco carcinogen 4-[methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone (NNK) drives metabolic rewiring and epigenetic reprograming in A/J mice lung cancer model and prevention with diallyl sulphide (DAS). Carcinogenesis. 2022;43(2):140&#x2013;9. 10.1093/carcin/bgab119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8947221</ArticleId><ArticleId IdType="pubmed">34888630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wu R, Sargsyan D, Su S, Kuo HC, Li S, Chou P, Sarwar MS, Phadnis A, Wang Y, Su X, Kong AN. Nfe2l2 regulates metabolic rewiring and epigenetic reprogramming in mediating cancer protective effect by fucoxanthin. Aaps J. 2022;24(1):30. 10.1208/s12248-022-00679-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">35043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Shannar AAF, Wu R, Chou P, Sarwar MS, Kuo HC, Peter RM, Wang Y, Su X, Kong AN. Butyrate drives metabolic rewiring and epigenetic reprogramming in human colon cancer cells. Mol Nutr Food Res. 2022;66(12):e2200028. 10.1002/mnfr.202200028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9233026</ArticleId><ArticleId IdType="pubmed">35429118</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Dina Kuo HC, Wang L, Wu R, Sargsyan D, Kong AN. UVB drives metabolic rewiring and epigenetic reprograming and protection by sulforaphane in human skin keratinocytes. Chem Res Toxicol. 2022;35(7):1220&#x2013;33. 10.1021/acs.chemrestox.1c00432.</Citation><ArticleIdList><ArticleId IdType="pubmed">35700067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou PJ, Sarwar MS, Wang L, Wu R, Li S, Hudlikar RR, Wang Y, Su X, Kong AN. Metabolomic, DNA methylomic, and transcriptomic profiling of suberoylanilide hydroxamic acid effects on LPS-exposed lung epithelial cells. Cancer Prev Res (Phila). 2023;16(6):321&#x2013;32. 10.1158/1940-6207.CAPR-22-0384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10238674</ArticleId><ArticleId IdType="pubmed">36867722</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RM, Sarwar MS, Mostafa SZ, Wang Y, Su X, Kong AN. Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS-mutant human lung cancer cells. Mol Carcinog. 2023;62(8):1136&#x2013;46. 10.1002/mc.23551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10524423</ArticleId><ArticleId IdType="pubmed">37144836</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39998355</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1768-3238</ISSN><JournalIssue CitedMedium="Internet"><Volume>348</Volume><PubDate><Year>2025</Year><Month>Feb</Month><Day>25</Day></PubDate></JournalIssue><Title>Comptes rendus biologies</Title><ISOAbbreviation>C R Biol</ISOAbbreviation></Journal><ArticleTitle>A possible role for epigenetics in cancer initiation.</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>53</EndPage><MedlinePgn>43-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5802/crbiol.171</ELocationID><Abstract><AbstractText>Cancer is one of the leading causes of mortality worldwide. Known since antiquity, its understanding has evolved over time and has significantly advanced with new technologies over the past four decades. Cancer initiation is currently admitted to be explainable by the somatic mutation theory, which postulates that DNA mutations altering the function of oncogenes and tumor suppressor genes initiate cancer. In addition to these mutations, epigenetic alterations, which heritably change gene expression without altering the DNA sequence, also play a key role. Recent data suggests that epigenetic components regulate all aspects of tumor progression, including cancer initiation. These discoveries prompt a reevaluation of the somatic mutation theory, of cancer prevention and treatment strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-8562-7627</Identifier></Author><Author ValidYN="Y"><LastName>Cavalli</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3709-3469</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>C R Biol</MedlineTA><NlmUniqueID>101140040</NlmUniqueID><ISSNLinking>1631-0691</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063646" MajorTopicYN="Y">Carcinogenesis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Le cancer est une des principales causes de mortalit&#xe9; mondiale. Connu depuis l&#x2019;Antiquit&#xe9;, sa compr&#xe9;hension a &#xe9;volu&#xe9; au fil du temps et a progress&#xe9; &#xe9;norm&#xe9;ment gr&#xe2;ce aux nouvelles technologies durant les quatre derni&#xe8;res d&#xe9;cennies. L&#x2019;initiation du cancer est aujourd&#x2019;hui expliqu&#xe9;e par la th&#xe9;orie des mutations somatiques, sugg&#xe9;rant que des mutations d&#x2019;ADN alt&#xe9;rant la fonction d&#x2019;oncog&#xe8;nes et de g&#xe8;nes suppresseurs de tumeurs initieraient le cancer. Outre ces mutations, les alt&#xe9;rations &#xe9;pig&#xe9;n&#xe9;tiques, qui changent l&#x2019;expression des g&#xe8;nes de mani&#xe8;re h&#xe9;ritable sans changement de la s&#xe9;quence d&#x2019;ADN, jouent cependant aussi un r&#xf4;le cl&#xe9;. Des donn&#xe9;es r&#xe9;centes sugg&#xe8;rent que les composantes &#xe9;pig&#xe9;n&#xe9;tiques r&#xe9;gulent tous les aspects de la progression tumorale, y compris l&#x2019;initiation des cancers. Ces d&#xe9;couvertes am&#xe8;nent &#xe0; revisiter la th&#xe9;orie des mutations somatiques et &#xe0; revoir les strat&#xe9;gies de pr&#xe9;vention et traitement des cancers.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Chromatin</Keyword><Keyword MajorTopicYN="N">Development</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Polycomb proteins</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>9</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>25</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>25</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39998355</ArticleId><ArticleId IdType="doi">10.5802/crbiol.171</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39991103</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1878-5077</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The EPMA journal</Title><ISOAbbreviation>EPMA J</ISOAbbreviation></Journal><ArticleTitle>Epigenetic and biogenetic regulation by polyphenols in prostate cancer in the context of 3P medicine.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>125</EndPage><MedlinePgn>113-125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13167-024-00391-3</ELocationID><Abstract><AbstractText>Prostate cancer (PCa) can remain asymptomatic for years, complicating early detection and effective intervention. Predictive, Preventive, and Personalized Medicine (3PM) provides a transformative framework for addressing these challenges by integrating novel biomarkers, targeted prevention, and individualized therapies. Recent studies highlight the pivotal role of dysregulated microRNAs (miRNAs) and epigenetic alterations in cancer progression and metastasis. miRNAs, as non-coding RNAs approximately 22 nucleotides in length, regulate gene expression through translational inhibition or mRNA degradation. Dysregulated miRNAs are linked to the overexpression of oncogenic proteins and suppression of tumor suppressor genes in malignancies. Polyphenols such as curcumin, quercetin, resveratrol, and green tea catechins (EGCG) have demonstrated potential in modulating miRNA expression and reversing aberrant epigenetic modifications. Despite their established anticancer effects, the clinical application of polyphenols in stratified patient groups, particularly in primary and secondary cancer prevention, remains underexplored. Beyond their anti-inflammatory and antioxidant properties, polyphenols modulate early epigenetic and biogenetic events critical for cancer prevention and therapy. By targeting predictive biomarkers and improving therapy response, polyphenols contribute significantly to 3PM by enabling early diagnostics, mitigating risks, and personalizing treatments. This review evaluates current knowledge of polyphenols' impact on miRNAs and epigenetics in PCa and explores their potential applications within the 3PM framework, emphasizing predictive diagnostics, targeted prevention, and personalized treatment strategies.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to European Association for Predictive, Preventive and Personalised Medicine (EPMA) 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Huke</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Anhui Province, Hefei City, 230000 China.</Affiliation><Identifier Source="ROR">https://ror.org/03t1yn780</Identifier><Identifier Source="GRID">grid.412679.f</Identifier><Identifier Source="ISNI">0000 0004 1771 3402</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The First Clinical Medical College, The First Affiliated of Anhui University of Traditional Chinese Medicine, Anhui Province, Hefei City, 230000 China.</Affiliation><Identifier Source="ROR">https://ror.org/0139j4p80</Identifier><Identifier Source="GRID">grid.252251.3</Identifier><Identifier Source="ISNI">0000 0004 1757 8247</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>EPMA J</MedlineTA><NlmUniqueID>101517307</NlmUniqueID><ISSNLinking>1878-5077</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-inflammatory and antioxidant properties</Keyword><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">Cancer progression and metastasis</Keyword><Keyword MajorTopicYN="N">Curcumin</Keyword><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">Epigenetic regulation</Keyword><Keyword MajorTopicYN="N">Green tea</Keyword><Keyword MajorTopicYN="N">MiRNAs</Keyword><Keyword MajorTopicYN="N">Oncology</Keyword><Keyword MajorTopicYN="N">Polyphenols</Keyword><Keyword MajorTopicYN="N">Predictive, Preventive, and Personalized Medicine (3PM /&#xa0;PPPM)</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword><Keyword MajorTopicYN="N">Quercetin</Keyword><Keyword MajorTopicYN="N">Resveratrol</Keyword><Keyword MajorTopicYN="N">Risk mitigation</Keyword><Keyword MajorTopicYN="N">Therapy response</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39991103</ArticleId><ArticleId IdType="pmc">PMC11842649</ArticleId><ArticleId IdType="doi">10.1007/s13167-024-00391-3</ArticleId><ArticleId IdType="pii">391</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68:394&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22424666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuruma H, Egawa S. Words of Wisdom: re: international variation in prostate cancer incidence and mortality rates. Eur Urol. 2013;63:583&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23357896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008&#x2013;2010. BMC Med. 2015;13:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4520076</ArticleId><ArticleId IdType="pubmed">26224061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokhorst LP, Roobol MJ. Ethnicity and prostate cancer: the way to solve the screening problem? BMC Med. 2015;13:179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524025</ArticleId><ArticleId IdType="pubmed">26239718</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcey E, Boyle T. Tobacco smoking and survival after a prostate cancer diagnosis: a systematic review and meta-analysis. Cancer Treat Rev. 2018;70:30&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30055462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieken M, Shariat SF, Kluth LA, Fajkovic H, Rink M, Karakiewicz PI, et al. Association of Cigarette smoking and smoking cessation with biochemical recurrence of prostate cancer in patients treated with radical prostatectomy. Eur Urol. 2015;68:949&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26050111</ArticleId></ArticleIdList></Reference><Reference><Citation>Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass-Kortsak A. Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis Can. 2007;27:145&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">17623560</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Wang J, Wu HL, Wang H, Wang JX, Zhou R, et al. Leisure time physical activity and risk of prostate cancer: a dose-response meta-analysis. Minerva Urol e Nefrol = Italian J Urol Nephrol. 2018;70:152&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">28707842</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56:317&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9838798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, Gemetzi C, et al. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer. 2000;37:223&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">11142097</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SB, DePrimo SE, Whitfield ML, Brooks JD. Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2005;14:596&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889115</ArticleId><ArticleId IdType="pubmed">15767336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TT, Schoene NW, Kim YS, Mizuno CS, Rimando AM. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res. 2010;54:335&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">20077416</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114:A160&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1392256</ArticleId><ArticleId IdType="pubmed">16507447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzio EA, Soliman KF. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics. 2012;7:119&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3335905</ArticleId><ArticleId IdType="pubmed">22395460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung P, Lau P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol. 2005;19:563&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15677708</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem (Shariqah United Arab Emirates)). 2006;2:169&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">16787365</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanacore D, Boccellino M, Rossetti S, Cavaliere C, D&#x2019;Aniello C, Di Franco R, et al. Micrornas in prostate cancer: an overview. Oncotarget. 2017;8:50240&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564846</ArticleId><ArticleId IdType="pubmed">28445135</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, et al. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS ONE. 2012;7:e43812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3426544</ArticleId><ArticleId IdType="pubmed">22928040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang FQ, Liu M, Li W, Che JP, Wang GC, Zheng JH. Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Mol Med Rep. 2015;11:1085&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25354548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, Rybak LP, et al. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS ONE. 2012;7:e51655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521661</ArticleId><ArticleId IdType="pubmed">23272133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro M, Ungaro P, Cimmino A, Lucarelli G, Busetto GM, Cantiello F, et al. Epigenetic signature: a new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS). Journal [serial on the Internet]. 2017;18(6):1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485970</ArticleId><ArticleId IdType="pubmed">28555004</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis. Cell Mol Life Sci. 2011;68:1681&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11114845</ArticleId><ArticleId IdType="pubmed">21249513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3193420</ArticleId><ArticleId IdType="pubmed">21321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghdam SG, Ebrazeh M, Hemmatzadeh M, Seyfizadeh N, Shabgah AG, Azizi G, et al. The role of microRNAs in prostate cancer migration, invasion, and metastasis. J Cell Physiol. 2019;234:9927&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">30536403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosutti A, Zanconati F, Grassi G, Dapas B, Passamonti S, Scaggiante B. Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals. Anti-Cancer Agents Med Chem - Anti-Cancer Agents. 2016;16:1385&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068501</ArticleId><ArticleId IdType="pubmed">27109021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall RK, Syed DN, Adhami VM, Khan MI, Mukhtar H. Dietary polyphenols in prevention and treatment of prostate cancer. Journal [serial on the Internet]. 2015;16(2):3350&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4346900</ArticleId><ArticleId IdType="pubmed">25654230</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjaly K, Tiku AB. MicroRNA mediated therapeutic effects of natural agents in prostate cancer. Mol Biol Rep. 2021;48:5759&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">34304390</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo S, Naponelli V, Bettuzzi S. Flavonoids as epigenetic modulators for prostate cancer prevention. Nutrients. 2020;12:1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231128</ArticleId><ArticleId IdType="pubmed">32268584</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran P, Abdelsalam SA, Renu K, Veeraraghavan V, Ben Ammar R, Ahmed EA. Polyphenols as potent epigenetics agents for cancer. Int J Mol Sci. 2022;23:11712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9570183</ArticleId><ArticleId IdType="pubmed">36233012</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Xiao X, Zhang X, Yi D, Li T, Hao Q, et al. Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects. EPMA J. 2024;15:207&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11147989</ArticleId><ArticleId IdType="pubmed">38841625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurakova A, Samec M, Koklesova L, Biringer K, Kudela E, Al-Ishaq RK, et al. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine &#x2014; comprehensive effects of phytochemicals in primary, secondary and tertiary care. EPMA J. 2022;13:461&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9263437</ArticleId><ArticleId IdType="pubmed">35821883</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubnitschaja O, Kapinova A, Sargheini N, Bojkova B, Kapalla M, Heinrich L, et al. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care&#x2014;clinically relevant 3PM innovation. EPMA J. 2024;15:163&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11148002</ArticleId><ArticleId IdType="pubmed">38841620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11:399&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429585</ArticleId><ArticleId IdType="pubmed">32843909</ArticleId></ArticleIdList></Reference><Reference><Citation>Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, et al. Cell-free nucleic acid patterns in disease prediction and monitoring&#x2014;hype or hope? EPMA J. 2020;11:603&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594983</ArticleId><ArticleId IdType="pubmed">33144898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinger J, Alajati A, Kubatka P, Giordano FA, Ritter M, Costigliola V, et al. Prostate cancer treatment costs increase more rapidly than for any other cancer&#x2014;how to reverse the trend? EPMA J. 2022;13:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886338</ArticleId><ArticleId IdType="pubmed">35251382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JF, Yan Q. The roles of epigenetics in cancer progression and metastasis. Biochem J. 2021;478:3373&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524384</ArticleId><ArticleId IdType="pubmed">34520519</ArticleId></ArticleIdList></Reference><Reference><Citation>Murr R. Interplay between different epigenetic modifications and mechanisms. Adv Genet. 2010;70:101&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20920747</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantin N, Sina AA, Korbie D, Trau M. Opportunities for early cancer detection: the rise of ctDNA methylation-based pan-cancer screening technologies. Epigenomes. 2022;6:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8883983</ArticleId><ArticleId IdType="pubmed">35225958</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdgate GA, Bardelle C, Lanne A, Read J, O&#x2019;Donovan DH, Smith JM, et al. Drug discovery for epigenetics targets. Drug Discovery Today. 2022;27:1088&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">34728375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Ren T, Zhang Y, Nan N. Methylation multiplicity and its clinical values in cancer. Expert Rev Mol Med. 2021;23:e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086398</ArticleId><ArticleId IdType="pubmed">33787478</ArticleId></ArticleIdList></Reference><Reference><Citation>Paluszczak J, Baer-Dubowska W. Epigenetic diagnostics of cancer&#x2013;the application of DNA methylation markers. J Appl Genet. 2006;47:365&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">17132902</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhao H, Huang Y, Xu S, Zhou Y, Zhang W, et al. Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer. Mol Cancer. 2021;20:36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893735</ArticleId><ArticleId IdType="pubmed">33608029</ArticleId></ArticleIdList></Reference><Reference><Citation>Uehiro N, Sato F, Pu F, Tanaka S, Kawashima M, Kawaguchi K, et al. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res&#x202f;: BCR. 2016;18:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5168705</ArticleId><ArticleId IdType="pubmed">27993161</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossell&#xf3;-Tortella M, Bueno-Costa A, Mart&#xed;nez-Verbo L, Villanueva L, Esteller M. DNA methylation-associated dysregulation of transfer RNA expression in human cancer. Mol Cancer. 2022;21:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8840503</ArticleId><ArticleId IdType="pubmed">35151331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yang C, Wu C, Cui W, Wang L. DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy. Cancers. 2020;12:2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465608</ArticleId><ArticleId IdType="pubmed">32751889</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Yang F, Zhang L, Hu Y, Chen B, Wang J, et al. Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Front Pharmacol. 2022;13:958146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453300</ArticleId><ArticleId IdType="pubmed">36091786</ArticleId></ArticleIdList></Reference><Reference><Citation>Argentieri MA, Nagarajan S, Seddighzadeh B, Baccarelli AA, Shields AE. Epigenetic pathways in human disease: the impact of dna methylation on stress-related pathogenesis and current challenges in biomarker development. EBioMedicine. 2017;18:327&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405197</ArticleId><ArticleId IdType="pubmed">28434943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Kumar L, Mohanty SK, Maikhuri JP, Rajender S, Gupta G. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - synergistic action of quercetin and curcumin. Mol Cell Endocrinol. 2016;431:12&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">27132804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayani RS, Ramanujam PL, Galande S. Studying histone modifications and their genomic functions by employing chromatin immunoprecipitation and immunoblotting. Methods Cell Biol. 2010;98:35&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">20816229</ArticleId></ArticleIdList></Reference><Reference><Citation>Huebert DJ, Kamal M, O&#x2019;Donovan A, Bernstein BE. Genome-wide analysis of histone modifications by ChIP-on-chip. Methods (San Diego, Calif). 2006;40:365&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17101450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao F, Kale S, Dimitrov S, Hayes JJ. Unraveling linker histone interactions in nucleosomes. Curr Opin Struct Biol. 2021;71:87&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8648876</ArticleId><ArticleId IdType="pubmed">34246862</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Dalal Y, Papoian GA. Binding dynamics of disordered linker histone H1 with a nucleosomal particle. J Mol Biol. 2021;433:166881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9272445</ArticleId><ArticleId IdType="pubmed">33617899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunadis E, Lakiotaki E, Korkolopoulou P, Piperi C. Targeting post-translational histone modifying enzymes in glioblastoma. Pharmacol Ther. 2021;220:107721.</Citation><ArticleIdList><ArticleId IdType="pubmed">33144118</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Zhou X, Qi G, Guo Y. Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation. J Biochem Mol Toxicol. 2018;32:e22049.</Citation><ArticleIdList><ArticleId IdType="pubmed">29485738</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3&#x2019;-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30:905&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">17332930</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Wang F, Wang X, Xu W, Liu F, Hu R, et al. Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C. J Biochem Mol Toxicol. 2024;38:e23645.</Citation><ArticleIdList><ArticleId IdType="pubmed">38348716</ArticleId></ArticleIdList></Reference><Reference><Citation>Panahizadeh R, Vatankhah MA, Jeddi F, Arabzadeh A, Nejati-Koshki K, Salimnejad R, et al. Cytotoxicity of curcumin against CD44(&#xb1;) prostate cancer cells: Roles of miR-383 and miR-708. Avicenna journal of phytomedicine. 2023;13:429&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10474917</ArticleId><ArticleId IdType="pubmed">37663388</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li M, Wang Y, Luo J. Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition. J Drug Target. 2017;25:645&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">28391715</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H, Yu H, Feng Y, Chen L, Liang F. Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis. Cancer Chemother Pharmacol. 2017;79:985&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">28391351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zheng J, Shen H, Huang Y, Liu T, Xi H, et al. Curcumin suppresses in vitro proliferation and invasion of human prostate cancer stem cells by modulating DLK1-DIO3 imprinted gene cluster microRNAs. Genet Test Mol Biomarkers. 2018;22:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29172709</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Chi H, Chen J, Chen C, Huang Y, Xi H, et al. Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene. 2017;631:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">28843521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Zheng Z, Huang J, Ma X, Huang C, Wu R, et al. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells. J Cell Biochem. 2019;120:15616&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">31042325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatankhah MA, Panahizadeh R, Nejati-Koshki K, Arabzadeh M, Arabzadeh AA, Najafzadeh N. Curcumin upregulates miR-148a to increase the chemosensitivity of CD44-positive prostate cancer stem cells to paclitaxel through targeting the MSK1/IRS1 axis. Drug Res. 2022;72:457&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">35868335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Rimando AM, Levenson AS. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer. Ann N Y Acad Sci. 2017;1403:15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">28662290</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar S, Kumar A, Rimando AM, Zhang X, Levenson AS. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget. 2015;6:27214&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4694984</ArticleId><ArticleId IdType="pubmed">26318586</ArticleId></ArticleIdList></Reference><Reference><Citation>Safari F, Dadeh Amirfard K. Efficacy of green tea extract on PC3 prostate cancer cells through upregulation of miR-195 expression and suppression of epithelial to mesenchymal transition. J Tradit Chin Med Chung i tsa chih ying wen pan. 2022;42:681&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9924716</ArticleId><ArticleId IdType="pubmed">36083473</ArticleId></ArticleIdList></Reference><Reference><Citation>Safari F, Rayat Azad N, Alizadeh Ezdiny A, Pakizehkar S, Khazaei Koohpar Z, Ranji N. Antitumor activities of green tea by up-regulation of miR-181a expression in LNCaP cells using 3D cell culture model. Avicenna J Med Biotechnol. 2022;14:89&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017474</ArticleId><ArticleId IdType="pubmed">35509367</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Kong D, Ahmad A, Bao B, Dyson G, Sarkar FH. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics. 2012;7:940&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427289</ArticleId><ArticleId IdType="pubmed">22805767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Chen Z, Shi J, Feng Y, Yu M, Sun Y, et al. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells. Prostate. 2020;80:977&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32542727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kai L, Samuel SK, Levenson AS. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer. 2010;126:1538&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">19810103</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 2009;383:280&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19302977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, et al. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res. 2009;69:7165&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2861586</ArticleId><ArticleId IdType="pubmed">19738047</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbuzova A, Schmitz AA, Verg&#xe8;res G. Cross-talk unfolded: MARCKS proteins. Biochem J. 2002;362:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1222354</ArticleId><ArticleId IdType="pubmed">11829734</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb G, Shankar E, Thakur VS, Ponsky LE, Bodner DR, Fu P, et al. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes. Mol Carcinog. 2019;58:1194&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">30854739</ArticleId></ArticleIdList></Reference><Reference><Citation>Morey Kinney SR, Zhang W, Pascual M, Greally JM, Gillard BM, Karasik E, et al. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev Res (Phila). 2009;2:1065&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2789312</ArticleId><ArticleId IdType="pubmed">19934341</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M, Shukla S, Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer. 2010;126:2520&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2874465</ArticleId><ArticleId IdType="pubmed">19856314</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning SM, Wang P, Said J, Magyar C, Castor B, Doan N, et al. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem. 2012;23:1537&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3374889</ArticleId><ArticleId IdType="pubmed">22405694</ArticleId></ArticleIdList></Reference><Reference><Citation>Molini&#xe9; B, Georgel P. Genetic and epigenetic regulations of prostate cancer by genistein. Drug News Perspect. 2009;22:247&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">19609462</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjakly M, Bosviel R, Rabiau N, Boiteux JP, Bignon YJ, Guy L, et al. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics. 2011;3:795&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">22126297</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 2010;116:66&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954042</ArticleId><ArticleId IdType="pubmed">19885928</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res. 2005;11:7033&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16203797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulger M. Hyperacetylated chromatin domains: lessons from heterochromatin. J Biol Chem. 2005;280:21689&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">15840568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39946195</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e177545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.177545</ELocationID><Abstract><AbstractText>Colorectal precancers in Lynch syndrome (LS) exhibit a distinct immune profile, presenting unique opportunities for developing immune-interception strategies to prevent carcinogenesis. Epigenetic modulation by EZH2 of immune-related genes is implicated in the carcinogenesis of different cancer types, including colorectal cancer. This study utilizes a mouse model of LS and ex vivo colonic organoids to assess the effects of the EZH2 inhibitor GSK503 on immune regulatory pathways, tumorigenesis, and epigenetic reprogramming. Our findings revealed that GSK503 significantly increased CD4+ and CD8+ T cells in both splenocytes and colonic mucosa of treated mice compared with controls. Additionally, a preventive dose of GSK503 over 9 weeks notably reduced adenoma multiplicity, demonstrating its efficacy as a preventive modality. Single-cell RNA-Seq and molecular analyses showed activation of immune and apoptotic markers, along with a reduction in H3K27 methylation levels in colonic crypts. ChIP sequencing further revealed decreased levels of H3K27me3 and H3K4me1, while levels of the active enhancer marks H3K4me3 and H3K27Ac increased in treated mice. Collectively, these findings indicate that EZH2 inhibition enhances immune responses through epigenetic reprogramming in the genome of LS mice, establishing a promising framework for the clinical development of EZH2 inhibitors as a cancer prevention strategy for LS carriers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Charles M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duzagac</LastName><ForeName>Fahriye</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martel-Martel</LastName><ForeName>Abel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Uribe</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaheer</LastName><ForeName>Mahira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Jacklyn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Ria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazumdar</LastName><ForeName>Soham</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taggart</LastName><ForeName>Melissa W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Pathology, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Abhinav K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosti</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edelmann</LastName><ForeName>Winfried</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Krishna M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilar</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Cancer Prevention.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA016672</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA248536</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA257375</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.1.1.43</RegistryNumber><NameOfSubstance UI="D000071221">Enhancer of Zeste Homolog 2 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.43</RegistryNumber><NameOfSubstance UI="C498410">Ezh2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011728">Pyridones</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.43</RegistryNumber><NameOfSubstance UI="C498409">EZH2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071221" MajorTopicYN="Y">Enhancer of Zeste Homolog 2 Protein</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003123" MajorTopicYN="Y">Colorectal Neoplasms, Hereditary Nonpolyposis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011728" MajorTopicYN="N">Pyridones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Oncology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>24</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>13</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39946195</ArticleId><ArticleId IdType="pmc">PMC11949072</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.177545</ArticleId><ArticleId IdType="pii">177545</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145&#x2013;164. doi: 10.3322/caac.21601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21601</ArticleId><ArticleId IdType="pubmed">32133645</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasperson KW, et al. Hereditary and familial colon cancer. Gastroenterology. 2010;138(6):2044&#x2013;2058. doi: 10.1053/j.gastro.2010.01.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2010.01.054</ArticleId><ArticleId IdType="pmc">PMC3057468</ArticleId><ArticleId IdType="pubmed">20420945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153&#x2013;162. doi: 10.1038/nrclinonc.2009.237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2009.237</ArticleId><ArticleId IdType="pmc">PMC3427139</ArticleId><ArticleId IdType="pubmed">20142816</ArticleId></ArticleIdList></Reference><Reference><Citation>Baretti M, Le DT. DNA mismatch repair in cancer. Pharmacol Ther. 2018;189:45&#x2013;62. doi: 10.1016/j.pharmthera.2018.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.04.004</ArticleId><ArticleId IdType="pubmed">29669262</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479&#x2013;507. doi: 10.1146/annurev-pathol-011110-130235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-011110-130235</ArticleId><ArticleId IdType="pubmed">21090969</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011;8(12):686&#x2013;700. doi: 10.1038/nrgastro.2011.173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2011.173</ArticleId><ArticleId IdType="pmc">PMC3391545</ArticleId><ArticleId IdType="pubmed">22009203</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung G, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111&#x2013;130. doi: 10.1038/s41575-019-0230-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-019-0230-y</ArticleId><ArticleId IdType="pmc">PMC7228650</ArticleId><ArticleId IdType="pubmed">31900466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohaumilitzky L, et al. Implications of hereditary origin on the immune phenotype of mismatch repair-deficient cancers: systematic literature review. J Clin Med. 2020;9(6):1741. doi: 10.3390/jcm9061741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061741</ArticleId><ArticleId IdType="pmc">PMC7357024</ArticleId><ArticleId IdType="pubmed">32512823</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagarsheth N, et al. PRC2 epigenetically silences Th1-type chemokines to suppress effector T-cell trafficking in colon cancer. Cancer Res. 2016;76(2):275&#x2013;282. doi: 10.1158/0008-5472.CAN-15-1938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-15-1938</ArticleId><ArticleId IdType="pmc">PMC4715964</ArticleId><ArticleId IdType="pubmed">26567139</ArticleId></ArticleIdList></Reference><Reference><Citation>Musella M, et al. Epigenetics behind tumor immunology: a mini review. Oncogene. 2023;42(39):2932&#x2013;2938. doi: 10.1038/s41388-023-02791-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-023-02791-7</ArticleId><ArticleId IdType="pubmed">37604925</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681&#x2013;8686. doi: 10.1073/pnas.96.15.8681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.15.8681</ArticleId><ArticleId IdType="pmc">PMC17576</ArticleId><ArticleId IdType="pubmed">10411935</ArticleId></ArticleIdList></Reference><Reference><Citation>Della Chiara G, et al. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ. Nat Commun. 2021;12(1):2340. doi: 10.1038/s41467-021-22544-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22544-y</ArticleId><ArticleId IdType="pmc">PMC8058065</ArticleId><ArticleId IdType="pubmed">33879786</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel A, Boland CR. Epigenetics of colorectal cancer. Gastroenterology. 2012;143(6):1442&#x2013;1460. doi: 10.1053/j.gastro.2012.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2012.09.032</ArticleId><ArticleId IdType="pmc">PMC3611241</ArticleId><ArticleId IdType="pubmed">23000599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramblet RM, et al. Methylated DNA markers for sporadic colorectal and endometrial cancer are strongly associated with Lynch syndrome cancers. Cancer Prev Res (Phila) 2023;16(11):611&#x2013;620. doi: 10.1158/1940-6207.CAPR-23-0107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-23-0107</ArticleId><ArticleId IdType="pmc">PMC10870731</ArticleId><ArticleId IdType="pubmed">37728516</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, et al. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010;29(1):181&#x2013;206. doi: 10.1007/s10555-010-9207-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-010-9207-6</ArticleId><ArticleId IdType="pubmed">20135198</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabritz J, Menheniott TR. Linking immunity, epigenetics, and cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(9):1638&#x2013;1654. doi: 10.1097/MIB.0000000000000063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000063</ArticleId><ArticleId IdType="pubmed">24896241</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R, et al. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13(1):104. doi: 10.1186/s13045-020-00937-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00937-8</ArticleId><ArticleId IdType="pmc">PMC7385862</ArticleId><ArticleId IdType="pubmed">32723346</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L, et al. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018;6:10. doi: 10.1186/s40364-018-0122-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40364-018-0122-2</ArticleId><ArticleId IdType="pmc">PMC5845366</ArticleId><ArticleId IdType="pubmed">29556394</ArticleId></ArticleIdList></Reference><Reference><Citation>DuPage M, et al. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation. Immunity. 2015;42(2):227&#x2013;238. doi: 10.1016/j.immuni.2015.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.01.007</ArticleId><ArticleId IdType="pmc">PMC4347854</ArticleId><ArticleId IdType="pubmed">25680271</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumes DJ, et al. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells. Immunity. 2013;39(5):819&#x2013;832. doi: 10.1016/j.immuni.2013.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.09.012</ArticleId><ArticleId IdType="pubmed">24238339</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, et al. EZH2 inhibitor GSK126 suppresses antitumor immunity by driving production of myeloid-derived suppressor cells. Cancer Res. 2019;79(8):2009&#x2013;2020. doi: 10.1158/0008-5472.CAN-18-2395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-2395</ArticleId><ArticleId IdType="pubmed">30737232</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K, et al. Immune profiling of premalignant lesions in patients with Lynch syndrome. JAMA Oncol. 2018;4(8):1085&#x2013;1092. doi: 10.1001/jamaoncol.2018.1482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2018.1482</ArticleId><ArticleId IdType="pmc">PMC6087485</ArticleId><ArticleId IdType="pubmed">29710228</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen CM, et al. Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch syndrome colorectal mucosa. Front Immunol. 2023;14:1162669. doi: 10.3389/fimmu.2023.1162669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1162669</ArticleId><ArticleId IdType="pmc">PMC10189148</ArticleId><ArticleId IdType="pubmed">37207208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolivar AM, et al. Genomic landscape of Lynch syndrome colorectal neoplasia identifies shared mutated neoantigens for immunoprevention. Gastroenterology. 2024;166(5):787&#x2013;801. doi: 10.1053/j.gastro.2024.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2024.01.016</ArticleId><ArticleId IdType="pmc">PMC11034773</ArticleId><ArticleId IdType="pubmed">38244726</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, et al. Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation. Nat Commun. 2019;10(1):2427. doi: 10.1038/s41467-019-10176-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10176-2</ArticleId><ArticleId IdType="pmc">PMC6547712</ArticleId><ArticleId IdType="pubmed">31160593</ArticleId></ArticleIdList></Reference><Reference><Citation>Beguelin W, et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013;23(5):677&#x2013;692. doi: 10.1016/j.ccr.2013.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2013.04.011</ArticleId><ArticleId IdType="pmc">PMC3681809</ArticleId><ArticleId IdType="pubmed">23680150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingg D, et al. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat Commun. 2015;6:6051. doi: 10.1038/ncomms7051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7051</ArticleId><ArticleId IdType="pubmed">25609585</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Uribe L, et al. Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut. 2021;70(3):555&#x2013;566. doi: 10.1136/gutjnl-2020-320946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320946</ArticleId><ArticleId IdType="pmc">PMC7790993</ArticleId><ArticleId IdType="pubmed">32641470</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert J, et al. Recurrent frameshift neoantigen vaccine elicits protective immunity with reduced tumor burden and improved overall survival in a Lynch syndrome mouse model. Gastroenterology. 2021;161(4):1288&#x2013;1302. doi: 10.1053/j.gastro.2021.06.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.06.073</ArticleId><ArticleId IdType="pmc">PMC10184299</ArticleId><ArticleId IdType="pubmed">34224739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingg D, et al. The histone methyltransferase Ezh2 controls mechanisms of adaptive resistance to tumor immunotherapy. Cell Rep. 2017;20(4):854&#x2013;867. doi: 10.1016/j.celrep.2017.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.07.007</ArticleId><ArticleId IdType="pubmed">28746871</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng D, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 2015;527(7577):249&#x2013;253. doi: 10.1038/nature15520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15520</ArticleId><ArticleId IdType="pmc">PMC4779053</ArticleId><ArticleId IdType="pubmed">26503055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22(2):128&#x2013;134. doi: 10.1038/nm.4036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4036</ArticleId><ArticleId IdType="pmc">PMC4918227</ArticleId><ArticleId IdType="pubmed">26845405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucherlapati MH, et al. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents. Gastroenterology. 2010;138(3):993&#x2013;1002. doi: 10.1053/j.gastro.2009.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2009.11.009</ArticleId><ArticleId IdType="pmc">PMC2862591</ArticleId><ArticleId IdType="pubmed">19931261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosti E, et al. Loss of MMR and TGFBR2 increases the susceptibility to microbiota-dependent inflammation-associated colon cancer. Cell Mol Gastroenterol Hepatol. 2022;14(3):693&#x2013;717. doi: 10.1016/j.jcmgh.2022.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2022.05.010</ArticleId><ArticleId IdType="pmc">PMC9421583</ArticleId><ArticleId IdType="pubmed">35688320</ArticleId></ArticleIdList></Reference><Reference><Citation>Itano O, et al. Effect of caloric intake on Western-style diet-induced intestinal tumors in a mouse model for hereditary colon cancer. Nutr Cancer. 2012;64(3):401&#x2013;408. doi: 10.1080/01635581.2012.660672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2012.660672</ArticleId><ArticleId IdType="pubmed">22439692</ArticleId></ArticleIdList></Reference><Reference><Citation> Davarinejad H. Quantifications of Western Blots with ImageJ.  https://www.yorku.ca/yisheng/Internal/Protocols/ImageJ.pdf Accessed February 13, 2025.</Citation></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. doi: 10.1186/1471-2105-12-323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-323</ArticleId><ArticleId IdType="pmc">PMC3163565</ArticleId><ArticleId IdType="pubmed">21816040</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284&#x2013;287. doi: 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Varn FS, et al. Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles. Nat Commun. 2016;7:10248. doi: 10.1038/ncomms10248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10248</ArticleId><ArticleId IdType="pmc">PMC4725766</ArticleId><ArticleId IdType="pubmed">26725977</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297&#x2013;1303. doi: 10.1101/gr.107524.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.107524.110</ArticleId><ArticleId IdType="pmc">PMC2928508</ArticleId><ArticleId IdType="pubmed">20644199</ArticleId></ArticleIdList></Reference><Reference><Citation>Danecek P, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10(2):giab008. doi: 10.1093/gigascience/giab008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giab008</ArticleId><ArticleId IdType="pmc">PMC7931819</ArticleId><ArticleId IdType="pubmed">33590861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS) Genome Biol. 2008;9(9):R137. doi: 10.1186/gb-2008-9-9-r137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2008-9-9-r137</ArticleId><ArticleId IdType="pmc">PMC2592715</ArticleId><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez F, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44(w1):W160&#x2013;W165. doi: 10.1093/nar/gkw257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw257</ArticleId><ArticleId IdType="pmc">PMC4987876</ArticleId><ArticleId IdType="pubmed">27079975</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576&#x2013;589. doi: 10.1016/j.molcel.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JT, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24&#x2013;26. doi: 10.1038/nbt.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1754</ArticleId><ArticleId IdType="pmc">PMC3346182</ArticleId><ArticleId IdType="pubmed">21221095</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39595564</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1387</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14111387</ELocationID><Abstract><AbstractText>One-carbon (1C) metabolism is a complex network of metabolic reactions closely related to producing 1C units (as methyl groups) and utilizing them for different anabolic processes, including nucleotide synthesis, methylation, protein synthesis, and reductive metabolism. These pathways support the high proliferative rate of cancer cells. While drugs that target 1C metabolism (like methotrexate) have been used for cancer treatment, they often have significant side effects. Therefore, developing new drugs with minimal side effects is necessary for effective cancer treatment. Methionine, glycine, and serine are the main three precursors of 1C metabolism. One-carbon metabolism is vital not only for proliferative cells but also for non-proliferative cells in regulating energy homeostasis and the aging process. Understanding the potential role of 1C metabolism in aging is crucial for advancing our knowledge of neoplastic progression. This review provides a comprehensive understanding of the molecular complexities of 1C metabolism in the context of cancer and aging, paving the way for researchers to explore new avenues for developing advanced therapeutic interventions for cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Majumder</LastName><ForeName>Avisek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6761-2242</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bano</LastName><ForeName>Shabana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nayak</LastName><ForeName>Kasturi Bala</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, Department of Medicine, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7440-44-0</RegistryNumber><NameOfSubstance UI="D002244">Carbon</NameOfSubstance></Chemical><Chemical><RegistryNumber>AE28F7PNPL</RegistryNumber><NameOfSubstance UI="D008715">Methionine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002244" MajorTopicYN="Y">Carbon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008715" MajorTopicYN="N">Methionine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Warburg effect</Keyword><Keyword MajorTopicYN="N">anti-cancer therapeutics</Keyword><Keyword MajorTopicYN="N">antioxidants</Keyword><Keyword MajorTopicYN="N">antiproliferative response</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">cancer therapy</Keyword><Keyword MajorTopicYN="N">chemotherapeutic agents</Keyword><Keyword MajorTopicYN="N">diet</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">folate</Keyword><Keyword MajorTopicYN="N">glutathione</Keyword><Keyword MajorTopicYN="N">glycine biosynthesis</Keyword><Keyword MajorTopicYN="N">homocysteine</Keyword><Keyword MajorTopicYN="N">hydrogen sulfide (H2S)</Keyword><Keyword MajorTopicYN="N">hyperhomocysteinemia</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">lifestyle</Keyword><Keyword MajorTopicYN="N">methionine addition</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">redox statuses</Keyword><Keyword MajorTopicYN="N">senescence</Keyword><Keyword MajorTopicYN="N">serine biosynthesis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39595564</ArticleId><ArticleId IdType="pmc">PMC11591851</ArticleId><ArticleId IdType="doi">10.3390/biom14111387</ArticleId><ArticleId IdType="pii">biom14111387</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Majumder A. Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures. Cancers. 2023;16:39. doi: 10.3390/cancers16010039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16010039</ArticleId><ArticleId IdType="pmc">PMC10777914</ArticleId><ArticleId IdType="pubmed">38201467</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., Tyagi S.C. Post-menopausal breast cancer: From estrogen to androgen receptor. Oncotarget. 2017;8:102739&#x2013;102758. doi: 10.18632/oncotarget.22156.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.22156</ArticleId><ArticleId IdType="pmc">PMC5731994</ArticleId><ArticleId IdType="pubmed">29254284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecham J.O., Rowitch D., Wallace C.D., Stern P.H., Hoffman R.M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun. 1983;117:429&#x2013;434. doi: 10.1016/0006-291X(83)91218-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(83)91218-4</ArticleId><ArticleId IdType="pubmed">6661235</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberti M.V., Locasale J.W. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem. Sci. 2016;41:211&#x2013;218. doi: 10.1016/j.tibs.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.12.001</ArticleId><ArticleId IdType="pmc">PMC4783224</ArticleId><ArticleId IdType="pubmed">26778478</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 2009;324:1029&#x2013;1033. doi: 10.1126/science.1160809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1160809</ArticleId><ArticleId IdType="pmc">PMC2849637</ArticleId><ArticleId IdType="pubmed">19460998</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra D., Singh K.K. Genetic insights into OXPHOS defect and its role in cancer. Biochim. Biophys. Acta. 2011;1807:620&#x2013;625. doi: 10.1016/j.bbabio.2010.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2010.10.023</ArticleId><ArticleId IdType="pmc">PMC4681500</ArticleId><ArticleId IdType="pubmed">21074512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanbari Movahed Z., Rastegari-Pouyani M., Mohammadi M.H., Mansouri K. Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell? Biomed. Pharmacother. 2019;112:108690. doi: 10.1016/j.biopha.2019.108690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108690</ArticleId><ArticleId IdType="pubmed">30798124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghannad-Zadeh K., Das S. One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review. Cancers. 2021;13:3067. doi: 10.3390/cancers13123067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13123067</ArticleId><ArticleId IdType="pmc">PMC8235277</ArticleId><ArticleId IdType="pubmed">34205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. Novel Aspects on Chemistry and Biochemistry Vol.8. BP International; West Bengal, India: 2023. Exploiting Methionine Addiction as a Potential Treatment Strategy for Cancer; pp. 133&#x2013;181.</Citation></Reference><Reference><Citation>Burt B.M., Humm J.L., Kooby D.A., Squire O.D., Mastorides S., Larson S.M., Fong Y. Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia. 2001;3:189&#x2013;195. doi: 10.1038/sj.neo.7900147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.neo.7900147</ArticleId><ArticleId IdType="pmc">PMC1505592</ArticleId><ArticleId IdType="pubmed">11494112</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Majumder A., Ice H., Homme R.P., Eyob W., Tyagi S.C., Singh M. Genes and genetics in hyperhomocysteinemia and the &#x201c;1-carbon metabolism&#x201d;: Implications for retinal structure and eye functions. Can. J. Physiol. Pharmacol. 2020;98:51&#x2013;60. doi: 10.1139/cjpp-2019-0236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2019-0236</ArticleId><ArticleId IdType="pubmed">31369712</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. Ph. D. Thesis. University of Louisville; Louisville, KY, USA: 2018. Effects of Hydrogen Sulfide in Hyperhomocysteinemia-Mediated Skeletal Muscle Myopathy.</Citation></Reference><Reference><Citation>Laha A., Majumder A., Singh M., Tyagi S.C. Connecting homocysteine and obesity through pyroptosis, gut microbiome, epigenetics, peroxisome proliferator-activated receptor &#x3b3;, and zinc finger protein 407. Can. J. Physiol. Pharmacol. 2018;96:971&#x2013;976. doi: 10.1139/cjpp-2018-0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2018-0037</ArticleId><ArticleId IdType="pubmed">29890083</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Homme R.P., Laha A., Tyagi S.C. Remote ischemic conditioning as a cytoprotective strategy in vasculopathies during hyperhomocysteinemia: An emerging research perspective. J. Cell Biochem. 2019;120:77&#x2013;92. doi: 10.1002/jcb.27603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.27603</ArticleId><ArticleId IdType="pubmed">30272816</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment. Antioxidants. 2023;12:1520. doi: 10.3390/antiox12081520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12081520</ArticleId><ArticleId IdType="pmc">PMC10451792</ArticleId><ArticleId IdType="pubmed">37627515</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak K.B., Sajitha I.S., Kumar T.R.S., Chakraborty S. Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells. Cell Death Dis. 2018;9:18. doi: 10.1038/s41419-017-0036-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0036-1</ArticleId><ArticleId IdType="pmc">PMC5833819</ArticleId><ArticleId IdType="pubmed">29339729</ArticleId></ArticleIdList></Reference><Reference><Citation>Farber S., Diamond L.K. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N. Engl. J. Med. 1948;238:787&#x2013;793. doi: 10.1056/NEJM194806032382301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM194806032382301</ArticleId><ArticleId IdType="pubmed">18860765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646&#x2013;674. doi: 10.1016/j.cell.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.013</ArticleId><ArticleId IdType="pubmed">21376230</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller D.R. A tribute to Sidney Farber&#x2014;The father of modern chemotherapy. Br. J. Haematol. 2006;134:20&#x2013;26. doi: 10.1111/j.1365-2141.2006.06119.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2006.06119.x</ArticleId><ArticleId IdType="pubmed">16803563</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn M.J., Freeman M., Huennekens F.M. Inhibition of dihydrofolic reductase by aminopterin and amethopterin. Proc. Soc. Exp. Biol. Med. 1958;97:429&#x2013;431. doi: 10.3181/00379727-97-23764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-97-23764</ArticleId><ArticleId IdType="pubmed">13518295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernasocchi T., Mostoslavsky R. Subcellular one carbon metabolism in cancer, aging and epigenetics. Front. Epigenetics Epigenom. 2024;2:1451971. doi: 10.3389/freae.2024.1451971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/freae.2024.1451971</ArticleId><ArticleId IdType="pmc">PMC11375787</ArticleId><ArticleId IdType="pubmed">39239102</ArticleId></ArticleIdList></Reference><Reference><Citation>Annibal A., Tharyan R.G., Schonewolff M.F., Tam H., Latza C., Auler M.M.K., Gr&#xf6;nke S., Partridge L., Antebi A. Regulation of the one carbon folate cycle as a shared metabolic signature of longevity. Nat. Commun. 2021;12:3486. doi: 10.1038/s41467-021-23856-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23856-9</ArticleId><ArticleId IdType="pmc">PMC8190293</ArticleId><ArticleId IdType="pubmed">34108489</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.C., Holman D.M., Boehm J.E., Peipins L.A., Grossman M., Henley S.J. Age and cancer risk: A potentially modifiable relationship. Am. J. Prev. Med. 2014;46:S7&#x2013;S15. doi: 10.1016/j.amepre.2013.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2013.10.029</ArticleId><ArticleId IdType="pmc">PMC4544764</ArticleId><ArticleId IdType="pubmed">24512933</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., Sung B., Aggarwal B.B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008;25:2097&#x2013;2116. doi: 10.1007/s11095-008-9661-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-008-9661-9</ArticleId><ArticleId IdType="pmc">PMC2515569</ArticleId><ArticleId IdType="pubmed">18626751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bano S., Majumder A., Srivastava A., Nayak K.B. Deciphering the Potentials of Cardamom in Cancer Prevention and Therapy: From Kitchen to Clinic. Biomolecules. 2024;14:1166. doi: 10.3390/biom14091166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom14091166</ArticleId><ArticleId IdType="pmc">PMC11430645</ArticleId><ArticleId IdType="pubmed">39334932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionaki E., Ploumi C., Tavernarakis N. One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration. Cells. 2022;11:214. doi: 10.3390/cells11020214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11020214</ArticleId><ArticleId IdType="pmc">PMC8773781</ArticleId><ArticleId IdType="pubmed">35053330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad N.S., Yedluri R., Addepalli P., Gottumukkala S.R., Digumarti R.R., Kutala V.K. Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol. Cell. Biochem. 2011;349:159&#x2013;167. doi: 10.1007/s11010-010-0670-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-010-0670-8</ArticleId><ArticleId IdType="pubmed">21113649</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein Geltink R.I., Pearce E.L. The importance of methionine metabolism. eLife. 2019;8:e47221. doi: 10.7554/eLife.47221.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.47221</ArticleId><ArticleId IdType="pmc">PMC6497440</ArticleId><ArticleId IdType="pubmed">31043227</ArticleId></ArticleIdList></Reference><Reference><Citation>Allowances R.D. Recommended Dietary Allowances. National Research Council-National Academy Press; Washington, DC, USA: 1989.</Citation></Reference><Reference><Citation>Sinclair L.V., Howden A.J., Brenes A., Spinelli L., Hukelmann J.L., Macintyre A.N., Liu X., Thomson S., Taylor P.M., Rathmell J.C., et al. Antigen receptor control of methionine metabolism in T cells. eLife. 2019;8:e44210. doi: 10.7554/eLife.44210.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.44210</ArticleId><ArticleId IdType="pmc">PMC6497464</ArticleId><ArticleId IdType="pubmed">30916644</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Tyagi S.C. Restoration of skeletal muscle homeostasis by hydrogen sulfide during hyperhomocysteinemia-mediated oxidative/ER stress condition (1) Can. J. Physiol. Pharmacol. 2019;97:441&#x2013;456. doi: 10.1139/cjpp-2018-0501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2018-0501</ArticleId><ArticleId IdType="pmc">PMC6719301</ArticleId><ArticleId IdType="pubmed">30422673</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Behera J., Jeremic N., Tyagi S.C. Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy. J. Cell Biochem. 2017;118:2108&#x2013;2117. doi: 10.1002/jcb.25841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.25841</ArticleId><ArticleId IdType="pmc">PMC6563903</ArticleId><ArticleId IdType="pubmed">27982479</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Fan T.W.M., Brandon J.A., Lane A.N., Higashi R.M. Rapid analysis of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) isotopologues in stable isotope-resolved metabolomics (SIRM) using direct infusion nanoelectrospray ultra-high-resolution Fourier transform mass spectrometry (DI-nESI-UHR-FTMS) Anal. Chim. Acta. 2021;1181:338873. doi: 10.1016/j.aca.2021.338873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338873</ArticleId><ArticleId IdType="pmc">PMC8992776</ArticleId><ArticleId IdType="pubmed">34556237</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrubsole M.J., Wagner C., Zhu X., Hou L., Loukachevitch L.V., Ness R.M., Zheng W. Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex. Am. J. Cancer Res. 2015;5:458&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300688</ArticleId><ArticleId IdType="pubmed">25628954</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco C.M., Cervantes M., Fustin J.M., Ito K., Ceglia N., Samad M., Shi J., Koronowski K.B., Forne I., Ranjit S., et al. S-adenosyl-l-homocysteine hydrolase links methionine metabolism to the circadian clock and chromatin remodeling. Sci. Adv. 2020;6:eabc5629. doi: 10.1126/sciadv.abc5629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5629</ArticleId><ArticleId IdType="pmc">PMC7744083</ArticleId><ArticleId IdType="pubmed">33328229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.O., Wang L., Kuo Y.M., Andrews A.J., Gupta S., Kruger W.D. S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice. Mol. Genet. Metab. Rep. 2018;15:15&#x2013;21. doi: 10.1016/j.ymgmr.2018.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgmr.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC6047060</ArticleId><ArticleId IdType="pubmed">30023284</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., Behera J., Theilen N.T., George A.K., Tyagi N., Metreveli N., Tyagi S.C. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury. Am. J. Physiol. Cell Physiol. 2018;315:C609&#x2013;C622. doi: 10.1152/ajpcell.00147.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00147.2018</ArticleId><ArticleId IdType="pmc">PMC6293052</ArticleId><ArticleId IdType="pubmed">30110564</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbodio J.I., Snyder S.H., Paul B.D. Regulators of the transsulfuration pathway. Br. J. Pharmacol. 2019;176:583&#x2013;593. doi: 10.1111/bph.14446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14446</ArticleId><ArticleId IdType="pmc">PMC6346075</ArticleId><ArticleId IdType="pubmed">30007014</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowczyk K., Piechocka J., G&#x142;owacki R., Dhar I., Midtun &#xd8;., Tell G.S., Ueland P.M., Nyg&#xe5;rd O., Jakubowski H. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: The WENBIT trial. J. Intern. Med. 2019;285:232&#x2013;244. doi: 10.1111/joim.12834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12834</ArticleId><ArticleId IdType="pmc">PMC6378604</ArticleId><ArticleId IdType="pubmed">30193001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Chan K.T., Huang X., Cerra C., Blake S., Trigos A.S., Anderson D., Creek D.J., De Souza D.P., Wang X., et al. Cystathionine-&#x3b2;-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation. eLife. 2022;11:e71929. doi: 10.7554/eLife.71929.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.71929</ArticleId><ArticleId IdType="pmc">PMC9236611</ArticleId><ArticleId IdType="pubmed">35758651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura H. Production and physiological effects of hydrogen sulfide. Antioxid. Redox Signal. 2014;20:783&#x2013;793. doi: 10.1089/ars.2013.5309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5309</ArticleId><ArticleId IdType="pmc">PMC3910667</ArticleId><ArticleId IdType="pubmed">23581969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuhra K., Augsburger F., Majtan T., Szabo C. Cystathionine-&#x3b2;-Synthase: Molecular Regulation and Pharmacological Inhibition. Biomolecules. 2020;10:697. doi: 10.3390/biom10050697.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10050697</ArticleId><ArticleId IdType="pmc">PMC7277093</ArticleId><ArticleId IdType="pubmed">32365821</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavuoto P., Fenech M.F. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat. Rev. 2012;38:726&#x2013;736. doi: 10.1016/j.ctrv.2012.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2012.01.004</ArticleId><ArticleId IdType="pubmed">22342103</ArticleId></ArticleIdList></Reference><Reference><Citation>Locasale J.W. Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nat. Rev. Cancer. 2013;13:572&#x2013;583. doi: 10.1038/nrc3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3557</ArticleId><ArticleId IdType="pmc">PMC3806315</ArticleId><ArticleId IdType="pubmed">23822983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Vousden K.H. Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer. 2016;16:650&#x2013;662. doi: 10.1038/nrc.2016.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc.2016.81</ArticleId><ArticleId IdType="pubmed">27634448</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiducci G., Paone A., Tramonti A., Giardina G., Rinaldo S., Bouzidi A., Magnifico M.C., Marani M., Menendez J.A., Fatica A., et al. The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism. Nucleic Acids Res. 2019;47:4240&#x2013;4254. doi: 10.1093/nar/gkz129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz129</ArticleId><ArticleId IdType="pmc">PMC6486632</ArticleId><ArticleId IdType="pubmed">30809670</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakkar D., Sancenon V., Taguiam M.M., Guan S., Wu Z., Ng E., Paszkiewicz K.H., Ingram P.J., Boyd-Kirkup J.D. 10D1F, an Anti-HER3 Antibody that Uniquely Blocks the Receptor Heterodimerization Interface, Potently Inhibits Tumor Growth Across a Broad Panel of Tumor Models. Mol. Cancer Ther. 2020;19:490&#x2013;501. doi: 10.1158/1535-7163.MCT-19-0515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-19-0515</ArticleId><ArticleId IdType="pubmed">31911530</ArticleId></ArticleIdList></Reference><Reference><Citation>Labuschagne C.F., van den Broek N.J., Mackay G.M., Vousden K.H., Maddocks O.D. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep. 2014;7:1248&#x2013;1258. doi: 10.1016/j.celrep.2014.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.04.045</ArticleId><ArticleId IdType="pubmed">24813884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducker G.S., Chen L., Morscher R.J., Ghergurovich J.M., Esposito M., Teng X., Kang Y., Rabinowitz J.D. Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. Cell Metab. 2016;23:1140&#x2013;1153. doi: 10.1016/j.cmet.2016.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.04.016</ArticleId><ArticleId IdType="pmc">PMC4909566</ArticleId><ArticleId IdType="pubmed">27211901</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuvalov O., Petukhov A., Daks A., Fedorova O., Vasileva E., Barlev N.A. One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy. Oncotarget. 2017;8:23955&#x2013;23977. doi: 10.18632/oncotarget.15053.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15053</ArticleId><ArticleId IdType="pmc">PMC5410357</ArticleId><ArticleId IdType="pubmed">28177894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane A.N., Fan T.W. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 2015;43:2466&#x2013;2485. doi: 10.1093/nar/gkv047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv047</ArticleId><ArticleId IdType="pmc">PMC4344498</ArticleId><ArticleId IdType="pubmed">25628363</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vitto H., Arachchige D.B., Richardson B.C., French J.B. The Intersection of Purine and Mitochondrial Metabolism in Cancer. Cells. 2021;10:2603. doi: 10.3390/cells10102603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10102603</ArticleId><ArticleId IdType="pmc">PMC8534091</ArticleId><ArticleId IdType="pubmed">34685583</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrova B., Maynard A.G., Wang P., Kanarek N. Regulatory mechanisms of one-carbon metabolism enzymes. J. Biol. Chem. 2023;299:105457. doi: 10.1016/j.jbc.2023.105457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.105457</ArticleId><ArticleId IdType="pmc">PMC10758965</ArticleId><ArticleId IdType="pubmed">37949226</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezo Y., Elder K., Clement A., Clement P. Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles. Biomolecules. 2022;12:197. doi: 10.3390/biom12020197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12020197</ArticleId><ArticleId IdType="pmc">PMC8961567</ArticleId><ArticleId IdType="pubmed">35204698</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A.M., Ye J. Reprogramming of serine, glycine and one-carbon metabolism in cancer. Biochim. Et Biophys. Acta Mol. Basis Dis. 2020;1866:165841. doi: 10.1016/j.bbadis.2020.165841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.165841</ArticleId><ArticleId IdType="pmc">PMC7442608</ArticleId><ArticleId IdType="pubmed">32439610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason J.B., Levesque T. Folate: Effects on carcinogenesis and the potential for cancer chemoprevention. Oncology. 1996;10</Citation><ArticleIdList><ArticleId IdType="pubmed">8953590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.I. Does a high folate intake increase the risk of breast cancer? Nutr. Rev. 2006;64:468&#x2013;475. doi: 10.1111/j.1753-4887.2006.tb00178.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1753-4887.2006.tb00178.x</ArticleId><ArticleId IdType="pubmed">17063929</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Li H., Deng H., Wang Z. Association of One-Carbon Metabolism-Related Vitamins (Folate, B6, B12), Homocysteine and Methionine With the Risk of Lung Cancer: Systematic Review and Meta-Analysis. Front. Oncol. 2018;8:493. doi: 10.3389/fonc.2018.00493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2018.00493</ArticleId><ArticleId IdType="pmc">PMC6220054</ArticleId><ArticleId IdType="pubmed">30430082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ess&#xe9;n A., Santaolalla A., Garmo H., Hammar N., Walldius G., Jungner I., Malmstr&#xf6;m H., Holmberg L., Van Hemelrijck M. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort. Cancer Causes Control. 2019;30:603&#x2013;615. doi: 10.1007/s10552-019-01170-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-019-01170-6</ArticleId><ArticleId IdType="pubmed">31020446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason J.B., Dickstein A., Jacques P.F., Haggarty P., Selhub J., Dallal G., Rosenberg I.H. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: A hypothesis. Cancer Epidemiol. Biomark. Prev. 2007;16:1325&#x2013;1329. doi: 10.1158/1055-9965.EPI-07-0329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-07-0329</ArticleId><ArticleId IdType="pubmed">17626997</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt J.F., Pedersen L., Nexo E., S&#xf8;rensen H.T. Elevated plasma vitamin B12 levels as a marker for cancer: A population-based cohort study. J. Natl. Cancer Inst. 2013;105:1799&#x2013;1805. doi: 10.1093/jnci/djt315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djt315</ArticleId><ArticleId IdType="pmc">PMC3848986</ArticleId><ArticleId IdType="pubmed">24249744</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt J.F.H., S&#xf8;rensen H.T., Horsfall L.J., Petersen I. Elevated Vitamin B12 Levels and Cancer Risk in UK Primary Care: A THIN Database Cohort Study. Cancer Epidemiol. Biomark. Prev. 2019;28:814&#x2013;821. doi: 10.1158/1055-9965.EPI-17-1136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-17-1136</ArticleId><ArticleId IdType="pubmed">30642843</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe8;s E., Serraj K., Zhu J., Vermorken A.J. The pathophysiology of elevated vitamin B12 in clinical practice. QJM. 2013;106:505&#x2013;515. doi: 10.1093/qjmed/hct051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hct051</ArticleId><ArticleId IdType="pubmed">23447660</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin S.M., Metcalfe C., Refsum H., Lewis S.J., Zuccolo L., Smith G.D., Chen L., Harris R., Davis M., Marsden G., et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: A case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomark. Prev. 2010;19:1632&#x2013;1642. doi: 10.1158/1055-9965.EPI-10-0180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-10-0180</ArticleId><ArticleId IdType="pmc">PMC3759018</ArticleId><ArticleId IdType="pubmed">20501771</ArticleId></ArticleIdList></Reference><Reference><Citation>Gates S.B., Mendelsohn L.G., Shackelford K.A., Habeck L.L., Kursar J.D., Gossett L.S., Worzalla J.F., Shih C., Grindey G.B. Characterization of folate receptor from normal and neoplastic murine tissue: Influence of dietary folate on folate receptor expression. Clin. Cancer Res. 1996;2:1135&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pubmed">9816279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross J.F., Chaudhuri P.K., Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer. 1994;73:2432&#x2013;2443. doi: 10.1002/1097-0142(19940501)73:9&lt;2432::AID-CNCR2820730929&gt;3.0.CO;2-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(19940501)73:9&lt;2432::AID-CNCR2820730929&gt;3.0.CO;2-S</ArticleId><ArticleId IdType="pubmed">7513252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.I. Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies. Environ. Mol. Mutagen. 2004;44:10&#x2013;25. doi: 10.1002/em.20025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/em.20025</ArticleId><ArticleId IdType="pubmed">15199543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole B.F., Baron J.A., Sandler R.S., Haile R.W., Ahnen D.J., Bresalier R.S., McKeown-Eyssen G., Summers R.W., Rothstein R.I., Burke C.A., et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. Jama. 2007;297:2351&#x2013;2359. doi: 10.1001/jama.297.21.2351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.21.2351</ArticleId><ArticleId IdType="pubmed">17551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wipperman M.F., Montrose D.C., Gotto A.M., Jr., Hajjar D.P. Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health. Am. J. Pathol. 2019;189:492&#x2013;501. doi: 10.1016/j.ajpath.2018.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2018.11.013</ArticleId><ArticleId IdType="pmc">PMC6412382</ArticleId><ArticleId IdType="pubmed">30803496</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Steri V., Salangsang F., Moasser M. Abstract LB-326: The role of HER3 in HER2-amplified cancers other than breast cancers. Cancer Res. 2020;80:LB-326. doi: 10.1158/1538-7445.AM2020-LB-326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1538-7445.AM2020-LB-326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Mancuso A., Tong X., Ward P.S., Fan J., Rabinowitz J.D., Thompson C.B. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc. Natl. Acad. Sci. USA. 2012;109:6904&#x2013;6909. doi: 10.1073/pnas.1204176109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1204176109</ArticleId><ArticleId IdType="pmc">PMC3345000</ArticleId><ArticleId IdType="pubmed">22509023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Sahra I., Hoxhaj G., Ricoult S.J.H., Asara J.M., Manning B.D. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science. 2016;351:728&#x2013;733. doi: 10.1126/science.aad0489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad0489</ArticleId><ArticleId IdType="pmc">PMC4786372</ArticleId><ArticleId IdType="pubmed">26912861</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X., Orozco J.M., Saxton R.A., Condon K.J., Liu G.Y., Krawczyk P.A., Scaria S.M., Harper J.W., Gygi S.P., Sabatini D.M. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science. 2017;358:813&#x2013;818. doi: 10.1126/science.aao3265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao3265</ArticleId><ArticleId IdType="pmc">PMC5747364</ArticleId><ArticleId IdType="pubmed">29123071</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes A.P., Blenis J. A nexus for cellular homeostasis: The interplay between metabolic and signal transduction pathways. Curr. Opin. Biotechnol. 2015;34:110&#x2013;117. doi: 10.1016/j.copbio.2014.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2014.12.007</ArticleId><ArticleId IdType="pmc">PMC4490161</ArticleId><ArticleId IdType="pubmed">25562138</ArticleId></ArticleIdList></Reference><Reference><Citation>Audet-Walsh &#xc9;., Papadopoli D.J., Gravel S.P., Yee T., Bridon G., Caron M., Bourque G., Gigu&#xe8;re V., St-Pierre J. The PGC-1&#x3b1;/ERR&#x3b1; Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer. Cell Rep. 2016;14:920&#x2013;931. doi: 10.1016/j.celrep.2015.12.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.12.086</ArticleId><ArticleId IdType="pubmed">26804918</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Behra J., Singh M., Tyagi N., Tyagi S.C. Hyperhomocysteinemia-Mediated Endoplasmic Reticulum Stress in Skeletal Muscle Dysfunction via JNK/pro-inflammatory Pathway. FASEB J. 2018;32:538.4. doi: 10.1096/fasebj.2018.32.1_supplement.538.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2018.32.1_supplement.538.4</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducker G.S., Rabinowitz J.D. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017;25:27&#x2013;42. doi: 10.1016/j.cmet.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.08.009</ArticleId><ArticleId IdType="pmc">PMC5353360</ArticleId><ArticleId IdType="pubmed">27641100</ArticleId></ArticleIdList></Reference><Reference><Citation>DeNicola G.M., Chen P.H., Mullarky E., Sudderth J.A., Hu Z., Wu D., Tang H., Xie Y., Asara J.M., Huffman K.E., et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat. Genet. 2015;47:1475&#x2013;1481. doi: 10.1038/ng.3421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3421</ArticleId><ArticleId IdType="pmc">PMC4721512</ArticleId><ArticleId IdType="pubmed">26482881</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Ye J., Kamphorst J.J., Shlomi T., Thompson C.B., Rabinowitz J.D. Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 2014;510:298&#x2013;302. doi: 10.1038/nature13236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13236</ArticleId><ArticleId IdType="pmc">PMC4104482</ArticleId><ArticleId IdType="pubmed">24805240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Samanta D., Xiang L., Zhang H., Hu H., Chen I., Bullen J.W., Semenza G.L. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc. Natl. Acad. Sci. USA. 2015;112:E4600&#x2013;E4609. doi: 10.1073/pnas.1513433112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1513433112</ArticleId><ArticleId IdType="pmc">PMC4547233</ArticleId><ArticleId IdType="pubmed">26229077</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama K., Nakaki T. Impaired glutathione synthesis in neurodegeneration. Int. J. Mol. Sci. 2013;14:21021&#x2013;21044. doi: 10.3390/ijms141021021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141021021</ArticleId><ArticleId IdType="pmc">PMC3821656</ArticleId><ArticleId IdType="pubmed">24145751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan M.K., Lekli I., Ray D., Yodoi J., Das D.K. Redox regulation of cell survival by the thioredoxin superfamily: An implication of redox gene therapy in the heart. Antioxid. Redox Signal. 2009;11:2741&#x2013;2758. doi: 10.1089/ars.2009.2683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2683</ArticleId><ArticleId IdType="pmc">PMC2821134</ArticleId><ArticleId IdType="pubmed">19583492</ArticleId></ArticleIdList></Reference><Reference><Citation>Dringen R., Gutterer J.M. Glutathione reductase from bovine brain. Methods Enzymol. 2002;348:281&#x2013;288. doi: 10.1016/s0076-6879(02)48646-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0076-6879(02)48646-6</ArticleId><ArticleId IdType="pubmed">11885281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert H.F. Redox control of enzyme activities by thiol/disulfide exchange. Methods Enzymol. 1984;107:330&#x2013;351. doi: 10.1016/0076-6879(84)07022-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0076-6879(84)07022-1</ArticleId><ArticleId IdType="pubmed">6239077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert H.F. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol. 1995;251:8&#x2013;28. doi: 10.1016/0076-6879(95)51107-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0076-6879(95)51107-5</ArticleId><ArticleId IdType="pubmed">7651233</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Bano S. How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer. Biomolecules. 2024;14:633. doi: 10.3390/biom14060633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom14060633</ArticleId><ArticleId IdType="pmc">PMC11201633</ArticleId><ArticleId IdType="pubmed">38927037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimura T., Birnbaum S.M., Winitz M., Greenstein J.P. Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Arch. Biochem. Biophys. 1959;81:448&#x2013;455. doi: 10.1016/0003-9861(59)90225-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-9861(59)90225-5</ArticleId><ArticleId IdType="pubmed">13638009</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman R.M., Erbe R.W. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc. Natl. Acad. Sci. USA. 1976;73:1523&#x2013;1527. doi: 10.1073/pnas.73.5.1523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.73.5.1523</ArticleId><ArticleId IdType="pmc">PMC430329</ArticleId><ArticleId IdType="pubmed">179090</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern B.C., Clark B.R., Hardy D.N., Halpern R.M., Smith R.A. The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc. Natl. Acad. 1974;71:1133&#x2013;1136. doi: 10.1073/pnas.71.4.1133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.71.4.1133</ArticleId><ArticleId IdType="pmc">PMC388177</ArticleId><ArticleId IdType="pubmed">4524624</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern P.H., Wallace C.D., Hoffman R.M. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J. Cell Physiol. 1984;119:29&#x2013;34. doi: 10.1002/jcp.1041190106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.1041190106</ArticleId><ArticleId IdType="pubmed">6707100</ArticleId></ArticleIdList></Reference><Reference><Citation>Booher K., Lin D.W., Borrego S.L., Kaiser P. Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells. Cell Cycle. 2012;11:4414&#x2013;4423. doi: 10.4161/cc.22767.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.22767</ArticleId><ArticleId IdType="pmc">PMC3552924</ArticleId><ArticleId IdType="pubmed">23159852</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., D&#x2019;Souza M., Jaimini A., Hazari P.P., Saw S., Pandey S., Singh D., Solanki Y., Kumar N., Mishra A.K., et al. A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors. Indian. J. Nucl. Med. 2016;31:93&#x2013;102. doi: 10.4103/0972-3919.178254.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-3919.178254</ArticleId><ArticleId IdType="pmc">PMC4815400</ArticleId><ArticleId IdType="pubmed">27095856</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto J., Han Q., Inubushi S., Sugisawa N., Hamada K., Nishino H., Miyake K., Kumamoto T., Matsuyama R., Bouvet M., et al. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells. Biochem. Biophys. Res. Commun. 2020;533:1034&#x2013;1038. doi: 10.1016/j.bbrc.2020.09.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.09.108</ArticleId><ArticleId IdType="pubmed">33019978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien E.C., Ghisolfi L., Geck R.C., Asara J.M., Toker A. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT. Sci. Signal. 2017;10:eaao6604. doi: 10.1126/scisignal.aao6604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aao6604</ArticleId><ArticleId IdType="pmc">PMC5808948</ArticleId><ArticleId IdType="pubmed">29259101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S., Epner D.E. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr. Cancer. 2000;38:123&#x2013;130. doi: 10.1207/S15327914NC381_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/S15327914NC381_17</ArticleId><ArticleId IdType="pubmed">11341037</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., Kafri R., Kirschner M.W., Clish C.B., Mootha V.K. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012;336:1040&#x2013;1044. doi: 10.1126/science.1218595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218595</ArticleId><ArticleId IdType="pmc">PMC3526189</ArticleId><ArticleId IdType="pubmed">22628656</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddocks O.D., Labuschagne C.F., Adams P.D., Vousden K.H. Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells. Mol. Cell. 2016;61:210&#x2013;221. doi: 10.1016/j.molcel.2015.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.12.014</ArticleId><ArticleId IdType="pmc">PMC4728077</ArticleId><ArticleId IdType="pubmed">26774282</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Behera J., Tyagi N., Tyagi S.C. Hydrogen sulfide improves postischemic neoangiogenesis in the hind limb of cystathionine-&#x3b2;-synthase mutant mice via PPAR-&#x3b3;/VEGF axis. Physiol. Rep. 2018;6:e13858. doi: 10.14814/phy2.13858.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13858</ArticleId><ArticleId IdType="pmc">PMC6119702</ArticleId><ArticleId IdType="pubmed">30175474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrmohamadi M., Liu X., Shestov A.A., Locasale J.W. Characterization of the usage of the serine metabolic network in human cancer. Cell Rep. 2014;9:1507&#x2013;1519. doi: 10.1016/j.celrep.2014.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.10.026</ArticleId><ArticleId IdType="pmc">PMC4317399</ArticleId><ArticleId IdType="pubmed">25456139</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishnoi K., Viswakarma N., Rana A., Rana B. Transcription Factors in Cancer Development and Therapy. Cancers. 2020;12:2296. doi: 10.3390/cancers12082296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12082296</ArticleId><ArticleId IdType="pmc">PMC7464564</ArticleId><ArticleId IdType="pubmed">32824207</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore R., Schutt C.R., Van Tine B.A. PHGDH as a mechanism for resistance in metabolically-driven cancers. Cancer Drug Resist. 2020;3:762&#x2013;774. doi: 10.20517/cdr.2020.46.</Citation><ArticleIdList><ArticleId IdType="doi">10.20517/cdr.2020.46</ArticleId><ArticleId IdType="pmc">PMC7840151</ArticleId><ArticleId IdType="pubmed">33511334</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson R., Jain M., Madhusudhan N., Sheppard N.G., Strittmatter L., Kampf C., Huang J., Asplund A., Mootha V.K. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat. Commun. 2014;5:3128. doi: 10.1038/ncomms4128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4128</ArticleId><ArticleId IdType="pmc">PMC4106362</ArticleId><ArticleId IdType="pubmed">24451681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G.Y., Haverty P.M., Li L., Kljavin N.M., Bourgon R., Lee J., Stern H., Modrusan Z., Seshagiri S., Zhang Z., et al. Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes. Cancer Res. 2014;74:3114&#x2013;3126. doi: 10.1158/0008-5472.CAN-13-2683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-13-2683</ArticleId><ArticleId IdType="pubmed">24755469</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez A., Tedeschi P.M., Bertino J.R. Overexpression of the mitochondrial folate and glycine-serine pathway: A new determinant of methotrexate selectivity in tumors. Cancer Res. 2013;73:478&#x2013;482. doi: 10.1158/0008-5472.CAN-12-3709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-3709</ArticleId><ArticleId IdType="pmc">PMC4083755</ArticleId><ArticleId IdType="pubmed">23135910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtinen L., Ketola K., M&#xe4;kel&#xe4; R., Mpindi J.P., Viitala M., Kallioniemi O., Iljin K. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion. Oncotarget. 2013;4:48&#x2013;63. doi: 10.18632/oncotarget.756.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.756</ArticleId><ArticleId IdType="pmc">PMC3702207</ArticleId><ArticleId IdType="pubmed">23295955</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Liu Y., He C., Tao L., He X., Song H., Zhang G. Increased MTHFD2 expression is associated with poor prognosis in breast cancer. Tumor Biol. 2014;35:8685&#x2013;8690. doi: 10.1007/s13277-014-2111-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-014-2111-x</ArticleId><ArticleId IdType="pubmed">24870594</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela-Moreiras G., P&#xe9;rez-Olleros L., Garc&#xed;a-Cuevas M., Ruiz-Roso B. Effects of ageing on folate metabolism in rats fed a long-term folate deficient diet. Int. J. Vitam. Nutr. Res. 1994;64:294&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">7883468</ArticleId></ArticleIdList></Reference><Reference><Citation>Challet E., Dumont S., Mehdi M.K., Allemann C., Bousser T., Gourmelen S., Sage-Ciocca D., Hicks D., P&#xe9;vet P., Claustrat B. Aging-like circadian disturbances in folate-deficient mice. Neurobiol. Aging. 2013;34:1589&#x2013;1598. doi: 10.1016/j.neurobiolaging.2012.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.11.021</ArticleId><ArticleId IdType="pubmed">23273571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon J.A., Boreham D.R., Rollo C.D. A complex dietary supplement extends longevity of mice. J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:275&#x2013;279. doi: 10.1093/gerona/60.3.275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/60.3.275</ArticleId><ArticleId IdType="pubmed">15860460</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabrizio P., Longo V.D. The chronological life span of Saccharomyces cerevisiae. Methods Mol. Biol. 2007;371:89&#x2013;95. doi: 10.1007/978-1-59745-361-5_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-59745-361-5_8</ArticleId><ArticleId IdType="pubmed">17634576</ArticleId></ArticleIdList></Reference><Reference><Citation>Troen A.M., French E.E., Roberts J.F., Selhub J., Ordovas J.M., Parnell L.D., Lai C.Q. Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet. Age. 2007;29:29&#x2013;39. doi: 10.1007/s11357-006-9018-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-006-9018-4</ArticleId><ArticleId IdType="pmc">PMC2267680</ArticleId><ArticleId IdType="pubmed">19424828</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.A., Buehner G., Chang Y., Harper J.M., Sigler R., Smith-Wheelock M. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell. 2005;4:119&#x2013;125. doi: 10.1111/j.1474-9726.2005.00152.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2005.00152.x</ArticleId><ArticleId IdType="pmc">PMC7159399</ArticleId><ArticleId IdType="pubmed">15924568</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.E., Johnson F.B. Methionine restriction activates the retrograde response and confers both stress tolerance and lifespan extension to yeast, mouse and human cells. PLoS ONE. 2014;9:e97729. doi: 10.1371/journal.pone.0097729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097729</ArticleId><ArticleId IdType="pmc">PMC4022668</ArticleId><ArticleId IdType="pubmed">24830393</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabreiro F., Au C., Leung K.Y., Vergara-Irigaray N., Cochem&#xe9; H.M., Noori T., Weinkove D., Schuster E., Greene N.D., Gems D. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013;153:228&#x2013;239. doi: 10.1016/j.cell.2013.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.02.035</ArticleId><ArticleId IdType="pmc">PMC3898468</ArticleId><ArticleId IdType="pubmed">23540700</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz A., Caro P., Ayala V., Portero-Otin M., Pamplona R., Barja G. Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins. FASEB J. 2006;20:1064&#x2013;1073. doi: 10.1096/fj.05-5568com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5568com</ArticleId><ArticleId IdType="pubmed">16770005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrakhovitch E.A., Tabibzadeh S. Homocysteine and age-associated disorders. Ageing Res. Rev. 2019;49:144&#x2013;164. doi: 10.1016/j.arr.2018.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2018.10.010</ArticleId><ArticleId IdType="pubmed">30391754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabil H., Kabil O., Banerjee R., Harshman L.G., Pletcher S.D. Increased transsulfuration mediates longevity and dietary restriction in Drosophila. Proc. Natl. Acad. Sci. USA. 2011;108:16831&#x2013;16836. doi: 10.1073/pnas.1102008108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102008108</ArticleId><ArticleId IdType="pmc">PMC3189063</ArticleId><ArticleId IdType="pubmed">21930912</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaposhnikov M., Proshkina E., Koval L., Zemskaya N., Zhavoronkov A., Moskalev A. Overexpression of CBS and CSE genes affects lifespan, stress resistance and locomotor activity in Drosophila melanogaster. Aging. 2018;10:3260&#x2013;3272. doi: 10.18632/aging.101630.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101630</ArticleId><ArticleId IdType="pmc">PMC6286861</ArticleId><ArticleId IdType="pubmed">30408770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J., Noormohammadi A., Koyuncu S., Calculli G., Simic M.S., Herholz M., Trifunovic A., Vilchez D. Prostaglandin signals from adult germ stem cells delay somatic aging of Caenorhabditis elegans. Nat. Metab. 2019;1:790&#x2013;810. doi: 10.1038/s42255-019-0097-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-019-0097-9</ArticleId><ArticleId IdType="pmc">PMC6726479</ArticleId><ArticleId IdType="pubmed">31485561</ArticleId></ArticleIdList></Reference><Reference><Citation>Friso S., Udali S., De Santis D., Choi S.W. One-carbon metabolism and epigenetics. Mol. Asp. Med. 2017;54:28&#x2013;36. doi: 10.1016/j.mam.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2016.11.007</ArticleId><ArticleId IdType="pubmed">27876555</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoccoro A., Lari M., Migliore L., Copped&#xe8; F. Associations between Circulating Biomarkers of One-Carbon Metabolism and Mitochondrial D-Loop Region Methylation Levels. Epigenomes. 2024;8:38. doi: 10.3390/epigenomes8040038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/epigenomes8040038</ArticleId><ArticleId IdType="pmc">PMC11503383</ArticleId><ArticleId IdType="pubmed">39449362</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzitoyeva S., Chen H., Manev H. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol. Aging. 2012;33:2881&#x2013;2891. doi: 10.1016/j.neurobiolaging.2012.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.006</ArticleId><ArticleId IdType="pmc">PMC3462297</ArticleId><ArticleId IdType="pubmed">22445327</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science. 2006;311:1257. doi: 10.1126/science.1122446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1122446</ArticleId><ArticleId IdType="pubmed">16456035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartke A. Pleiotropic effects of growth hormone signaling in aging. Trends Endocrinol. Metab. 2011;22:437&#x2013;442. doi: 10.1016/j.tem.2011.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2011.07.004</ArticleId><ArticleId IdType="pmc">PMC4337825</ArticleId><ArticleId IdType="pubmed">21852148</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D.J., Childs B.G., Durik M., Wijers M.E., Sieben C.J., Zhong J., Saltness R.A., Jeganathan K.B., Verzosa G.C., Pezeshki A., et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016;530:184&#x2013;189. doi: 10.1038/nature16932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16932</ArticleId><ArticleId IdType="pmc">PMC4845101</ArticleId><ArticleId IdType="pubmed">26840489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull C., Fenech M. Genome-health nutrigenomics and nutrigenetics: Nutritional requirements or &#x2018;nutriomes&#x2019; for chromosomal stability and telomere maintenance at the individual level: Symposium on &#x2018;Diet and cancer&#x2019;. Proc. Nutr. Soc. 2008;67:146&#x2013;156. doi: 10.1017/S0029665108006988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665108006988</ArticleId><ArticleId IdType="pubmed">18412988</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores C.J., Fenech M., O&#x2019;Callaghan N.J. Telomere dynamics: The influence of folate and DNA methylation. Ann. N. Y. Acad. Sci. 2011;1229:76&#x2013;88. doi: 10.1111/j.1749-6632.2011.06101.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2011.06101.x</ArticleId><ArticleId IdType="pubmed">21793842</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul L. Diet, nutrition and telomere length. J. Nutr. Biochem. 2011;22:895&#x2013;901. doi: 10.1016/j.jnutbio.2010.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2010.12.001</ArticleId><ArticleId IdType="pubmed">21429730</ArticleId></ArticleIdList></Reference><Reference><Citation>Go Y.M., Jones D.P. Redox theory of aging: Implications for health and disease. Clin. Sci. 2017;131:1669&#x2013;1688. doi: 10.1042/CS20160897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20160897</ArticleId><ArticleId IdType="pmc">PMC5773128</ArticleId><ArticleId IdType="pubmed">28667066</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz T.J., Zarse K., Voigt A., Urban N., Birringer M., Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007;6:280&#x2013;293. doi: 10.1016/j.cmet.2007.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2007.08.011</ArticleId><ArticleId IdType="pubmed">17908557</ArticleId></ArticleIdList></Reference><Reference><Citation>Tello-Padilla M.F., Perez-Gonzalez A.Y., Canizal-Garc&#xed;a M., Gonz&#xe1;lez-Hern&#xe1;ndez J.C., Cortes-Rojo C., Olivares-Marin I.K., Madrigal-Perez L.A. Glutathione levels influence chronological life span of Saccharomyces cerevisiae in a glucose-dependent manner. Yeast. 2018;35:387&#x2013;396. doi: 10.1002/yea.3302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.3302</ArticleId><ArticleId IdType="pubmed">29277922</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr W.C., Radyuk S.N., Prabhudesai L., Toroser D., Benes J.J., Luchak J.M., Mockett R.J., Rebrin I., Hubbard J.G., Sohal R.S. Overexpression of glutamate-cysteine ligase extends life span in Drosophila melanogaster. J. Biol. Chem. 2005;280:37331&#x2013;37338. doi: 10.1074/jbc.M508272200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M508272200</ArticleId><ArticleId IdType="pubmed">16148000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusarov I., Shamovsky I., Pani B., Gautier L., Eremina S., Katkova-Zhukotskaya O., Mironov A., Makarov A., Nudler E. Dietary thiols accelerate aging of C. elegans. Nat. Commun. 2021;12:4336. doi: 10.1038/s41467-021-24634-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24634-3</ArticleId><ArticleId IdType="pmc">PMC8282788</ArticleId><ArticleId IdType="pubmed">34267196</ArticleId></ArticleIdList></Reference><Reference><Citation>Berben L., Floris G., Wildiers H., Hatse S. Cancer and Aging: Two Tightly Interconnected Biological Processes. Cancers. 2021;13:1400. doi: 10.3390/cancers13061400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13061400</ArticleId><ArticleId IdType="pmc">PMC8003441</ArticleId><ArticleId IdType="pubmed">33808654</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou Ghanem A., Hussayni Y., Kadbey R., Ratel Y., Yehya S., Khouzami L., Ghadieh H.E., Kanaan A., Azar S., Harb F. Exploring the complexities of 1C metabolism: Implications in aging and neurodegenerative diseases. Front. Aging Neurosci. 2023;15:1322419. doi: 10.3389/fnagi.2023.1322419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2023.1322419</ArticleId><ArticleId IdType="pmc">PMC10794399</ArticleId><ArticleId IdType="pubmed">38239489</ArticleId></ArticleIdList></Reference><Reference><Citation>Crider K.S., Qi Y.P., Yeung L.F., Mai C.T., Head Zauche L., Wang A., Daniels K., Williams J.L. Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies. Annu. Rev. Nutr. 2022;42:423&#x2013;452. doi: 10.1146/annurev-nutr-043020-091647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-043020-091647</ArticleId><ArticleId IdType="pmc">PMC9875360</ArticleId><ArticleId IdType="pubmed">35995050</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Chen J. One-carbon metabolism and breast cancer: An epidemiological perspective. J. Genet. Genom. 2009;36:203&#x2013;214. doi: 10.1016/S1673-8527(08)60108-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1673-8527(08)60108-3</ArticleId><ArticleId IdType="pmc">PMC2694962</ArticleId><ArticleId IdType="pubmed">19376481</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Tyagi S.C. Hydrogen Sulfide Improves Hyperhomocysteinemia-Mediated Impairment of Angiogenesis in Skeletal Muscle. FASEB J. 2018;32:573.2. doi: 10.1096/fasebj.2018.32.1_supplement.573.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2018.32.1_supplement.573.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Selhub J., Jacques P.F., Wilson P.W., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Jama. 1993;270:2693&#x2013;2698. doi: 10.1001/jama.1993.03510220049033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510220049033</ArticleId><ArticleId IdType="pubmed">8133587</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebrin I., Sohal R.S. Pro-oxidant shift in glutathione redox state during aging. Adv. Drug Deliv. Rev. 2008;60:1545&#x2013;1552. doi: 10.1016/j.addr.2008.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2008.06.001</ArticleId><ArticleId IdType="pmc">PMC2585506</ArticleId><ArticleId IdType="pubmed">18652861</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrisi F., D&#x2019;Aprile S., Denaro S., Pavone A.M., Alberghina C., Zappal&#xe0; A., Giuffrida R., Salvatorelli L., Broggi G., Magro G.G., et al. Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms. Antioxidants. 2023;12:220. doi: 10.3390/antiox12020220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12020220</ArticleId><ArticleId IdType="pmc">PMC9952003</ArticleId><ArticleId IdType="pubmed">36829778</ArticleId></ArticleIdList></Reference><Reference><Citation>Heard E., Martienssen R.A. Transgenerational epigenetic inheritance: Myths and mechanisms. Cell. 2014;157:95&#x2013;109. doi: 10.1016/j.cell.2014.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.02.045</ArticleId><ArticleId IdType="pmc">PMC4020004</ArticleId><ArticleId IdType="pubmed">24679529</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchegaray J.P., Mostoslavsky R. Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes. Mol. Cell. 2016;62:695&#x2013;711. doi: 10.1016/j.molcel.2016.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.029</ArticleId><ArticleId IdType="pmc">PMC4893201</ArticleId><ArticleId IdType="pubmed">27259202</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentch S.J., Mehrmohamadi M., Huang L., Liu X., Gupta D., Mattocks D., G&#xf3;mez Padilla P., Ables G., Bamman M.M., Thalacker-Mercer A.E., et al. Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. Cell Metab. 2015;22:861&#x2013;873. doi: 10.1016/j.cmet.2015.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.08.024</ArticleId><ArticleId IdType="pmc">PMC4635069</ArticleId><ArticleId IdType="pubmed">26411344</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore L.D., Le T., Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23&#x2013;38. doi: 10.1038/npp.2012.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.112</ArticleId><ArticleId IdType="pmc">PMC3521964</ArticleId><ArticleId IdType="pubmed">22781841</ArticleId></ArticleIdList></Reference><Reference><Citation>Saavedra O.M., Isakovic L., Llewellyn D.B., Zhan L., Bernstein N., Claridge S., Raeppel F., Vaisburg A., Elowe N., Petschner A.J., et al. SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorganic Med. Chem. Lett. 2009;19:2747&#x2013;2751. doi: 10.1016/j.bmcl.2009.03.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2009.03.113</ArticleId><ArticleId IdType="pubmed">19362833</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Gong Y., Meng H., Li C., Xue L. Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor. Clin. Epigenetics. 2020;12:72. doi: 10.1186/s13148-020-00862-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-00862-0</ArticleId><ArticleId IdType="pmc">PMC7245796</ArticleId><ArticleId IdType="pubmed">32448308</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J., You Y., Chen X., Tang Y., Chen Y., Liu Q., Liu Z., Ling W. Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine. Front. Nutr. 2022;9:918698. doi: 10.3389/fnut.2022.918698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.918698</ArticleId><ArticleId IdType="pmc">PMC9399787</ArticleId><ArticleId IdType="pubmed">36034911</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yang Q. The roles of EZH2 in cancer and its inhibitors. Med. Oncol. 2023;40:167. doi: 10.1007/s12032-023-02025-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12032-023-02025-6</ArticleId><ArticleId IdType="pmc">PMC10162908</ArticleId><ArticleId IdType="pubmed">37148376</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Scott H., Carlsson S.V., Sjoberg D.D., Cerundolo L., Lilja H., Prevo R., Rieunier G., Macaulay V., Higgins G.S., et al. Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy. Prostate. 2019;79:1079&#x2013;1089. doi: 10.1002/pros.23817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pros.23817</ArticleId><ArticleId IdType="pmc">PMC6563086</ArticleId><ArticleId IdType="pubmed">31104332</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X., Liu Y., Hsu Y.J., Fujiwara Y., Kim J., Mao X., Yuan G.C., Orkin S.H. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell. 2008;32:491&#x2013;502. doi: 10.1016/j.molcel.2008.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.10.016</ArticleId><ArticleId IdType="pmc">PMC2630502</ArticleId><ArticleId IdType="pubmed">19026780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Su&#xe1;rez M., Aguilar-Arnal L. Histone methylation: At the crossroad between circadian rhythms in transcription and metabolism. Front. Genet. 2024;15:1343030. doi: 10.3389/fgene.2024.1343030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2024.1343030</ArticleId><ArticleId IdType="pmc">PMC11137191</ArticleId><ArticleId IdType="pubmed">38818037</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Wu H., Qimuge N., Pang W., Li X., Chu G., Yang G. MAT2A promotes porcine adipogenesis by mediating H3K27me3 at Wnt10b locus and repressing Wnt/&#x3b2;-catenin signaling. Biochim. Et Biophys. Acta BBA Mol. Cell Biol. Lipids. 2018;1863:132&#x2013;142. doi: 10.1016/j.bbalip.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2017.11.001</ArticleId><ArticleId IdType="pubmed">29133280</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Yang Y., Buettner R., Rosen S.T. Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy. Curr. Opin. Oncol. 2022;34:546&#x2013;551. doi: 10.1097/CCO.0000000000000870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCO.0000000000000870</ArticleId><ArticleId IdType="pmc">PMC9365249</ArticleId><ArticleId IdType="pubmed">35788128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kera Y., Katoh Y., Ohta M., Matsumoto M., Takano-Yamamoto T., Igarashi K. Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus. J. Biol. Chem. 2013;288:13592&#x2013;13601. doi: 10.1074/jbc.M112.429738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.429738</ArticleId><ArticleId IdType="pmc">PMC3650394</ArticleId><ArticleId IdType="pubmed">23539621</ArticleId></ArticleIdList></Reference><Reference><Citation>Topart C., Werner E., Arimondo P.B. Wandering along the epigenetic timeline. Clin. Epigenetics. 2020;12:97. doi: 10.1186/s13148-020-00893-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-00893-7</ArticleId><ArticleId IdType="pmc">PMC7330981</ArticleId><ArticleId IdType="pubmed">32616071</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto-Palma C., Niedernhofer L.J., Faulk C.D., Dong X. Epigenetics, DNA damage, and aging. J. Clin. Investig. 2022;132:e158446. doi: 10.1172/JCI158446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI158446</ArticleId><ArticleId IdType="pmc">PMC9374376</ArticleId><ArticleId IdType="pubmed">35968782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J., Benjamin D.I., Kim S., Salvi J.S., Dhaliwal G., Lam R., Goshayeshi A., Brett J.O., Liu L., Rando T.A. Depletion of SAM leading to loss of heterochromatin drives muscle stem cell ageing. Nat. Metab. 2024;6:153&#x2013;168. doi: 10.1038/s42255-023-00955-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-023-00955-z</ArticleId><ArticleId IdType="pmc">PMC10976122</ArticleId><ArticleId IdType="pubmed">38243132</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh D., Gil J. Senescence and aging: Causes, consequences, and therapeutic avenues. J. Cell Biol. 2018;217:65&#x2013;77. doi: 10.1083/jcb.201708092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201708092</ArticleId><ArticleId IdType="pmc">PMC5748990</ArticleId><ArticleId IdType="pubmed">29114066</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong D., Cai G.Y., Ning Y.C., Wang J.C., Lv Y., Hong Q., Cui S.Y., Fu B., Guo Y.N., Chen X.M. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling. Oncotarget. 2017;8:16109&#x2013;16121. doi: 10.18632/oncotarget.14884.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14884</ArticleId><ArticleId IdType="pmc">PMC5369951</ArticleId><ArticleId IdType="pubmed">28147330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattison J.A., Colman R.J., Beasley T.M., Allison D.B., Kemnitz J.W., Roth G.S., Ingram D.K., Weindruch R., de Cabo R., Anderson R.M. Caloric restriction improves health and survival of rhesus monkeys. Nat. Commun. 2017;8:14063. doi: 10.1038/ncomms14063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14063</ArticleId><ArticleId IdType="pmc">PMC5247583</ArticleId><ArticleId IdType="pubmed">28094793</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson R.M., Shanmuganayagam D., Weindruch R. Caloric restriction and aging: Studies in mice and monkeys. Toxicol. Pathol. 2009;37:47&#x2013;51. doi: 10.1177/0192623308329476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0192623308329476</ArticleId><ArticleId IdType="pmc">PMC3734859</ArticleId><ArticleId IdType="pubmed">19075044</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M.E., Shi Y., Van Remmen H. The effects of dietary restriction on oxidative stress in rodents. Free Radic. Biol. Med. 2014;66:88&#x2013;99. doi: 10.1016/j.freeradbiomed.2013.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.05.037</ArticleId><ArticleId IdType="pmc">PMC4017324</ArticleId><ArticleId IdType="pubmed">23743291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S.J., Ford E., Haigis M., Liszt G., Guarente L. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 2004;18:12&#x2013;16. doi: 10.1101/gad.1164804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1164804</ArticleId><ArticleId IdType="pmc">PMC314267</ArticleId><ArticleId IdType="pubmed">14724176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.C., Kaya A., Gladyshev V.N. Methionine restriction and life-span control. Ann. N. Y. Acad. Sci. 2016;1363:116&#x2013;124. doi: 10.1111/nyas.12973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12973</ArticleId><ArticleId IdType="pmc">PMC5008916</ArticleId><ArticleId IdType="pubmed">26663138</ArticleId></ArticleIdList></Reference><Reference><Citation>Richie J.P., Jr., Leutzinger Y., Parthasarathy S., Maixoy V., Orentreich N., Zimmerman J.A. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J. 1994;8:1302&#x2013;1307. doi: 10.1096/fasebj.8.15.8001743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.8.15.8001743</ArticleId><ArticleId IdType="pubmed">8001743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Sadighi Akha A.A., Miller R.A., Harper J.M. Life-Span Extension in Mice by Preweaning Food Restriction and by Methionine Restriction in Middle Age. J. Gerontol. Ser. A. 2009;64:711&#x2013;722. doi: 10.1093/gerona/glp051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glp051</ArticleId><ArticleId IdType="pmc">PMC2691799</ArticleId><ArticleId IdType="pubmed">19414512</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Doshi B., Sheth F., Patel M., Shah N., Premal T., Vaidya R., Sheth J. Association of Vitamin D 3 levels with glycemic control in Type 2 diabetes subjects from Gujarati population-India. Mol. Cytogenet. 2014;7:36. doi: 10.1186/1755-8166-7-S1-P36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8166-7-S1-P36</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Sheth F., Patel M., Doshi B., Shah N., Thankor P., Vaidya R., Sheth J. Effect of PPAR-&#x3b3;2 Gene Pro12Ala polymorphism (Rs1801282) and Vitamin D3 on glucose homeostasis in Type 2 diabetic subjects from Gujarat-India. Mol. Cytogenet. 2014;7:37. doi: 10.1186/1755-8166-7-S1-P37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8166-7-S1-P37</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Simile M.M., Latte G., Feo C.F., Feo F., Calvisi D.F., Pascale R.M. Alterations of methionine metabolism in hepatocarcinogenesis: The emergent role of glycine N-methyltransferase in liver injury. Ann. Gastroenterol. 2018;31:552&#x2013;560. doi: 10.20524/aog.2018.0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.20524/aog.2018.0288</ArticleId><ArticleId IdType="pmc">PMC6102450</ArticleId><ArticleId IdType="pubmed">30174391</ArticleId></ArticleIdList></Reference><Reference><Citation>Luka Z., Capdevila A., Mato J.M., Wagner C. A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res. 2006;15:393&#x2013;397. doi: 10.1007/s11248-006-0008-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-006-0008-1</ArticleId><ArticleId IdType="pmc">PMC2792375</ArticleId><ArticleId IdType="pubmed">16779654</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.J., Janssens G.E., McIntyre R.L., Molenaars M., Kamble R., Gao A.W., Jongejan A., Weeghel M.V., MacInnes A.W., Houtkooper R.H. Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion. PLoS Genet. 2019;15:e1007633. doi: 10.1371/journal.pgen.1007633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007633</ArticleId><ArticleId IdType="pmc">PMC6424468</ArticleId><ArticleId IdType="pubmed">30845140</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata F., Miura M. Enhancing S-adenosyl-methionine catabolism extends Drosophila lifespan. Nat. Commun. 2015;6:8332. doi: 10.1038/ncomms9332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9332</ArticleId><ArticleId IdType="pmc">PMC4595730</ArticleId><ArticleId IdType="pubmed">26383889</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A.A., Cuellar T.L. Glycine and aging: Evidence and mechanisms. Ageing Res. Rev. 2023;87:101922. doi: 10.1016/j.arr.2023.101922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2023.101922</ArticleId><ArticleId IdType="pubmed">37004845</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res. Rev. 2005;4:288&#x2013;314. doi: 10.1016/j.arr.2005.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2005.02.005</ArticleId><ArticleId IdType="pubmed">15936251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Chantar M.L., V&#xe1;zquez-Chantada M., Ariz U., Mart&#xed;nez N., Varela M., Luka Z., Capdevila A., Rodr&#xed;guez J., Aransay A.M., Matthiesen R., et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology. 2008;47:1191&#x2013;1199. doi: 10.1002/hep.22159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22159</ArticleId><ArticleId IdType="pmc">PMC2405897</ArticleId><ArticleId IdType="pubmed">18318442</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfield C.-A., Bradshaw P. Amino acids in the regulation of aging and aging-related diseases. Transl. Med. Aging. 2019;3:70&#x2013;89. doi: 10.1016/j.tma.2019.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tma.2019.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Chen X., Li J., Sun S. Serine and Metabolism Regulation: A Novel Mechanism in Antitumor Immunity and Senescence. Aging Dis. 2020;11:1640&#x2013;1653. doi: 10.14336/AD.2020.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0314</ArticleId><ArticleId IdType="pmc">PMC7673844</ArticleId><ArticleId IdType="pubmed">33269112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw P.C. Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging. Nutrients. 2019;11:504. doi: 10.3390/nu11030504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11030504</ArticleId><ArticleId IdType="pmc">PMC6471790</ArticleId><ArticleId IdType="pubmed">30818813</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinzinger R. Programmed ageing: The theory of maximal metabolic scope. How does the biological clock tick? EMBO Rep. 2005;6:S14&#x2013;S19. doi: 10.1038/sj.embor.7400425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400425</ArticleId><ArticleId IdType="pmc">PMC1369273</ArticleId><ArticleId IdType="pubmed">15995655</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado E., Morales-Pison S., Urbina F., Solari A. Aging Hallmarks and the Role of Oxidative Stress. Antioxidants. 2023;12:651. doi: 10.3390/antiox12030651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12030651</ArticleId><ArticleId IdType="pmc">PMC10044767</ArticleId><ArticleId IdType="pubmed">36978899</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer. Cells. 2023;12:2517. doi: 10.3390/cells12212517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12212517</ArticleId><ArticleId IdType="pmc">PMC10648638</ArticleId><ArticleId IdType="pubmed">37947595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Arcoraci V., Squadrito F., Altavilla D., Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxidative Med. Cell. Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8416763</ArticleId><ArticleId IdType="pmc">PMC5551541</ArticleId><ArticleId IdType="pubmed">28819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Feitelson M.A., Arzumanyan A., Kulathinal R.J., Blain S.W., Holcombe R.F., Mahajna J., Marino M., Martinez-Chantar M.L., Nawroth R., Sanchez-Garcia I., et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin. Cancer Biol. 2015;35:S25&#x2013;S54. doi: 10.1016/j.semcancer.2015.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2015.02.006</ArticleId><ArticleId IdType="pmc">PMC4898971</ArticleId><ArticleId IdType="pubmed">25892662</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Sandhu M., Banerji D., Steri V., Olshen A., Moasser M.M. The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers. Sci. Rep. 2021;11:9091. doi: 10.1038/s41598-021-88683-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88683-w</ArticleId><ArticleId IdType="pmc">PMC8079373</ArticleId><ArticleId IdType="pubmed">33907275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.H., Hales C.N., Ozanne S.E. DNA damage, cellular senescence and organismal ageing: Causal or correlative? Nucleic Acids Res. 2007;35:7417&#x2013;7428. doi: 10.1093/nar/gkm681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm681</ArticleId><ArticleId IdType="pmc">PMC2190714</ArticleId><ArticleId IdType="pubmed">17913751</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Homme R.P., Majumder A., Tyagi S.C., Singh M. Effect of MMP-9 gene knockout on retinal vascular form and function. Physiol. Genom. 2019;51:613&#x2013;622. doi: 10.1152/physiolgenomics.00041.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00041.2019</ArticleId><ArticleId IdType="pmc">PMC6962592</ArticleId><ArticleId IdType="pubmed">31709889</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari R., Jat P. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. Front. Cell Dev. Biol. 2021;9:645593. doi: 10.3389/fcell.2021.645593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.645593</ArticleId><ArticleId IdType="pmc">PMC8039141</ArticleId><ArticleId IdType="pubmed">33855023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrenti V., Buriani A., Fortinguerra S., Davinelli S., Scapagnini G., Cassidy A., De Vivo I. Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: The Role of (Poly)phenols. Adv. Nutr. 2023;14:1111&#x2013;1130. doi: 10.1016/j.advnut.2023.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advnut.2023.05.014</ArticleId><ArticleId IdType="pmc">PMC10509428</ArticleId><ArticleId IdType="pubmed">37271484</ArticleId></ArticleIdList></Reference><Reference><Citation>Shreeya T., Ansari M.S., Kumar P., Saifi M., Shati A.A., Alfaifi M.Y., Elbehairi S.E.I. Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases. Front. Aging. 2023;4:1292053. doi: 10.3389/fragi.2023.1292053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2023.1292053</ArticleId><ArticleId IdType="pmc">PMC11002673</ArticleId><ArticleId IdType="pubmed">38596783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xe9;chal A., Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. 2013;5:a012716. doi: 10.1101/cshperspect.a012716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a012716</ArticleId><ArticleId IdType="pmc">PMC3753707</ArticleId><ArticleId IdType="pubmed">24003211</ArticleId></ArticleIdList></Reference><Reference><Citation>Helt C.E., Cliby W.A., Keng P.C., Bambara R.A., O&#x2019;Reilly M.A. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J. Biol. Chem. 2005;280:1186&#x2013;1192. doi: 10.1074/jbc.M410873200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410873200</ArticleId><ArticleId IdType="pubmed">15533933</ArticleId></ArticleIdList></Reference><Reference><Citation>Torgovnick A., Schumacher B. DNA repair mechanisms in cancer development and therapy. Front. Genet. 2015;6:157. doi: 10.3389/fgene.2015.00157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2015.00157</ArticleId><ArticleId IdType="pmc">PMC4407582</ArticleId><ArticleId IdType="pubmed">25954303</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495&#x2013;516. doi: 10.1080/01926230701320337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01926230701320337</ArticleId><ArticleId IdType="pmc">PMC2117903</ArticleId><ArticleId IdType="pubmed">17562483</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs B.G., Baker D.J., Kirkland J.L., Campisi J., van Deursen J.M. Senescence and apoptosis: Dueling or complementary cell fates? EMBO Rep. 2014;15:1139&#x2013;1153. doi: 10.15252/embr.201439245.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201439245</ArticleId><ArticleId IdType="pmc">PMC4253488</ArticleId><ArticleId IdType="pubmed">25312810</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshima H., Ushijima T. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precis. Oncol. 2019;3:7. doi: 10.1038/s41698-019-0079-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41698-019-0079-0</ArticleId><ArticleId IdType="pmc">PMC6403339</ArticleId><ArticleId IdType="pubmed">30854468</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., Qin D., Hou X., Tian L., Yu Y., Zhang R., Lyu H., Guo D., Chen X.Z., Zhou C., et al. Cellular senescence: A double-edged sword in cancer therapy. Front. Oncol. 2023;13:1189015. doi: 10.3389/fonc.2023.1189015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2023.1189015</ArticleId><ArticleId IdType="pmc">PMC10522834</ArticleId><ArticleId IdType="pubmed">37771436</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Micco R., Krizhanovsky V., Baker D., d&#x2019;Adda di Fagagna F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 2021;22:75&#x2013;95. doi: 10.1038/s41580-020-00314-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00314-w</ArticleId><ArticleId IdType="pmc">PMC8344376</ArticleId><ArticleId IdType="pubmed">33328614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayess H., Wang M.B., Srivatsan E.S. Cellular senescence and tumor suppressor gene p16. Int. J. Cancer. 2012;130:1715&#x2013;1725. doi: 10.1002/ijc.27316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.27316</ArticleId><ArticleId IdType="pmc">PMC3288293</ArticleId><ArticleId IdType="pubmed">22025288</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez Borrero L.J., El-Deiry W.S. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim. Biophys. Acta Rev. Cancer. 2021;1876:188556. doi: 10.1016/j.bbcan.2021.188556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2021.188556</ArticleId><ArticleId IdType="pmc">PMC8730328</ArticleId><ArticleId IdType="pubmed">33932560</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak K.B., Kuila N., Das Mohapatra A., Panda A.K., Chakraborty S. EVI1 targets &#x394;Np63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells. Int. J. Biochem. Cell Biol. 2013;45:1568&#x2013;1576. doi: 10.1016/j.biocel.2013.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2013.04.032</ArticleId><ArticleId IdType="pubmed">23665236</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana R., Ranieri M., La Mantia G., Vivo M. Dual Role of the Alternative Reading Frame ARF Protein in Cancer. Biomolecules. 2019;9:87. doi: 10.3390/biom9030087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9030087</ArticleId><ArticleId IdType="pmc">PMC6468759</ArticleId><ArticleId IdType="pubmed">30836703</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell B.B., Gregory F.J., Stott F.J., Hara E., Peters G. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell Biol. 1999;19:1981&#x2013;1989. doi: 10.1128/MCB.19.3.1981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.3.1981</ArticleId><ArticleId IdType="pmc">PMC83991</ArticleId><ArticleId IdType="pubmed">10022885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Hickson L.J., Eirin A., Kirkland J.L., Lerman L.O. Cellular senescence: The good, the bad and the unknown. Nat. Rev. Nephrol. 2022;18:611&#x2013;627. doi: 10.1038/s41581-022-00601-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00601-z</ArticleId><ArticleId IdType="pmc">PMC9362342</ArticleId><ArticleId IdType="pubmed">35922662</ArticleId></ArticleIdList></Reference><Reference><Citation>Donehower L.A. Using mice to examine p53 functions in cancer, aging, and longevity. Cold Spring Harb. Perspect. Biol. 2009;1:a001081. doi: 10.1101/cshperspect.a001081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a001081</ArticleId><ArticleId IdType="pmc">PMC2882127</ArticleId><ArticleId IdType="pubmed">20457560</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Cao I., Garc&#xed;a-Cao M., Tom&#xe1;s-Loba A., Mart&#xed;n-Caballero J., Flores J.M., Klatt P., Blasco M.A., Serrano M. Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep. 2006;7:546&#x2013;552. doi: 10.1038/sj.embor.7400667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400667</ArticleId><ArticleId IdType="pmc">PMC1479549</ArticleId><ArticleId IdType="pubmed">16582880</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D.H., Waterland R.A., Zhang P., Schady D., Chen M.H., Guan Y., Gadkari M., Shen L. Targeted p16(Ink4a) epimutation causes tumorigenesis and reduces survival in mice. J. Clin. Investig. 2014;124:3708&#x2013;3712. doi: 10.1172/JCI76507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI76507</ArticleId><ArticleId IdType="pmc">PMC4151219</ArticleId><ArticleId IdType="pubmed">25061879</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulak M., Fong L., Mika K., Chigurupati S., Yon L., Mongan N.P., Emes R.D., Lynch V.J. TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants. eLife. 2016;5:e11994. doi: 10.7554/eLife.11994.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.11994</ArticleId><ArticleId IdType="pmc">PMC5061548</ArticleId><ArticleId IdType="pubmed">27642012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladyshev V.N. The free radical theory of aging is dead. Long live the damage theory! Antioxid. Redox Signal. 2014;20:727&#x2013;731. doi: 10.1089/ars.2013.5228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5228</ArticleId><ArticleId IdType="pmc">PMC3901353</ArticleId><ArticleId IdType="pubmed">24159899</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D.J., Alimirah F., van Deursen J.M., Campisi J., Hildesheim J. Oncogenic senescence: A multi-functional perspective. Oncotarget. 2017;8:27661&#x2013;27672. doi: 10.18632/oncotarget.15742.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15742</ArticleId><ArticleId IdType="pmc">PMC5432366</ArticleId><ArticleId IdType="pubmed">28416761</ArticleId></ArticleIdList></Reference><Reference><Citation>Cichorek M., Wachulska M., Stasiewicz A., Tymi&#x144;ska A. Skin melanocytes: Biology and development. Postep. Dermatol. Alergol. 2013;30:30&#x2013;41. doi: 10.5114/pdia.2013.33376.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pdia.2013.33376</ArticleId><ArticleId IdType="pmc">PMC3834696</ArticleId><ArticleId IdType="pubmed">24278043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak S.S., Moriyama M., Nishioka E., Osawa M., Nishikawa S. Indispensable role of Bcl2 in the development of the melanocyte stem cell. Dev. Biol. 2006;291:144&#x2013;153. doi: 10.1016/j.ydbio.2005.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2005.12.025</ArticleId><ArticleId IdType="pubmed">16427619</ArticleId></ArticleIdList></Reference><Reference><Citation>Barriuso D., Alvarez-Frutos L., Gonzalez-Gutierrez L., Moti&#xf1;o O., Kroemer G., Palacios-Ramirez R., Senovilla L. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence. Int. J. Mol. Sci. 2023;24:6374. doi: 10.3390/ijms24076374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076374</ArticleId><ArticleId IdType="pmc">PMC10094710</ArticleId><ArticleId IdType="pubmed">37047342</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian S., Wei Z., Yang W., Huang J., Yang Y., Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front. Oncol. 2022;12:985363. doi: 10.3389/fonc.2022.985363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.985363</ArticleId><ArticleId IdType="pmc">PMC9597512</ArticleId><ArticleId IdType="pubmed">36313628</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimann M., Lee S., Schmitt C.A. Cellular senescence: Neither irreversible nor reversible. J. Exp. Med. 2024;221:e20232136. doi: 10.1084/jem.20232136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20232136</ArticleId><ArticleId IdType="pmc">PMC10883852</ArticleId><ArticleId IdType="pubmed">38385946</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 2013;75:685&#x2013;705. doi: 10.1146/annurev-physiol-030212-183653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-030212-183653</ArticleId><ArticleId IdType="pmc">PMC4166529</ArticleId><ArticleId IdType="pubmed">23140366</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt C.A., Wang B., Demaria M. Senescence and cancer-role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 2022;19:619&#x2013;636. doi: 10.1038/s41571-022-00668-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-022-00668-4</ArticleId><ArticleId IdType="pmc">PMC9428886</ArticleId><ArticleId IdType="pubmed">36045302</ArticleId></ArticleIdList></Reference><Reference><Citation>Copp&#xe9; J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu. Rev. Pathol. 2010;5:99&#x2013;118. doi: 10.1146/annurev-pathol-121808-102144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-121808-102144</ArticleId><ArticleId IdType="pmc">PMC4166495</ArticleId><ArticleId IdType="pubmed">20078217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Lankhorst L., Bernards R. Exploiting senescence for the treatment of cancer. Nat. Rev. Cancer. 2022;22:340&#x2013;355. doi: 10.1038/s41568-022-00450-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-022-00450-9</ArticleId><ArticleId IdType="pubmed">35241831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Vega R., Chen C.F., Razzak E., Vasudeva P., Krasieva T.B., Shiu J., Caldwell M.G., Yan H., Lowengrub J., Ganesan A.K., et al. Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes. eLife. 2020;9:e61026. doi: 10.7554/eLife.61026.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61026</ArticleId><ArticleId IdType="pmc">PMC7553774</ArticleId><ArticleId IdType="pubmed">33047672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L.E., Gomes A.P., Sinclair D.A. Geroncogenesis: Metabolic changes during aging as a driver of tumorigenesis. Cancer cell. 2014;25:12&#x2013;19. doi: 10.1016/j.ccr.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2013.12.005</ArticleId><ArticleId IdType="pmc">PMC3970212</ArticleId><ArticleId IdType="pubmed">24434207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong L.R., Gupta K., Wu A.J., Perera D., Ivanyi-Nagy R., Ahmed S.M., Tan T.Z., Tan S.L., Fuddin A., Sundaramoorthy E., et al. A glycolytic metabolite bypasses &#x201c;two-hit&#x201d; tumor suppression by BRCA2. Cell. 2024;187:2269&#x2013;2287.E16. doi: 10.1016/j.cell.2024.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2024.03.006</ArticleId><ArticleId IdType="pubmed">38608703</ArticleId></ArticleIdList></Reference><Reference><Citation>Parreno V., Loubiere V., Schuettengruber B., Fritsch L., Rawal C.C., Erokhin M., Gy&#x151;rffy B., Normanno D., Di Stefano M., Moreaux J., et al. Transient loss of Polycomb components induces an epigenetic cancer fate. Nature. 2024;629:688&#x2013;696. doi: 10.1038/s41586-024-07328-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07328-w</ArticleId><ArticleId IdType="pmc">PMC11096130</ArticleId><ArticleId IdType="pubmed">38658752</ArticleId></ArticleIdList></Reference><Reference><Citation>Carthew R.W. Gene Regulation and Cellular Metabolism: An Essential Partnership. Trends Genet. 2021;37:389&#x2013;400. doi: 10.1016/j.tig.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2020.09.018</ArticleId><ArticleId IdType="pmc">PMC7969386</ArticleId><ArticleId IdType="pubmed">33092903</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Beltran L., Cano C., Wall D.P., Esteban F.J. Systems biology as a comparative approach to understand complex gene expression in neurological diseases. Behav. Sci. 2013;3:253&#x2013;272. doi: 10.3390/bs3020253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bs3020253</ArticleId><ArticleId IdType="pmc">PMC4217627</ArticleId><ArticleId IdType="pubmed">25379238</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39537414</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0253-9624</ISSN><JournalIssue CitedMedium="Print"><Volume>58</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>06</Day></PubDate></JournalIssue><Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title><ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Mechanisms and perspectives of B vitamins associated one carbon metabolism on colorectal cancer risk].</ArticleTitle><Pagination><StartPage>1739</StartPage><EndPage>1751</EndPage><MedlinePgn>1739-1751</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112150-20240517-00400</ELocationID><Abstract><AbstractText>Colorectal cancer (CRC) represents a significant global health challenge as a common malignancy of the digestive tract. The involvement of B vitamins-specifically folic acid (B9), riboflavin (B2), pyridoxine (B6), and cobalamin (B12)-is crucial in metabolic processes by mediating the transfer of one-carbon (1C) units, which plays a fundamental role in cellular functions and tumor growth. 1C metabolism is involved in synthesis of proteins, lipids, nucleic acids, and other cofactors. 1C metabolism, intertwined with the metabolism of other nutrients, forms complex pathways where B vitamins act as precursors or coenzymes, influencing the production of various intermediates. These vitamins, as essential nutrients, are implicated to varying the pathogenesis and progression of colorectal cancer such as epigenetics. Furthermore, 1C metabolism affects tumor cell fate through multiple aspects including nucleotide synthesis, redox homeostasis, and the interaction with gut microbiota. Given these roles, understanding and monitoring B vitamin levels and their metabolic pathways are essential for colorectal cancer prevention and management. This approach not only helps in reducing tumor-related mortality but also opens new avenues for research into CRC mechanisms and potential therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Y H</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>L S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Y X</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200092, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>82071753</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>20224Z0025</GrantID><Agency>Shanghai "Rising Stars of Medical Talents"-Outstanding Youth Medical Talents Program</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7904962</NlmUniqueID><ISSNLinking>0253-9624</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>12001-76-2</RegistryNumber><NameOfSubstance UI="D014803">Vitamin B Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>7440-44-0</RegistryNumber><NameOfSubstance UI="D002244">Carbon</NameOfSubstance></Chemical><Chemical><RegistryNumber>935E97BOY8</RegistryNumber><NameOfSubstance UI="D005492">Folic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>TLM2976OFR</RegistryNumber><NameOfSubstance UI="D012256">Riboflavin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014803" MajorTopicYN="Y">Vitamin B Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002244" MajorTopicYN="N">Carbon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005492" MajorTopicYN="N">Folic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012256" MajorTopicYN="N">Riboflavin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x7ed3;&#x76f4;&#x80a0;&#x764c;&#x4f5c;&#x4e3a;&#x4e00;&#x79cd;&#x5e38;&#x89c1;&#x7684;&#x6d88;&#x5316;&#x9053;&#x6076;&#x6027;&#x80bf;&#x7624;&#xff0c;&#x5728;&#x5168;&#x4e16;&#x754c;&#x8303;&#x56f4;&#x5185;&#x4e25;&#x91cd;&#x5a01;&#x80c1;&#x7740;&#x4eba;&#x7c7b;&#x7684;&#x5065;&#x5eb7;&#x3002;B&#x65cf;&#x7ef4;&#x751f;&#x7d20;&#xff08;&#x53f6;&#x9178;&#x3001;&#x7ef4;&#x751f;&#x7d20;B2&#x3001;&#x7ef4;&#x751f;&#x7d20;B6&#x548c;&#x7ef4;&#x751f;&#x7d20;B12&#xff09;&#x5728;&#x4ee3;&#x8c22;&#x8fc7;&#x7a0b;&#x4e2d;&#x80fd;&#x4ecb;&#x5bfc;&#x8f6c;&#x79fb;&#x542b;&#x4e00;&#x4e2a;&#x78b3;&#x539f;&#x5b50;&#x7684;&#x57fa;&#x56e2;&#xff0c;&#x53c2;&#x4e0e;&#x751f;&#x7269;&#x4e00;&#x78b3;&#x4ee3;&#x8c22;&#xff0c;&#x5305;&#x62ec;&#x86cb;&#x767d;&#x8d28;&#x3001;&#x8102;&#x8d28;&#x3001;&#x6838;&#x9178;&#x548c;&#x5176;&#x4ed6;&#x8f85;&#x56e0;&#x5b50;&#x7b49;&#x5408;&#x6210;&#x3002;&#x4e00;&#x78b3;&#x4ee3;&#x8c22;&#x4e0e;&#x5176;&#x4ed6;&#x8425;&#x517b;&#x7d20;&#x7684;&#x4ee3;&#x8c22;&#x5f62;&#x6210;&#x590d;&#x6742;&#x901a;&#x8def;&#xff0c;B&#x65cf;&#x7ef4;&#x751f;&#x7d20;&#x5728;&#x5176;&#x4e2d;&#x8d77;&#x5230;&#x539f;&#x6599;&#x6216;&#x8f85;&#x9176;&#x7684;&#x4f5c;&#x7528;&#xff0c;&#x5f71;&#x54cd;&#x5404;&#x7c7b;&#x4e2d;&#x95f4;&#x4ea7;&#x7269;&#x7684;&#x751f;&#x6210;&#xff0c;&#x4f5c;&#x4e3a;&#x91cd;&#x8981;&#x8425;&#x517b;&#x5143;&#x7d20;&#x4e0d;&#x540c;&#x7a0b;&#x5ea6;&#x5730;&#x53c2;&#x4e0e;&#x7ed3;&#x76f4;&#x80a0;&#x764c;&#x7684;&#x53d1;&#x751f;&#x53d1;&#x5c55;&#x3002;&#x540c;&#x65f6;&#xff0c;&#x4e00;&#x78b3;&#x4ee3;&#x8c22;&#x5728;&#x8868;&#x89c2;&#x9057;&#x4f20;&#x5b66;&#x3001;&#x6838;&#x82f7;&#x9178;&#x5408;&#x6210;&#x3001;&#x6c27;&#x5316;&#x8fd8;&#x539f;&#x7a33;&#x6001;&#x4e0e;&#x80a0;&#x9053;&#x83cc;&#x7fa4;&#x76f8;&#x4e92;&#x4f5c;&#x7528;&#x7b49;&#x591a;&#x65b9;&#x9762;&#x5171;&#x540c;&#x5f71;&#x54cd;&#x80bf;&#x7624;&#x7ec6;&#x80de;&#x547d;&#x8fd0;&#x3002;&#x9274;&#x4e8e;&#x8fd9;&#x4e9b;&#x4f5c;&#x7528;&#xff0c;&#x7406;&#x89e3;&#x548c;&#x76d1;&#x6d4b;B&#x65cf;&#x7ef4;&#x751f;&#x7d20;&#x6c34;&#x5e73;&#x53ca;&#x5176;&#x4ee3;&#x8c22;&#x9014;&#x5f84;&#x5bf9;&#x4e8e;&#x7ed3;&#x76f4;&#x80a0;&#x764c;&#x7684;&#x9884;&#x9632;&#x548c;&#x7ba1;&#x7406;&#x81f3;&#x5173;&#x91cd;&#x8981;&#x3002;&#x8fd9;&#x4e0d;&#x4ec5;&#x6709;&#x52a9;&#x4e8e;&#x964d;&#x4f4e;&#x4e0e;&#x80bf;&#x7624;&#x76f8;&#x5173;&#x7684;&#x6b7b;&#x4ea1;&#x7387;&#xff0c;&#x8fd8;&#x4e3a;&#x7ed3;&#x76f4;&#x80a0;&#x764c;&#x5f62;&#x6210;&#x548c;&#x53d1;&#x5c55;&#x673a;&#x5236;&#x7814;&#x7a76;&#x53ca;&#x6f5c;&#x5728;&#x6cbb;&#x7597;&#x7b56;&#x7565;&#x5f00;&#x8f9f;&#x4e86;&#x65b0;&#x9014;&#x5f84;&#x3002;.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39537414</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112150-20240517-00400</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39435289</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2234-943X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in oncology</Title><ISOAbbreviation>Front Oncol</ISOAbbreviation></Journal><ArticleTitle><i>Aronia melanocarpa</i> L. fruit peels show anti-cancer effects in preclinical models of breast carcinoma: The perspectives in the chemoprevention and therapy modulation.</ArticleTitle><Pagination><StartPage>1463656</StartPage><MedlinePgn>1463656</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1463656</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2024.1463656</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Within oncology research, there is a high effort for new approaches to prevent and treat cancer as a life-threatening disease. Specific plant species that adapt to harsh conditions may possess unique properties that may be utilized in the management of cancer.</AbstractText><AbstractText Label="HYPOTHESIS" NlmCategory="UNASSIGNED">Chokeberry fruit is rich in secondary metabolites with anti-cancer activities potentially useful in cancer prevention and treatment.</AbstractText><AbstractText Label="AIMS OF THE STUDY AND METHODS" NlmCategory="UNASSIGNED">Based on mentioned hypothesis, the main goal of our study was to evaluate the antitumor effects of dietary administered <i>Aronia melanocarpa</i> L. fruit peels (in two concentrations of 0.3 and 3% [w/w]) in the therapeutic syngeneic 4T1 mouse adenocarcinoma model, the chemopreventive model of chemically induced mammary carcinogenesis in rats, a cell antioxidant assay, and robust <i>in vitro</i> analyses using MCF-7 and MDA-MB-231 cancer cells.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The dominant metabolites in the <i>A. melanocarpa</i> fruit peel extract tested were phenolic derivatives classified as anthocyanins and procyanidins. In a therapeutic model, aronia significantly reduced the volume of 4T1 tumors at both higher and lower doses. In the same tumors, we noted a significant dose-dependent decrease in the mitotic activity index compared to the control. In the chemopreventive model, the expression of Bax was significantly increased by aronia at both doses. Additionally, aronia decreased Bcl-2 and VEGF levels, increasing the Bax/Bcl-2 ratio compared to the control group. The cytoplasmic expression of caspase-3 was significantly enhanced when aronia was administered at a higher dosage, in contrast to both the control group and the aronia group treated with a lower dosage. Furthermore, the higher dosage of aronia exhibited a significant reduction in the expression of the tumor stem cell marker CD133 compared to the control group. In addition, the examination of aronia`s epigenetic impact on tumor tissue through <i>in vivo</i> analyses revealed significant alterations in histone chemical modifications, specifically H3K4m3 and H3K9m3, miRNAs expression (miR155, miR210, and miR34a) and methylation status of tumor suppressor genes (<i>PTEN</i> and <i>TIMP3</i>). <i>In vitro</i> studies utilizing a methanolic extract of <i>A.melanocarpa</i> demonstrated significant anti-cancer properties in the MCF-7 and MDA-MB-231 cell lines. Various analyses, including Resazurin, cell cycle, annexin V/PI, caspase-3/7, Bcl-2, PARP, and mitochondrial membrane potential, were conducted in this regard. Additionally, the aronia extract enhanced the responsiveness to epirubicin in both cancer cell lines.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study is the first to analyze the antitumor effect of <i>A. melanocarpa</i> in selected models of experimental breast carcinoma <i>in vivo</i> and <i>in vitro</i>. The utilization of the antitumor effects of aronia in clinical practice is still minimal and requires precise and long-term clinical evaluations. Individualized cancer-type profiling and patient stratification are crucial for effectively implementing plant nutraceuticals within targeted anti-cancer strategies in clinical oncology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Dvorska, Mazurakova, Lackova, Sebova, Kajo, Samec, Brany, Svajdlenka, Treml, Mersakova, Strnadel, Adamkov, Lasabova, Biringer, Mojzis, B&#xfc;sselberg, Smejkal, Kello and Kubatka.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dvorska</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurakova</LastName><ForeName>Alena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lackova</LastName><ForeName>Lenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebova</LastName><ForeName>Dominika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, P. J. &#x160;af&#xe1;rik University, Ko&#x161;ice, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajo</LastName><ForeName>Karol</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, St. Elisabeth Oncology Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samec</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brany</LastName><ForeName>Dusan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svajdlenka</LastName><ForeName>Emil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Brno, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treml</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Brno, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mersakova</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strnadel</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biomedical Centre Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamkov</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lasabova</LastName><ForeName>Zora</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Genomics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biringer</LastName><ForeName>Kamil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mojzis</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, P. J. &#x160;af&#xe1;rik University, Ko&#x161;ice, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;sselberg</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Qatar Foundation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smejkal</LastName><ForeName>Karel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Brno, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kello</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine, P. J. &#x160;af&#xe1;rik University, Ko&#x161;ice, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubatka</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Oncol</MedlineTA><NlmUniqueID>101568867</NlmUniqueID><ISSNLinking>2234-943X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aronia melanocarpa L.</Keyword><Keyword MajorTopicYN="N">breast carcinoma</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">in vitro models</Keyword><Keyword MajorTopicYN="N">mechanism of action</Keyword><Keyword MajorTopicYN="N">rodent models</Keyword></KeywordList><CoiStatement>The authors declare the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39435289</ArticleId><ArticleId IdType="pmc">PMC11491292</ArticleId><ArticleId IdType="doi">10.3389/fonc.2024.1463656</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. (2021) 71:209&#x2013;49. doi:&#xa0;10.3322/caac.21660</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liskova A, Stefanicka P, Samec M, Smejkal K, Zubor P, Bielik T, et al. . Dietary phytochemicals as the potential protectors against carcinogenesis and their role in cancer chemoprevention. Clin Exp Med. (2020) 20:173&#x2013;90. doi:&#xa0;10.1007/s10238-020-00611-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00611-w</ArticleId><ArticleId IdType="pubmed">32016615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Mazurakova A, Samec M, Koklesova L, Zhai K, AL-Ishaq R, et al. . Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression&#x2014;3PM pathways. EPMA J. (2021) 12:559&#x2013;87. doi:&#xa0;10.1007/s13167-021-00257-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-021-00257-y</ArticleId><ArticleId IdType="pmc">PMC8648878</ArticleId><ArticleId IdType="pubmed">34950252</ArticleId></ArticleIdList></Reference><Reference><Citation>Koklesova L, Liskova A, Samec M, Qaradakhi T, Zulli A, Smejkal K, et al. . Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. EPMA J. (2020) 11:261&#x2013;87. doi:&#xa0;10.1007/s13167-020-00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-020-00210-5</ArticleId><ArticleId IdType="pmc">PMC7272522</ArticleId><ArticleId IdType="pubmed">32547652</ArticleId></ArticleIdList></Reference><Reference><Citation>Liskova A, Samec M, Koklesova L, Brockmueller A, Zhai K, Abdellatif B, et al. . Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA J. (2021) 12:155&#x2013;76. doi:&#xa0;10.1007/s13167-021-00242-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-021-00242-5</ArticleId><ArticleId IdType="pmc">PMC8126506</ArticleId><ArticleId IdType="pubmed">34025826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapinova A, Kubatka P, Liskova A, Baranenko D, Kruzliak P, Matta M, et al. . Controlling metastatic cancer: the role of phytochemicals in cell signaling. J Cancer Res Clin Oncol. (2019) 145:1087&#x2013;109. doi:&#xa0;10.1007/s00432-019-02892-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-019-02892-5</ArticleId><ArticleId IdType="pmc">PMC11810423</ArticleId><ArticleId IdType="pubmed">30903319</ArticleId></ArticleIdList></Reference><Reference><Citation>Uramova S, Kubatka P, Dankova Z, Kapinova A, Zolakova B, Samec M, et al. . Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach. EPMA J. (2018) 9:403&#x2013;19. doi:&#xa0;10.1007/s13167-018-0154-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-018-0154-6</ArticleId><ArticleId IdType="pmc">PMC6261910</ArticleId><ArticleId IdType="pubmed">30538792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurakova A, Koklesova L, Samec M, Kudela E, Kajo K, Skuciova V, et al. . Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care. EPMA J. (2022) 13:315&#x2013;34. doi:&#xa0;10.1007/s13167-022-00277-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-022-00277-2</ArticleId><ArticleId IdType="pmc">PMC9008621</ArticleId><ArticleId IdType="pubmed">35437454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidor A, Gramza-Micha&#x142;owska A. Black chokeberry aronia melanocarpa L.-A qualitative composition, phenolic profile and antioxidant potential. Molecules. (2019) 24:3710. doi:&#xa0;10.3390/molecules24203710</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24203710</ArticleId><ArticleId IdType="pmc">PMC6832535</ArticleId><ArticleId IdType="pubmed">31619015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill NK, Rios D, Osorio-Camacena E, Mojica BE, Kaur B, Soderstrom MA, et al. . Anticancer effects of extracts from three different chokeberry species. Nutr Cancer. (2021) 73:1168&#x2013;74. doi:&#xa0;10.1080/01635581.2020.1789679</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2020.1789679</ArticleId><ArticleId IdType="pubmed">32643413</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamkut&#x117; L, Jan&#x10d;iuk&#x117; G, Pukalskien&#x117; M, Sarapinien&#x117; I, Arvydas Skeberdis V, Rimantas Venskutonis P. Cranberry and black chokeberry extracts isolated with pressurized ethanol from defatted by supercritical CO2 pomace inhibit colorectal carcinoma cells and increase global antioxidant response of meat products during in vitro digestion. Food Res Int. (2022) 161:111803. doi:&#xa0;10.1016/j.foodres.2022.111803</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2022.111803</ArticleId><ArticleId IdType="pubmed">36192948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Yu W, Hao R, Fan J, Gao J. Anthocyanins from Aronia melanocarpa Induce Apoptosis in Caco-2 Cells through Wnt/&#x3b2;-Catenin Signaling Pathway. Chem Biodivers. (2020) 17:e2000654. doi:&#xa0;10.1002/cbdv.202000654</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbdv.202000654</ArticleId><ArticleId IdType="pubmed">33016000</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HS, Kim J-H, Kim S-L, Deng H-Y, Lee D, Kim CS, et al. . Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway. Mol Carcinog. (2018) 57:1467&#x2013;79. doi:&#xa0;10.1002/mc.22870</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.22870</ArticleId><ArticleId IdType="pubmed">29964299</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HS, Kim S-L, Kim J-H, Deng H-Y, Yun B-S, Lee D-S. Triterpene Acid (3-O-p-Coumaroyltormentic Acid) Isolated From Aronia Extracts Inhibits Breast Cancer Stem Cell Formation through Downregulation of c-Myc Protein. Int J Mol Sci. (2018) 19:2528. doi:&#xa0;10.3390/ijms19092528</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19092528</ArticleId><ArticleId IdType="pmc">PMC6164992</ArticleId><ArticleId IdType="pubmed">30149665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak JH, Kim Y, Ryu SI, Lee M, Lee H-J, Lim YP, et al. . Anti-inflammatory effect from extracts of Red Chinese cabbage and Aronia in LPS-stimulated RAW 264.7 cells. Food Sci Nutr. (2020) 8:1898&#x2013;903. doi:&#xa0;10.1002/fsn3.1472</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.1472</ArticleId><ArticleId IdType="pmc">PMC7174213</ArticleId><ArticleId IdType="pubmed">32328255</ArticleId></ArticleIdList></Reference><Reference><Citation>Thani NAA, Keshavarz S, Lwaleed BA, Cooper AJ, Rooprai HK. Cytotoxicity of gemcitabine enhanced by polyphenolics from Aronia melanocarpa in pancreatic cancer cell line AsPC-1. J Clin Pathol. (2014) 67:949&#x2013;54. doi:&#xa0;10.1136/jclinpath-2013-202075</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2013-202075</ArticleId><ArticleId IdType="pubmed">25232128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kapinov&#xe1; A, Kru&#x17e;liak P, Kello M, V&#xfd;bohov&#xe1; D, Kajo K, et al. . Antineoplastic effects of Chlorella pyrenoidosa in the breast cancer model. Nutrition. (2015) 31:560&#x2013;9. doi:&#xa0;10.1016/j.nut.2014.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2014.08.010</ArticleId><ArticleId IdType="pubmed">25770318</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kello M, Kajo K, Kruzliak P, V&#xfd;bohov&#xe1; D, &#x160;mejkal K, et al. . Young barley indicates antitumor effects in experimental breast cancer. In Vivo In Vitro Nutr Cancer. (2016) 68:611&#x2013;21. doi:&#xa0;10.1080/01635581.2016.1154577</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2016.1154577</ArticleId><ArticleId IdType="pubmed">27042893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kapinov&#xe1; A, Kello M, Kruzliak P, Kajo K, V&#xfd;bohov&#xe1; D, et al. . Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. Eur J Nutr. (2016) 55:955&#x2013;65. doi:&#xa0;10.1007/s00394-015-0910-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-015-0910-5</ArticleId><ArticleId IdType="pubmed">25930965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kello M, Kajo K, Kruzliak P, V&#xfd;bohov&#xe1; D, Moj&#x17e;i&#x161; J, et al. . Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Eur J Nutr. (2017) 56:1303&#x2013;16. doi:&#xa0;10.1007/s00394-016-1181-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-016-1181-5</ArticleId><ArticleId IdType="pubmed">26907089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Uramova S, Kello M, Kajo K, Kruzliak P, Mojzis J, et al. . Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. J Cell Mol Med. (2017) 21:2837&#x2013;51. doi:&#xa0;10.1111/jcmm.13197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13197</ArticleId><ArticleId IdType="pmc">PMC5661249</ArticleId><ArticleId IdType="pubmed">28524540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Uramova S, Kello M, Kajo K, Samec M, Jasek K, et al. . Anticancer activities of thymus vulgaris L. in experimental breast carcinoma in vivo and in vitro. Int J Mol Sci. (2019) 20:1749. doi:&#xa0;10.3390/ijms20071749</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20071749</ArticleId><ArticleId IdType="pmc">PMC6479806</ArticleId><ArticleId IdType="pubmed">30970626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kello M, Kajo K, Samec M, Jasek K, Vybohova D, et al. . Chemopreventive and therapeutic efficacy of cinnamomum zeylanicum L. Bark in experimental breast carcinoma: mechanistic in vivo and in vitro analyses. Molecules. (2020) 25:1399. doi:&#xa0;10.3390/molecules25061399</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25061399</ArticleId><ArticleId IdType="pmc">PMC7144360</ArticleId><ArticleId IdType="pubmed">32204409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kello M, Kajo K, Samec M, Liskova A, Jasek K, et al. . (Sumac) demonstrates oncostatic activity in the therapeutic and preventive model of breast carcinoma. Int J Mol Sci. (2020) 22:183. doi:&#xa0;10.3390/ijms22010183</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010183</ArticleId><ArticleId IdType="pmc">PMC7795985</ArticleId><ArticleId IdType="pubmed">33375383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravoori S, Vadhanam MV, Aqil F, Gupta RC. Inhibition of estrogen-mediated mammary tumorigenesis by blueberry and black raspberry. J Agric Food Chem. (2012) 60:5547&#x2013;55. doi:&#xa0;10.1021/jf205325p</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf205325p</ArticleId><ArticleId IdType="pubmed">22571764</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeyabalan J, Aqil F, Munagala R, Annamalai L, Vadhanam MV, Gupta RC. Chemopreventive and therapeutic activity of dietary blueberry against estrogen-mediated breast cancer. J Agric Food Chem. (2014) 62:3963&#x2013;71. doi:&#xa0;10.1021/jf403734j</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf403734j</ArticleId><ArticleId IdType="pmc">PMC4334276</ArticleId><ArticleId IdType="pubmed">24245576</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia. (2000) 5:187&#x2013;200. doi:&#xa0;10.1023/a:1026443305758</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1026443305758</ArticleId><ArticleId IdType="pubmed">11149572</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo J. Significance of rat mammary tumors for human risk assessment. Toxicol Pathol. (2015) 43:145&#x2013;70. doi:&#xa0;10.1177/0192623314532036</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0192623314532036</ArticleId><ArticleId IdType="pmc">PMC4358771</ArticleId><ArticleId IdType="pubmed">25714400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Kajo K, Zihlavnikova K, Adamicova K, Vybohova D, Pec M, et al. . Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment. Neoplasma. (2012) 59:516&#x2013;23. doi:&#xa0;10.4149/neo_2012_066</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/neo_2012_066</ArticleId><ArticleId IdType="pubmed">22668016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho&#x161;ek J, Bartos M, Chud&#xed;k S, Dall&#x2019;Acqua S, Innocenti G, Kartal M, et al. . Natural compound cudraflavone B shows promising anti-inflammatory properties. vitro J Nat Prod. (2011) 74:614&#x2013;9. doi:&#xa0;10.1021/np100638h</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/np100638h</ArticleId><ArticleId IdType="pubmed">21319773</ArticleId></ArticleIdList></Reference><Reference><Citation>Malan&#xed;k M, Treml J, Lel&#xe1;kov&#xe1; V, Nykod&#xfd;mov&#xe1; D, Oravec M, Marek J, et al. . Anti-inflammatory and antioxidant properties of chemical constituents of Broussonetia papyrifera. Bioorg Chem. (2020) 104:104298. doi:&#xa0;10.1016/j.bioorg.2020.104298</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2020.104298</ArticleId><ArticleId IdType="pubmed">33011537</ArticleId></ArticleIdList></Reference><Reference><Citation>Han&#xe1;kov&#xe1; Z, Ho&#x161;ek J, Babula P, Dall&#x2019;Acqua S, V&#xe1;clav&#xed;k J, &#x160;mejkal K. C-Geranylated Flavanones from Paulownia tomentosa Fruits as Potential Anti-inflammatory Compounds Acting via Inhibition of TNF-&#x3b1; Production. J Nat Prod. (2015) 78:850&#x2013;63. doi:&#xa0;10.1021/acs.jnatprod.5b00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jnatprod.5b00005</ArticleId><ArticleId IdType="pubmed">25735399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe KL, Liu RH. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J Agric Food Chem. (2007) 55:8896&#x2013;907. doi:&#xa0;10.1021/jf0715166</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf0715166</ArticleId><ArticleId IdType="pubmed">17902627</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte D, Vale N. Evaluation of synergism in drug combinations and reference models for future orientations in oncology. Curr Res Pharmacol Drug Discov. (2022) 3:100110. doi:&#xa0;10.1016/j.crphar.2022.100110</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crphar.2022.100110</ArticleId><ArticleId IdType="pmc">PMC9127325</ArticleId><ArticleId IdType="pubmed">35620200</ArticleId></ArticleIdList></Reference><Reference><Citation>Abotaleb M, Samuel S, Varghese E, Varghese S, Kubatka P, Liskova A, et al. . Flavonoids in cancer and apoptosis. Cancers. (2018) 11:28. doi:&#xa0;10.3390/cancers11010028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11010028</ArticleId><ArticleId IdType="pmc">PMC6357032</ArticleId><ArticleId IdType="pubmed">30597838</ArticleId></ArticleIdList></Reference><Reference><Citation>Liskova A, Kubatka P, Samec M, Zubor P, Mlyncek M, Bielik T, et al. . Dietary phytochemicals targeting cancer stem cells. Molecules. (2019) 24:899. doi:&#xa0;10.3390/molecules24050899</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24050899</ArticleId><ArticleId IdType="pmc">PMC6429493</ArticleId><ArticleId IdType="pubmed">30836718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapinova A, Stefanicka P, Kubatka P, Zubor P, Uramova S, Kello M, et al. . Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. BioMed Pharmacother. (2017) 96:1465&#x2013;77. doi:&#xa0;10.1016/j.biopha.2017.11.134</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.11.134</ArticleId><ArticleId IdType="pubmed">29198744</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitzmann C. Characteristics and health benefits of phytochemicals. CMR. (2016) 23:69&#x2013;74. doi:&#xa0;10.1159/000444063</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444063</ArticleId><ArticleId IdType="pubmed">27160996</ArticleId></ArticleIdList></Reference><Reference><Citation>Farvid MS, Chen WY, Rosner BA, Tamimi RM, Willett WC, Eliassen AH. Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow-up. Int J Cancer. (2019) 144:1496&#x2013;510. doi:&#xa0;10.1002/ijc.31653</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.31653</ArticleId><ArticleId IdType="pmc">PMC6440478</ArticleId><ArticleId IdType="pubmed">29978479</ArticleId></ArticleIdList></Reference><Reference><Citation>Farvid MS, Barnett JB, Spence ND. Fruit and vegetable consumption and incident breast cancer: a systematic review and meta-analysis of prospective studies. Br J Cancer. (2021) 125:284&#x2013;98. doi:&#xa0;10.1038/s41416-021-01373-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-021-01373-2</ArticleId><ArticleId IdType="pmc">PMC8292326</ArticleId><ArticleId IdType="pubmed">34006925</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo E, Salas-Salvad&#xf3; J, Donat-Vargas C, Buil-Cosiales P, Estruch R, Ros E, et al. . Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: A randomized clinical trial. JAMA Intern Med. (2015) 175:1752&#x2013;60. doi:&#xa0;10.1001/jamainternmed.2015.4838</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.4838</ArticleId><ArticleId IdType="pubmed">26365989</ArticleId></ArticleIdList></Reference><Reference><Citation>Castell&#xf3; A, Poll&#xe1;n M, Buijsse B, Ruiz A, Casas AM, Baena-Ca&#xf1;ada JM, et al. . Spanish Mediterranean diet and other dietary patterns and breast cancer risk: Case-control EpiGEICAM study. Br J Cancer. (2014) 111:1454&#x2013;62. doi:&#xa0;10.1038/bjc.2014.434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2014.434</ArticleId><ArticleId IdType="pmc">PMC4183855</ArticleId><ArticleId IdType="pubmed">25101568</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hasasna H, Saleh A, Samri HA, Athamneh K, Attoub S, Arafat K, et al. . Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NF&#x3ba;B and nitric oxide pathways. Sci Rep. (2016) 6:21144. doi:&#xa0;10.1038/srep21144</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21144</ArticleId><ArticleId IdType="pmc">PMC4758048</ArticleId><ArticleId IdType="pubmed">26888313</ArticleId></ArticleIdList></Reference><Reference><Citation>Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. . Flavonoids in cancer metastasis. Cancers (Basel). (2020) 12:1498. doi:&#xa0;10.3390/cancers12061498</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12061498</ArticleId><ArticleId IdType="pmc">PMC7352928</ArticleId><ArticleId IdType="pubmed">32521759</ArticleId></ArticleIdList></Reference><Reference><Citation>Liskova A, Koklesova L, Samec M, Varghese E, Abotaleb M, Samuel SM, et al. . Implications of flavonoids as potential modulators of cancer neovascularity. J Cancer Res Clin Oncol. (2020) 146:3079&#x2013;96. doi:&#xa0;10.1007/s00432-020-03383-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-020-03383-8</ArticleId><ArticleId IdType="pmc">PMC11804697</ArticleId><ArticleId IdType="pubmed">32902794</ArticleId></ArticleIdList></Reference><Reference><Citation>Abotaleb M, Liskova A, Kubatka P, B&#xfc;sselberg D. Therapeutic potential of plant phenolic acids in the treatment of cancer. Biomolecules. (2020) 10:221. doi:&#xa0;10.3390/biom10020221</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10020221</ArticleId><ArticleId IdType="pmc">PMC7072661</ArticleId><ArticleId IdType="pubmed">32028623</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri R, Connolly BA, Brand MH, Bolling BW. Underutilized chokeberry (Aronia melanocarpa, Aronia arbutifolia, Aronia prunifolia) accessions are rich sources of anthocyanins, flavonoids, hydroxycinnamic acids, and proanthocyanidins. J Agric Food Chem. (2013) 61:8581&#x2013;8. doi:&#xa0;10.1021/jf402449q</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf402449q</ArticleId><ArticleId IdType="pubmed">23941506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Liu X, He J, Shao Y, Liu J, Wang Z, et al. . Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells. Biochimie. (2019) 162:107&#x2013;15. doi:&#xa0;10.1016/j.biochi.2019.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2019.03.004</ArticleId><ArticleId IdType="pubmed">30876970</ArticleId></ArticleIdList></Reference><Reference><Citation>
Black rice (Oryza sativa L.) extract modulates ultraviolet-induced expression of matrix metalloproteinases and procollagen in a skin cell model . Available online at: https://pubmed.ncbi.nlm.nih.gov/29484380/ (Accessed June 16, 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">29484380</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastorkov&#xe1; B, Ill&#xe9;s P, Dvo&#x159;&#xe1;k Z. Profiling of anthocyanidins against transcriptional activities of steroid and nuclear receptors. Drug Chem Toxicol. (2018) 41:434&#x2013;40. doi:&#xa0;10.1080/01480545.2017.1380659</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01480545.2017.1380659</ArticleId><ArticleId IdType="pubmed">29072505</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanashima N, Horie K, Maeda H. Phytoestrogenic activity of blackcurrant anthocyanins is partially mediated through estrogen receptor beta. Molecules. (2017) 23:74. doi:&#xa0;10.3390/molecules23010074</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23010074</ArticleId><ArticleId IdType="pmc">PMC6017224</ArticleId><ArticleId IdType="pubmed">29286333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X, Ning S. Cyanidin-3-glucoside attenuates the angiogenesis of breast cancer via inhibiting STAT3/VEGF pathway. Phytother Res. (2019) 33:81&#x2013;9. doi:&#xa0;10.1002/ptr.6201</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6201</ArticleId><ArticleId IdType="pubmed">30251280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Li H, Yang S, Ma W, Liu M, Guo S, et al. . Cyanidin-3-o-glucoside directly binds to ER&#x3b1;36 and inhibits EGFR-positive triple-negative breast cancer. Oncotarget. (2016) 7:68864&#x2013;82. doi:&#xa0;10.18632/oncotarget.12025</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.12025</ArticleId><ArticleId IdType="pmc">PMC5356596</ArticleId><ArticleId IdType="pubmed">27655695</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Peng C, Zhaojie L, Wei W. Chemopreventive and therapeutic properties of anthocyanins in breast cancer: A comprehensive review. Nutr Res. (2022) 107:48&#x2013;64. doi:&#xa0;10.1016/j.nutres.2022.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2022.08.005</ArticleId><ArticleId IdType="pubmed">36179643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubatka P, Mazurakova A, Koklesova L, Kuruc T, Samec M, Kajo K, et al. . Salvia officinalis L. exerts oncostatic effects in rodent and in vitro models of breast carcinoma. Front Pharmacol. (2024) 15:1216199. doi:&#xa0;10.3389/fphar.2024.1216199</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2024.1216199</ArticleId><ArticleId IdType="pmc">PMC10921418</ArticleId><ArticleId IdType="pubmed">38464730</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselly C, Denis M, Bourguignon A, Talhi N, Mathe D, Tourette A, et al. . The antitumor activity of combinations of cytotoxic chemotherapy and immune checkpoint inhibitors is model-dependent. Front Immunol. (2018) 9:2100. doi:&#xa0;10.3389/fimmu.2018.02100</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02100</ArticleId><ArticleId IdType="pmc">PMC6190749</ArticleId><ArticleId IdType="pubmed">30356816</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe1;r P, Sa&#x10d;kov&#xe1; V, Hr&#x10d;kov&#xe1; G, Deme&#x10d;kov&#xe1; V, Kassayov&#xe1; M, Bojkov&#xe1; B, et al. . Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model. Oncol Rep. (2017) 37:368&#x2013;78. doi:&#xa0;10.3892/or.2016.5265</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2016.5265</ArticleId><ArticleId IdType="pubmed">27878284</ArticleId></ArticleIdList></Reference><Reference><Citation>Deme&#x10d;kov&#xe1; V, Sol&#xe1;r P, Hr&#x10d;kov&#xe1; G, Mudro&#x148;ov&#xe1; D, Bojkov&#xe1; B, Kassayov&#xe1; M, et al. . Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer. BioMed Pharmacother. (2017) 89:245&#x2013;56. doi:&#xa0;10.1016/j.biopha.2017.02.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.02.034</ArticleId><ArticleId IdType="pubmed">28235687</ArticleId></ArticleIdList></Reference><Reference><Citation>Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett. (1996) 104:43&#x2013;8. doi:&#xa0;10.1016/0304-3835(96)04227-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3835(96)04227-9</ArticleId><ArticleId IdType="pubmed">8640744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishayee A, Mandal A, Bhattacharyya P, Bhatia D. Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr Cancer. (2016) 68:120&#x2013;30. doi:&#xa0;10.1080/01635581.2016.1115094</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2016.1115094</ArticleId><ArticleId IdType="pmc">PMC4784500</ArticleId><ArticleId IdType="pubmed">26699876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D&#x2019;Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). (2016) 8:603&#x2013;19. doi:&#xa0;10.18632/aging.100934</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100934</ArticleId><ArticleId IdType="pmc">PMC4925817</ArticleId><ArticleId IdType="pubmed">27019364</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouad YA, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res. (2017) 7:1016&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446472</ArticleId><ArticleId IdType="pubmed">28560055</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Meng Y, Xie C, Zhu J, Wang X, Li Y, et al. . Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/&#x3b2;-catenin pathway. J Cell Biochem. (2018) 119:4134&#x2013;41. doi:&#xa0;10.1002/jcb.26613</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26613</ArticleId><ArticleId IdType="pubmed">29243835</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith CD, Bond DR, Jankowski H, Weidenhofer J, Stathopoulos CE, Roach PD, et al. . The olive biophenols oleuropein and hydroxytyrosol selectively reduce proliferation, influence the cell cycle, and induce apoptosis in pancreatic cancer cells. Int J Mol Sci. (2018) 19:1937. doi:&#xa0;10.3390/ijms19071937</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19071937</ArticleId><ArticleId IdType="pmc">PMC6073890</ArticleId><ArticleId IdType="pubmed">30004416</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghadam ER, Ang HL, Asnaf SE, Zabolian A, Saleki H, Yavari M, et al. . Broad-spectrum preclinical antitumor activity of chrysin: current trends and future perspectives. Biomolecules. (2020) 10:1374. doi:&#xa0;10.3390/biom10101374</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10101374</ArticleId><ArticleId IdType="pmc">PMC7600196</ArticleId><ArticleId IdType="pubmed">32992587</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardsen E, Andersen S, Al-Saad S, Rakaee M, Nordby Y, Pedersen MI, et al. . Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort. PloS One. (2017) 12:e0186852. doi:&#xa0;10.1371/journal.pone.0186852</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186852</ArticleId><ArticleId IdType="pmc">PMC5687762</ArticleId><ArticleId IdType="pubmed">29141018</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams LS, Phung S, Yee N, Seeram NP, Li L, Chen S. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res. (2010) 70:3594&#x2013;605. doi:&#xa0;10.1158/0008-5472.CAN-09-3565</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-3565</ArticleId><ArticleId IdType="pmc">PMC2862148</ArticleId><ArticleId IdType="pubmed">20388778</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kumar N, Singh R, Saminathan M, Singh KP, Dhama K, Milton AAP, et al. . Therapeutic effect of hydroethanolic extract of Trianthema portulacastrum L. against N-Nitroso-N-Methylurea-induced mammary tumors in Wistar rats. IJTK. (2020) 19:406&#x2013;15. http://nopr.niscpr.res.in/handle/123456789/54343.</Citation></Reference><Reference><Citation>Yu SS, Spicer DV, Hawes D, Tseng C-C, Yang CS, Pike MC, et al. . Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Front Oncol. (2013) 3:298. doi:&#xa0;10.3389/fonc.2013.00298</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2013.00298</ArticleId><ArticleId IdType="pmc">PMC3861892</ArticleId><ArticleId IdType="pubmed">24380073</ArticleId></ArticleIdList></Reference><Reference><Citation>Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, et al. . Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. (2018) 19:1264. doi:&#xa0;10.3390/ijms19041264</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19041264</ArticleId><ArticleId IdType="pmc">PMC5979509</ArticleId><ArticleId IdType="pubmed">29690653</ArticleId></ArticleIdList></Reference><Reference><Citation>Batmomolin A, Ahsan A, I. Wiyasa WA, Santoso S. Ethanolic extract of Moringa oleifera leaves improve inflammation, angiogenesis, and blood pressure in rat model of preeclampsia. J App Pharm Sci. (2020) 10:52&#x2013;7. doi:&#xa0;10.7324/JAPS.2020.10806</Citation><ArticleIdList><ArticleId IdType="doi">10.7324/JAPS.2020.10806</ArticleId></ArticleIdList></Reference><Reference><Citation>Zunica ERM, Yang S, Coulter A, White C, Kirwan JP, Gilmore LA. Moringa oleifera seed extract concomitantly supplemented with chemotherapy worsens tumor progression in mice with triple negative breast cancer and obesity. Nutrients. (2021) 13:2923. doi:&#xa0;10.3390/nu13092923</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13092923</ArticleId><ArticleId IdType="pmc">PMC8472177</ArticleId><ArticleId IdType="pubmed">34578801</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ataby IA, Talib WH. Daily consumption of lemon and ginger herbal infusion caused tumor regression and activation of the immune system in a mouse model of breast cancer. Front Nutr. (2022) 9:829101. doi:&#xa0;10.3389/fnut.2022.829101</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.829101</ArticleId><ArticleId IdType="pmc">PMC9043650</ArticleId><ArticleId IdType="pubmed">35495945</ArticleId></ArticleIdList></Reference><Reference><Citation>Telang NT. Stem cell models for breast and colon cancer: experimental approach for drug discovery. Int J Mol Sci. (2022) 23:9223. doi:&#xa0;10.3390/ijms23169223</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23169223</ArticleId><ArticleId IdType="pmc">PMC9409032</ArticleId><ArticleId IdType="pubmed">36012489</ArticleId></ArticleIdList></Reference><Reference><Citation>Deldar Abad Paskeh M, Asadi S, Zabolian A, Saleki H, Khoshbakht MA, Sabet S, et al. . Targeting cancer stem cells by dietary agents: an important therapeutic strategy against human Malignancies. Int J Mol Sci. (2021) 22:11669. doi:&#xa0;10.3390/ijms222111669</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111669</ArticleId><ArticleId IdType="pmc">PMC8584029</ArticleId><ArticleId IdType="pubmed">34769099</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabtree JS, Miele L. Breast cancer stem cells. Biomedicines. (2018) 6:77. doi:&#xa0;10.3390/biomedicines6030077</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines6030077</ArticleId><ArticleId IdType="pmc">PMC6163894</ArticleId><ArticleId IdType="pubmed">30018256</ArticleId></ArticleIdList></Reference><Reference><Citation>Shima H, Yamada A, Ishikawa T, Endo I. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy? Gland Surg. (2017) 6:82&#x2013;8. doi:&#xa0;10.21037/gs.2016.08.03</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/gs.2016.08.03</ArticleId><ArticleId IdType="pmc">PMC5293654</ArticleId><ArticleId IdType="pubmed">28210556</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu TT, Li XF, Wang L, Yang JL. CD133 expressionand clinicopathologic significance in benign and Malignant breast lesions. Cancer biomark. (2020) 28:293&#x2013;9. doi:&#xa0;10.3233/CBM-190196</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CBM-190196</ArticleId><ArticleId IdType="pubmed">32390595</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Singh P, Pradhan A, Srivastava R, Sahoo SK. Reprogramming cancer stem-like cells with nanoforskolin enhances the efficacy of paclitaxel in targeting breast cancer. ACS Appl Bio Mater. (2021) 4:3670&#x2013;85. doi:&#xa0;10.1021/acsabm.1c00141</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.1c00141</ArticleId><ArticleId IdType="pubmed">35014452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S-H, Singh SV. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide. Mol Carcinog. (2022) 61:752&#x2013;63. doi:&#xa0;10.1002/mc.23415</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.23415</ArticleId><ArticleId IdType="pmc">PMC9262868</ArticleId><ArticleId IdType="pubmed">35512572</ArticleId></ArticleIdList></Reference><Reference><Citation>Prajapati KS, Shuaib M, Kushwaha PP, Singh AK, Kumar S. Identification of cancer stemness related miRNA(s) using integrated bioinformatics analysis and in vitro validation. 3 Biotech. (2021) 11:446. doi:&#xa0;10.1007/s13205-021-02994-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-021-02994-3</ArticleId><ArticleId IdType="pmc">PMC8460704</ArticleId><ArticleId IdType="pubmed">34631347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mese G, Yalcin-Ozuysal O. Epigenetics of Breast Cancer: DNA Methylome and Global Histone Modifications. In: Mishra MK, Bishnupuri KS, editors. Epigenetic Advancements in Cancer. Springer International Publishing, Cham: (2016). p. 207&#x2013;28. doi:&#xa0;10.1007/978-3-319-24951-3_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-24951-3_9</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasculli B, Barbano R, Parrella P. Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine. Semin Cancer Biol. (2018) 51:22&#x2013;35. doi:&#xa0;10.1016/j.semcancer.2018.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2018.01.007</ArticleId><ArticleId IdType="pubmed">29339244</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsli-Ceppioglu S, Dagdemir A, Judes G, Ngollo M, Penault-Llorca F, Pajon A, et al. . Epigenetic mechanisms of breast cancer: an update of the current knowledge. Epigenomics. (2014) 6:651&#x2013;64. doi:&#xa0;10.2217/epi.14.59</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi.14.59</ArticleId><ArticleId IdType="pubmed">25531258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B, Ghosh K, Kanade SR. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines. Biofactors. (2019) 45:818&#x2013;29. doi:&#xa0;10.1002/biof.1544</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1544</ArticleId><ArticleId IdType="pubmed">31317586</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston K, Udayakumar N, Lewis K, Tollefsbol T. A novel combination of withaferin A and sulforaphane inhibits epigenetic machinery, cellular viability and induces apoptosis of breast cancer cells. IJMS. (2017) 18:1092. doi:&#xa0;10.3390/ijms18051092</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18051092</ArticleId><ArticleId IdType="pmc">PMC5455001</ArticleId><ArticleId IdType="pubmed">28534825</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston KJ, Paul B, Nozell S, Rajbhandari R, Tollefsbol TO. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms. Exp Cell Res. (2018) 368:67&#x2013;74. doi:&#xa0;10.1016/j.yexcr.2018.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.04.015</ArticleId><ArticleId IdType="pmc">PMC6733260</ArticleId><ArticleId IdType="pubmed">29689276</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolarz B, Durczy&#x144;ski A, Romanowicz H, Szy&#x142;&#x142;o K, Hogendorf P. miRNAs in cancer (Review of literature). Int J Mol Sci. (2022) 23:2805. doi:&#xa0;10.3390/ijms23052805</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052805</ArticleId><ArticleId IdType="pmc">PMC8910953</ArticleId><ArticleId IdType="pubmed">35269947</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Mo Y-Y. Role of microRNAs in breast cancer. Cancer Biol Ther. (2013) 14:201&#x2013;12. doi:&#xa0;10.4161/cbt.23296</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cbt.23296</ArticleId><ArticleId IdType="pmc">PMC3595302</ArticleId><ArticleId IdType="pubmed">23291983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahiri A, Leivonen S-K, L&#xfc;ders T, Steinfeld I, Ragle Aure M, Geisler J, et al. . Deregulation of cancer-related miRNAs is a common event in both benign and Malignant human breast tumors. Carcinogenesis. (2014) 35:76&#x2013;85. doi:&#xa0;10.1093/carcin/bgt333</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgt333</ArticleId><ArticleId IdType="pubmed">24104550</ArticleId></ArticleIdList></Reference><Reference><Citation>Samec M, Liskova A, Kubatka P, Uramova S, Zubor P, Samuel SM, et al. . The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression. J Cancer Res Clin Oncol. (2019) 145:1665&#x2013;79. doi:&#xa0;10.1007/s00432-019-02940-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-019-02940-0</ArticleId><ArticleId IdType="pmc">PMC11810323</ArticleId><ArticleId IdType="pubmed">31127362</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar S, Syed RU, Bin Break MK, Alsukaybi RH, Alanzi RA, Alshobrmi AM, et al. . The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling. Pathol - Res Pract. (2024) 253:155018. doi:&#xa0;10.1016/j.prp.2023.155018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2023.155018</ArticleId><ArticleId IdType="pubmed">38070222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Bian S, Yang CS. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1&#x3b1;. Carcinogenesis. (2011) 32:1881&#x2013;9. doi:&#xa0;10.1093/carcin/bgr218</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgr218</ArticleId><ArticleId IdType="pmc">PMC3220612</ArticleId><ArticleId IdType="pubmed">21965273</ArticleId></ArticleIdList></Reference><Reference><Citation>Attari F, Keighobadi F, Abdollahi M, Arefian E, Lotfizadeh R, Sepehri H, et al. . Inhibitory effect of flavonoid xanthomicrol on triple-negative breast tumor via regulation of cancer-associated microRNAs. Phytother Res. (2021) 35:1967&#x2013;82. doi:&#xa0;10.1002/ptr.6940</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6940</ArticleId><ArticleId IdType="pubmed">33217075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D-W, Zhang H-D, Mao L, Mao C-F, Chen W, Cui M, et al. . Luteolin inhibits breast cancer development and progression in vitro and in vivo by suppressing notch signaling and regulating miRNAs. Cell Physiol Biochem. (2015) 37:1693&#x2013;711. doi:&#xa0;10.1159/000438535</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000438535</ArticleId><ArticleId IdType="pubmed">26545287</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasek K, Kubatka P, Samec M, Liskova A, Smejkal K, Vybohova D, et al. . DNA methylation status in cancer disease: modulations by plant-derived natural compounds and dietary interventions. Biomolecules. (2019) 9:289. doi:&#xa0;10.3390/biom9070289</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9070289</ArticleId><ArticleId IdType="pmc">PMC6680848</ArticleId><ArticleId IdType="pubmed">31323834</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietri MT, D&#x2019;Elia G, Benincasa G, Ferraro G, Caliendo G, Nicoletti GF, et al. . DNA methylation and breast cancer: A way forward (Review). Int J Oncol. (2021) 59:1&#x2013;12. doi:&#xa0;10.3892/ijo.2021.5278</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2021.5278</ArticleId><ArticleId IdType="pubmed">34726251</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Ao L, Zhou Z, Cui Z, Zhou Y, Yuan X, et al. . CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Biochem Biophys Res Commun. (2010) 402:507&#x2013;14. doi:&#xa0;10.1016/j.bbrc.2010.10.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.10.061</ArticleId><ArticleId IdType="pubmed">20970405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L-S, Kuo C-T, Huang TH-M, Yearsley M, Oshima K, Stoner GD, et al. . Black raspberries protectively regulate methylation of Wnt pathway genes in precancerous colon tissue. Cancer Prev Res (Phila). (2013) 6:1317&#x2013;27. doi:&#xa0;10.1158/1940-6207.CAPR-13-0077</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-13-0077</ArticleId><ArticleId IdType="pmc">PMC3902171</ArticleId><ArticleId IdType="pubmed">24129635</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y-W, Gu F, Dombkowski A, Wang L-S, Stoner GD. Black raspberries demethylate Sfrp4, a WNT pathway antagonist, in rat esophageal squamous cell papilloma. Mol Carcinog. (2016) 55:1867&#x2013;75. doi:&#xa0;10.1002/mc.22435</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.22435</ArticleId><ArticleId IdType="pubmed">27696538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai K, Mazurakova A, Koklesova L, Kubatka P, B&#xfc;sselberg D. Flavonoids synergistically enhance the anti-glioblastoma effects of chemotherapeutic drugs. Biomolecules. (2021) 11:1841. doi:&#xa0;10.3390/biom11121841</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11121841</ArticleId><ArticleId IdType="pmc">PMC8699565</ArticleId><ArticleId IdType="pubmed">34944485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H, Yuan B, Hu X, Okazaki M. Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents. Am J Cancer Res. (2019) 9:1517&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726994</ArticleId><ArticleId IdType="pubmed">31497340</ArticleId></ArticleIdList></Reference><Reference><Citation>Polivka J, Altun I, Golubnitschaja O. Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine. EPMA J. (2018) 9:1&#x2013;13. doi:&#xa0;10.1007/s13167-018-0129-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-018-0129-7</ArticleId><ArticleId IdType="pmc">PMC5833893</ArticleId><ArticleId IdType="pubmed">29515683</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, B&#xfc;sselberg D, et al. . Caution, &#x201c;normal&#x201d; BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021. EPMA J. (2021) 12:243&#x2013;64. doi:&#xa0;10.1007/s13167-021-00251-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-021-00251-4</ArticleId><ArticleId IdType="pmc">PMC8368050</ArticleId><ArticleId IdType="pubmed">34422142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Yan Y, Guo Z, Hou H, Garcia M, Tan X, et al. . All around suboptimal health &#x2014; a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine. EPMA J. (2021) 12:403&#x2013;33. doi:&#xa0;10.1007/s13167-021-00253-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-021-00253-2</ArticleId><ArticleId IdType="pmc">PMC8435766</ArticleId><ArticleId IdType="pubmed">34539937</ArticleId></ArticleIdList></Reference><Reference><Citation>Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, et al. . Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J. (2020) 11:603&#x2013;27. doi:&#xa0;10.1007/s13167-020-00226-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-020-00226-x</ArticleId><ArticleId IdType="pmc">PMC7594983</ArticleId><ArticleId IdType="pubmed">33144898</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich H, Patjoshi S, Yeghiazaryan K, Kehrer C, Kuhn W, Golubnitschaja O. Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification. EPMA J. (2018) 9:175&#x2013;86. doi:&#xa0;10.1007/s13167-018-0131-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-018-0131-0</ArticleId><ArticleId IdType="pmc">PMC5972143</ArticleId><ArticleId IdType="pubmed">29896316</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fr&#xf6;hlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver Malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J. (2020) 11:505&#x2013;15. doi:&#xa0;10.1007/s13167-020-00221-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-020-00221-2</ArticleId><ArticleId IdType="pmc">PMC7416811</ArticleId><ArticleId IdType="pubmed">32839667</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39415281</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-8935</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Epigenetics &amp; chromatin</Title><ISOAbbreviation>Epigenetics Chromatin</ISOAbbreviation></Journal><ArticleTitle>Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy.</ArticleTitle><Pagination><StartPage>31</StartPage><MedlinePgn>31</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">31</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13072-024-00554-6</ELocationID><Abstract><AbstractText>Cancer has arisen from both genetic mutations and epigenetic changes, making epigenetics a crucial area of research for innovative cancer prevention and treatment strategies. This dual perspective has propelled epigenetics into the forefront of cancer research. This review highlights the important roles of DNA methylation, histone modifications and non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs) and long non-coding RNAs, which are key regulators of cancer-related gene expression. It explores the potential of epigenetic-based therapies to revolutionize patient outcomes by selectively modulating specific epigenetic markers involved in tumorigenesis. The review examines promising epigenetic biomarkers for early cancer detection and prognosis. It also highlights recent progress in oligonucleotide-based therapies, including antisense oligonucleotides (ASOs) and antimiRs, to precisely modulate epigenetic processes. Furthermore, the concept of epigenetic editing is discussed, providing insight into the future role of precision medicine for cancer patients. The integration of nanomedicine into cancer therapy has been explored and offers innovative approaches to improve therapeutic efficacy. This comprehensive review of recent advances in epigenetic-based cancer therapy seeks to advance the field of precision oncology, ultimately culminating in improved patient outcomes in the fight against cancer.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prabhakaran</LastName><ForeName>Rajkumar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Central Research Facility, Santosh Deemed to be University, Ghaziabad, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thamarai</LastName><ForeName>Rajkumar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UGC Dr. D.S. Kothari Postdoctoral Fellow, Department of Animal Science, Manonmaniam Sundaranar University, Tirunelveli, Tamil Nadu, 627012, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivasamy</LastName><ForeName>Sivabalan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Central Research Facility, Santosh Deemed to be University, Ghaziabad, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhandayuthapani</LastName><ForeName>Sivanesan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Central Research Facility, Santosh Deemed to be University, Ghaziabad, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batra</LastName><ForeName>Jyoti</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Research Facility, Santosh Deemed to be University, Ghaziabad, UP, India. Dean.research@santosh.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamaraj</LastName><ForeName>Chinnaperumal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Interdisciplinary Institute of Indian System of Medicine, Directorate of Research, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India. kamarajc@srmist.edu.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karthik</LastName><ForeName>Krishnasamy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, Vel Tech Rangarajan Dr. Sagunthala R&amp;D Institute of Science and Technology, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Mohd Asif</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Economics, Kardan University, Parwane Du, 1001, Kabul, Afghanistan. m.asif@kardan.edu.af.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Research and Development, Lovely Professional University, Phagwara, Punjab, 144001, India. m.asif@kardan.edu.af.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Research Impact and Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, 140401, India. m.asif@kardan.edu.af.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallik</LastName><ForeName>Saurav</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Harvard T H Chan School of Public Health, Boston, Massachusetts, 02115, United States. sauravmtech2@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology &amp; Toxicology, University of Arizona, Tucson, AZ, 85721, USA. sauravmtech2@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epigenetics Chromatin</MedlineTA><NlmUniqueID>101471619</NlmUniqueID><ISSNLinking>1756-8935</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049329" MajorTopicYN="N">Nanostructures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">Histone modifications</Keyword><Keyword MajorTopicYN="N">Nanomedicine</Keyword><Keyword MajorTopicYN="N">Non-coding RNAs epigenetic therapy</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39415281</ArticleId><ArticleId IdType="pmc">PMC11484394</ArticleId><ArticleId IdType="doi">10.1186/s13072-024-00554-6</ArticleId><ArticleId IdType="pii">10.1186/s13072-024-00554-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cusenza VY, et al. The lncRNA epigenetics: the significance of m6A and m5C lncRNA modifications in cancer. Front Oncol. 2023;13:1063636. 10.3389/fonc.2023.1063636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10033960</ArticleId><ArticleId IdType="pubmed">36969033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nencioni A, et al. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer. 2018;18(11):707&#x2013;19. 10.1038/s41568-018-0061-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938162</ArticleId><ArticleId IdType="pubmed">30327499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203&#x2013;22. 10.1038/nrd.2016.246.</Citation><ArticleIdList><ArticleId IdType="pubmed">28209991</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Emerging epigenetic-based nanotechnology for cancer therapy: modulating the tumor microenvironment. Adv Sci. 2023;10(7): e2206169. 10.1002/advs.202206169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9982594</ArticleId><ArticleId IdType="pubmed">36599655</ArticleId></ArticleIdList></Reference><Reference><Citation>Janin M, Davalos V, Esteller M. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. Cancer Metastasis Rev. 2023. 10.1007/s10555-023-10120-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10713773</ArticleId><ArticleId IdType="pubmed">37369946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu DT, Ngo AD, Wu CC. Epigenetics in cancer development, diagnosis and therapy. Prog Mol Biol Transl Sci. 2023;198:73&#x2013;92. 10.1016/bs.pmbts.2023.01.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">37225325</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379(6632):eaaw3835. 10.1126/science.aaw3835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249049</ArticleId><ArticleId IdType="pubmed">36758093</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihl C, et al. Improving the efficacy of photodynamic therapy for actinic keratosis: a comprehensive review of pharmacological pretreatment strategies. Photodiagnosis Photodyn Ther. 2023;43:103703. 10.1016/j.pdpdt.2023.103703.</Citation><ArticleIdList><ArticleId IdType="pubmed">37429460</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthy K, et al. Improved specificity for breast cancer screening using an oncogenic (miRNA-21) and a gene suppressor (miRNA-195) miRNA in the serum for a point of care (POC) screening solution. Biomed Environ Sci. 2023;36(6):549&#x2013;52. 10.3967/bes2023.067.</Citation><ArticleIdList><ArticleId IdType="pubmed">37424249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. LncRNA MCM3AP-AS1 enhances cell invasion, migration and tumor formation in non-small cell lung cancer cells by epigenetic inhibition of miR-34a. Curr Pharm Biotechnol. 2023. 10.2174/1389201024666230223113047.</Citation><ArticleIdList><ArticleId IdType="pubmed">36815649</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir HK, et al. Heart disease and cancer deaths&#x2014;trends and projections in the United States, 1969&#x2013;2020. Prev Chronic Dis. 2016;13:E157. 10.5888/pcd13.160211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127176</ArticleId><ArticleId IdType="pubmed">27854420</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783&#x2013;91. 10.1097/CM9.0000000000001474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104205</ArticleId><ArticleId IdType="pubmed">33734139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferlay J, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. 10.1002/ijc.33588.</Citation><ArticleIdList><ArticleId IdType="pubmed">33818764</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura J, et al. Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. Front Endocrinol. 2023;14:1191311. 10.3389/fendo.2023.1191311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10349394</ArticleId><ArticleId IdType="pubmed">37455903</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh VK, Kainat KM, Sharma PK. Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer. Vitam Horm. 2023;122:253&#x2013;82. 10.1016/bs.vh.2022.11.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">36863797</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczepanek J, et al. Harnessing epigenetics for breast cancer therapy: the role of DNA methylation, histone modifications, and MicroRNA. Int J Mol Sci. 2023. 10.3390/ijms24087235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10138995</ArticleId><ArticleId IdType="pubmed">37108398</ArticleId></ArticleIdList></Reference><Reference><Citation>Arif KMT, et al. Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets. Cancers. 2020. 10.3390/cancers12102922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600069</ArticleId><ArticleId IdType="pubmed">33050637</ArticleId></ArticleIdList></Reference><Reference><Citation>Anchimowicz J, Wyzewski Z, Switlik W. Role of the glucosinolates in cancer epigenetics. Postepy Biochem. 2023;69(2):96&#x2013;103. 10.18388/pb.2023_478.</Citation><ArticleIdList><ArticleId IdType="pubmed">37493557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu Z, et al. Sequential ubiquitination and phosphorylation epigenetics reshaping by MG132-loaded Fe-MOF disarms treatment resistance to repulse metastatic colorectal cancer. Adv Sci. 2023;10(23): e2301638. 10.1002/advs.202301638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10427397</ArticleId><ArticleId IdType="pubmed">37303273</ArticleId></ArticleIdList></Reference><Reference><Citation>Clermont PL. Epigenetics-based diagnostic and therapeutic strategies: shifting the paradigm in prostate cancer. Epigenomics. 2023;15(2):75&#x2013;87. 10.2217/epi-2023-0045.</Citation><ArticleIdList><ArticleId IdType="pubmed">36974615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragavi R, et al. Epigenetics regulation of prostate cancer: biomarker and therapeutic potential. Urol Oncol. 2023;41(8):340&#x2013;53. 10.1016/j.urolonc.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">37032230</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TO, Lam LHT, Le NQK. Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer. Funct Integr Genom. 2023;23(3):256. 10.1007/s10142-023-01185-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">37523012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, et al. Lactate-induced protein lactylation: a bridge between epigenetics and metabolic reprogramming in cancer. Cell Prolif. 2023;56(10): e13478. 10.1111/cpr.13478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10542650</ArticleId><ArticleId IdType="pubmed">37060186</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CY, et al. Significance of hypermethylation of tumor-suppressor genes PTGER4 and ZNF43 at CpG sites in the prognosis of colorectal cancer. Int J Mol Sci. 2022. 10.3390/ijms231810225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499344</ArticleId><ArticleId IdType="pubmed">36142151</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27&#x2013;56. 10.1016/B978-0-12-380866-0.60002-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">20920744</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Xu L. Epigenetic function of TET Family, 5-methylcytosine, and 5-hydroxymethylcytosine in hematologic malignancies. Oncol Res Treat. 2019;42(6):309&#x2013;18. 10.1159/000498947.</Citation><ArticleIdList><ArticleId IdType="pubmed">31055566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai HC, Baylin SB. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 2011;21(3):502&#x2013;17. 10.1038/cr.2011.24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3193419</ArticleId><ArticleId IdType="pubmed">21321605</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinjo K, Kondo Y. Targeting cancer epigenetics: linking basic biology to clinical medicine. Adv Drug Deliv Rev. 2015;95:56&#x2013;64. 10.1016/j.addr.2015.10.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">26494398</ArticleId></ArticleIdList></Reference><Reference><Citation>Villicana S, Bell JT. Genetic impacts on DNA methylation: research findings and future perspectives. Genome Biol. 2021;22(1):127. 10.1186/s13059-021-02347-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086086</ArticleId><ArticleId IdType="pubmed">33931130</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12&#x2013;27. 10.1016/j.cell.2012.06.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">22770212</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrehaili AA, et al. Evaluation of TET family gene expression and 5-hydroxymethylcytosine as potential epigenetic markers in non-small cell lung cancer. In Vivo. 2023;37(1):445&#x2013;53. 10.21873/invivo.13098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843776</ArticleId><ArticleId IdType="pubmed">36593050</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado-Pelaez M, Bueno-Costa A, Esteller M. Single cell cancer epigenetics. Trends Cancer. 2022;8(10):820&#x2013;38. 10.1016/j.trecan.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">35821003</ArticleId></ArticleIdList></Reference><Reference><Citation>Du P, et al. The miR-27a-3p/FTO axis modifies hypoxia-induced malignant behaviors of glioma cells. Acta Biochim Biophys Sin. 2023;55(1):103&#x2013;16. 10.3724/abbs.2023002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10157519</ArticleId><ArticleId IdType="pubmed">36718644</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012&#x2013;27. 10.1016/j.tig.2021.05.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">34120771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3&#x2013;55. 10.1007/978-981-15-3449-2_1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32445090</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubber I, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176&#x2013;90. 10.1016/j.eururo.2023.03.029.</Citation><ArticleIdList><ArticleId IdType="pubmed">37198015</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller L, et al. The epidemiology of colorectal cancer in younger and older patients. Dtsch Arztebl Int. 2023;120(16):277&#x2013;83. 10.3238/arztebl.m2023.0041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10304004</ArticleId><ArticleId IdType="pubmed">36919357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mederos N, et al. Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer. ESMO Open. 2020;5(Suppl 4): e000796. 10.1136/esmoopen-2020-000796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643520</ArticleId><ArticleId IdType="pubmed">33148544</ArticleId></ArticleIdList></Reference><Reference><Citation>Abood RA, Abdahmed KA, Mazyed SS. Epidemiology of different types of cancers reported in Basra Iraq. Sultan Qaboos Univ Med J. 2020;20(3):e295&#x2013;300. 10.18295/squmj.2020.20.03.008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574812</ArticleId><ArticleId IdType="pubmed">33110644</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra P, et al. Translational modeling identifies synergy between nanoparticle-delivered miRNA-22 and standard-of-care drugs in triple-negative breast cancer. Pharm Res. 2022;39(3):511&#x2013;28. 10.1007/s11095-022-03176-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8986735</ArticleId><ArticleId IdType="pubmed">35294699</ArticleId></ArticleIdList></Reference><Reference><Citation>Perepelyuk M, et al. Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins. Int J Nanomed. 2016;11:3533&#x2013;44. 10.2147/IJN.S110488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970448</ArticleId><ArticleId IdType="pubmed">27555773</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu A, et al. Quantitative zeptomolar imaging of miRNA cancer markers with nanoparticle assemblies. Proc Natl Acad Sci U S A. 2019;116(9):3391&#x2013;400. 10.1073/pnas.1810764116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6397542</ArticleId><ArticleId IdType="pubmed">30808736</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberti A, et al. Epigenetics in cancer therapy and nanomedicine. Clin Epigenetics. 2019;11(1):81. 10.1186/s13148-019-0675-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524244</ArticleId><ArticleId IdType="pubmed">31097014</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda Furtado CL, et al. Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics. 2019;14(12):1164&#x2013;76. 10.1080/15592294.2019.1640546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6791710</ArticleId><ArticleId IdType="pubmed">31282279</ArticleId></ArticleIdList></Reference><Reference><Citation>Nebbioso A, et al. Cancer epigenetics: moving forward. PLoS Genet. 2018;14(6): e1007362. 10.1371/journal.pgen.1007362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991666</ArticleId><ArticleId IdType="pubmed">29879107</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva L, Alvarez-Errico D, Esteller M. The contribution of epigenetics to cancer immunotherapy. Trends Immunol. 2020;41(8):676&#x2013;91. 10.1016/j.it.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">32622854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, et al. Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types. Epigenetics. 2023;18(1):2222245. 10.1080/15592294.2023.2222245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10259304</ArticleId><ArticleId IdType="pubmed">37300822</ArticleId></ArticleIdList></Reference><Reference><Citation>Usui G, et al. DNA methylation and genetic aberrations in gastric cancer. Digestion. 2021;102(1):25&#x2013;32. 10.1159/000511243.</Citation><ArticleIdList><ArticleId IdType="pubmed">33070127</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat A, et al. Reactome diagram viewer: data structures and strategies to boost performance. Bioinformatics. 2018;34(7):1208&#x2013;14. 10.1093/bioinformatics/btx752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030826</ArticleId><ArticleId IdType="pubmed">29186351</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao YL, Pecot CV. Targeting epigenetics in lung cancer. Cold Spring Harb Perspect Med. 2021. 10.1101/cshperspect.a038000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168531</ArticleId><ArticleId IdType="pubmed">32900703</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata A, et al. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma. Oncotarget. 2015;6(27):23372&#x2013;82. 10.18632/oncotarget.4281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4695124</ArticleId><ArticleId IdType="pubmed">26093090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. m6A modification in RNA: biogenesis, functions and roles in gliomas. J Exp Clin Cancer Res. 2020;39(1):192. 10.1186/s13046-020-01706-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500025</ArticleId><ArticleId IdType="pubmed">32943100</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biol. 2019;20(1):245. 10.1186/s13059-019-1870-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6868810</ArticleId><ArticleId IdType="pubmed">31747960</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhu J, Ding L. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjogren&#x2019;s syndrome. Cell Signal. 2023;106:110650. 10.1016/j.cellsig.2023.110650.</Citation><ArticleIdList><ArticleId IdType="pubmed">36935085</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeck J, Esteller M. Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia. 2010;15(1):5&#x2013;17. 10.1007/s10911-010-9165-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824126</ArticleId><ArticleId IdType="pubmed">20101446</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao D, et al. An m6A/m5C/m1A/m7G-Related Long non-coding RNA signature to predict prognosis and immune features of glioma. Front Genet. 2022;13:903117. 10.3389/fgene.2022.903117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9178125</ArticleId><ArticleId IdType="pubmed">35692827</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, et al. The m6A/m5C/m1A regulated gene signature predicts the prognosis and correlates with the immune status of hepatocellular carcinoma. Front Immunol. 2022;13:918140. 10.3389/fimmu.2022.918140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9272990</ArticleId><ArticleId IdType="pubmed">35833147</ArticleId></ArticleIdList></Reference><Reference><Citation>Saliminejad K, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451&#x2013;65. 10.1002/jcp.27486.</Citation><ArticleIdList><ArticleId IdType="pubmed">30471116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321&#x2013;33. 10.1038/nrc3932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859809</ArticleId><ArticleId IdType="pubmed">25998712</ArticleId></ArticleIdList></Reference><Reference><Citation>Yague-Sanz C, et al. Co-transcriptional RNA cleavage by Drosha homolog Pac1 triggers transcription termination in fission yeast. Nucleic Acids Res. 2021;49(15):8610&#x2013;24. 10.1093/nar/gkab654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8421224</ArticleId><ArticleId IdType="pubmed">34352089</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou Zeid LY, et al. Caspase-mediated cleavage of miRNA processing proteins Drosha, DGCR8, Dicer, and TRBP2 in heat-shocked cells and its inhibition by HSP70 overexpression. Cell Stress Chaperones. 2022;27(1):11&#x2013;25. 10.1007/s12192-021-01242-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8821752</ArticleId><ArticleId IdType="pubmed">34719748</ArticleId></ArticleIdList></Reference><Reference><Citation>Calado A, et al. Exportin-5-mediated nuclear export of eukaryotic elongation factor 1A and tRNA. EMBO J. 2002;21(22):6216&#x2013;24. 10.1093/emboj/cdf620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC137209</ArticleId><ArticleId IdType="pubmed">12426393</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YY, Kim H, Kim VN. Sequence determinant of small RNA production by DICER. Nature. 2023;615(7951):323&#x2013;30. 10.1038/s41586-023-05722-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">36813957</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumeier J, Meister G. siRNA specificity: RNAi mechanisms and strategies to reduce off-target effects. Front Plant Sci. 2020;11:526455. 10.3389/fpls.2020.526455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876455</ArticleId><ArticleId IdType="pubmed">33584737</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi K. Anatomy of four human Argonaute proteins. Nucleic Acids Res. 2022;50(12):6618&#x2013;38. 10.1093/nar/gkac519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262622</ArticleId><ArticleId IdType="pubmed">35736234</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, et al. MiR-34a inhibits cell proliferation and induces apoptosis in human nasopharyngeal carcinoma by targeting lncRNA MCM3AP-AS1. Cancer Manag Res. 2020;12:4799&#x2013;806. 10.2147/CMAR.S245520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319531</ArticleId><ArticleId IdType="pubmed">32606969</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani-Habibabadi F, et al. Hotair and Malat1 long noncoding RNAs regulate Bdnf expression and oligodendrocyte precursor cell differentiation. Mol Neurobiol. 2022;59(7):4209&#x2013;22. 10.1007/s12035-022-02844-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">35499794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, et al. Ultrasensitive miRNA-21 biosensor based on Zn(TCPP) PET-RAFT polymerization signal amplification and multiple logic gate molecular recognition. ACS Appl Mater Interfaces. 2023;15(14):17716&#x2013;25. 10.1021/acsami.3c02428.</Citation><ArticleIdList><ArticleId IdType="pubmed">36988387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawan RR, Astuti I, Danarto HR. miRNA-21 as high potential prostate cancer biomarker in prostate cancer patients in Indonesia. Asian Pac J Cancer Prev. 2023;24(3):1095&#x2013;9. 10.31557/APJCP.2023.24.3.1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10334082</ArticleId><ArticleId IdType="pubmed">36974566</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubrzycka A, et al. The expression of TGF-beta1, SMAD3, ILK and miRNA-21 in the ectopic and eutopic endometrium of women with endometriosis. Int J Mol Sci. 2023. 10.3390/ijms24032453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917033</ArticleId><ArticleId IdType="pubmed">36768775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, et al. In situ detection of miRNA-21 in MCF-7 cell-derived extracellular vesicles using the red blood cell membrane vesicle strategy. Chem Commun. 2023;59(14):1987&#x2013;90. 10.1039/d2cc05954a.</Citation><ArticleIdList><ArticleId IdType="pubmed">36723001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Mi Y, He C. 2-methoxyestradiol restrains non-small cell lung cancer tumorigenesis through regulating circ_0010235/miR-34a-5p/NFAT5 axis. Thorac Cancer. 2023;14(22):2105&#x2013;15. 10.1111/1759-7714.14993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10396792</ArticleId><ArticleId IdType="pubmed">37439026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayraktar R, Van Roosbroeck K. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics. Cancer Metastasis Rev. 2018;37(1):33&#x2013;44. 10.1007/s10555-017-9724-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29282605</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson KL, et al. The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line. Exp Cell Res. 2018;369(1):17&#x2013;26. 10.1016/j.yexcr.2018.04.024.</Citation><ArticleIdList><ArticleId IdType="pubmed">29702103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo G, Wu CY, Yang HY. MiR-17-92 cluster and immunity. J Formos Med Assoc. 2019;118(1 Pt 1):2&#x2013;6. 10.1016/j.jfma.2018.04.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">29857952</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamine PS, et al. Age-related increase of let-7 family microRNA in rat retina and vitreous. Exp Eye Res. 2021;204:108434. 10.1016/j.exer.2020.108434.</Citation><ArticleIdList><ArticleId IdType="pubmed">33412132</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, et al. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner. Cell Mol Biol Lett. 2022;27(1):55. 10.1186/s11658-022-00349-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284900</ArticleId><ArticleId IdType="pubmed">35836108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian XP, et al. Acidic microenvironment up-regulates exosomal miR-21 and miR-10b in early-stage hepatocellular carcinoma to promote cancer cell proliferation and metastasis. Theranostics. 2019;9(7):1965&#x2013;79. 10.7150/thno.30958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485281</ArticleId><ArticleId IdType="pubmed">31037150</ArticleId></ArticleIdList></Reference><Reference><Citation>Harati-Sadegh M, et al. Relationship between miR-143/145 cluster variations and cancer risk: proof from a Meta-analysis. Nucleosides Nucleotides Nucl Acids. 2021;40(5):578&#x2013;91. 10.1080/15257770.2021.1916030.</Citation><ArticleIdList><ArticleId IdType="pubmed">33980135</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZY, et al. c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer. Cancer Lett. 2022;526:322&#x2013;34. 10.1016/j.canlet.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">34767926</ArticleId></ArticleIdList></Reference><Reference><Citation>Soofiyani SR, et al. Prognostic value and biological role of miR-126 in breast cancer. Microrna. 2022;11(2):95&#x2013;103. 10.2174/1876402914666220428123203.</Citation><ArticleIdList><ArticleId IdType="pubmed">35507794</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer. 2019;18(1):110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588935</ArticleId><ArticleId IdType="pubmed">31228940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi J, et al. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis. Aging. 2018;10(8):1964&#x2013;76. 10.18632/aging.101520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128440</ArticleId><ArticleId IdType="pubmed">30103209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. The role of miRNA-29 family in cancer. Eur J Cell Biol. 2013;92(3):123&#x2013;8. 10.1016/j.ejcb.2012.11.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">23357522</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Pinheiro P, et al. Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics. 2015;7(6):1003&#x2013;15. 10.2217/epi.15.56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26479312</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady WM, Yu M, Markowitz SD. Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer. Gastroenterology. 2021;160(3):690&#x2013;709. 10.1053/j.gastro.2020.09.058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878343</ArticleId><ArticleId IdType="pubmed">33279516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafon C, et al. DNA methylation in thyroid cancer. Endocr Relat Cancer. 2019;26(7):R415&#x2013;39. 10.1530/ERC-19-0093.</Citation><ArticleIdList><ArticleId IdType="pubmed">31035251</ArticleId></ArticleIdList></Reference><Reference><Citation>Okugawa Y, Grady WM, Goel A. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology. 2015;149(5):1204-1225 e12. 10.1053/j.gastro.2015.07.011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589488</ArticleId><ArticleId IdType="pubmed">26216839</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem ME, et al. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors. Int J Cancer. 2020;147(10):2948&#x2013;56. 10.1002/ijc.33115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530095</ArticleId><ArticleId IdType="pubmed">32449172</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, et al. MGMT status as a clinical biomarker in glioblastoma. Trends Cancer. 2020;6(5):380&#x2013;91. 10.1016/j.trecan.2020.02.010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315323</ArticleId><ArticleId IdType="pubmed">32348734</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmore MA, et al. Epigenetic regulation of host defense peptide synthesis: synergy between histone deacetylase inhibitors and DNA/Histone methyltransferase inhibitors. Front Immunol. 2022;13:874706. 10.3389/fimmu.2022.874706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9074817</ArticleId><ArticleId IdType="pubmed">35529861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, et al. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenetics. 2021;13(1):166. 10.1186/s13148-021-01154-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394595</ArticleId><ArticleId IdType="pubmed">34452630</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarhadi VK, Armengol G. Molecular biomarkers in cancer. Biomolecules. 2022. 10.3390/biom12081021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9331210</ArticleId><ArticleId IdType="pubmed">35892331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapienza C, Issa JP. Diet, nutrition, and cancer epigenetics. Annu Rev Nutr. 2016;36:665&#x2013;81. 10.1146/annurev-nutr-121415-112634.</Citation><ArticleIdList><ArticleId IdType="pubmed">27022771</ArticleId></ArticleIdList></Reference><Reference><Citation>Acar Y, Akbulut G. Nutritional epigenetics and phytochemicals in cancer formation. J Am Nutr Assoc. 2023;42(7):700&#x2013;5. 10.1080/27697061.2022.2147106.</Citation><ArticleIdList><ArticleId IdType="pubmed">36416668</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27&#x2013;36. 10.1093/carcin/bgp220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2802667</ArticleId><ArticleId IdType="pubmed">19752007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigalotti L, et al. Epigenetic drugs as immunomodulators for combination therapies in solid tumors. Pharmacol Ther. 2014;142(3):339&#x2013;50. 10.1016/j.pharmthera.2013.12.015.</Citation><ArticleIdList><ArticleId IdType="pubmed">24384533</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017. 10.1126/science.aal2380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5940341</ArticleId><ArticleId IdType="pubmed">28729483</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, De Carvalho DD. Clinical advances in targeting epigenetics for cancer therapy. FEBS J. 2022;289(5):1214&#x2013;39. 10.1111/febs.15750.</Citation><ArticleIdList><ArticleId IdType="pubmed">33545740</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, et al. A new trend in cancer treatment: the combination of epigenetics and immunotherapy. Front Immunol. 2022;13:809761. 10.3389/fimmu.2022.809761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8818678</ArticleId><ArticleId IdType="pubmed">35140720</ArticleId></ArticleIdList></Reference><Reference><Citation>Oieni J, et al. Nano-ghosts: novel biomimetic nano-vesicles for the delivery of antisense oligonucleotides. J Control Release. 2021;333:28&#x2013;40. 10.1016/j.jconrel.2021.03.018.</Citation><ArticleIdList><ArticleId IdType="pubmed">33741386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner E. Tumor-targeted delivery of Anti-microRNA for cancer therapy: pHLIP is key. Angew Chem Int Ed Engl. 2015;54(20):5824&#x2013;6. 10.1002/anie.201502146.</Citation><ArticleIdList><ArticleId IdType="pubmed">25892205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardo BC, et al. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem. 2015;7(13):1771&#x2013;92. 10.4155/fmc.15.107.</Citation><ArticleIdList><ArticleId IdType="pubmed">26399457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CJ, et al. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature. 2015;518(7537):107&#x2013;10. 10.1038/nature13905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4367962</ArticleId><ArticleId IdType="pubmed">25409146</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausse V, et al. Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21. Nucleic Acids Res. 2022;50(19):10839&#x2013;56. 10.1093/nar/gkac864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9638920</ArticleId><ArticleId IdType="pubmed">36215040</ArticleId></ArticleIdList></Reference><Reference><Citation>Maryam M, Naemi M, Hasani SS. A comprehensive review on oncogenic miRNAs in breast cancer. J Genet. 2021. 10.1007/s12041-021-01265-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33764337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennox KA, Vakulskas CA, Behlke MA. Non-nucleotide modification of anti-miRNA oligonucleotides. Methods Mol Biol. 2017;1517:51&#x2013;69. 10.1007/978-1-4939-6563-2_3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27924473</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Mancy SS, et al. Enhancement of bottle gourd oil activity via optimized self-dispersing lipid formulations (SDLFs) to mitigate isoproterenol-evoked cardiac toxicity in rats via modulating BMP, MMP2, and miRNA-21 and miRNA-23a genes&#x2019; expression. Molecules. 2023. 10.3390/molecules28166168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10458851</ArticleId><ArticleId IdType="pubmed">37630419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, et al. CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett. 2019;447:48&#x2013;55. 10.1016/j.canlet.2019.01.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">30684591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S, et al. An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML. Cancer Discov. 2022;12(2):432&#x2013;49. 10.1158/2159-8290.CD-20-1851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831447</ArticleId><ArticleId IdType="pubmed">34531254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurata M, et al. CRISPR/Cas9 library screening for drug target discovery. J Hum Genet. 2018;63(2):179&#x2013;86. 10.1038/s10038-017-0376-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29158600</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadtmauer EA, et al. CRISPR-engineered T cells in patients with refractory cancer. Science. 2020. 10.1038/s10038-017-0376-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11249135</ArticleId><ArticleId IdType="pubmed">32029687</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, et al. Genome-wide CRISPR/Cas9 library screening identified that DUSP4 deficiency induces lenvatinib resistance in hepatocellular carcinoma. Int J Biol Sci. 2022;18(11):4357&#x2013;71. 10.7150/ijbs.69969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295068</ArticleId><ArticleId IdType="pubmed">35864956</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293(5532):1068&#x2013;70. 10.1126/science.1063852.</Citation><ArticleIdList><ArticleId IdType="pubmed">11498573</ArticleId></ArticleIdList></Reference><Reference><Citation>Buocikova V, et al. Epigenetics in breast cancer therapy-new strategies and future nanomedicine perspectives. Cancers. 2020. 10.3390/cancers12123622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7761669</ArticleId><ArticleId IdType="pubmed">33287297</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadzada T, Reid G, McKenzie DR. Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophys Rev. 2018;10(1):69&#x2013;86. 10.1007/s12551-017-0392-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803180</ArticleId><ArticleId IdType="pubmed">29327101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, et al. In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model. Nanoscale. 2014;6(23):14343&#x2013;53. 10.1039/c4nr03003f.</Citation><ArticleIdList><ArticleId IdType="pubmed">25327162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendi H, et al. Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis. Cancer Res. 2022;82(1):105&#x2013;13. 10.1158/0008-5472.CAN-21-2269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8732321</ArticleId><ArticleId IdType="pubmed">34753773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartor O, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091&#x2013;103. 10.1056/NEJMoa2107322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446332</ArticleId><ArticleId IdType="pubmed">34161051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BS, et al. Improving theranostic gallium-68/lutetium-177-labeled PSMA inhibitors with an albumin binder for prostate cancer. Mol Cancer Ther. 2021;20(12):2410&#x2013;9. 10.1158/1535-7163.MCT-21-0251.</Citation><ArticleIdList><ArticleId IdType="pubmed">34725194</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieger K, et al. 90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6&#xa0;years. Ann Hematol. 2022;101(4):781&#x2013;8. 10.1007/s00277-022-04781-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8913448</ArticleId><ArticleId IdType="pubmed">35150296</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez C, Nunez R, Wendt R. High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease. Curr Opin Endocrinol Diabetes Obes. 2020;27(3):162&#x2013;9. 10.1097/MED.0000000000000544.</Citation><ArticleIdList><ArticleId IdType="pubmed">32250976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyvakka A, et al. Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: a real-world evidence multicenter study. Cancer Med. 2023;12(4):4064&#x2013;76. 10.1002/cam4.5262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9972699</ArticleId><ArticleId IdType="pubmed">36156455</ArticleId></ArticleIdList></Reference><Reference><Citation>Havlena GT, et al. Cure of micrometastatic B-cell lymphoma in a SCID mouse model using (213)Bi-Anti-CD20 monoclonal antibody. J Nucl Med. 2023;64(1):109&#x2013;16. 10.2967/jnumed.122.263962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841256</ArticleId><ArticleId IdType="pubmed">35981897</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneshima Y, et al. Phase 3 trial comparing nanoparticle albumin-bound paclitaxel with docetaxel for previously treated advanced NSCLC. J Thorac Oncol. 2021;16(9):1523&#x2013;32. 10.1016/j.jtho.2021.03.027.</Citation><ArticleIdList><ArticleId IdType="pubmed">33915251</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H, et al. 64Cu-DOTATATE uptake in a pulmonary hamartoma. Clin Nucl Med. 2023;48(1):58&#x2013;60. 10.1097/RLU.0000000000004390.</Citation><ArticleIdList><ArticleId IdType="pubmed">36469060</ArticleId></ArticleIdList></Reference><Reference><Citation>Jungels C, Karfis I. 131I-metaiodobenzylguanidine and peptide receptor radionuclide therapy in pheochromocytoma and paraganglioma. Curr Opin Oncol. 2021;33(1):33&#x2013;9. 10.1097/CCO.0000000000000691.</Citation><ArticleIdList><ArticleId IdType="pubmed">33093336</ArticleId></ArticleIdList></Reference><Reference><Citation>Goins B, Bao A, Phillips WT. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into preformed liposomes for diagnostic imaging and radionuclide therapy. Methods Mol Biol. 2017;1522:155&#x2013;78. 10.1007/978-1-4939-6591-5_13.</Citation><ArticleIdList><ArticleId IdType="pubmed">27837538</ArticleId></ArticleIdList></Reference><Reference><Citation>Strosberg JR, et al. (177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22(12):1752&#x2013;63. 10.1016/S1470-2045(21)00572-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34793718</ArticleId></ArticleIdList></Reference><Reference><Citation>Reda M, et al. Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment. Nat Commun. 2022;13(1):4261. 10.1038/s41467-022-31926-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308817</ArticleId><ArticleId IdType="pubmed">35871223</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, et al. Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer. Cancer Res. 2023;83(17):2924&#x2013;37. 10.1158/0008-5472.CAN-22-3559.</Citation><ArticleIdList><ArticleId IdType="pubmed">37326467</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzayat EM, et al. Enhanced codelivery of gefitinib and azacitidine for treatment of metastatic-resistant lung cancer using biodegradable lipid nanoparticles. Materials. 2023. 10.3390/ma16155364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10419431</ArticleId><ArticleId IdType="pubmed">37570067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrotra N, et al. Polylactic acid based polymeric nanoparticle mediated co-delivery of navitoclax and decitabine for cancer therapy. Nanomedicine. 2023;47:102627. 10.1016/j.nano.2022.102627.</Citation><ArticleIdList><ArticleId IdType="pubmed">36410699</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, et al. A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity. J Pharm Pharmacol. 2013;65(2):236&#x2013;42. 10.1111/j.2042-7158.2012.01599.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539214</ArticleId><ArticleId IdType="pubmed">23278691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jueliger S, et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma. Epigenetics. 2016;11(10):709&#x2013;20. 10.1080/15592294.2016.1214781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5094635</ArticleId><ArticleId IdType="pubmed">27646854</ArticleId></ArticleIdList></Reference><Reference><Citation>Marczak M, et al. A new face of the old gene: deletion of the PssA, encoding monotopic inner membrane phosphoglycosyl transferase in rhizobium leguminosarum, leads to diverse phenotypes that could be attributable to downstream effects of the lack of exopolysaccharide. Int J Mol Sci. 2023. 10.3390/ijms24021035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9860679</ArticleId><ArticleId IdType="pubmed">36674551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan H, et al. A dual-bioresponsive drug-delivery depot for combination of epigenetic modulation and immune checkpoint blockade. Adv Mater. 2019;31(17): e1806957. 10.1002/adma.201806957.</Citation><ArticleIdList><ArticleId IdType="pubmed">30856290</ArticleId></ArticleIdList></Reference><Reference><Citation>Meka AK, et al. Enhanced solubility, permeability and anticancer activity of vorinostat using tailored mesoporous silica nanoparticles. Pharmaceutics. 2018. 10.3390/pharmaceutics10040283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6321298</ArticleId><ArticleId IdType="pubmed">30562958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, et al. Co-delivery of vorinostat and etoposide via disulfide cross-linked biodegradable polymeric nanogels: synthesis, characterization, biodegradation, and anticancer activity. AAPS PharmSciTech. 2018;19(2):634&#x2013;47. 10.1208/s12249-017-0863-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28948528</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan S, et al. Functionalized macrophage exosomes with panobinostat and PPM1D-siRNA for diffuse intrinsic pontine gliomas therapy. Adv Sci. 2022;9(21): e2200353. 10.1002/advs.202200353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9313473</ArticleId><ArticleId IdType="pubmed">35585670</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn AD, et al. The histone deacetylase inhibiting drug Entinostat induces lipid accumulation in differentiated HepaRG cells. Sci Rep. 2016;6:28025. 10.1038/srep28025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913258</ArticleId><ArticleId IdType="pubmed">27320682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig O, et al. Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1. J Control Release. 2022;345:646&#x2013;60. 10.1016/j.jconrel.2022.03.037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9168449</ArticleId><ArticleId IdType="pubmed">35339579</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhan MA, Filipczak N, Torchilin VP. Advances with lipid-based nanosystems for siRNA delivery to breast cancers. Pharmaceuticals. 2023. 10.3390/ph16070970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10386415</ArticleId><ArticleId IdType="pubmed">37513882</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott LJ. Givosiran: first approval. Drugs. 2020;80(3):335&#x2013;9. 10.1007/s40265-020-01269-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32034693</ArticleId></ArticleIdList></Reference><Reference><Citation>Viiavabaskar MS, Obier N, et al. Integrated analyses of chromatin accessibility and gene expression data for elucidating the transcriptional regulatory mechanisms during early hematopoietic development in mouse. Epigenetics Chromatin. 2013;6:1&#x2013;2. 10.1186/1756-8935-6-S1-P50.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Disatham J, et al. Changes in DNA methylation hallmark alterations in chromatin accessibility and gene expression for eye lens differentiation. Epigenetics Chromatin. 2022;15(1):8. 10.1186/s13072-022-00440-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8897925</ArticleId><ArticleId IdType="pubmed">35246225</ArticleId></ArticleIdList></Reference><Reference><Citation>Decombe S, et al. Epigenetic rewriting at centromeric DNA repeats leads to increased chromatin accessibility and chromosomal instability. Epigenetics Chromatin. 2021;14:1&#x2013;7. 10.1186/s13072-021-00410-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317386</ArticleId><ArticleId IdType="pubmed">34321103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Sunkel BD, Ray WC, Stanton BZ, Wang M, Sunkel BD, Ray WC, Stanton BZ. Chromatin structure in cancer. BMC Mol Cell Biol. 2022;23(1):35. 10.1186/s12860-022-00433-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9331575</ArticleId><ArticleId IdType="pubmed">35902807</ArticleId></ArticleIdList></Reference><Reference><Citation>Siggens L, Cordeddu L, R&#xf6;nnerblad M, et al. Transcription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3. 3 occupancy at active chromatin regions. Epigenetics Chromatin. 2015;8:1&#x2013;4. 10.1186/1756-8935-8-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4305392</ArticleId><ArticleId IdType="pubmed">25621013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang JJ, Cheng LH, Wu H, et al. Insights into long noncoding RNAs of naked mole rat (Heterocephalus glaber) and their potential association with cancer resistance. Epigenetics Chromatin. 2016;9:51. 10.1186/s13072-016-0101-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5103457</ArticleId><ArticleId IdType="pubmed">27833660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahadevan IA, Kumar S, Rao MRS. Linker histone variant H1t is closely associated with repressed repeat-element chromatin domains in pachytene spermatocytes. Epigenetics Chromatin. 2020;13:9. 10.1186/s13072-020-00335-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7057672</ArticleId><ArticleId IdType="pubmed">32131873</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev. 2010;19(8):1893&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">20647400</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">37479810</ArticleId></ArticleIdList></Reference><Reference><Citation>Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Lung Cancer Personal Med Curr Knowl Ther. 2016;893:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26667336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun. 2021;41(11):1183&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626596</ArticleId><ArticleId IdType="pubmed">34399040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R. A comparative examination of colorectal cancer burden in European Union, 1990&#x2013;2019: estimates from global burden of disease 2019 Study. Int J Clin Oncol. 2022;27:1309&#x2013;20. 10.1007/s10147-022-02182-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">35590123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Li N, Luo C, Y., et al. Colorectal cancer incidence and mortality: the current status, temporal trends and their attributable risk factors in 60 countries in 2000&#x2013;2019. Chin Med J. 2021;134(16):1941&#x2013;51. 10.1097/CM9.0000000000001619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8382382</ArticleId><ArticleId IdType="pubmed">34238851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187. 10.3748/wjg.v28.i12.1187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968487</ArticleId><ArticleId IdType="pubmed">35431510</ArticleId></ArticleIdList></Reference><Reference><Citation>Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598&#x2013;606. 10.1016/j.jhep.2022.08.021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9670241</ArticleId><ArticleId IdType="pubmed">36208844</ArticleId></ArticleIdList></Reference><Reference><Citation>Subhan MA, Choudhury KP, Neogi N. Advances with molecular nanomaterials in industrial manufacturing applications. Nanomanufacturing. 2021;1(2):75&#x2013;97. 10.3390/nanomanufacturing1020008.</Citation></Reference><Reference><Citation>Fadeel B, Feliu N, Vogt C, Abdelmonem AM, Parak WJ. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(2):111&#x2013;29. 10.1002/wnan.1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">23335558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Xie Q, Sun Y. Advances in nanomaterial-based targeted drug delivery systems. Front Bioeng Biotechnol. 2023;11:1177151. 10.3389/fbioe.2023.1177151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10133513</ArticleId><ArticleId IdType="pubmed">37122851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehelgerdi M, Chehelgerdi M, Allela OQB, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169. 10.1186/s12943-023-01865-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10561438</ArticleId><ArticleId IdType="pubmed">37814270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Ghosh S. Nanomedicine for overcoming drug resistance in cancer. J Control Release. 2017;266:169&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">28893609</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zhang J, Xia F, Zhang Z, Qin S. Recent advances in stimuli-responsive drug delivery systems for cancer therapy. J Drug Target. 2015;23(7&#x2013;8):580&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliwal R, Babu RJ, Palakurthi S. Nanomedicine scale-up technologies: feasibilities and challenges. AAPS PharmSciTech. 2014;15(6):1527&#x2013;34. 10.1208/s12249-014-0177-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4245446</ArticleId><ArticleId IdType="pubmed">25047256</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Scale-up polymeric-based nanoparticles drug delivery systems: development and challenges. OpenNano. 2022;7:100048. 10.1016/j.onano.2022.100048.</Citation></Reference><Reference><Citation>Allan J, Belz S, Hoeveler A, et al. Regulatory landscape of nanotechnology and nanoplastics from a global perspective. Regul Toxicol Pharmacol. 2021;122:104885. 10.1016/j.yrtph.2021.104885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121750</ArticleId><ArticleId IdType="pubmed">33617940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Liu H, Ye Y, et al. Smart nanoparticles for cancer therapy. Sig Transduct Target Ther. 2023;8:418. 10.1038/s41392-023-01642-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10622502</ArticleId><ArticleId IdType="pubmed">37919282</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudasama M, Goyary J. Nanostructured materials in food science: current progress and future prospects. Next Mater. 2024. 10.1016/j.nxmate.2024.100206.</Citation></Reference><Reference><Citation>Pateiro M, G&#xf3;mez B, Munekata PES, et al. Nanoencapsulation of promising bioactive compounds to improve their absorption, stability, functionality, and the appearance of the final food products. Molecules. 2021;26(6):1547. 10.3390/molecules26061547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7999092</ArticleId><ArticleId IdType="pubmed">33799855</ArticleId></ArticleIdList></Reference><Reference><Citation>Elumalai K, Srinivasan S, Shanmugam A. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomed Technol. 2024;5:109&#x2013;22. 10.1016/j.bmt.2023.09.001.</Citation></Reference><Reference><Citation>Egbuna C, Parmar VK, Jeevanandam J, et al. Toxicity of nanoparticles in biomedical application: nanotoxicology. J Toxicol. 2021;2021:9954443. 10.1155/2021/9954443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8376461</ArticleId><ArticleId IdType="pubmed">34422042</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaldurgam FF, Ahmad Z, Touati F. Synthesis and performance of large-scale cost-effective environment-friendly nanostructured thermoelectric materials. Nanomaterials. 2021;11(5):1091. 10.3390/nano11051091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146525</ArticleId><ArticleId IdType="pubmed">33922455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasti S, Lee IH, Kim S, Lee JH, Kim H. Ethical and legal challenges in nanomedical innovations: a scoping review. Front Genet. 2023;14:1163392. 10.3389/fgene.2023.1163392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10213273</ArticleId><ArticleId IdType="pubmed">37252668</ArticleId></ArticleIdList></Reference><Reference><Citation>Anselmo AC, Mitragotri S. Nanoparticles in the clinic. Bioeng Transl Med. 2016;1(1):10&#x2013;29. 10.1002/btm2.10003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689513</ArticleId><ArticleId IdType="pubmed">29313004</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NHA, Falagan-Lotsch P. Mechanistic insights into the biological effects of engineered nanomaterials: a focus on gold nanoparticles. Int J Mol Sci. 2023;24(4):4109. 10.3390/ijms24044109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9963226</ArticleId><ArticleId IdType="pubmed">36835521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brz&#xf3;ska K, Sochanowicz B, Szczygie&#x142; M, et al. Silver nanoparticles induced changes in DNA methylation and histone H3 methylation in a mouse model of breast cancer. Materials. 2023;16(11):4163. 10.3390/ma16114163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10254218</ArticleId><ArticleId IdType="pubmed">37297299</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzin A, Etesami SA, Quint J, Memic A, Tamayol A. Magnetic nanoparticles in cancer therapy and diagnosis. Adv Healthc Mater. 2020;9(9): e1901058. 10.1002/adhm.201901058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7482193</ArticleId><ArticleId IdType="pubmed">32196144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang TH. Quantum dot enabled molecular sensing and diagnostics. Theranostics. 2012;2(7):631. 10.7150/thno.4308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3425091</ArticleId><ArticleId IdType="pubmed">22916072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zare H, Ahmadi S, Ghasemi A, et al. Carbon nanotubes: smart drug/gene delivery carriers. Int J Nanomed. 2021;16:1681&#x2013;706. 10.2147/IJN.S299448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936533</ArticleId><ArticleId IdType="pubmed">33688185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022;8(5): e09394. 10.1016/j.heliyon.2022.e09394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9118483</ArticleId><ArticleId IdType="pubmed">35600452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi A, Giuliano E, Venkateswararao E, et al. Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol. 2021;12:601626. 10.3389/fphar.2021.601626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887387</ArticleId><ArticleId IdType="pubmed">33613290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenze M, Daniels A, Singh M. Dendrimers as modifiers of inorganic nanoparticles for therapeutic delivery in cancer. Pharmaceutics. 2023;15(2):398. 10.3390/pharmaceutics15020398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9961584</ArticleId><ArticleId IdType="pubmed">36839720</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;ivojevi&#x107; K, Mladenovi&#x107; M, Djisalov M, Mundzic M, Ruiz-Hernandez E, Gadjanski I, Kne&#x17e;evi&#x107; N&#x17d;. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications. J Control Release. 2021;337:193&#x2013;211. 10.1016/j.jconrel.2021.07.029.</Citation><ArticleIdList><ArticleId IdType="pubmed">34293320</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39369836</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0384</ISSN><JournalIssue CitedMedium="Internet"><Volume>761</Volume><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives of biochemistry and biophysics</Title><ISOAbbreviation>Arch Biochem Biophys</ISOAbbreviation></Journal><ArticleTitle>The role of short-chain fatty acids in cancer prevention and cancer treatment.</ArticleTitle><Pagination><StartPage>110172</StartPage><MedlinePgn>110172</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.abb.2024.110172</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0003-9861(24)00294-7</ELocationID><Abstract><AbstractText>Short-chain fatty acids (SCFAs) are microbial metabolites in the gut that may play a role in cancer prevention and treatment. They affect the metabolism of both normal and cancer cells, regulating various cellular energetic processes. SCFAs also inhibit histone deacetylases, which are targets for cancer therapy. The three main SCFAs are acetate, propionate, and butyrate, which are transported into cells through specific transporters. SCFAs may enhance the efficacy of chemotherapeutic agents and modulate immune cell metabolism, potentially reprogramming the tumor microenvironment. Although SCFAs and SCFA-generating microbes enhance therapeutic efficacy of several forms of cancer therapy, published data also support the opposing viewpoint that SCFAs mitigate the efficacy of some cancer therapies. Therefore, the relationship between SCFAs and cancer is more complex, and this review discusses some of these aspects. Clearly, further research is needed to understand the role of SCFAs, their mechanisms, and applications in cancer prevention and treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalyanaraman</LastName><ForeName>Balaraman</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, United States. Electronic address: balarama@mcw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>Micael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aix-Marseille Univ, CNRS, ICR, UMR 7273, Marseille, 13013, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>75N90019D00020</GrantID><Acronym>CL</Acronym><Agency>CLC NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N99019D00020</GrantID><Acronym>OF</Acronym><Agency>ORFDO NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA208648</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA232433</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Biochem Biophys</MedlineTA><NlmUniqueID>0372430</NlmUniqueID><ISSNLinking>0003-9861</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005232">Fatty Acids, Volatile</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005232" MajorTopicYN="Y">Fatty Acids, Volatile</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059016" MajorTopicYN="N">Tumor Microenvironment</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer prevention</Keyword><Keyword MajorTopicYN="N">Chemotherapy</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Ferroptosis</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList><CoiStatement>Conflicts of interest. There are no conflicts to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>19</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39369836</ArticleId><ArticleId IdType="mid">NIHMS2028461</ArticleId><ArticleId IdType="pmc">PMC11784870</ArticleId><ArticleId IdType="doi">10.1016/j.abb.2024.110172</ArticleId><ArticleId IdType="pii">S0003-9861(24)00294-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deleu S, Machiels K, Raes J, Verbeke K, Vermeire S, Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?, EBioMedicine 66 (2021) 103293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047503</ArticleId><ArticleId IdType="pubmed">33813134</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G, Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota, Nutrients 15(9) (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10180739</ArticleId><ArticleId IdType="pubmed">37432351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nfeld P, Wojtczak L, Short- and medium-chain fatty acids in energy metabolism: the cellular perspective, J. Lipid Res. 57(6) (2016) 943&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878196</ArticleId><ArticleId IdType="pubmed">27080715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyanaraman B, Cheng G, Hardy M, Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson&#x2019;s disease and therapeutic implications, Redox Biol 71 (2024) 103092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10891329</ArticleId><ArticleId IdType="pubmed">38377788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Bosch C, Boorman E, Zunszain PA, Mann GE, Short-chain fatty acids as modulators of redox signaling in health and disease, Redox Biol 47 (2021) 102165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577496</ArticleId><ArticleId IdType="pubmed">34662811</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P, Gut microbiota are related to Parkinson&#x2019;s disease and clinical phenotype, Mov Disord 30(3) (2015) 350&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25476529</ArticleId></ArticleIdList></Reference><Reference><Citation>Magliocca G, Mone P, Di Iorio BR, Heidland A, Marzocco S, Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation, Int J Mol Sci 23(10) (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9140893</ArticleId><ArticleId IdType="pubmed">35628164</ArticleId></ArticleIdList></Reference><Reference><Citation>den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J. Lipid Res. 54(9) (2013) 2325&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3735932</ArticleId><ArticleId IdType="pubmed">23821742</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman JC, Verdin E, &#x3b2;-Hydroxybutyrate: A Signaling Metabolite, Annu. Rev. Nutr. 37 (2017) 51&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6640868</ArticleId><ArticleId IdType="pubmed">28826372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrarelli LK, Focus issue: noncoding RNAs in cancer, Sci Signal 8(368) (2015) eg3.</Citation><ArticleIdList><ArticleId IdType="pubmed">25783156</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis P, Flint HJ, Formation of propionate and butyrate by the human colonic microbiota, Environ. Microbiol. 19(1) (2017) 29&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27928878</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis P, Hold GL, Flint HJ, The gut microbiota, bacterial metabolites and colorectal cancer, Nat. Rev. Microbiol. 12(10) (2014) 661&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25198138</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hee B, Wells JM, Microbial Regulation of Host Physiology by Short-chain Fatty Acids, Trends Microbiol. 29(8) (2021) 700&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">33674141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Bosch C, Zunszain PA, Mann GE, Control of Redox Homeostasis by Short-Chain Fatty Acids: Implications for the Prevention and Treatment of Breast Cancer, Pathogens 12(3) (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10058806</ArticleId><ArticleId IdType="pubmed">36986408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaei R, Afaghi A, Babakhani S, Sohrabi MR, Hosseini-Fard SR, Babolhavaeji K, Khani Ali Akbari S, Yousefimashouf R, Karampoor S, Role of microbiota-derived short-chain fatty acids in cancer development and prevention, Biomed Pharmacother 139 (2021) 111619.</Citation><ArticleIdList><ArticleId IdType="pubmed">33906079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PR, Rosella O, Wilson AJ, Mariadason JM, Rickard K, Byron K, Barkla DH, Colonic epithelial cell activation and the paradoxical effects of butyrate, Carcinogenesis 20(4) (1999) 539&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">10223179</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohoe DR, Garge N, Zhang X, Sun W, O&#x2019;Connell TM, Bunger MK, Bultman SJ, The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon, Cell Metab 13(5) (2011) 517&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099420</ArticleId><ArticleId IdType="pubmed">21531334</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova MR, Azevedo-Silva J, Rodrigues LR, Preto A, Colorectal Cancer Cells Increase the Production of Short Chain Fatty Acids by Propionibacterium freudenreichii Impacting on Cancer Cells Survival, Front Nutr 5 (2018) 44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976756</ArticleId><ArticleId IdType="pubmed">29881727</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, Liu MD, Zhou HL, Wang YS, Xu ZX, Short-chain fatty acids in diseases, Cell Commun Signal 21(1) (2023) 212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10436623</ArticleId><ArticleId IdType="pubmed">37596634</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop KS, Xu H, Marlow G, Epigenetic Regulation of Gene Expression Induced by Butyrate in Colorectal Cancer: Involvement of MicroRNA, Genet Epigenet 9 (2017) 1179237&#xd7;17729900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5617089</ArticleId><ArticleId IdType="pubmed">28979170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Chen S, Zang D, Sun H, Sun Y, Chen J, Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review), Int. J. Oncol. 64(4) (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10919761</ArticleId><ArticleId IdType="pubmed">38426581</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden MG, Cantley LC, Thompson CB, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science 324(5930) (2009) 1029&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849637</ArticleId><ArticleId IdType="pubmed">19460998</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBerardinis RJ, Chandel NS, Fundamentals of cancer metabolism, Science Advances 2(5) (2016) e1600200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928883</ArticleId><ArticleId IdType="pubmed">27386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul Kader S, Dib S, Achkar IW, Thareja G, Suhre K, Rafii A, Halama A, Defining the landscape of metabolic dysregulations in cancer metastasis, Clin. Exp. Metastasis 39(2) (2022) 345&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8971193</ArticleId><ArticleId IdType="pubmed">34921655</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin DI, Cravatt BF, Nomura DK, Global profiling strategies for mapping dysregulated metabolic pathways in cancer, Cell Metab 16(5) (2012) 565&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539740</ArticleId><ArticleId IdType="pubmed">23063552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz S, LaBarge MA, Hijacking EMT: Better Fat Than Dead, Cancer Cell 35(1) (2019) 1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">30645968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh V, Gollavilli PN, Pinna L, Siddiqui MA, Turtos AM, Napoli F, Antonelli Y, Leal-Ega&#xf1;a A, Havelund JF, Jakobsen ST, Boiteux EL, Volante M, Faergeman NJ, Jensen ON, Siersbaek R, Somyajit K, Ceppi P, Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma, EMBO Mol Med 15(12) (2023) e17836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10701619</ArticleId><ArticleId IdType="pubmed">37766669</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Salz T, Zajac-Kaye M, Liao D, Huang S, Qiu Y, Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators, FASEB J. 28(10) (2014) 4265&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4202103</ArticleId><ArticleId IdType="pubmed">24948597</ArticleId></ArticleIdList></Reference><Reference><Citation>Luu M, Visekruna A, Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells, Eur. J. Immunol. 49(6) (2019) 842&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">31054154</ArticleId></ArticleIdList></Reference><Reference><Citation>Suraweera A, O&#x2019;Byrne KJ, Richard DJ, Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi, Front Oncol 8 (2018) 92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884928</ArticleId><ArticleId IdType="pubmed">29651407</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SP, Denu JM, Short-chain fatty acids activate acetyltransferase p300, Elife 10 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8585482</ArticleId><ArticleId IdType="pubmed">34677127</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT, Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology, Compr Physiol 8(3) (2018) 1091&#x2013;1115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6058973</ArticleId><ArticleId IdType="pubmed">29978895</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlatterer K, Peschel A, Kretschmer D, Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections?, Front Cell Infect Microbiol 11 (2021) 785833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674814</ArticleId><ArticleId IdType="pubmed">34926327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Zhang K, Wei J, Ding Y, Wang X, Hou H, Wu J, Liu T, Wang B, Cao H, Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?, Front Immunol 14 (2023) 1158200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10140337</ArticleId><ArticleId IdType="pubmed">37122756</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippel RJ, Drewes JL, Sears CL, The Cancer Microbiome: Recent Highlights and Knowledge Gaps, Cancer Discov 11(10) (2021) 2378&#x2013;2395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487941</ArticleId><ArticleId IdType="pubmed">34400408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, Scott KP, Buc Calderon P, Feron O, Muccioli GG, Sonveaux P, Cani PD, Delzenne NM, Gut microbiota-derived propionate reduces cancer cell proliferation in the liver, Br. J. Cancer 107(8) (2012) 1337&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494429</ArticleId><ArticleId IdType="pubmed">22976799</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Kwon O, Ryu TY, Jung CR, Kim J, Min JK, Kim DS, Son MY, Cho HS, Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer, Mol Med Rep 20(2) (2019) 1569&#x2013;1574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625448</ArticleId><ArticleId IdType="pubmed">31257531</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Garc&#xed;a A, Arroyo A, Garc&#xed;a-Vicente R, Morales ML, G&#xf3;mez-Gordo R, Justo P, Cu&#xe9;llar C, S&#xe1;nchez-Pina J, L&#xf3;pez N, Alonso R, Puig N, Mateos MV, Ayala R, G&#xf3;mez-Garre D, Mart&#xed;nez-L&#xf3;pez J, Linares M, Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma, Clin. Cancer. Res. 30(4) (2024) 904&#x2013;917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10870002</ArticleId><ArticleId IdType="pubmed">38109212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, Newton K, Gaskins HR, O&#x2019;Keefe SJ, Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans, Am. J. Clin. Nutr. 98(1) (2013) 111&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683814</ArticleId><ArticleId IdType="pubmed">23719549</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato KR, Arrieta MC, Azad MB, Bailey MT, Broussard JL, Bruggeling CE, Claud EC, Costello EK, Davenport ER, Dutilh BE, Swain Ewald HA, Ewald P, Hanlon EC, Julion W, Keshavarzian A, Maurice CF, Miller GE, Preidis GA, Segurel L, Singer B, Subramanian S, Zhao L, Kuzawa CW, The human gut microbiome and health inequities, Proc Natl Acad Sci U S A 118(25) (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237592</ArticleId><ArticleId IdType="pubmed">34161260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA, Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients, Science 359(6371) (2018) 97&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5827966</ArticleId><ArticleId IdType="pubmed">29097493</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangan P, Mondino A, Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy, J Immunother Cancer 10(7) (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9330349</ArticleId><ArticleId IdType="pubmed">35882448</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruch EN, Wang J, Wargo JA, Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect, Cancer Immunol Res 9(4) (2021) 365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003768</ArticleId></ArticleIdList></Reference><Reference><Citation>Villemin C, Six A, Neville BA, Lawley TD, Robinson MJ, Bakdash G, The heightened importance of the microbiome in cancer immunotherapy, Trends Immunol. 44(1) (2023) 44&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">36464584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wawruszak A, Halasa M, Okon E, Kukula-Koch W, Stepulak A, Valproic Acid and Breast Cancer: State of the Art in 2021, Cancers (Basel) 13(14) (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8306563</ArticleId><ArticleId IdType="pubmed">34298623</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf8;gh RI, M&#xf8;ller SH, Jepsen SD, Mellergaard M, Lund A, Pejtersen M, Fitzner E, Andresen L, Skov S, Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells, FASEB J. 34(11) (2020) 15531&#x2013;15546.</Citation><ArticleIdList><ArticleId IdType="pubmed">32996653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes AP, Ilter D, Low V, Drapela S, Schild T, Mullarky E, Han J, Elia I, Broekaert D, Rosenzweig A, Nagiec M, Nunes JB, Schaffer BE, Mutvei AP, Asara JM, Cantley LC, Fendt SM, Blenis J, Altered propionate metabolism contributes to tumour progression and aggressiveness, Nat Metab 4(4) (2022) 435&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9050834</ArticleId><ArticleId IdType="pubmed">35361954</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KD, O&#x2019;Connor S, Pniewski KA, Kannan T, Acosta R, Mirji G, Papp S, Hulse M, Mukha D, Hlavaty SI, Salcido KN, Bertolazzi F, Srikanth YVV, Zhao S, Wellen KE, Shinde RS, Claiborne DT, Kossenkov A, Salvino JM, Schug ZT, Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer, Nat Cancer 4(10) (2023) 1491&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10615731</ArticleId><ArticleId IdType="pubmed">37723305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho RH, Chan JCY, Fan H, Kioh DYQ, Lee BW, Chan ECY, In Silico and in Vitro Interactions between Short Chain Fatty Acids and Human Histone Deacetylases, Biochemistry 56(36) (2017) 4871&#x2013;4878.</Citation><ArticleIdList><ArticleId IdType="pubmed">28809557</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam G, Rakshit S, Sarkar K, HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases, Transl Oncol 16 (2022) 101312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688863</ArticleId><ArticleId IdType="pubmed">34922087</ArticleId></ArticleIdList></Reference><Reference><Citation>Davie JR, Inhibition of histone deacetylase activity by butyrate, J. Nutr. 133(7 Suppl) (2003) 2485s&#x2013;2493s.</Citation><ArticleIdList><ArticleId IdType="pubmed">12840228</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes S, Rodrigues AC, Pazienza V, Preto A, Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy, Int J Mol Sci 24(6) (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10048801</ArticleId><ArticleId IdType="pubmed">36982144</ArticleId></ArticleIdList></Reference><Reference><Citation>Son MY, Cho HS, Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers, J. Microbiol. Biotechnol. 33(7) (2023) 849&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10394342</ArticleId><ArticleId IdType="pubmed">37100764</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, Guo K, Shi Q, Zhang X, Huo L, Wang K, Guo H, Shen W, Shen M, Feng W, Xiao P, Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression, Redox Biol 65 (2023) 102822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10388208</ArticleId><ArticleId IdType="pubmed">37494767</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qadami GH, Secombe KR, Subramaniam CB, Wardill HR, Bowen JM, Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities, Microorganisms 10(10) (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9612155</ArticleId><ArticleId IdType="pubmed">36296324</ArticleId></ArticleIdList></Reference><Reference><Citation>Danne C, Sokol H, Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy?, Cell Rep Med 2(7) (2021) 100328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324458</ArticleId><ArticleId IdType="pubmed">34337557</ArticleId></ArticleIdList></Reference><Reference><Citation>Semaan J, El-Hakim S, Ibrahim J-N, Safi R, Elnar AA, El Boustany C, Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7, Breast cancer (Tokyo, Japan) 27(4) (2020) 696&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">32095987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi M, Mikami D, Uwada J, Yazawa T, Kamiyama K, Kimura H, Taniguchi T, Iwano M, A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells, Oncotarget 9(59) (2018) 31342&#x2013;31354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6101142</ArticleId><ArticleId IdType="pubmed">30140374</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwen H, Yangyanqiu W, Jian C, Boyang H, Gong C, Jing Z, Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer, Transl Oncol 27 (2023) 101598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9763735</ArticleId><ArticleId IdType="pubmed">36512976</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderton GK, Metabolism: acetate nourishes stressed tumour cells, Nat. Rev. Cancer 15(2) (2015) 67.</Citation><ArticleIdList><ArticleId IdType="pubmed">25613999</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Chou WC, Lai Y, Liang K, Tam JW, Brickey WJ, Chen L, Montgomery ND, Li X, Bohannon LM, Sung AD, Chao NJ, Peled JU, Gomes ALC, van den Brink MRM, French MJ, Macintyre AN, Sempowski GD, Tan X, Sartor RB, Lu K, Ting JPY, Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites, Science 370(6516) (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898465</ArticleId><ArticleId IdType="pubmed">33122357</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Zhao Y, Yang Y, Wang T, Jin S, Guo J, Liu Z, The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation, Am J Cancer Res 10(11) (2020) 3508&#x2013;3531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716145</ArticleId><ArticleId IdType="pubmed">33294252</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K, Hou Y, Zhang Y, Liang H, Sharma A, Zheng W, Wang L, Torres R, Tatebe K, Chmura SJ, Pitroda SP, Gilbert JA, Fu YX, Weichselbaum RR, Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation, J. Exp. Med. 218(3) (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844434</ArticleId><ArticleId IdType="pubmed">33496784</ArticleId></ArticleIdList></Reference><Reference><Citation>Uribe-Herranz M, Rafail S, Beghi S, Gil-de-G&#xf3;mez L, Verginadis I, Bittinger K, Pustylnikov S, Pierini S, Perales-Linares R, Blair IA, Mesaros CA, Snyder NW, Bushman F, Koumenis C, Facciabene A, Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response, J. Clin. Invest. 130(1) (2020) 466&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6934221</ArticleId><ArticleId IdType="pubmed">31815742</ArticleId></ArticleIdList></Reference><Reference><Citation>Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, Klein M, Wempe A, Leister H, Raifer H, Picard F, Muhammad K, Ohl K, Romero R, Fischer F, Bauer CA, Huber M, Gress TM, Lauth M, Danhof S, Bopp T, Nerreter T, Mulder IE, Steinhoff U, Hudecek M, Visekruna A, Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer, Nat Commun 12(1) (2021) 4077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249424</ArticleId><ArticleId IdType="pubmed">34210970</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, Asvatourian V, Cassard L, Saulnier P, Lacroix L, Woerther PL, Vozy A, Naigeon M, Nebot-Bral L, Desbois M, Simeone E, Mateus C, Boselli L, Grivel J, Soularue E, Lepage P, Carbonnel F, Ascierto PA, Robert C, Chaput N, Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer, Nat Commun 11(1) (2020) 2168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195489</ArticleId><ArticleId IdType="pubmed">32358520</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, Fu YX, Chen Y, Guo X, Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity, Cell Metab 33(5) (2021) 988&#x2013;1000.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33761313</ArticleId></ArticleIdList></Reference><Reference><Citation>MetaboMed Inc., Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors, 2021. https://classic.clinicaltrials.gov/ct2/show/NCT04990739.</Citation></Reference><Reference><Citation>Wang J, Yang Y, Shao F, Meng Y, Guo D, He J, Lu Z, Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc, Nat Metab 6(5) (2024) 914&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pubmed">38702440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelek C, Mignion L, Joudiou N, Terrasi R, Gourgue F, Van Hul M, Delzenne N, Gallez B, Corbet C, Muccioli GG, Feron O, Cani PD, Jordan BF, Acetate: Friend or foe against breast tumour growth in the context of obesity?, J. Cell. Mol. Med. 24(24) (2020) 14195&#x2013;14204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753876</ArticleId><ArticleId IdType="pubmed">33107196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitvogel L, Daill&#xe8;re R, Roberti MP, Routy B, Kroemer G, Anticancer effects of the microbiome and its products, Nat. Rev. Microbiol. 15(8) (2017) 465&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">28529325</ArticleId></ArticleIdList></Reference><Reference><Citation>Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O, Zidi B, Zhang S, Badger JH, Vetizou M, Cole AM, Fernandes MR, Prescott S, Costa RGF, Balaji AK, Morgun A, Vujkovic-Cvijin I, Wang H, Borhani AA, Schwartz MB, Dubner HM, Ernst SJ, Rose A, Najjar YG, Belkaid Y, Kirkwood JM, Trinchieri G, Zarour HM, Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients, Science 371(6529) (2021) 595&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8097968</ArticleId><ArticleId IdType="pubmed">33542131</ArticleId></ArticleIdList></Reference><Reference><Citation>Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF, The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients, Science 359(6371) (2018) 104&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6707353</ArticleId><ArticleId IdType="pubmed">29302014</ArticleId></ArticleIdList></Reference><Reference><Citation>Botticelli A, Vernocchi P, Marini F, Quagliariello A, Cerbelli B, Reddel S, Del Chierico F, Di Pietro F, Giusti R, Tomassini A, Giampaoli O, Miccheli A, Zizzari IG, Nuti M, Putignani L, Marchetti P, Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment, J Transl Med 18(1) (2020) 49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6998840</ArticleId><ArticleId IdType="pubmed">32014010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura M, Nagatomo R, Doi K, Shimizu J, Baba K, Saito T, Matsumoto S, Inoue K, Muto M, Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors, JAMA Netw Open 3(4) (2020) e202895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7163404</ArticleId><ArticleId IdType="pubmed">32297948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhou X, Wang Y, Wang D, Ke Y, Zeng X, Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice, Mol. Nutr. Food Res. 65(15) (2021) e2100096.</Citation><ArticleIdList><ArticleId IdType="pubmed">34061433</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham F, Moinard-Butot F, Coutzac C, Chaput N, Cancer and immunotherapy: a role for microbiota composition, Eur. J. Cancer 155 (2021) 145&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">34375896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou CB, Zhou YL, Fang JY, Gut Microbiota in Cancer Immune Response and Immunotherapy, Trends Cancer 7(7) (2021) 647&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">33674230</ArticleId></ArticleIdList></Reference><Reference><Citation>Feitelson MA, Arzumanyan A, Medhat A, Spector I, Short-chain fatty acids in cancer pathogenesis, Cancer Metastasis Rev 42(3) (2023) 677&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10584782</ArticleId><ArticleId IdType="pubmed">37432606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Mao X, Xu H, Dang Q, Weng S, Zhang Y, Chen S, Liu S, Ba Y, Zhou Z, Han X, Liu Z, Zhang G, Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance, Cell. Mol. Life Sci. 80(9) (2023) 263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10439860</ArticleId><ArticleId IdType="pubmed">37598126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiel C, Le Gal K, Ibrahim MX, Jahangir CA, Kashif M, Yao H, Ziegler DV, Xu X, Ghosh T, Mondal T, Kanduri C, Lindahl P, Sayin VI, Bergo MO, BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis, Cell 178(2) (2019) 330&#x2013;345.e22.</Citation><ArticleIdList><ArticleId IdType="pubmed">31257027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei G, Zhuang L, Gan B, The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions, Cancer Cell 42(4) (2024) 513&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">38593779</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello S, Yu H, Voisin V, Haddad H, He X, Foutz AS, Sebri&#xe9; C, Gillet B, Roulot M, Fougerousse F, Perronnet C, Vaillend C, Matecki S, Escolar D, Bossi L, Isra&#xeb;l M, de la Porte S, Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy, FASEB J. 27(6) (2013) 2256&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">23430975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuefer R, Hofer MD, Altug V, Zorn C, Genze F, Kunzi-Rapp K, Hautmann RE, Gschwend JE, Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer, Br. J. Cancer 90(2) (2004) 535&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2409572</ArticleId><ArticleId IdType="pubmed">14735205</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier S, Reich E, Martin R, Bachem M, Altug V, Hautmann RE, Gschwend JE, Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines, Int. J. Cancer 88(2) (2000) 245&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">11004676</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM, p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells, Oncol. Rep. 13(6) (2005) 1139&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">15870934</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo M, Guida F, Paparo L, Trinchese G, Aitoro R, Avagliano C, Fiordelisi A, Napolitano F, Mercurio V, Sala V, Li M, Sorriento D, Ciccarelli M, Ghigo A, Hirsch E, Bianco R, Iaccarino G, Abete P, Bonaduce D, Calignano A, Berni Canani R, Tocchetti CG, The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity, Eur J Heart Fail 21(4) (2019) 519&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">30843309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattace Raso G, Simeoli R, Russo R, Iacono A, Santoro A, Paciello O, Ferrante MC, Canani RB, Calignano A, Meli R, Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet, PLoS One 8(7) (2013) e68626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3702592</ArticleId><ArticleId IdType="pubmed">23861927</ArticleId></ArticleIdList></Reference><Reference><Citation>Patnaik A, Rowinsky EK, Villalona MA, Hammond LA, Britten CD, Siu LL, Goetz A, Felton SA, Burton S, Valone FH, Eckhardt SG, A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies, Clin. Cancer. Res. 8(7) (2002) 2142&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12114414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulery BD, Nair LS, Laurencin CT, Biomedical Applications of Biodegradable Polymers, J Polym Sci B Polym Phys 49(12) (2011) 832&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3136871</ArticleId><ArticleId IdType="pubmed">21769165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganapathy V, Prasad PD, Martindale RG, Prodrugs of Short-Chain Fatty Acids and Treatment Methods, Augusta University Research Institute Inc, US, 2009.</Citation></Reference><Reference><Citation>Hatanaka T, Haramura M, Fei YJ, Miyauchi S, Bridges CC, Ganapathy PS, Smith SB, Ganapathy V, Ganapathy ME, Transport of amino acid-based prodrugs by the Na+- and Cl(&#x2212;) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery, J. Pharmacol. Exp. Ther. 308(3) (2004) 1138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">14617696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieu EL, Nguyen T, Rhyne S, Kim J, Amino acids in cancer, Exp Mol Med 52(1) (2020) 15&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7000687</ArticleId><ArticleId IdType="pubmed">31980738</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao S, Budina E, Raczy MM, Solanki A, Nguyen M, Beckman TN, Reda JW, Hultgren K, Ang PS, Slezak AJ, Hesser LA, Alpar AT, Refvik KC, Shores LS, Pillai I, Wallace RP, Dhar A, Watkins EA, Hubbell JA, A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice, Nat Biomed Eng 8(5) (2024) 611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11161413</ArticleId><ArticleId IdType="pubmed">38561491</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd D, Wolf P, The microbiome as a determinant of racial and ethnic cancer disparities, Nat. Rev. Cancer 24(2) (2024) 89&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">37872443</ArticleId></ArticleIdList></Reference><Reference><Citation>Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F, Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes, Cell 178(4) (2019) 795&#x2013;806.e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288240</ArticleId><ArticleId IdType="pubmed">31398337</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan L, Yang P, Wei G, Hu X, Chen S, Lu J, Yang L, He X, Bao G, Tumor microbiome diversity influences papillary thyroid cancer invasion, Commun Biol 5(1) (2022) 864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9402670</ArticleId><ArticleId IdType="pubmed">36002642</ArticleId></ArticleIdList></Reference><Reference><Citation>El Tekle G, Garrett WS, Bacteria in cancer initiation, promotion and progression, Nat. Rev. Cancer 23(9) (2023) 600&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">37400581</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell BR, Jiang X, The Chemistry and Biology of Ferroptosis, Cell Chem Biol 27(4) (2020) 365&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204503</ArticleId><ArticleId IdType="pubmed">32294465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbah NE, Lyssiotis CA, Metabolic regulation of ferroptosis in the tumor microenvironment, J. Biol. Chem. 298(3) (2022) 101617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8892088</ArticleId><ArticleId IdType="pubmed">35065965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Liu X, Jin S, Chen Y, Guo R, Ferroptosis in cancer therapy: a novel approach to reversing drug resistance, Mol Cancer 21(1) (2022) 47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8840702</ArticleId><ArticleId IdType="pubmed">35151318</ArticleId></ArticleIdList></Reference><Reference><Citation>Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, Molina H, Garcia-Bermudez J, Pratt DA, Birsoy K, Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers, Nat. Chem. Biol. 16(12) (2020) 1351&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299533</ArticleId><ArticleId IdType="pubmed">32778843</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas FP, Alborzinia H, Dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, Inague A, Klein C, Aroua N, Kaushal K, Kast B, Lorenz SM, Kunz V, Nehring H, Xavier da Silva TN, Chen Z, Atici S, Doll SG, Schaefer EL, Ekpo I, Schmitz W, Horling A, Imming P, Miyamoto S, Wehman AM, Genaro-Mattos TC, Mirnics K, Kumar L, Klein-Seetharaman J, Meierjohann S, Weigand I, Kroiss M, Bornkamm GW, Gomes F, Netto LES, Sathian MB, Konrad DB, Covey DF, Michalke B, Bommert K, Bargou RC, Garcia-Saez A, Pratt DA, Fedorova M, Trumpp A, Conrad M, Friedmann Angeli JP, 7Dehydrocholesterol is an endogenous suppressor of ferroptosis, Nature 626(7998) (2024) 401&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">38297129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougl&#xe9; D, Vaghefi-Vaezzadeh N, Roland N, Bouvard G, Arhan P, Bureau F, Neuville D, Maubois JL, Influence of short-chain fatty acids on iron absorption by proximal colon, Scand J Gastroenterol 37(9) (2002) 1008&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">12374223</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostal A, Chassard C, Hilty FM, Zimmermann MB, Jaeggi T, Rossi S, Lacroix C, Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats, J. Nutr. 142(2) (2012) 271&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3260059</ArticleId><ArticleId IdType="pubmed">22190022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostal A, Fehlbaum S, Chassard C, Zimmermann MB, Lacroix C, Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites, FEMS Microbiol. Ecol. 83(1) (2013) 161&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3511601</ArticleId><ArticleId IdType="pubmed">22845175</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B, Understanding mechanisms of antioxidant action in health and disease, Nat. Rev. Mol. Cell Biol. 25(1) (2024) 13&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">37714962</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Zhang H, Targeting oxidative stress in disease: promise and limitations of antioxidant therapy, Nat. Rev. Drug Discov. 20(9) (2021) 689&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8243062</ArticleId><ArticleId IdType="pubmed">34194012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, Yu F, Liu L, Li Y, Liao X, Xu L, Xiao Y, Zheng Z, Li M, Wang H, Hu G, Du L, Chen Q, Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance, Nat Cancer 5(4) (2024) 572&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">38291304</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Xie B, Li Z, Chen L, Chen Y, Zhou J, Ju S, Zhou Y, Zhang X, Zhuo W, Yang J, Mao M, Xu L, Wang L, Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis, Cell Death Dis 13(2) (2022) 150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8844358</ArticleId><ArticleId IdType="pubmed">35165254</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian Z, Sun X, Liu L, Qin Y, Zhang Q, Liu H, Mao L, Sun S, Sodium Butyrate Induces CRC Cell Ferroptosis via the CD44/SLC7A11 Pathway and Exhibits a Synergistic Therapeutic Effect with Erastin, Cancers (Basel) 15(2) (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9856855</ArticleId><ArticleId IdType="pubmed">36672372</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi R, Hu R, Jiang L, Wen B, Jiang Z, Liu H, Mei J, Butyrate enhances erastin-induced ferroptosis of lung cancer cells via modulating the ATF3/SLC7A11 pathway, Environ. Toxicol. 39(2) (2024) 529&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">37341073</ArticleId></ArticleIdList></Reference><Reference><Citation>Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC, System X(c) (&#x2212;)/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy, Front Pharmacol 13 (2022) 910292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465090</ArticleId><ArticleId IdType="pubmed">36105219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Liu W, Wang R, Chen Y, Liu J, Guo X, Can C, Yang X, Wang D, Hu X, Ma D, Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity, Free Radic Biol Med 213 (2024) 36&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">38215892</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyayula PS, Higgins DM, Mela A, Banu M, Dovas A, Zandkarimi F, Patel P, Mahajan A, Humala N, Nguyen TTT, Chaudhary KR, Liao L, Argenziano M, Sudhakar T, Sperring CP, Shapiro BL, Ahmed ER, Kinslow C, Ye LF, Siegelin MD, Cheng S, Soni R, Bruce JN, Stockwell BR, Canoll P, Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism, Nat Commun 14(1) (2023) 1187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981683</ArticleId><ArticleId IdType="pubmed">36864031</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr., de Cabo R, Ulrich S, Akassoglou K, Verdin E, Suppression of oxidative stress by &#x3b2;-hydroxybutyrate, an endogenous histone deacetylase inhibitor, Science 339(6116) (2013) 211&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3735349</ArticleId><ArticleId IdType="pubmed">23223453</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlett BS, Stadtman ER, Protein oxidation in aging, disease, and oxidative stress, J. Biol. Chem. 272(33) (1997) 20313&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9252331</ArticleId></ArticleIdList></Reference><Reference><Citation>Esterbauer H, Schaur RJ, Zollner H, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic Biol Med 11(1) (1991) 81&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">1937131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Gao ZQ, Wang YY, Wan BB, Liu G, Chen JL, Wu YX, Zhou Q, Jiang SY, Yu RQ, Pang QF, Sodium Propionate Enhances Nrf2-Mediated Protective Defense Against Oxidative Stress and Inflammation in Lipopolysaccharide-Induced Neonatal Mice, J Inflamm Res 14 (2021) 803&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957230</ArticleId><ArticleId IdType="pubmed">33732006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zielonka J, Kalyanaraman B, Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth, Free Radical Biol. Med. 48(8) (2010) 983&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587154</ArticleId><ArticleId IdType="pubmed">20116425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ 2nd, Ischiropoulos H, Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations, Free Radic Biol Med 52(1) (2012) 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911769</ArticleId><ArticleId IdType="pubmed">22027063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Qin S, Chen L, Geng H, Zheng Y, Xia C, Yao J, Deng L, Butyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling, Cell Death Dis 14(4) (2023) 292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10130170</ArticleId><ArticleId IdType="pubmed">37185889</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy MP, Bayir H, Belousov V, Change CJ, Davies KJ, Davies MJ, Dick TP, Finkel T, Forman HJ, Janssen-Heininger Y, Gems D, Kagan VE, Kalyanaraman B, Van Remmen H, Schumacker PT, Thornalley PJ, Toyokuni S, Winterbourn CC, Yin H, Halliwell B, Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo, Nature Metabolism 4(6) (2022) 651&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9711940</ArticleId><ArticleId IdType="pubmed">35760871</ArticleId></ArticleIdList></Reference><Reference><Citation>Salimi V, Shahsavari Z, Safizadeh B, Hosseini A, Khademian N, Tavakoli-Yaraki M, Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment, Lipids Health Dis 16(1) (2017) 208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669027</ArticleId><ArticleId IdType="pubmed">29096636</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan G, Belzacq AS, Haouzi D, Rouault A, M&#xe9;tivier D, Kroemer G, Brenner C, Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria, Cell Death Differ. 9(2) (2002) 179&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">11840168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita-Ochiai T, Amano S, Fukushima K, Ochiai K, Cellular events involved in butyric acid-induced T cell apoptosis, J. Immunol. 171(7) (2003) 3576&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">14500654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant K, Yadav AK, Gupta P, Islam R, Saraya A, Venugopal SK, Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells, Redox Biol 12 (2017) 340&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5350572</ArticleId><ArticleId IdType="pubmed">28288414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE, Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species, Science 262(5137) (1993) 1274&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8235659</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG, Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis, Cell 122(2) (2005) 221&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">16051147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonini MG, Rota C, Tomasi A, Mason RP, The oxidation of 2&#x2019;,7&#x2019;-dichlorofluorescin to reactive oxygen species: a self-fulfilling prophesy?, Free Radic Biol Med 40(6) (2006) 968&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">16540392</ArticleId></ArticleIdList></Reference><Reference><Citation>Tampo Y, Kotamraju S, Chitambar CR, Kalivendi SV, Keszler A, Joseph J, Kalyanaraman B, Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis, Circul. Res. 92(1) (2003) 56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">12522121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardman P, Factors Important in the Use of Fluorescent or Luminescent Probes and Other Chemical Reagents to Measure Oxidative and Radical Stress, Biomolecules 13(7) (2023) 1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10377120</ArticleId><ArticleId IdType="pubmed">37509077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334932</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Deciphering the Potentials of Cardamom in Cancer Prevention and Therapy: From Kitchen to Clinic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1166</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14091166</ELocationID><Abstract><AbstractText>Cardamom (cardamum) is a spice produced from the seeds of several Elettaria and Amomum plants of the Zingiberaceae family. Cardamom has been demonstrated to offer numerous benefits, including its antioxidant, antimicrobial, anti-inflammatory, and other metabolic (anti-diabetic) properties, and its potential to reduce cancer risk. Recently, researchers have extracted and tested multiple phytochemicals from cardamom to assess their potential effectiveness against various types of human malignancy. These studies have indicated that cardamom can help overcome drug resistance to standard chemotherapy and protect against chemotherapy-induced toxicity due to its scavenging properties. Furthermore, chemical compounds in cardamom, including limonene, cymene, pinene, linalool, borneol, cardamonin, indole-3-carbinol, and diindolylmethane, primarily target the programmed cell death lignin-1 gene, which is more prevalent in cancer cells than in healthy cells. This review provides the medicinal properties and pharmacological uses of cardamom, its cellular effects, and potential therapeutic uses in cancer prevention and treatment, as well as its use in reducing drug resistance and improving the overall health of cancer patients. Based on previous preclinical studies, cardamom shows significant potential as an anti-cancer agent, but further exploration for clinical use is warranted due to its diverse mechanisms of action.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bano</LastName><ForeName>Shabana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majumder</LastName><ForeName>Avisek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6761-2242</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>Ayush</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nayak</LastName><ForeName>Kasturi Bala</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Quantitative Biosciences Institute, Department of Medicine, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028523" MajorTopicYN="Y">Elettaria</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000972" MajorTopicYN="N">Antineoplastic Agents, Phytogenic</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elettaria cardamomum</Keyword><Keyword MajorTopicYN="N">anti-microbial</Keyword><Keyword MajorTopicYN="N">antioxidants</Keyword><Keyword MajorTopicYN="N">ayurveda</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">cancer therapy</Keyword><Keyword MajorTopicYN="N">chemoprevention</Keyword><Keyword MajorTopicYN="N">chemoprotectant</Keyword><Keyword MajorTopicYN="N">diet</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">flavonoids</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">natural medicine</Keyword><Keyword MajorTopicYN="N">pharmacological use</Keyword><Keyword MajorTopicYN="N">phytochemicals</Keyword><Keyword MajorTopicYN="N">traditional Indian medicine</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334932</ArticleId><ArticleId IdType="pmc">PMC11430645</ArticleId><ArticleId IdType="doi">10.3390/biom14091166</ArticleId><ArticleId IdType="pii">biom14091166</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Majumder A. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer. Cells. 2023;12:2517. doi: 10.3390/cells12212517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12212517</ArticleId><ArticleId IdType="pmc">PMC10648638</ArticleId><ArticleId IdType="pubmed">37947595</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures. Cancers. 2023;16:39. doi: 10.3390/cancers16010039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16010039</ArticleId><ArticleId IdType="pmc">PMC10777914</ArticleId><ArticleId IdType="pubmed">38201467</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., Tyagi S.C. Post-menopausal breast cancer: From estrogen to androgen receptor. Oncotarget. 2017;8:102739&#x2013;102758. doi: 10.18632/oncotarget.22156.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.22156</ArticleId><ArticleId IdType="pmc">PMC5731994</ArticleId><ArticleId IdType="pubmed">29254284</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Sandhu M., Banerji D., Steri V., Olshen A., Moasser M.M. The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers. Sci. Rep. 2021;11:9091. doi: 10.1038/s41598-021-88683-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88683-w</ArticleId><ArticleId IdType="pmc">PMC8079373</ArticleId><ArticleId IdType="pubmed">33907275</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Bano S. How the Western Diet Thwarts the Epigenetic Efforts of Gut Microbes in Ulcerative Colitis and Its Association with Colorectal Cancer. Biomolecules. 2024;14:633. doi: 10.3390/biom14060633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom14060633</ArticleId><ArticleId IdType="pmc">PMC11201633</ArticleId><ArticleId IdType="pubmed">38927037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M.M., Rastogi S., Rawat A.K. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid. Based Complement. Altern. Med. 2013;2013:376327. doi: 10.1155/2013/376327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/376327</ArticleId><ArticleId IdType="pmc">PMC3705899</ArticleId><ArticleId IdType="pubmed">23864888</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold J.T. Integrating ayurvedic medicine into cancer research programs part 1: Ayurveda background and applications. J. Ayurveda Integr. Med. 2023;14:100676. doi: 10.1016/j.jaim.2022.100676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2022.100676</ArticleId><ArticleId IdType="pmc">PMC10307688</ArticleId><ArticleId IdType="pubmed">36543691</ArticleId></ArticleIdList></Reference><Reference><Citation>Maqbool M., Chaudhary K., Chalotra R., Chauhan S., Dahiya R.S. Phyto-pharmacology of Most Common Indian Culinary Spices and their Potential in Developing New Pharmaceutical Therapies. Curr. Tradit. Med. 2024;10:117&#x2013;140. doi: 10.2174/2215083810666230330161740.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2215083810666230330161740</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain R., Kosta S., Tiwari A. Ayurveda and cancer. Pharmacogn. Res. 2010;2:393&#x2013;394. doi: 10.4103/0974-8490.75463.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-8490.75463</ArticleId><ArticleId IdType="pmc">PMC3111701</ArticleId><ArticleId IdType="pubmed">21713145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2013.00177</ArticleId><ArticleId IdType="pmc">PMC3887317</ArticleId><ArticleId IdType="pubmed">24454289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg G.M., Newman D.J. Biodiversity: A continuing source of novel drug leads. Pure Appl. Chem. 2005;77:7&#x2013;24. doi: 10.1351/pac200577010007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1351/pac200577010007</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold J.T. Integrating ayurvedic medicine into cancer research programs part 2: Ayurvedic herbs and research opportunities. J. Ayurveda Integr. Med. 2023;14:100677. doi: 10.1016/j.jaim.2022.100677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2022.100677</ArticleId><ArticleId IdType="pmc">PMC10307689</ArticleId><ArticleId IdType="pubmed">36529638</ArticleId></ArticleIdList></Reference><Reference><Citation>Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/jns.2016.41</ArticleId><ArticleId IdType="pmc">PMC5465813</ArticleId><ArticleId IdType="pubmed">28620474</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawaz J., Rasul A., Shah M.A., Hussain G., Riaz A., Sarfraz I., Zafar S., Adnan M., Khan A.H., Selamoglu Z. Cardamonin: A new player to fight cancer via multiple cancer signaling pathways. Life Sci. 2020;250:117591. doi: 10.1016/j.lfs.2020.117591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117591</ArticleId><ArticleId IdType="pubmed">32224026</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as &#x201c;Curecumin&#x201d;: From kitchen to clinic. Biochem. Pharmacol. 2008;75:787&#x2013;809. doi: 10.1016/j.bcp.2007.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2007.08.016</ArticleId><ArticleId IdType="pubmed">17900536</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan S., Nair V., Cisneros-Zevallos L. Protective Role of Phenolic Compounds from Whole Cardamom (Elettaria cardamomum (L.) Maton) against LPS-Induced Inflammation in Colon and Macrophage Cells. Nutrients. 2023;15:2965. doi: 10.3390/nu15132965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15132965</ArticleId><ArticleId IdType="pmc">PMC10346154</ArticleId><ArticleId IdType="pubmed">37447289</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah, Asghar A., Butt M.S., Shahid M., Huang Q. Evaluating the antimicrobial potential of green cardamom essential oil focusing on quorum sensing inhibition of Chromobacterium violaceum. J. Food Sci. Technol. 2017;54:2306&#x2013;2315. doi: 10.1007/s13197-017-2668-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13197-017-2668-7</ArticleId><ArticleId IdType="pmc">PMC5502022</ArticleId><ArticleId IdType="pubmed">28740287</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah, Ahmad N., Tian W., Zengliu S., Zou Y., Farooq S., Huang Q., Xiao J. Recent advances in the extraction, chemical composition, therapeutic potential, and delivery of cardamom phytochemicals. Front. Nutr. 2022;9:1024820. doi: 10.3389/fnut.2022.1024820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.1024820</ArticleId><ArticleId IdType="pmc">PMC9562589</ArticleId><ArticleId IdType="pubmed">36245491</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hilphy A.R., Ahmed A.-H.K., Gavahian M., Chen H.-H., Chemat F., Al-Behadli T.-K.M., Mohd Nor M.Z., Ahmad S.b. Solar energy-based extraction of essential oils from cloves, cinnamon, orange, lemon, eucalyptus, and cardamom: A clean energy technology for green extraction. J. Food Process Eng. 2022;45:e14038. doi: 10.1111/jfpe.14038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfpe.14038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Zhang M., Ju R., Chen K., Bhandari B., Wang H. Advances in efficient extraction of essential oils from spices and its application in food industry: A critical review. Crit. Rev. Food Sci. Nutr. 2023;63:11482&#x2013;11503. doi: 10.1080/10408398.2022.2092834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2092834</ArticleId><ArticleId IdType="pubmed">35766478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L.J., Huang X.B., Lv Z.C. Isolation and identification of flavonoids components from Pteris vittata L. SpringerPlus. 2016;5:1649. doi: 10.1186/s40064-016-3308-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-016-3308-9</ArticleId><ArticleId IdType="pmc">PMC5033795</ArticleId><ArticleId IdType="pubmed">27722067</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa A.F.L., Paim R.T.T. Food habits of different worker categories: An integrative review. Rev. Bras. de Med. do Trab. 2022;20:624&#x2013;632. doi: 10.47626/1679-4435-2022-703.</Citation><ArticleIdList><ArticleId IdType="doi">10.47626/1679-4435-2022-703</ArticleId><ArticleId IdType="pmc">PMC10124809</ArticleId><ArticleId IdType="pubmed">37101444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagat N., Chaturvedi A. Spices as an alternative therapy for cancer treatment. Syst. Rev. Pharm. 2016;7:46&#x2013;56. doi: 10.5530/srp.2016.7.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.5530/srp.2016.7.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampe J.W. Spicing up a vegetarian diet: Chemopreventive effects of phytochemicals. Am. J. Clin. Nutr. 2003;78:579s&#x2013;583s. doi: 10.1093/ajcn/78.3.579S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/78.3.579S</ArticleId><ArticleId IdType="pubmed">12936952</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet P., Skalko-Basnet N. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16:4567&#x2013;4598. doi: 10.3390/molecules16064567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16064567</ArticleId><ArticleId IdType="pmc">PMC6264403</ArticleId><ArticleId IdType="pubmed">21642934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J., Zhou Y., Li Y., Xu D.P., Li S., Li H.B. Spices for Prevention and Treatment of Cancers. Nutrients. 2016;8:495. doi: 10.3390/nu8080495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8080495</ArticleId><ArticleId IdType="pmc">PMC4997408</ArticleId><ArticleId IdType="pubmed">27529277</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K.M., Asish G.R., Sabu M., Balachandran I. Significance of gingers (Zingiberaceae) in Indian System of Medicine&#x2014;Ayurveda: An overview. Anc. Sci. Life. 2013;32:253&#x2013;261. doi: 10.4103/0257-7941.131989.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0257-7941.131989</ArticleId><ArticleId IdType="pmc">PMC4078479</ArticleId><ArticleId IdType="pubmed">24991077</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabana B., Asif J., Nashrah A., Sharma A.K., Md A. A Comparative Antibacterial Activity of Three Common Spices Extract and their Anti-Proliferative and Apoptotic Effectiveness against Human Breast Adenocarcinoma Cells. Pharmacogn. J. 2019;11:88&#x2013;93.</Citation></Reference><Reference><Citation>Sengottuvelu S. Nuts and Seeds in Health and Disease Prevention. Elsevier; Amsterdam, The Netherlands: 2011. Cardamom (Elettaria cardamomum Linn. Maton) seeds in health; pp. 285&#x2013;291.</Citation></Reference><Reference><Citation>Balachandran P., Govindarajan R. Cancer--an ayurvedic perspective. Pharmacol. Res. 2005;51:19&#x2013;30. doi: 10.1016/j.phrs.2004.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2004.04.010</ArticleId><ArticleId IdType="pubmed">15519531</ArticleId></ArticleIdList></Reference><Reference><Citation>Barah B. Hill agriculture: Problems and prospects for mountain agriculture. Indian J. Agric. Econ. 2010;65:584&#x2013;601.</Citation></Reference><Reference><Citation>Ravindran P., Madhusoodanan K. Cardamom: The Genus Elettaria. CRC Press; Boca Raton, FL, USA: Taylor and Francis Group; London, UK: 2002. (Medicinal and Aromatic Plants Industrial Series).</Citation></Reference><Reference><Citation>Ravindran P., Divakaran M., Pillai G. Handbook of Herbs and Spice. Volume 1. Woodhead Publishing; Sawston, UK: 2012. pp. 86&#x2013;115.</Citation></Reference><Reference><Citation>Monti D., Chetoni P., Burgalassi S., Najarro M., Saettone M.F., Boldrini E. Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin. Int. J. Pharm. 2002;237:209&#x2013;214. doi: 10.1016/S0378-5173(02)00032-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-5173(02)00032-7</ArticleId><ArticleId IdType="pubmed">11955818</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Lam S., Ho S. Bioactivities of essential oil from Elletaria cardamomum (L.) Maton. to Sitophilus zeamais Motschulsky and: Tribolium castaneum (Herbst) J. Stored Prod. Res. 2000;36:107&#x2013;117. doi: 10.1016/S0022-474X(99)00040-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-474X(99)00040-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanta A., Dobhal K., Singh A., Verma S., Jakhmola V. Potential action of cardamom (Elettaria cardamomum) against triple-negative breast cancer. BLDE Univ. J. Health Sci. 2023;8:210. doi: 10.4103/bjhs.bjhs_36_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/bjhs.bjhs_36_23</ArticleId></ArticleIdList></Reference><Reference><Citation>Govindarajan V.S., Narasimhan S., Raghuveer K.G., Lewis Y.S. Cardamom&#x2014;Production, technology, chemistry, and quality. Crit. Rev. Food Sci. Nutr. 1982;16:229&#x2013;326. doi: 10.1080/10408398209527337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398209527337</ArticleId><ArticleId IdType="pubmed">7039980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirtikar K.R., Basu B.D. Indian Medicinal Plants; Publisher Not Identified Basu, Bhuwane&#x15b;wari &#xc2;&#x15b;rama, 1918; Volume 2.  [(accessed on 24 July 2024)].  Available online:  https://www.biodiversitylibrary.org/item/124087#page/9/mode/1up.</Citation></Reference><Reference><Citation>Korikanthimathm V., Prasath D., Rao G. Medicinal properties of Elettaria cardamomum. J. Med. Aromat. Plant Sci. 2001;22:683&#x2013;685.</Citation></Reference><Reference><Citation>Polunin M., Robbins C. The Natural Pharmacy: An Encyclopedic Illustrated Guide to Medicine from Nature. Dorling Kindersley Publishers Ltd.; London, UK: 1992.</Citation></Reference><Reference><Citation>Krishnamurthy K.H. The Wealth of Susruta. International Institute of Ayurveda; Gualala, CA, USA: 1991.</Citation></Reference><Reference><Citation>El-Bastawesy A.M., Mohamed R.H. Evaluation of cardamom oil role as antimicrobial anticarcenogenic and anti-inflammatory agents. Egypt. J. Agric. Res. 2005;83:789&#x2013;809. doi: 10.21608/ejar.2005.245564.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejar.2005.245564</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal A., Javed K., Aslam M., Jafri M.A. Gastroprotective effect of cardamom, Elettaria cardamomum Maton. fruits in rats. J. Ethnopharmacol. 2006;103:149&#x2013;153. doi: 10.1016/j.jep.2005.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2005.07.016</ArticleId><ArticleId IdType="pubmed">16298093</ArticleId></ArticleIdList></Reference><Reference><Citation>Suneetha W.J., Krishnakantha T.P. Cardamom extract as inhibitor of human platelet aggregation. Phytother. Res. PTR. 2005;19:437&#x2013;440. doi: 10.1002/ptr.1681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.1681</ArticleId><ArticleId IdType="pubmed">16106388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bano S., Ahmad N., Sharma A. Phytochemical screening and evaluation of anti-microbial and anti-oxidant activity of Elettaria cardamom (Cardamom) J. Appl. Nat. Sci. 2016;8:1966&#x2013;1970. doi: 10.31018/jans.v8i4.1071.</Citation><ArticleIdList><ArticleId IdType="doi">10.31018/jans.v8i4.1071</ArticleId></ArticleIdList></Reference><Reference><Citation>Badei A., Morsi H., El-Akel A. Chemical Composition and Antioxidant Properties of Cardamom Essential Oil. 1991.  [(accessed on 30 August 2024)].  Available online:  https://www.cabidigitallibrary.org/doi/full/10.5555/19920314104.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/19920314104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.D. Dietary and Nutritional Guidelines for Cancer Prevention and Recovery.  [(accessed on 30 August 2024)].  Available online:  https://mammalive.net/wp-content/uploads/2016/05/Dietary-and-Nutritional-Guidelines-for-Cancer-Prevention-and-Recovery.pdf.</Citation></Reference><Reference><Citation>Majdalawieh A.F., Carr R.I. In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum) J. Med. Food. 2010;13:371&#x2013;381. doi: 10.1089/jmf.2009.1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2009.1131</ArticleId><ArticleId IdType="pubmed">20210607</ArticleId></ArticleIdList></Reference><Reference><Citation>Amma K.P., Sasidharan I., Sreekumar M., Sumathykutty M., Arumughan C. Total antioxidant capacity and change in phytochemicals of four major varieties of cardamom oils during decortication. Int. J. Food Prop. 2015;18:1317&#x2013;1325. doi: 10.1080/10942912.2011.587621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10942912.2011.587621</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zuhair H., El-Sayeh B., Ameen H.A., Al-Shoora H. Pharmacological studies of cardamom oil in animals. Pharmacol. Res. 1996;34:79&#x2013;82. doi: 10.1006/phrs.1996.0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/phrs.1996.0067</ArticleId><ArticleId IdType="pubmed">8981560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalemba D., Kunicka A. Antibacterial and antifungal properties of essential oils. Curr. Med. Chem. 2003;10:813&#x2013;829. doi: 10.2174/0929867033457719.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867033457719</ArticleId><ArticleId IdType="pubmed">12678685</ArticleId></ArticleIdList></Reference><Reference><Citation>Winarsi H., Yuniaty A., Nuraeni I. Improvement of antioxidant and immune status of atherosclerotic rats adrenaline and egg-yolks-induced using cardamom-rhizome-ethanolic-extract: An initial study of functional food. Agric. Agric. Sci. Procedia. 2016;9:264&#x2013;270. doi: 10.1016/j.aaspro.2016.02.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aaspro.2016.02.147</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pradier E. Trial of a mixture of three essential oils in the treatment of postoperative nausea and vomiting. Phytoth&#xe9;rapie. 2006;4:181&#x2013;187. doi: 10.1007/s10298-006-0179-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10298-006-0179-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorm&#xe1;n G., Flachner B., Hajd&#xfa; I., Andr&#xe1;s C.D. Chapter 21&#x2014;Target Identification and Polypharmacology of Nutraceuticals. In: Gupta R.C., editor. Nutraceuticals. Academic Press; Boston, MA, USA: 2016. pp. 263&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802147-7.00021-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzoyem J.P., McGaw L.J., Kuete V., Bakowsky U. Chapter 9&#x2014;Anti-inflammatory and Anti-nociceptive Activities of African Medicinal Spices and Vegetables. In: Kuete V., editor. Medicinal Spices and Vegetables from Africa. Academic Press; Cambridge, MA, USA: 2017. pp. 239&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-809286-6.00009-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Botsaris A.S. Plants used traditionally to treat malaria in Brazil: The archives of Flora Medicinal. J. Ethnobiol. Ethnomed. 2007;3:18. doi: 10.1186/1746-4269-3-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1746-4269-3-18</ArticleId><ArticleId IdType="pmc">PMC1891273</ArticleId><ArticleId IdType="pubmed">17472740</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin B., Liu J., Liu S., Li B.-j., Ren J. Kaempferol targets estrogen-related receptor &#x3b1; and inhibits cell proliferation and invasion in retinoblastoma via Wnt/&#x3b2;-catenin signaling pathway. Int. J. Clin. Exp. Med. 2016;9:21415&#x2013;21423.</Citation></Reference><Reference><Citation>Lin Y., Shi R., Wang X., Shen H.M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets. 2008;8:634&#x2013;646. doi: 10.2174/156800908786241050.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156800908786241050</ArticleId><ArticleId IdType="pmc">PMC2615542</ArticleId><ArticleId IdType="pubmed">18991571</ArticleId></ArticleIdList></Reference><Reference><Citation>Brglez Mojzer E., Knez Hrn&#x10d;i&#x10d; M., &#x160;kerget M., Knez &#x17d;., Bren U. Polyphenols: Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects. Molecules. 2016;21:901. doi: 10.3390/molecules21070901.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules21070901</ArticleId><ArticleId IdType="pmc">PMC6273793</ArticleId><ArticleId IdType="pubmed">27409600</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjeet K.R., Ghosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages. Int. J. Immunopharmacol. 1999;21:435&#x2013;443. doi: 10.1016/s0192-0561(99)00024-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0192-0561(99)00024-7</ArticleId><ArticleId IdType="pubmed">10454017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 1998;421:277&#x2013;279. doi: 10.1016/S0014-5793(97)01572-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(97)01572-X</ArticleId><ArticleId IdType="pubmed">9468322</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno J.J. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J. Pharmacol. Exp. Ther. 2000;294:333&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">10871330</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiner J.F.W., M&#xfc;ller J., Zeuner M.-T., Hauser S., Seidel T., Klenke C., Grunwald L.-M., Schomann T., Widera D., Sudhoff H., et al. 1,8-Cineol inhibits nuclear translocation of NF-&#x3ba;B p65 and NF-&#x3ba;B-dependent transcriptional activity. Biochim. Biophys. Acta (BBA)&#x2014;Mol. Cell Res. 2013;1833:2866&#x2013;2878. doi: 10.1016/j.bbamcr.2013.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.07.001</ArticleId><ArticleId IdType="pubmed">23872422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Chen R., Li W.Y., Zhu H.Y., Chen X.X., Hou Z.F., Cao R.S., Zang G., Li Y.X., Zhang W. D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-&#x3b1;/NF-&#x3ba;B p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis. Front. Med. 2021;8:591830. doi: 10.3389/fmed.2021.591830.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.591830</ArticleId><ArticleId IdType="pmc">PMC7985179</ArticleId><ArticleId IdType="pubmed">33768100</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos W.B.R., Melo M.A.O., Alves R.S., de Brito R.G., Rabelo T.K., Prado L.d.S., Silva V.K. dos S.; Bezerra, D.P.; de Menezes-Filho, J.E.R.; Souza, D.S.; et al. p-Cymene attenuates cancer pain via inhibitory pathways and modulation of calcium currents. Phytomedicine. 2019;61:152836. doi: 10.1016/j.phymed.2019.152836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2019.152836</ArticleId><ArticleId IdType="pubmed">31035053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.S., Lee H.J., Jeon Y.D., Han Y.H., Kee J.Y., Kim H.J., Shin H.J., Kang J., Lee B.S., Kim S.H., et al. Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-&#x3ba;B Pathway in Mouse Peritoneal Macrophages. Am. J. Chin. Med. 2015;43:731&#x2013;742. doi: 10.1142/S0192415X15500457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X15500457</ArticleId><ArticleId IdType="pubmed">26119957</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaseelan S., Balupillai A., Govindasamy K., Ramasamy K., Muthusamy G., Shanmugam M., Thangaiyan R., Robert B.M., Nagarajan R.P., Ponniresan V.K., et al. Linalool prevents oxidative stress activated protein kinases in single UVB-exposed human skin cells. PLOS ONE. 2017;12:e0176699. doi: 10.1371/journal.pone.0176699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0176699</ArticleId><ArticleId IdType="pmc">PMC5415184</ArticleId><ArticleId IdType="pubmed">28467450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Li Q., Xia L., Li X., Sun C., Wang Q., Cai X., Yang G. Borneol promotes apoptosis of Human Glioma Cells through regulating HIF-1a expression via mTORC1/eIF4E pathway. J. Cancer. 2020;11:4810&#x2013;4822. doi: 10.7150/jca.45304.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.45304</ArticleId><ArticleId IdType="pmc">PMC7330691</ArticleId><ArticleId IdType="pubmed">32626528</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronchik I., Chen T., Durkin K.A., Horwitz M.S., Preobrazhenskaya M.N., Bjeldanes L.F., Firestone G.L. Target protein interactions of indole-3-carbinol and the highly potent derivative 1-benzyl-I3C with the C-terminal domain of human elastase uncouples cell cycle arrest from apoptotic signaling. Mol. Carcinog. 2012;51:881&#x2013;894. doi: 10.1002/mc.20857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20857</ArticleId><ArticleId IdType="pubmed">22012859</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S., Kong D., Wang Z., Bao B., Hillman G.G., Sarkar F.H. Attenuation of multi-targeted proliferation-linked signaling by 3,3&#x2032;-diindolylmethane (DIM): From bench to clinic. Mutat. Res. 2011;728:47&#x2013;66. doi: 10.1016/j.mrrev.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2011.06.001</ArticleId><ArticleId IdType="pmc">PMC4120774</ArticleId><ArticleId IdType="pubmed">21703360</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment. Antioxidants. 2023;12:1520. doi: 10.3390/antiox12081520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12081520</ArticleId><ArticleId IdType="pmc">PMC10451792</ArticleId><ArticleId IdType="pubmed">37627515</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. ploiting Methionine Addiction as a Potential Treatment Strategy for Cancer. 2023.  [(accessed on 30 August 2024)].  Available online:  http://research.sdpublishers.net/id/eprint/3430/</Citation></Reference><Reference><Citation>Majumder A., Steri V., Salangsang F., Moasser M. Abstract LB-326: The role of HER3 in HER2-amplified cancers other than breast cancers. Cancer Res. 2020;80:LB&#x2013;326. doi: 10.1158/1538-7445.AM2020-LB-326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1538-7445.AM2020-LB-326</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Majumder A., Ice H., Homme R.P., Eyob W., Tyagi S.C., Singh M. Genes and genetics in hyperhomocysteinemia and the &#x201c;1-carbon metabolism&#x201d;: Implications for retinal structure and eye functions. Can. J. Physiol. Pharmacol. 2020;98:51&#x2013;60. doi: 10.1139/cjpp-2019-0236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2019-0236</ArticleId><ArticleId IdType="pubmed">31369712</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Behra J., Singh M., Tyagi N., Tyagi S.C. Hyperhomocysteinemia-Mediated Endoplasmic Reticulum Stress in Skeletal Muscle Dysfunction via JNK/pro-inflammatory Pathway. FASEB J. 2018;32:538-4. doi: 10.1096/fasebj.2018.32.1_supplement.538.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2018.32.1_supplement.538.4</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Tyagi S.C. Hydrogen Sulfide Improves Hyperhomocysteinemia-Mediated Impairment of Angiogenesis in Skeletal Muscle. FASEB J. 2018;32:573-2. doi: 10.1096/fasebj.2018.32.1_supplement.573.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2018.32.1_supplement.573.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman A.C., Maddocks O.D.K. One-carbon metabolism in cancer. Br. J. Cancer. 2017;116:1499&#x2013;1504. doi: 10.1038/bjc.2017.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2017.118</ArticleId><ArticleId IdType="pmc">PMC5518849</ArticleId><ArticleId IdType="pubmed">28472819</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A. Ph. D. Thesis. University of Louisville; Louisville, KY, USA: 2018. Effects of Hydrogen Sulfide in Hyperhomocysteinemia-Mediated Skeletal Muscle Myopathy.</Citation></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Tyagi S.C. Restoration of skeletal muscle homeostasis by hydrogen sulfide during hyperhomocysteinemia-mediated oxidative/ER stress condition (1) Can. J. Physiol. Pharmacol. 2019;97:441&#x2013;456. doi: 10.1139/cjpp-2018-0501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2018-0501</ArticleId><ArticleId IdType="pmc">PMC6719301</ArticleId><ArticleId IdType="pubmed">30422673</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., Behera J., Theilen N.T., George A.K., Tyagi N., Metreveli N., Tyagi S.C. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury. Am. J. Physiol. Cell Physiol. 2018;315:C609&#x2013;C622. doi: 10.1152/ajpcell.00147.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00147.2018</ArticleId><ArticleId IdType="pmc">PMC6293052</ArticleId><ArticleId IdType="pubmed">30110564</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Behera J., Jeremic N., Tyagi S.C. Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy. J. Cell Biochem. 2017;118:2108&#x2013;2117. doi: 10.1002/jcb.25841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.25841</ArticleId><ArticleId IdType="pmc">PMC6563903</ArticleId><ArticleId IdType="pubmed">27982479</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Master K., Majumder A., Homme R.P., Laha A., Sandhu H.S., Tyagi S.C., Singh M. Circular RNAs constitute an inherent gene regulatory axis in the mammalian eye and brain (1) Can. J. Physiol. Pharmacol. 2019;97:463&#x2013;472. doi: 10.1139/cjpp-2018-0505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2018-0505</ArticleId><ArticleId IdType="pubmed">30444648</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., George A.K., Homme R.P., Majumder A., Laha A., Sandhu H.S., Tyagi S.C. Expression Analysis of the Circular RNA Molecules in the Human Retinal Cells Treated with Homocysteine. Curr. Eye Res. 2019;44:287&#x2013;293. doi: 10.1080/02713683.2018.1542005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02713683.2018.1542005</ArticleId><ArticleId IdType="pmc">PMC6709669</ArticleId><ArticleId IdType="pubmed">30369271</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., George A.K., Homme R.P., Majumder A., Laha A., Sandhu H.S., Tyagi S.C. Circular RNAs profiling in the cystathionine-&#x3b2;-synthase mutant mouse reveals novel gene targets for hyperhomocysteinemia induced ocular disorders. Exp. Eye Res. 2018;174:80&#x2013;92. doi: 10.1016/j.exer.2018.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2018.05.026</ArticleId><ArticleId IdType="pubmed">29803556</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Montes E., Salamanca-Fern&#xe1;ndez E., Garcia-Villanova B., S&#xe1;nchez M.J. The Impact of Plant-Based Dietary Patterns on Cancer-Related Outcomes: A Rapid Review and Meta-Analysis. Nutrients. 2020;12:2010. doi: 10.3390/nu12072010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072010</ArticleId><ArticleId IdType="pmc">PMC7400843</ArticleId><ArticleId IdType="pubmed">32640737</ArticleId></ArticleIdList></Reference><Reference><Citation>Asma S.T., Acaroz U., Imre K., Morar A., Shah S.R.A., Hussain S.Z., Arslan-Acaroz D., Demirbas H., Hajrulai-Musliu Z., Istanbullugil F.R., et al. Natural Products/Bioactive Compounds as a Source of Anticancer Drugs. Cancers. 2022;14:6203. doi: 10.3390/cancers14246203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14246203</ArticleId><ArticleId IdType="pmc">PMC9777303</ArticleId><ArticleId IdType="pubmed">36551687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramchandani S., Naz I., Dhudha N., Garg M. An overview of the potential anticancer properties of cardamonin. Explor. Target. Antitumor Ther. 2020;1:413&#x2013;426. doi: 10.37349/etat.2020.00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.37349/etat.2020.00026</ArticleId><ArticleId IdType="pmc">PMC9400778</ArticleId><ArticleId IdType="pubmed">36046386</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiblawi S., Kausar A., Shahid S., Saeed M., Alazzeh A. Therapeutic Interventions of Cardamom in Cancer and Other Human Diseases. J. Pharm. Res. Int. 2020;32:74&#x2013;78. doi: 10.9734/jpri/2020/v32i2230774.</Citation><ArticleIdList><ArticleId IdType="doi">10.9734/jpri/2020/v32i2230774</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S., Rana T., Sengupta A. Inhibition of lipid peroxidation and enhancement of GST activity by cardamom and cinnamon during chemically induced colon carcinogenesis in Swiss albino mice. Asian Pac. J. Cancer Prev. 2007;8:578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">18260732</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiblawi S., Al-Hazimi A., Al-Mogbel M., Hossain A., Bagchi D. Chemopreventive Effects of Cardamom (Elettaria cardamomum L.) on Chemically Induced Skin Carcinogenesis in Swiss Albino Mice. J. Med. Food. 2012;15:576&#x2013;580. doi: 10.1089/jmf.2011.0266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2011.0266</ArticleId><ArticleId IdType="pubmed">22404574</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiblawi S., Dhanarasu S., Faris M.A. Chemopreventive Effect of Cardamom (Elettaria cardamomum L.) Against Benzo(&#x3b1;)Pyrene-Induced Forestomach Papillomagenesis in Swiss Albino Mice. J. Environ. Pathol. Toxicol. Oncol. 2015;34:95&#x2013;104. doi: 10.1615/JEnvironPatholToxicolOncol.2015010838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/JEnvironPatholToxicolOncol.2015010838</ArticleId><ArticleId IdType="pubmed">26081028</ArticleId></ArticleIdList></Reference><Reference><Citation>Vutakuri N., Somara S. Natural and herbal medicine for breast cancer using Elettaria cardamomum (L.) Maton. Int. J. Herbal. Med. 2018;6:91&#x2013;96.</Citation></Reference><Reference><Citation>Kamada N., Chen G.Y., Inohara N., N&#xfa;&#xf1;ez G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 2013;14:685&#x2013;690. doi: 10.1038/ni.2608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2608</ArticleId><ArticleId IdType="pmc">PMC4083503</ArticleId><ArticleId IdType="pubmed">23778796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G.-A., Hwang K.-A., Choi K.-C. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis. Toxins. 2016;8:162. doi: 10.3390/toxins8060162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins8060162</ArticleId><ArticleId IdType="pmc">PMC4926129</ArticleId><ArticleId IdType="pubmed">27231938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasril T., Hilbertina N., Elliyanti A. Treatment Problems In Triple Negative Breast Cancer. Int. Islam. Med. J. 2023;4:51&#x2013;58. doi: 10.33086/iimj.v4i2.3951.</Citation><ArticleIdList><ArticleId IdType="doi">10.33086/iimj.v4i2.3951</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia D., Tan Y., Liu H., Ooi S., Li L., Wright K., Bennett S., Addison C.L., Wang L. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget. 2016;7:771&#x2013;785. doi: 10.18632/oncotarget.5819.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.5819</ArticleId><ArticleId IdType="pmc">PMC4808032</ArticleId><ArticleId IdType="pubmed">26506421</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairani S.P., Cuandra K.N., Ramadhannisa Z.D., Rahman A.T., Arisanty D., Hilbertina N. Unravelling the apoptosis induction potential of Amomum cardamomum seed: A combination in silico and in vitro approach. J. Herbmed Pharmacol. 2024;13:427&#x2013;438. doi: 10.34172/jhp.2024.49345.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/jhp.2024.49345</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S., Gwak J., Han S.J., Oh S. Cardamonin suppresses the proliferation of colon cancer cells by promoting &#x3b2;-catenin degradation. Biol. Pharm. Bull. 2013;36:1040&#x2013;1044. doi: 10.1248/bpb.b13-00158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b13-00158</ArticleId><ArticleId IdType="pubmed">23538439</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Y., Liu L., Liu P., Li Y., Lu H., Li Y., Zhang G., Duan X. Cardamonin as a potential treatment for melanoma induces human melanoma cell apoptosis. Oncol. Lett. 2020;19:1393&#x2013;1399. doi: 10.3892/ol.2019.11242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2019.11242</ArticleId><ArticleId IdType="pmc">PMC6960385</ArticleId><ArticleId IdType="pubmed">32002030</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu P., Shi D., Zhang S., Zhu Y., Zhou J. Cardamonin enhances the anti-proliferative effect of cisplatin on ovarian cancer. Oncol. Lett. 2018;15:3991&#x2013;3997. doi: 10.3892/ol.2018.7743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2018.7743</ArticleId><ArticleId IdType="pmc">PMC5795861</ArticleId><ArticleId IdType="pubmed">29456744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Sikka S., Siveen K.S., Lee J.H., Um J.Y., Kumar A.P., Chinnathambi A., Alharbi S.A., Basappa, Rangappa K.S., et al. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer. Apoptosis. 2017;22:158&#x2013;168. doi: 10.1007/s10495-016-1313-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-016-1313-7</ArticleId><ArticleId IdType="pubmed">27900636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Kim J.H. Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro. PLoS ONE. 2016;11:e0155264. doi: 10.1371/journal.pone.0155264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155264</ArticleId><ArticleId IdType="pmc">PMC4866780</ArticleId><ArticleId IdType="pubmed">27175782</ArticleId></ArticleIdList></Reference><Reference><Citation>Das I., Acharya A., Berry D.L., Sen S., Williams E., Permaul E., Sengupta A., Bhattacharya S., Saha T. Antioxidative effects of the spice cardamom against non-melanoma skin cancer by modulating nuclear factor erythroid-2-related factor 2 and NF-&#x3ba;B signalling pathways. Br. J. Nutr. 2011;108:984&#x2013;997. doi: 10.1017/S0007114511006283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114511006283</ArticleId><ArticleId IdType="pubmed">22182368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki M., Farag H., Abd El Wahed S. Investigation Of The Apoptotic Effect Of Cardamom Oil On Laryngeal Cancer Cell Line (A Non-Randomized In Vitro Study) Egypt. Dent. J. 2024;70:189&#x2013;198. doi: 10.21608/edj.2023.239191.2728.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/edj.2023.239191.2728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Song D., Fang Z., Sun D., Wang L., Shi L., Gao L., Jiang X. Cardamomin Inhibits the Proliferation and Tumorigenesis of Bladder Cancer by ESR1 in PI3K/AKT Pathway. Biochem. Genet. 2024:1&#x2013;21. doi: 10.1007/s10528-024-10854-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10528-024-10854-x</ArticleId><ArticleId IdType="pubmed">38867088</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Sheth F., Patel M., Doshi B., Shah N., Thankor P., Vaidya R., Sheth J. Effect of PPAR-&#x3b3;2 Gene Pro12Ala polymorphism (Rs1801282) and Vitamin D(3) on glucose homeostasis in Type 2 diabetic subjects from Gujarat-India. Mol. Cytogenet. 2014;7((Suppl. S1)):P37. doi: 10.1186/1755-8166-7-S1-P37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8166-7-S1-P37</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A., Sheth F., Majumder A., Doshi B., Shah N., Thakor P., Vaidya R., Sheth J. Effect of PPAR-&#x3b3;2 gene Pro12Ala and ADR-&#x3b2;3 gene Trp64AArg polymorphism on glucose homeostasis in Type 2 diabetes subjects from Western India. Mol. Cytogenet. 2014;7((Suppl. S1)):P101. doi: 10.1186/1755-8166-7-S1-P101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8166-7-S1-P101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaefer C.M., Milner J.A. Herbs and Spices in Cancer Prevention and Treatment. In: Benzie I.F.F., Wachtel-Galor S., editors. Herbal Medicine: Biomolecular and Clinical Aspects. CRC Press; Boca Raton, FL, USA: Taylor &amp; Francis; Boca Raton, FL, USA: 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">22593937</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward W.P., Brown K. Cancer chemoprevention: A rapidly evolving field. Br. J. Cancer. 2013;109:1&#x2013;7. doi: 10.1038/bjc.2013.280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2013.280</ArticleId><ArticleId IdType="pmc">PMC3708589</ArticleId><ArticleId IdType="pubmed">23736035</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves L.M., Valente I.M., Rodrigues J.A. An overview on cardamonin. J. Med. Food. 2014;17:633&#x2013;640. doi: 10.1089/jmf.2013.0061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2013.0061</ArticleId><ArticleId IdType="pmc">PMC4060836</ArticleId><ArticleId IdType="pubmed">24433078</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava S., Jeengar M.K., Thummuri D., Koval A., Katanaev V.L., Marepally S., Naidu V.G.M. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/&#x3b2;-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Biofactors. 2017;43:152&#x2013;169. doi: 10.1002/biof.1315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1315</ArticleId><ArticleId IdType="pubmed">27580587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak K.B., Sajitha I.S., Kumar T.R.S., Chakraborty S. Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells. Cell Death Dis. 2018;9:18. doi: 10.1038/s41419-017-0036-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0036-1</ArticleId><ArticleId IdType="pmc">PMC5833819</ArticleId><ArticleId IdType="pubmed">29339729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Aggarwal R. An overview of triple-negative breast cancer. Arch. Gynecol. Obstet. 2016;293:247&#x2013;269. doi: 10.1007/s00404-015-3859-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-015-3859-y</ArticleId><ArticleId IdType="pubmed">26341644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukumar J., Gast K., Quiroga D., Lustberg M., Williams N. Triple-negative breast cancer: Promising prognostic biomarkers currently in development. Expert. Rev. Anticancer Ther. 2021;21:135&#x2013;148. doi: 10.1080/14737140.2021.1840984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737140.2021.1840984</ArticleId><ArticleId IdType="pmc">PMC8174647</ArticleId><ArticleId IdType="pubmed">33198517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamzaa R., Nour N. Using of Coffee and Cardamom Mixture to Ameliorate Oxidative Stress Induced in &#x3b3;-irradiated Rats. Biochem. Anal. Biochem. 2012;1:2161-1009. doi: 10.4172/2161-1009.1000113.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2161-1009.1000113</ArticleId></ArticleIdList></Reference><Reference><Citation>Umamaheswari M., Chatterjee T.K. In vitro antioxidant activities of the fractions of Coccinia grandis L. leaf extract. Afr. J. Tradit. Complement. Altern. Med. 2007;5:61&#x2013;73. doi: 10.4314/ajtcam.v5i1.31258.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ajtcam.v5i1.31258</ArticleId><ArticleId IdType="pmc">PMC2816591</ArticleId><ArticleId IdType="pubmed">20162057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee B., Chatterjee J. Identification of proapoptopic, anti-inflammatory, anti- proliferative, anti-invasive and anti-angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis. Asian Pac. J. Cancer Prev. 2013;14:3735&#x2013;3742. doi: 10.7314/APJCP.2013.14.6.3735.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2013.14.6.3735</ArticleId><ArticleId IdType="pubmed">23886174</ArticleId></ArticleIdList></Reference><Reference><Citation>Saed A., Sultana B., Anwar F., Mushtaq M., Gilani A.-H., Alkharfy K., Gilani A. Antioxidant and Antimutagenic Potential of Seeds and Pods of Green Cardamom (Elettaria cardamomum) Int. J. Pharmacol. 2014;10:461&#x2013;469. doi: 10.3923/ijp.2014.461.469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3923/ijp.2014.461.469</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair S.C., Salomi M.J., Varghese C.D., Panikkar B., Panikkar K.R. Effect of saffron on thymocyte proliferation, intracellular glutathione levels and its antitumor activity. Biofactors. 1992;4:51&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">1292476</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellosa J.C. Antioxidant and cytotoxic studies for kaempferol, quercetin and isoquercitrin. Ecl&#xe9;tica Qu&#xed;mica. 2011;36:07. doi: 10.1590/S0100-46702011000200001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-46702011000200001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashin A., Yashin Y., Xia X., Nemzer B. Antioxidant Activity of Spices and Their Impact on Human Health: A Review. Antioxidants. 2017;6:70. doi: 10.3390/antiox6030070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox6030070</ArticleId><ArticleId IdType="pmc">PMC5618098</ArticleId><ArticleId IdType="pubmed">28914764</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq S., Sehgal A. Evaluation of antioxidant and antigenotoxic effects of kahwa. Indian J. Tradit. Knowl. 2017;16:277&#x2013;283.</Citation></Reference><Reference><Citation>Ahmed A.S., Ahmed Q., Saxena A.K., Jamal P. Evaluation of in vitro antidiabetic and antioxidant characterizations of Elettaria cardamomum (L.) Maton (Zingiberaceae), Piper cubeba L. f. (Piperaceae), and Plumeria rubra L. (Apocynaceae) Pak. J. Pharm. Sci. 2017;30:113&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">28603121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandikattu H.K., Rachitha P., Jayashree G.V., Krupashree K., Sukhith M., Majid A., Amruta N., Khanum F. Anti-inflammatory and anti-oxidant effects of Cardamom (Elettaria repens (Sonn.) Baill) and its phytochemical analysis by 4D GCXGC TOF-MS. Biomed. Pharmacother. 2017;91:191&#x2013;201. doi: 10.1016/j.biopha.2017.04.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.04.049</ArticleId><ArticleId IdType="pubmed">28458157</ArticleId></ArticleIdList></Reference><Reference><Citation>Nithya S. Anti-inflammatory effect of elettaria cardamom oil on carrageenan-induced paw edema using rats based on tumor necrosis factor &#x3b1;, interleukin 6, and interleukin 1 levels in serum. Asian J. Pharm. Clin. Res. 2018;11:207. doi: 10.22159/ajpcr.2018.v11i2.20434.</Citation><ArticleIdList><ArticleId IdType="doi">10.22159/ajpcr.2018.v11i2.20434</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;m&#xe4;l&#xe4;inen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-B Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-B Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages. Mediat. Inflamm. 2007;2007:45673. doi: 10.1155/2007/45673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2007/45673</ArticleId><ArticleId IdType="pmc">PMC2220047</ArticleId><ArticleId IdType="pubmed">18274639</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed R., Hussain I., Tawab A., Tariq M., Rahman M., Hameed S., Mahmood M.S., Siddique A.B., Iqbal M. Antimicrobial activity of the bioactive components of essential oils from Pakistani spices against Salmonella and other multi-drug resistant bacteria. BMC Complement. Altern. Med. 2013;13:265. doi: 10.1186/1472-6882-13-265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6882-13-265</ArticleId><ArticleId IdType="pmc">PMC3853939</ArticleId><ArticleId IdType="pubmed">24119438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali&#xe8;re C., Rinc&#xe9; A., Delannoy S., Fach P., Gourmelon M. Molecular Profiling of Shiga Toxin-Escherichia coli and Enteropathogenic E. coli Strains Isolated from French Coastal Environments. Appl. Environ. Microbiol. 2016;82:3913&#x2013;3927. doi: 10.1128/AEM.00271-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00271-16</ArticleId><ArticleId IdType="pmc">PMC4907183</ArticleId><ArticleId IdType="pubmed">27107119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shegarfi H., Naper C., Rolstad B., Inngjerdingen M. Listeria monocytogenes infection affects a subset of Ly49-expressing NK cells in the rat. PLoS ONE. 2010;5:e15579. doi: 10.1371/journal.pone.0015579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015579</ArticleId><ArticleId IdType="pmc">PMC3002286</ArticleId><ArticleId IdType="pubmed">21179539</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass G., Bierbaum G., Molitor E., G&#xf6;tte N., Antwerpen M. Genome Sequence of Bacillus pumilus Strain Bonn, Isolated from an Anthrax-Like Necrotic Skin Infection Site of a Child. Genome Announc. 2016;4:10&#x2013;1128. doi: 10.1128/genomeA.01741-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/genomeA.01741-15</ArticleId><ArticleId IdType="pmc">PMC4751334</ArticleId><ArticleId IdType="pubmed">26868410</ArticleId></ArticleIdList></Reference><Reference><Citation>Jebur M.H., Yasri A.A., Khazal N., Hindi K., Universi B., Province B. Antimicrobial Effect of Seed Extracts, Leaves and Crude oil of Cardamom (elettariacardamomum) against Different Types of Bacteriain Hilla City, Iraq. World J. Pharm. Res. 2014;3:710&#x2013;2277.</Citation></Reference><Reference><Citation>Alemdar S. Antimicrobial Effect of Seed Extract of Cardamom (Elettaria cardamomum Maton) YY&#xdc; Vet Fak Derg. 2005;16:99&#x2013;101.</Citation></Reference><Reference><Citation>Dehghan M., Noorizadeh E., latifi Navid M. Survey of anti-bacterial effects of turmeric, ginger, clove and cardamom on Helicobacter pylori. J. Ardabil Univ. Med. Sci. 2002;2:19&#x2013;26.</Citation></Reference><Reference><Citation>Kaushik P., Goyal P., Chauhan A., Chauhan G. In Vitro Evaluation of Antibacterial Potential of Dry FruitExtracts of Elettaria cardamomum Maton (Chhoti Elaichi) Iran. J. Pharm. Res. 2010;9:287&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863444</ArticleId><ArticleId IdType="pubmed">24363739</ArticleId></ArticleIdList></Reference><Reference><Citation>Akrayi H.F.S. Antibacterial Effect of Seed Extracts of Cardamom (Elettaria cardamomum) against Staphylococcus aureus and Proteus mirabilis. Tikrit J. Pure Sci. 2012;17:14&#x2013;18.</Citation></Reference><Reference><Citation>Islam M., Rahman M., Sheikh M.M.I., Rahman, Jamal M.A., Firoz A. In vitro Antibacterial Activity of Methanol Seed Extract of Elettaria cardamomum (L.) Maton. Agric. Conspec. Sci. (ACS) 2010;75</Citation></Reference><Reference><Citation>Mishra N., Behal K.K. Antimicrobial activity of some spices against selected microbes. Int. J. Pharm. Pharm. Sci. 2010;2:187&#x2013;196.</Citation></Reference><Reference><Citation>Fernandez C.J., George A.S., Subrahmanyan N.A., Pappachan J.M. Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J. Methodol. 2021;11:23&#x2013;45. doi: 10.5662/wjm.v11.i3.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.5662/wjm.v11.i3.23</ArticleId><ArticleId IdType="pmc">PMC8127420</ArticleId><ArticleId IdType="pubmed">34026577</ArticleId></ArticleIdList></Reference><Reference><Citation>Homme R.P., Anewesha L., Majumder A., George A., Singh M., Tyagi S. NF-kB p65 Subunit Inhibitor: JSH-23 Mitigates Diabetic Retinopathy via Reducing Oxidative Stress. FASEB J. 2019;33:685-5. doi: 10.1096/fasebj.2019.33.1_supplement.685.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2019.33.1_supplement.685.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Homme R.P., Singh M., Majumder A., George A.K., Nair K., Sandhu H.S., Tyagi N., Lominadze D., Tyagi S.C. Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis. Front. Physiol. 2018;9:1268. doi: 10.3389/fphys.2018.01268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01268</ArticleId><ArticleId IdType="pmc">PMC6134046</ArticleId><ArticleId IdType="pubmed">30233418</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Behera J., Tyagi N., Tyagi S.C. Hydrogen sulfide improves postischemic neoangiogenesis in the hind limb of cystathionine-&#x3b2;-synthase mutant mice via PPAR-&#x3b3;/VEGF axis. Physiol. Rep. 2018;6:e13858. doi: 10.14814/phy2.13858.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13858</ArticleId><ArticleId IdType="pmc">PMC6119702</ArticleId><ArticleId IdType="pubmed">30175474</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Doshi B., Sheth F., Patel M., Shah N., Premal T., Vaidya R., Sheth J. Association of Vitamin D(3) levels with glycemic control in Type 2 diabetes subjects from Gujarati population-India. Mol. Cytogenet. 2014;7((Suppl. S1)):P36. doi: 10.1186/1755-8166-7-S1-P36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8166-7-S1-P36</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Singh M., Homme R.P., Majumder A., Sandhu H.S., Tyagi S.C. A hypothesis for treating inflammation and oxidative stress with hydrogen sulfide during age-related macular degeneration. Int. J. Ophthalmol. 2018;11:881&#x2013;887. doi: 10.18240/ijo.2018.05.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.18240/ijo.2018.05.26</ArticleId><ArticleId IdType="pmc">PMC5957044</ArticleId><ArticleId IdType="pubmed">29862191</ArticleId></ArticleIdList></Reference><Reference><Citation>Laha A., Majumder A., Singh M., Tyagi S.C. Connecting homocysteine and obesity through pyroptosis, gut microbiome, epigenetics, peroxisome proliferator-activated receptor &#x3b3;, and zinc finger protein 407. Can. J. Physiol. Pharmacol. 2018;96:971&#x2013;976. doi: 10.1139/cjpp-2018-0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2018-0037</ArticleId><ArticleId IdType="pubmed">29890083</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Homme R.P., Majumder A., Laha A., Metreveli N., Sandhu H.S., Tyagi S.C., Singh M. Hydrogen sulfide intervention in cystathionine-&#x3b2;-synthase mutant mouse helps restore ocular homeostasis. Int. J. Ophthalmol. 2019;12:754&#x2013;764. doi: 10.18240/ijo.2019.05.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.18240/ijo.2019.05.09</ArticleId><ArticleId IdType="pmc">PMC6520274</ArticleId><ArticleId IdType="pubmed">31131233</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Singh M., Homme R.P., Majumder A., Tyagi S. Role of Hydrogen Sulfide (H2S) on Homocysteine Mediated Glutamate Excitotoxicity, Endoplasmic Reticulum Stress and Pyroptosis in Retina. FASEB J. 2018;32:748-5. doi: 10.1096/fasebj.2018.32.1_supplement.748.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2018.32.1_supplement.748.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Homme R.P., Laha A., Tyagi S.C. Remote ischemic conditioning as a cytoprotective strategy in vasculopathies during hyperhomocysteinemia: An emerging research perspective. J. Cell Biochem. 2019;120:77&#x2013;92. doi: 10.1002/jcb.27603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.27603</ArticleId><ArticleId IdType="pubmed">30272816</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.M., Alam M.N., Ulla A., Sumi F.A., Subhan N., Khan T., Sikder B., Hossain H., Reza H.M., Alam M.A. Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats. Lipids Health Dis. 2017;16:151. doi: 10.1186/s12944-017-0539-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12944-017-0539-x</ArticleId><ArticleId IdType="pmc">PMC5557534</ArticleId><ArticleId IdType="pubmed">28806968</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatemeh Y., Siassi F., Rahimi A., Koohdani F., Doostan F., Qorbani M., Sotoudeh G. The effect of cardamom supplementation on serum lipids, glycemic indices and blood pressure in overweight and obese pre-diabetic women: A randomized controlled trial. J. Diabetes Metab. Disord. 2017;16:40. doi: 10.1186/s40200-017-0320-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40200-017-0320-8</ArticleId><ArticleId IdType="pmc">PMC5623966</ArticleId><ArticleId IdType="pubmed">29026804</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghasi M., Koohdani F., Qorbani M., Nasli-Esfahani E., Ghazi-Zahedi S., Khoshamal H., Keshavarz A., Sotoudeh G. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: A randomized double-blind placebo controlled clinical trial. J. Sci. Food Agric. 2019;99:3933&#x2013;3940. doi: 10.1002/jsfa.9617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jsfa.9617</ArticleId><ArticleId IdType="pubmed">30701554</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul K., Chakraborty S., Mallick P., Bhattacharjee P., Pal T.K., Chatterjee N., Chakrabarti S. Supercritical carbon dioxide extracts of small cardamom and yellow mustard seeds have fasting hypoglycaemic effects: Diabetic rat, predictive iHOMA2 models and molecular docking study. Br. J. Nutr. 2021;125:377&#x2013;388. doi: 10.1017/S000711452000286X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S000711452000286X</ArticleId><ArticleId IdType="pubmed">32713360</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed E.A., Siddiqui M.J., Ang L.F., Sadikun A., Chan S.H., Tan S.C., Asmawi M.Z., Yam M.F. Potent &#x3b1;-glucosidase and &#x3b1;-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism. BMC Complement. Altern. Med. 2012;12:176. doi: 10.1186/1472-6882-12-176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6882-12-176</ArticleId><ArticleId IdType="pmc">PMC3533584</ArticleId><ArticleId IdType="pubmed">23039079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahyazadeh R., Ghasemzadeh Rahbardar M., Razavi B.M., Karimi G., Hosseinzadeh H. The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review. Iran. J. Basic. Med. Sci. 2021;24:1462&#x2013;1469. doi: 10.22038/ijbms.2021.54417.12228.</Citation><ArticleIdList><ArticleId IdType="doi">10.22038/ijbms.2021.54417.12228</ArticleId><ArticleId IdType="pmc">PMC8917848</ArticleId><ArticleId IdType="pubmed">35317114</ArticleId></ArticleIdList></Reference><Reference><Citation>Links M., Lewis C. Chemoprotectants: A review of their clinical pharmacology and therapeutic efficacy. Drugs. 1999;57:293&#x2013;308. doi: 10.2165/00003495-199957030-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-199957030-00003</ArticleId><ArticleId IdType="pubmed">10193684</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A., Bhattacharjee A., Bhattacharya S. Chemoprotectants in cancer chemotherapy: An update. Biomed. Res. J. 2016;3:157&#x2013;181.</Citation></Reference><Reference><Citation>Rohilla S., Dureja H., Chawla V. Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A Review. Curr. Cancer Drug Targets. 2019;19:765&#x2013;781. doi: 10.2174/1568009619666190326120457.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568009619666190326120457</ArticleId><ArticleId IdType="pubmed">30914026</ArticleId></ArticleIdList></Reference><Reference><Citation>Roszkowski S. Application of Polyphenols and Flavonoids in Oncological Therapy. Molecules. 2023;28:4080. doi: 10.3390/molecules28104080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28104080</ArticleId><ArticleId IdType="pmc">PMC10220832</ArticleId><ArticleId IdType="pubmed">37241819</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., George A.K., Homme R.P., Majumder A., Laha A., Metreveli N., Pushpakumar S.B., Tyagi S.C. Probiotic Supplementation Mitigates Vascular Remodeling in the Retina. FASEB J. 2019;33:484-11. doi: 10.1096/fasebj.2019.33.1_supplement.484.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2019.33.1_supplement.484.11</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., George A.K., Homme R.P., Majumder A., Metreveli N., Laha A., Pushpakumar S.B., Tyagi S.C. Studying Long-term Effects of a Probiotic on Neuroretinal Health. Investig. Ophthalmol. Vis. Sci. 2019;60:4885.</Citation></Reference><Reference><Citation>George A.K., Singh M., Majumder A., Homme R.P., Metreveli N., Pushpakumar S.B., Tyagi S.C. Hyperhomocysteinemia and the effects of Lactobacillus rhamnosus GG on cardiac functions in CBS+/&#x2212; mice. FASEB J. 2019;33:531-7. doi: 10.1096/fasebj.2019.33.1_supplement.531.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2019.33.1_supplement.531.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Singh M., George A.K., Homme R.P., Metreveli N., Tyagi S.C. Lactobacillus rhamnosus GG improves skeletal muscle fatigability in a mouse model of hyperhomocysteinemia. FASEB J. 2019;33:592-12. doi: 10.1096/fasebj.2019.33.1_supplement.592.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.2019.33.1_supplement.592.12</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash J., Kumar C., Kujur A., Kumar S., Kumar D.A. Anti-cancerous Effect of Amomum subulatum Against DMBA Induced Breast Cancer in Rats. J. Cancer Sci. Clin. Ther. 2023;8:1&#x2013;9. doi: 10.26502/jcsct.5079221.</Citation><ArticleIdList><ArticleId IdType="doi">10.26502/jcsct.5079221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M.L., Noushin F., Sadia Q.A., Metu A.F., Meem J.N., Chowdhury M.T., Rasel M.H., Suma K.J., Alim M.A., Jalil M.A., et al. Spices and culinary herbs for the prevention and treatment of breast cancer: A comprehensive review with mechanistic insights. Cancer Pathog. Ther. 2024;2:E082&#x2013;E142. doi: 10.1016/j.cpt.2024.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpt.2024.07.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W., Li C., Qi Q., Shen J., Chang K. Cardamonin induces G2/M arrest and apoptosis via activation of the JNK-FOXO3a pathway in breast cancer cells. Cell Biol. Int. 2020;44:177&#x2013;188. doi: 10.1002/cbin.11217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11217</ArticleId><ArticleId IdType="pubmed">31393045</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Qiu S., Wang P., Liang X., Huang F., Wu H., Zhang B., Zhang W., Tian X., Xu R., et al. Cardamonin inhibits breast cancer growth by repressing HIF-1&#x3b1;-dependent metabolic reprogramming. J. Exp. Clin. Cancer Res. 2019;38:377. doi: 10.1186/s13046-019-1351-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-019-1351-4</ArticleId><ArticleId IdType="pmc">PMC6712736</ArticleId><ArticleId IdType="pubmed">31455352</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinde A., Hardy S.D., Kim D., Akhand S.S., Jolly M.K., Wang W.H., Anderson J.C., Khodadadi R.B., Brown W.S., George J.T., et al. Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer. Cancer Res. 2019;79:1831&#x2013;1843. doi: 10.1158/0008-5472.CAN-18-2636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-2636</ArticleId><ArticleId IdType="pmc">PMC6467765</ArticleId><ArticleId IdType="pubmed">30733195</ArticleId></ArticleIdList></Reference><Reference><Citation>Libring S., Shinde A., Chanda M.K., Nuru M., George H., Saleh A.M., Abdullah A., Kinzer-Ursem T.L., Calve S., Wendt M.K., et al. The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites. Cancers. 2020;12:1270. doi: 10.3390/cancers12051270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12051270</ArticleId><ArticleId IdType="pmc">PMC7281295</ArticleId><ArticleId IdType="pubmed">32429591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ningegowda R., Shivananju N.S., Rajendran P., Basappa, Rangappa K.S., Chinnathambi A., Li F., Achar R.R., Shanmugam M.K., Bist P., et al. A novel 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivative inhibits tumor cell invasion and potentiates the apoptotic effect of TNF&#x3b1; by abrogating NF-&#x3ba;B activation cascade. Apoptosis. 2017;22:145&#x2013;157. doi: 10.1007/s10495-016-1312-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-016-1312-8</ArticleId><ArticleId IdType="pubmed">27882436</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu P., Li J., Chen H., Zhu Y., Zhou J., Shi D. Anti-proliferative effect of cardamonin on mTOR inhibitor-resistant cancer cells. Mol. Med. Rep. 2020;21:1399&#x2013;1407. doi: 10.3892/mmr.2019.10898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10898</ArticleId><ArticleId IdType="pubmed">31894316</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Y., Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl. Oncol. 2021;14:101174. doi: 10.1016/j.tranon.2021.101174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tranon.2021.101174</ArticleId><ArticleId IdType="pmc">PMC8273208</ArticleId><ArticleId IdType="pubmed">34243011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S., Lin C., Cheng X., Hua H., Xiang T., Huang Y., Huang X. Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-&#x3ba;B pathway in vitro. Oncol. Lett. 2018;15:9641&#x2013;9646. doi: 10.3892/ol.2018.8580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2018.8580</ArticleId><ArticleId IdType="pmc">PMC6004643</ArticleId><ArticleId IdType="pubmed">29928339</ArticleId></ArticleIdList></Reference><Reference><Citation>Manu K.A., Shanmugam M.K., Ramachandran L., Li F., Siveen K.S., Chinnathambi A., Zayed M.E., Alharbi S.A., Arfuso F., Kumar A.P., et al. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-&#x3ba;B signaling cascade in gastric cancer. Cancer Lett. 2015;363:28&#x2013;36. doi: 10.1016/j.canlet.2015.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2015.03.033</ArticleId><ArticleId IdType="pubmed">25827070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostelecka K., Bryli&#x144;ski &#x141;., Komar O., Michalczyk J., Mi&#x142;osz A., Bi&#x142;ogras J., Woli&#x144;ski F., Forma A., Baj J. An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer. Cancers. 2024;16:1611. doi: 10.3390/cancers16081611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16081611</ArticleId><ArticleId IdType="pmc">PMC11049028</ArticleId><ArticleId IdType="pubmed">38672692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Tang X., Wu X., Yang M., Wang W., Wang L., Tang D., Wang D. Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis. Biosci. Rep. 2019;39:357. doi: 10.1042/BSR20190357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20190357</ArticleId><ArticleId IdType="pmc">PMC6522749</ArticleId><ArticleId IdType="pubmed">31028131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou G., Yuan X., Li Y., Hou G., Liu X. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/&#x3b2;-catenin signal pathway. Investig. New Drugs. 2020;38:329&#x2013;339. doi: 10.1007/s10637-019-00781-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-019-00781-9</ArticleId><ArticleId IdType="pubmed">31102118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabnam B., Padmavathi G., Banik K., Girisa S., Monisha J., Sethi G., Fan L., Wang L., Mao X., Kunnumakkara A.B. Sorcin a Potential Molecular Target for Cancer Therapy. Transl. Oncol. 2018;11:1379&#x2013;1389. doi: 10.1016/j.tranon.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tranon.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6134165</ArticleId><ArticleId IdType="pubmed">30216763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N., Liu J., Zhao X., Yan Z., Jiang B., Wang L., Cao S., Shi D., Lin X. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells. Tumour Biol. 2015;36:9667&#x2013;9676. doi: 10.1007/s13277-015-3673-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-3673-y</ArticleId><ArticleId IdType="pubmed">26150336</ArticleId></ArticleIdList></Reference><Reference><Citation>George A.K., Homme R.P., Majumder A., Tyagi S.C., Singh M. Effect of MMP-9 gene knockout on retinal vascular form and function. Physiol. Genom. 2019;51:613&#x2013;622. doi: 10.1152/physiolgenomics.00041.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00041.2019</ArticleId><ArticleId IdType="pmc">PMC6962592</ArticleId><ArticleId IdType="pubmed">31709889</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao N.C., Shih Y.L., Chou J.S., Chen K.W., Chen Y.L., Lee M.H., Peng S.F., Leu S.J., Chung J.G. Cardamonin Induces Cell Cycle Arrest, Apoptosis and Alters Apoptosis Associated Gene Expression in WEHI-3 Mouse Leukemia Cells. Am. J. Chin. Med. 2019;47:635&#x2013;656. doi: 10.1142/S0192415X19500332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X19500332</ArticleId><ArticleId IdType="pubmed">31023073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Syn N.L., Subhash V.V., Any Y., Thuya W.L., Cheow E.S.H., Kong L., Yu F., Peethala P.C., Wong A.L., et al. Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling. Cancer Lett. 2018;417:152&#x2013;160. doi: 10.1016/j.canlet.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2017.12.030</ArticleId><ArticleId IdType="pubmed">29306016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Zhou R., Li Q., Jie X., Hong J., Zong Y., Dong X., Zhang S., Li Z., Wu G. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway. Anticancer Drugs. 2019;30:241&#x2013;250. doi: 10.1097/CAD.0000000000000709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CAD.0000000000000709</ArticleId><ArticleId IdType="pubmed">30640793</ArticleId></ArticleIdList></Reference><Reference><Citation>He W., Jiang Y., Zhang X., Zhang Y., Ji H., Zhang N. Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells. Mol. Cell Biochem. 2014;389:25&#x2013;33. doi: 10.1007/s11010-013-1923-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-013-1923-0</ArticleId><ArticleId IdType="pubmed">24390014</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzunalli G., Dieterly A.M., Kemet C.M., Weng H.Y., Soepriatna A.H., Goergen C.J., Shinde A.B., Wendt M.K., Lyle L.T. Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases. Oncotarget. 2019;10:6334&#x2013;6348. doi: 10.18632/oncotarget.27274.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.27274</ArticleId><ArticleId IdType="pmc">PMC6824867</ArticleId><ArticleId IdType="pubmed">31695842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., Lee J.H., Ko J.H., Chinnathambi A., Alharbi S.A., Shair O.H.M., Sethi G., Ahn K.S. Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model. Biomolecules. 2019;9:262. doi: 10.3390/biom9070262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9070262</ArticleId><ArticleId IdType="pmc">PMC6681380</ArticleId><ArticleId IdType="pubmed">31284669</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Sun C.Y., Lu F.R., Shu X.R., Yang D., Chen L., She X.M., Gregg N.M., Guo T., Hu Y. Cardamonin exerts potent activity against multiple myeloma through blockade of NF-&#x3ba;B pathway in vitro. Leuk. Res. 2012;36:514&#x2013;520. doi: 10.1016/j.leukres.2011.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.leukres.2011.11.014</ArticleId><ArticleId IdType="pubmed">22226224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Qiu R., Yuan L., Meng F., Tang Q. Analysis on the Alpinia katsumadai components of Zingiberaceae plants and their functions on myeloma resistance. Pak. J. Pharm. Sci. 2015;28:1065&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">26051719</ArticleId></ArticleIdList></Reference><Reference><Citation>Charkhchi P., Cybulski C., Gronwald J., Wong F.O., Narod S.A., Akbari M.R. CA125 and Ovarian Cancer: A Comprehensive Review. Cancers. 2020;12:3730. doi: 10.3390/cancers12123730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12123730</ArticleId><ArticleId IdType="pmc">PMC7763876</ArticleId><ArticleId IdType="pubmed">33322519</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D., Zhao D., Niu P., Zhu Y., Zhou J., Chen H. Glycolysis inhibition via mTOR suppression is a key step in cardamonin-induced autophagy in SKOV3 cells. BMC Complement. Altern. Med. 2018;18:317. doi: 10.1186/s12906-018-2380-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-018-2380-9</ArticleId><ArticleId IdType="pmc">PMC6278091</ArticleId><ArticleId IdType="pubmed">30514289</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawla P. Epidemiology of Prostate Cancer. World J. Oncol. 2019;10:63&#x2013;89. doi: 10.14740/wjon1191.</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/wjon1191</ArticleId><ArticleId IdType="pmc">PMC6497009</ArticleId><ArticleId IdType="pubmed">31068988</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascoal A.C., Ehrenfried C.A., Lopez B.G., de Araujo T.M., Pascoal V.D., Gilioli R., Anh&#xea; G.F., Ruiz A.L., Carvalho J.E., Stefanello M.E., et al. Antiproliferative activity and induction of apoptosis in PC-3 cells by the chalcone cardamonin from Campomanesia adamantium (Myrtaceae) in a bioactivity-guided study. Molecules. 2014;19:1843&#x2013;1855. doi: 10.3390/molecules19021843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules19021843</ArticleId><ArticleId IdType="pmc">PMC6271740</ArticleId><ArticleId IdType="pubmed">24514747</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39312452</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1540-336X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><MedlineDate>2024 Sep-Oct 01</MedlineDate></PubDate></JournalIssue><Title>Cancer journal (Sudbury, Mass.)</Title><ISOAbbreviation>Cancer J</ISOAbbreviation></Journal><ArticleTitle>Epigenetics of Dietary Phytochemicals in Cancer Prevention: Fact or Fiction.</ArticleTitle><Pagination><StartPage>320</StartPage><EndPage>328</EndPage><MedlinePgn>320-328</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PPO.0000000000000742</ELocationID><Abstract><AbstractText>Cancer development takes 10 to 50 years, and epigenetics plays an important role. Recent evidence suggests that ~80% of human cancers are linked to environmental factors impinging upon genetics/epigenetics. Because advanced metastasized cancers are resistant to radiation/chemotherapeutic drugs, cancer prevention by relatively nontoxic "epigenetic modifiers" will be logical. Many dietary phytochemicals possess powerful antioxidant and anti-inflammatory properties that are hallmarks of cancer prevention. Dietary phytochemicals can regulate gene expression of the cellular genome via epigenetic mechanisms. In this review, we will summarize preclinical studies that demonstrate epigenetic mechanisms of dietary phytochemicals in skin, colorectal, and prostate cancer prevention. Key examples of the importance of epigenetic regulation in carcinogenesis include hypermethylation of the NRF2 promoter region in cancer cells, resulting in inhibition of NRF2-ARE signaling. Many dietary phytochemicals demethylate NRF2 promoter region and restore NRF2 signaling. Phytochemicals can also inhibit inflammatory responses via hypermethylation of inflammation-relevant genes to block gene expression. Altogether, dietary phytochemicals are excellent candidates for cancer prevention due to their low toxicity, potent antioxidant and anti-inflammatory properties, and powerful epigenetic effects in reversing procarcinogenic events.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>PoChung Jordan</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Peter</LastName><ForeName>Rebecca Mary</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Shannar</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Dave</LastName><ForeName>Parv Dushyant</ForeName><Initials>PD</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sarwar</LastName><ForeName>Md Shahid</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Ah-Ng</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES005022</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AT009152</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA200129</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer J</MedlineTA><NlmUniqueID>100931981</NlmUniqueID><ISSNLinking>1528-9117</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064209">Phytochemicals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064209" MajorTopicYN="Y">Phytochemicals</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. This work was supported in part by institutional funds and by R01 AT009152 from the National Center for Complementary and Integrative Health, R01 CA200129 from the National Cancer Institute, and P30 ES005022 from the National Institute of Environmental Health.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>22</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39312452</ArticleId><ArticleId IdType="mid">NIHMS1997157</ArticleId><ArticleId IdType="pmc">PMC11573353</ArticleId><ArticleId IdType="doi">10.1097/PPO.0000000000000742</ArticleId><ArticleId IdType="pii">00130404-202409000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Varmus H, Unni AM, Lockwood WW. How Cancer Genomics Drives Cancer Biology: Does Synthetic Lethality Explain Mutually Exclusive Oncogenic Mutations? Cold Spring Harb Symp Quant Biol 2016;81:247&#x2013;55. Epub 2017/01/27. doi: 10.1101/sqb.2016.81.030866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2016.81.030866</ArticleId><ArticleId IdType="pubmed">28123049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouad YA, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res 2017;7(5):1016&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446472</ArticleId><ArticleId IdType="pubmed">28560055</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 2004;36(12):1505&#x2013;16. Epub 2004/06/09. doi: 10.1016/j.freeradbiomed.2004.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.03.015</ArticleId><ArticleId IdType="pubmed">15182853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Khor TO, Shu L, Su ZY, Fuentes F, Kong AN. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol Ther 2013;137(2):153&#x2013;71. Epub 2012/10/09. doi: 10.1016/j.pharmthera.2012.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2012.09.008</ArticleId><ArticleId IdType="pmc">PMC3694988</ArticleId><ArticleId IdType="pubmed">23041058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho SM, Johnson A, Tarapore P, Janakiram V, Zhang X, Leung YK. Environmental epigenetics and its implication on disease risk and health outcomes. Ilar j 2012;53(3&#x2013;4):289&#x2013;305. Epub 2013/06/08. doi: 10.1093/ilar.53.3-4.289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ilar.53.3-4.289</ArticleId><ArticleId IdType="pmc">PMC4021822</ArticleId><ArticleId IdType="pubmed">23744968</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg AP. The Key Role of Epigenetics in Human Disease Prevention and Mitigation. N Engl J Med 2018;378(14):1323&#x2013;34. Epub 2018/04/05. doi: 10.1056/NEJMra1402513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1402513</ArticleId><ArticleId IdType="pmc">PMC11567374</ArticleId><ArticleId IdType="pubmed">29617578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571(7766):489&#x2013;99. Epub 2019/07/26. doi: 10.1038/s41586-019-1411-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1411-0</ArticleId><ArticleId IdType="pubmed">31341302</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha NK, Arfin S, Jha SK, Kar R, Dey A, Gundamaraju R, Ashraf GM, Gupta PK, Dhanasekaran S, Abomughaid MM, Das SS, Singh SK, Dua K, Roychoudhury S, Kumar D, Ruokolainen J, Ojha S, Kesari KK. Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling. Semin Cancer Biol 2022;86(Pt 2):1086&#x2013;104. Epub 20220223. doi: 10.1016/j.semcancer.2022.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2022.02.022</ArticleId><ArticleId IdType="pubmed">35218902</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaunig JE. Oxidative Stress and Cancer. Curr Pharm Des 2018;24(40):4771&#x2013;8. doi: 10.2174/1381612825666190215121712.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666190215121712</ArticleId><ArticleId IdType="pubmed">30767733</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Li S, Hudlikar R, Wang L, Shannar A, Peter R, Chou PJ, Kuo HD, Liu Z, Kong AN. Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals. Free Radic Biol Med 2022;179:328&#x2013;36. Epub 20201224. doi: 10.1016/j.freeradbiomed.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC8222414</ArticleId><ArticleId IdType="pubmed">33359432</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott RE, Wille JJ, Jr., Wier ML. Mechanisms for the Initiation and Promotion of Carcinogenesis: A Review and a New Concept. Mayo Clinic Proceedings. 1984;59(2):107&#x2013;17. doi: 10.1016/S0025&#x2013;6196(12)60244&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">6366382</ArticleId></ArticleIdList></Reference><Reference><Citation>Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 1985;228(4696):187&#x2013;90. Epub 1985/04/12. doi: 10.1126/science.2579435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2579435</ArticleId><ArticleId IdType="pubmed">2579435</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg AP, Vogelstein B. Alterations in DNA methylation in human colon neoplasia. Semin Surg Oncol 1987;3(3):149&#x2013;51. Epub 1987/01/01. doi: 10.1002/ssu.2980030304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ssu.2980030304</ArticleId><ArticleId IdType="pubmed">3659719</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg AP, Koldobskiy MA, G&#xf6;nd&#xf6;r A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet 2016;17(5):284&#x2013;99. Epub 2016/03/15. doi: 10.1038/nrg.2016.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2016.13</ArticleId><ArticleId IdType="pmc">PMC4888057</ArticleId><ArticleId IdType="pubmed">26972587</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird A Perceptions of epigenetics. Nature. 2007;447(7143):396&#x2013;8. doi: 10.1038/nature05913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05913</ArticleId><ArticleId IdType="pubmed">17522671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudlikar R, Wang L, Wu R, Li S, Peter R, Shannar A, Chou PJ, Liu X, Liu Z, Kuo HD, Kong AN. Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates. Cancer Prev Res (Phila). 2021;14(2):151&#x2013;64. Epub 2020/10/16. doi: 10.1158/1940-6207.Capr-20-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.Capr-20-0217</ArticleId><ArticleId IdType="pmc">PMC8044264</ArticleId><ArticleId IdType="pubmed">33055265</ArticleId></ArticleIdList></Reference><Reference><Citation>Loscalzo J, Handy DE. Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ 2014;4(2):169&#x2013;74. doi: 10.1086/675979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/675979</ArticleId><ArticleId IdType="pmc">PMC4070783</ArticleId><ArticleId IdType="pubmed">25006435</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito S, D&#x2019;Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466(7310):1129&#x2013;33. doi: 10.1038/nature09303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09303</ArticleId><ArticleId IdType="pmc">PMC3491567</ArticleId><ArticleId IdType="pubmed">20639862</ArticleId></ArticleIdList></Reference><Reference><Citation>Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11(10):726&#x2013;34. Epub 20110923. doi: 10.1038/nrc3130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3130</ArticleId><ArticleId IdType="pmc">PMC3307543</ArticleId><ArticleId IdType="pubmed">21941284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YL, Lin ZJ, Li CC, Lin X, Shan SK, Guo B, Zheng MH, Li F, Yuan LQ, Li ZH. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther 2023;8(1):98. Epub 20230302. doi: 10.1038/s41392-023-01333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01333-7</ArticleId><ArticleId IdType="pmc">PMC9981733</ArticleId><ArticleId IdType="pubmed">36864020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11(12):849&#x2013;64. Epub 20111124. doi: 10.1038/nrc3166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3166</ArticleId><ArticleId IdType="pmc">PMC4314215</ArticleId><ArticleId IdType="pubmed">22113163</ArticleId></ArticleIdList></Reference><Reference><Citation>Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101(9):2999&#x2013;3004. Epub 20040218. doi: 10.1073/pnas.0307323101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307323101</ArticleId><ArticleId IdType="pmc">PMC365734</ArticleId><ArticleId IdType="pubmed">14973191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther 2019;4:62. Epub 20191217. doi: 10.1038/s41392-019-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-019-0095-0</ArticleId><ArticleId IdType="pmc">PMC6915746</ArticleId><ArticleId IdType="pubmed">31871779</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Yu S, Zhang C, Kong AN. Epigenetic regulation of Keap1-Nrf2 signaling. Free Radic Biol Med 2015;88(Pt B):337&#x2013;49. Epub 20150625. doi: 10.1016/j.freeradbiomed.2015.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.06.013</ArticleId><ArticleId IdType="pmc">PMC4955581</ArticleId><ArticleId IdType="pubmed">26117320</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerriero G, Berni R, Munoz-Sanchez JA, Apone F, Abdel-Salam EM, Qahtan AA, Alatar AA, Cantini C, Cai G, Hausman JF, Siddiqui KS, Hernandez-Sotomayor SMT, Faisal M. Production of Plant Secondary Metabolites: Examples, Tips and Suggestions for Biotechnologists. Genes (Basel). 2018;9(6). Epub 20180620. doi: 10.3390/genes9060309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes9060309</ArticleId><ArticleId IdType="pmc">PMC6027220</ArticleId><ArticleId IdType="pubmed">29925808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya T, Dutta S, Akter R, Rahman MH, Karthika C, Nagaswarupa HP, Murthy HCA, Fratila O, Brata R, Bungau S. Role of Phytonutrients in Nutrigenetics and Nutrigenomics Perspective in Curing Breast Cancer. Biomolecules. 2021;11(8). Epub 20210809. doi: 10.3390/biom11081176.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081176</ArticleId><ArticleId IdType="pmc">PMC8394348</ArticleId><ArticleId IdType="pubmed">34439842</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr 2013;4(3):384S&#x2013;92S. Epub 20130501. doi: 10.3945/an.112.003517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.112.003517</ArticleId><ArticleId IdType="pmc">PMC3650511</ArticleId><ArticleId IdType="pubmed">23674808</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl T, Kumar K, Brisc C, Rus M, Nistor-Cseppento DC, Bustea C, Aron RAC, Pantis C, Zengin G, Sehgal A, Kaur R, Kumar A, Arora S, Setia D, Chandel D, Bungau S. Exploring the multifocal role of phytochemicals as immunomodulators. Biomed Pharmacother 2021;133:110959. Epub 20201113. doi: 10.1016/j.biopha.2020.110959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110959</ArticleId><ArticleId IdType="pubmed">33197758</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl T, Bungau S, Kumar K, Zengin G, Khan F, Kumar A, Kaur R, Venkatachalam T, Tit DM, Vesa CM, Barsan G, Mosteanu DE. Pleotropic Effects of Polyphenols in Cardiovascular System. Biomed Pharmacother 2020;130:110714. Epub 20200928. doi: 10.1016/j.biopha.2020.110714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110714</ArticleId><ArticleId IdType="pubmed">34321158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapinova A, Kubatka P, Golubnitschaja O, Kello M, Zubor P, Solar P, Pec M. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med 2018;23(1):36. Epub 20180809. doi: 10.1186/s12199-018-0724-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12199-018-0724-1</ArticleId><ArticleId IdType="pmc">PMC6085646</ArticleId><ArticleId IdType="pubmed">30092754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Li S, Hudlikar R, Wang L, Shannar A, Peter R, Chou PJ, Kuo HD, Liu Z, Kong AN. Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals. Free Radic Biol Med 2020. Epub 2020/12/29. doi: 10.1016/j.freeradbiomed.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC8222414</ArticleId><ArticleId IdType="pubmed">33359432</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhiravel S, Bekhit AEA, Mendis E, Jacobs JL, Dunshea FR, Rajapakse N, Ponnampalam EN. The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life. Int J Mol Sci 2022;23(15). Epub 20220723. doi: 10.3390/ijms23158124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158124</ArticleId><ArticleId IdType="pmc">PMC9332059</ArticleId><ArticleId IdType="pubmed">35897699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Thakur D. Health Promoting Phytochemicals in Vegetables: A Mini Review. International Journal of Food and Fermentation Technology. 2018;8:107&#x2013;17. doi: 10.30954/2277-9396.02.2018.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.30954/2277-9396.02.2018.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2009;2(5):270&#x2013;8. doi: 10.4161/oxim.2.5.9498.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/oxim.2.5.9498</ArticleId><ArticleId IdType="pmc">PMC2835915</ArticleId><ArticleId IdType="pubmed">20716914</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthocyanins Clifford M. &#x2013; Nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture. 2000;80:1063&#x2013;72. doi: 10.1002/(SICI)1097-0010(20000515)80:7&lt;1063::AID-JSFA605&gt;3.0.CO;2-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0010(20000515)80:7&lt;1063::AID-JSFA605&gt;3.0.CO;2-Q</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Lafuente A, Guillam&#xf3;n E, Villares A, Rostagno MA, Mart&#xed;nez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009;58(9):537&#x2013;52. Epub 20090421. doi: 10.1007/s00011-009-0037-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-009-0037-3</ArticleId><ArticleId IdType="pubmed">19381780</ArticleId></ArticleIdList></Reference><Reference><Citation>Falleh H, Ben Jemaa M, Saada M, Ksouri R. Essential oils: A promising eco-friendly food preservative. Food Chemistry. 2020;330:127268. doi: 10.1016/j.foodchem.2020.127268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2020.127268</ArticleId><ArticleId IdType="pubmed">32540519</ArticleId></ArticleIdList></Reference><Reference><Citation>Burt S Essential oils: their antibacterial properties and potential applications in foods&#x2014;a review. International Journal of Food Microbiology. 2004;94(3):223&#x2013;53. doi: 10.1016/j.ijfoodmicro.2004.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijfoodmicro.2004.03.022</ArticleId><ArticleId IdType="pubmed">15246235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D-D, Jiang L-L, Li H-Y, Yan P-F, Zhang Y-L. Chemical Components and Pharmacological Activities of Terpene Natural Products from the Genus Paeonia. Molecules. 2016;21(10):1362. PubMed PMID: doi:10.3390/molecules21101362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules21101362</ArticleId><ArticleId IdType="pmc">PMC6273841</ArticleId><ArticleId IdType="pubmed">27754383</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhiravel S, Bekhit AE- DA, Mendis E, Jacobs JL, Dunshea FR, Rajapakse N, Ponnampalam EN. The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life. International Journal of Molecular Sciences. 2022;23(15):8124. PubMed PMID: doi:10.3390/ijms23158124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158124</ArticleId><ArticleId IdType="pmc">PMC9332059</ArticleId><ArticleId IdType="pubmed">35897699</ArticleId></ArticleIdList></Reference><Reference><Citation>Su ZY, Zhang C, Lee JH, Shu L, Wu TY, Khor TO, Conney AH, Lu YP, Kong AN. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane. Cancer Prev Res (Phila). 2014;7(3):319&#x2013;29. Epub 2014/01/21. doi: 10.1158/1940-6207.Capr-13-0313-t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.Capr-13-0313-t</ArticleId><ArticleId IdType="pubmed">24441674</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbourne N, Marete E, Jacquier J-C, O&#x2019;Riordan D. Stability of phytochemicals as sources of anti-inflammatory nutraceuticals in beverages &#x2014; A review. Food Research International - FOOD RES INT. 2013;50. doi: 10.1016/j.foodres.2011.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2011.03.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfurayhi R, Huang L, Brandt K. Pathways Affected by Falcarinol-Type Polyacetylenes and Implications for Their Anti-Inflammatory Function and Potential in Cancer Chemoprevention. Foods. 2023;12(6). Epub 20230311. doi: 10.3390/foods12061192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods12061192</ArticleId><ArticleId IdType="pmc">PMC10048309</ArticleId><ArticleId IdType="pubmed">36981118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Wang L, Yin R, Hudlikar R, Li S, Kuo H- CD, Peter R, Sargsyan D, Guo Y, Liu X, Kong AN. Epigenetics/epigenomics and prevention by curcumin of early stages of inflammatory-driven colon cancer. Molecular Carcinogenesis. 2020;59(2):227&#x2013;36. doi: 10.1002/mc.23146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.23146</ArticleId><ArticleId IdType="pmc">PMC6946865</ArticleId><ArticleId IdType="pubmed">31820492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudlikar R, Wang L, Wu R, Li S, Peter R, Shannar A, Chou PJ, Liu X, Liu Z, Kuo HD, Kong AN. Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates. Cancer Prev Res (Phila). 2020. Epub 2020/10/16. doi: 10.1158/1940-6207.CAPR-20-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-20-0217</ArticleId><ArticleId IdType="pmc">PMC8044264</ArticleId><ArticleId IdType="pubmed">33055265</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005;571(1&#x2013;2):91&#x2013;106. doi: 10.1016/j.mrfmmm.2004.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2004.11.015</ArticleId><ArticleId IdType="pubmed">15748641</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalhout SZ, Kaufman HL, Emerick KS, Miller DM. Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes. Clin Cancer Res 2022;28(11):2211&#x2013;20. doi: 10.1158/1078-0432.Ccr-21-2971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.Ccr-21-2971</ArticleId><ArticleId IdType="pubmed">35121622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ci&#x105;&#x17c;y&#x144;ska M, Kami&#x144;ska-Winciorek G, Lange D, Lewandowski B, Reich A, S&#x142;awi&#x144;ska M, Pabianek M, Szczepaniak K, Hankiewicz A, U&#x142;a&#x144;ska M, Morawiec J, B&#x142;asi&#x144;ska-Morawiec M, Morawiec Z, Piekarski J, Nejc D, Brodowski R, Zarycza&#x144;ska A, Sobjanek M, Nowicki RJ, Owczarek W, S&#x142;owi&#x144;ska M, Wr&#xf3;bel K, Bieniek A, Wo&#x17a;niacka A, Skibi&#x144;ska M, Narbutt J, Niemczyk W, Ci&#x105;&#x17c;y&#x144;ski K, Lesiak A. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep 2021;11(1):4337. Epub 20210222. doi: 10.1038/s41598-021-83502-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83502-8</ArticleId><ArticleId IdType="pmc">PMC7900109</ArticleId><ArticleId IdType="pubmed">33619293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper M, Jaks V, Hohl D, Toftg&#xe5;rd R. Basal cell carcinoma - molecular biology and potential new therapies. J Clin Invest 2012;122(2):455&#x2013;63. Epub 20120201. doi: 10.1172/jci58779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci58779</ArticleId><ArticleId IdType="pmc">PMC3266783</ArticleId><ArticleId IdType="pubmed">22293184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wu R, Sargsyan D, Yin R, Kuo HC, Yang I, Wang L, Cheng D, Wang C, Li S, Hudlikar R, Lu Y, Kong AN. UVB drives different stages of epigenome alterations during progression of skin cancer. Cancer Lett 2019;449:20&#x2013;30. Epub 20190213. doi: 10.1016/j.canlet.2019.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2019.02.010</ArticleId><ArticleId IdType="pmc">PMC6411449</ArticleId><ArticleId IdType="pubmed">30771437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar MS, Ramirez CN, Dina Kuo HC, Chou P, Wu R, Sargsyan D, Yang Y, Shannar A, Mary Peter R, Yin R, Wang Y, Su X, Kong AN. The environmental carcinogen benzo[a]pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model. Carcinogenesis. 2023;44(5):436&#x2013;49. doi: 10.1093/carcin/bgad024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgad024</ArticleId><ArticleId IdType="pmc">PMC10414144</ArticleId><ArticleId IdType="pubmed">37100755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandakumar V, Vaid M, Katiyar SK. (&#x2212;)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 2011;32(4):537&#x2013;44. Epub 2011/01/07. doi: 10.1093/carcin/bgq285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgq285</ArticleId><ArticleId IdType="pmc">PMC3066414</ArticleId><ArticleId IdType="pubmed">21209038</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei H, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990;50(3):499&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">2105157</ArticleId></ArticleIdList></Reference><Reference><Citation>Birt DF, Mitchell D, Gold B, Pour P, Pinch HC. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 1997;17(1A):85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">9066634</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-Gonzalez X, Fuentes F, Su ZY, Kong AN. Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications. AAPS J 2014;16(4):727&#x2013;35. doi: 10.1208/s12248-014-9613-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-014-9613-8</ArticleId><ArticleId IdType="pmc">PMC4070251</ArticleId><ArticleId IdType="pubmed">24830944</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Li W, Wang C, Wu R, Yin R, Kuo HC, Wang L, Kong AN. Pelargonidin reduces the TPA induced transformation of mouse epidermal cells -potential involvement of Nrf2 promoter demethylation. Chem Biol Interact 2019;309:108701. Epub 2019/06/11. doi: 10.1016/j.cbi.2019.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2019.06.014</ArticleId><ArticleId IdType="pmc">PMC6679730</ArticleId><ArticleId IdType="pubmed">31181187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsiogianni M, Amery T, Franco R, Zoumpourlis V, Pappa A, Panayiotidis MI. From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention. Pharmacol Ther 2018;190:187&#x2013;201. Epub 2018/06/12. doi: 10.1016/j.pharmthera.2018.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.06.001</ArticleId><ArticleId IdType="pubmed">29890115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsiogianni M, Koutsidis G, Mavroudis N, Trafalis DT, Botaitis S, Franco R, Zoumpourlis V, Amery T, Galanis A, Pappa A, Panayiotidis MI. The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents. Antioxidants (Basel). 2019;8(4). Epub 2019/04/21. doi: 10.3390/antiox8040106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8040106</ArticleId><ArticleId IdType="pmc">PMC6523696</ArticleId><ArticleId IdType="pubmed">31003534</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha K, Hornyak TJ, Eckert RL. Epigenetic cancer prevention mechanisms in skin cancer. AAPS J 2013;15(4):1064&#x2013;71. Epub 2013/08/02. doi: 10.1208/s12248-013-9513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-013-9513-3</ArticleId><ArticleId IdType="pmc">PMC3787232</ArticleId><ArticleId IdType="pubmed">23904153</ArticleId></ArticleIdList></Reference><Reference><Citation>Penta D, Somashekar BS, Meeran SM. Epigenetics of skin cancer: Interventions by selected bioactive phytochemicals. Photodermatol Photoimmunol Photomed 2018;34(1):42&#x2013;9. Epub 2017/10/05. doi: 10.1111/phpp.12353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/phpp.12353</ArticleId><ArticleId IdType="pubmed">28976029</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian S, Adhikary G, Eckert RL. The Bmi-1 polycomb protein antagonizes the (&#x2212;)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis. 2010;31(3):496&#x2013;503. Epub 2009/12/18. doi: 10.1093/carcin/bgp314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgp314</ArticleId><ArticleId IdType="pmc">PMC2832547</ArticleId><ArticleId IdType="pubmed">20015867</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury SR, Balasubramanian S, Chew YC, Han B, Marquez VE, Eckert RL. (&#x2212;)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis. 2011;32(10):1525&#x2013;32. Epub 2011/07/30. doi: 10.1093/carcin/bgr171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgr171</ArticleId><ArticleId IdType="pmc">PMC3179425</ArticleId><ArticleId IdType="pubmed">21798853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Wu R, Sargsyan D, Zheng M, Li S, Yin R, Su S, Raskin I, Kong AN. CpG methyl-seq and RNA-seq epigenomic and transcriptomic studies on the preventive effects of Moringa isothiocyanate in mouse epidermal JB6 cells induced by the tumor promoter TPA. J Nutr Biochem 2019;68:69&#x2013;78. Epub 20190328. doi: 10.1016/j.jnutbio.2019.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2019.03.011</ArticleId><ArticleId IdType="pmc">PMC6546543</ArticleId><ArticleId IdType="pubmed">31030169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lora JM, Zhang DM, Liao SM, Burwell T, King AM, Barker PA, Singh L, Keaveney M, Morgenstern J, Gutierrez-Ramos JC, Coyle AJ, Fraser CC. Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. J Biol Chem 2005;280(43):36510&#x2013;7. Epub 20050825. doi: 10.1074/jbc.M507977200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M507977200</ArticleId><ArticleId IdType="pubmed">16123045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo HD, Wu R, Sarwar MS, Zheng M, Wang C, Sargsyan D, Suh N, Kong AT. DNA Methylome and Transcriptome Study of Triterpenoid CDDO in TPA-Mediated Skin Carcinogenesis Model. AAPS J 2022;24(6):115. Epub 20221102. doi: 10.1208/s12248-022-00763-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-022-00763-5</ArticleId><ArticleId IdType="pubmed">36324037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yang I, Cao M, Su ZY, Wu R, Guo Y, Fang M, Kong AN. Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells. Aaps j 2018;20(2):32. Epub 2018/04/01. doi: 10.1208/s12248-018-0197-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-018-0197-6</ArticleId><ArticleId IdType="pmc">PMC6286093</ArticleId><ArticleId IdType="pubmed">29603113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yin R, Wu R, Ramirez CN, Sargsyan D, Li S, Wang L, Cheng D, Wang C, Hudlikar R, Kuo HC, Lu Y, Kong AN. DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice. Mol Carcinog 2019;58(10):1738&#x2013;53. Epub 2019/06/27. doi: 10.1002/mc.23046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.23046</ArticleId><ArticleId IdType="pmc">PMC6722003</ArticleId><ArticleId IdType="pubmed">31237383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudlikar RR, Sargsyan D, Wu R, Su S, Zheng M, Kong AN. Triterpenoid corosolic acid modulates global CpG methylation and transcriptome of tumor promotor TPA induced mouse epidermal JB6 P+ cells. Chem Biol Interact 2020;321:109025. Epub 20200303. doi: 10.1016/j.cbi.2020.109025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2020.109025</ArticleId><ArticleId IdType="pmc">PMC7238714</ArticleId><ArticleId IdType="pubmed">32135139</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung YC, Sung PH, Chen PC, Wang HC, Lee JH, Su ZY. Chemoprevention of lotus leaf ethanolic extract through epigenetic activation of the NRF2-mediated pathway in murine skin JB6 P+ cell neoplastic transformation. J Tradit Complement Med 2023;13(4):337&#x2013;44. Epub 2023/07/03. doi: 10.1016/j.jtcme.2023.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcme.2023.02.002</ArticleId><ArticleId IdType="pmc">PMC10310861</ArticleId><ArticleId IdType="pubmed">37396151</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, Ariakia F, Fiuji H, Sahebkar A, Avan A. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer. Journal of cellular physiology. 2018;233(10):6785&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">29737515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012;61(6):847&#x2013;54. doi: 10.1136/gutjnl-2011-300865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2011-300865</ArticleId><ArticleId IdType="pmc">PMC3345105</ArticleId><ArticleId IdType="pubmed">22427238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60(3):397&#x2013;411. doi: 10.1136/gut.2010.217182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2010.217182</ArticleId><ArticleId IdType="pmc">PMC3040598</ArticleId><ArticleId IdType="pubmed">21036793</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S, Rauf A, Aljohani ASM, Simal-Gandara J. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chemico-Biological Interactions. 2022;368:110170. doi: 10.1016/j.cbi.2022.110170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2022.110170</ArticleId><ArticleId IdType="pubmed">36202214</ArticleId></ArticleIdList></Reference><Reference><Citation>Per&#x161;e M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012;2012:718617. Epub 20120514. doi: 10.1155/2012/718617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/718617</ArticleId><ArticleId IdType="pmc">PMC3361365</ArticleId><ArticleId IdType="pubmed">22665990</ArticleId></ArticleIdList></Reference><Reference><Citation>Delker DA, McKnight SJ, 3rd, Rosenberg DW. The role of alcohol dehydrogenase in the metabolism of the colon carcinogen methylazoxymethanol. Toxicol Sci 1998;45(1):66&#x2013;71. doi: 10.1006/toxs.1998.2499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/toxs.1998.2499</ArticleId><ArticleId IdType="pubmed">9848112</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Wu R, Gaspar JM, Sargsyan D, Su ZY, Zhang C, Gao L, Cheng D, Li W, Wang C, Yin R, Fang M, Verzi MP, Hart RP, Kong AN. DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. Carcinogenesis. 2018;39(5):669&#x2013;80. doi: 10.1093/carcin/bgy043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgy043</ArticleId><ArticleId IdType="pmc">PMC6248359</ArticleId><ArticleId IdType="pubmed">29547900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003;198(8):1225&#x2013;35. doi: 10.1084/jem.20022194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20022194</ArticleId><ArticleId IdType="pmc">PMC2194240</ArticleId><ArticleId IdType="pubmed">14568981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M, Edmundson P, Araujo-Perez F, McCoy AN, Galanko J, Keku TO. Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer. 2013;13:91. Epub 20130226. doi: 10.1186/1471-2407-13-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-13-91</ArticleId><ArticleId IdType="pmc">PMC3599094</ArticleId><ArticleId IdType="pubmed">23442743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Huang Q, Huang Y, Zheng W, Hua J, Yang S, Zhuang J, Wang J, Ye J. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-&#x3ba;B/JNK pathways in colorectal cancer. Oncotarget 2016;7(45):73711&#x2013;24. doi: 10.18632/oncotarget.12449.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.12449</ArticleId><ArticleId IdType="pmc">PMC5342009</ArticleId><ArticleId IdType="pubmed">27713159</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Shu L, Zhang C, Su Z-Y, Kong A- NT. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. Biochemical pharmacology. 2015;94(2):69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524742</ArticleId><ArticleId IdType="pubmed">25640947</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Wu R, Gaspar JM, Sargsyan D, Su Z-Y, Zhang C, Gao L, Cheng D, Li W, Wang C. DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. Carcinogenesis. 2018;39(5):669&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248359</ArticleId><ArticleId IdType="pubmed">29547900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Q, Wu R, Xiao X, Yang C, Yang Y, Wang C, Lin L, Kong AN. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. Journal of Cellular Biochemistry. 2018;119(11):9573&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195448</ArticleId><ArticleId IdType="pubmed">30129150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Jin Y, Hofseth AB, Pena E, Habiger J, Chumanevich A, Poudyal D, Nagarkatti M, Nagarkatti PS, Singh UP. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer prevention research. 2010;3(4):549&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2853724</ArticleId><ArticleId IdType="pubmed">20332304</ArticleId></ArticleIdList></Reference><Reference><Citation>Altamemi I, Murphy EA, Catroppo JF, Zumbrun EE, Zhang J, McClellan JL, Singh UP, Nagarkatti PS, Nagarkatti M. Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice. J Pharmacol Exp Ther 2014;350(1):99&#x2013;109. Epub 20140509. doi: 10.1124/jpet.114.213306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.114.213306</ArticleId><ArticleId IdType="pmc">PMC4056272</ArticleId><ArticleId IdType="pubmed">24817032</ArticleId></ArticleIdList></Reference><Reference><Citation>Okonkwo A, Mitra J, Johnson GS, Li L, Dashwood WM, Hegde ML, Yue C, Dashwood RH, Rajendran P. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs. Mol Nutr Food Res 2018;62(18):e1800228. Epub 20180719. doi: 10.1002/mnfr.201800228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201800228</ArticleId><ArticleId IdType="pmc">PMC6553464</ArticleId><ArticleId IdType="pubmed">29924908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou JW, Wang M, Sun NX, Qing Y, Yin TF, Li C, Wu D. Sulforaphane-induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco-2 cells. Oncol Lett 2019;18(3):2639&#x2013;47. Epub 20190705. doi: 10.3892/ol.2019.10569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2019.10569</ArticleId><ArticleId IdType="pmc">PMC6676568</ArticleId><ArticleId IdType="pubmed">31452747</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Dey M. Dietary Phenethyl Isothiocyanate Protects Mice from Colitis Associated Colon Cancer. Int J Mol Sci 2017;18(9). Epub 20170906. doi: 10.3390/ijms18091908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091908</ArticleId><ArticleId IdType="pmc">PMC5618557</ArticleId><ArticleId IdType="pubmed">28878142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragusa MA, Naselli F, Cruciata I, Volpes S, Schimmenti C, Serio G, Mauro M, Librizzi M, Luparello C, Chiarelli R, La Rosa C, Lauria A, Gentile C, Caradonna F. Indicaxanthin Induces Autophagy in Intestinal Epithelial Cancer Cells by Epigenetic Mechanisms Involving DNA Methylation. Nutrients. 2023;15(15). Epub 20230807. doi: 10.3390/nu15153495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15153495</ArticleId><ArticleId IdType="pmc">PMC10420994</ArticleId><ArticleId IdType="pubmed">37571432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Han Y, Feng Y, Wang A, Li X, Deng S, Zhang L, Xiao J, Li Y, Li N. Extract of Ilex rotunda Thunb alleviates experimental colitis-associated cancer via suppressing inflammation-induced miR-31&#x2013;5p/YAP overexpression. Phytomedicine. 2019;62:152941.</Citation><ArticleIdList><ArticleId IdType="pubmed">31100679</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67(1):7&#x2013;30. Epub 20170105. doi: 10.3322/caac.21387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21387</ArticleId><ArticleId IdType="pubmed">28055103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Li S, Sargsyan D, Yin R, Kuo HC, Peter R, Wang L, Hudlikar R, Liu X, Kong AN. DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice. Mol Carcinog 2021;60(6):391&#x2013;402. Epub 20210413. doi: 10.1002/mc.23299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.23299</ArticleId><ArticleId IdType="pmc">PMC8201649</ArticleId><ArticleId IdType="pubmed">33848375</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrylak DP. The current role of chemotherapy in metastatic hormone-refractory prostate cancer. Urology. 2005;65(5 Suppl):3&#x2013;7; discussion &#x2212;8. doi: 10.1016/j.urology.2005.03.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2005.03.053</ArticleId><ArticleId IdType="pubmed">15885271</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Pung D, Su ZY, Guo Y, Zhang C, Yang AY, Zheng X, Du ZY, Zhang K, Kong AN. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1. Chem Res Toxicol 2016;29(4):694&#x2013;703. Epub 20160329. doi: 10.1021/acs.chemrestox.6b00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrestox.6b00016</ArticleId><ArticleId IdType="pmc">PMC4955590</ArticleId><ArticleId IdType="pubmed">26991801</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995;92(8):3439&#x2013;43. doi: 10.1073/pnas.92.8.3439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.8.3439</ArticleId><ArticleId IdType="pmc">PMC42182</ArticleId><ArticleId IdType="pubmed">7724580</ArticleId></ArticleIdList></Reference><Reference><Citation>Barve A, Khor TO, Reuhl K, Reddy B, Newmark H, Kong AN. Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice. Nutr Cancer. 2010;62(6):789&#x2013;94. doi: 10.1080/01635581003605896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581003605896</ArticleId><ArticleId IdType="pmc">PMC4699666</ArticleId><ArticleId IdType="pubmed">20661828</ArticleId></ArticleIdList></Reference><Reference><Citation>Valkenburg KC, Williams BO. Mouse models of prostate cancer. Prostate Cancer. 2011;2011:895238. doi: 10.1155/2011/895238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/895238</ArticleId><ArticleId IdType="pmc">PMC3221286</ArticleId><ArticleId IdType="pubmed">22111002</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell PJ, Coulter J, Walker SM, McKechnie M, Neisen J, McCabe N, Kennedy RD, Salto-Tellez M, Albanese C, Waugh DJ. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma. European urology. 2013;64(2):177&#x2013;88. doi: 10.1016/j.eururo.2012.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2012.08.032</ArticleId><ArticleId IdType="pmc">PMC4185293</ArticleId><ArticleId IdType="pubmed">22939387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Feng Y, Zhang C, Cheng D, Wu R, Yang Y, Sargsyan D, Kumar D, Kong AN. PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020;34(1):1304&#x2013;18. Epub 2020/01/10. doi: 10.1096/fj.201901205RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201901205RR</ArticleId><ArticleId IdType="pmc">PMC6956734</ArticleId><ArticleId IdType="pubmed">31914691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Du Z-Y, Zheng X, Cui X-X, Conney AH, Zhang K. Synthesis and evaluation of curcumin-related compounds for anticancer activity. European Journal of Medicinal Chemistry. 2012;53:235&#x2013;45. doi: 10.1016/j.ejmech.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2012.04.005</ArticleId><ArticleId IdType="pubmed">22551677</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Su ZY, Guo Y, Zhang C, Wu R, Gao L, Zheng X, Du ZY, Zhang K, Kong AN. Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells. Chem Res Toxicol 2018;31(2):88&#x2013;96. Epub 20180108. doi: 10.1021/acs.chemrestox.7b00248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrestox.7b00248</ArticleId><ArticleId IdType="pmc">PMC6295337</ArticleId><ArticleId IdType="pubmed">29228771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Su ZY, Khor TO, Shu L, Kong AN. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochem Pharmacol 2013;85(9):1398&#x2013;404. Epub 20130214. doi: 10.1016/j.bcp.2013.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2013.02.010</ArticleId><ArticleId IdType="pmc">PMC4123317</ArticleId><ArticleId IdType="pubmed">23416117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Shu L, Kim H, Khor TO, Wu R, Li W, Kong AN. Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194. Mol Nutr Food Res 2016;60(6):1427&#x2013;36. Epub 20160517. doi: 10.1002/mnfr.201500918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201500918</ArticleId><ArticleId IdType="pmc">PMC5495185</ArticleId><ArticleId IdType="pubmed">26820911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodi A, Saha A, Lu X, Wang B, Sentandreu E, Collins M, Kolonin MG, DiGiovanni J, Tiziani S. Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism. Npj Precis Oncol 2017;1. Epub 2017/12/05. doi: 10.1038/s41698-017-0024-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41698-017-0024-z</ArticleId><ArticleId IdType="pmc">PMC5705091</ArticleId><ArticleId IdType="pubmed">29202102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang C, Sarwar MS, Chou P, Wang Y, Su X, Kong AT. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid. Faseb j 2022;36(11):e22626. Epub 2022/10/29. doi: 10.1096/fj.202201195R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202201195R</ArticleId><ArticleId IdType="pmc">PMC9703918</ArticleId><ArticleId IdType="pubmed">36305462</ArticleId></ArticleIdList></Reference><Reference><Citation>Su ZY, Khor TO, Shu L, Lee JH, Saw CL, Wu TY, Huang Y, Suh N, Yang CS, Conney AH, Wu Q, Kong AN. Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation. Chem Res Toxicol 2013;26(3):477&#x2013;85. Epub 20130308. doi: 10.1021/tx300524p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx300524p</ArticleId><ArticleId IdType="pubmed">23441843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39057032</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1467-3045</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Current issues in molecular biology</Title><ISOAbbreviation>Curr Issues Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology.</ArticleTitle><Pagination><StartPage>6533</StartPage><EndPage>6565</EndPage><MedlinePgn>6533-6565</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/cimb46070390</ELocationID><Abstract><AbstractText>Technological advancements in cell-free DNA (cfDNA) liquid biopsy have triggered exponential growth in numerous clinical applications. While cfDNA-based liquid biopsy has made significant strides in personalizing cancer treatment, the exploration and translation of epigenetics in liquid biopsy to clinical practice is still nascent. This comprehensive review seeks to provide a broad yet in-depth narrative of the present status of epigenetics in cfDNA liquid biopsy and its associated challenges. It highlights the potential of epigenetics in cfDNA liquid biopsy technologies with the hopes of enhancing its clinical translation. The momentum of cfDNA liquid biopsy technologies in recent years has propelled epigenetics to the forefront of molecular biology. We have only begun to reveal the true potential of epigenetics in both our understanding of disease and leveraging epigenetics in the diagnostic and therapeutic domains. Recent clinical applications of epigenetics-based cfDNA liquid biopsy revolve around DNA methylation in screening and early cancer detection, leading to the development of multi-cancer early detection tests and the capability to pinpoint tissues of origin. The clinical application of epigenetics in cfDNA liquid biopsy in minimal residual disease, monitoring, and surveillance are at their initial stages. A notable advancement in fragmentation patterns analysis has created a new avenue for epigenetic biomarkers. However, the widespread application of cfDNA liquid biopsy has many challenges, including biomarker sensitivity, specificity, logistics including infrastructure and personnel, data processing, handling, results interpretation, accessibility, and cost effectiveness. Exploring and translating epigenetics in cfDNA liquid biopsy technology can transform our understanding and perception of cancer prevention and management. cfDNA liquid biopsy has great potential in precision oncology to revolutionize conventional ways of early cancer detection, monitoring residual disease, treatment response, surveillance, and drug development. Adapting the implementation of liquid biopsy workflow to the local policy worldwide and developing point-of-care testing holds great potential to overcome global cancer disparity and improve cancer outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Wan Ying</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Norwalk Hospital, Norwalk, CT 06850, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hematology &amp; Oncology, Neag Comprehensive Cancer Center, UConn Health, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagabhyrava</LastName><ForeName>Snigdha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Norwalk Hospital, Norwalk, CT 06850, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ang-Olson</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><Identifier Source="ORCID">0009-0000-6840-8748</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Paromita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladel</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Norwalk Hospital, Norwalk, CT 06850, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sailo</LastName><ForeName>Bethsebie</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Anup</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahuja</LastName><ForeName>Nita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Yale School of Medicine, New Haven, CT 06520-8000, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biological and Biomedical Sciences Program (BBS), Yale University, New Haven, CT 06520-8084, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Issues Mol Biol</MedlineTA><NlmUniqueID>100931761</NlmUniqueID><ISSNLinking>1467-3037</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">cancer disparity</Keyword><Keyword MajorTopicYN="N">cancer screening</Keyword><Keyword MajorTopicYN="N">cell-free DNA</Keyword><Keyword MajorTopicYN="N">chromatin remodeling</Keyword><Keyword MajorTopicYN="N">circulating tumor DNA</Keyword><Keyword MajorTopicYN="N">early cancer detection</Keyword><Keyword MajorTopicYN="N">epigenetic drugs</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">epigenomics</Keyword><Keyword MajorTopicYN="N">fragmentomics</Keyword><Keyword MajorTopicYN="N">histone modification</Keyword><Keyword MajorTopicYN="N">liquid biopsy</Keyword><Keyword MajorTopicYN="N">nucleosome positioning</Keyword><Keyword MajorTopicYN="N">personalized medicine</Keyword><Keyword MajorTopicYN="N">precision oncology</Keyword><Keyword MajorTopicYN="N">targeted therapy</Keyword><Keyword MajorTopicYN="N">translational medicine</Keyword></KeywordList><CoiStatement>Dr. Nita Ahuja has received grant funding from Cepheid, the Ron Foley Foundation, the Dr. Ralph and Marian Falk Medical Research Trust, and the National Cancer Institute. She has licensed biomarkers to Cepheid (patent number 10167513). Dr. Nita Ahuja is also an uncompensated adjunct professor at Johns Hopkins University. She is a Voting Independent Member of the Wake Forest University Baptist Medical Center Board of Directors, serving on the Medical Center Health System Quality, Safety, and Experience Improvement Committee, and the Medical Center Academic Committee. Additionally, she holds a seat on the AAMC Board of Directors and serves on the Yale New Haven Hospital Board of Trustees.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>26</Day><Hour>8</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39057032</ArticleId><ArticleId IdType="pmc">PMC11276574</ArticleId><ArticleId IdType="doi">10.3390/cimb46070390</ArticleId><ArticleId IdType="pii">cimb46070390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Levin T.R., Lavin P., Lidgard G.P., Ahlquist D.A., Berger B.M. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 2014;370:1287&#x2013;1297. doi: 10.1056/NEJMoa1311194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1311194</ArticleId><ArticleId IdType="pubmed">24645800</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D., Li Y., Wang M., Gu J., Xu W., Cai H., Fang X., Zhang X. Exosomes as a new frontier of cancer liquid biopsy. Mol. Cancer. 2022;21:56. doi: 10.1186/s12943-022-01509-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-022-01509-9</ArticleId><ArticleId IdType="pmc">PMC8855550</ArticleId><ArticleId IdType="pubmed">35180868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Sagar S., Ravindran R., Najor R.H., Quiles J.M., Chi L., Diao R.Y., Woodall B.P., Leon L.J., Zumaya E., et al. Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired. Nat. Commun. 2023;14:5031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10439183</ArticleId><ArticleId IdType="pubmed">37596294</ArticleId></ArticleIdList></Reference><Reference><Citation>Stackpole M.L., Zeng W., Li S., Liu C.C., Zhou Y., He S., Yeh A., Wang Z., Sun F., Li Q., et al. Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer. Nat. Commun. 2022;13:5566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9522828</ArticleId><ArticleId IdType="pubmed">36175411</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., He C., Wang M., Ma X., Mo F., Yang S., Han J., Wei X. Targeting epigenetic regulators for cancer therapy: Mechanisms and advances in clinical trials. Signal Transduct. Target. Ther. 2019;4:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6915746</ArticleId><ArticleId IdType="pubmed">31871779</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddington C.H. Towards a theoretical biology. Nature. 1968;218:525&#x2013;527. doi: 10.1038/218525a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/218525a0</ArticleId><ArticleId IdType="pubmed">5650959</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddington C.H. The epigenotype. Endeavour. 1942;1:18&#x2013;20.</Citation></Reference><Reference><Citation>Wu C., Morris J.R. Genes, genetics, and epigenetics: A correspondence. Science. 2001;293:1103&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">11498582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin H. Etymology of Epigenetics. Science. 2001;294:2477&#x2013;2478.</Citation><ArticleIdList><ArticleId IdType="pubmed">11770516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont C., Armant D.R., Brenner C.A. Epigenetics: Definition, mechanisms and clinical perspective. Semin. Reprod. Med. 2009;27:351&#x2013;357. doi: 10.1055/s-0029-1237423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1237423</ArticleId><ArticleId IdType="pmc">PMC2791696</ArticleId><ArticleId IdType="pubmed">19711245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57&#x2013;70. doi: 10.1016/S0092-8674(00)81683-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81683-9</ArticleId><ArticleId IdType="pubmed">10647931</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646&#x2013;674. doi: 10.1016/j.cell.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.013</ArticleId><ArticleId IdType="pubmed">21376230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-David U., Beroukhim R., Golub T.R. Genomic evolution of cancer models: Perils and opportunities. Nat. Rev. Cancer. 2019;19:97&#x2013;109. doi: 10.1038/s41568-018-0095-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-018-0095-3</ArticleId><ArticleId IdType="pmc">PMC6493335</ArticleId><ArticleId IdType="pubmed">30578414</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Y.C., Zheng S., Wang L.J., Iskra B.S., Rao M.K., Houghton P.J., Huang Y., Chen Y. Predicting and characterizing a cancer dependency map of tumors with deep learning. Sci. Adv. 2021;7:eabh1275. doi: 10.1126/sciadv.abh1275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh1275</ArticleId><ArticleId IdType="pmc">PMC8378822</ArticleId><ArticleId IdType="pubmed">34417181</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis A., Gao R., Navin N. Tumor evolution: Linear, branching, neutral or punctuated? Biochim. Biophys. Acta Rev. Cancer. 2017;2:151&#x2013;161. doi: 10.1016/j.bbcan.2017.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2017.01.003</ArticleId><ArticleId IdType="pmc">PMC5558210</ArticleId><ArticleId IdType="pubmed">28110020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelucchi C., Tramacere I., Boffetta P., Negri E., La Vecchia C. Alcohol consumption and cancer risk. Nutr. Cancer. 2011;63:983&#x2013;990. doi: 10.1080/01635581.2011.596642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2011.596642</ArticleId><ArticleId IdType="pubmed">21864055</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob L., Freyn M., Kalder M., Dinas K., Kostev K. Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: A retrospective study of 422,010 patients followed for up to 30 years. Oncotarget. 2018;9:17420&#x2013;17429. doi: 10.18632/oncotarget.24724.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24724</ArticleId><ArticleId IdType="pmc">PMC5915125</ArticleId><ArticleId IdType="pubmed">29707117</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan D.L., Saladi R.N., Fox J.L. Ultraviolet radiation and skin cancer. Int. J. Dermatol. 2010;49:978&#x2013;986. doi: 10.1111/j.1365-4632.2010.04474.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-4632.2010.04474.x</ArticleId><ArticleId IdType="pubmed">20883261</ArticleId></ArticleIdList></Reference><Reference><Citation>Korda R.J., Clements M.S., Armstrong B.K., Law H.D., Guiver T., Anderson P.R., Trevenar S.M., Kirk M.D. Risk of cancer associated with residential exposure to asbestos insulation: A whole-population cohort study. Lancet Public Health. 2017;2:e522&#x2013;e528. doi: 10.1016/S2468-2667(17)30192-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(17)30192-5</ArticleId><ArticleId IdType="pubmed">29253374</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton L.M., Karyadi D.M., Stewart C., Bogdanova T.I., Dawson E.T., Steinberg M.K., Dai J., Hartley S.W., Schonfeld S.J., Sampson J.N., et al. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021;372:eabg2538. doi: 10.1126/science.abg2538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg2538</ArticleId><ArticleId IdType="pmc">PMC9022889</ArticleId><ArticleId IdType="pubmed">33888599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozasa K. Epidemiological research on radiation-induced cancer in atomic bomb survivors. J. Radiat. Res. 2016;57((Suppl. S1)):i112&#x2013;i117. doi: 10.1093/jrr/rrw005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rrw005</ArticleId><ArticleId IdType="pmc">PMC4990102</ArticleId><ArticleId IdType="pubmed">26976124</ArticleId></ArticleIdList></Reference><Reference><Citation>Abnet C.C. Carcinogenic food contaminants. Cancer Investig. 2007;25:189&#x2013;196. doi: 10.1080/07357900701208733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07357900701208733</ArticleId><ArticleId IdType="pmc">PMC2782753</ArticleId><ArticleId IdType="pubmed">17530489</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Urso A., Brickner J.H. Mechanisms of epigenetic memory. Trend Genet. 2014;30:230&#x2013;236. doi: 10.1016/j.tig.2014.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2014.04.004</ArticleId><ArticleId IdType="pmc">PMC4072033</ArticleId><ArticleId IdType="pubmed">24780085</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiagalingam S. Epigenetic memory in development and disease: Unraveling the mechanism. Biochim. Biophys. Acta Rev. Cancer. 2020;2:23. doi: 10.1016/j.bbcan.2020.188349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2020.188349</ArticleId><ArticleId IdType="pmc">PMC7225062</ArticleId><ArticleId IdType="pubmed">31982403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahar L., Foster S.L., Sherman R.L., Henry K.A., Goldberg D.W., Stinchcomb D.G., Bauer J.E. GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology. Cancer. 2019;125:2544&#x2013;2560. doi: 10.1002/cncr.32052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.32052</ArticleId><ArticleId IdType="pmc">PMC6625915</ArticleId><ArticleId IdType="pubmed">31145834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadiel A., Eichenbaum K.D., Abbasi M., Lee N.K., Odunsi K. Utilizing geospatial artificial intelligence to map cancer disparities across health regions. Sci. Rep. 2024;14:7693. doi: 10.1038/s41598-024-57604-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-57604-y</ArticleId><ArticleId IdType="pmc">PMC10987573</ArticleId><ArticleId IdType="pubmed">38565582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez S.L., Shariff-Marco S., DeRouen M., Keegan T.H., Yen I.H., Mujahid M., Satariano W.A., Glaser S.L. The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions. Cancer. 2015;121:2314&#x2013;2330. doi: 10.1002/cncr.29345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.29345</ArticleId><ArticleId IdType="pmc">PMC4490083</ArticleId><ArticleId IdType="pubmed">25847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Schootman M., Gomez S.L., Henry K.A., Paskett E.D., Ellison G.L., Oh A., Taplin S.H., Tatalovich Z., Berrigan D.A. Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol. Biomark. Prev. 2017;26:472&#x2013;475. doi: 10.1158/1055-9965.EPI-17-0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-17-0104</ArticleId><ArticleId IdType="pmc">PMC5380532</ArticleId><ArticleId IdType="pubmed">28325736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhoda A., Noriega M., Kahan T., Cartelle A.L., Anderson K., Zuberi S.A., Olivares M., Kelly J., Freedman S.D., Rabinowitz L.G., et al. Impact of Geospatial Food Access on Acute Pancreatitis Outcomes. Dig. Dis. Sci. 2024;22:2247&#x2013;2255. doi: 10.1007/s10620-024-08425-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-024-08425-6</ArticleId><ArticleId IdType="pubmed">38649654</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L., Ahuja N., Shen Y., Habib N.A., Toyota M., Rashid A., Issa J.-P.J. DNA Methylation and Environmental Exposures in Human Hepatocellular Carcinoma. JNCI J. Natl. Cancer Inst. 2002;94:755&#x2013;761. doi: 10.1093/jnci/94.10.755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/94.10.755</ArticleId><ArticleId IdType="pubmed">12011226</ArticleId></ArticleIdList></Reference><Reference><Citation>Shantz E., Elliott S.J. From social determinants to social epigenetics: Health geographies of chronic disease. Health Place. 2021;69:102561. doi: 10.1016/j.healthplace.2021.102561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthplace.2021.102561</ArticleId><ArticleId IdType="pubmed">33761408</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Huang X., Dou L., Yan M., Shen T., Tang W., Li J. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments. Signal Transduct. Target. Ther. 2022;7:391. doi: 10.1038/s41392-022-01251-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01251-0</ArticleId><ArticleId IdType="pmc">PMC9755275</ArticleId><ArticleId IdType="pubmed">36522308</ArticleId></ArticleIdList></Reference><Reference><Citation>The importance of aging in cancer research. Nat. Aging. 2022;2:365&#x2013;366. doi: 10.1038/s43587-022-00231-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00231-x</ArticleId><ArticleId IdType="pubmed">37118075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja N., Issa J.P. Aging, methylation and cancer. Histol. Histopathol. 2000;15:835&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pubmed">10963127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja N., Li Q., Mohan A.L., Baylin S.B., Issa J.P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998;58:5489&#x2013;5494.</Citation><ArticleIdList><ArticleId IdType="pubmed">9850084</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho W.C. Molecular Connections of Aging and Cancer. Aging Dis. 2017;8:685&#x2013;687. doi: 10.14336/AD.2017.0822.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2017.0822</ArticleId><ArticleId IdType="pmc">PMC5614330</ArticleId><ArticleId IdType="pubmed">28966810</ArticleId></ArticleIdList></Reference><Reference><Citation>Issa J.P., Ahuja N., Toyota M., Bronner M.P., Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573&#x2013;3577.</Citation><ArticleIdList><ArticleId IdType="pubmed">11325821</ArticleId></ArticleIdList></Reference><Reference><Citation>Issa J.-P. Aging, DNA methylation and cancer. Crit. Rev. Oncol./Hematol. 1999;32:31&#x2013;43. doi: 10.1016/S1040-8428(99)00019-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1040-8428(99)00019-0</ArticleId><ArticleId IdType="pubmed">10586353</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA. 1999;96:8681&#x2013;8686. doi: 10.1073/pnas.96.15.8681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.15.8681</ArticleId><ArticleId IdType="pmc">PMC17576</ArticleId><ArticleId IdType="pubmed">10411935</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi S.J., Kim K. New Insights into the Role of Histone Changes in Aging. Int. J. Mol. Sci. 2020;21:8241. doi: 10.3390/ijms21218241.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218241</ArticleId><ArticleId IdType="pmc">PMC7662996</ArticleId><ArticleId IdType="pubmed">33153221</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagogo-Jack I., Shaw A.T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 2018;15:81&#x2013;94. doi: 10.1038/nrclinonc.2017.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2017.166</ArticleId><ArticleId IdType="pubmed">29115304</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Peng Y., Gao A., Du C., Herman J.G. Epigenetic heterogeneity in cancer. Biomark. Res. 2019;7:23. doi: 10.1186/s40364-019-0174-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40364-019-0174-y</ArticleId><ArticleId IdType="pmc">PMC6824025</ArticleId><ArticleId IdType="pubmed">31695915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee D., Bakar J., Chitnis S.P., Sausville E.L., Ashtekar K.D., Mendelson B.E., Long K., Smith J.C., Heppner D.E., Sheltzer J.M. Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor. Cell Chem. Biol. 2023;30:1211&#x2013;1222. doi: 10.1016/j.chembiol.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC10715717</ArticleId><ArticleId IdType="pubmed">37827156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang T.J., Carpenter D., Lauffenburger J.C., Wang B., Franklin J.M., Kesselheim A.S. Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results. JAMA Intern. Med. 2016;176:1826&#x2013;1833. doi: 10.1001/jamainternmed.2016.6008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.6008</ArticleId><ArticleId IdType="pubmed">27723879</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin A., Giuliano C.J., Palladino A., John K.M., Abramowicz C., Yuan M.L., Sausville E.L., Lukow D.A., Liu L., Chait A.R., et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci. Transl. Med. 2019;11:eaaw8412. doi: 10.1126/scitranslmed.aaw8412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaw8412</ArticleId><ArticleId IdType="pmc">PMC7717492</ArticleId><ArticleId IdType="pubmed">31511426</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyes S., Bediaga N.G., Zippo A. An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields. Cancers. 2021;13:4969. doi: 10.3390/cancers13194969.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13194969</ArticleId><ArticleId IdType="pmc">PMC8508087</ArticleId><ArticleId IdType="pubmed">34638453</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H., Laird P.W. Interplay between the cancer genome and epigenome. Cell. 2013;153:38&#x2013;55. doi: 10.1016/j.cell.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.03.008</ArticleId><ArticleId IdType="pmc">PMC3648790</ArticleId><ArticleId IdType="pubmed">23540689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja N., Sharma A.R., Baylin S.B. Epigenetic Therapeutics: A New Weapon in the War Against Cancer. Annu. Rev. Med. 2016;67:73&#x2013;89. doi: 10.1146/annurev-med-111314-035900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-111314-035900</ArticleId><ArticleId IdType="pmc">PMC4937439</ArticleId><ArticleId IdType="pubmed">26768237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja N., Easwaran H., Baylin S.B. Harnessing the potential of epigenetic therapy to target solid tumors. J. Clin. Investig. 2014;124:56&#x2013;63. doi: 10.1172/JCI69736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI69736</ArticleId><ArticleId IdType="pmc">PMC3871229</ArticleId><ArticleId IdType="pubmed">24382390</ArticleId></ArticleIdList></Reference><Reference><Citation>Torborg S.R., Li Z., Chan J.E., Tammela T. Cellular and molecular mechanisms of plasticity in cancer. Trends Cancer. 2022;8:735&#x2013;746. doi: 10.1016/j.trecan.2022.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2022.04.007</ArticleId><ArticleId IdType="pmc">PMC9388572</ArticleId><ArticleId IdType="pubmed">35618573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ring N.A.R., Valdivieso K., Grillari J., Redl H., Ogrodnik M. The role of senescence in cellular plasticity: Lessons from regeneration and development and implications for age-related diseases. Dev. Cell. 2022;57:1083&#x2013;1101. doi: 10.1016/j.devcel.2022.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2022.04.005</ArticleId><ArticleId IdType="pubmed">35472291</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouch J., Shvedova M., Thanapaul R., Botchkarev V., Roh D. Epigenetic Regulation of Cellular Senescence. Cells. 2022;11:672. doi: 10.3390/cells11040672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11040672</ArticleId><ArticleId IdType="pmc">PMC8870565</ArticleId><ArticleId IdType="pubmed">35203320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano-Torres B., Estepa-Fern&#xe1;ndez A., Rovira M., Orz&#xe1;ez M., Serrano M., Mart&#xed;nez-M&#xe1;&#xf1;ez R., Sancen&#xf3;n F. The chemistry of senescence. Nat. Rev. Chem. 2019;3:426&#x2013;441. doi: 10.1038/s41570-019-0108-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41570-019-0108-0</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A., B&#xe9;vant K., Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer. 2023;4:1063&#x2013;1082. doi: 10.1038/s43018-023-00595-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43018-023-00595-y</ArticleId><ArticleId IdType="pmc">PMC7615147</ArticleId><ArticleId IdType="pubmed">37537300</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg A.P., Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379:eaaw3835. doi: 10.1126/science.aaw3835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw3835</ArticleId><ArticleId IdType="pmc">PMC10249049</ArticleId><ArticleId IdType="pubmed">36758093</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanova M., Buocikova V., Trnkova L., Strapcova S., Kajabova V.H., Melian E.B., Novisedlakova M., Tomas M., Dubovan P., Earl J., et al. DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Int. J. Mol. Sci. 2022;23:2117. doi: 10.3390/ijms23042117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042117</ArticleId><ArticleId IdType="pmc">PMC8879087</ArticleId><ArticleId IdType="pubmed">35216235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Fang J. Epigenetic regulation of epithelial-mesenchymal transition. Cell. Mol. Life Sci. 2016;73:4493&#x2013;4515. doi: 10.1007/s00018-016-2303-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2303-1</ArticleId><ArticleId IdType="pmc">PMC5459373</ArticleId><ArticleId IdType="pubmed">27392607</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan N.V., Prat A., Abell A.N., Zawistowski J.S., Sciaky N., Karginova O.A., Zhou B., Golitz B.T., Perou C.M., Johnson G.L. SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling. Mol. Cell. Biol. 2013;33:3011&#x2013;3025. doi: 10.1128/MCB.01443-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01443-12</ArticleId><ArticleId IdType="pmc">PMC3719671</ArticleId><ArticleId IdType="pubmed">23716599</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q.L., Luo M., Huang C., Chen H.N., Zhou Z.G. Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy. Front. Oncol. 2021;11:657546. doi: 10.3389/fonc.2021.657546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.657546</ArticleId><ArticleId IdType="pmc">PMC8117142</ArticleId><ArticleId IdType="pubmed">33996581</ArticleId></ArticleIdList></Reference><Reference><Citation>Peixoto P., Etcheverry A., Aubry M., Missey A., Lachat C., Perrard J., Hendrick E., Delage-Mourroux R., Mosser J., Borg C., et al. EMT is associated with an epigenetic signature of ECM remodeling genes. Cell Death Dis. 2019;10:205. doi: 10.1038/s41419-019-1397-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1397-4</ArticleId><ArticleId IdType="pmc">PMC6393505</ArticleId><ArticleId IdType="pubmed">30814494</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhikari S., Bhattacharya A., Adhikary S., Singh V., Gadad S.S., Roy S., Das C. The paradigm of drug resistance in cancer: An epigenetic perspective. Biosci. Rep. 2022;42:BSR20211812. doi: 10.1042/BSR20211812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20211812</ArticleId><ArticleId IdType="pmc">PMC9069444</ArticleId><ArticleId IdType="pubmed">35438143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.J., Jaffee E.M., Zheng L. The tumour microenvironment in pancreatic cancer&#x2014;Clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 2020;17:527&#x2013;540. doi: 10.1038/s41571-020-0363-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-020-0363-5</ArticleId><ArticleId IdType="pmc">PMC7442729</ArticleId><ArticleId IdType="pubmed">32398706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chava S., Gayatri M.B., Reddy A.B.M. Chapter 3&#x2014;EMT Contributes to Chemoresistance in Pancreatic Cancer. In: Nagaraju G.P., editor. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. Academic Press; Cambridge, MA, USA: 2019. pp. 25&#x2013;43.</Citation></Reference><Reference><Citation>Wang S., Prizment A., Thyagarajan B., Blaes A. Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment. Cancers. 2021;13:427. doi: 10.3390/cancers13030427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13030427</ArticleId><ArticleId IdType="pmc">PMC7865902</ArticleId><ArticleId IdType="pubmed">33498754</ArticleId></ArticleIdList></Reference><Reference><Citation>Uprety D., Adjei A.A. KRAS: From undruggable to a druggable Cancer Target. Cancer Treat. Rev. 2020;89:15. doi: 10.1016/j.ctrv.2020.102070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2020.102070</ArticleId><ArticleId IdType="pubmed">32711246</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyn H., Esteller M. DNA methylation profiling in the clinic: Applications and challenges. Nat. Rev. Genet. 2012;13:679&#x2013;692. doi: 10.1038/nrg3270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3270</ArticleId><ArticleId IdType="pubmed">22945394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;beler D. Function and information content of DNA methylation. Nature. 2015;517:321&#x2013;326. doi: 10.1038/nature14192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14192</ArticleId><ArticleId IdType="pubmed">25592537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., Heravi-Moussavi A., Kheradpour P., Zhang Z., Wang J., Ziller M.J., et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518:317&#x2013;330. doi: 10.1038/nature14248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14248</ArticleId><ArticleId IdType="pmc">PMC4530010</ArticleId><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran S., Mart&#xed;nez-Card&#xfa;s A., Sayols S., Musul&#xe9;n E., Bala&#xf1;&#xe1; C., Estival-Gonzalez A., Moutinho C., Heyn H., Diaz-Lagares A., de Moura M.C., et al. Epigenetic profiling to classify cancer of unknown primary: A multicentre, retrospective analysis. Lancet Oncol. 2016;17:1386&#x2013;1395. doi: 10.1016/S1470-2045(16)30297-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(16)30297-2</ArticleId><ArticleId IdType="pubmed">27575023</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez A.F., Assenov Y., Martin-Subero J.I., Balint B., Siebert R., Taniguchi H., Yamamoto H., Hidalgo M., Tan A.C., Galm O., et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2012;22:407&#x2013;419. doi: 10.1101/gr.119867.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.119867.110</ArticleId><ArticleId IdType="pmc">PMC3266047</ArticleId><ArticleId IdType="pubmed">21613409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann-Werman R., Neiman D., Zemmour H., Moss J., Magenheim J., Vaknin-Dembinsky A., Rubertsson S., Nellg&#xe5;rd B., Blennow K., Zetterberg H., et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl. Acad. Sci. USA. 2016;113:14. doi: 10.1073/pnas.1519286113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1519286113</ArticleId><ArticleId IdType="pmc">PMC4822610</ArticleId><ArticleId IdType="pubmed">26976580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam W.K.J., Gai W., Sun K., Wong R.S.M., Chan R.W.Y., Jiang P., Chan N.P.H., Hui W.W.I., Chan A.W.H., Szeto C.C., et al. DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia. Clin. Chem. 2017;63:1614&#x2013;1623. doi: 10.1373/clinchem.2017.272401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2017.272401</ArticleId><ArticleId IdType="pubmed">28784691</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss J., Magenheim J., Neiman D., Zemmour H., Loyfer N., Korach A., Samet Y., Maoz M., Druid H., Arner P., et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun. 2018;9:5068. doi: 10.1038/s41467-018-07466-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07466-6</ArticleId><ArticleId IdType="pmc">PMC6265251</ArticleId><ArticleId IdType="pubmed">30498206</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W.Y., Sharma A., Das P., Ahuja N. Early Detection of Cancers in the Era of Precision Oncology. Curr. Opin. Oncol. 2023;35:115&#x2013;124. doi: 10.1097/CCO.0000000000000931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCO.0000000000000931</ArticleId><ArticleId IdType="pubmed">36721896</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel P., Metais P. [Nuclear Acids In Human Blood Plasma] C. R. Seances Soc. Biol. Fil. 1948;142:241&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">18875018</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroun M., Anker P., Lyautey J., Lederrey C., Maurice P.A. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol. 1987;23:707&#x2013;712. doi: 10.1016/0277-5379(87)90266-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0277-5379(87)90266-5</ArticleId><ArticleId IdType="pubmed">3653190</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Zeng Q., Wang Z., Li C., Xu Y., Cui P., Zhu X., Lu H., Wang G., Cai S., et al. Circulating cell-free DNA for cancer early detection. Innovation. 2022;3:12. doi: 10.1016/j.xinn.2022.100259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2022.100259</ArticleId><ArticleId IdType="pmc">PMC9133648</ArticleId><ArticleId IdType="pubmed">35647572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladel L., Tan W.Y., Jeyakanthan T., Sailo B., Sharma A., Ahuja N. The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms. Cells. 2023;12:1962. doi: 10.3390/cells12151962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12151962</ArticleId><ArticleId IdType="pmc">PMC10417136</ArticleId><ArticleId IdType="pubmed">37566041</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue F., Sone K., Toyohara Y., Takahashi Y., Kukita A., Hara A., Taguchi A., Tanikawa M., Tsuruga T., Osuga Y. Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications. Int. J. Mol. Sci. 2021;22:2305. doi: 10.3390/ijms22052305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052305</ArticleId><ArticleId IdType="pmc">PMC7956745</ArticleId><ArticleId IdType="pubmed">33669072</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M., Jia L., Lv W., Wang L., Cui W. Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors. Front. Oncol. 2019;9:194. doi: 10.3389/fonc.2019.00194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2019.00194</ArticleId><ArticleId IdType="pmc">PMC6449417</ArticleId><ArticleId IdType="pubmed">30984620</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemtsova M.V., Kalinkin A.I., Kuznetsova E.B., Bure I.V., Alekseeva E.A., Bykov I.I., Khorobrykh T.V., Mikhaylenko D.S., Tanas A.S., Strelnikov V.V. Mutations in Epigenetic Regulation Genes in Gastric Cancer. Cancers. 2021;13:4586. doi: 10.3390/cancers13184586.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13184586</ArticleId><ArticleId IdType="pmc">PMC8467700</ArticleId><ArticleId IdType="pubmed">34572812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro A.F., Pratcorona M., Erpelinck-Verschueren C., Rockova V., Sanders M., Abbas S., Figueroa M.E., Zeilemaker A., Melnick A., L&#xf6;wenberg B., et al. Mutant DNMT3A: A marker of poor prognosis in acute myeloid leukemia. Blood. 2012;119:5824&#x2013;5831. doi: 10.1182/blood-2011-07-367961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-07-367961</ArticleId><ArticleId IdType="pubmed">22490330</ArticleId></ArticleIdList></Reference><Reference><Citation>Couronn&#xe9; L., Bastard C., Bernard O.A. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl. J. Med. 2012;366:95&#x2013;96. doi: 10.1056/NEJMc1111708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1111708</ArticleId><ArticleId IdType="pubmed">22216861</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimmino L., Dolgalev I., Wang Y., Yoshimi A., Martin G.H., Wang J., Ng V., Xia B., Witkowski M.T., Mitchell-Flack M., et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell. 2017;170:1079&#x2013;1095.e20. doi: 10.1016/j.cell.2017.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.07.032</ArticleId><ArticleId IdType="pmc">PMC5755977</ArticleId><ArticleId IdType="pubmed">28823558</ArticleId></ArticleIdList></Reference><Reference><Citation>Russler-Germain D.A., Spencer D.H., Young M.A., Lamprecht T.L., Miller C.A., Fulton R., Meyer M.R., Erdmann-Gilmore P., Townsend R.R., Wilson R.K., et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell. 2014;25:442&#x2013;454. doi: 10.1016/j.ccr.2014.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2014.02.010</ArticleId><ArticleId IdType="pmc">PMC4018976</ArticleId><ArticleId IdType="pubmed">24656771</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Wang Y.Y., Dai Y.J., Zhang W., Zhang W.N., Xiong S.M., Gu Z.H., Wang K.K., Zeng R., Chen Z., et al. DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells. Proc. Natl. Acad. Sci. USA. 2014;111:2620&#x2013;2625. doi: 10.1073/pnas.1400150111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1400150111</ArticleId><ArticleId IdType="pmc">PMC3932885</ArticleId><ArticleId IdType="pubmed">24497509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval J.E., Huang Y.H., Muise A., Goodell M.A., Reich N.O. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners. J. Biol. Chem. 2019;294:4898&#x2013;4910. doi: 10.1074/jbc.RA118.006795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006795</ArticleId><ArticleId IdType="pmc">PMC6442042</ArticleId><ArticleId IdType="pubmed">30705090</ArticleId></ArticleIdList></Reference><Reference><Citation>Souroullas G.P., Jeck W.R., Parker J.S., Simon J.M., Liu J.Y., Paulk J., Xiong J., Clark K.S., Fedoriw Y., Qi J., et al. An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat. Med. 2016;22:632&#x2013;640. doi: 10.1038/nm.4092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4092</ArticleId><ArticleId IdType="pmc">PMC4899144</ArticleId><ArticleId IdType="pubmed">27135738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Gao J., Popovic R., Wolniak K., Parimi V., Winter J.N., Licht J.D., Chen Y.H. Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation. Leuk Lymphoma. 2015;56:2895&#x2013;2901. doi: 10.3109/10428194.2015.1006220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10428194.2015.1006220</ArticleId><ArticleId IdType="pubmed">25651430</ArticleId></ArticleIdList></Reference><Reference><Citation>Holliday R., Pugh J.E. DNA modification mechanisms and gene activity during development. Science. 1975;187:226&#x2013;232. doi: 10.1126/science.187.4173.226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.187.4173.226</ArticleId><ArticleId IdType="pubmed">1111098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P.A. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012;13:484&#x2013;492. doi: 10.1038/nrg3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3230</ArticleId><ArticleId IdType="pubmed">22641018</ArticleId></ArticleIdList></Reference><Reference><Citation>Janitz K., Janitz M. Chapter 12&#x2014;Assessing Epigenetic Information. In: Tollefsbol T., editor. Handbook of Epigenetics. Academic Press; San Diego, CA, USA: 2011. pp. 173&#x2013;181.</Citation></Reference><Reference><Citation>Saxonov S., Berg P., Brutlag D.L. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl. Acad. Sci. USA. 2006;103:1412&#x2013;1417. doi: 10.1073/pnas.0510310103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0510310103</ArticleId><ArticleId IdType="pmc">PMC1345710</ArticleId><ArticleId IdType="pubmed">16432200</ArticleId></ArticleIdList></Reference><Reference><Citation>Long H.K., Sims D., Heger A., Blackledge N.P., Kutter C., Wright M.L., Gr&#xfc;tzner F., Odom D.T., Patient R., Ponting C.P., et al. Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates. elife. 2013;2:e00348. doi: 10.7554/eLife.00348.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00348</ArticleId><ArticleId IdType="pmc">PMC3583005</ArticleId><ArticleId IdType="pubmed">23467541</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen F., Gundersen G., Lopez R., Prydz H. CpG islands as gene markers in the human genome. Genomics. 1992;13:1095&#x2013;1107. doi: 10.1016/0888-7543(92)90024-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0888-7543(92)90024-M</ArticleId><ArticleId IdType="pubmed">1505946</ArticleId></ArticleIdList></Reference><Reference><Citation>Antequera F., Bird A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA. 1993;90:11995&#x2013;11999. doi: 10.1073/pnas.90.24.11995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.24.11995</ArticleId><ArticleId IdType="pmc">PMC48112</ArticleId><ArticleId IdType="pubmed">7505451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Nakanishi M. Navigating the DNA methylation landscape of cancer. Trend Genet. 2021;37:1012&#x2013;1027. doi: 10.1016/j.tig.2021.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2021.05.002</ArticleId><ArticleId IdType="pubmed">34120771</ArticleId></ArticleIdList></Reference><Reference><Citation>Greger V., Passarge E., H&#xf6;pping W., Messmer E., Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 1989;83:155&#x2013;158. doi: 10.1007/BF00286709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00286709</ArticleId><ArticleId IdType="pubmed">2550354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashktorab H., Brim H. DNA Methylation and Colorectal Cancer. Curr. Color. Cancer Rep. 2014;10:425&#x2013;430. doi: 10.1007/s11888-014-0245-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11888-014-0245-2</ArticleId><ArticleId IdType="pmc">PMC4286876</ArticleId><ArticleId IdType="pubmed">25580099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gl&#xf6;ckner S.C., Dhir M., Yi J.M., McGarvey K.E., Van Neste L., Louwagie J., Chan T.A., Kleeberger W., de Bru&#xef;ne A.P., Smits K.M., et al. Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009;69:4691&#x2013;4699. doi: 10.1158/0008-5472.CAN-08-0142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-0142</ArticleId><ArticleId IdType="pmc">PMC3062162</ArticleId><ArticleId IdType="pubmed">19435926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang P.H., Landi M.T. DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors. Cancers. 2022;14:961. doi: 10.3390/cancers14040961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14040961</ArticleId><ArticleId IdType="pmc">PMC8870477</ArticleId><ArticleId IdType="pubmed">35205708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Li C., Yin H., Huang J., Yu S., Zhao J., Tang Y., Yu M., Lin J., Ding L., et al. The Mechanism of DNA Methylation and miRNA in Breast Cancer. Int. J. Mol. Sci. 2023;24:9360. doi: 10.3390/ijms24119360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24119360</ArticleId><ArticleId IdType="pmc">PMC10253858</ArticleId><ArticleId IdType="pubmed">37298314</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yang M., Wang S., Abbas S.J., Zhang J., Li Y., Shao R., Liu Y. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Front. Oncol. 2022;12:854773. doi: 10.3389/fonc.2022.854773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.854773</ArticleId><ArticleId IdType="pmc">PMC8918690</ArticleId><ArticleId IdType="pubmed">35296007</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissa M.A.L., Lerner L., Abdelfatah E., Shankar N., Canner J.K., Hasan N.M., Yaghoobi V., Huang B., Kerner Z., Takaesu F., et al. Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood. Clin. Epigenetics. 2019;11:59. doi: 10.1186/s13148-019-0650-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-019-0650-0</ArticleId><ArticleId IdType="pmc">PMC6451253</ArticleId><ArticleId IdType="pubmed">30953539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S.G., Chen W.S., Li H., Foye A., Zhang M., Sj&#xf6;str&#xf6;m M., Aggarwal R., Playdle D., Liao A., Alumkal J.J., et al. The DNA methylation landscape of advanced prostate cancer. Nat. Genet. 2020;52:778&#x2013;789. doi: 10.1038/s41588-020-0648-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0648-8</ArticleId><ArticleId IdType="pmc">PMC7454228</ArticleId><ArticleId IdType="pubmed">32661416</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M., Tsui S.K.-W., Wu H., Wei Y. Pan-cancer analysis of differential DNA methylation patterns. BMC Med. Genom. 2020;13:154. doi: 10.1186/s12920-020-00780-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-020-00780-3</ArticleId><ArticleId IdType="pmc">PMC7579968</ArticleId><ArticleId IdType="pubmed">33087120</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Gao L., Zhang S. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Brief. Bioinform. 2017;18:761&#x2013;773. doi: 10.1093/bib/bbw063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbw063</ArticleId><ArticleId IdType="pubmed">27436122</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickhardt P.J. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: The importance of cancer prevention in addition to cancer detection. Abdom. Radiol. 2016;41:1441&#x2013;1444. doi: 10.1007/s00261-016-0798-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00261-016-0798-4</ArticleId><ArticleId IdType="pmc">PMC4974132</ArticleId><ArticleId IdType="pubmed">27259335</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull C., Wald N., Sullivan R., Pharoah P., Houlston R.S., Aggarwal A., Hogarth S., McCartney M. GRAIL-Galleri: Why the special treatment? Lancet. 2024;403:431&#x2013;432. doi: 10.1016/S0140-6736(23)02830-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)02830-1</ArticleId><ArticleId IdType="pubmed">38253053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381&#x2013;395. doi: 10.1038/cr.2011.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.22</ArticleId><ArticleId IdType="pmc">PMC3193420</ArticleId><ArticleId IdType="pubmed">21321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence M., Daujat S., Schneider R. Lateral Thinking: How Histone Modifications Regulate Gene Expression. Trend Genet. 2016;32:42&#x2013;56. doi: 10.1016/j.tig.2015.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2015.10.007</ArticleId><ArticleId IdType="pubmed">26704082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Ren B., Yang J., Wang H., Yang G., Xu R., You L., Zhao Y. The role of histone methylation in the development of digestive cancers: A potential direction for cancer management. Signal Transduct. Target. Ther. 2020;5:143. doi: 10.1038/s41392-020-00252-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00252-1</ArticleId><ArticleId IdType="pmc">PMC7398912</ArticleId><ArticleId IdType="pubmed">32747629</ArticleId></ArticleIdList></Reference><Reference><Citation>Audia J.E., Campbell R.M. Histone Modifications and Cancer. Cold Spring Harb. Perspect. Biol. 2016;8:a019521. doi: 10.1101/cshperspect.a019521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a019521</ArticleId><ArticleId IdType="pmc">PMC4817802</ArticleId><ArticleId IdType="pubmed">27037415</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer E.L., Shi Y. Histone methylation: A dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 2012;13:343&#x2013;357. doi: 10.1038/nrg3173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3173</ArticleId><ArticleId IdType="pmc">PMC4073795</ArticleId><ArticleId IdType="pubmed">22473383</ArticleId></ArticleIdList></Reference><Reference><Citation>Burlibasa L., Nicu A.T., Chifiriuc M.C., Medar C., Petrescu A., Jinga V., Stoica I. H3 histone methylation landscape in male urogenital cancers: From molecular mechanisms to epigenetic biomarkers and therapeutic targets. Front. Cell Dev. Biol. 2023;11:1181764. doi: 10.3389/fcell.2023.1181764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2023.1181764</ArticleId><ArticleId IdType="pmc">PMC10203431</ArticleId><ArticleId IdType="pubmed">37228649</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen K.A., Sidoli S., Garcia B.A. Recent Achievements in Characterizing the Histone Code and Approaches to Integrating Epigenomics and Systems Biology. Methods Enzymol. 2017;586:359&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512434</ArticleId><ArticleId IdType="pubmed">28137571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biol. 2019;20:245. doi: 10.1186/s13059-019-1870-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1870-5</ArticleId><ArticleId IdType="pmc">PMC6868810</ArticleId><ArticleId IdType="pubmed">31747960</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.K., Mueller-Planitz F. Nucleosome Positioning and Spacing: From Mechanism to Function. J. Mol. Biol. 2021;433:166847. doi: 10.1016/j.jmb.2021.166847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.166847</ArticleId><ArticleId IdType="pubmed">33539878</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou K., Gaullier G., Luger K. Nucleosome structure and dynamics are coming of age. Nat. Struct. Mol. Biol. 2019;26:3&#x2013;13. doi: 10.1038/s41594-018-0166-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0166-x</ArticleId><ArticleId IdType="pmc">PMC7386248</ArticleId><ArticleId IdType="pubmed">30532059</ArticleId></ArticleIdList></Reference><Reference><Citation>Radman-Livaja M., Rando O.J. Nucleosome positioning: How is it established, and why does it matter? Dev. Biol. 2010;339:258&#x2013;266. doi: 10.1016/j.ydbio.2009.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2009.06.012</ArticleId><ArticleId IdType="pmc">PMC2830277</ArticleId><ArticleId IdType="pubmed">19527704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozsolak F., Song J.S., Liu X.S., Fisher D.E. High-throughput mapping of the chromatin structure of human promoters. Nat. Biotechnol. 2007;25:244&#x2013;248. doi: 10.1038/nbt1279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1279</ArticleId><ArticleId IdType="pubmed">17220878</ArticleId></ArticleIdList></Reference><Reference><Citation>Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., Wei G., Zhao K. Dynamic regulation of nucleosome positioning in the human genome. Cell. 2008;132:887&#x2013;898. doi: 10.1016/j.cell.2008.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.02.022</ArticleId><ArticleId IdType="pmc">PMC10894452</ArticleId><ArticleId IdType="pubmed">18329373</ArticleId></ArticleIdList></Reference><Reference><Citation>Valouev A., Johnson S.M., Boyd S.D., Smith C.L., Fire A.Z., Sidow A. Determinants of nucleosome organization in primary human cells. Nature. 2011;474:516&#x2013;520. doi: 10.1038/nature10002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10002</ArticleId><ArticleId IdType="pmc">PMC3212987</ArticleId><ArticleId IdType="pubmed">21602827</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y. At the dawn: Cell-free DNA fragmentomics and gene regulation. Br. J. Cancer. 2022;126:379&#x2013;390. doi: 10.1038/s41416-021-01635-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-021-01635-z</ArticleId><ArticleId IdType="pmc">PMC8810841</ArticleId><ArticleId IdType="pubmed">34815523</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdenrieder S., Stieber P., Chan L.Y.S., Geiger S., Kremer A., Nagel D., Lo Y.M.D. Cell-Free DNA in Serum and Plasma: Comparison of ELISA and Quantitative PCR. Clin. Chem. 2005;51:1544&#x2013;1546. doi: 10.1373/clinchem.2005.049320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2005.049320</ArticleId><ArticleId IdType="pubmed">16040855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov M., Baranova A., Butler T., Spellman P., Mileyko V. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation. BMC Genom. 2015;16((Suppl. S13)):S1. doi: 10.1186/1471-2164-16-S13-S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-16-S13-S1</ArticleId><ArticleId IdType="pmc">PMC4686799</ArticleId><ArticleId IdType="pubmed">26693644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez C., Snyder M.W., Tanos R., Shendure J., Thierry A.R. New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis. NPJ Genom. Med. 2018;3:31. doi: 10.1038/s41525-018-0069-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-018-0069-0</ArticleId><ArticleId IdType="pmc">PMC6251887</ArticleId><ArticleId IdType="pubmed">30479833</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill H.R., Kitzman J.O., Hellwig S., Welker N.C., Daza R., Baker D.N., Gligorich K.M., Rostomily R.C., Bronner M.P., Shendure J. Fragment Length of Circulating Tumor DNA. PLoS Genet. 2016;12:e1006162. doi: 10.1371/journal.pgen.1006162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006162</ArticleId><ArticleId IdType="pmc">PMC4948782</ArticleId><ArticleId IdType="pubmed">27428049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouliere F., Robert B., Peyrotte E.A., Del Rio M., Ychou M., Molina F., Gongora C., Thierry A.R. High fragmentation characterizes tumour-derived circulating DNA. PLoS ONE. 2011;6:e23418. doi: 10.1371/journal.pone.0023418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023418</ArticleId><ArticleId IdType="pmc">PMC3167805</ArticleId><ArticleId IdType="pubmed">21909401</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristiano S., Leal A., Phallen J., Fiksel J., Adleff V., Bruhm D.C., Jensen S., Medina J.E., Hruban C., White J.R., et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570:385&#x2013;389. doi: 10.1038/s41586-019-1272-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1272-6</ArticleId><ArticleId IdType="pmc">PMC6774252</ArticleId><ArticleId IdType="pubmed">31142840</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., Knippers R. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">11245480</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi T., Pan M., Shi H., Wang L., Bai Y., Ge Q. Cell-Free DNA Fragmentomics: The Novel Promising Biomarker. Int. J. Mol. Sci. 2023;24:1503. doi: 10.3390/ijms24021503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021503</ArticleId><ArticleId IdType="pmc">PMC9866579</ArticleId><ArticleId IdType="pubmed">36675018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouliere F., Chandrananda D., Piskorz A.M., Moore E.K., Morris J., Ahlborn L.B., Mair R., Goranova T., Marass F., Heider K., et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci. Transl. Med. 2018;10:eaat4921. doi: 10.1126/scitranslmed.aat4921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aat4921</ArticleId><ArticleId IdType="pmc">PMC6483061</ArticleId><ArticleId IdType="pubmed">30404863</ArticleId></ArticleIdList></Reference><Reference><Citation>Skidmore Z.L., Erve I.v.t., Lumbard K., Alipanahi B., Keefer L., Rinaldi L., Carey J., Tom J., Punt C.J.A., Dracopoli N.C., et al. Cell-free DNA fragmentation profiling for therapeutic response monitoring in metastatic colorectal cancer. J. Clin. Oncol. 2023;41((Suppl. S16)):e15664. doi: 10.1200/JCO.2023.41.16_suppl.e15664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2023.41.16_suppl.e15664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianni C., Palleschi M., Merloni F., Di Menna G., Sirico M., Sarti S., Virga A., Ulivi P., Cecconetto L., Mariotti M., et al. Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer. Int. J. Mol. Sci. 2022;23:14197. doi: 10.3390/ijms232214197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232214197</ArticleId><ArticleId IdType="pmc">PMC9695769</ArticleId><ArticleId IdType="pubmed">36430675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahat D., Schneor L., Liscovitch-Brauer N., Shomron N. P125: Detection of pancreatic cancer in liquid biopsies using integrative fragmentomics. Genet. Med. Open. 2024;2:101006. doi: 10.1016/j.gimo.2024.101006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gimo.2024.101006</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes A.A., Marcum R.D., He Y. Structure and Function of Chromatin Remodelers. J. Mol. Biol. 2021;433:166929. doi: 10.1016/j.jmb.2021.166929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.166929</ArticleId><ArticleId IdType="pmc">PMC8184634</ArticleId><ArticleId IdType="pubmed">33711345</ArticleId></ArticleIdList></Reference><Reference><Citation>Caumanns J.J., Wisman G.B.A., Berns K., van der Zee A.G.J., de Jong S. ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies. Biochim. Biophys. Acta (BBA)&#x2014;Rev. Cancer. 2018;1870:176&#x2013;184. doi: 10.1016/j.bbcan.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2018.07.005</ArticleId><ArticleId IdType="pubmed">30025943</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Hoang L., Ji J.X., Huntsman D.G. SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models. Annu. Rev. Pathol. Mech. Dis. 2020;15:467&#x2013;492. doi: 10.1146/annurev-pathmechdis-012418-012917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012917</ArticleId><ArticleId IdType="pmc">PMC6986318</ArticleId><ArticleId IdType="pubmed">31977292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S., Duan R., Cong L., Song Y. The effects of ARID1A mutation in gastric cancer and its significance for treatment. Cancer Cell Int. 2023;23:296. doi: 10.1186/s12935-023-03154-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12935-023-03154-8</ArticleId><ArticleId IdType="pmc">PMC10676575</ArticleId><ArticleId IdType="pubmed">38008753</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N.Q., Paassen I., Custers L., Zeller P., Teunissen H., Ayyildiz D., He J., Buhl J.L., Hoving E.W., van Oudenaarden A., et al. SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors. Nat. Commun. 2023;14:7762. doi: 10.1038/s41467-023-43498-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-43498-3</ArticleId><ArticleId IdType="pmc">PMC10692191</ArticleId><ArticleId IdType="pubmed">38040699</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper G.W., Hong A.L. SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities. Cancers. 2022;14:3645. doi: 10.3390/cancers14153645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14153645</ArticleId><ArticleId IdType="pmc">PMC9332782</ArticleId><ArticleId IdType="pubmed">35892904</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawel B.R. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pediatr. Dev. Pathol. 2018;21:6&#x2013;28. doi: 10.1177/1093526617749671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1093526617749671</ArticleId><ArticleId IdType="pubmed">29280680</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Gigi L., Zhao D. CHD1, a multifaceted epigenetic remodeler in prostate cancer. Front. Oncol. 2023;13:1123362. doi: 10.3389/fonc.2023.1123362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2023.1123362</ArticleId><ArticleId IdType="pmc">PMC9909554</ArticleId><ArticleId IdType="pubmed">36776288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D., Lu X., Wang G., Lan Z., Liao W., Li J., Liang X., Chen J.R., Shah S., Shang X., et al. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature. 2017;542:484&#x2013;488. doi: 10.1038/nature21357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21357</ArticleId><ArticleId IdType="pmc">PMC5448706</ArticleId><ArticleId IdType="pubmed">28166537</ArticleId></ArticleIdList></Reference><Reference><Citation>Farnung L., Vos S.M., Wigge C., Cramer P. Nucleosome-Chd1 structure and implications for chromatin remodelling. Nature. 2017;550:539&#x2013;542. doi: 10.1038/nature24046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24046</ArticleId><ArticleId IdType="pmc">PMC5697743</ArticleId><ArticleId IdType="pubmed">29019976</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R., Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 2004;14:155&#x2013;164. doi: 10.1016/j.gde.2004.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2004.02.001</ArticleId><ArticleId IdType="pubmed">15196462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan L., Yang Y., Li Q., Feng Y., Liu T., Guo W. Epigenetic regulation of cancer progression by EZH2: From biological insights to therapeutic potential. Biomark. Res. 2018;6:10. doi: 10.1186/s40364-018-0122-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40364-018-0122-2</ArticleId><ArticleId IdType="pmc">PMC5845366</ArticleId><ArticleId IdType="pubmed">29556394</ArticleId></ArticleIdList></Reference><Reference><Citation>Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419:624&#x2013;629. doi: 10.1038/nature01075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01075</ArticleId><ArticleId IdType="pubmed">12374981</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens C., Solis L.M., Lin H., Yuan P., Tang X., Kadara H., Riquelme E., Galindo H., Moran C.A., Kalhor N., et al. EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma. Clin. Cancer Res. 2013;19:6556&#x2013;6565. doi: 10.1158/1078-0432.CCR-12-3946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-3946</ArticleId><ArticleId IdType="pmc">PMC3890101</ArticleId><ArticleId IdType="pubmed">24097870</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Tollefsbol T.O. DNA methylation detection: Bisulfite genomic sequencing analysis. Methods Mol. Biol. 2011;791:11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233226</ArticleId><ArticleId IdType="pubmed">21913068</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeley B., Stark A., Pisanic T.R., Kwak R., Zhang Y., Wrangle J., Baylin S., Herman J., Ahuja N., Brock M.V., et al. Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin. Chim. Acta. 2013;425:169&#x2013;175. doi: 10.1016/j.cca.2013.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2013.07.023</ArticleId><ArticleId IdType="pmc">PMC3963364</ArticleId><ArticleId IdType="pubmed">23911908</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzzetta A.A., Ii T.R.P., Sharma P., Yi J.M., Stark A., Wang T.H., Ahuja N. The promise of methylation on beads for cancer detection and treatment. Expert Rev. Mol. Diagn. 2014;14:845&#x2013;852. doi: 10.1586/14737159.2014.943665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737159.2014.943665</ArticleId><ArticleId IdType="pmc">PMC4427839</ArticleId><ArticleId IdType="pubmed">25136840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga M.F., Ballestar E., Montoya G., Taysavang P., Wade P.A., Esteller M. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic. Acids Res. 2003;31:1765&#x2013;1774. doi: 10.1093/nar/gkg249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg249</ArticleId><ArticleId IdType="pmc">PMC152853</ArticleId><ArticleId IdType="pubmed">12626718</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberg K.A., Xie L., Chan R.F., Zhao M., Pandey A.K., Kumar G., Clark S.L., van den Oord E.J. Evaluation of Methyl-Binding Domain Based Enrichment Approaches Revisited. PLoS ONE. 2015;10:e0132205. doi: 10.1371/journal.pone.0132205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132205</ArticleId><ArticleId IdType="pmc">PMC4503759</ArticleId><ArticleId IdType="pubmed">26177298</ArticleId></ArticleIdList></Reference><Reference><Citation>Serre D., Lee B.H., Ting A.H. MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic. Acids Res. 2010;38:391&#x2013;399. doi: 10.1093/nar/gkp992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp992</ArticleId><ArticleId IdType="pmc">PMC2811030</ArticleId><ArticleId IdType="pubmed">19906696</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberg K.A., Chan R.F., van den Oord E. MBD-seq&#x2014;Realities of a misunderstood method for high-quality methylome-wide association studies. Epigenetics. 2020;15:431&#x2013;438. doi: 10.1080/15592294.2019.1695339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2019.1695339</ArticleId><ArticleId IdType="pmc">PMC7153543</ArticleId><ArticleId IdType="pubmed">31739727</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair S.S., Coolen M.W., Stirzaker C., Song J.Z., Statham A.L., Strbenac D., Robinson M.D., Clark S.J. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics. 2011;6:34&#x2013;44. doi: 10.4161/epi.6.1.13313.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.6.1.13313</ArticleId><ArticleId IdType="pubmed">20818161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H., Zhu M.S., Liu Y. FinaleDB: A browser and database of cell-free DNA fragmentation patterns. Bioinformatics. 2020;37:2502&#x2013;2503. doi: 10.1093/bioinformatics/btaa999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa999</ArticleId><ArticleId IdType="pmc">PMC8388032</ArticleId><ArticleId IdType="pubmed">33258919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallermayr A., Wohlfrom T., Steinke-Lange V., Benet-Pag&#xe8;s A., Scharf F., Heitzer E., Mansmann U., Haberl C., de Wit M., Vogelsang H., et al. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients. J. Hematol. Oncol. 2022;15:125. doi: 10.1186/s13045-022-01342-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-022-01342-z</ArticleId><ArticleId IdType="pmc">PMC9438339</ArticleId><ArticleId IdType="pubmed">36056434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasa P., Jain R., Juneja D. Delphi methodology in healthcare research: How to decide its appropriateness. World J. Methodol. 2021;11:116&#x2013;129. doi: 10.5662/wjm.v11.i4.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.5662/wjm.v11.i4.116</ArticleId><ArticleId IdType="pmc">PMC8299905</ArticleId><ArticleId IdType="pubmed">34322364</ArticleId></ArticleIdList></Reference><Reference><Citation>Teif V.B. Nucleosome positioning: Resources and tools online. Brief. Bioinform. 2015;17:745&#x2013;757. doi: 10.1093/bib/bbv086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbv086</ArticleId><ArticleId IdType="pubmed">26411474</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin L.N., Barnett K.R., Hodges E. Dual detection of chromatin accessibility and DNA methylation using ATAC-Me. Nat. Protoc. 2021;16:5377&#x2013;5397. doi: 10.1038/s41596-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC11057009</ArticleId><ArticleId IdType="pubmed">34663963</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperiale T.F., Porter K., Zella J., Gagrat Z.D., Olson M.C., Statz S., Garces J., Lavin P.T., Aguilar H., Brinberg D., et al. Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening. N. Engl. J. Med. 2024;390:984&#x2013;993. doi: 10.1056/NEJMoa2310336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2310336</ArticleId><ArticleId IdType="pubmed">38477986</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirley M. Epi proColon(&#xae;) for Colorectal Cancer Screening: A Profile of Its Use in the USA. Mol. Diagn. Ther. 2020;24:497&#x2013;503. doi: 10.1007/s40291-020-00473-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-020-00473-8</ArticleId><ArticleId IdType="pubmed">32557236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin N., Lin Y., Xu J., Liu D., Li D., Meng H., Gallant M.A., Kubota N., Roy D., Li J.S., et al. A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma. Hepatol. Commun. 2022;6:1753&#x2013;1763. doi: 10.1002/hep4.1918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep4.1918</ArticleId><ArticleId IdType="pmc">PMC9234637</ArticleId><ArticleId IdType="pubmed">35244350</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R.H., Wei W., Krawczyk M., Wang W., Luo H., Flagg K., Yi S., Shi W., Quan Q., Li K., et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat. Mater. 2017;16:1155&#x2013;1161. doi: 10.1038/nmat4997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmat4997</ArticleId><ArticleId IdType="pubmed">29035356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Liu Z., Zhou L., Fan J., Ruan W., Wang H., Wei Q., Chen H., Xu T., Li L., et al. UriFind assay and association with whole course management of urothelial carcinoma in a large multicentric, prospective China cohort. J. Clin. Oncol. 2023;41((Suppl. S16)):e16588. doi: 10.1200/JCO.2023.41.16_suppl.e16588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2023.41.16_suppl.e16588</ArticleId></ArticleIdList></Reference><Reference><Citation>Piatti P., Chew Y.C., Suwoto M., Yamada T., Jara B., Jia X.Y., Guo W., Ghodoussipour S., Daneshmand S., Ahmadi H., et al. Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples. Clin. Epigenetics. 2021;13:84. doi: 10.1186/s13148-021-01029-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01029-1</ArticleId><ArticleId IdType="pmc">PMC8059345</ArticleId><ArticleId IdType="pubmed">33882992</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh T.J., Lee J.Y., Seo Y., Woo M.A., Lim J.S., Na Y.G., Song K.H., Bang B.R., Lee J.J., Shin J.H., et al. Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with Hematuria. J. Mol. Diagn. 2023;25:646&#x2013;654. doi: 10.1016/j.jmoldx.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2023.05.003</ArticleId><ArticleId IdType="pubmed">37330048</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein E.A., Richards D., Cohn A., Tummala M., Lapham R., Cosgrove D., Chung G., Clement J., Gao J., Hunkapiller N., et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann. Oncol. 2021;32:1167&#x2013;1177. doi: 10.1016/j.annonc.2021.05.806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2021.05.806</ArticleId><ArticleId IdType="pubmed">34176681</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang N., Li B., Jia Z., Wang C., Wu P., Zheng T., Wang Y., Qiu F., Wu Y., Su J., et al. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat. Biomed. Eng. 2021;5:586&#x2013;599. doi: 10.1038/s41551-021-00746-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-021-00746-5</ArticleId><ArticleId IdType="pubmed">34131323</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y.D., Oh T.J., Chung T.H., Jang H.W., Kim Y.N., An S., Kim N.K. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clin. Epigenetics. 2019;11:51. doi: 10.1186/s13148-019-0642-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-019-0642-0</ArticleId><ArticleId IdType="pmc">PMC6419806</ArticleId><ArticleId IdType="pubmed">30876480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung D.C., Gray D.M., 2nd, Singh H., Issaka R.B., Raymond V.M., Eagle C., Hu S., Chudova D.I., Talasaz A., Greenson J.K., et al. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening. N. Engl. J. Med. 2024;390:973&#x2013;983. doi: 10.1056/NEJMoa2304714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2304714</ArticleId><ArticleId IdType="pubmed">38477985</ArticleId></ArticleIdList></Reference><Reference><Citation>Young G.P., Pedersen S.K., Mansfield S., Murray D.H., Baker R.T., Rabbitt P., Byrne S., Bambacas L., Hollington P., Symonds E.L. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer. Cancer Med. 2016;5:2763&#x2013;2772. doi: 10.1002/cam4.868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.868</ArticleId><ArticleId IdType="pmc">PMC5083729</ArticleId><ArticleId IdType="pubmed">27726312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai G., Cai M., Feng Z., Liu R., Liang L., Zhou P., Zhu B., Mo S., Wang H., Lan X., et al. A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer. Gastroenterology. 2021;161:2053&#x2013;2056.e2. doi: 10.1053/j.gastro.2021.08.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.08.054</ArticleId><ArticleId IdType="pubmed">34487783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W.-H., Xiao J., Ye Z.-Y., Wei D.-L., Zhai X.-H., Xu R.-H., Zeng Z.-L., Luo H.-Y. Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer. Clin. Epigenetics. 2021;13:232. doi: 10.1186/s13148-021-01216-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01216-0</ArticleId><ArticleId IdType="pmc">PMC8713401</ArticleId><ArticleId IdType="pubmed">34961566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewin J., Kottwitz D., Aoyama J., deVos T., Garces J., Hasinger O., Kasielke S., Knaust F., Rathi P., Rausch S., et al. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: A case control study. BMC Gastroenterol. 2021;21:136. doi: 10.1186/s12876-021-01714-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-021-01714-8</ArticleId><ArticleId IdType="pmc">PMC7995734</ArticleId><ArticleId IdType="pubmed">33765926</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheishvili D., Wong C., Karim M.M., Kibria M.G., Jahan N., Das P.C., Yousuf M.A.K., Islam M.A., Das D.C., Noor E.A.S.M., et al. A high-throughput test enables specific detection of hepatocellular carcinoma. Nat. Commun. 2023;14:3306. doi: 10.1038/s41467-023-39055-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39055-7</ArticleId><ArticleId IdType="pmc">PMC10247794</ArticleId><ArticleId IdType="pubmed">37286539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying L., Sharma A., Chhoda A., Ruzgar N., Hasan N., Kwak R., Wolfgang C.L., Wang T.H., Kunstman J.W., Salem R.R., et al. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer. Pancreas. 2021;50:1267&#x2013;1273. doi: 10.1097/MPA.0000000000001919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPA.0000000000001919</ArticleId><ArticleId IdType="pubmed">34860810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhoda A., Sharma A., Sailo B., Tang H., Ruzgar N., Tan W.Y., Ying L., Khatri R., Narayanan A., Mane S., et al. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms. Clin. Epigenetics. 2023;15:28. doi: 10.1186/s13148-023-01429-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-023-01429-5</ArticleId><ArticleId IdType="pmc">PMC9942382</ArticleId><ArticleId IdType="pubmed">36803844</ArticleId></ArticleIdList></Reference><Reference><Citation>Witjes J.A., Morote J., Cornel E.B., Gakis G., van Valenberg F.J.P., Lozano F., Sternberg I.A., Willemsen E., Hegemann M.L., Paitan Y., et al. Performance of the Bladder EpiCheck&#x2122; Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial. Eur. Urol. Oncol. 2018;1:307&#x2013;313. doi: 10.1016/j.euo.2018.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euo.2018.06.011</ArticleId><ArticleId IdType="pubmed">31100252</ArticleId></ArticleIdList></Reference><Reference><Citation>Territo A., Gallioli A., Diana P., Boissier R., Fontana M., Gaya J.M., Sanguedolce F., Calder&#xf3;n J., Piana A., Fontanet S., et al. DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial. J. Urol. 2022;208:570&#x2013;579. doi: 10.1097/JU.0000000000002748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JU.0000000000002748</ArticleId><ArticleId IdType="pubmed">35549312</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel K.E., Van Neste L., Lurkin I., Zwarthoff E.C., Van Criekinge W. Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria. J. Urol. 2016;195:601&#x2013;607. doi: 10.1016/j.juro.2015.08.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2015.08.085</ArticleId><ArticleId IdType="pubmed">26327355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich D., Kneip C., Raji O., Liloglou T., Seegebarth A., Schlegel T., Flemming N., Rausch S., Distler J., Fleischhacker M., et al. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int. J. Oncol. 2012;40:825&#x2013;832. doi: 10.3892/ijo.2011.1264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2011.1264</ArticleId><ArticleId IdType="pubmed">22108652</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Chen Z., Li C., Liu J., Tao J., Liu X., Zhao D., Yin W., Chen H., Cheng C., et al. Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test. J. Clin. Investig. 2021;131:e145973. doi: 10.1172/JCI145973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI145973</ArticleId><ArticleId IdType="pmc">PMC8121527</ArticleId><ArticleId IdType="pubmed">33793424</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Li Q., Kang S., Same M., Zhou Y., Sun C., Liu C.-C., Matsuoka L., Sher L., Wong W.H., et al. CancerDetector: Ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data. Nucleic Acids Res. 2018;46:e89. doi: 10.1093/nar/gky423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky423</ArticleId><ArticleId IdType="pmc">PMC6125664</ArticleId><ArticleId IdType="pubmed">29897492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Li Q., Chen Q., Zhou Y., Park S., Lee G., Grimes B., Krysan K., Yu M., Wang W., et al. CancerLocator: Non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017;18:53. doi: 10.1186/s13059-017-1191-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-017-1191-5</ArticleId><ArticleId IdType="pmc">PMC5364586</ArticleId><ArticleId IdType="pubmed">28335812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Gole J., Gore A., He Q., Lu M., Min J., Yuan Z., Yang X., Jiang Y., Zhang T., et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat. Commun. 2020;11:3475. doi: 10.1038/s41467-020-17316-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17316-z</ArticleId><ArticleId IdType="pmc">PMC7374162</ArticleId><ArticleId IdType="pubmed">32694610</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantin N., Sina A.A., Korbie D., Trau M. Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies. Epigenomes. 2022;6:6. doi: 10.3390/epigenomes6010006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/epigenomes6010006</ArticleId><ArticleId IdType="pmc">PMC8883983</ArticleId><ArticleId IdType="pubmed">35225958</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrag D., Beer T.M., McDonnell C.H., 3rd, Nadauld L., Dilaveri C.A., Reid R., Marinac C.R., Chung K.C., Lopatin M., Fung E.T., et al. Blood-based tests for multicancer early detection (PATHFINDER): A prospective cohort study. Lancet. 2023;402:1251&#x2013;1260. doi: 10.1016/S0140-6736(23)01700-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01700-2</ArticleId><ArticleId IdType="pmc">PMC11027492</ArticleId><ArticleId IdType="pubmed">37805216</ArticleId></ArticleIdList></Reference><Reference><Citation>Munugalavadla V., de Jesus G., Markovets A., Liu Q., Venn O., White R., Fabbri G., Labrousse P., Stetson D., Dougherty B., et al. Abstract 3369: Utility of ctDNA-based targeted methylation MRD assay for hematological malignancies. Cancer Res. 2023;83((Suppl. S7)):3369. doi: 10.1158/1538-7445.AM2023-3369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1538-7445.AM2023-3369</ArticleId></ArticleIdList></Reference><Reference><Citation>GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research Annual Meeting. 2023.  [(accessed on 3 April 2024)].  Available online:  https://grail.com/press-releases/grail-presents-new-data-demonstrating-that-methylation-assay-detects-residual-hematologic-cancer-after-treatment-at-american-association-for-cancer-research-annual-meeting-2023/</Citation></Reference><Reference><Citation>Schwartzentruber J., Korshunov A., Liu X.-Y., Jones D.T.W., Pfaff E., Jacob K., Sturm D., Fontebasso A.M., Quang D.-A.K., T&#xf6;njes M., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482:226&#x2013;231. doi: 10.1038/nature10833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10833</ArticleId><ArticleId IdType="pubmed">22286061</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu V.M., Alvi M.A., McDonald K.L., Daniels D.J. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: A systematic review and meta-analysis. J. Neurosurg. Pediatr. 2018;23:308&#x2013;316. doi: 10.3171/2018.9.PEDS18419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2018.9.PEDS18419</ArticleId><ArticleId IdType="pubmed">30544362</ArticleId></ArticleIdList></Reference><Reference><Citation>Karremann M., Gielen G.H., Hoffmann M., Wiese M., Colditz N., Warmuth-Metz M., Bison B., Claviez A., van Vuurden D.G., von Bueren A.O., et al. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol. 2018;20:123&#x2013;131. doi: 10.1093/neuonc/nox149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuonc/nox149</ArticleId><ArticleId IdType="pmc">PMC5761525</ArticleId><ArticleId IdType="pubmed">29016894</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.S., Kim Y.S., Kim D.K., Park S.I., Jang S.J. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients. Pathol. Int. 2012;62:182&#x2013;190. doi: 10.1111/j.1440-1827.2011.02776.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1827.2011.02776.x</ArticleId><ArticleId IdType="pubmed">22360506</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Broeck A., Brambilla E., Moro-Sibilot D., Lantuejoul S., Brambilla C., Eymin B., Gazzeri S. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer. Clin. Cancer Res. 2008;14:7237&#x2013;7245. doi: 10.1158/1078-0432.CCR-08-0869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-08-0869</ArticleId><ArticleId IdType="pubmed">18974389</ArticleId></ArticleIdList></Reference><Reference><Citation>Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., Kurdistani S.K. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435:1262&#x2013;1266. doi: 10.1038/nature03672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03672</ArticleId><ArticleId IdType="pubmed">15988529</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsheikh S.E., Green A.R., Rakha E.A., Powe D.G., Ahmed R.A., Collins H.M., Soria D., Garibaldi J.M., Paish C.E., Ammar A.A., et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 2009;69:3802&#x2013;3809. doi: 10.1158/0008-5472.CAN-08-3907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-3907</ArticleId><ArticleId IdType="pubmed">19366799</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuyakorn A., Paulus R., Farrell J., Dawson N.A., Tze S., Cheung-Lau G., Hines O.J., Reber H., Seligson D.B., Horvath S., et al. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: Results from RTOG 9704. J. Clin. Oncol. 2010;28:1358&#x2013;1365. doi: 10.1200/JCO.2009.24.5639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2009.24.5639</ArticleId><ArticleId IdType="pmc">PMC2834495</ArticleId><ArticleId IdType="pubmed">20142597</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.S., Jin M.Y., Kim Y.J., Yook J.H., Kim B.S., Jang S.J. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann. Surg. Oncol. 2008;15:1968&#x2013;1976. doi: 10.1245/s10434-008-9927-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-008-9927-9</ArticleId><ArticleId IdType="pubmed">18470569</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.C., Oxnard G.R., Klein E.A., Swanton C., Seiden M.V., Liu M.C., Oxnard G.R., Klein E.A., Smith D., Richards D., et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 2020;31:745&#x2013;759. doi: 10.1016/j.annonc.2020.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.02.011</ArticleId><ArticleId IdType="pmc">PMC8274402</ArticleId><ArticleId IdType="pubmed">33506766</ArticleId></ArticleIdList></Reference><Reference><Citation>Galleri.  [(accessed on 5 May 2024)].  Available online:  https://www.galleri.com/</Citation></Reference><Reference><Citation>Yi J.M., Guzzetta A.A., Bailey V.J., Downing S.R., Van Neste L., Chiappinelli K.B., Keeley B.P., Stark A., Herrera A., Wolfgang C., et al. Novel methylation biomarker panel for the early detection of pancreatic cancer. Clin. Cancer Res. 2013;19:6544&#x2013;6555. doi: 10.1158/1078-0432.CCR-12-3224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-3224</ArticleId><ArticleId IdType="pmc">PMC4310572</ArticleId><ArticleId IdType="pubmed">24088737</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Zhao H., Wang R., Chen Y., Ouyang X., Li W., Sun Y., Peng A. Cancer epigenetics: From laboratory studies and clinical trials to precision medicine. Cell Death Discov. 2024;10:28. doi: 10.1038/s41420-024-01803-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-024-01803-z</ArticleId><ArticleId IdType="pmc">PMC10789753</ArticleId><ArticleId IdType="pubmed">38225241</ArticleId></ArticleIdList></Reference><Reference><Citation>Feehley T., O&#x2019;Donnell C.W., Mendlein J., Karande M., McCauley T. Drugging the epigenome in the age of precision medicine. Clin Epigenetics. 2023;15:6. doi: 10.1186/s13148-022-01419-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01419-z</ArticleId><ArticleId IdType="pmc">PMC9832256</ArticleId><ArticleId IdType="pubmed">36631803</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorstova T., Foulkes W.D., Witcher M. Achieving clinical success with BET inhibitors as anti-cancer agents. Br. J. Cancer. 2021;124:1478&#x2013;1490. doi: 10.1038/s41416-021-01321-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-021-01321-0</ArticleId><ArticleId IdType="pmc">PMC8076232</ArticleId><ArticleId IdType="pubmed">33723398</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston A.D., Ross J.P., Ma C., Fung K.Y.C., Locke W.J. Epigenetic liquid biopsies for minimal residual disease, what&#x2019;s around the corner? Front. Oncol. 2023;13:1103797. doi: 10.3389/fonc.2023.1103797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2023.1103797</ArticleId><ArticleId IdType="pmc">PMC10110851</ArticleId><ArticleId IdType="pubmed">37081990</ArticleId></ArticleIdList></Reference><Reference><Citation>Symonds E.L., Pedersen S.K., Murray D., Byrne S.E., Roy A., Karapetis C., Hollington P., Rabbitt P., Jones F.S., LaPointe L., et al. Circulating epigenetic biomarkers for detection of recurrent colorectal cancer. Cancer. 2020;126:1460&#x2013;1469. doi: 10.1002/cncr.32695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.32695</ArticleId><ArticleId IdType="pmc">PMC7155014</ArticleId><ArticleId IdType="pubmed">31909823</ArticleId></ArticleIdList></Reference><Reference><Citation>Symonds E.L., Pedersen S.K., Yeo B., Al Naji H., Byrne S.E., Roy A., Young G.P. Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1. Mol. Oncol. 2022;16:2031&#x2013;2041. doi: 10.1002/1878-0261.13178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1878-0261.13178</ArticleId><ArticleId IdType="pmc">PMC9120880</ArticleId><ArticleId IdType="pubmed">35000264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierconti F., Martini M., Fiorentino V., Cenci T., Racioppi M., Foschi N., Di Gianfrancesco L., Sacco E., Rossi E., Larocca L.M., et al. Upper urothelial tract high-grade carcinoma: Comparison of urine cytology and DNA methylation analysis in urinary samples. Hum. Pathol. 2021;118:42&#x2013;48. doi: 10.1016/j.humpath.2021.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2021.09.007</ArticleId><ArticleId IdType="pubmed">34582934</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino V., Pizzimenti C., Franchina M., Rossi E.D., Tralongo P., Carlino A., Larocca L.M., Martini M., Fadda G., Pierconti F. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples. Int. J. Mol. Sci. 2023;24:12489. doi: 10.3390/ijms241512489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241512489</ArticleId><ArticleId IdType="pmc">PMC10420163</ArticleId><ArticleId IdType="pubmed">37569864</ArticleId></ArticleIdList></Reference><Reference><Citation>Frattini M., Gallino G., Signoroni S., Balestra D., Battaglia L., Sozzi G., Leo E., Pilotti S., Pierotti M.A. Quantitative analysis of plasma DNA in colorectal cancer patients: A novel prognostic tool. Ann. N. Y. Acad. Sci. 2006;1075:185&#x2013;190. doi: 10.1196/annals.1368.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1368.025</ArticleId><ArticleId IdType="pubmed">17108210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sozzi G., Conte D., Mariani L., Vullo S.L., Roz L., Lombardo C., Pierotti M.A., Tavecchio L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 2001;61:4675&#x2013;4678.</Citation><ArticleIdList><ArticleId IdType="pubmed">11406535</ArticleId></ArticleIdList></Reference><Reference><Citation>Volik S., Alcaide M., Morin R.D., Collins C. Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies. Mol. Cancer Res. 2016;14:898&#x2013;908. doi: 10.1158/1541-7786.MCR-16-0044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-16-0044</ArticleId><ArticleId IdType="pubmed">27422709</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedvilait&#x117; V., Schveigert D., Cic&#x117;nas S. Cell-free DNA in non-small cell lung cancer. Acta Medica Litu. 2017;24:138&#x2013;144. doi: 10.6001/actamedica.v24i2.3495.</Citation><ArticleIdList><ArticleId IdType="doi">10.6001/actamedica.v24i2.3495</ArticleId><ArticleId IdType="pmc">PMC5566953</ArticleId><ArticleId IdType="pubmed">28845132</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito A., Criscitiello C., Trapani D., Curigliano G. The Emerging Role of &#x201c;Liquid Biopsies,&#x201d; Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations. Curr. Oncol. Rep. 2017;19:1. doi: 10.1007/s11912-017-0564-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11912-017-0564-y</ArticleId><ArticleId IdType="pubmed">28110461</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona N., Gimeno-Valiente F., Gambardella V., Zu&#xf1;iga S., Rentero-Garrido P., Huerta M., Rosell&#xf3; S., Martinez-Ciarpaglini C., Carbonell-Asins J.A., Carrasco F., et al. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer. Ann. Oncol. 2019;30:1804&#x2013;1812. doi: 10.1093/annonc/mdz390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdz390</ArticleId><ArticleId IdType="pubmed">31562764</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie J., Wang Y., Tomasetti C., Li L., Springer S., Kinde I., Silliman N., Tacey M., Wong H.L., Christie M., et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci. Transl. Med. 2016;8:346ra92. doi: 10.1126/scitranslmed.aaf6219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6219</ArticleId><ArticleId IdType="pmc">PMC5346159</ArticleId><ArticleId IdType="pubmed">27384348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri A.A., Chabon J.J., Lovejoy A.F., Newman A.M., Stehr H., Azad T.D., Khodadoust M.S., Esfahani M.S., Liu C.L., Zhou L., et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. Cancer Discov. 2017;7:1394&#x2013;1403. doi: 10.1158/2159-8290.CD-17-0716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-17-0716</ArticleId><ArticleId IdType="pmc">PMC5895851</ArticleId><ArticleId IdType="pubmed">28899864</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao W., Mei C., Nan X., Hui L. Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study. Gene. 2016;590:142&#x2013;148. doi: 10.1016/j.gene.2016.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.06.033</ArticleId><ArticleId IdType="pubmed">27317895</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietsch E.E., Graham G.T., McCutcheon J.N., Javaid A., Giaccone G., Marshall J.L., Wellstein A. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Cancer Genet. 2017;218&#x2013;219:39&#x2013;50. doi: 10.1016/j.cancergen.2017.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cancergen.2017.08.006</ArticleId><ArticleId IdType="pmc">PMC5726797</ArticleId><ArticleId IdType="pubmed">29153095</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl F., Schmidt K., Choti M.A., Romans K., Goodman S., Li M., Thornton K., Agrawal N., Sokoll L., Szabo S.A., et al. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 2008;14:985&#x2013;990. doi: 10.1038/nm.1789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1789</ArticleId><ArticleId IdType="pmc">PMC2820391</ArticleId><ArticleId IdType="pubmed">18670422</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronkhorst A.J., Ungerer V., Oberhofer A., Holdenrieder S. The rising tide of cell-free DNA profiling: From snapshot to temporal genome analysis. J. Lab. Med. 2022;46:207&#x2013;224. doi: 10.1515/labmed-2022-0030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/labmed-2022-0030</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecular In Vitro Diagnostic Examinations&#x2014;Specifications for Pre-Examination Processes for Venous Whole Blood&#x2014;Part 3: Isolated Circulating Cell Free DNA from Plasma. ISO; Geneva, Switzerland: 2019.</Citation></Reference><Reference><Citation>Febbo P.G., Allo M., Alme E.B., Carter G.C., Dumanois R., Essig A., Kiernan E., Kubler C.B., Martin N., Popescu M.C., et al. Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care. JCO Precis. Oncol. 2024;8:00382. doi: 10.1200/PO.23.00382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/PO.23.00382</ArticleId><ArticleId IdType="pmc">PMC10803048</ArticleId><ArticleId IdType="pubmed">38166232</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagery M., Khorshidi H.A., Wong S.Q., Vu M., IJzerman M. Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review. Pharmacoeconomics. 2023;41:1229&#x2013;1248. doi: 10.1007/s40273-023-01292-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-023-01292-5</ArticleId><ArticleId IdType="pmc">PMC10492680</ArticleId><ArticleId IdType="pubmed">37351802</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz Z., Wagner S., Agyekum A., Pumpalova Y.S., Prest M., Lim F., Rustgi S., Kastrinos F., Grady W.M., Hur C. Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened. JAMA Netw. Open. 2023;6:e2343392. doi: 10.1001/jamanetworkopen.2023.43392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.43392</ArticleId><ArticleId IdType="pmc">PMC10654798</ArticleId><ArticleId IdType="pubmed">37971743</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafazzoli A., Ramsey S.D., Shaul A., Chavan A., Ye W., Kansal A.R., Ofman J., Fendrick A.M. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA. Pharmacoeconomics. 2022;40:1107&#x2013;1117. doi: 10.1007/s40273-022-01181-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-022-01181-3</ArticleId><ArticleId IdType="pmc">PMC9550746</ArticleId><ArticleId IdType="pubmed">36038710</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Global Cancer Burden Growing, Amidst Mounting Need for Services.  [(accessed on 4 April 2024)];2024  Available online:  https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11115397</ArticleId><ArticleId IdType="pubmed">38438207</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . WHO Global Survey on the Inclusion of Cancer Care in Health-Benefit Packages 2020&#x2013;2021. WHO; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>American Cancer Society . Global Cancer Facts &amp; Figures. 5th ed. American Cancer Society; Atlanta, GA, USA: 2024.</Citation></Reference><Reference><Citation>Wang Z., He Z., Shah M., Zhang T., Fan D., Zhang W. Network-based multi-task learning models for biomarker selection and cancer outcome prediction. Bioinformatics. 2020;36:1814&#x2013;1822. doi: 10.1093/bioinformatics/btz809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz809</ArticleId><ArticleId IdType="pubmed">31688914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Yang L., Goodison S., Sun Y. Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data. Bioinformatics. 2019;36:1476&#x2013;1483. doi: 10.1093/bioinformatics/btz769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz769</ArticleId><ArticleId IdType="pmc">PMC8215925</ArticleId><ArticleId IdType="pubmed">31603461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini S.R., Diaz-Uriarte R., Markowetz F., Beerenwinkel N. Estimating the predictability of cancer evolution. Bioinformatics. 2019;35:i389&#x2013;i397. doi: 10.1093/bioinformatics/btz332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz332</ArticleId><ArticleId IdType="pmc">PMC6612861</ArticleId><ArticleId IdType="pubmed">31510665</ArticleId></ArticleIdList></Reference><Reference><Citation>Eledkawy A., Hamza T., El-Metwally S. Precision cancer classification using liquid biopsy and advanced machine learning techniques. Sci. Rep. 2024;14:5841. doi: 10.1038/s41598-024-56419-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-56419-1</ArticleId><ArticleId IdType="pmc">PMC10925597</ArticleId><ArticleId IdType="pubmed">38462648</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Zhang J., Fu Q., Taly V., Tan F. Integrative analysis of multi-omics data for liquid biopsy. Br. J. Cancer. 2023;128:505&#x2013;518. doi: 10.1038/s41416-022-02048-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-022-02048-2</ArticleId><ArticleId IdType="pmc">PMC9938261</ArticleId><ArticleId IdType="pubmed">36357703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.D., Li L., Wang Y., Thoburn C., Afsari B., Danilova L., Douville C., Javed A.A., Wong F., Mattox A., et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359:926&#x2013;930. doi: 10.1126/science.aar3247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar3247</ArticleId><ArticleId IdType="pmc">PMC6080308</ArticleId><ArticleId IdType="pubmed">29348365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38972997</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>MicroRNAs and the Mediterranean diet: a nutri-omics perspective for lung cancer.</ArticleTitle><Pagination><StartPage>632</StartPage><MedlinePgn>632</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">632</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-024-05454-7</ELocationID><Abstract><AbstractText>Lung cancer is the deadliest cancer type worldwide with&#x2009;~&#x2009;1.8 million deaths per-year. Smoking accounts for&#x2009;~&#x2009;85% of all cases, with a described joint effect with unhealthy diet in lung cancer risk increase. Public health policies to prevent carcinogens exposure, promote smoking cessation and advocacy for healthy nutrition, are therefore highly recommended. Here we have examined the benefits of the Mediterranean Diet (MedDiet) in protecting against some non-communicable diseases including lung cancer, highlighting the epidemiological and biomolecular aspects of MedDiet anti-inflammatory effect and its interaction with smoking habits closely linked to risk of lung cancer. Considering the high incidence and mortality rates of lung cancer, we discussed also about the global impact that a Planeterranean extension of the benefits of MedDiet could have on controlling lung cancer risk. We also debated the impact of personalized nutrition on lung cancer prevention, considering individual heterogeneity in response to diet plans as well as recent advancements on nutri-omics in lung cancer research, with a specific focus on the role of microRNAs (miRNAs) as a promising nutritional molecular hub for lung cancer prevention. We strongly believe that a deep understanding of the molecular link between food components and genetic/epigenetics factors can expand effective intervention strategies.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cuttano</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini Snc, 71013, San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzarelli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini Snc, 71013, San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afanga</LastName><ForeName>Kuku Miriam</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini Snc, 71013, San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bianchi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7412-8638</Identifier><AffiliationInfo><Affiliation>Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini Snc, 71013, San Giovanni Rotondo, Italy. f.bianchi@operapadrepio.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dama</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini Snc, 71013, San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IG-22827</GrantID><Agency>Fondazione AIRC per la ricerca sul cancro ETS</Agency><Country/></Grant><Grant><GrantID>RF-2021-12372433</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038441" MajorTopicYN="Y">Diet, Mediterranean</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054647" MajorTopicYN="N">Nutrigenomics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung cancer</Keyword><Keyword MajorTopicYN="N">Mediterranean diet</Keyword><Keyword MajorTopicYN="N">Nutri-omics</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList><CoiStatement>The study funders had no role in the design of the study, the collection, analysis, and interpretation of the data, the writing of the manuscript, and the decision to submit the manuscript for publication. All the authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>7</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38972997</ArticleId><ArticleId IdType="pmc">PMC11227714</ArticleId><ArticleId IdType="doi">10.1186/s12967-024-05454-7</ArticleId><ArticleId IdType="pii">10.1186/s12967-024-05454-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71:209&#x2013;249. doi: 10.3322/caac.21660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA A Cancer J Clin. 2021;71:7&#x2013;33. doi: 10.3322/caac.21654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21654</ArticleId><ArticleId IdType="pubmed">33433946</ArticleId></ArticleIdList></Reference><Reference><Citation>The National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395&#x2013;409. doi: 10.1056/NEJMoa1102873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1102873</ArticleId><ArticleId IdType="pmc">PMC4356534</ArticleId><ArticleId IdType="pubmed">21714641</ArticleId></ArticleIdList></Reference><Reference><Citation>De Koning HJ, Van Der Aalst CM, De Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503&#x2013;513. doi: 10.1056/NEJMoa1911793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1911793</ArticleId><ArticleId IdType="pubmed">31995683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dama E, Colangelo T, Fina E, Cremonesi M, Kallikourdis M, Veronesi G, et al. Biomarkers and lung cancer early detection: state of the art. Cancers (Basel) 2021;13:3919. doi: 10.3390/cancers13153919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13153919</ArticleId><ArticleId IdType="pmc">PMC8345487</ArticleId><ArticleId IdType="pubmed">34359818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;z J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, et al. European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015;39:S1&#x2013;10. doi: 10.1016/j.canep.2015.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canep.2015.05.009</ArticleId><ArticleId IdType="pubmed">26164654</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe9;ber A, Morgan E, Vignat J, Laversanne M, Pizzato M, Rumgay H, et al. Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040. BMJ Open. 2023;13:e065303. doi: 10.1136/bmjopen-2022-065303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065303</ArticleId><ArticleId IdType="pmc">PMC10174019</ArticleId><ArticleId IdType="pubmed">37164477</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer. Chest. 2013;143:e1S&#x2013;e29S. doi: 10.1378/chest.12-2345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-2345</ArticleId><ArticleId IdType="pmc">PMC4694610</ArticleId><ArticleId IdType="pubmed">23649439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge AM, Bassett JK, Shivappa N, H&#xe9;bert JR, English DR, Giles GG, et al. Dietary inflammatory index, Mediterranean diet score, and lung cancer: a prospective study. Cancer Causes Control. 2016;27:907&#x2013;917. doi: 10.1007/s10552-016-0770-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-016-0770-1</ArticleId><ArticleId IdType="pmc">PMC5550291</ArticleId><ArticleId IdType="pubmed">27294725</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisonneuve P, Shivappa N, H&#xe9;bert JR, Bellomi M, Rampinelli C, Bertolotti R, et al. Dietary inflammatory index and risk of lung cancer and other respiratory conditions among heavy smokers in the COSMOS screening study. Eur J Nutr. 2016;55:1069&#x2013;1079. doi: 10.1007/s00394-015-0920-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-015-0920-3</ArticleId><ArticleId IdType="pmc">PMC4846387</ArticleId><ArticleId IdType="pubmed">25953452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnagnarella P, Maisonneuve P, Bellomi M, Rampinelli C, Bertolotti R, Spaggiari L, et al. Red meat, Mediterranean diet and lung cancer risk among heavy smokers in the COSMOS screening study. Ann Oncol. 2013;24:2606&#x2013;2611. doi: 10.1093/annonc/mdt302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdt302</ArticleId><ArticleId IdType="pubmed">23956193</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardavila-Belio MI, De La OV, Hershey MS, Barber&#xed;a-Latasa M, Toledo E, Martin-Moreno JM, et al. Joint association of the Mediterranean diet and smoking with all-cause mortality in the Seguimiento Universidad de Navarra (SUN) cohort. Nutrition. 2022;103&#x2013;104:111761. doi: 10.1016/j.nut.2022.111761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2022.111761</ArticleId><ArticleId IdType="pubmed">35843044</ArticleId></ArticleIdList></Reference><Reference><Citation>Du H, Cao T, Lu X, Zhang T, Luo B, Li Z. Mediterranean diet patterns in relation to lung cancer risk: a meta-analysis. Front Nutr. 2022;9:844382. doi: 10.3389/fnut.2022.844382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.844382</ArticleId><ArticleId IdType="pmc">PMC9039180</ArticleId><ArticleId IdType="pubmed">35495942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Kase B, Zheng J, Steck SE. Dietary patterns and risk of lung cancer: a systematic review and meta-analyses of observational studies. Curr Nutr Rep. 2023;12:338&#x2013;357. doi: 10.1007/s13668-023-00469-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-023-00469-w</ArticleId><ArticleId IdType="pubmed">37097371</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro HM, Yu D, Zheng W, Blot WJ, Cai Q, Shrubsole MJ. Diet quality and lung cancer incidence in a low-income population in the United States. Br J Cancer. 2023;129:626&#x2013;635. doi: 10.1038/s41416-023-02342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-023-02342-7</ArticleId><ArticleId IdType="pmc">PMC10421925</ArticleId><ArticleId IdType="pubmed">37400676</ArticleId></ArticleIdList></Reference><Reference><Citation>Menotti A, Kromhout D, Blackburn H, Fidanza F, Buzina R, Nissinen A. Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur J Epidemiol. 1999;15:507&#x2013;515. doi: 10.1023/A:1007529206050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1007529206050</ArticleId><ArticleId IdType="pubmed">10485342</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett W, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995;61:1402S&#x2013;1406S. doi: 10.1093/ajcn/61.6.1402S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/61.6.1402S</ArticleId><ArticleId IdType="pubmed">7754995</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean diet; a literature review. Nutrients. 2015;7:9139&#x2013;9153. doi: 10.3390/nu7115459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7115459</ArticleId><ArticleId IdType="pmc">PMC4663587</ArticleId><ArticleId IdType="pubmed">26556369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastorini C-M, Critselis E, Zota D, Coritsidis AL, Nagarajan MK, Papadimitriou E, et al. National Dietary Guidelines of Greece for children and adolescents: a tool for promoting healthy eating habits. Public Health Nutr. 2019;22:2688&#x2013;2699. doi: 10.1017/S1368980019001034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980019001034</ArticleId><ArticleId IdType="pmc">PMC10260517</ArticleId><ArticleId IdType="pubmed">31111809</ArticleId></ArticleIdList></Reference><Reference><Citation>Donini LM, Berry EM, Pinto A, Giusti AM, Muzzioli L, Lenzi A, et al. The Sapienza count-down for a healthy and sustainable diet. Ann Ig. 2023;35:359&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">36896954</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014;17:2769&#x2013;2782. doi: 10.1017/S1368980013003169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980013003169</ArticleId><ArticleId IdType="pmc">PMC10282340</ArticleId><ArticleId IdType="pubmed">24476641</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthy diet. Available at https://www.who.int/news-room/fact-sheets/detail/healthy-diet (accessed on Jun 2023).</Citation></Reference><Reference><Citation>L&#x103;c&#x103;tu&#x219;u C-M, Grigorescu E-D, Floria M, Onofriescu A, Mihai B-M. The Mediterranean diet: from an environment-driven food culture to an emerging medical prescription. IJERPH. 2019;16:942. doi: 10.3390/ijerph16060942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16060942</ArticleId><ArticleId IdType="pmc">PMC6466433</ArticleId><ArticleId IdType="pubmed">30875998</ArticleId></ArticleIdList></Reference><Reference><Citation>Dernini S, Berry E, Serra-Majem L, La Vecchia C, Capone R, Medina F, et al. Med Diet 4.0: the Mediterranean diet with four sustainable benefits. Public Health Nutr. 2017;20:1322&#x2013;1330. doi: 10.1017/S1368980016003177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980016003177</ArticleId><ArticleId IdType="pmc">PMC10261651</ArticleId><ArticleId IdType="pubmed">28003037</ArticleId></ArticleIdList></Reference><Reference><Citation>Dernini S. The erosion and the renaissance of the Mediterranean diet: a sustainable cultural resource. Quaderns de la Mediterr&#xe0;nia. 2011;16:75&#x2013;82.</Citation></Reference><Reference><Citation>Georgousopoulou EN, George ES, Mellor DD, Panagiotakos DB. Mediterranean lifestyle: Linking social life and behaviors, residential environment, and cardiovascular disease prevention. The Mediterranean Diet [Internet]. Elsevier; 2020 [cited 2024 May 2]. p. 67&#x2013;71. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128186497000060.</Citation></Reference><Reference><Citation>UNESCO. Representative list of the intangible cultural heritage of humanity. Paris. (2010). Available at https://ich.unesco.org/doc/src/17331-EN.pdf (Accessed May 2023).</Citation></Reference><Reference><Citation>Vetrani C, Piscitelli P, Muscogiuri G, Barrea L, Laudisio D, Graziadio C, et al. &#x201c;Planeterranea&#x201d;: an attempt to broaden the beneficial effects of the Mediterranean diet worldwide. Front Nutr. 2022;9:973757. doi: 10.3389/fnut.2022.973757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.973757</ArticleId><ArticleId IdType="pmc">PMC9480100</ArticleId><ArticleId IdType="pubmed">36118764</ArticleId></ArticleIdList></Reference><Reference><Citation>Scannell N, Villani A, Mantzioris E, Swanepoel L. Understanding the self-perceived barriers and enablers toward adopting a Mediterranean diet in Australia: an application of the theory of planned behaviour framework. IJERPH. 2020;17:9321. doi: 10.3390/ijerph17249321.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249321</ArticleId><ArticleId IdType="pmc">PMC7764290</ArticleId><ArticleId IdType="pubmed">33322111</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore SE, McEvoy CT, Prior L, Lawton J, Patterson CC, Kee F, et al. Barriers to adopting a Mediterranean diet in Northern European adults at high risk of developing cardiovascular disease. J Hum Nutr Diet. 2018;31:451&#x2013;462. doi: 10.1111/jhn.12523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhn.12523</ArticleId><ArticleId IdType="pubmed">29159932</ArticleId></ArticleIdList></Reference><Reference><Citation>Colao A, Vetrani C, Muscogiuri G, Barrea L, Tricopoulou A, Soldati L, et al. &#x201c;Planeterranean&#x201d; Diet: extending worldwide the health benefits of Mediterranean Diet based on nutritional properties of locally available foods. J Transl Med. 2022;20:232. doi: 10.1186/s12967-022-03433-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03433-4</ArticleId><ArticleId IdType="pmc">PMC9115921</ArticleId><ArticleId IdType="pubmed">35581590</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoun C, Papazian T, Helou K, El Osta N, Khabbaz LR. Comparison of five international indices of adherence to the Mediterranean diet among healthy adults: similarities and differences. Nutr Res Pract. 2019;13:333. doi: 10.4162/nrp.2019.13.4.333.</Citation><ArticleIdList><ArticleId IdType="doi">10.4162/nrp.2019.13.4.333</ArticleId><ArticleId IdType="pmc">PMC6669066</ArticleId><ArticleId IdType="pubmed">31388410</ArticleId></ArticleIdList></Reference><Reference><Citation>Pic&#xf3; C, Serra F, Rodr&#xed;guez AM, Keijer J, Palou A. Biomarkers of nutrition and health: new tools for new approaches. Nutrients. 2019;11:1092. doi: 10.3390/nu11051092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11051092</ArticleId><ArticleId IdType="pmc">PMC6567133</ArticleId><ArticleId IdType="pubmed">31100942</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobiecki JG, Imamura F, Davis CR, Sharp SJ, Koulman A, Hodgson JM, et al. A nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes: integrated analysis of data from the MedLey randomised controlled trial and the EPIC-InterAct case-cohort study. PLoS Med. 2023;20:e1004221. doi: 10.1371/journal.pmed.1004221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004221</ArticleId><ArticleId IdType="pmc">PMC10138823</ArticleId><ArticleId IdType="pubmed">37104291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennant M, Steur M, Moore C, Butterworth A, Johnson L. Comparative validity of vitamin C and carotenoids as indicators of fruit and vegetable intake: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr. 2015;114:1331&#x2013;1340. doi: 10.1017/S0007114515003165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114515003165</ArticleId><ArticleId IdType="pubmed">26349405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross AB, Bourgeois A, Macharia HN, Kochhar S, Jebb SA, Brownlee IA, et al. Plasma alkylresorcinols as a biomarker of whole-grain food consumption in a large population: results from the WHOLEheart Intervention Study. Am J Clin Nutr. 2012;95:204&#x2013;211. doi: 10.3945/ajcn.110.008508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.110.008508</ArticleId><ArticleId IdType="pmc">PMC3592483</ArticleId><ArticleId IdType="pubmed">22170369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Ross AB, Shea MK, Bruce SJ, Jacques PF, Saltzman E, et al. Plasma alkylresorcinols, biomarkers of whole-grain intake, are related to lower BMI in older adults. J Nutr. 2012;142:1859&#x2013;1864. doi: 10.3945/jn.112.163253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.112.163253</ArticleId><ArticleId IdType="pmc">PMC3442796</ArticleId><ArticleId IdType="pubmed">22955514</ArticleId></ArticleIdList></Reference><Reference><Citation>Estruch R, Ros E, Salas-Salvad&#xf3; J, Covas M-I, Corella D, Ar&#xf3;s F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34. doi: 10.1056/NEJMoa1800389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800389</ArticleId><ArticleId IdType="pubmed">29897866</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco GA, Interdonato L, Cordaro M, Cuzzocrea S, Di Paola R. Bioactive compounds of the Mediterranean diet as nutritional support to fight neurodegenerative disease. IJMS. 2023;24:7318. doi: 10.3390/ijms24087318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24087318</ArticleId><ArticleId IdType="pmc">PMC10139089</ArticleId><ArticleId IdType="pubmed">37108480</ArticleId></ArticleIdList></Reference><Reference><Citation>Morze J, Danielewicz A, Przyby&#x142;owicz K, Zeng H, Hoffmann G, Schwingshackl L. An updated systematic review and meta-analysis on adherence to Mediterranean diet and risk of cancer. Eur J Nutr. 2021;60:1561&#x2013;1586. doi: 10.1007/s00394-020-02346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-020-02346-6</ArticleId><ArticleId IdType="pmc">PMC7987633</ArticleId><ArticleId IdType="pubmed">32770356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JJ, Yu D, Xiang Y-B, Blot W, White E, Robien K, et al. Association of dietary fiber and yogurt consumption with lung cancer risk: a pooled analysis. JAMA Oncol. 2020;6:e194107. doi: 10.1001/jamaoncol.2019.4107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2019.4107</ArticleId><ArticleId IdType="pmc">PMC6813596</ArticleId><ArticleId IdType="pubmed">31647500</ArticleId></ArticleIdList></Reference><Reference><Citation>World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Available at dietandcancerreport.org (Accessed May 2023).</Citation></Reference><Reference><Citation>IARC, IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. A Review of Human Carcinogens: Arsenic, Metals Fibers and Dusts. 2012, Lyon, France: International Agency for Research on Cancer.</Citation></Reference><Reference><Citation>Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin a on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150&#x2013;1155. doi: 10.1056/NEJM199605023341802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199605023341802</ArticleId><ArticleId IdType="pubmed">8602180</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003;290:476&#x2013;485. doi: 10.1001/jama.290.4.476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.290.4.476</ArticleId><ArticleId IdType="pubmed">12876090</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue X-J, Gao Q, Qiao J-H, Zhang J, Xu C-P, Liu J. Red and processed meat consumption and the risk of lung cancer: a dose-response meta-analysis of 33 published studies. Int J Clin Exp Med. 2014;7:1542&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4100964</ArticleId><ArticleId IdType="pubmed">25035778</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, Wong MY, Vogtmann E, Tang RQ, Xie L, Yang YS, et al. Meat consumption and risk of lung cancer: evidence from observational studies. Ann Oncol. 2012;23:3163&#x2013;3170. doi: 10.1093/annonc/mds207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mds207</ArticleId><ArticleId IdType="pmc">PMC3501234</ArticleId><ArticleId IdType="pubmed">22855553</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwingshackl L, Morze J, Hoffmann G. Mediterranean diet and health status: active ingredients and pharmacological mechanisms. Br J Pharmacol. 2020;177:1241&#x2013;1257. doi: 10.1111/bph.14778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14778</ArticleId><ArticleId IdType="pmc">PMC7056467</ArticleId><ArticleId IdType="pubmed">31243760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng Y-L, et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. JNCI J Natl Cancer Inst. 2011;103:1112&#x2013;1122. doi: 10.1093/jnci/djr216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djr216</ArticleId><ArticleId IdType="pmc">PMC3139587</ArticleId><ArticleId IdType="pubmed">21685357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein1&#x2013;3. J Nutr. 2009;139:2365&#x2013;2372. doi: 10.3945/jn.109.114025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.109.114025</ArticleId><ArticleId IdType="pmc">PMC2777480</ArticleId><ArticleId IdType="pubmed">19864399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Peng L, Gu H, Tang Y, Xiao Y, He H, et al. Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study. Front Nutr. 2023;10:1142067. doi: 10.3389/fnut.2023.1142067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1142067</ArticleId><ArticleId IdType="pmc">PMC10225695</ArticleId><ArticleId IdType="pubmed">37255940</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S-Y, Boushey CJ, Shvetsov YB, Wirth MD, Shivappa N, H&#xe9;bert JR, et al. Diet quality and risk of lung cancer in the multiethnic cohort study. Nutrients. 2021;13:1614. doi: 10.3390/nu13051614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13051614</ArticleId><ArticleId IdType="pmc">PMC8151689</ArticleId><ArticleId IdType="pubmed">34065794</ArticleId></ArticleIdList></Reference><Reference><Citation>DeClercq V, Nearing JT, Sweeney E. Plant-based diets and cancer risk: what is the evidence? Curr Nutr Rep. 2022;11:354&#x2013;369. doi: 10.1007/s13668-022-00409-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-022-00409-0</ArticleId><ArticleId IdType="pubmed">35334103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte LA, Lee KA, Bj&#xf6;rk JR, Leeming ER, Campmans-Kuijpers MJE, de Haan JJ, et al. Association of a Mediterranean diet with outcomes for patients treated with immune checkpoint blockade for advanced melanoma. JAMA Oncol. 2023;9:705&#x2013;709. doi: 10.1001/jamaoncol.2022.7753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2022.7753</ArticleId><ArticleId IdType="pmc">PMC9936383</ArticleId><ArticleId IdType="pubmed">36795408</ArticleId></ArticleIdList></Reference><Reference><Citation>Reck M, Rodr&#xed;guez-Abreu D, Robinson AG, Hui R, Cs&#x151;szi T, F&#xfc;l&#xf6;p A, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375:1823&#x2013;1833. doi: 10.1056/NEJMoa1606774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1606774</ArticleId><ArticleId IdType="pubmed">27718847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi L, Rodr&#xed;guez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378:2078&#x2013;2092. doi: 10.1056/NEJMoa1801005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1801005</ArticleId><ArticleId IdType="pubmed">29658856</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingstone KM, Ramos-Lopez O, P&#xe9;russe L, Kato H, Ordovas JM, Mart&#xed;nez JA. Reprint of: precision nutrition: a review of current approaches and future endeavors. Trends Food Sci Technol. 2022;130:51&#x2013;62. doi: 10.1016/j.tifs.2022.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2022.10.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchelson KAJ, N&#xed; Chathail MB, Roche HM. Systems biology approaches to inform precision nutrition. Proc Nutr Soc. 2023;82:208&#x2013;218. doi: 10.1017/S0029665123002732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665123002732</ArticleId><ArticleId IdType="pubmed">37264892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Lopez O, Martinez JA, Milagro FI. Holistic integration of omics tools for precision nutrition in health and disease. Nutrients. 2022;14:4074. doi: 10.3390/nu14194074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14194074</ArticleId><ArticleId IdType="pmc">PMC9572439</ArticleId><ArticleId IdType="pubmed">36235725</ArticleId></ArticleIdList></Reference><Reference><Citation>Malcomson FC, Mathers JC. Translation of nutrigenomic research for personalised and precision nutrition for cancer prevention and for cancer survivors. Redox Biol. 2023;62:102710. doi: 10.1016/j.redox.2023.102710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2023.102710</ArticleId><ArticleId IdType="pmc">PMC10165138</ArticleId><ArticleId IdType="pubmed">37105011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannataro R, Fazio A, La Torre C, Caroleo MC, Cione E. Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation. Antioxidants. 2021;10:328. doi: 10.3390/antiox10020328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10020328</ArticleId><ArticleId IdType="pmc">PMC7926722</ArticleId><ArticleId IdType="pubmed">33672251</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata M, Marugame Y, Yamada S, Lin I, Yamashita S, Fujimura Y, et al. Circulating miRNA profiles in mice plasma following flavonoid intake. Mol Biol Rep. 2022;49:10399&#x2013;10407. doi: 10.1007/s11033-022-07918-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07918-9</ArticleId><ArticleId IdType="pubmed">36098884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AE, Piegholdt S, Ferraro M, Pallauf K, Rimbach G. Food derived microRNAs. Food Funct. 2015;6:714&#x2013;718. doi: 10.1039/C4FO01119H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4FO01119H</ArticleId><ArticleId IdType="pubmed">25644027</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, et al. Plant-derived exosomal MicroRNAs shape the gut microbiota. Cell Host Microbe. 2018;24:637&#x2013;652.e8. doi: 10.1016/j.chom.2018.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.10.001</ArticleId><ArticleId IdType="pmc">PMC6746408</ArticleId><ArticleId IdType="pubmed">30449315</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. Metazoan MicroRNAs. Cell. 2018;173:20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 MicroRNA family. Cell. 2005;120:635&#x2013;647. doi: 10.1016/j.cell.2005.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.01.014</ArticleId><ArticleId IdType="pubmed">15766527</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102:13944&#x2013;13949. doi: 10.1073/pnas.0506654102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506654102</ArticleId><ArticleId IdType="pmc">PMC1236577</ArticleId><ArticleId IdType="pubmed">16166262</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, He X, Lim LP, De Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130&#x2013;1134. doi: 10.1038/nature05939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05939</ArticleId><ArticleId IdType="pmc">PMC4590999</ArticleId><ArticleId IdType="pubmed">17554337</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839&#x2013;843. doi: 10.1038/nature03677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03677</ArticleId><ArticleId IdType="pubmed">15944709</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA. 2008;105:3903&#x2013;3908. doi: 10.1073/pnas.0712321105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712321105</ArticleId><ArticleId IdType="pmc">PMC2268826</ArticleId><ArticleId IdType="pubmed">18308936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kie&#x142;bowski K, Ptaszy&#x144;ski K, W&#xf3;jcik J, Wojty&#x15b; ME. The role of selected non-coding RNAs in the biology of non-small cell lung cancer. Adv Med Sci. 2023;68:121&#x2013;137. doi: 10.1016/j.advms.2023.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2023.02.004</ArticleId><ArticleId IdType="pubmed">36933328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y-H, Zhu Z-R, Tong D, Zhou R, Xiao K, Peng L. MicroRNAs and lung cancer: a review focused on targeted genes. Exploratory Res Hypothesis Med. 2021;000:1&#x2013;10. doi: 10.14218/ERHM.2020.00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/ERHM.2020.00058</ArticleId></ArticleIdList></Reference><Reference><Citation>Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007;26:731&#x2013;743. doi: 10.1016/j.molcel.2007.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.05.017</ArticleId><ArticleId IdType="pubmed">17540598</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 2009;7:1234&#x2013;1243. doi: 10.1158/1541-7786.MCR-08-0507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-08-0507</ArticleId><ArticleId IdType="pmc">PMC2741087</ArticleId><ArticleId IdType="pubmed">19671678</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp TV, Al-Attar A, Foxler DE, Ding L, De Vallim TQ, Zhang Y, et al. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development. Proc Natl Acad Sci USA. 2008;105:19932&#x2013;19937. doi: 10.1073/pnas.0805003105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0805003105</ArticleId><ArticleId IdType="pmc">PMC2604919</ArticleId><ArticleId IdType="pubmed">19060205</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Can Res. 2005;65:9628&#x2013;9632. doi: 10.1158/0008-5472.CAN-05-2352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-2352</ArticleId><ArticleId IdType="pubmed">16266980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T-C, Yu D, Lee Y-S, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40:43&#x2013;50. doi: 10.1038/ng.2007.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2007.30</ArticleId><ArticleId IdType="pmc">PMC2628762</ArticleId><ArticleId IdType="pubmed">18066065</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol. 2008;19:1053&#x2013;1059. doi: 10.1093/annonc/mdn006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdn006</ArticleId><ArticleId IdType="pubmed">18304967</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi MP, Mazzarelli F, et al. miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. J Hematol Oncol. 2022;15:178. doi: 10.1186/s13045-022-01394-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-022-01394-1</ArticleId><ArticleId IdType="pmc">PMC9805174</ArticleId><ArticleId IdType="pubmed">36587234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia&#x144;ska-Lasota E. Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. IJMS. 2021;22:8885. doi: 10.3390/ijms22168885.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168885</ArticleId><ArticleId IdType="pmc">PMC8396273</ArticleId><ArticleId IdType="pubmed">34445588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zyla J, Dziadziuszko R, Marczyk M, Sitkiewicz M, Szczepanowska M, Bottoni E, et al. miR-122 and miR-21 are stable components of miRNA signatures of early lung cancer after validation in three independent cohorts. J Mol Diagn. 2023;S1525157823002453.</Citation><ArticleIdList><ArticleId IdType="pubmed">37865291</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani F, Marzi MJ, Dezi F, Dama E, Carletti RM, Bonizzi G, et al. miR-test: a blood test for lung cancer early detection. JNCI J Natl Cancer Inst. 2015 doi: 10.1093/jnci/djv063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djv063</ArticleId><ArticleId IdType="pubmed">25794889</ArticleId></ArticleIdList></Reference><Reference><Citation>Seijo LM, Peled N, Ajona D, Boeri M, Field JK, Sozzi G, et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol. 2019;14:343&#x2013;357. doi: 10.1016/j.jtho.2018.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtho.2018.11.023</ArticleId><ArticleId IdType="pmc">PMC6494979</ArticleId><ArticleId IdType="pubmed">30529598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayraktar R, Van Roosbroeck K, Calin GA. Cell-to-cell communication: microRNAs as hormones. Mol Oncol. 2017;11:1673&#x2013;1686. doi: 10.1002/1878-0261.12144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1878-0261.12144</ArticleId><ArticleId IdType="pmc">PMC5709614</ArticleId><ArticleId IdType="pubmed">29024380</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Meiners S, Lukas C, Stathopoulos GT, Chen J. Role of exosomal microRNAs in lung cancer biology and clinical applications. Cell Prolif. 2020;53:e12828. doi: 10.1111/cpr.12828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12828</ArticleId><ArticleId IdType="pmc">PMC7309943</ArticleId><ArticleId IdType="pubmed">32391938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam TK, Shao S, Zhao Y, Marincola F, Pesatori A, Bertazzi PA, et al. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol Biomark Prev. 2012;21:2176&#x2013;2184. doi: 10.1158/1055-9965.EPI-12-0745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-12-0745</ArticleId><ArticleId IdType="pmc">PMC3538163</ArticleId><ArticleId IdType="pubmed">23035181</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Khan MA, Siddique HR. Apigenin, A plant flavone playing noble roles in cancer prevention via modulation of key cell signaling networks. Recent Pat Anticancer Drug Discov. 2019;14:298&#x2013;311. doi: 10.2174/1574892814666191026095728.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574892814666191026095728</ArticleId><ArticleId IdType="pubmed">31746310</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Gupta M, Sarwat M, Siddique HR. Apigenin in cancer prevention and therapy: a systematic review and meta-analysis of animal models. Crit Rev Oncol Hematol. 2022;176:103751. doi: 10.1016/j.critrevonc.2022.103751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2022.103751</ArticleId><ArticleId IdType="pubmed">35752426</ArticleId></ArticleIdList></Reference><Reference><Citation>Aida R, Hagiwara K, Okano K, Nakata K, Obata Y, Yamashita T, et al. miR-34a-5p might have an important role for inducing apoptosis by down-regulation of SNAI1 in apigenin-treated lung cancer cells. Mol Biol Rep. 2021;48:2291&#x2013;2297. doi: 10.1007/s11033-021-06255-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06255-7</ArticleId><ArticleId IdType="pmc">PMC8060201</ArticleId><ArticleId IdType="pubmed">33675467</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace E, Di Vincenzo S, Di Salvo E, Genovese S, Dino P, Sangiorgi C, et al. MiR-21 upregulation increases IL-8 expression and tumorigenesis program in airway epithelial cells exposed to cigarette smoke. J Cell Physiol. 2019;234:22183&#x2013;22194. doi: 10.1002/jcp.28786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28786</ArticleId><ArticleId IdType="pubmed">31054160</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsu Cincin Z, Unlu M, Kiran B, Sinem Bireller E, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cell Oncol (Dordr) 2015;38:195&#x2013;204. doi: 10.1007/s13402-015-0222-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13402-015-0222-z</ArticleId><ArticleId IdType="pubmed">25860498</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R, Sheng X, Xu X, Yu C, Lu H. Hesperidin induces apoptosis and G0/G1 arrest in human non-small cell lung cancer A549 cells. Int J Mol Med. 2018;41:464&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">29138795</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R, Xu G, Huang Y, Sheng X, Xu X, Lu H. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway. Life Sci. 2018;201:111&#x2013;120. doi: 10.1016/j.lfs.2018.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.03.046</ArticleId><ArticleId IdType="pubmed">29604270</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S, Dai L, Tan P, Liu W, Mu Y, Wang J, et al. Hesperidin administration suppresses the proliferation of lung cancer cells by promoting apoptosis via targeting the miR-132/ZEB2 signalling pathway. Int J Mol Med. 2020;46:2069&#x2013;2077. doi: 10.3892/ijmm.2020.4756.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4756</ArticleId><ArticleId IdType="pmc">PMC7595658</ArticleId><ArticleId IdType="pubmed">33125117</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoki H, Sato T, Endo S, Matsunaga T, Yamaguchi M, Yamazaki Y, et al. Quercetin decreases claudin-2 expression mediated by up-regulation of microRNA miR-16 in lung adenocarcinoma A549 cells. Nutrients. 2015;7:4578&#x2013;4592. doi: 10.3390/nu7064578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7064578</ArticleId><ArticleId IdType="pmc">PMC4488803</ArticleId><ArticleId IdType="pubmed">26061016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Chen Y, Lu H, Wang H, Feng H, Xu J, et al. Quercetin radiosensitizes non-small cell lung cancer cells through the regulation of miR-16-5p/WEE1 axis. IUBMB Life. 2020;72:1012&#x2013;1022. doi: 10.1002/iub.2242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2242</ArticleId><ArticleId IdType="pubmed">32027086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai R, Xu C, Lu L, Liu X, Ma Z. Quercetin inhibits proliferation of and induces apoptosis in non-small-cell lung carcinoma via the lncRNA SNHG7/miR-34a-5p pathway. Immunopharmacol Immunotoxicol. 2021;43:693&#x2013;703. doi: 10.1080/08923973.2021.1966032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08923973.2021.1966032</ArticleId><ArticleId IdType="pubmed">34448661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukprasansap M, Chanvorachote P. Evidence of potential plant-derived compounds with anticancer effects on lung cancer: clinical and molecular pharmacology approaches. Anticancer Res. 2022;42:4247&#x2013;4258. doi: 10.21873/anticanres.15924.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.15924</ArticleId><ArticleId IdType="pubmed">36039440</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S, Lee E-M, Cha HJ, Kim K, Yoon Y, Lee H, et al. Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol Cells. 2011;32:243&#x2013;249. doi: 10.1007/s10059-011-1037-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10059-011-1037-z</ArticleId><ArticleId IdType="pmc">PMC3887628</ArticleId><ArticleId IdType="pubmed">21887509</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z, Yang Q, Liu B, Wu J, Li Y, Yang C, et al. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol. Carcinogenesis. 2012;33:131&#x2013;139. doi: 10.1093/carcin/bgr226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgr226</ArticleId><ArticleId IdType="pubmed">22016468</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y-H, Chen H-A, Chen P-S, Cheng Y-J, Hsu W-H, Chang Y-W, et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene. 2013;32:431&#x2013;443. doi: 10.1038/onc.2012.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2012.74</ArticleId><ArticleId IdType="pubmed">22410781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong F, Zhang L, Zhao X, Zhao L, Wang P, Zhang R, et al. Resveratrol augments paclitaxel sensitivity by modulating miR-671-5p/STOML2/PINK1/Parkin-mediated autophagy signaling in A549 cell. J Biochem Mol Toxicol. 2024;38:e23557. doi: 10.1002/jbt.23557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.23557</ArticleId><ArticleId IdType="pubmed">37840424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Zou Y, Zhuang X, Chen S, Lin Y, Li W, et al. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3&#x3b2;/&#x3b2;-catenin signaling pathways. Acta Pharmacol Sin. 2017;38:241&#x2013;251. doi: 10.1038/aps.2016.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2016.122</ArticleId><ArticleId IdType="pmc">PMC5309754</ArticleId><ArticleId IdType="pubmed">27890917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Wang S, Chen Y, Li X, Jiang Y, Yang X, et al. miR-19 targeting of GSK3&#x3b2; mediates sulforaphane suppression of lung cancer stem cells. J Nutr Biochem. 2017;44:80&#x2013;91. doi: 10.1016/j.jnutbio.2017.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2017.02.020</ArticleId><ArticleId IdType="pubmed">28431267</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q-Q, Xie Y-K, Wu Y, Li L-L, Liu Y, Miao X-B, et al. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer. Oncotarget. 2017;8:12067&#x2013;12080. doi: 10.18632/oncotarget.14512.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14512</ArticleId><ArticleId IdType="pmc">PMC5355326</ArticleId><ArticleId IdType="pubmed">28076844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Cheng D, Yang J, Wu R, Li W, Kong A-N. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells. J Nutr Biochem. 2018;56:109&#x2013;115. doi: 10.1016/j.jnutbio.2018.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.01.015</ArticleId><ArticleId IdType="pmc">PMC8111486</ArticleId><ArticleId IdType="pubmed">29525530</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe1;valos A, Pinilla L, L&#xf3;pez De Las Hazas M-C, Pinto-Hern&#xe1;ndez P, Barb&#xe9; F, Iglesias-Guti&#xe9;rrez E, et al. Dietary microRNAs and cancer: a new therapeutic approach? Seminars Cancer Biol. 2021;73:19&#x2013;29. doi: 10.1016/j.semcancer.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2020.10.006</ArticleId><ArticleId IdType="pubmed">33086083</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pozo-Acebo L, L&#xf3;pez De Las Hazas M, Margoll&#xe9;s A, D&#xe1;valos A, Garc&#xed;a-Ruiz A. Eating microRNAs: pharmacological opportunities for cross-kingdom regulation and implications in host gene and gut microbiota modulation. Br J Pharmacol. 2021;178:2218&#x2013;2245. doi: 10.1111/bph.15421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15421</ArticleId><ArticleId IdType="pubmed">33644849</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalieri D, Rizzetto L, Tocci N, Rivero D, Asquini E, Si-Ammour A, et al. Plant microRNAs as novel immunomodulatory agents. Sci Rep. 2016;6:25761. doi: 10.1038/srep25761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25761</ArticleId><ArticleId IdType="pmc">PMC4863160</ArticleId><ArticleId IdType="pubmed">27167363</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha N, Mangukia N, Gadhavi H, Patel M, Bhavsar M, Rawal R, et al. Small RNA sequencing and identification of papaya (Carica papaya L.) miRNAs with potential cross-kingdom human gene targets. Mol Genet Genomics. 2022;297:981&#x2013;997. doi: 10.1007/s00438-022-01904-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-022-01904-3</ArticleId><ArticleId IdType="pmc">PMC9107959</ArticleId><ArticleId IdType="pubmed">35570207</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin AR, Fong MY, Somlo G, Wu J, Swiderski P, Wu X, et al. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res. 2016;26:217&#x2013;228. doi: 10.1038/cr.2016.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2016.13</ArticleId><ArticleId IdType="pmc">PMC4746606</ArticleId><ArticleId IdType="pubmed">26794868</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou D, He F, Ma L, Cao M, Zhou Z, Wei Z, et al. The potential atheroprotective role of plant MIR156a as a repressor of monocyte recruitment on inflamed human endothelial cells. J Nutr Biochem. 2018;57:197&#x2013;205. doi: 10.1016/j.jnutbio.2018.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.03.026</ArticleId><ArticleId IdType="pubmed">29751293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Wan H, Zhang X. miRNA in food simultaneously controls animal viral disease and human tumorigenesis. Mol Ther Nucleic Acids. 2021;23:995&#x2013;1006. doi: 10.1016/j.omtn.2021.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.01.011</ArticleId><ArticleId IdType="pmc">PMC7868940</ArticleId><ArticleId IdType="pubmed">33614246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan SY, Snow JW. Formidable challenges to the notion of biologically important roles for dietary small RNAs in ingesting mammals. Genes Nutr. 2017;12:13. doi: 10.1186/s12263-017-0561-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12263-017-0561-7</ArticleId><ArticleId IdType="pmc">PMC5753850</ArticleId><ArticleId IdType="pubmed">29308096</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusk RW. Diverse and widespread contamination evident in the unmapped depths of high throughput sequencing data. PLoS ONE. 2014;9:e110808. doi: 10.1371/journal.pone.0110808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110808</ArticleId><ArticleId IdType="pmc">PMC4213012</ArticleId><ArticleId IdType="pubmed">25354084</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F, Du J, Liang Z, Xu Z, Xu J, Zhao Y, et al. Large-scale analysis of small RNAs derived from traditional Chinese herbs in human tissues. Sci China Life Sci. 2019;62:321&#x2013;332. doi: 10.1007/s11427-018-9323-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-018-9323-5</ArticleId><ArticleId IdType="pubmed">30238279</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Sainz E, Lorente-Cebri&#xe1;n S, Aranaz P, Riezu-Boj JI, Mart&#xed;nez JA, Milagro FI. Potential mechanisms linking food-derived MicroRNAs, gut microbiota and intestinal barrier functions in the context of nutrition and human health. Front Nutr. 2021;8:586564. doi: 10.3389/fnut.2021.586564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.586564</ArticleId><ArticleId IdType="pmc">PMC7985180</ArticleId><ArticleId IdType="pubmed">33768107</ArticleId></ArticleIdList></Reference><Reference><Citation>Munir J, Lee M, Ryu S. Exosomes in food: health benefits and clinical relevance in diseases. Adv Nutr. 2020;11:687&#x2013;696. doi: 10.1093/advances/nmz123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz123</ArticleId><ArticleId IdType="pmc">PMC7231590</ArticleId><ArticleId IdType="pubmed">31796948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly NP, Han HS, Kim M, Park JH, Choi KY. Plant-derived nanovesicles: current understanding and applications for cancer therapy. Bioactive Mater. 2023;22:365&#x2013;383. doi: 10.1016/j.bioactmat.2022.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioactmat.2022.10.005</ArticleId><ArticleId IdType="pmc">PMC9588993</ArticleId><ArticleId IdType="pubmed">36311046</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanly C, Moubarak M, Fiume I, Turi&#xe1;k L, Pocsfalvi G. Membrane transporters in citrus clementina fruit juice-derived nanovesicles. IJMS. 2019;20:6205. doi: 10.3390/ijms20246205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246205</ArticleId><ArticleId IdType="pmc">PMC6941005</ArticleId><ArticleId IdType="pubmed">31835328</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Feng S, Wang X, Long K, Luo Y, Wang Y, et al. Identification of exosome-like nanoparticle-derived microRNAs from 11 edible fruits and vegetables. PeerJ. 2018;6:e5186. doi: 10.7717/peerj.5186.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.5186</ArticleId><ArticleId IdType="pmc">PMC6074755</ArticleId><ArticleId IdType="pubmed">30083436</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Y, Mu J, Hu X, Samykutty A, Zhuang X, Deng Z, et al. Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages. Oncotarget. 2016;7:25683&#x2013;25697. doi: 10.18632/oncotarget.8361.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8361</ArticleId><ArticleId IdType="pmc">PMC5041936</ArticleId><ArticleId IdType="pubmed">27028860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Liu B, Li X, An TT, Zhou Y, Li G, et al. Identification of anti-inflammatory vesicle-like nanoparticles in honey. J Extracellular Vesicles. 2021 doi: 10.1002/jev2.12069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12069</ArticleId><ArticleId IdType="pmc">PMC7879699</ArticleId><ArticleId IdType="pubmed">33613874</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L, Ma J, Yang Y, Liao T, Wang J, Chen L, et al. Cooked pork-derived exosome nanovesicles mediate metabolic disorder&#x2014;microRNA could be the culprit. J Nanobiotechnol. 2023;21:83. doi: 10.1186/s12951-023-01837-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-023-01837-y</ArticleId><ArticleId IdType="pmc">PMC9999493</ArticleId><ArticleId IdType="pubmed">36894941</ArticleId></ArticleIdList></Reference><Reference><Citation>Billatos E, Vick JL, Lenburg ME, Spira AE. The airway transcriptome as a biomarker for early lung cancer detection. Clin Cancer Res. 2018;24:2984&#x2013;2992. doi: 10.1158/1078-0432.CCR-16-3187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-16-3187</ArticleId><ArticleId IdType="pmc">PMC7397497</ArticleId><ArticleId IdType="pubmed">29463557</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Vaart H. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax. 2004;59:713&#x2013;721. doi: 10.1136/thx.2003.012468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2003.012468</ArticleId><ArticleId IdType="pmc">PMC1747102</ArticleId><ArticleId IdType="pubmed">15282395</ArticleId></ArticleIdList></Reference><Reference><Citation>Caliri AW, Tommasi S, Besaratinia A. Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res/Rev Mutat Res. 2021;787:108365. doi: 10.1016/j.mrrev.2021.108365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2021.108365</ArticleId><ArticleId IdType="pmc">PMC8287787</ArticleId><ArticleId IdType="pubmed">34083039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38596245</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Phytocompounds targeting epigenetic modulations: an assessment in cancer.</ArticleTitle><Pagination><StartPage>1273993</StartPage><MedlinePgn>1273993</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1273993</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2023.1273993</ELocationID><Abstract><AbstractText>For centuries, plants have been serving as sources of potential therapeutic agents. In recent years, there has been a growing interest in investigating the effects of plant-derived compounds on epigenetic processes, a novel and captivating Frontier in the field of epigenetics research. Epigenetic changes encompass modifications to DNA, histones, and microRNAs that can influence gene expression. Aberrant epigenetic changes can perturb key cellular processes, including cell cycle control, intercellular communication, DNA repair, inflammation, stress response, and apoptosis. Such disruptions can contribute to cancer development by altering the expression of genes involved in tumorigenesis. However, these modifications are reversible, offering a unique avenue for therapeutic intervention. Plant secondary compounds, including terpenes, phenolics, terpenoids, and sulfur-containing compounds are widely found in grains, vegetables, spices, fruits, and medicinal plants. Numerous plant-derived compounds have demonstrated the potential to target these abnormal epigenetic modifications, including apigenin (histone acetylation), berberine (DNA methylation), curcumin (histone acetylation and epi-miRs), genistein (histone acetylation and DNA methylation), lycopene (epi-miRs), quercetin (DNA methylation and epi-miRs), <i>etc.</i> This comprehensive review highlights these abnormal epigenetic alterations and discusses the promising efficacy of plant-derived compounds in mitigating these deleterious epigenetic signatures in human cancer. Furthermore, it addresses ongoing clinical investigations to evaluate the therapeutic potential of these phytocompounds in cancer treatment, along with their limitations and challenges.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Khan, Khan, Khan, Malik, Massey, Parveen, Mustafa, Shamsi and Husain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Khan</LastName><ForeName>Aqsa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Khan</LastName><ForeName>Asifa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mohammad Aasif</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, The University of Texas Health Science Centre at San Antonio, San Antonio, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Zoya</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massey</LastName><ForeName>Sheersh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parveen</LastName><ForeName>Rabea</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Saad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shamsi</LastName><ForeName>Anas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>Syed A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Faculty of Natural Sciences, Jamia Millia Islamia (A Central University), New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNMTs</Keyword><Keyword MajorTopicYN="N">HDACs</Keyword><Keyword MajorTopicYN="N">bioactive compounds</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">cancer epigenetics</Keyword><Keyword MajorTopicYN="N">cancer prevention</Keyword><Keyword MajorTopicYN="N">miRNAs</Keyword><Keyword MajorTopicYN="N">phytocompounds</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38596245</ArticleId><ArticleId IdType="pmc">PMC11002180</ArticleId><ArticleId IdType="doi">10.3389/fphar.2023.1273993</ArticleId><ArticleId IdType="pii">1273993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbas A., Hall J. A., Patterson W. L., Ho E., Hsu A., Al-Mulla F., et al. (2015). Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines. Biochem. Cell Biol. 94 (1), 71&#x2013;81. 10.1139/bcb-2015-0038</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2015-0038</ArticleId><ArticleId IdType="pubmed">26458818</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjakly M., Bosviel R., Rabiau N., Boiteux J. P., Bignon Y. J., Guy L., et al. (2011). DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 3, 795&#x2013;803. 10.2217/epi.11.103</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi.11.103</ArticleId><ArticleId IdType="pubmed">22126297</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal B. B., Shishodia S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397&#x2013;1421. 10.1016/j.bcp.2006.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2006.02.009</ArticleId><ArticleId IdType="pubmed">16563357</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal R., Jha M., Shrivastava A., Jha A. K. (2015). Natural compounds: role in reversal of epigenetic changes. Biochem. 80 (8), 972&#x2013;989. 10.1134/S0006297915080027</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297915080027</ArticleId><ArticleId IdType="pubmed">26547065</ArticleId></ArticleIdList></Reference><Reference><Citation>Altaf M. M., Ahmad Khan M. S., Ahmad I. (2018). &#x201c;Diversity of bioactive compounds and their therapeutic potential,&#x201d; in New look to phytomedicine: advancements in herbal products as novel drug leads (Elsevier; ), 15&#x2013;34.</Citation></Reference><Reference><Citation>Alumkal J. J., Slottke R., Schwartzman J., Cherala G., Munar M., Graff J. N., et al. (2015). A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest. New Drugs 33 (2), 480&#x2013;489. 10.1007/s10637-014-0189-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-014-0189-z</ArticleId><ArticleId IdType="pmc">PMC4390425</ArticleId><ArticleId IdType="pubmed">25431127</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M. C., Maso V., Torello C. O., Ferro K. P., Saad S. T. O. (2018). The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin. Epigenetics 10 (1), 139. 10.1186/s13148-018-0563-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-018-0563-3</ArticleId><ArticleId IdType="pmc">PMC6225654</ArticleId><ArticleId IdType="pubmed">30409182</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Yousef N., Shinwari Z., Al-Shahrani B., Al-Showimi M., Al-Moghrabi N. (2020). Curcumin induces Re-expression of BRCA1 and suppression of &#x3b3; synuclein by modulating DNA promoter methylation in breast cancer cell lines. Oncol. Rep. 43 (3), 827&#x2013;838. 10.3892/or.2020.7473</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2020.7473</ArticleId><ArticleId IdType="pmc">PMC7041105</ArticleId><ArticleId IdType="pubmed">32020216</ArticleId></ArticleIdList></Reference><Reference><Citation>Aqil F., Munagala R., Jeyabalan J., Vadhanam M. V. (2013). Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 28, 133&#x2013;141. 10.1016/j.canlet.2013.02.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2013.02.032</ArticleId><ArticleId IdType="pmc">PMC3815990</ArticleId><ArticleId IdType="pubmed">23435377</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasov A. G., Zotchev S. B., Dirsch V. M., Orhan I. E., Banach M., Rollinger J. M., et al. (2021). Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200&#x2013;216. 10.1038/s41573-020-00114-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-00114-z</ArticleId><ArticleId IdType="pmc">PMC7841765</ArticleId><ArticleId IdType="pubmed">33510482</ArticleId></ArticleIdList></Reference><Reference><Citation>Audia J. E., Campbell R. M. (2016). Histone modifications and cancer. Cold Spring Harb. Perspect. Biol. 8 (4), a019521. 10.1101/cshperspect.a019521</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a019521</ArticleId><ArticleId IdType="pmc">PMC4817802</ArticleId><ArticleId IdType="pubmed">27037415</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailon-Moscoso N., Cevallos-Solorzano G., Romero-Benavides J., Ramirez Orellana M. (2017). Natural compounds as modulators of cell cycle arrest: application for anticancer chemotherapies. Curr. Genomics 18, 106&#x2013;131. 10.2174/1389202917666160808125645</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389202917666160808125645</ArticleId><ArticleId IdType="pmc">PMC5345333</ArticleId><ArticleId IdType="pubmed">28367072</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S., Bueso-Ramos C., Aggarwal B. B. (2002). Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62 (17), 4945&#x2013;4954.</Citation><ArticleIdList><ArticleId IdType="pubmed">12208745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister A. J., Kouzarides T. (2011). Regulation of chromatin by histone modifications. Cell Res. 21, 381&#x2013;395. 10.1038/cr.2011.22</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.22</ArticleId><ArticleId IdType="pmc">PMC3193420</ArticleId><ArticleId IdType="pubmed">21321607</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister A. J., Schneider R., Kouzarides T. (2002). Histone methylation: dynamic or static? Cell 109 (7), 801&#x2013;806. 10.1016/s0092-8674(02)00798-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(02)00798-5</ArticleId><ArticleId IdType="pubmed">12110177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashir A. O., El-Mesery M. E., Anwer R., Eissa L. A. (2020). Thymoquinone potentiates MiR-16 and MiR-375 expressions in hepatocellular carcinoma. Life Sci., 254. 10.1016/j.lfs.2020.117794</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117794</ArticleId><ArticleId IdType="pubmed">32422307</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgart S. J., Haendler B. (2017). Exploiting epigenetic alterations in prostate cancer. Int. J. Mol. Sci. 18, 1017. 10.3390/ijms18051017</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18051017</ArticleId><ArticleId IdType="pmc">PMC5454930</ArticleId><ArticleId IdType="pubmed">28486411</ArticleId></ArticleIdList></Reference><Reference><Citation>Baylin S. B., Esteller M., Rountree M. R., Bachman K. E., Schuebel K., Herman J. G. (2001). Abberant patterns of DNA methylation, chromatin formation and gene expression in cancer. Human molecular genetics . Hum. Mol. Genet. 10, 687&#x2013;692. 10.1093/hmg/10.7.687</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.7.687</ArticleId><ArticleId IdType="pubmed">11257100</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger A., Venturelli S., Kallnischkies M., B&#xf6;cker A., Busch C., Weiland T., et al. (2013). Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. J. Nutr. Biochem. 24 (6), 977&#x2013;985. 10.1016/j.jnutbio.2012.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2012.07.001</ArticleId><ArticleId IdType="pubmed">23159065</ArticleId></ArticleIdList></Reference><Reference><Citation>Berson A., Nativio R., Berger S. L., Bonini N. M. (2018). Epigenetic regulation in neurodegenerative diseases. Trends Neurosci. 41, 587&#x2013;598. 10.1016/j.tins.2018.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.05.005</ArticleId><ArticleId IdType="pmc">PMC6174532</ArticleId><ArticleId IdType="pubmed">29885742</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestor T. H. (2000). The DNA methyltransferases of mammals. Hum. Mol. Genet. 9 (16), 2395&#x2013;2402. 10.1093/hmg/9.16.2395</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.16.2395</ArticleId><ArticleId IdType="pubmed">11005794</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16 (1), 6&#x2013;21. 10.1101/gad.947102</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.947102</ArticleId><ArticleId IdType="pubmed">11782440</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode A. M., Dong Z. (2015). Toxic phytochemicals and their potential risks for human cancer. Cancer Prev. Res. 1, 1&#x2013;8. 10.1158/1940-6207.CAPR-14-0160</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-14-0160</ArticleId><ArticleId IdType="pmc">PMC4289646</ArticleId><ArticleId IdType="pubmed">25348854</ArticleId></ArticleIdList></Reference><Reference><Citation>Bora-Tatar G., Dayanga&#xe7;-Erden D., Demir A. S., Dalkara S., Yelek&#xe7;i K., Erdem-Yurter H. (2009). Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: activity and docking studies. Bioorg. Med. Chem. 17 (14), 5219&#x2013;5228. 10.1016/j.bmc.2009.05.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2009.05.042</ArticleId><ArticleId IdType="pubmed">19520580</ArticleId></ArticleIdList></Reference><Reference><Citation>Botti-Millet J., Nascimbeni A. C., Dupont N., Morel E., Codogno P. (2016). Fine-tuning autophagy: from transcriptional to posttranslational regulation. Am. J. Physiol. Physiol. 311 (3), C351&#x2013;C362. 10.1152/ajpcell.00129.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00129.2016</ArticleId><ArticleId IdType="pubmed">27335173</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyanapalli S. S. S., Li W., Fuentes F., Guo Y., Ramirez C. N., Gonzalez X. P., et al. (2016). Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells. Pharmacol. Res. 114, 175&#x2013;184. 10.1016/j.phrs.2016.10.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2016.10.021</ArticleId><ArticleId IdType="pmc">PMC5396455</ArticleId><ArticleId IdType="pubmed">27818231</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H., Scott E., Kholghi A., Andreadi C., Rufini A., Karmokar A., et al. (2015). Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci. Transl. Med. 7 (298), 298ra117. 10.1126/scitranslmed.aaa7619</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa7619</ArticleId><ArticleId IdType="pmc">PMC4827609</ArticleId><ArticleId IdType="pubmed">26223300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J. H., Cheng C. W., Yang Y. C., Chen W. S., Hung W. Y., Chow J. M., et al. (2018). Downregulating CD26/DPPIV by apigenin modulates the interplay between akt and snail/slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses. J. Exp. Clin. Cancer Res. 37 (1), 199. 10.1186/s13046-018-0869-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-018-0869-1</ArticleId><ArticleId IdType="pmc">PMC6104010</ArticleId><ArticleId IdType="pubmed">30134935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B., Ghosh K., Kanade S. R. (2019). Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, P53, P21CIP1 in human breast cancer cell lines. BioFactors 45 (5), 818&#x2013;829. 10.1002/biof.1544</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1544</ArticleId><ArticleId IdType="pubmed">31317586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X. J., Wu M. Y., Li D. H., You J. (2016). Apigenin inhibits glioma cell growth through promoting MicroRNA-16 and suppression of BCL-2 and nuclear factor-&#x39a;B/MMP-9. Mol. Med. Rep. 14 (3), 2352&#x2013;2358. 10.3892/mmr.2016.5460</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.5460</ArticleId><ArticleId IdType="pubmed">27430517</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiyomaru T., Yamamura S., Fukuhara S., Hidaka H., Majid S., Saini S., et al. (2013). Genistein up-regulates tumor suppressor MicroRNA-574-3p in prostate cancer. PLoS One 8 (3), e58929. 10.1371/journal.pone.0058929</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058929</ArticleId><ArticleId IdType="pmc">PMC3595226</ArticleId><ArticleId IdType="pubmed">23554959</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B. Y., Kim B.-W. (2015). Withaferin-A inhibits colon cancer cell growth by blocking STAT3 transcriptional activity. J. Cancer Prev. 20 (3), 185&#x2013;192. 10.15430/JCP.2015.20.3.185</Citation><ArticleIdList><ArticleId IdType="doi">10.15430/JCP.2015.20.3.185</ArticleId><ArticleId IdType="pmc">PMC4597807</ArticleId><ArticleId IdType="pubmed">26473157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung F. F. L., Herceg Z. (2020). The promises and challenges of toxico-epigenomics: environmental chemicals and their impacts on the epigenome. Environ. Health Perspect. 128, 15001. 10.1289/EHP6104</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/EHP6104</ArticleId><ArticleId IdType="pmc">PMC7015548</ArticleId><ArticleId IdType="pubmed">31950866</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell J. A., Korytko P. J., Morrissey R. L., Booth T. D., Levine B. S. (2004). Resveratrol-associated renal toxicity. Toxicol. Sci. 82 (2), 614&#x2013;619. 10.1093/toxsci/kfh263</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfh263</ArticleId><ArticleId IdType="pubmed">15329443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai E., Yu X., Zhang Y., Meng F., Wang S., Liu X., et al. (2014). EpimiR: a database of curated mutual regulation between MiRNAs and epigenetic modifications. Database 2014, bau023. 10.1093/database/bau023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/bau023</ArticleId><ArticleId IdType="pmc">PMC4037167</ArticleId><ArticleId IdType="pubmed">24682734</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L., Chen L., Wang W., Lin P. (2020). Resveratrol inhibits ACHN cells via regulation of histone acetylation. Pharm. Biol. 58 (1), 231&#x2013;238. 10.1080/13880209.2020.1738503</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2020.1738503</ArticleId><ArticleId IdType="pmc">PMC7144206</ArticleId><ArticleId IdType="pubmed">32202448</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawood M., Ooko E., Efferth T. (2019). Collateral sensitivity of parthenolide via NF-&#x3ba;B and HIF-&#x3b1; inhibition and epigenetic changes in drug-resistant cancer cell lines. Front. Pharmacol. 10, 542. 10.3389/fphar.2019.00542</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00542</ArticleId><ArticleId IdType="pmc">PMC6536578</ArticleId><ArticleId IdType="pubmed">31164821</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehan P., Kustermans G., Guenin S., Horion J., Boniver J., Delvenne P. (2009). DNA methylation and cancer diagnosis: new methods and applications. Expert Rev. Mol. Diagnostics 9, 651&#x2013;657. 10.1586/erm.09.53</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erm.09.53</ArticleId><ArticleId IdType="pubmed">19817550</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittharot K., Dakeng S., Suebsakwong P., Suksamrarn A., Patmasiriwat P., Promkan M. (2019). Cucurbitacin B induces hypermethylation of oncogenes in breast cancer cells. Planta Med. 85 (5), 370&#x2013;378. 10.1055/a-0791-1591</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0791-1591</ArticleId><ArticleId IdType="pubmed">30463098</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan M. G., Selmin O. I., Doetschman T. C., Romagnolo D. F. (2019). Epigenetic activation of BRCA1 by genistein in vivo and triple negative breast cancer cells linked to antagonism toward aryl hydrocarbon receptor. Nutrients 11 (11), 2559. 10.3390/nu11112559</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112559</ArticleId><ArticleId IdType="pmc">PMC6893467</ArticleId><ArticleId IdType="pubmed">31652854</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou J., Wang Z., Ma L., Peng B., Mao K., Li C., et al. (2018). Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget 9 (28), 20089&#x2013;20102. 10.18632/oncotarget.24015</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24015</ArticleId><ArticleId IdType="pmc">PMC5929448</ArticleId><ArticleId IdType="pubmed">29732005</ArticleId></ArticleIdList></Reference><Reference><Citation>Druesne N., Pagniez A., Mayeur C., Thomas M., Cherbuy C., Du&#xe9;e P. H., et al. (2004). Diallyl disulfide (DADS) increases histone acetylation and P21waf1/cip1 expression in human colon tumor cell lines. Carcinogenesis 25, 1227&#x2013;1236. 10.1093/carcin/bgh123</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgh123</ArticleId><ArticleId IdType="pubmed">14976134</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Xu W., Kong D. (2019). Icariin inhibits cell proliferation, migration and invasion by down-regulation of MicroRNA-625-3p in thyroid cancer cells. Biomed. Pharmacother. 109, 2456&#x2013;2463. 10.1016/j.biopha.2018.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.04.012</ArticleId><ArticleId IdType="pubmed">30551506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M., Chen D., Yang C. S. (2007). Dietary polyphenols may affect DNA methylation. J. Nutr. 137 (1), 223S-228S&#x2013;228S. 10.1093/jn/137.1.223S</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/137.1.223S</ArticleId><ArticleId IdType="pubmed">17182830</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L. J., Ding Y. B., Wu L. X., Wen C. J., Qu Q., Zhang X., et al. (2014). The effects of lycopene on the methylation of the GSTP1 promoter and global methylation in prostatic cancer cell lines PC3 and LNCaP. Int. J. Endocrinol. 2014, 620165. 10.1155/2014/620165</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/620165</ArticleId><ArticleId IdType="pmc">PMC4217342</ArticleId><ArticleId IdType="pubmed">25389438</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto A., Sakanashi Y., Matsui H., Oyama T., Nishimura Y., Masuda T., et al. (2009). Cytometric analysis of cytotoxicity of polyphenols and related phenolics to rat thymocytes: potent cytotoxicity of resveratrol to normal cells. Basic Clin. Pharmacol. Toxicol. 104 (6), 455&#x2013;462. 10.1111/j.1742-7843.2009.00386.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-7843.2009.00386.x</ArticleId><ArticleId IdType="pubmed">19389048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallardo M., Kemmerling U., Aguayo F., Bleak T. C., Mu&#xf1;oz J. P., Calaf G. M. (2020). Curcumin rescues breast cells from epithelial-mesenchymal transition and invasion induced by anti-miR-34a. Int. J. Oncol. 56, 480&#x2013;493. 10.3892/ijo.2019.4939</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2019.4939</ArticleId><ArticleId IdType="pmc">PMC6959390</ArticleId><ArticleId IdType="pubmed">31894298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gama-Sosa M. A., Slagel V. A., Trewyn R. W., Oxenhandler R., Kuo K. C., Gehrke C. W., et al. (1983). The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11 (19), 6883&#x2013;6894. 10.1093/nar/11.19.6883</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/11.19.6883</ArticleId><ArticleId IdType="pmc">PMC326421</ArticleId><ArticleId IdType="pubmed">6314264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonelimali F. D., Lin J., Miao W., Xuan J., Charles F., Chen M., et al. (2018). Antimicrobial properties and mechanism of action of some plant extracts against Food pathogens and spoilage microorganisms. Front. Microbiol. 9, 1639. 10.3389/fmicb.2018.01639</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01639</ArticleId><ArticleId IdType="pmc">PMC6066648</ArticleId><ArticleId IdType="pubmed">30087662</ArticleId></ArticleIdList></Reference><Reference><Citation>Guldiken B., Ozkan G., Catalkaya G., Ceylan F. D., Ekin Yalcinkaya I., Capanoglu E. (2018). Phytochemicals of herbs and spices: health versus toxicological effects. Food Chem. Toxicol. 119, 37&#x2013;49. 10.1016/j.fct.2018.05.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2018.05.050</ArticleId><ArticleId IdType="pubmed">29802945</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J., Mei Y., Li K., Huang X., Yang H. (2016). Downregulation of MiR-17-92a cluster promotes autophagy induction in response to celastrol treatment in prostate cancer cells. Biochem. Biophys. Res. Commun. 478 (2), 804&#x2013;810. 10.1016/j.bbrc.2016.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.08.029</ArticleId><ArticleId IdType="pubmed">27501757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S. C., Hevia D., Patchva S., Park B., Koh W., Aggarwal B. B. (2012). Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxidants Redox Signal. 1, 1295&#x2013;1322. 10.1089/ars.2011.4414</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.4414</ArticleId><ArticleId IdType="pmc">PMC3324815</ArticleId><ArticleId IdType="pubmed">22117137</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Liu C. F., Gao N., Zhao J., Xu J. (2018). RETRACTED: kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microRNA-340 in human lung cancer cells. Biomed. Pharmacother. 108, 809&#x2013;816. 10.1016/j.biopha.2018.09.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.09.087</ArticleId><ArticleId IdType="pubmed">30253373</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y., Ma L., Zhao L., Feng W., Zheng X. (2019). Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating MiR-506 and suppressing MMP2/16 expression in pancreatic cancer. Biomed. Pharmacother. 115, 108878. 10.1016/j.biopha.2019.108878</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108878</ArticleId><ArticleId IdType="pubmed">31060006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hang S., Wang X., Li H. (2019). Triptolide inhibits viability and migration while promotes apoptosis in nephroblastoma cells by regulation of MiR-193b-3p. Exp. Mol. Pathol. 108, 80&#x2013;88. 10.1016/j.yexmp.2019.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2019.04.006</ArticleId><ArticleId IdType="pubmed">30978333</ArticleId></ArticleIdList></Reference><Reference><Citation>Henikoff S., Matzke M. A. (1997). Exploring and explaining epigenetic effects. Trends Genet. 13 (8), 293&#x2013;295. 10.1016/s0168-9525(97)01219-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0168-9525(97)01219-5</ArticleId><ArticleId IdType="pubmed">9260513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong T., Nakagawa T., Pan W. J., Kim M. Y., Kraus W. L., Ikehara T., et al. (2004). Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem. Biophys. Res. Commun. 317 (1), 259&#x2013;264. 10.1016/j.bbrc.2004.03.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.03.041</ArticleId><ArticleId IdType="pubmed">15047177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao Y. C., Peng S. F., Lai K. C., Liao C. L., Huang Y. P., Lin C. C., et al. (2019). Genistein induces apoptosis in vitro and has antitumor activity against human leukemia HL-60 cancer cell xenograft growth in vivo . Environ. Toxicol. 34 (4), 443&#x2013;456. 10.1002/tox.22698</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tox.22698</ArticleId><ArticleId IdType="pubmed">30618158</ArticleId></ArticleIdList></Reference><Reference><Citation>Issa J. P. J., Kantarjian H. M. (2009). Targeting DNA methylation. Clin. Cancer Res. 15 (12), 3938&#x2013;3946. 10.1158/1078-0432.CCR-08-2783</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-08-2783</ArticleId><ArticleId IdType="pmc">PMC2732562</ArticleId><ArticleId IdType="pubmed">19509174</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang S. Y., Hong D., Jeong S. Y., Kim J. H. (2015). Shikonin causes apoptosis by up-regulating P73 and down-regulating ICBP90 in human cancer cells. Biochem. Biophys. Res. Commun. 465 (1), 71&#x2013;76. 10.1016/j.bbrc.2015.07.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.07.131</ArticleId><ArticleId IdType="pubmed">26235879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang Y. G., Hwang K. A., Choi K. C. (2018). Rosmarinic acid, a component of rosemary tea, induced the cell cycle arrest and apoptosis through modulation of HDAC2 expression in prostate cancer cell lines. Nutrients 10, 1784. 10.3390/nu10111784</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111784</ArticleId><ArticleId IdType="pmc">PMC6266655</ArticleId><ArticleId IdType="pubmed">30453545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson W. N., Padilla-Banks E., Newbold R. R. (2005). Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol. Reprod. 73 (4), 798&#x2013;806. 10.1095/biolreprod.105.041277</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.105.041277</ArticleId><ArticleId IdType="pubmed">15930323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang A., Wang X., Shan X., Li Y., Wang P., Jiang P., et al. (2015). Curcumin reactivates silenced tumor suppressor gene RAR&#x3b2; by reducing DNA methylation. Phyther. Res. 29, 1237&#x2013;1245. 10.1002/ptr.5373</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.5373</ArticleId><ArticleId IdType="pubmed">25981383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J., Chen J., Shi Y., Jia J., Zhang Y. (2005). Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem. Pharmacol. 69 (8), 1205&#x2013;1213. 10.1016/j.bcp.2005.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2005.01.014</ArticleId><ArticleId IdType="pubmed">15794941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang K. A., Piao M. J., Hyun Y. J., Zhen A. X., Cho S. J., Ahn M. J., et al. (2019). Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with P53 in human colon cancer cells. Exp. Mol. Med. 51 (4), 1&#x2013;14. 10.1038/s12276-019-0238-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0238-y</ArticleId><ArticleId IdType="pmc">PMC6465248</ArticleId><ArticleId IdType="pubmed">30988303</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi Dermani F., Saidijam M., Amini R., Mahdavinezhad A., Heydari K., Najafi R. (2017). Resveratrol inhibits proliferation, invasion, and epithelial&#x2013;mesenchymal transition by increasing MiR-200c expression in HCT-116 colorectal cancer cells. J. Cell. Biochem. 118 (6), 1547&#x2013;1555. 10.1002/jcb.25816</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.25816</ArticleId><ArticleId IdType="pubmed">27918105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedhari Sundaram M., Hussain A., Haque S., Raina R., Afroze N. (2019). Quercetin modifies 5&#x2032;CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells. J. Cell. Biochem. 120 (10), 18357&#x2013;18369. 10.1002/jcb.29147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.29147</ArticleId><ArticleId IdType="pubmed">31172592</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Mohammad T., Shamsi A., Hussain A., Alajmi M. F., Husain S. A., et al. (2021b). Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies. J. Biomol. Struct. Dyn. 40, 10319&#x2013;10331. 10.1080/07391102.2021.1942217</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2021.1942217</ArticleId><ArticleId IdType="pubmed">34176437</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Siddiqui S., Husain S. A., Mazurek S., Iqbal M. A. (2021a). Phytocompounds targeting metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways, and therapeutic relevance. J. Agric. Food Chem. 16, 6897&#x2013;6928. 10.1021/acs.jafc.1c01173</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.1c01173</ArticleId><ArticleId IdType="pubmed">34133161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.-Y., Kim S.-H., Cheong H.-T., Ra C.-S., Rhee K.-J., Jung B. D. (2020). Berberine induces P53-dependent apoptosis through inhibition of DNA Methyltransferase3b in Hep3B cells. Korean J. Clin. Lab. Sci. 52 (1), 69&#x2013;77. 10.15324/kjcls.2020.52.1.69</Citation><ArticleIdList><ArticleId IdType="doi">10.15324/kjcls.2020.52.1.69</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornberg R. D., Lorch Y. (1999). Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285&#x2013;294. 10.1016/s0092-8674(00)81958-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81958-3</ArticleId><ArticleId IdType="pubmed">10458604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouzarides T. (2007). Chromatin modifications and their function. Cell 23, 693&#x2013;705. 10.1016/j.cell.2007.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.005</ArticleId><ArticleId IdType="pubmed">17320507</ArticleId></ArticleIdList></Reference><Reference><Citation>Krifa M., Leloup L., Ghedira K., Mousli M., Chekir-Ghedira L. (2014). Luteolin induces apoptosis in BE colorectal cancer cells by downregulating calpain, UHRF1, and DNMT1 expressions. Nutr. Cancer 66 (7), 1220&#x2013;1227. 10.1080/01635581.2014.951729</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2014.951729</ArticleId><ArticleId IdType="pubmed">25207720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu J. K., Surh Y. J. (2009). Molecular basis of chemoprevention with dietary phytochemicals: redox-regulated transcription factors as relevant targets. Phytochem. Rev. 8 (2), 333&#x2013;347. 10.1007/s11101-009-9132-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11101-009-9132-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunnumakkara A. B., Bordoloi D., Harsha C., Banik K., Gupta S. C., Aggarwal B. B. (2017). Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin. Sci. 1, 1781&#x2013;1799. 10.1042/CS20160935</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20160935</ArticleId><ArticleId IdType="pubmed">28679846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppusamy P., Nagalingam A., Muniraj N., Saxena N. K., Sharma D. (2017). Concomitant activation of ETS-like transcription factor-1 and death receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice. Sci. Rep. 7 (1), 17943. 10.1038/s41598-017-18190-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18190-4</ArticleId><ArticleId IdType="pmc">PMC5738353</ArticleId><ArticleId IdType="pubmed">29263422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea M. A., Randolph V. M., Lee J. E., DesBordes C. (2001). Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate. Int. J. Cancer 92 (6), 784&#x2013;789. 10.1002/ijc.1277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.1277</ArticleId><ArticleId IdType="pubmed">11351296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W. J., Chen Y. R., Tseng T. H. (2011). Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol. Rep. 25 (2), 583&#x2013;591. 10.3892/or.2010.1097</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2010.1097</ArticleId><ArticleId IdType="pubmed">21165570</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B. B., Huang G. L., Li H. H., Kong X., He Z. W. (2017). Epigallocatechin-3-Gallate modulates MicroRNA expression profiles in human nasopharyngeal carcinoma CNE2 cells. Chin. Med. J. Engl. 130 (1), 93&#x2013;99. 10.4103/0366-6999.196586</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.196586</ArticleId><ArticleId IdType="pmc">PMC5221119</ArticleId><ArticleId IdType="pubmed">28051030</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Chen L., Zhao W., Hao J., An R. (2016). MicroRNA-Let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer. Mol. Med. Rep. 13 (3), 2708&#x2013;2714. 10.3892/mmr.2016.4841</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.4841</ArticleId><ArticleId IdType="pubmed">26847233</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Sarkar F. H. (2016). Role of BioResponse 3,3&#x2032;-diindolylmethane in the treatment of human prostate cancer: clinical experience. Med. Princ. Pract. 25 (2), 11&#x2013;17. 10.1159/000439307</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000439307</ArticleId><ArticleId IdType="pmc">PMC4848191</ArticleId><ArticleId IdType="pubmed">26501150</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Sun W., Han N., Zou Y., Yin D. (2018). Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of MiR-99a and JAK/STAT pathway. BMC Cancer 18 (1), 1230. 10.1186/s12885-018-5130-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-018-5130-y</ArticleId><ArticleId IdType="pmc">PMC6288931</ArticleId><ArticleId IdType="pubmed">30526546</ArticleId></ArticleIdList></Reference><Reference><Citation>Link A., Balaguer F., Shen Y., Lozano J. J., Leung H. C. E., Boland C. R., et al. (2013). Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One 8 (2), e57709. 10.1371/journal.pone.0057709</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057709</ArticleId><ArticleId IdType="pmc">PMC3584082</ArticleId><ArticleId IdType="pubmed">23460897</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H. L., Chen Y., Cui G. H., Zhou J. F. (2005). Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-nhl cell line Raji proliferation. Acta Pharmacol. Sin. 26 (5), 603&#x2013;609. 10.1111/j.1745-7254.2005.00081.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2005.00081.x</ArticleId><ArticleId IdType="pubmed">15842781</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li M., Wang Y., Luo J. (2017). Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of MiR-143 and MiR-143 mediated autophagy inhibition. J. Drug Target. 25 (7), 645&#x2013;652. 10.1080/1061186X.2017.1315686</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2017.1315686</ArticleId><ArticleId IdType="pubmed">28391715</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Li H., Wu M. L., Wu J., Sun Y., Zhang K. L., et al. (2019b). Resveratrol reverses retinoic acid resistance of anaplastic thyroid cancer cells via demethylating CRABP2 gene. Front. Endocrinol. (Lausanne). 10, 734. 10.3389/fendo.2019.00734</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00734</ArticleId><ArticleId IdType="pmc">PMC6828648</ArticleId><ArticleId IdType="pubmed">31736873</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Gao Y., Li X. (2019a). Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors. Expert Rev. Anticancer Ther. 19, 139&#x2013;149. 10.1080/14737140.2019.1552139</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737140.2019.1552139</ArticleId><ArticleId IdType="pubmed">30470148</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-L&#xe1;zaro M. (2008). Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res. 52, S103&#x2013;S127. 10.1002/mnfr.200700238</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200700238</ArticleId><ArticleId IdType="pubmed">18496811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubin F. D., Gupta S., Parrish R. R., Grissom N. M., Davis R. L. (2011). Epigenetic mechanisms: critical contributors to long-term memory formation. Neurosci 17 (6), 616&#x2013;632. 10.1177/1073858411386967</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858411386967</ArticleId><ArticleId IdType="pubmed">22130638</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger K., Richmond T. J. (1998). The histone tails of the nucleosome. Curr. Opin. Genet. Dev. 8, 140&#x2013;146. 10.1016/s0959-437x(98)80134-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-437x(98)80134-2</ArticleId><ArticleId IdType="pubmed">9610403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Feugang J. M., Konarski P., Wang J., Lu J., Fu S., et al. (2006). Growth inhibitory effects of quercetin on bladder cancer cell. Front. Biosci. 11 (Suppl. 1), 2275&#x2013;2285. 10.2741/1970</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/1970</ArticleId><ArticleId IdType="pubmed">16720314</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid S., Kikuno N., Nelles J., Noonan E., Tanaka Y., Kawamoto K., et al. (2008). Genistein induces the P21WAF1/CIP1 and P16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 68 (8), 2736&#x2013;2744. 10.1158/0008-5472.CAN-07-2290</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-07-2290</ArticleId><ArticleId IdType="pubmed">18413741</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik Z., Parveen R., Parveen B., Zahiruddin S., Aasif Khan M., Khan A., et al. (2021). Anticancer potential of andrographolide from andrographis paniculata (Burm.f.) nees and its mechanisms of action. J. Ethnopharmacol. 272, 113936. 10.1016/j.jep.2021.113936</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.113936</ArticleId><ArticleId IdType="pubmed">33610710</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S. L., Kala R., Tollefsbol T. O. (2017). Mechanisms for the inhibition of colon cancer cells by sulforaphane through epigenetic modulation of MicroRNA-21 and human telomerase reverse Transcriptase (HTERT) down-regulation. Curr. Cancer Drug Targets 18 (1), 97&#x2013;106. 10.2174/1568009617666170206104032</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568009617666170206104032</ArticleId><ArticleId IdType="pmc">PMC5577390</ArticleId><ArticleId IdType="pubmed">28176652</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa Y., Nishino H., Yoshida M., Sugihara H., Katsura K., Takamatsu T., et al. (2002). Quercetin enhances tumorigenicity induced by N-ethyl-N&#x2019;-Nitro-N-nitrosoguanidine in the duodenum of mice. Environ. Health Prev. Med. 6 (4), 235&#x2013;239. 10.1007/BF02897975</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02897975</ArticleId><ArticleId IdType="pmc">PMC2723474</ArticleId><ArticleId IdType="pubmed">21432340</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S., Yadav T., Rani V. (2016). Exploring MiRNA based approaches in cancer diagnostics and therapeutics. Crit. Rev. Oncology/Hematology 98, 12&#x2013;23. 10.1016/j.critrevonc.2015.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2015.10.003</ArticleId><ArticleId IdType="pubmed">26481951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsiogianni M., Trafalis D. T., Franco R., Zoumpourlis V., Pappa A., Panayiotidis M. I. (2020). Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma. Eur. J. Nutr. 60, 147&#x2013;158. 10.1007/s00394-020-02227-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-020-02227-y</ArticleId><ArticleId IdType="pubmed">32215717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi K., Sani M. A., Azizi-Lalabadi M., McClements D. J. (2022). Recent progress in the application of plant-based colloidal drug delivery systems in the pharmaceutical Sciences. Adv. Colloid Interface Sci. 307, 102734. 10.1016/j.cis.2022.102734</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cis.2022.102734</ArticleId><ArticleId IdType="pubmed">35917768</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery M., Srinivasan A. (2019). Epigenetic gene regulation by dietary compounds in cancer prevention. Adv. Nutr. 10, 1012&#x2013;1028. 10.1093/advances/nmz046</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz046</ArticleId><ArticleId IdType="pmc">PMC6855955</ArticleId><ArticleId IdType="pubmed">31100104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mottet D., Castronovo V. (2008). Histone deacetylases: target enzymes for cancer therapy. Clin. Exp. Metastasis 25, 183&#x2013;189. 10.1007/s10585-007-9131-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10585-007-9131-5</ArticleId><ArticleId IdType="pubmed">18058245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu J., Zhu D., Shen Z., Ning S., Liu Y., Chen J., et al. (2017). The repressive effect of MiR-148a on wnt/&#x3b2;-catenin signaling involved in glabridin-induced anti-angiogenesis in human breast cancer cells. BMC Cancer 17 (1), 307. 10.1186/s12885-017-3298-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-017-3298-1</ArticleId><ArticleId IdType="pmc">PMC5414299</ArticleId><ArticleId IdType="pubmed">28464803</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandakumar V., Vaid M., Katiyar S. K. (2011). (-)-Epigallocatechin-3-Gallate reactivates silenced tumor suppressor genes, Cip1/P21 and P16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32, 537&#x2013;544. 10.1093/carcin/bgq285</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgq285</ArticleId><ArticleId IdType="pmc">PMC3066414</ArticleId><ArticleId IdType="pubmed">21209038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardi I., Reno T., Yun X., Sztain T., Wang J., Dai H., et al. (2018). Triptolide inhibits wnt signaling in NSCLC through upregulation of multiple wnt inhibitory factors via epigenetic modifications to histone H3. Int. J. Cancer 143 (10), 2470&#x2013;2478. 10.1002/ijc.31756</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.31756</ArticleId><ArticleId IdType="pmc">PMC6483070</ArticleId><ArticleId IdType="pubmed">30006924</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouriemamzaden F., Word B., Cotton E., Hawkins A., Littlejohn K., Moore R., et al. (2020). Modulation of estrogen &#x3b1; and progesterone receptors in triple negative breast cancer cell lines: the effects of vorinostat and indole-3-carbinol in vitro . Anticancer Res. 40 (7), 3669&#x2013;3683. 10.21873/anticanres.14356</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.14356</ArticleId><ArticleId IdType="pubmed">32620606</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano M., Bell D. W., Haber D. A., Li E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (3), 247&#x2013;257. 10.1016/s0092-8674(00)81656-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81656-6</ArticleId><ArticleId IdType="pubmed">10555141</ArticleId></ArticleIdList></Reference><Reference><Citation>Paluszczak J., Krajka-Ku&#x17a;niak V., Baer-Dubowska W. (2010). The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 192, 119&#x2013;125. 10.1016/j.toxlet.2009.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxlet.2009.10.010</ArticleId><ArticleId IdType="pubmed">19840838</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Feng F., Wu J., Fan S., Han J., Wang S., et al. (2022). Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol. Res. 181, 106270. 10.1016/j.phrs.2022.106270</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106270</ArticleId><ArticleId IdType="pubmed">35605812</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M., Kaur P., Shukla S., Abbas A., Fu P., Gupta S. (2012). Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol. Carcinog. 51 (12), 952&#x2013;962. 10.1002/mc.20866</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20866</ArticleId><ArticleId IdType="pmc">PMC4019962</ArticleId><ArticleId IdType="pubmed">22006862</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M., Shukla S., Gupta S. (2010). Promoter demethylation and chromatin remodeling by green tea polyphenols leads to Re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer 126 (11), 2520&#x2013;2533. 10.1002/ijc.24988</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.24988</ArticleId><ArticleId IdType="pmc">PMC2874465</ArticleId><ArticleId IdType="pubmed">19856314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pani S., Sahoo A., Patra A., Debata P. R. (2020). Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate&#x2013;pyruvate level along with cytotoxic activity in HeLa cervical cancer cells. Biotechnol. Appl. Biochem. 68, 1396&#x2013;1402. 10.1002/bab.2061</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bab.2061</ArticleId><ArticleId IdType="pubmed">33099806</ArticleId></ArticleIdList></Reference><Reference><Citation>Parbin S., Shilpi A., Kar S., Pradhan N., Sengupta D., Deb M., et al. (2016). Insights into the molecular interactions of thymoquinone with histone deacetylase: evaluation of the therapeutic intervention potential against breast cancer. Mol. Biosyst. 12 (1), 48&#x2013;58. 10.1039/c5mb00412h</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5mb00412h</ArticleId><ArticleId IdType="pubmed">26540192</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-Gonzalez X., Fuentes F., Su Z. Y., Kong A. N. T. (2014). Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications. AAPS J. 16 (4), 727&#x2013;735. 10.1208/s12248-014-9613-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-014-9613-8</ArticleId><ArticleId IdType="pmc">PMC4070251</ArticleId><ArticleId IdType="pubmed">24830944</ArticleId></ArticleIdList></Reference><Reference><Citation>Payer B., Lee J. T. (2008). X chromosome dosage compensation: how mammals keep the balance. Annu. Rev. Genet. 42, 733&#x2013;772. 10.1146/annurev.genet.42.110807.091711</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genet.42.110807.091711</ArticleId><ArticleId IdType="pubmed">18729722</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Z., Zhang Y. (2017). Methyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by MicroRNA-101. Mol. Med. Rep. 15 (2), 957&#x2013;962. 10.3892/mmr.2016.6061</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.6061</ArticleId><ArticleId IdType="pubmed">28000868</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer C. M., Singh A. T. K. (2018). Apoptosis: a target for anticancer therapy. Int. J. Mol. Sci. 2, 448. 10.3390/ijms19020448</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19020448</ArticleId><ArticleId IdType="pmc">PMC5855670</ArticleId><ArticleId IdType="pubmed">29393886</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan M. A. T., Paterson J., Bucknall M., Arcot J. (2018). Interactions between phytochemicals from fruits and vegetables: effects on bioactivities and bioavailability. Crit. Rev. Food Sci. Nutr. 58 (8), 1310&#x2013;1329. 10.1080/10408398.2016.1254595</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2016.1254595</ArticleId><ArticleId IdType="pubmed">27880063</ArticleId></ArticleIdList></Reference><Reference><Citation>Prajapati K. S., Shuaib M., Gupta S., Kumar S. (2022). Withaferin A mediated changes of MiRNA expression in breast cancer-derived mammospheres. Mol. Carcinog. 61 (9), 876&#x2013;889. 10.1002/mc.23440</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.23440</ArticleId><ArticleId IdType="pubmed">35770722</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad S., Gupta S. C., Tyagi A. K. (2017). Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 28, 95&#x2013;105. 10.1016/j.canlet.2016.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2016.03.042</ArticleId><ArticleId IdType="pubmed">27037062</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad S., Yadav V. R., Sung B., Reuter S., Kannappan R., Deorukhkar A., et al. (2012). Ursolic acid inhibits growth and metastasis of human, colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin. Cancer Res. 18 (18), 4942&#x2013;4953. 10.1158/1078-0432.CCR-11-2805</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-11-2805</ArticleId><ArticleId IdType="pmc">PMC3677707</ArticleId><ArticleId IdType="pubmed">22832932</ArticleId></ArticleIdList></Reference><Reference><Citation>Qazi A., Pal J., Maitah M., Fulciniti M., Pelluru D., Nanjappa P., et al. (2010). Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Transl. Oncol. 3 (6), 389&#x2013;399. 10.1593/tlo.10235</Citation><ArticleIdList><ArticleId IdType="doi">10.1593/tlo.10235</ArticleId><ArticleId IdType="pmc">PMC3000464</ArticleId><ArticleId IdType="pubmed">21151478</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W., Zhang K., Clarke K., Weiland T., Sauter E. R. (2014). Methylation and MiRNA effects of resveratrol on mammary tumors vs. Normal tissue. Nutr. Cancer 66 (2), 270&#x2013;277. 10.1080/01635581.2014.868910</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01635581.2014.868910</ArticleId><ArticleId IdType="pubmed">24447120</ArticleId></ArticleIdList></Reference><Reference><Citation>Reunanen N., K&#xe4;h&#xe4;ri V. (2013). &#x201c;Matrix metalloproteinases in cancer cell invasion,&#x201d; in Madame curie bioscience database (Austin, TX: Landes Bioscience; ).</Citation></Reference><Reference><Citation>Sadakierska-Chudy A. (2020). Micrornas: diverse mechanisms of action and their potential applications as cancer epi-therapeutics. Biomolecules 10, 1285. 10.3390/biom10091285</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10091285</ArticleId><ArticleId IdType="pmc">PMC7565521</ArticleId><ArticleId IdType="pubmed">32906681</ArticleId></ArticleIdList></Reference><Reference><Citation>Safi-Stibler S., Gabory A. (2020). Epigenetics and the developmental origins of health and disease: parental environment signalling to the epigenome, critical time windows and sculpting the adult phenotype. Seminars Cell Dev. Biol. 97, 172&#x2013;180. 10.1016/j.semcdb.2019.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.09.008</ArticleId><ArticleId IdType="pubmed">31587964</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi B., Ata A., Kumar N. V. A., Sharopov F., Ram&#xed;rez-Alarc&#xf3;n K., Ruiz-Ortega A., et al. (2019). Antidiabetic potential of medicinal plants and their active components. Biomolecules 9, 551. 10.3390/biom9100551</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9100551</ArticleId><ArticleId IdType="pmc">PMC6843349</ArticleId><ArticleId IdType="pubmed">31575072</ArticleId></ArticleIdList></Reference><Reference><Citation>Santi D. V., Garrett C. E., Barr P. J. (1983). On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 33, 9&#x2013;10. 10.1016/0092-8674(83)90327-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(83)90327-6</ArticleId><ArticleId IdType="pubmed">6205762</ArticleId></ArticleIdList></Reference><Reference><Citation>Setoyama T., Ling H., Natsugoe S., Calin G. A. (2011). Non-coding RNAs for medical practice in oncology. Keio J. Med. 60 (4), 106&#x2013;113. 10.2302/kjm.60.106</Citation><ArticleIdList><ArticleId IdType="doi">10.2302/kjm.60.106</ArticleId><ArticleId IdType="pubmed">22200634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar S., Ganapathy S., Srivastava R. K. (2007). Green tea polyphenols: biology and therapeutic implications in cancer. Front. Biosci. 12, 4881&#x2013;4899. 10.2741/2435</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2435</ArticleId><ArticleId IdType="pubmed">17569617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J., Shi W., Guo H., Long W., Wang Y., Qi J., et al. (2019). The inhibitory effect of (-)-Epigallocatechin-3 -gallate on breast cancer progression via reducing SCUBE2 methylation and DNMT activity. Molecules 24 (16), 2899. 10.3390/molecules24162899</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24162899</ArticleId><ArticleId IdType="pmc">PMC6719997</ArticleId><ArticleId IdType="pubmed">31404982</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q., Li J., Feng Z., Zhao L., Luo L., You Z., et al. (2014). Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol. Med. Rep. 10 (4), 1779&#x2013;1785. 10.3892/mmr.2014.2392</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2392</ArticleId><ArticleId IdType="pmc">PMC4148366</ArticleId><ArticleId IdType="pubmed">25051397</ArticleId></ArticleIdList></Reference><Reference><Citation>Shruti K., Shrey K., Vibha R. (2011). Micro RNAs: tiny sequences with enormous potential. Biochem. Biophys. Res. Commun. 15, 445&#x2013;449. 10.1016/j.bbrc.2011.03.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.03.058</ArticleId><ArticleId IdType="pubmed">21419103</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu L., Khor T. O., Lee J. H., Boyanapalli S. S. S., Huang Y., Wu T. Y., et al. (2011). Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J. 13 (4), 606&#x2013;614. 10.1208/s12248-011-9300-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-011-9300-y</ArticleId><ArticleId IdType="pmc">PMC3231852</ArticleId><ArticleId IdType="pubmed">21938566</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Mishra S. K., Noel S., Sharma S., Rath S. K. (2012). Acute exposure of apigenin induces hepatotoxicity in Swiss mice. PLoS One 7, e31964. 10.1371/journal.pone.0031964</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031964</ArticleId><ArticleId IdType="pmc">PMC3281105</ArticleId><ArticleId IdType="pubmed">22359648</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Sharma B., Kanwar S. S., Kumar A. (2016). Lead phytochemicals for anticancer drug development. Front. Plant Sci. 7, 1667. 10.3389/fpls.2016.01667</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2016.01667</ArticleId><ArticleId IdType="pmc">PMC5099879</ArticleId><ArticleId IdType="pubmed">27877185</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith C. J., Ryckman K. K. (2015). Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes, Metabolic Syndrome Obes. 8, 295&#x2013;302. 10.2147/DMSO.S61296</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S61296</ArticleId><ArticleId IdType="pmc">PMC4492644</ArticleId><ArticleId IdType="pubmed">26170704</ArticleId></ArticleIdList></Reference><Reference><Citation>Su C. C., Lin J. G., Li T. M., Chung J. G., Yang J. S., Ip S. W., et al. (2006). Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3. Anticancer Res. 26, 4379&#x2013;4389.</Citation><ArticleIdList><ArticleId IdType="pubmed">17201158</ArticleId></ArticleIdList></Reference><Reference><Citation>Suman S., Das T. P., Sirimulla S., Alatassi H., Ankem M. K., Damodaran C. (2016). Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells. Oncotarget 7 (12), 13854&#x2013;13864. 10.18632/oncotarget.7351</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.7351</ArticleId><ArticleId IdType="pmc">PMC4924683</ArticleId><ArticleId IdType="pubmed">26883103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaram M. K., Unni S., Somvanshi P., Bhardwaj T., Mandal R. K., Hussain A., et al. (2019). Genistein modulates signaling pathways and targets several epigenetic markers in hela cells. Genes (Basel). 10 (12), 955. 10.3390/genes10120955</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes10120955</ArticleId><ArticleId IdType="pmc">PMC6947182</ArticleId><ArticleId IdType="pubmed">31766427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca. Cancer J. Clin. 71, 209&#x2013;249. 10.3322/caac.21660</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21660</ArticleId><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoronos A. A., Engelman D. M., Slack F. J. (2016). OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer. Cancer Res. 1, 3666&#x2013;3670. 10.1158/0008-5472.CAN-16-0359</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-16-0359</ArticleId><ArticleId IdType="pmc">PMC4930690</ArticleId><ArticleId IdType="pubmed">27325641</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B. L., Norhaizan M. E. (2019). Curcumin combination chemotherapy: the implication and efficacy in cancer. Molecules 24, 2527. 10.3390/molecules24142527</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24142527</ArticleId><ArticleId IdType="pmc">PMC6680685</ArticleId><ArticleId IdType="pubmed">31295906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Wang Z., Chen L., Huang G., Hu X. (2015). Gossypol acetate induced apoptosis of pituitary tumor cells by targeting the BCL-2 via the upregulated MicroRNA MiR-15a. Int. J. Clin. Exp. Med. 8 (6), 9079&#x2013;9085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4538161</ArticleId><ArticleId IdType="pubmed">26309203</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S. F., He H. F., Chen Q. (2015). Quercetin inhibits proliferation and invasion acts by up-regulating MiR-146a in human breast cancer cells. Mol. Cell. Biochem. 402 (1&#x2013;2), 93&#x2013;100. 10.1007/s11010-014-2317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-014-2317-7</ArticleId><ArticleId IdType="pubmed">25596948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Y., Zhan S., Wang Y., Zhou G., Liang H., Chen X., et al. (2018). Baicalin, the major component of traditional Chinese medicine scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of OncomiRNAs. Sci. Rep. 8 (1), 14477. 10.1038/s41598-018-32734-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32734-2</ArticleId><ArticleId IdType="pmc">PMC6160418</ArticleId><ArticleId IdType="pubmed">30262902</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur V. S., Gupta K., Gupta S. (2012). Green tea polyphenols increase P53 transcriptional activity and acetylation by suppressing class I histone deacetylases. Int. J. Oncol. 41 (1), 353&#x2013;361. 10.3892/ijo.2012.1449</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2012.1449</ArticleId><ArticleId IdType="pmc">PMC3580388</ArticleId><ArticleId IdType="pubmed">22552582</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangapazham R. L., Singh A. K., Sharma A., Warren J., Gaddipati J. P., Maheshwari R. K. (2007). Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo . Cancer Lett. 245 (1&#x2013;2), 232&#x2013;241. 10.1016/j.canlet.2006.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2006.01.027</ArticleId><ArticleId IdType="pubmed">16519995</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi K., Mir&#xf3; R., Fern&#xe1;ndez-Jim&#xe9;nez N., Quintanilla I., Ramos L., Prat E., et al. (2015). Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer. Carcinogenesis 36 (10), 1103&#x2013;1110. 10.1093/carcin/bgv115</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgv115</ArticleId><ArticleId IdType="pmc">PMC4598814</ArticleId><ArticleId IdType="pubmed">26243311</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang W. P., Kwok T. T. (2010). Epigallocatechin gallate up-regulation of MiR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 21 (2), 140&#x2013;146. 10.1016/j.jnutbio.2008.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2008.12.003</ArticleId><ArticleId IdType="pubmed">19269153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng T. H., Chien M. H., Lin W. L., Wen Y. C., Chow J. M., Chen C. K., et al. (2017). Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated P21WAF1/CIP1 expression. Environ. Toxicol. 32 (2), 434&#x2013;444. 10.1002/tox.22247</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tox.22247</ArticleId><ArticleId IdType="pubmed">26872304</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuna M., Knuutila S., Mills G. B. (2009). Uniparental disomy in cancer. Trends Mol. Med. 15, 120&#x2013;128. 10.1016/j.molmed.2009.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2009.01.005</ArticleId><ArticleId IdType="pubmed">19246245</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoesel A. Q., Sato Y., Elashoff D. A., Turner R. R., Giuliano A. E., Shamonki J. M., et al. (2013). Assessment of DNA methylation status in early stages of breast cancer development. Br. J. Cancer 108 (10), 2033&#x2013;2038. 10.1038/bjc.2013.136</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2013.136</ArticleId><ArticleId IdType="pmc">PMC3670495</ArticleId><ArticleId IdType="pubmed">23652305</ArticleId></ArticleIdList></Reference><Reference><Citation>vel Szic K. S., Declerck K., Crans R. A. J., Diddens J., Scherf D. B., Gerh&#xe4;user C., et al. (2017). Epigenetic silencing of triple negative breast cancer hallmarks by withaferin A. Oncotarget 8, 40434&#x2013;40453. 10.18632/oncotarget.17107</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.17107</ArticleId><ArticleId IdType="pmc">PMC5522326</ArticleId><ArticleId IdType="pubmed">28467815</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S. (2016). Medicinal plants with anti-inflammatory activity. J. Phytopharm. 5 (4), 157&#x2013;159. 10.31254/phyto.2016.5407</Citation><ArticleIdList><ArticleId IdType="doi">10.31254/phyto.2016.5407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Wang Y., Wan X., Yang C. S., Zhang J. (2015). Green tea polyphenol (-)-Epigallocatechin-3-Gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicol. Appl. Pharmacol. 283 (1), 65&#x2013;74. 10.1016/j.taap.2014.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2014.12.018</ArticleId><ArticleId IdType="pubmed">25585349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Li Y., Wang X., Jiang C. (2012). Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-&#x3b2;1/MiR-21/PDCD4 pathway. Basic Clin. Pharmacol. Toxicol. 111, 106&#x2013;112. 10.1111/j.1742-7843.2012.00870.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-7843.2012.00870.x</ArticleId><ArticleId IdType="pubmed">22353043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Wu M., Zheng D., Zhang H., Lv Y., Zhang L., et al. (2020). Garcinol inhibits esophageal cancer metastasis by suppressing the P300 and TGF-&#x3b2;1 signaling pathways. Acta Pharmacol. Sin. 41 (1), 82&#x2013;92. 10.1038/s41401-019-0271-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-019-0271-3</ArticleId><ArticleId IdType="pmc">PMC7471459</ArticleId><ArticleId IdType="pubmed">31371781</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L. G., Beklemisheva A., Liu X. M., Ferrari A. C., Feng J., Chiao J. W. (2007). Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol. Carcinog. 46 (1), 24&#x2013;31. 10.1002/mc.20258</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20258</ArticleId><ArticleId IdType="pubmed">16921492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei D., Yang L., Lv B., Chen L. (2017). Genistein suppresses retinoblastoma cell viability and growth and induces apoptosis by upregulating MiR-145 and inhibiting its target ABCE1. Mol. Vis. 23, 385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501691</ArticleId><ArticleId IdType="pubmed">28706438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X. Y., Wu S. Y., Li Z. Q., Liu Z. Q., Zhang J. J., Wang G. F., et al. (2009). Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of MiRNAs in HepG2 cancer cells. Phyther. Res. 23, 778&#x2013;784. 10.1002/ptr.2616</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.2616</ArticleId><ArticleId IdType="pubmed">19142982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C. P., Hsu A., Buchanan A., Palomera-Sanchez Z., Beaver L. M., Houseman E. A., et al. (2014). Effects of sulforaphane and 3,3&#x2032;-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells. PLoS One 9 (1), e86787. 10.1371/journal.pone.0086787</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086787</ArticleId><ArticleId IdType="pmc">PMC3899342</ArticleId><ArticleId IdType="pubmed">24466240</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Lu H., Bai Y. (2019). Nrf2 in cancers: a double-edged sword. Cancer Med. 8, 2252&#x2013;2267. 10.1002/cam4.2101</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.2101</ArticleId><ArticleId IdType="pmc">PMC6536957</ArticleId><ArticleId IdType="pubmed">30929309</ArticleId></ArticleIdList></Reference><Reference><Citation>Xhemalce B., Dawson M. A., Bannister A. J. (2011). &#x201c;Histone modifications,&#x201d; in Encyclopedia of molecular cell biology and molecular medicine (American Cancer Society; ).</Citation></Reference><Reference><Citation>Xiao L., Huang Y., Zhen R., Chiao J. W., Liu D., Ma X. (2010). Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate. Acta Haematol. 123 (2), 71&#x2013;76. 10.1159/000264628</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000264628</ArticleId><ArticleId IdType="pubmed">20051681</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Hale S., Awasthee N., Meng C., Zhang X., Liu Y., et al. (2023). HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation. Cell Chem. Biol. 10.1016/j.chembiol.2023.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2023.07.010</ArticleId><ArticleId IdType="pmc">PMC10802846</ArticleId><ArticleId IdType="pubmed">37572669</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z., Morris-Natschke S. L., Lee K. H. (2016). Strategies for the optimization of natural leads to anticancer drugs or drug candidates. Med. Res. Rev. 36 (1), 32&#x2013;91. 10.1002/med.21377</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21377</ArticleId><ArticleId IdType="pmc">PMC4679534</ArticleId><ArticleId IdType="pubmed">26359649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X., Xie T., Wang S., Wang Z., Li H. Y., Ye Z. M. (2018). Apigenin inhibits proliferation of human chondrosarcoma cells via cell cycle arrest and mitochondrial apoptosis induced by ROS generation-an in vitro and in vivo study. J. Clin. Exp. Med. 11 (3), 1615&#x2013;1631.</Citation></Reference><Reference><Citation>Ye Y., Fang Y., Xu W., Wang Q., Zhou J., Lu R. (2016). 3,3&#x2032;-Diindolylmethane induces anti-human gastric cancer cells by the MiR-30e-ATG5 modulating autophagy. Biochem. Pharmacol. 115, 77&#x2013;84. 10.1016/j.bcp.2016.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2016.06.018</ArticleId><ArticleId IdType="pubmed">27372603</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin L., Xiao X., Georgikou C., Luo Y., Liu L., Gladkich J., et al. (2019). Sulforaphane induces MiR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer. Mol. Ther. - Oncolytics 14, 74&#x2013;81. 10.1016/j.omto.2019.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omto.2019.03.011</ArticleId><ArticleId IdType="pmc">PMC6479751</ArticleId><ArticleId IdType="pubmed">31044154</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino M., Haneda M., Naruse M., Htay H. H., Tsubouchi R., Qiao S. L., et al. (2004). Prooxidant activity of curcumin: copper-dependent formation of 8-hydroxy-2&#x2032;-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol. Vitr. 18 (6), 783&#x2013;789. 10.1016/j.tiv.2004.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2004.03.009</ArticleId><ArticleId IdType="pubmed">15465643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun C. W., Lee S. H. (2018). The roles of autophagy in cancer. Int. J. Mol. Sci. 19, 3466. 10.3390/ijms19113466</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19113466</ArticleId><ArticleId IdType="pmc">PMC6274804</ArticleId><ArticleId IdType="pubmed">30400561</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Wang Q., Pan X. (2007). MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiology 210, 279&#x2013;289. 10.1002/jcp.20869</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.20869</ArticleId><ArticleId IdType="pubmed">17096367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Shu L., Kim H., Khor T. O., Wu R., Li W., et al. (2016). Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating MicroRNA-194. Mol. Nutr. Food Res. 60 (6), 1427&#x2013;1436. 10.1002/mnfr.201500918</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201500918</ArticleId><ArticleId IdType="pmc">PMC5495185</ArticleId><ArticleId IdType="pubmed">26820911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Tang Z., Huang H., Zhou G., Cui C., Weng Y., et al. (2019). Metabolic regulation of gene expression by histone lactylation. Nature 574 (7779), 575&#x2013;580. 10.1038/s41586-019-1678-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1678-1</ArticleId><ArticleId IdType="pmc">PMC6818755</ArticleId><ArticleId IdType="pubmed">31645732</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Jia R., Wang C., Hu T., Wang F. (2014). Piceatannol promotes apoptosis via up-regulation of MicroRNA-129 expression in colorectal cancer cell lines. Biochem. Biophys. Res. Commun. 452 (3), 775&#x2013;781. 10.1016/j.bbrc.2014.08.150</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.08.150</ArticleId><ArticleId IdType="pubmed">25218158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Huang L., Shi H., Chen H., Tao J., Shen R., et al. (2018). Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance. Cancer Sci. 109 (1), 94&#x2013;102. 10.1111/cas.13425</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.13425</ArticleId><ArticleId IdType="pmc">PMC5765292</ArticleId><ArticleId IdType="pubmed">29034540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Li Q., Zhou D., Chen H. (2013). Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/&#x3b2;-Catenin signalling and reduces colon pre-neoplasia in rats. Br. J. Nutr. 109 (1), 33&#x2013;42. 10.1017/S0007114512000876</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114512000876</ArticleId><ArticleId IdType="pubmed">22716201</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Fang Z., Zha Z., Sun Q., Wang H., Sun M., et al. (2019). Quercetin inhibits cell viability, migration and invasion by regulating MiR-16/HOXA10 Axis in oral cancer. Eur. J. Pharmacol. 847, 11&#x2013;18. 10.1016/j.ejphar.2019.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.01.006</ArticleId><ArticleId IdType="pubmed">30639311</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Wu Y. (2020). Piceatannol suppresses proliferation and induces apoptosis by regulation of the MicroRNA-21/phosphatase and tensin homolog/protein kinase B signaling pathway in osteosarcoma cells. Mol. Med. Rep. 22 (5), 3985&#x2013;3993. 10.3892/mmr.2020.11484</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11484</ArticleId><ArticleId IdType="pmc">PMC7533446</ArticleId><ArticleId IdType="pubmed">32901863</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Liu M., Chen Y., Xu S., Guo Y., Zhao L. (2019b). Cucurbitacin B suppresses proliferation of pancreatic cancer cells by CeRNA: effect of MiR-146b-5p and LncRNA-AFAP1-AS1. J. Cell. Physiol. 234 (4), 4655&#x2013;4667. 10.1002/jcp.27264</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27264</ArticleId><ArticleId IdType="pubmed">30206930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J. W., Wang M., Sun N. X., Qing Y., Yin T. F., Li C., et al. (2019a). Sulforaphane-induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human caco-2 cells. Oncol. Lett. 18 (3), 2639&#x2013;2647. 10.3892/ol.2019.10569</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2019.10569</ArticleId><ArticleId IdType="pmc">PMC6676568</ArticleId><ArticleId IdType="pubmed">31452747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W. Q., Wang J., Guo X. F., Liu Z., Dong W. G. (2016). Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro . World J. Gastroenterol. 22 (16), 4149&#x2013;4159. 10.3748/wjg.v22.i16.4149</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v22.i16.4149</ArticleId><ArticleId IdType="pmc">PMC4837432</ArticleId><ArticleId IdType="pubmed">27122665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi H. Y., Beaudet A. L. (2016). Epigenetics and human disease. Cold Spring Harb. Perspect. Biol. 8 (2), a019497. 10.1101/cshperspect.a019497</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a019497</ArticleId><ArticleId IdType="pmc">PMC4743078</ArticleId><ArticleId IdType="pubmed">26834142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Q., Wu R., Xiao X., Yang C., Yang Y., Wang C., et al. (2018). The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. J. Cell. Biochem. 119 (11), 9573&#x2013;9582. 10.1002/jcb.27275</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.27275</ArticleId><ArticleId IdType="pmc">PMC6195448</ArticleId><ArticleId IdType="pubmed">30129150</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38474826</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>29</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Epigenetic Effects of Resveratrol on Oncogenic Signaling in Breast Cancer.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">699</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16050699</ELocationID><Abstract><AbstractText>The crosstalk between oncogenic signaling pathways plays a crucial role in driving cancer development. We previously demonstrated that dietary polyphenols, specifically resveratrol (RSV) and other stilbenoids, epigenetically target oncogenes for silencing via DNA hypermethylation in breast cancer. In the present study, we identify signal transduction regulators among RSV-hypermethylated targets and investigate the functional role of RSV-mediated DNA hypermethylation in the regulation of Hedgehog and Wnt signaling. Non-invasive ER-positive MCF-7 and highly invasive triple-negative MCF10CA1a human breast cancer cell lines were used as experimental models. Upon 9-day exposure to 15 &#xb5;M RSV, pyrosequencing and qRT-PCR were performed to assess DNA methylation and expression of <i>GLI2</i> and <i>WNT4</i>, which are upstream regulators of the Hedgehog and Wnt pathways, respectively. Our results showed that RSV led to a DNA methylation increase within <i>GLI2</i> and <i>WNT4</i> enhancers, which was accompanied by decreases in gene expression. Consistently, we observed the downregulation of genes downstream of the Hedgehog and Wnt signaling, including common targets shared by both pathways, <i>CCND1</i> and <i>CYR61</i>. Further analysis using chromatin immunoprecipitation identified increased H3K27 trimethylation and decreased H3K9 and H3K27 acetylation, along with abolishing OCT1 transcription factor binding. Those changes indicate a transcriptionally silent chromatin state at <i>GLI2</i> and <i>WNT4</i> enhancers. The inhibition of the Wnt signal transduction was confirmed using a phospho-antibody array that demonstrated suppression of positive and stimulation of negative Wnt regulators. In conclusion, our results provide scientific evidence for dietary polyphenols as epigenetics-modulating agents that act to re-methylate and silence oncogenes, reducing the oncogenic signal transduction. Targeting such an action could be an effective strategy in breast cancer prevention and/or adjuvant therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kurzava Kendall</LastName><ForeName>Lucinda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nutritional Sciences, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yuexi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Food, Nutrition and Health Program, Faculty of Land and Food Systems, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Food, Nutrition and Health Program, Faculty of Land and Food Systems, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubecka</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4250-0922</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Chemistry, Medical University of Lodz, 92-215 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanska</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Food, Nutrition and Health Program, Faculty of Land and Food Systems, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001108</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>Q369O8926L</RegistryNumber><NameOfSubstance UI="D000077185">Resveratrol</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077185" MajorTopicYN="N">Resveratrol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006364" MajorTopicYN="N">Hedgehogs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064726" MajorTopicYN="Y">Triple Negative Breast Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">Hedgehog</Keyword><Keyword MajorTopicYN="N">Wnt</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">chromatin</Keyword><Keyword MajorTopicYN="N">oncogenes</Keyword><Keyword MajorTopicYN="N">resveratrol</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38474826</ArticleId><ArticleId IdType="pmc">PMC10934115</ArticleId><ArticleId IdType="doi">10.3390/nu16050699</ArticleId><ArticleId IdType="pii">nu16050699</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel R.L., Miller K.D., Wagle N.S., Jemal A. Cancer statistics, 2023. CA Cancer J. Clin. 2023;73:17&#x2013;48. doi: 10.3322/caac.21763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21763</ArticleId><ArticleId IdType="pubmed">36633525</ArticleId></ArticleIdList></Reference><Reference><Citation>Vietri M.T., D&#x2019;Elia G., Benincasa G., Ferraro G., Caliendo G., Nicoletti G.F., Napoli C. DNA methylation and breast cancer: A way forward (Review) Int. J. Oncol. 2021;59:98. doi: 10.3892/ijo.2021.5278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2021.5278</ArticleId><ArticleId IdType="pubmed">34726251</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussos Torres E.T., Connolly R.M. Epigenetic Cancer Therapy&#x2014;Translational Epigenetics. Academic Press; Cambridge, MA, USA: 2023. Breast cancer epigenetics (Chapter 13) pp. 275&#x2013;299.</Citation></Reference><Reference><Citation>Jenkins B.D., Rossi E., Pichardo C., Wooten W., Pichardo M., Tang W., Dorsey T.H., Ajao A., Hutchison R., Moubadder L., et al. Neighborhood Deprivation and DNA Methylation and Expression of Cancer Genes in Breast Tumors. JAMA Netw. Open. 2023;6:e2341651. doi: 10.1001/jamanetworkopen.2023.41651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.41651</ArticleId><ArticleId IdType="pmc">PMC10628736</ArticleId><ArticleId IdType="pubmed">37930698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012&#x2013;1027. doi: 10.1016/j.tig.2021.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2021.05.002</ArticleId><ArticleId IdType="pubmed">34120771</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanska B., Salame P., Bednarek A., Fabianowska-Majewska K. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br. J. Nutr. 2012;107:781&#x2013;790. doi: 10.1017/S0007114511003631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114511003631</ArticleId><ArticleId IdType="pubmed">21801466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Kroller L., Miao B., Boekhoff H., Bauer A.S., Buchler M.W., Hackert T., Giese N.A., Taipale J., Hoheisel J.D. Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer. Cancers. 2021;13:4569. doi: 10.3390/cancers13184569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13184569</ArticleId><ArticleId IdType="pmc">PMC8471171</ArticleId><ArticleId IdType="pubmed">34572796</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanska B., Huang J., Bhattacharyya B., Suderman M., Hallett M., Han Z.G., Szyf M. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res. 2011;71:5891&#x2013;5903. doi: 10.1158/0008-5472.CAN-10-3823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-3823</ArticleId><ArticleId IdType="pubmed">21747116</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanska B., Cheishvili D., Suderman M., Arakelian A., Huang J., Hallett M., Han Z.G., Al-Mahtab M., Akbar S.M., Khan W.A., et al. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Clin. Cancer Res. 2014;20:3118&#x2013;3132. doi: 10.1158/1078-0432.CCR-13-0283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-13-0283</ArticleId><ArticleId IdType="pubmed">24763612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayol G., Martin-Subero J.I., Rios J., Queiros A., Kulis M., Sunol M., Esteller M., Gomez S., Garcia I., de Torres C., et al. DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS ONE. 2012;7:e48401. doi: 10.1371/journal.pone.0048401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048401</ArticleId><ArticleId IdType="pmc">PMC3492354</ArticleId><ArticleId IdType="pubmed">23144874</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukeir N., Stefanska B., Parashar S., Chik F., Arakelian A., Szyf M., Rabbani S.A. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. Br. J. Pharmacol. 2015;172:2769&#x2013;2781. doi: 10.1111/bph.13102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13102</ArticleId><ArticleId IdType="pmc">PMC4439874</ArticleId><ArticleId IdType="pubmed">25631332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakneshan P., Szyf M., Farias-Eisner R., Rabbani S.A. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J. Biol. Chem. 2004;279:31735&#x2013;31744. doi: 10.1074/jbc.M401669200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M401669200</ArticleId><ArticleId IdType="pubmed">15150277</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukeir N., Pakneshan P., Chen G., Szyf M., Rabbani S.A. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res. 2006;66:9202&#x2013;9210. doi: 10.1158/0008-5472.CAN-06-1954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-06-1954</ArticleId><ArticleId IdType="pubmed">16982764</ArticleId></ArticleIdList></Reference><Reference><Citation>Harandi-Zadeh S., Boycott C., Beetch M., Yang T., Martin B.J.E., Ren K., Kwasniak A., Dupuis J.H., Lubecka K., Yada R.Y., et al. Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells. Antioxidants. 2021;10:1232. doi: 10.3390/antiox10081232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10081232</ArticleId><ArticleId IdType="pmc">PMC8388921</ArticleId><ArticleId IdType="pubmed">34439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Beetch M., Boycott C., Harandi-Zadeh S., Yang T., Martin B.J.E., Dixon-McDougall T., Ren K., Gacad A., Dupuis J.H., Ullmer M., et al. Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells. J. Nutr. Biochem. 2021;98:108815. doi: 10.1016/j.jnutbio.2021.108815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2021.108815</ArticleId><ArticleId IdType="pmc">PMC8819711</ArticleId><ArticleId IdType="pubmed">34242723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubecka K., Kurzava L., Flower K., Buvala H., Zhang H., Teegarden D., Camarillo I., Suderman M., Kuang S., Andrisani O., et al. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. Carcinogenesis. 2016;37:656&#x2013;668. doi: 10.1093/carcin/bgw048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgw048</ArticleId><ArticleId IdType="pmc">PMC4936385</ArticleId><ArticleId IdType="pubmed">27207652</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Aguilar R., Perez-Plasencia C., Marchat L.A., Gariglio P., Garcia Mena J., Rodriguez Cuevas S., Ruiz-Garcia E., Astudillo-de la Vega H., Hernandez Juarez J., Flores-Perez A., et al. Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol. PLoS ONE. 2016;11:e0157866. doi: 10.1371/journal.pone.0157866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0157866</ArticleId><ArticleId IdType="pmc">PMC4927060</ArticleId><ArticleId IdType="pubmed">27355345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigafoos A.N., Paradise B.D., Fernandez-Zapico M.E. Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease. Cancers. 2021;13:3410. doi: 10.3390/cancers13143410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13143410</ArticleId><ArticleId IdType="pmc">PMC8304605</ArticleId><ArticleId IdType="pubmed">34298625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F., Yu C., Li F., Zuo Y., Wang Y., Yao L., Wu C., Wang C., Ye L. Wnt/beta-catenin signaling in cancers and targeted therapies. Signal Transduct. Target. Ther. 2021;6:307. doi: 10.1038/s41392-021-00701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00701-5</ArticleId><ArticleId IdType="pmc">PMC8403677</ArticleId><ArticleId IdType="pubmed">34456337</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang M., Xu F., Jiang S. Wnt signaling in breast cancer: Biological mechanisms, challenges and opportunities. Mol. Cancer. 2020;19:165. doi: 10.1186/s12943-020-01276-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-020-01276-5</ArticleId><ArticleId IdType="pmc">PMC7686704</ArticleId><ArticleId IdType="pubmed">33234169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl S.G., Brook N., Agostino M., Arfuso F., Kumar A.P., Dharmarajan A. Wnt signaling in triple-negative breast cancer. Oncogenesis. 2017;6:e310. doi: 10.1038/oncsis.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oncsis.2017.14</ArticleId><ArticleId IdType="pmc">PMC5520491</ArticleId><ArticleId IdType="pubmed">28368389</ArticleId></ArticleIdList></Reference><Reference><Citation>Riobo-Del Galdo N.A., Lara Montero A., Wertheimer E.V. Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics. Cells. 2019;8:375. doi: 10.3390/cells8040375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8040375</ArticleId><ArticleId IdType="pmc">PMC6523618</ArticleId><ArticleId IdType="pubmed">31027259</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey S.C., Tong L., Li Y., Do R., Walz S., Fitzgerald K.N., Gouw A.M., Baylot V., Gutgemann I., Eilers M., et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science. 2016;352:227&#x2013;231. doi: 10.1126/science.aac9935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac9935</ArticleId><ArticleId IdType="pmc">PMC4940030</ArticleId><ArticleId IdType="pubmed">26966191</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipitsin M., Campbell L.L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M., et al. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007;11:259&#x2013;273. doi: 10.1016/j.ccr.2007.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2007.01.013</ArticleId><ArticleId IdType="pubmed">17349583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z.M., Wu J.F., Luo Q.C., Liu Q.F., Wu Q.W., Ye G.D., She H.Q., Li B.A. Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/beta-catenin pathway. Oncogene. 2016;35:4787&#x2013;4797. doi: 10.1038/onc.2016.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2016.10</ArticleId><ArticleId IdType="pubmed">26876203</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Samant R.S., Shevde L.A. Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition. J. Biol. Chem. 2013;288:11824&#x2013;11833. doi: 10.1074/jbc.M112.432302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.432302</ArticleId><ArticleId IdType="pmc">PMC3636870</ArticleId><ArticleId IdType="pubmed">23508962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Haaf A., Bektas N., von Serenyi S., Losen I., Arweiler E.C., Hartmann A., Knuchel R., Dahl E. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer. 2009;9:298. doi: 10.1186/1471-2407-9-298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-9-298</ArticleId><ArticleId IdType="pmc">PMC2753634</ArticleId><ArticleId IdType="pubmed">19706168</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris-Pages M., Sotgia F., Lisanti M.P. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells. Oncotarget. 2015;6:10728&#x2013;10745. doi: 10.18632/oncotarget.3828.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.3828</ArticleId><ArticleId IdType="pmc">PMC4484415</ArticleId><ArticleId IdType="pubmed">25915429</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Li Z.Y., Liu W.P., Zhao M.R. Crosstalk between Wnt/beta-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy. Cancer Biol. Ther. 2015;16:1&#x2013;7. doi: 10.4161/15384047.2014.972215.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/15384047.2014.972215</ArticleId><ArticleId IdType="pmc">PMC4622601</ArticleId><ArticleId IdType="pubmed">25692617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M., Wang X. Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity. Oncol. Lett. 2017;14:6327&#x2013;6333. doi: 10.3892/ol.2017.7030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2017.7030</ArticleId><ArticleId IdType="pmc">PMC5770609</ArticleId><ArticleId IdType="pubmed">29391876</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Yu P., Wang S., Jiang L., Chen F., Chen W. Crosstalk between Hh and Wnt signaling promotes osteosarcoma progression. Int. J. Clin. Exp. Pathol. 2019;12:768&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945176</ArticleId><ArticleId IdType="pubmed">31933884</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada T. Activation of the Hedgehog and Wnt/beta-Catenin Signaling Pathways in Basal Cell Carcinoma. Case Rep. Dermatol. 2021;13:506&#x2013;512. doi: 10.1159/000520256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000520256</ArticleId><ArticleId IdType="pmc">PMC8738910</ArticleId><ArticleId IdType="pubmed">35082610</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold K.M., Pohlig R.T., Sims-Mourtada J. Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer. Oncol. Lett. 2017;14:5285&#x2013;5292. doi: 10.3892/ol.2017.6874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2017.6874</ArticleId><ArticleId IdType="pmc">PMC5666657</ArticleId><ArticleId IdType="pubmed">29142600</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqi A.A., Khalid S., Ahmad A. Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers. Int. J. Mol. Sci. 2018;19:652. doi: 10.3390/ijms19030652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030652</ArticleId><ArticleId IdType="pmc">PMC5877513</ArticleId><ArticleId IdType="pubmed">29495357</ArticleId></ArticleIdList></Reference><Reference><Citation>Behroozaghdam M., Dehghani M., Zabolian A., Kamali D., Javanshir S., Hasani Sadi F., Hashemi M., Tabari T., Rashidi M., Mirzaei S., et al. Resveratrol in breast cancer treatment: From cellular effects to molecular mechanisms of action. Cell. Mol. Life Sci. 2022;79:539. doi: 10.1007/s00018-022-04551-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04551-4</ArticleId><ArticleId IdType="pmc">PMC11802982</ArticleId><ArticleId IdType="pubmed">36194371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Chang H., Peng X., Bai Q., Yi L., Zhou Y., Zhu J., Mi M. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. PLoS ONE. 2014;9:e102535. doi: 10.1371/journal.pone.0102535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102535</ArticleId><ArticleId IdType="pmc">PMC4113212</ArticleId><ArticleId IdType="pubmed">25068516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo W., Xu X., Xu L., Wang F., Ke A., Wang X., Guo C. Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Pancreatology. 2011;11:601&#x2013;609. doi: 10.1159/000333542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000333542</ArticleId><ArticleId IdType="pubmed">22301921</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Yuan Y., Gan H.Z., Peng Q. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol. Lett. 2015;9:2381&#x2013;2387. doi: 10.3892/ol.2015.2988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2015.2988</ArticleId><ArticleId IdType="pmc">PMC4467343</ArticleId><ArticleId IdType="pubmed">26137075</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Liu Z., Zhou X., Peng F., Wang Z., Li F., Li M. Resveratrol Induces Apoptosis, Suppresses Migration, and Invasion of Cervical Cancer Cells by Inhibiting the Hedgehog Signaling Pathway. Biomed. Res. Int. 2022;2022:8453011. doi: 10.1155/2022/8453011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/8453011</ArticleId><ArticleId IdType="pmc">PMC9568329</ArticleId><ArticleId IdType="pubmed">36246980</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Cao L., Chen X., Lei J., Ma Q. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway. Oncol. Rep. 2016;35:1718&#x2013;1726. doi: 10.3892/or.2015.4504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2015.4504</ArticleId><ArticleId IdType="pubmed">26707376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tost J., Gut I.G. DNA methylation analysis by pyrosequencing. Nat. Protoc. 2007;2:2265&#x2013;2275. doi: 10.1038/nprot.2007.314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.314</ArticleId><ArticleId IdType="pubmed">17853883</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S.E., Suderman M.J., Hallett M., Szyf M. DNA demethylation induced by the methyl-CpG-binding domain protein MBD3. Gene. 2008;420:99&#x2013;106. doi: 10.1016/j.gene.2008.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2008.05.009</ArticleId><ArticleId IdType="pubmed">18602768</ArticleId></ArticleIdList></Reference><Reference><Citation>Beetch M., Lubecka K., Shen K., Flower K., Harandi-Zadeh S., Suderman M., Flanagan J.M., Stefanska B. Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor. Mol. Nutr. Food Res. 2019;63:e1801386. doi: 10.1002/mnfr.201801386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201801386</ArticleId><ArticleId IdType="pubmed">31327173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H., Scott E., Kholghi A., Andreadi C., Rufini A., Karmokar A., Britton R.G., Horner-Glister E., Greaves P., Jawad D., et al. Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci. Transl. Med. 2015;7:298ra117. doi: 10.1126/scitranslmed.aaa7619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa7619</ArticleId><ArticleId IdType="pmc">PMC4827609</ArticleId><ArticleId IdType="pubmed">26223300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai Y., Su J., Yang C., Xia C., Fu L. The strategies to cure cancer patients by eradicating cancer stem-like cells. Mol. Cancer. 2023;22:171. doi: 10.1186/s12943-023-01867-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-023-01867-y</ArticleId><ArticleId IdType="pmc">PMC10583358</ArticleId><ArticleId IdType="pubmed">37853413</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J., Johnson L.M., Jacobsen S.E., Patel D.J. DNA methylation pathways and their crosstalk with histone methylation. Nat. Rev. Mol. Cell Biol. 2015;16:519&#x2013;532. doi: 10.1038/nrm4043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm4043</ArticleId><ArticleId IdType="pmc">PMC4672940</ArticleId><ArticleId IdType="pubmed">26296162</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaissiere T., Sawan C., Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 2008;659:40&#x2013;48. doi: 10.1016/j.mrrev.2008.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2008.02.004</ArticleId><ArticleId IdType="pubmed">18407786</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsompana M., Buck M.J. Chromatin accessibility: A window into the genome. Epigenetics Chromatin. 2014;7:33. doi: 10.1186/1756-8935-7-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-8935-7-33</ArticleId><ArticleId IdType="pmc">PMC4253006</ArticleId><ArticleId IdType="pubmed">25473421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Zhang Y., Loh Y.P., Tng J.Q., Lim M.C., Cao Z., Raju A., Lieberman Aiden E., Li S., Manikandan L., et al. H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions. Nat. Commun. 2021;12:719. doi: 10.1038/s41467-021-20940-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-20940-y</ArticleId><ArticleId IdType="pmc">PMC7846766</ArticleId><ArticleId IdType="pubmed">33514712</ArticleId></ArticleIdList></Reference><Reference><Citation>Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA. 2010;107:21931&#x2013;21936. doi: 10.1073/pnas.1016071107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1016071107</ArticleId><ArticleId IdType="pmc">PMC3003124</ArticleId><ArticleId IdType="pubmed">21106759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Zhang Z., Dong Q., Xiong J., Zhu B. Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells. Genome Biol. 2020;21:45. doi: 10.1186/s13059-020-01957-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-020-01957-w</ArticleId><ArticleId IdType="pmc">PMC7035716</ArticleId><ArticleId IdType="pubmed">32085783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramazi S., Zahiri J. Posttranslational modifications in proteins: Resources, tools and prediction methods. Database. 2021;2021:baab012. doi: 10.1093/database/baab012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baab012</ArticleId><ArticleId IdType="pmc">PMC8040245</ArticleId><ArticleId IdType="pubmed">33826699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardito F., Giuliani M., Perrone D., Troiano G., Lo Muzio L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review) Int. J. Mol. Med. 2017;40:271&#x2013;280. doi: 10.3892/ijmm.2017.3036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.3036</ArticleId><ArticleId IdType="pmc">PMC5500920</ArticleId><ArticleId IdType="pubmed">28656226</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah K., Kazi J.U. Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling. Front. Oncol. 2022;12:858782. doi: 10.3389/fonc.2022.858782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.858782</ArticleId><ArticleId IdType="pmc">PMC8964056</ArticleId><ArticleId IdType="pubmed">35359365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C., Xiao G., Hu J. Regulation of Wnt/beta-catenin signaling by posttranslational modifications. Cell Biosci. 2014;4:13. doi: 10.1186/2045-3701-4-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-3701-4-13</ArticleId><ArticleId IdType="pmc">PMC3977945</ArticleId><ArticleId IdType="pubmed">24594309</ArticleId></ArticleIdList></Reference><Reference><Citation>Qadir Nanakali N.M., Maleki Dana P., Sadoughi F., Asemi Z., Sharifi M., Asemi R., Yousefi B. The role of dietary polyphenols in alternating DNA methylation in cancer. Crit. Rev. Food Sci. Nutr. 2023;63:12256&#x2013;12269. doi: 10.1080/10408398.2022.2100313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2100313</ArticleId><ArticleId IdType="pubmed">35848113</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann A., Meir A.Y., Hagemann T., Czechowski P., Muller L., Engelmann B., Haange S.B., Rolle-Kampczyk U., Tsaban G., Zelicha H., et al. A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: The DIRECT PLUS randomized controlled trial. Metabolism. 2023;145:155594. doi: 10.1016/j.metabol.2023.155594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2023.155594</ArticleId><ArticleId IdType="pubmed">37236302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora I., Sharma M., Tollefsbol T.O. Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy. Int. J. Mol. Sci. 2019;20:4567. doi: 10.3390/ijms20184567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184567</ArticleId><ArticleId IdType="pmc">PMC6769666</ArticleId><ArticleId IdType="pubmed">31540128</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Pan Y., Ji J., Xu Y., Zhang Q., Qin L. Roles and action mechanisms of WNT4 in cell differentiation and human diseases: A review. Cell Death Discov. 2021;7:287. doi: 10.1038/s41420-021-00668-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00668-w</ArticleId><ArticleId IdType="pmc">PMC8511224</ArticleId><ArticleId IdType="pubmed">34642299</ArticleId></ArticleIdList></Reference><Reference><Citation>Vouyovitch C.M., Perry J.K., Liu D.X., Bezin L., Vilain E., Diaz J.J., Lobie P.E., Mertani H.C. WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells. Endocr. Relat. Cancer. 2016;23:571&#x2013;585. doi: 10.1530/ERC-15-0528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ERC-15-0528</ArticleId><ArticleId IdType="pubmed">27323961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreibich E., Kleinendorst R., Barzaghi G., Kaspar S., Krebs A.R. Single-molecule footprinting identifies context-dependent regulation of enhancers by DNA methylation. Mol. Cell. 2023;83:787&#x2013;802.e9. doi: 10.1016/j.molcel.2023.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2023.01.017</ArticleId><ArticleId IdType="pubmed">36758546</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Chen X., Lu C. The interplay between DNA and histone methylation: Molecular mechanisms and disease implications. EMBO Rep. 2021;22:e51803. doi: 10.15252/embr.202051803.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202051803</ArticleId><ArticleId IdType="pmc">PMC8097341</ArticleId><ArticleId IdType="pubmed">33844406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Xu J., Sun Y., Cao S., Zeng H., Jin N., Shou M., Tang S., Chen Y., Huang M. Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer. Acta Pharm. Sin. B. 2023;13:2601&#x2013;2612. doi: 10.1016/j.apsb.2023.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2023.03.009</ArticleId><ArticleId IdType="pmc">PMC10326305</ArticleId><ArticleId IdType="pubmed">37425067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Mir R., Galande S. Epigenetic Regulation of the Wnt/beta-Catenin Signaling Pathway in Cancer. Front. Genet. 2021;12:681053. doi: 10.3389/fgene.2021.681053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.681053</ArticleId><ArticleId IdType="pmc">PMC8450413</ArticleId><ArticleId IdType="pubmed">34552611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils L.J., Bijlsma M.F. Epigenetic regulation of the Hedgehog and Wnt pathways in cancer. Crit. Rev. Oncol. Hematol. 2018;121:23&#x2013;44. doi: 10.1016/j.critrevonc.2017.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2017.11.013</ArticleId><ArticleId IdType="pubmed">29279097</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Li Q., Shang R., Yao L., Wu L., Zhang M., Zhang L., Xu M., Lu Z., Zhou J., et al. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/beta-catenin signalling pathway. J. Exp. Clin. Cancer Res. 2020;39:251. doi: 10.1186/s13046-020-01774-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-020-01774-w</ArticleId><ArticleId IdType="pmc">PMC7682076</ArticleId><ArticleId IdType="pubmed">33222684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J., Huang X., Li Z., Shen Y., Lai J., Su Q., Zhao J., Xu J. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/beta-catenin pathway. J. Cell. Physiol. 2019;234:17739&#x2013;17748. doi: 10.1002/jcp.28399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28399</ArticleId><ArticleId IdType="pubmed">30793770</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Zhang X., Lin H., Deng S., Qin Y., He J., Hu F., Zhu X., Feng X., Wang J., et al. Dual activation of Hedgehog and Wnt/beta-catenin signaling pathway caused by downregulation of SUFU targeted by miRNA-150 in human gastric cancer. Aging. 2021;13:10749&#x2013;10769. doi: 10.18632/aging.202895.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202895</ArticleId><ArticleId IdType="pmc">PMC8064165</ArticleId><ArticleId IdType="pubmed">33848981</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracci L., Fabbri A., Del Corno M., Conti L. Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies. Cancers. 2021;13:4499. doi: 10.3390/cancers13184499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13184499</ArticleId><ArticleId IdType="pmc">PMC8465098</ArticleId><ArticleId IdType="pubmed">34572726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobusic Brala C., Karkovic Markovic A., Kugic A., Toric J., Barbaric M. Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies-An Update Overview. Molecules. 2023;28:3746. doi: 10.3390/molecules28093746.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28093746</ArticleId><ArticleId IdType="pmc">PMC10180288</ArticleId><ArticleId IdType="pubmed">37175156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad J., Ahamad J., Algahtani M.S., Garg A., Shahzad N., Ahmad M.Z., Imam S.S. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): Progress and promises. Expert Opin. Drug Deliv. 2024. Online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17425247.2024.2317194</ArticleId><ArticleId IdType="pubmed">38344809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X.L., Lin S.G., Mao Y.W., Wu J.X., Hu C.D., Lv R., Zeng H.D., Zhang M.H., Lin L.Z., Ouyang S.S., et al. Wnt/beta-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine. Expert Rev. Mol. Med. 2023;25:e21. doi: 10.1017/erm.2023.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2023.16</ArticleId><ArticleId IdType="pubmed">37332167</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Han Y., Wu X., Cao X., Gao Z., Sun Y., Wang M., Xiao H. Gut Microbiota-Derived Resveratrol Metabolites, Dihydroresveratrol and Lunularin, Significantly Contribute to the Biological Activities of Resveratrol. Front. Nutr. 2022;9:912591. doi: 10.3389/fnut.2022.912591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.912591</ArticleId><ArticleId IdType="pmc">PMC9131081</ArticleId><ArticleId IdType="pubmed">35634412</ArticleId></ArticleIdList></Reference><Reference><Citation>Springer M., Moco S. Resveratrol and Its Human Metabolites-Effects on Metabolic Health and Obesity. Nutrients. 2019;11:143. doi: 10.3390/nu11010143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11010143</ArticleId><ArticleId IdType="pmc">PMC6357128</ArticleId><ArticleId IdType="pubmed">30641865</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthrie A.R., Chow H.S., Martinez J.A. Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention. Pharmacol. Res. Perspect. 2017;5:e00294. doi: 10.1002/prp2.294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.294</ArticleId><ArticleId IdType="pmc">PMC5461649</ArticleId><ArticleId IdType="pubmed">28596842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38417241</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1618-095X</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Phytomedicine : international journal of phytotherapy and phytopharmacology</Title><ISOAbbreviation>Phytomedicine</ISOAbbreviation></Journal><ArticleTitle>Rubus Occidentalis and its bioactive compounds against cancer: From molecular mechanisms to translational advances.</ArticleTitle><Pagination><StartPage>155029</StartPage><MedlinePgn>155029</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phymed.2023.155029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0944-7113(23)00390-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cancer ranks as the second leading cause of death globally, imposing a significant public health burden. The rise in cancer resistance to current therapeutic agents underscores the potential role of phytotherapy. Black raspberry (BRB, Rubus Occidentalis) is a fruit rich in anthocyanins, ellagic acid, and ellagitannins. Accumulating evidence suggests that BRB exhibits promising anticancer effects, positioning it as a viable candidate for phytotherapy.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This article aims to review the existing research on BRB regarding its role in cancer prevention and treatment. It further analyzes the effective components of BRB, their metabolic pathways, and the potential mechanisms underlying the fruit's anticancer effects.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Ovid MEDLINE, EMBASE, Web of Science, and CENTRAL were searched through the terms of Black Raspberry, Raspberry, and Rubus Occidentali up to January 2023. Two reviewers performed the study selection by screening the title and abstract. Full texts of potentially eligible studies were retrieved to access the details.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of the 767 articles assessed, 73 papers met the inclusion criteria. Among them, 63 papers investigated the anticancer mechanisms, while 10 conducted clinical trials focusing on cancer treatment or prevention. BRB was found to influence multiple cancer hallmarks by targeting various pathways. Decomposition of free radicals and regulation of estrogen metabolism, BRB can reduce DNA damage caused by reactive oxygen species. BRB can also enhance the function of nucleotide excision repair to repair DNA lesions. Through regulation of epigenetics, BRB can enhance the expression of tumor suppressor genes, inducing cell cycle arrest, and promoting apoptosis and pyroptosis. BRB can reduce the energy and nutrients supply to the cancer nest by inhibiting glycolysis and reducing angiogenesis. The immune and inflammatory microenvironment surrounding cancer cells can also be ameliorated by BRB, inhibiting cancer initiation and progression. However, the limited bioavailability of BRB diminishes its anticancer efficacy. Notably, topical applications of BRB, such as gels and suppositories, have demonstrated significant clinical benefits.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">BRB inhibits cancer initiation, progression, and metastasis through diverse anticancer mechanisms while exhibiting minimal side effects. Given its potential, BRB emerges as a promising phototherapeutic agent for cancer treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier GmbH. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guanru</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Hengpei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Materials Science and Engineering, Sichuan University, No.29, Jiuyanqiao Wangjiang Rd., Chengdu 610064, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhishen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yubin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China; Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China. Electronic address: yubin.cao@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chunjie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oral Diseases &amp; National Center for Stomatology &amp; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China; Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section of Ren Min Nan Rd., Chengdu 610041, China. Electronic address: lichunjie@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Phytomedicine</MedlineTA><NlmUniqueID>9438794</NlmUniqueID><ISSNLinking>0944-7113</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000872">Anthocyanins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000872" MajorTopicYN="N">Anthocyanins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005638" MajorTopicYN="N">Fruit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008517" MajorTopicYN="N">Phytotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065856" MajorTopicYN="Y">Rubus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059016" MajorTopicYN="N">Tumor Microenvironment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anthocyanin</Keyword><Keyword MajorTopicYN="N">Anticancer</Keyword><Keyword MajorTopicYN="N">Mechanism</Keyword><Keyword MajorTopicYN="N">Rubus occidentalis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>28</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38417241</ArticleId><ArticleId IdType="doi">10.1016/j.phymed.2023.155029</ArticleId><ArticleId IdType="pii">S0944-7113(23)00390-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38337680</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">396</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16030396</ELocationID><Abstract><AbstractText>Cancer etiology involves complex interactions between genetic and non-genetic factors, with epigenetic mechanisms serving as key regulators at multiple stages of pathogenesis. Poor dietary habits contribute to cancer predisposition by impacting DNA methylation patterns, non-coding RNA expression, and histone epigenetic landscapes. Histone post-translational modifications (PTMs), including acyl marks, act as a molecular code and play a crucial role in translating changes in cellular metabolism into enduring patterns of gene expression. As cancer cells undergo metabolic reprogramming to support rapid growth and proliferation, nuanced roles have emerged for dietary- and metabolism-derived histone acylation changes in cancer progression. Specific types and mechanisms of histone acylation, beyond the standard acetylation marks, shed light on how dietary metabolites reshape the gut microbiome, influencing the dynamics of histone acyl repertoires. Given the reversible nature of histone PTMs, the corresponding acyl readers, writers, and erasers are discussed in this review in the context of cancer prevention and treatment. The evolving 'acyl code' provides for improved biomarker assessment and clinical validation in cancer diagnosis and prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neja</LastName><ForeName>Sultan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3972-0016</Identifier><AffiliationInfo><Affiliation>Center for Epigenetics &amp; Disease Prevention, Texas A&amp;M Health, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dashwood</LastName><ForeName>Wan Mohaiza</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Center for Epigenetics &amp; Disease Prevention, Texas A&amp;M Health, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dashwood</LastName><ForeName>Roderick H</ForeName><Initials>RH</Initials><Identifier Source="ORCID">0000-0003-0351-4034</Identifier><AffiliationInfo><Affiliation>Center for Epigenetics &amp; Disease Prevention, Texas A&amp;M Health, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Medical Sciences, Texas A&amp;M College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajendran</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6221-7366</Identifier><AffiliationInfo><Affiliation>Center for Epigenetics &amp; Disease Prevention, Texas A&amp;M Health, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Medical Sciences, Texas A&amp;M College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Antibody &amp; Biopharmaceuticals Core, Texas A&amp;M Health, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA122959</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA257559</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA122959</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>CA257559</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="Y">Histones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042421" MajorTopicYN="N">Histone Code</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acyl code</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">diet</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">histones</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>11</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38337680</ArticleId><ArticleId IdType="pmc">PMC10857208</ArticleId><ArticleId IdType="doi">10.3390/nu16030396</ArticleId><ArticleId IdType="pii">nu16030396</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Pi&#xf1;eros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; Lyon, France: 2020.</Citation></Reference><Reference><Citation>Ilango S., Paital B., Jayachandran P., Padma P.R., Nirmaladevi R. Epigenetic alterations in cancer. Front. Biosci.-Landmark. 2020;25:1058&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">32114424</ArticleId></ArticleIdList></Reference><Reference><Citation>Baylin S.B., Jones P.A. Epigenetic determinants of cancer. Cold Spring Harb. Perspect. Biol. 2016;8:a019505. doi: 10.1101/cshperspect.a019505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a019505</ArticleId><ArticleId IdType="pmc">PMC5008069</ArticleId><ArticleId IdType="pubmed">27194046</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L.N., Tan J., Chen Y.X., Fang J.Y. Genetic variants in the histone methylation and acetylation pathway and their risks in eight types of cancers. J. Dig. Dis. 2018;19:102&#x2013;111. doi: 10.1111/1751-2980.12574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-2980.12574</ArticleId><ArticleId IdType="pubmed">29292860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X., Zhou Y., Xue Z., Hao N., Li Y., Guo X., Wang D., Shi X., Li H. Histone benzoylation serves as an epigenetic mark for DPF and YEATS family proteins. Nucleic Acids Res. 2021;49:114&#x2013;126. doi: 10.1093/nar/gkaa1130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1130</ArticleId><ArticleId IdType="pmc">PMC7797077</ArticleId><ArticleId IdType="pubmed">33290558</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchegaray J.P., Mostoslavsky R. Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes. Mol. Cell. 2016;62:695&#x2013;711. doi: 10.1016/j.molcel.2016.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.029</ArticleId><ArticleId IdType="pmc">PMC4893201</ArticleId><ArticleId IdType="pubmed">27259202</ArticleId></ArticleIdList></Reference><Reference><Citation>Simithy J., Sidoli S., Yuan Z.-F., Coradin M., Bhanu N.V., Marchione D.M., Klein B.J., Bazilevsky G.A., McCullough C.E., Magin R.S. Characterization of histone acylations links chromatin modifications with metabolism. Nat. Commun. 2017;8:1141. doi: 10.1038/s41467-017-01384-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01384-9</ArticleId><ArticleId IdType="pmc">PMC5656686</ArticleId><ArticleId IdType="pubmed">29070843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabari B.R., Zhang D., Allis C.D., Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat. Rev. Mol. Cell Biol. 2017;18:90&#x2013;101. doi: 10.1038/nrm.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2016.140</ArticleId><ArticleId IdType="pmc">PMC5320945</ArticleId><ArticleId IdType="pubmed">27924077</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Shi Z., Bao L. An expanding repertoire of protein acylations. Mol. Cell. Proteom. 2022;21:100193. doi: 10.1016/j.mcpro.2022.100193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2022.100193</ArticleId><ArticleId IdType="pmc">PMC8933697</ArticleId><ArticleId IdType="pubmed">34999219</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Cooper D.E., Cluntun A.A., Warmoes M.O., Zhao S., Reid M.A., Liu J., Lund P.J., Lopes M., Garcia B.A., et al. Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals. Cell. 2018;175:502&#x2013;513.e513. doi: 10.1016/j.cell.2018.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.08.040</ArticleId><ArticleId IdType="pmc">PMC6173642</ArticleId><ArticleId IdType="pubmed">30245009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kebede A.F., Nieborak A., Shahidian L.Z., Le Gras S., Richter F., Gomez D.A., Baltissen M.P., Meszaros G., Magliarelli H.d.F., Taudt A. Histone propionylation is a mark of active chromatin. Nat. Struct. Mol. Biol. 2017;24:1048&#x2013;1056. doi: 10.1038/nsmb.3490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3490</ArticleId><ArticleId IdType="pubmed">29058708</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z., Wu H., Kim S., Yang X., Li Q., Huang H., Cai H., Bartlett M.G., Dong A., Zeng H. Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first) J. Biol. Chem. 2018;293:3410&#x2013;3420. doi: 10.1074/jbc.RA117.000529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.000529</ArticleId><ArticleId IdType="pmc">PMC5836141</ArticleId><ArticleId IdType="pubmed">29321206</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmuth F., Geyer M. Interaction of propionylated and butyrylated histone H3 lysine marks with Brd4 bromodomains. Angew. Chem. 2010;122:6920&#x2013;6924. doi: 10.1002/ange.201002724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ange.201002724</ArticleId><ArticleId IdType="pubmed">20715035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Zhang X., Li H. Beyond histone acetylation&#x2014;Writing and erasing histone acylations. Curr. Opin. Struct. Biol. 2018;53:169&#x2013;177. doi: 10.1016/j.sbi.2018.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2018.10.001</ArticleId><ArticleId IdType="pubmed">30391813</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M.Y., Cho H.S. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers. J. Microbiol. Biotechnol. 2023;33:849&#x2013;856. doi: 10.4014/jmb.2301.01031.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.2301.01031</ArticleId><ArticleId IdType="pmc">PMC10394342</ArticleId><ArticleId IdType="pubmed">37100764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Yu J., Li F., Ge S. Oncometabolites drive tumorigenesis by enhancing protein acylation: From chromosomal remodelling to nonhistone modification. J. Exp. Clin. Cancer Res. 2022;41:144. doi: 10.1186/s13046-022-02338-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-022-02338-w</ArticleId><ArticleId IdType="pmc">PMC9013066</ArticleId><ArticleId IdType="pubmed">35428309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Jin J., Chung M.W.H., Feng L., Sun H., Hao Q. Identification of the YEATS domain of GAS41 as a pH-dependent reader of histone succinylation. Proc. Natl. Acad. Sci. USA. 2018;115:2365&#x2013;2370. doi: 10.1073/pnas.1717664115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1717664115</ArticleId><ArticleId IdType="pmc">PMC5877980</ArticleId><ArticleId IdType="pubmed">29463709</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews F.H., Shinsky S.A., Shanle E.K., Bridgers J.B., Gest A., Tsun I.K., Krajewski K., Shi X., Strahl B.D., Kutateladze T.G. The Taf14 YEATS domain is a reader of histone crotonylation. Nat. Chem. Biol. 2016;12:396&#x2013;398. doi: 10.1038/nchembio.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2065</ArticleId><ArticleId IdType="pmc">PMC4871749</ArticleId><ArticleId IdType="pubmed">27089029</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J., Zhou Y., Su X., Yu J.J., Khan S., Jiang H., Kim J., Woo J., Kim J.H., Choi B.H. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science. 2011;334:806&#x2013;809. doi: 10.1126/science.1207861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1207861</ArticleId><ArticleId IdType="pmc">PMC3217313</ArticleId><ArticleId IdType="pubmed">22076378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D., Guan H., Zhao S., Mi W., Wen H., Li Y., Zhao Y., Allis C.D., Shi X., Li H. YEATS2 is a selective histone crotonylation reader. Cell Res. 2016;26:629&#x2013;632. doi: 10.1038/cr.2016.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2016.49</ArticleId><ArticleId IdType="pmc">PMC4856769</ArticleId><ArticleId IdType="pubmed">27103431</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellows R., Denizot J., Stellato C., Cuomo A., Jain P., Stoyanova E., Bal&#xe1;zsi S., Hajn&#xe1;dy Z., Liebert A., Kazakevych J., et al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat. Commun. 2018;9:105. doi: 10.1038/s41467-017-02651-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02651-5</ArticleId><ArticleId IdType="pmc">PMC5760624</ArticleId><ArticleId IdType="pubmed">29317660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan D., Wei W., Han Z., Ren X., Yan C., Qi S., Song X., Zheng Y.G., Wong J., Huang H. HBO1 catalyzes lysine benzoylation in mammalian cells. iScience. 2022;25:105443. doi: 10.1016/j.isci.2022.105443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105443</ArticleId><ArticleId IdType="pmc">PMC9647509</ArticleId><ArticleId IdType="pubmed">36388951</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Cao R., Niu J., Yang S., Ma H., Zhao S., Li H. Molecular basis for hierarchical histone de-&#x3b2;-hydroxybutyrylation by SIRT3. Cell Discov. 2019;5:35. doi: 10.1038/s41421-019-0103-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-019-0103-0</ArticleId><ArticleId IdType="pmc">PMC6796883</ArticleId><ArticleId IdType="pubmed">31636949</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaffney D.O., Jennings E.Q., Anderson C.C., Marentette J.O., Shi T., Oxvig A.-M.S., Streeter M.D., Johannsen M., Spiegel D.A., Chapman E. Non-enzymatic lysine lactoylation of glycolytic enzymes. Cell Chem. Biol. 2020;27:206&#x2013;213.e206. doi: 10.1016/j.chembiol.2019.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2019.11.005</ArticleId><ArticleId IdType="pmc">PMC7395678</ArticleId><ArticleId IdType="pubmed">31767537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Cheng X., He Y., Xie Y., Xu F., Xu Y., Huang W. Function and mechanism of histone &#x3b2;-hydroxybutyrylation in health and disease. Front. Immunol. 2022;13:981285. doi: 10.3389/fimmu.2022.981285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981285</ArticleId><ArticleId IdType="pmc">PMC9511043</ArticleId><ArticleId IdType="pubmed">36172354</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Luo Z., Qi S., Huang J., Xu P., Wang X., Gao L., Li F., Wang J., Zhao W. Landscape of the regulatory elements for lysine 2-hydroxyisobutyrylation pathway. Cell Res. 2018;28:111&#x2013;125. doi: 10.1038/cr.2017.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2017.149</ArticleId><ArticleId IdType="pmc">PMC5752845</ArticleId><ArticleId IdType="pubmed">29192674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Bons J., Scheidemantle G., Liu X., Bielska O., Carrico C., Rose J., Heckenbach I., Scheibye-Knudsen M., Schilling B., et al. Histone malonylation is regulated by SIRT5 and KAT2A. iScience. 2023;26:106193. doi: 10.1016/j.isci.2023.106193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106193</ArticleId><ArticleId IdType="pmc">PMC9985052</ArticleId><ArticleId IdType="pubmed">36879797</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteom. 2012;11:100&#x2013;107. doi: 10.1074/mcp.M111.015875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M111.015875</ArticleId><ArticleId IdType="pmc">PMC3418837</ArticleId><ArticleId IdType="pubmed">22389435</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y., Zwaans B.M., Skinner M.E. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell. 2013;50:919&#x2013;930. doi: 10.1016/j.molcel.2013.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.06.001</ArticleId><ArticleId IdType="pmc">PMC3769971</ArticleId><ArticleId IdType="pubmed">23806337</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Sabari B.R., Panchenko T., Wen H., Zhao D., Guan H., Wan L., Huang H., Tang Z., Zhao Y. Molecular coupling of histone crotonylation and active transcription by AF9 YEATS domain. Mol. Cell. 2016;62:181&#x2013;193. doi: 10.1016/j.molcel.2016.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.03.028</ArticleId><ArticleId IdType="pmc">PMC4841940</ArticleId><ArticleId IdType="pubmed">27105114</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakabe K., Wang Z., Hart G.W. &#x3b2;-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc. Natl. Acad. Sci. USA. 2010;107:19915&#x2013;19920. doi: 10.1073/pnas.1009023107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009023107</ArticleId><ArticleId IdType="pmc">PMC2993388</ArticleId><ArticleId IdType="pubmed">21045127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou C., Ellis B.M., Smith R.M., Chen B.B., Zhao Y., Mallampalli R.K. Acyl-CoA: Lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis. J. Biol. Chem. 2011;286:28019&#x2013;28025. doi: 10.1074/jbc.M111.253385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.253385</ArticleId><ArticleId IdType="pmc">PMC3151047</ArticleId><ArticleId IdType="pubmed">21685381</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Khan S., Wang Y., Charron G., He B., Sebastian C., Du J., Kim R., Ge E., Mostoslavsky R., et al. SIRT6 regulates TNF-&#x3b1; secretion through hydrolysis of long-chain fatty acyl lysine. Nature. 2013;496:110&#x2013;113. doi: 10.1038/nature12038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12038</ArticleId><ArticleId IdType="pmc">PMC3635073</ArticleId><ArticleId IdType="pubmed">23552949</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Yang T., Li X., Peng T., Hang H.C., Li X.D. Integrative chemical biology approaches to examine &#x2018;erasers&#x2019; for protein lysine fatty-acylation. Angew. Chem. (Int. Ed. Engl.) 2015;54:1149. doi: 10.1002/anie.201408763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201408763</ArticleId><ArticleId IdType="pmc">PMC4382910</ArticleId><ArticleId IdType="pubmed">25476551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E., H Bisson W., V Lohr C., E Williams D., Ho E., H Dashwood R., Rajendran P. Histone and non-histone targets of dietary deacetylase inhibitors. Curr. Top. Med. Chem. 2016;16:714&#x2013;731. doi: 10.2174/1568026615666150825125857.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026615666150825125857</ArticleId><ArticleId IdType="pmc">PMC5087604</ArticleId><ArticleId IdType="pubmed">26303421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur J., Daoud A., Eblen S.T. Targeting chromatin remodeling for cancer therapy. Curr. Mol. Pharmacol. 2019;12:215. doi: 10.2174/1874467212666190215112915.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874467212666190215112915</ArticleId><ArticleId IdType="pmc">PMC6875867</ArticleId><ArticleId IdType="pubmed">30767757</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqi A.A., Fayyaz S., Poltronieri P., Calin G., Mallardo M. Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs. Semin. Cancer Biol. 2022;83:197&#x2013;207. doi: 10.1016/j.semcancer.2020.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2020.07.013</ArticleId><ArticleId IdType="pubmed">32738290</ArticleId></ArticleIdList></Reference><Reference><Citation>Blot W.J., Tarone R.E. Doll and Peto&#x2019;s quantitative estimates of cancer risks: Holding generally true for 35 years. JNCI J. Natl. Cancer Inst. 2015;107:djv044. doi: 10.1093/jnci/djv044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djv044</ArticleId><ArticleId IdType="pubmed">25739419</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll R., Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. JNCI J. Natl. Cancer Inst. 1981;66:1192&#x2013;1308. doi: 10.1093/jnci/66.6.1192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/66.6.1192</ArticleId><ArticleId IdType="pubmed">7017215</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo D., Horio D.T., Grove J.S., Dashwood R.H. Inhibition by chlorophyllin of 2-amino-3-methylimidazo-[4,5-f] quinoline-induced tumorigenesis in the male F344 rat. Cancer Lett. 1995;95:161&#x2013;165. doi: 10.1016/0304-3835(95)03882-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3835(95)03882-W</ArticleId><ArticleId IdType="pubmed">7656225</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Dashwood W.M., Nian H., L&#xf6;hr C.V., Fischer K.A., Tsuchiya N., Nakagama H., Ashktorab H., Dashwood R.H. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP) Int. J. Cancer. 2011;128:2581&#x2013;2590. doi: 10.1002/ijc.25610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.25610</ArticleId><ArticleId IdType="pmc">PMC3262595</ArticleId><ArticleId IdType="pubmed">20715105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y., Nian H., Rajendran P., Kim E., Dashwood W., Pinto J., Boardman L., Thibodeau S., Limburg P., L&#xf6;hr C. HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death Dis. 2014;5:e1476. doi: 10.1038/cddis.2014.422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.422</ArticleId><ArticleId IdType="pmc">PMC4237248</ArticleId><ArticleId IdType="pubmed">25321483</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum C.A., Xu M., Orner G.A., Fong A.T., Bailey G.S., Stoner G.D., Horio D.T., Dashwood R.H. &#x3b2;-Catenin mutation in rat colon tumors initiated by 1, 2-dimethylhydrazine and 2-amino-3-methylimidazo [4, 5-f] quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis. 2001;22:315&#x2013;320. doi: 10.1093/carcin/22.2.315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/22.2.315</ArticleId><ArticleId IdType="pubmed">11181454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer C.M., Lynch T.P., Sodi V.L., Falcone J.N., Schwab L.P., Peacock D.L., Vocadlo D.J., Seagroves T.N., Reginato M.J. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol. Cell. 2014;54:820&#x2013;831. doi: 10.1016/j.molcel.2014.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.04.026</ArticleId><ArticleId IdType="pmc">PMC4104413</ArticleId><ArticleId IdType="pubmed">24857547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-A., Yeom Y.I. Metabolic signaling to epigenetic alterations in cancer. Biomol. Ther. 2018;26:69. doi: 10.4062/biomolther.2017.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2017.185</ArticleId><ArticleId IdType="pmc">PMC5746039</ArticleId><ArticleId IdType="pubmed">29212308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaelin W.G., McKnight S.L. Influence of metabolism on epigenetics and disease. Cell. 2013;153:56&#x2013;69. doi: 10.1016/j.cell.2013.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.03.004</ArticleId><ArticleId IdType="pmc">PMC3775362</ArticleId><ArticleId IdType="pubmed">23540690</ArticleId></ArticleIdList></Reference><Reference><Citation>Trefely S., Lovell C.D., Snyder N.W., Wellen K.E. Compartmentalised acyl-CoA metabolism and roles in chromatin regulation. Mol. Metab. 2020;38:100941. doi: 10.1016/j.molmet.2020.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2020.01.005</ArticleId><ArticleId IdType="pmc">PMC7300382</ArticleId><ArticleId IdType="pubmed">32199817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund P.J., Gates L.A., Leboeuf M., Smith S.A., Chau L., Lopes M., Friedman E.S., Saiman Y., Kim M.S., Shoffler C.A., et al. Stable isotope tracing in vivo reveals a metabolic bridge linking the microbiota to host histone acetylation. Cell Rep. 2022;41:111809. doi: 10.1016/j.celrep.2022.111809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111809</ArticleId><ArticleId IdType="pmc">PMC9994635</ArticleId><ArticleId IdType="pubmed">36516747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Zhang Y., Chen X.-F., Tang X. Acylations in cardiovascular biology and diseases, what&#x2019;s beyond acetylation. Ebiomedicine. 2023;87:104418. doi: 10.1016/j.ebiom.2022.104418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104418</ArticleId><ArticleId IdType="pmc">PMC9808004</ArticleId><ArticleId IdType="pubmed">36584593</ArticleId></ArticleIdList></Reference><Reference><Citation>Trub A.G., Hirschey M.D. Reactive acyl-CoA species modify proteins and induce carbon stress. Trends Biochem. Sci. 2018;43:369&#x2013;379. doi: 10.1016/j.tibs.2018.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2018.02.002</ArticleId><ArticleId IdType="pmc">PMC5924595</ArticleId><ArticleId IdType="pubmed">29478872</ArticleId></ArticleIdList></Reference><Reference><Citation>Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 2000;403:41&#x2013;45. doi: 10.1038/47412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/47412</ArticleId><ArticleId IdType="pubmed">10638745</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B.N., Zhang G., Hwa Y.L., Li J., Dowdy S.C., Jiang S.-W. Nonhistone protein acetylation as cancer therapy targets. Expert Rev. Anticancer. Ther. 2010;10:935&#x2013;954. doi: 10.1586/era.10.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/era.10.62</ArticleId><ArticleId IdType="pmc">PMC3273412</ArticleId><ArticleId IdType="pubmed">20553216</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Zhang C., Hassan S., Liu X., Song F., Chen K., Zhang W., Yang J. Histone deacetylase 6 in cancer. J. Hematol. Oncol. 2018;11:111. doi: 10.1186/s13045-018-0654-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-018-0654-9</ArticleId><ArticleId IdType="pmc">PMC6122547</ArticleId><ArticleId IdType="pubmed">30176876</ArticleId></ArticleIdList></Reference><Reference><Citation>Deakin N.O., Turner C.E. Paxillin inhibits HDAC6 to regulate microtubule acetylation, Golgi structure, and polarized migration. J. Cell Biol. 2014;206:395&#x2013;413. doi: 10.1083/jcb.201403039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201403039</ArticleId><ArticleId IdType="pmc">PMC4121979</ArticleId><ArticleId IdType="pubmed">25070956</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein B.J., Jang S.M., Lachance C., Mi W., Lyu J., Sakuraba S., Krajewski K., Wang W.W., Sidoli S., Liu J. Histone H3K23-specific acetylation by MORF is coupled to H3K14 acylation. Nat. Commun. 2019;10:4724. doi: 10.1038/s41467-019-12551-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12551-5</ArticleId><ArticleId IdType="pmc">PMC6797804</ArticleId><ArticleId IdType="pubmed">31624313</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A., Buchou T., Rousseaux S., Jin F., et al. Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark. Nat. Chem. Biol. 2014;10:365&#x2013;370. doi: 10.1038/nchembio.1497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1497</ArticleId><ArticleId IdType="pubmed">24681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z., Buchou T., Vitte A.-L., He T., et al. Dynamic Competing Histone H4 K5K8 Acetylation and Butyrylation Are Hallmarks of Highly Active Gene Promoters. Mol. Cell. 2016;62:169&#x2013;180. doi: 10.1016/j.molcel.2016.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.03.014</ArticleId><ArticleId IdType="pmc">PMC4850424</ArticleId><ArticleId IdType="pubmed">27105113</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabari B.R., Tang Z., Huang H., Yong-Gonzalez V., Molina H., Kong H.E., Dai L., Shimada M., Cross J.R., Zhao Y., et al. Intracellular Crotonyl-CoA Stimulates Transcription through p300-Catalyzed Histone Crotonylation. Mol. Cell. 2015;58:203&#x2013;215. doi: 10.1016/j.molcel.2015.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.02.029</ArticleId><ArticleId IdType="pmc">PMC4501262</ArticleId><ArticleId IdType="pubmed">25818647</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J., Colak G., Chen Y., et al. Metabolic Regulation of Gene Expression by Histone Lysine &#x3b2;-Hydroxybutyrylation. Mol. Cell. 2016;62:194&#x2013;206. doi: 10.1016/j.molcel.2016.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.03.036</ArticleId><ArticleId IdType="pmc">PMC5540445</ArticleId><ArticleId IdType="pubmed">27105115</ArticleId></ArticleIdList></Reference><Reference><Citation>Smestad J., Erber L., Chen Y., Maher L.J. Chromatin succinylation correlates with active gene expression and is perturbed by defective TCA cycle metabolism. Iscience. 2018;2:63&#x2013;75. doi: 10.1016/j.isci.2018.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2018.03.012</ArticleId><ArticleId IdType="pmc">PMC5993049</ArticleId><ArticleId IdType="pubmed">29888767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y., Wong J.W.H., Yuen K.W.Y., Li X.D. Glutarylation of Histone H4 Lysine 91 Regulates Chromatin Dynamics. Mol. Cell. 2019;76:660&#x2013;675.e669. doi: 10.1016/j.molcel.2019.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.08.018</ArticleId><ArticleId IdType="pubmed">31542297</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhang D., Wang Y., Perez-Neut M., Han Z., Zheng Y.G., Hao Q., Zhao Y. Lysine benzoylation is a histone mark regulated by SIRT2. Nat. Commun. 2018;9:3374. doi: 10.1038/s41467-018-05567-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05567-w</ArticleId><ArticleId IdType="pmc">PMC6113264</ArticleId><ArticleId IdType="pubmed">30154464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Tang Z., Huang H., Zhou G., Cui C., Weng Y., Liu W., Kim S., Lee S., Perez-Neut M., et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575&#x2013;580. doi: 10.1038/s41586-019-1678-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1678-1</ArticleId><ArticleId IdType="pmc">PMC6818755</ArticleId><ArticleId IdType="pubmed">31645732</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo C., Park S., Oh S., Choi J., Kim E.-K., Youn H.-D., Cho E.-J. Histone acylation marks respond to metabolic perturbations and enable cellular adaptation. Exp. Mol. Med. 2020;52:2005&#x2013;2019. doi: 10.1038/s12276-020-00539-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00539-x</ArticleId><ArticleId IdType="pmc">PMC8080766</ArticleId><ArticleId IdType="pubmed">33311704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Peng J., Jiang S. Role of histone acetyltransferases and histone deacetylases in adipocyte differentiation and adipogenesis. Eur. J. Cell Biol. 2014;93:170&#x2013;177. doi: 10.1016/j.ejcb.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2014.03.001</ArticleId><ArticleId IdType="pubmed">24810880</ArticleId></ArticleIdList></Reference><Reference><Citation>Peserico A., Simone C. Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J. Biomed. Biotechnol. 2011;2011:371832. doi: 10.1155/2011/371832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/371832</ArticleId><ArticleId IdType="pmc">PMC2997516</ArticleId><ArticleId IdType="pubmed">21151613</ArticleId></ArticleIdList></Reference><Reference><Citation>Wapenaar H., Dekker F.J. Histone acetyltransferases: Challenges in targeting bi-substrate enzymes. Clin. Epigenetics. 2016;8:59. doi: 10.1186/s13148-016-0225-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-016-0225-2</ArticleId><ArticleId IdType="pmc">PMC4881052</ArticleId><ArticleId IdType="pubmed">27231488</ArticleId></ArticleIdList></Reference><Reference><Citation>Audia J.E., Campbell R.M. Histone modifications and cancer. Cold Spring Harb. Perspect. Biol. 2016;8:a019521. doi: 10.1101/cshperspect.a019521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a019521</ArticleId><ArticleId IdType="pmc">PMC4817802</ArticleId><ArticleId IdType="pubmed">27037415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee A., Rodger E.J., Eccles M.R. Epigenetic drivers of tumourigenesis and cancer metastasis. Semin. Cancer Biol. 2018;51:149&#x2013;159. doi: 10.1016/j.semcancer.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2017.08.004</ArticleId><ArticleId IdType="pubmed">28807546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta A., Abmayr S.M., Workman J.L. Diverse Activities of Histone Acylations Connect Metabolism to Chromatin Function. Mol. Cell. 2016;63:547&#x2013;552. doi: 10.1016/j.molcel.2016.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.06.038</ArticleId><ArticleId IdType="pmc">PMC5298895</ArticleId><ArticleId IdType="pubmed">27540855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalieri V. The expanding constellation of histone post-translational modifications in the epigenetic landscape. Genes. 2021;12:1596. doi: 10.3390/genes12101596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12101596</ArticleId><ArticleId IdType="pmc">PMC8535662</ArticleId><ArticleId IdType="pubmed">34680990</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Cat A., Zheng Y.G. New Histone Lysine Acylation Biomarkers and Their Roles in Epigenetic Regulation. Curr. Protoc. 2023;3:e746. doi: 10.1002/cpz1.746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.746</ArticleId><ArticleId IdType="pubmed">37098732</ArticleId></ArticleIdList></Reference><Reference><Citation>Grevengoed T.J., Klett E.L., Coleman R.A. Acyl-CoA metabolism and partitioning. Annu. Rev. Nutr. 2014;34:1&#x2013;30. doi: 10.1146/annurev-nutr-071813-105541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-071813-105541</ArticleId><ArticleId IdType="pmc">PMC5881898</ArticleId><ArticleId IdType="pubmed">24819326</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison A.J. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation. FEBS J. 2022;289:1302&#x2013;1314. doi: 10.1111/febs.16032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16032</ArticleId><ArticleId IdType="pmc">PMC8613311</ArticleId><ArticleId IdType="pubmed">34036737</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrocola F., Galluzzi L., Bravo-San Pedro J.M., Madeo F., Kroemer G. Acetyl coenzyme A: A central metabolite and second messenger. Cell Metab. 2015;21:805&#x2013;821. doi: 10.1016/j.cmet.2015.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.05.014</ArticleId><ArticleId IdType="pubmed">26039447</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Z., Ramesh V., Locasale J.W. The evolving metabolic landscape of chromatin biology and epigenetics. Nat. Rev. Genet. 2020;21:737&#x2013;753. doi: 10.1038/s41576-020-0270-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-020-0270-8</ArticleId><ArticleId IdType="pmc">PMC8059378</ArticleId><ArticleId IdType="pubmed">32908249</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Guo Y.R., Liu K., Yin Z., Liu R., Xia Y., Tan L., Yang P., Lee J.-H., Li X.-j. KAT2A coupled with the &#x3b1;-KGDH complex acts as a histone H3 succinyltransferase. Nature. 2017;552:273&#x2013;277. doi: 10.1038/nature25003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25003</ArticleId><ArticleId IdType="pmc">PMC5841452</ArticleId><ArticleId IdType="pubmed">29211711</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T., Cheng Z., Rousseaux S., Rajagopal N. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell. 2011;146:1016&#x2013;1028. doi: 10.1016/j.cell.2011.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.08.008</ArticleId><ArticleId IdType="pmc">PMC3176443</ArticleId><ArticleId IdType="pubmed">21925322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntorla A., Burgoyne J.R. The regulation and function of histone crotonylation. Front. Cell Dev. Biol. 2021;9:624914. doi: 10.3389/fcell.2021.624914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.624914</ArticleId><ArticleId IdType="pmc">PMC8055951</ArticleId><ArticleId IdType="pubmed">33889571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorro Shahidian L., Haas M., Le Gras S., Nitsch S., Mour&#xe3;o A., Geerlof A., Margueron R., Michaelis J., Daujat S., Schneider R. Succinylation of H3K122 destabilizes nucleosomes and enhances transcription. EMBO Rep. 2021;22:e51009. doi: 10.15252/embr.202051009.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202051009</ArticleId><ArticleId IdType="pmc">PMC7926236</ArticleId><ArticleId IdType="pubmed">33512761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R., Peng J., Gu W., Zhao Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteom. 2007;6:812&#x2013;819. doi: 10.1074/mcp.M700021-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M700021-MCP200</ArticleId><ArticleId IdType="pmc">PMC2911958</ArticleId><ArticleId IdType="pubmed">17267393</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Zhang D., Weng Y., Delaney K., Tang Z., Yan C., Qi S., Peng C., Cole P.A., Roeder R.G. The regulatory enzymes and protein substrates for the lysine &#x3b2;-hydroxybutyrylation pathway. Sci. Adv. 2021;7:eabe2771. doi: 10.1126/sciadv.abe2771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe2771</ArticleId><ArticleId IdType="pmc">PMC7904266</ArticleId><ArticleId IdType="pubmed">33627428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324:1076&#x2013;1080. doi: 10.1126/science.1164097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1164097</ArticleId><ArticleId IdType="pmc">PMC2746744</ArticleId><ArticleId IdType="pubmed">19461003</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H., McCaffery J.M., Irizarry R.A., Boeke J.D. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell. 2006;23:207&#x2013;217. doi: 10.1016/j.molcel.2006.05.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2006.05.040</ArticleId><ArticleId IdType="pubmed">16857587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.V., Carrer A., Shah S., Snyder N.W., Wei S., Venneti S., Worth A.J., Yuan Z.-F., Lim H.-W., Liu S. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 2014;20:306&#x2013;319. doi: 10.1016/j.cmet.2014.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.06.004</ArticleId><ArticleId IdType="pmc">PMC4151270</ArticleId><ArticleId IdType="pubmed">24998913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai L., Sutter B.M., Li B., Tu B.P. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell. 2011;42:426&#x2013;437. doi: 10.1016/j.molcel.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.05.004</ArticleId><ArticleId IdType="pmc">PMC3109073</ArticleId><ArticleId IdType="pubmed">21596309</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett J.R., Puthillathu N., Vengilote R., Jaworski D.M., Namboodiri A.M. Acetate revisited: A key biomolecule at the nexus of metabolism, epigenetics and oncogenesis&#x2014;Part 1: Acetyl-CoA, acetogenesis and acyl-CoA short-chain synthetases. Front. Physiol. 2020;11:580167. doi: 10.3389/fphys.2020.580167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.580167</ArticleId><ArticleId IdType="pmc">PMC7689297</ArticleId><ArticleId IdType="pubmed">33281616</ArticleId></ArticleIdList></Reference><Reference><Citation>Legube G., Trouche D. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 2003;4:944&#x2013;947. doi: 10.1038/sj.embor.embor941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.embor941</ArticleId><ArticleId IdType="pmc">PMC1326399</ArticleId><ArticleId IdType="pubmed">14528264</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler C., T&#xfc;ting C., Meleshin M., Steegborn C., Schutkowski M. A novel continuous assay for the deacylase sirtuin 5 and other deacetylases. J. Med. Chem. 2015;58:7217&#x2013;7223. doi: 10.1021/acs.jmedchem.5b00293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00293</ArticleId><ArticleId IdType="pubmed">26308971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Ma X., He Y., Yuan C., Chen Q., Li G., Chen X. Sirtuin 5: A review of structure, known inhibitors and clues for developing new inhibitors. Sci. China Life Sci. 2017;60:249&#x2013;256. doi: 10.1007/s11427-016-0060-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-016-0060-7</ArticleId><ArticleId IdType="pubmed">27858336</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews A.J., Chen X., Zevin A., Stargell L.A., Luger K. The histone chaperone Nap1 promotes nucleosome assembly by eliminating nonnucleosomal histone DNA interactions. Mol. Cell. 2010;37:834&#x2013;842. doi: 10.1016/j.molcel.2010.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.01.037</ArticleId><ArticleId IdType="pmc">PMC2880918</ArticleId><ArticleId IdType="pubmed">20347425</ArticleId></ArticleIdList></Reference><Reference><Citation>Manohar M., Mooney A.M., North J.A., Nakkula R.J., Picking J.W., Edon A., Fishel R., Poirier M.G., Ottesen J.J. Acetylation of histone H3 at the nucleosome dyad alters DNA-histone binding. J. Biol. Chem. 2009;284:23312&#x2013;23321. doi: 10.1074/jbc.M109.003202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.003202</ArticleId><ArticleId IdType="pmc">PMC2749105</ArticleId><ArticleId IdType="pubmed">19520870</ArticleId></ArticleIdList></Reference><Reference><Citation>Khochbin S., Verdel A., Lemercier C., Seigneurin-Berny D. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 2001;11:162&#x2013;166. doi: 10.1016/S0959-437X(00)00174-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-437X(00)00174-X</ArticleId><ArticleId IdType="pubmed">11250139</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldensperger T., Glomb M.A. Pathways of non-enzymatic lysine acylation. Front. Cell Dev. Biol. 2021;9:664553. doi: 10.3389/fcell.2021.664553.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.664553</ArticleId><ArticleId IdType="pmc">PMC8116961</ArticleId><ArticleId IdType="pubmed">33996820</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldensperger T., Eggen M., Kappen J., Winterhalter P.R., Pfirrmann T., Glomb M.A. Comprehensive analysis of posttranslational protein modifications in aging of subcellular compartments. Sci. Rep. 2020;10:7596. doi: 10.1038/s41598-020-64265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64265-0</ArticleId><ArticleId IdType="pmc">PMC7200742</ArticleId><ArticleId IdType="pubmed">32371922</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda H., Sano N., Muto S., Horikoshi M. Simple histone acetylation plays a complex role in the regulation of gene expression. Brief. Funct. Genom. 2006;5:190&#x2013;208. doi: 10.1093/bfgp/ell032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/ell032</ArticleId><ArticleId IdType="pubmed">16980317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczmarska Z., Ortega E., Goudarzi A., Huang H., Kim S., M&#xe1;rquez J.A., Zhao Y., Khochbin S., Panne D. Structure of p300 in complex with acyl-CoA variants. Nat. Chem. Biol. 2017;13:21&#x2013;29. doi: 10.1038/nchembio.2217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2217</ArticleId><ArticleId IdType="pmc">PMC5757799</ArticleId><ArticleId IdType="pubmed">27820805</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay C., Madiraju S.R.M., Aumais A., Joly &#xc9;., Prentki M. A Role for ATP-Citrate Lyase, Malic Enzyme, and Pyruvate/Citrate Cycling in Glucose-induced Insulin Secretion*. J. Biol. Chem. 2007;282:35657&#x2013;35665. doi: 10.1074/jbc.M707294200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M707294200</ArticleId><ArticleId IdType="pubmed">17928289</ArticleId></ArticleIdList></Reference><Reference><Citation>Koren D., Palladino A. Chapter 3&#x2014;Hypoglycemia. In: Weiss R.E., Refetoff S., editors. Genetic Diagnosis of Endocrine Disorders. 2nd ed. Academic Press; San Diego, CA, USA: 2016. pp. 31&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-800892-8.00003-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasl A.-T., Schulze S., Qin C., Graf L.G., Vogt R., Lammers M. Post-translational lysine ac (et) ylation in health, ageing and disease. Biol. Chem. 2022;403:151&#x2013;194. doi: 10.1515/hsz-2021-0139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2021-0139</ArticleId><ArticleId IdType="pubmed">34433238</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.L., Jenesel S.E. Enzymology of butyrate formation by Butyrivibrio fibrisolvens. J. Bacteriol. 1979;138:99&#x2013;104. doi: 10.1128/jb.138.1.99-104.1979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jb.138.1.99-104.1979</ArticleId><ArticleId IdType="pmc">PMC218243</ArticleId><ArticleId IdType="pubmed">35524</ArticleId></ArticleIdList></Reference><Reference><Citation>Seto E., Yoshida M. Erasers of histone acetylation: The histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 2014;6:a018713. doi: 10.1101/cshperspect.a018713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018713</ArticleId><ArticleId IdType="pmc">PMC3970420</ArticleId><ArticleId IdType="pubmed">24691964</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A., Bridgers J.B., Strahl B.D. Expanding the Reader Landscape of Histone Acylation. Structure. 2017;25:571&#x2013;573. doi: 10.1016/j.str.2017.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2017.03.010</ArticleId><ArticleId IdType="pmc">PMC5594408</ArticleId><ArticleId IdType="pubmed">28380336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Daniel J., Espejo A., Lake A., Krishna M., Xia L., Zhang Y., Bedford M.T. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 2006;7:397&#x2013;403. doi: 10.1038/sj.embor.7400625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400625</ArticleId><ArticleId IdType="pmc">PMC1456902</ArticleId><ArticleId IdType="pubmed">16415788</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheid R., Chen J., Zhong X. Biological role and mechanism of chromatin readers in plants. Curr. Opin. Plant Biol. 2021;61:102008. doi: 10.1016/j.pbi.2021.102008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbi.2021.102008</ArticleId><ArticleId IdType="pmc">PMC8222062</ArticleId><ArticleId IdType="pubmed">33581373</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett R.L., Licht J.D. Targeting epigenetics in cancer. Annu. Rev. Pharmacol. Toxicol. 2018;58:187&#x2013;207. doi: 10.1146/annurev-pharmtox-010716-105106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010716-105106</ArticleId><ArticleId IdType="pmc">PMC5800772</ArticleId><ArticleId IdType="pubmed">28992434</ArticleId></ArticleIdList></Reference><Reference><Citation>Josling G.A., Selvarajah S.A., Petter M., Duffy M.F. The role of bromodomain proteins in regulating gene expression. Genes. 2012;3:320&#x2013;343. doi: 10.3390/genes3020320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes3020320</ArticleId><ArticleId IdType="pmc">PMC3899951</ArticleId><ArticleId IdType="pubmed">24704920</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber F.M., Greenblatt S.M., Davenport A.M., Martinez C., Xu Y., Vu L.P., Nimer S.D., Hoelz A. Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. Proc. Natl. Acad. Sci. USA. 2017;114:6016&#x2013;6021. doi: 10.1073/pnas.1700328114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1700328114</ArticleId><ArticleId IdType="pmc">PMC5468650</ArticleId><ArticleId IdType="pubmed">28533407</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohoe D.R., Collins L.B., Wali A., Bigler R., Sun W., Bultman S.J. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell. 2012;48:612&#x2013;626. doi: 10.1016/j.molcel.2012.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.08.033</ArticleId><ArticleId IdType="pmc">PMC3513569</ArticleId><ArticleId IdType="pubmed">23063526</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran P., Abdelsalam S.A., Renu K., Veeraraghavan V., Ben Ammar R., Ahmed E.A. Polyphenols as potent epigenetics agents for cancer. Int. J. Mol. Sci. 2022;23:11712. doi: 10.3390/ijms231911712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911712</ArticleId><ArticleId IdType="pmc">PMC9570183</ArticleId><ArticleId IdType="pubmed">36233012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonkowski M.S., Sinclair D.A. Slowing ageing by design: The rise of NAD+ and sirtuin-activating compounds. Nat. Rev. Mol. Cell Biol. 2016;17:679&#x2013;690. doi: 10.1038/nrm.2016.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2016.93</ArticleId><ArticleId IdType="pmc">PMC5107309</ArticleId><ArticleId IdType="pubmed">27552971</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne J.C., Denu J.M. The Sirtuin family: Therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 2008;12:11&#x2013;17. doi: 10.1016/j.cbpa.2008.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2008.01.019</ArticleId><ArticleId IdType="pubmed">18282481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-H., Song N.-Y., Suh J., Kim D.-H., Kim W., Ann J., Lee J., Baek J.-H., Na H.-K., Surh Y.-J. Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1. Cancer Lett. 2018;431:219&#x2013;229. doi: 10.1016/j.canlet.2018.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.05.036</ArticleId><ArticleId IdType="pubmed">29807115</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaac A.R., da Silva E.A.N., de Matos R.J.B., Augusto R.L., Moreno G.M.M., Mendon&#xe7;a I.P., de Souza R.F., Cabral-Filho P.E., Rodrigues C.G., Gon&#xe7;alves-Pimentel C., et al. Low omega-6/omega-3 ratio in a maternal protein-deficient diet promotes histone-3 changes in progeny neural cells and favors leukemia inhibitory factor gene transcription. J. Nutr. Biochem. 2018;55:229&#x2013;242. doi: 10.1016/j.jnutbio.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.02.004</ArticleId><ArticleId IdType="pubmed">29573696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadli N., Ackland M.L., De Mel D., Sinclair A.J., Suphioglu C. Effects of zinc and DHA on the epigenetic regulation of human neuronal cells. Cell. Physiol. Biochem. 2012;29:87&#x2013;98. doi: 10.1159/000337590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000337590</ArticleId><ArticleId IdType="pubmed">22415078</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhshi T.J., Way T., Muncy B., Georgel P.T. Effects of the omega-3 fatty acid DHA on histone and p53 acetylation in diffuse large B cell lymphoma. Biochem. Cell Biol. 2023;101:172&#x2013;191. doi: 10.1139/bcb-2022-0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/bcb-2022-0288</ArticleId><ArticleId IdType="pubmed">36599133</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzvinskyte R., Treigyte G., Savickiene J., Magnusson K.E., Navakauskiene R. Effects of histone deacetylase inhibitors, sodium phenyl butyrate and vitamin B3, in combination with retinoic acid on granulocytic differentiation of human promyelocytic leukemia HL-60 cells. Ann. N. Y. Acad. Sci. 2006;1091:356&#x2013;367. doi: 10.1196/annals.1378.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1378.080</ArticleId><ArticleId IdType="pubmed">17341628</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellows R.C. Ph.D. Thesis. University of Cambridge; Cambridge, UK: 2020. Microbiota Regulate Short Chain Fatty Acids and Influence Histone Acylations in Intestinal Epithelial Cells.</Citation></Reference><Reference><Citation>Bradshaw P.C. Acetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan. Antioxidants. 2021;10:572. doi: 10.3390/antiox10040572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10040572</ArticleId><ArticleId IdType="pmc">PMC8068152</ArticleId><ArticleId IdType="pubmed">33917812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidoli S., Trefely S., Garcia B.A., Carrer A. Integrated Analysis of Acetyl-CoA and Histone Modification via Mass Spectrometry to Investigate Metabolically Driven Acetylation. Methods Mol. Biol. 2019;1928:125&#x2013;147. doi: 10.1007/978-1-4939-9027-6_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9027-6_9</ArticleId><ArticleId IdType="pmc">PMC6462437</ArticleId><ArticleId IdType="pubmed">30725455</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrer A., Parris J.L., Trefely S., Henry R.A., Montgomery D.C., Torres A., Viola J.M., Kuo Y.-M., Blair I.A., Meier J.L. Impact of a high-fat diet on tissue Acyl-CoA and histone acetylation levels. J. Biol. Chem. 2017;292:3312&#x2013;3322. doi: 10.1074/jbc.M116.750620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.750620</ArticleId><ArticleId IdType="pmc">PMC5336165</ArticleId><ArticleId IdType="pubmed">28077572</ArticleId></ArticleIdList></Reference><Reference><Citation>Khajebishak Y., Alivand M., Faghfouri A.H., Moludi J., Payahoo L. The effects of vitamins and dietary pattern on epigenetic modification of non-communicable diseases. Int. J. Vitam. Nutr. Res. 2021;93:362&#x2013;377. doi: 10.1024/0300-9831/a000735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0300-9831/a000735</ArticleId><ArticleId IdType="pubmed">34643416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohde J.R., Cardenas M.E. The Tor Pathway Regulates Gene Expression by Linking Nutrient Sensing to Histone Acetylation. Mol. Cell. Biol. 2003;23:629&#x2013;635. doi: 10.1128/MCB.23.2.629-635.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.2.629-635.2003</ArticleId><ArticleId IdType="pmc">PMC151550</ArticleId><ArticleId IdType="pubmed">12509460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungard D., Fuerth B.J., Zeng P.Y., Faubert B., Maas N.L., Viollet B., Carling D., Thompson C.B., Jones R.G., Berger S.L. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science. 2010;329:1201&#x2013;1205. doi: 10.1126/science.1191241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1191241</ArticleId><ArticleId IdType="pmc">PMC3922052</ArticleId><ArticleId IdType="pubmed">20647423</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen A., Kauppinen A., Kaarniranta K. AMPK/Snf1 signaling regulates histone acetylation: Impact on gene expression and epigenetic functions. Cell. Signal. 2016;28:887&#x2013;895. doi: 10.1016/j.cellsig.2016.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2016.03.009</ArticleId><ArticleId IdType="pubmed">27010499</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., Sung B., Aggarwal B.B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008;25:2097&#x2013;2116. doi: 10.1007/s11095-008-9661-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-008-9661-9</ArticleId><ArticleId IdType="pmc">PMC2515569</ArticleId><ArticleId IdType="pubmed">18626751</ArticleId></ArticleIdList></Reference><Reference><Citation>Irigaray P., Newby J.A., Clapp R., Hardell L., Howard V., Montagnier L., Epstein S., Belpomme D. Lifestyle-related factors and environmental agents causing cancer: An overview. Biomed. Pharmacother. 2007;61:640&#x2013;658. doi: 10.1016/j.biopha.2007.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2007.10.006</ArticleId><ArticleId IdType="pubmed">18055160</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey P., Kimmelman A.C., DePinho R.A. Metabolic Codependencies in the Tumor Microenvironment. Cancer Discov. 2021;11:1067&#x2013;1081. doi: 10.1158/2159-8290.CD-20-1211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-1211</ArticleId><ArticleId IdType="pmc">PMC8102306</ArticleId><ArticleId IdType="pubmed">33504580</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell S.L., Wellen K.E. Metabolic signaling to the nucleus in cancer. Mol. Cell. 2018;71:398&#x2013;408. doi: 10.1016/j.molcel.2018.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.015</ArticleId><ArticleId IdType="pubmed">30075141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui L., Chen Y. Tumor microenvironment: Sanctuary of the devil. Cancer Lett. 2015;368:7&#x2013;13. doi: 10.1016/j.canlet.2015.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2015.07.039</ArticleId><ArticleId IdType="pubmed">26276713</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur C., Chen F. Connections between metabolism and epigenetics in cancers. Semin. Cancer Biol. 2019;57:52&#x2013;58. doi: 10.1016/j.semcancer.2019.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2019.06.006</ArticleId><ArticleId IdType="pmc">PMC6690786</ArticleId><ArticleId IdType="pubmed">31185282</ArticleId></ArticleIdList></Reference><Reference><Citation>Min H.Y., Lee H.Y. Oncogene-Driven Metabolic Alterations in Cancer. Biomol. Ther. 2018;26:45&#x2013;56. doi: 10.4062/biomolther.2017.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2017.211</ArticleId><ArticleId IdType="pmc">PMC5746037</ArticleId><ArticleId IdType="pubmed">29212306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge T., Gu X., Jia R., Ge S., Chai P., Zhuang A., Fan X. Crosstalk between metabolic reprogramming and epigenetics in cancer: Updates on mechanisms and therapeutic opportunities. Cancer Commun. 2022;42:1049&#x2013;1082. doi: 10.1002/cac2.12374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cac2.12374</ArticleId><ArticleId IdType="pmc">PMC9648395</ArticleId><ArticleId IdType="pubmed">36266736</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.I. Folate and colorectal cancer: An evidence-based critical review. Mol. Nutr. Food Res. 2007;51:267&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">17295418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich C.M., Potter J.D. Folate and cancer&#x2014;Timing is everything. JAMA. 2007;297:2408&#x2013;2409. doi: 10.1001/jama.297.21.2408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.297.21.2408</ArticleId><ArticleId IdType="pubmed">17551134</ArticleId></ArticleIdList></Reference><Reference><Citation>Loedin A.K., Speijer D. Is There a Carcinogenic Risk Attached to Vitamin B(12) Deficient Diets and What Should We Do About It? Reviewing the Facts. Mol. Nutr. Food Res. 2021;65:e2000945. doi: 10.1002/mnfr.202000945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.202000945</ArticleId><ArticleId IdType="pmc">PMC8126961</ArticleId><ArticleId IdType="pubmed">33548097</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksan A., Farrag K., Aksan S., Schroeder O., Stein J. Flipside of the coin: Iron deficiency and colorectal cancer. Front. Immunol. 2021;12:635899. doi: 10.3389/fimmu.2021.635899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635899</ArticleId><ArticleId IdType="pmc">PMC7991591</ArticleId><ArticleId IdType="pubmed">33777027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanders D., Hobson K., Ji X. Methionine Restriction and Cancer Biology. Nutrients. 2020;12:684. doi: 10.3390/nu12030684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12030684</ArticleId><ArticleId IdType="pmc">PMC7146589</ArticleId><ArticleId IdType="pubmed">32138282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulanda S., Janoszka B. Consumption of Thermally Processed Meat Containing Carcinogenic Compounds (Polycyclic Aromatic Hydrocarbons and Heterocyclic Aromatic Amines) versus a Risk of Some Cancers in Humans and the Possibility of Reducing Their Formation by Natural Food Additives-A Literature Review. Int. J. Environ. Res. Public Health. 2022;19:4781. doi: 10.3390/ijerph19084781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19084781</ArticleId><ArticleId IdType="pmc">PMC9024867</ArticleId><ArticleId IdType="pubmed">35457645</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Hecht S.S. Carcinogenic components of tobacco and tobacco smoke: A 2022 update. Food Chem. Toxicol. 2022;165:113179. doi: 10.1016/j.fct.2022.113179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2022.113179</ArticleId><ArticleId IdType="pmc">PMC9616535</ArticleId><ArticleId IdType="pubmed">35643228</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free. Radic. Biol. Med. 2010;49:1603&#x2013;1616. doi: 10.1016/j.freeradbiomed.2010.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.09.006</ArticleId><ArticleId IdType="pmc">PMC2990475</ArticleId><ArticleId IdType="pubmed">20840865</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Gim&#xe9;nez J.-L., Garc&#xe9;s C., Rom&#xe1;-Mateo C., Pallard&#xf3; F.V. Oxidative stress-mediated alterations in histone post-translational modifications. Free. Radic. Biol. Med. 2021;170:6&#x2013;18. doi: 10.1016/j.freeradbiomed.2021.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.02.027</ArticleId><ArticleId IdType="pubmed">33689846</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald O.G., Li X., Saunders T., Tryggvadottir R., Mentch S.J., Warmoes M.O., Word A.E., Carrer A., Salz T.H., Natsume S. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat. Genet. 2017;49:367&#x2013;376. doi: 10.1038/ng.3753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3753</ArticleId><ArticleId IdType="pmc">PMC5695682</ArticleId><ArticleId IdType="pubmed">28092686</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden M.G., DeBerardinis R.J. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168:657&#x2013;669. doi: 10.1016/j.cell.2016.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.12.039</ArticleId><ArticleId IdType="pmc">PMC5329766</ArticleId><ArticleId IdType="pubmed">28187287</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 1927;8:519. doi: 10.1085/jgp.8.6.519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1085/jgp.8.6.519</ArticleId><ArticleId IdType="pmc">PMC2140820</ArticleId><ArticleId IdType="pubmed">19872213</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., Hitosugi T., Chung T.-W., Xie J., Ge Q., Gu T.-L., Polakiewicz R.D., Chen G.Z., Boggon T.J., Lonial S. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD+ redox homeostasis in cancer cells. Mol. Cell. Biol. 2011;31:4938&#x2013;4950. doi: 10.1128/MCB.06120-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.06120-11</ArticleId><ArticleId IdType="pmc">PMC3233034</ArticleId><ArticleId IdType="pubmed">21969607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A.-N., Luo Y., Yang Y.-H., Fu J.-T., Geng X.-M., Shi J.-P., Yang J. Lactylation, a novel metabolic reprogramming code: Current status and prospects. Front. Immunol. 2021;12:688910. doi: 10.3389/fimmu.2021.688910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.688910</ArticleId><ArticleId IdType="pmc">PMC8222712</ArticleId><ArticleId IdType="pubmed">34177945</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlova N.N., Thompson C.B. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27&#x2013;47. doi: 10.1016/j.cmet.2015.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.12.006</ArticleId><ArticleId IdType="pmc">PMC4715268</ArticleId><ArticleId IdType="pubmed">26771115</ArticleId></ArticleIdList></Reference><Reference><Citation>Osthus R.C., Shim H., Kim S., Li Q., Reddy R., Mukherjee M., Xu Y., Wonsey D., Lee L.A., Dang C.V. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J. Biol. Chem. 2000;275:21797&#x2013;21800. doi: 10.1074/jbc.C000023200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C000023200</ArticleId><ArticleId IdType="pubmed">10823814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.-Y., Pfeiffer H.K., Nissim I., Daikhin E., Yudkoff M., McMahon S.B. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. USA. 2008;105:18782&#x2013;18787. doi: 10.1073/pnas.0810199105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810199105</ArticleId><ArticleId IdType="pmc">PMC2596212</ArticleId><ArticleId IdType="pubmed">19033189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitosugi T., Kang S., Vander Heiden M.G., Chung T.-W., Elf S., Lythgoe K., Dong S., Lonial S., Wang X., Chen G.Z. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci. Signal. 2009;2:ra73. doi: 10.1126/scisignal.2000431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2000431</ArticleId><ArticleId IdType="pmc">PMC2812789</ArticleId><ArticleId IdType="pubmed">19920251</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda-Gon&#xe7;alves V., Lameirinhas A., Henrique R., Jer&#xf3;nimo C. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets. Front. Genet. 2018;9:427. doi: 10.3389/fgene.2018.00427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00427</ArticleId><ArticleId IdType="pmc">PMC6190739</ArticleId><ArticleId IdType="pubmed">30356832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling R., Chen G., Tang X., Liu N., Zhou Y., Chen D. Acetyl-CoA synthetase 2(ACSS2): A review with a focus on metabolism and tumor development. Discov. Oncol. 2022;13:58. doi: 10.1007/s12672-022-00521-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12672-022-00521-1</ArticleId><ArticleId IdType="pmc">PMC9263018</ArticleId><ArticleId IdType="pubmed">35798917</ArticleId></ArticleIdList></Reference><Reference><Citation>Schug Z.T., Peck B., Jones D.T., Zhang Q., Grosskurth S., Alam I.S., Goodwin L.M., Smethurst E., Mason S., Blyth K. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell. 2015;27:57&#x2013;71. doi: 10.1016/j.ccell.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2014.12.002</ArticleId><ArticleId IdType="pmc">PMC4297291</ArticleId><ArticleId IdType="pubmed">25584894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Lin S.H., Ren F., Li J.T., Chen J.J., Yao C.B., Yang H.B., Jiang S.X., Yan G.Q., Wang D., et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat. Commun. 2016;7:11960. doi: 10.1038/ncomms11960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11960</ArticleId><ArticleId IdType="pmc">PMC4931325</ArticleId><ArticleId IdType="pubmed">27357947</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonnell E., Crown S.B., Fox D.B., Kitir B., Ilkayeva O.R., Olsen C.A., Grimsrud P.A., Hirschey M.D. Lipids reprogram metabolism to become a major carbon source for histone acetylation. Cell Rep. 2016;17:1463&#x2013;1472. doi: 10.1016/j.celrep.2016.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.10.012</ArticleId><ArticleId IdType="pmc">PMC5123807</ArticleId><ArticleId IdType="pubmed">27806287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabhi N., Hannou S.A., Froguel P., Annicotte J.-S. Cofactors as metabolic sensors driving cell adaptation in physiology and disease. Front. Endocrinol. 2017;8:304. doi: 10.3389/fendo.2017.00304.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00304</ArticleId><ArticleId IdType="pmc">PMC5675844</ArticleId><ArticleId IdType="pubmed">29163371</ArticleId></ArticleIdList></Reference><Reference><Citation>Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., Tsukamoto T., Rojas C.J., Slusher B.S., Zhang H. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012;15:110&#x2013;121. doi: 10.1016/j.cmet.2011.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.12.009</ArticleId><ArticleId IdType="pmc">PMC3345194</ArticleId><ArticleId IdType="pubmed">22225880</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M., Thaiss C.A., Elinav E. Metabolites: Messengers between the microbiota and the immune system. Genes Dev. 2016;30:1589&#x2013;1597. doi: 10.1101/gad.284091.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.284091.116</ArticleId><ArticleId IdType="pmc">PMC4973288</ArticleId><ArticleId IdType="pubmed">27474437</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi T., Vergara D., Fanini F., Maffia M., Bravaccini S., Pirini F. Microbiota-derived metabolites in tumor progression and metastasis. Int. J. Mol. Sci. 2020;21:5786. doi: 10.3390/ijms21165786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165786</ArticleId><ArticleId IdType="pmc">PMC7460823</ArticleId><ArticleId IdType="pubmed">32806665</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-S., Li J., Menon R., Jayaraman A., Lee K., Huang Y., Dashwood W.M., Zhang K., Sun D., Dashwood R.H. Dietary spinach reshapes the gut microbiome in an Apc-mutant genetic background: Mechanistic insights from integrated multi-omics. Gut Microbes. 2021;13:1972756. doi: 10.1080/19490976.2021.1972756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1972756</ArticleId><ArticleId IdType="pmc">PMC8437542</ArticleId><ArticleId IdType="pubmed">34494932</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanus M., Parada-Venegas D., Landskron G., Wielandt A.M., Hurtado C., Alvarez K., Hermoso M.A., L&#xf3;pez-K&#xf6;stner F., De la Fuente M. Immune system, microbiota, and microbial metabolites: The unresolved triad in colorectal cancer microenvironment. Front. Immunol. 2021;12:612826. doi: 10.3389/fimmu.2021.612826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.612826</ArticleId><ArticleId IdType="pmc">PMC8033001</ArticleId><ArticleId IdType="pubmed">33841394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kespohl M., Vachharajani N., Luu M., Harb H., Pautz S., Wolff S., Sillner N., Walker A., Schmitt-Kopplin P., Boettger T. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4+ T cells. Front. Immunol. 2017;8:1036. doi: 10.3389/fimmu.2017.01036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01036</ArticleId><ArticleId IdType="pmc">PMC5581317</ArticleId><ArticleId IdType="pubmed">28894447</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-S., Li J., Neja S., Kapoor S., Tovar Perez J.E., Tripathi C., Menon R., Jayaraman A., Lee K., Dashwood W.M. Metabolomics of Acute vs. Chronic Spinach Intake in an Apc&#x2013;Mutant Genetic Background: Linoleate and Butanoate Metabolites Targeting HDAC Activity and IFN&#x2013;&#x3b3; Signaling. Cells. 2022;11:573. doi: 10.3390/cells11030573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030573</ArticleId><ArticleId IdType="pmc">PMC8834217</ArticleId><ArticleId IdType="pubmed">35159382</ArticleId></ArticleIdList></Reference><Reference><Citation>Luu M., Weigand K., Wedi F., Breidenbend C., Leister H., Pautz S., Adhikary T., Visekruna A. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Sci. Rep. 2018;8:14430. doi: 10.1038/s41598-018-32860-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32860-x</ArticleId><ArticleId IdType="pmc">PMC6158259</ArticleId><ArticleId IdType="pubmed">30258117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiweler N., W&#xfc;nsch D., Wirth M., Mahendrarajah N., Schneider G., Stauber R.H., Brenner W., Butter F., Kr&#xe4;mer O.H. Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes. J. Cancer Res. Clin. Oncol. 2020;146:343&#x2013;356. doi: 10.1007/s00432-019-03118-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-019-03118-4</ArticleId><ArticleId IdType="pmc">PMC6985217</ArticleId><ArticleId IdType="pubmed">31932908</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zhou H., Wurtele H., Davies B., Horazdovsky B., Verreault A., Zhang Z. Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell. 2008;134:244&#x2013;255. doi: 10.1016/j.cell.2008.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.06.018</ArticleId><ArticleId IdType="pmc">PMC2597342</ArticleId><ArticleId IdType="pubmed">18662540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M., Wang J., Rousseaux S., Tan M., Pan L., Peng L., Wang S., Xu W., Ren J., Liu Y. Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution. Cell Rep. 2021;36:109460. doi: 10.1016/j.celrep.2021.109460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109460</ArticleId><ArticleId IdType="pubmed">34320364</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitsch S., Zorro Shahidian L., Schneider R. Histone acylations and chromatin dynamics: Concepts, challenges, and links to metabolism. EMBO Rep. 2021;22:e52774. doi: 10.15252/embr.202152774.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202152774</ArticleId><ArticleId IdType="pmc">PMC8406397</ArticleId><ArticleId IdType="pubmed">34159701</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang S., Liu J., Hua F. Protein acylation: Mechanisms, biological functions and therapeutic targets. Signal Transduct. Target. Ther. 2022;7:396. doi: 10.1038/s41392-022-01245-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01245-y</ArticleId><ArticleId IdType="pmc">PMC9797573</ArticleId><ArticleId IdType="pubmed">36577755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberti M.V., Locasale J.W. The Warburg effect: How does it benefit cancer cells? Trends Biochem. Sci. 2016;41:211&#x2013;218. doi: 10.1016/j.tibs.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.12.001</ArticleId><ArticleId IdType="pmc">PMC4783224</ArticleId><ArticleId IdType="pubmed">26778478</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Huang L., Gu Y., Cang W., Sun P., Xiang Y. Lactate-lactylation hands between metabolic reprogramming and immunosuppression. Int. J. Mol. Sci. 2022;23:11943. doi: 10.3390/ijms231911943.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911943</ArticleId><ArticleId IdType="pmc">PMC9569569</ArticleId><ArticleId IdType="pubmed">36233246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 2005;37:391&#x2013;400. doi: 10.1038/ng1531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1531</ArticleId><ArticleId IdType="pubmed">15765097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kami&#x144;ska K., Nalejska E., Kubiak M., Wojtysiak J., &#x17b;o&#x142;na &#x141;., Kowalewski J., Lewandowska M.A. Prognostic and predictive epigenetic biomarkers in oncology. Mol. Diagn. Ther. 2019;23:83&#x2013;95. doi: 10.1007/s40291-018-0371-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-018-0371-7</ArticleId><ArticleId IdType="pmc">PMC6394434</ArticleId><ArticleId IdType="pubmed">30523565</ArticleId></ArticleIdList></Reference><Reference><Citation>Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., Kurdistani S.K. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435:1262&#x2013;1266. doi: 10.1038/nature03672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03672</ArticleId><ArticleId IdType="pubmed">15988529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L., Wen H., Li Y., Lyu J., Xi Y., Hoshii T., Joseph J.K., Wang X., Loh Y.-H.E., Erb M.A., et al. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature. 2017;543:265&#x2013;269. doi: 10.1038/nature21687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21687</ArticleId><ArticleId IdType="pmc">PMC5372383</ArticleId><ArticleId IdType="pubmed">28241141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai X., Guo J., Dong R., Yang X., Deng C., Wei C., Xu J., Han W., Lu J., Gao C. Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma. Clin. Transl. Med. 2021;11:e313. doi: 10.1002/ctm2.313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.313</ArticleId><ArticleId IdType="pmc">PMC7939233</ArticleId><ArticleId IdType="pubmed">33783990</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan K., Rousseau J., Machol K., Cross L.A., Agre K.E., Gibson C.F., Goverde A., Engleman K.L., Verdin H., De Baere E. Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer. Sci. Adv. 2020;6:eaax0021. doi: 10.1126/sciadv.aax0021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aax0021</ArticleId><ArticleId IdType="pmc">PMC6976298</ArticleId><ArticleId IdType="pubmed">32010779</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Hamor C., An Y., Zhu L., Gong Y., Toh Y., Guo Y.R. Biological functions and therapeutic potential of acylation by histone acetyltransferases. Acta Mater. Medica. 2023;2:228&#x2013;254. doi: 10.15212/AMM-2023-0010.</Citation><ArticleIdList><ArticleId IdType="doi">10.15212/AMM-2023-0010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan J., Liu H., Ming L. Lysine crotonylation is involved in hepatocellular carcinoma progression. Biomed. Pharmacother. 2019;111:976&#x2013;982. doi: 10.1016/j.biopha.2018.12.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.12.148</ArticleId><ArticleId IdType="pubmed">30841477</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhu X., Liu F., Lu W., Wang Y., Yu J. The effects of histone crotonylation and bromodomain protein 4 on prostate cancer cell lines. Transl. Androl. Urol. 2021;10:900&#x2013;914. doi: 10.21037/tau-21-53.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tau-21-53</ArticleId><ArticleId IdType="pmc">PMC7947446</ArticleId><ArticleId IdType="pubmed">33718091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Chang Z., Qin L.-n., Liang B., Han J.-x., Qiao K.-l., Yang C., Liu Y.-r., Zhou H.-g., Sun T. MTA2 triggered R-loop trans-regulates BDH1-mediated &#x3b2;-hydroxybutyrylation and potentiates propagation of hepatocellular carcinoma stem cells. Signal Transduct. Target. Ther. 2021;6:135. doi: 10.1038/s41392-021-00464-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00464-z</ArticleId><ArticleId IdType="pmc">PMC8016859</ArticleId><ArticleId IdType="pubmed">33795651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Zhao K., Qiu P., Deng Z., Yao W., Wang J. Global landscape of 2-hydroxyisobutyrylation in human pancreatic cancer. Front. Oncol. 2022;12:1001807. doi: 10.3389/fonc.2022.1001807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.1001807</ArticleId><ArticleId IdType="pmc">PMC9563853</ArticleId><ArticleId IdType="pubmed">36249039</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Li F., Sun Q., Lin N., Han H., You K., Tian F., Mao Z., Li T., Tong T. p53 &#x3b2;-hydroxybutyrylation attenuates p53 activity. Cell Death Dis. 2019;10:243. doi: 10.1038/s41419-019-1463-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1463-y</ArticleId><ArticleId IdType="pmc">PMC6411878</ArticleId><ArticleId IdType="pubmed">30858356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Feng F., Wu J., Fan S., Han J., Wang S., Yang L., Liu W., Wang C., Xu K. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol. Res. 2022;181:106270. doi: 10.1016/j.phrs.2022.106270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106270</ArticleId><ArticleId IdType="pubmed">35605812</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Lin Y., Darwanto A., Song X., Xu G., Zhang K. Identification and characterization of propionylation at histone H3 lysine 23 in mammalian cells. J. Biol. Chem. 2009;284:32288&#x2013;32295. doi: 10.1074/jbc.M109.045856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.045856</ArticleId><ArticleId IdType="pmc">PMC2781642</ArticleId><ArticleId IdType="pubmed">19801601</ArticleId></ArticleIdList></Reference><Reference><Citation>Je&#x17e;ek P. 2-Hydroxyglutarate in Cancer Cells. Antioxid Redox Signal. 2020;33:903&#x2013;926. doi: 10.1089/ars.2019.7902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2019.7902</ArticleId><ArticleId IdType="pmc">PMC7533892</ArticleId><ArticleId IdType="pubmed">31847543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., Fantin V.R., Jang H.G., Jin S., Keenan M.C., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739&#x2013;744. doi: 10.1038/nature08617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08617</ArticleId><ArticleId IdType="pmc">PMC2818760</ArticleId><ArticleId IdType="pubmed">19935646</ArticleId></ArticleIdList></Reference><Reference><Citation>Janke R., Iavarone A.T., Rine J. Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases. eLife. 2017;6:e22451. doi: 10.7554/eLife.22451.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.22451</ArticleId><ArticleId IdType="pmc">PMC5388528</ArticleId><ArticleId IdType="pubmed">28346139</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoffel E.M., Koeppe E., Everett J., Ulintz P., Kiel M., Osborne J., Williams L., Hanson K., Gruber S.B., Rozek L.S. Germline genetic features of young individuals with colorectal cancer. Gastroenterology. 2018;154:897&#x2013;905.e891. doi: 10.1053/j.gastro.2017.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.11.004</ArticleId><ArticleId IdType="pmc">PMC5847426</ArticleId><ArticleId IdType="pubmed">29146522</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoffel E.M., Murphy C.C. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology. 2020;158:341&#x2013;353. doi: 10.1053/j.gastro.2019.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2019.07.055</ArticleId><ArticleId IdType="pmc">PMC6957715</ArticleId><ArticleId IdType="pubmed">31394082</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilar E., Stoffel E.M. Universal genetic testing for younger patients with colorectal cancer. JAMA Oncol. 2017;3:448&#x2013;449. doi: 10.1001/jamaoncol.2016.5193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2016.5193</ArticleId><ArticleId IdType="pubmed">27978567</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoffel E.M. Colorectal Cancer in Young Individuals: Opportunities for Prevention. J. Clin. Oncol. 2015;33:3525&#x2013;3527. doi: 10.1200/JCO.2015.62.8446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2015.62.8446</ArticleId><ArticleId IdType="pubmed">26371141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanherkar R.R., Bhatia-Dey N., Csoka A.B. Epigenetics across the human lifespan. Front. Cell Dev. Biol. 2014;2:49. doi: 10.3389/fcell.2014.00049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2014.00049</ArticleId><ArticleId IdType="pmc">PMC4207041</ArticleId><ArticleId IdType="pubmed">25364756</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch C., Burkard M., Leischner C., Lauer U.M., Frank J., Venturelli S. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin. Epigenetics. 2015;7:64. doi: 10.1186/s13148-015-0095-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-015-0095-z</ArticleId><ArticleId IdType="pmc">PMC4497414</ArticleId><ArticleId IdType="pubmed">26161152</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehlivan F.E. Epigenetics to Optogenetics&#x2014;A New Paradigm in the Study of Biology. IntechOpen; London, UK: 2021. Diet-Epigenome interactions: Epi-drugs modulating the epigenetic machinery during cancer prevention.</Citation></Reference><Reference><Citation>Szarc vel Szic K., Ndlovu M.N., Haegeman G., Vanden Berghe W. Nature or nurture: Let food be your epigenetic medicine in chronic inflammatory disorders. Biochem. Pharmacol. 2010;80:1816&#x2013;1832. doi: 10.1016/j.bcp.2010.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2010.07.029</ArticleId><ArticleId IdType="pubmed">20688047</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahid F., Zand H., Nosrat&#x2013;Mirshekarlou E., Najafi R., Hekmatdoost A. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review. Gene. 2015;562:8&#x2013;15. doi: 10.1016/j.gene.2015.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.02.045</ArticleId><ArticleId IdType="pubmed">25701602</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L.W., Ferguson B.S. Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure. Nutrients. 2018;10:1120. doi: 10.3390/nu10081120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10081120</ArticleId><ArticleId IdType="pmc">PMC6115944</ArticleId><ArticleId IdType="pubmed">30126190</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar E., Kanwal R., Candamo M., Gupta S. Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges. Semin. Cancer Biol. 2016;40&#x2013;41:82&#x2013;99. doi: 10.1016/j.semcancer.2016.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2016.04.002</ArticleId><ArticleId IdType="pmc">PMC5067170</ArticleId><ArticleId IdType="pubmed">27117759</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zyal&#xe7;in B., Sanlier N. The effect of diet components on cancer with epigenetic mechanisms. Trends Food Sci. Technol. 2020;102:138&#x2013;145. doi: 10.1016/j.tifs.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2020.06.004</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;vesque S., Pol J.G., Ferrere G., Galluzzi L., Zitvogel L., Kroemer G. Trial watch: Dietary interventions for cancer therapy. Oncoimmunology. 2019;8:1591878. doi: 10.1080/2162402X.2019.1591878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/2162402X.2019.1591878</ArticleId><ArticleId IdType="pmc">PMC6527263</ArticleId><ArticleId IdType="pubmed">31143510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercier B.D., Tizpa E., Philip E.J., Feng Q., Huang Z., Thomas R.M., Pal S.K., Dorff T.B., Li Y.R. Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review. Cancers. 2022;14:5149. doi: 10.3390/cancers14205149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14205149</ArticleId><ArticleId IdType="pmc">PMC9600754</ArticleId><ArticleId IdType="pubmed">36291933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mottamal M., Zheng S., Huang T.L., Wang G. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules. 2015;20:3898&#x2013;3941. doi: 10.3390/molecules20033898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules20033898</ArticleId><ArticleId IdType="pmc">PMC4372801</ArticleId><ArticleId IdType="pubmed">25738536</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal D., Raj K., Nandi S.S., Sinha S., Mishra A., Mondal A., Lagoa R., Burcher J.T., Bishayee A. Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. Cancers. 2023;15:2808. doi: 10.3390/cancers15102808.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15102808</ArticleId><ArticleId IdType="pmc">PMC10216849</ArticleId><ArticleId IdType="pubmed">37345145</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter E.R., Mohammed A. Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities. Pharmaceuticals. 2024;17:136. doi: 10.3390/ph17010136.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph17010136</ArticleId><ArticleId IdType="pmc">PMC10820118</ArticleId><ArticleId IdType="pubmed">38276009</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor E.M., Jones A.D., Henagan T.M. A review of mitochondrial-derived fatty acids in epigenetic regulation of obesity and type 2 diabetes. J. Nutr. Health Food Sci. 2014;2:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213944</ArticleId><ArticleId IdType="pubmed">25364776</ArticleId></ArticleIdList></Reference><Reference><Citation>McGee S.L., Fairlie E., Garnham A.P., Hargreaves M. Exercise-induced histone modifications in human skeletal muscle. J. Physiol. 2009;587:5951&#x2013;5958. doi: 10.1113/jphysiol.2009.181065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.181065</ArticleId><ArticleId IdType="pmc">PMC2808551</ArticleId><ArticleId IdType="pubmed">19884317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir A., Bullo M.M.H., Ahmed Z., Imtiaz A., Yaqoob E., Jadoon M., Ahmed H., Afreen A., Yaqoob S. Nutrigenomics: Epigenetics and cancer prevention: A comprehensive review. Crit. Rev. Food Sci. Nutr. 2020;60:1375&#x2013;1387. doi: 10.1080/10408398.2019.1571480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2019.1571480</ArticleId><ArticleId IdType="pubmed">30729798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy T.M., Tollefsbol T.O. Epigenetic diet: Impact on the epigenome and cancer. Epigenomics. 2011;3:503&#x2013;518. doi: 10.2217/epi.11.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi.11.71</ArticleId><ArticleId IdType="pmc">PMC3197720</ArticleId><ArticleId IdType="pubmed">22022340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho E., Beaver L.M., Williams D.E., Dashwood R.H. Dietary factors and epigenetic regulation for prostate cancer prevention. Adv. Nutr. 2011;2:497&#x2013;510. doi: 10.3945/an.111.001032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.111.001032</ArticleId><ArticleId IdType="pmc">PMC3226387</ArticleId><ArticleId IdType="pubmed">22332092</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckschlager T., Plch J., Stiborova M., Hrabeta J. Histone Deacetylase Inhibitors as Anticancer Drugs. Int. J. Mol. Sci. 2017;18:1414. doi: 10.3390/ijms18071414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18071414</ArticleId><ArticleId IdType="pmc">PMC5535906</ArticleId><ArticleId IdType="pubmed">28671573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieborak A., Schneider R. Metabolic intermediates&#x2013;cellular messengers talking to chromatin modifiers. Mol. Metab. 2018;14:39&#x2013;52. doi: 10.1016/j.molmet.2018.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2018.01.007</ArticleId><ArticleId IdType="pmc">PMC6034042</ArticleId><ArticleId IdType="pubmed">29397344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-P&#xe9;rez M.V., Sainero-Alcolado L., Oliynyk G., Matuschek I., Balboni N., Ubhayasekera S., Snaebjornsson M.T., Makowski K., Aaltonen K., Bexell D., et al. Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. iScience. 2021;24:102128. doi: 10.1016/j.isci.2021.102128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102128</ArticleId><ArticleId IdType="pmc">PMC7895756</ArticleId><ArticleId IdType="pubmed">33659885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena L.A., Denmeade S.R. Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon? Cancer Res. 2021;81:4385&#x2013;4393. doi: 10.1158/0008-5472.CAN-21-1392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-21-1392</ArticleId><ArticleId IdType="pmc">PMC8416800</ArticleId><ArticleId IdType="pubmed">34145040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Bollu L.R., Tozzi F., Ye X., Bhattacharya R., Gao G., Dupre E., Xia L., Lu J., Fan F. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38. Mol. Cancer Ther. 2013;12:2782&#x2013;2791. doi: 10.1158/1535-7163.MCT-13-0098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-13-0098</ArticleId><ArticleId IdType="pmc">PMC4302275</ArticleId><ArticleId IdType="pubmed">24132143</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P.L., Zhu S.N., Lu S.L., Dai Z.S., Jin Y.L. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J. Gastroenterol. 2000;6:295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4723510</ArticleId><ArticleId IdType="pubmed">11819582</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiragami R., Murata S., Kosugi C., Tezuka T., Yamazaki M., Hirano A., Yoshimura Y., Suzuki M., Shuto K., Koda K. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells. Int. J. Oncol. 2013;43:431&#x2013;438. doi: 10.3892/ijo.2013.1978.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2013.1978</ArticleId><ArticleId IdType="pubmed">23754252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull E.E., Montgomery M.R., Leyva K.J. HDAC inhibitors as epigenetic regulators of the immune system: Impacts on cancer therapy and inflammatory diseases. BioMed Res. Int. 2016;2016:8797206. doi: 10.1155/2016/8797206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8797206</ArticleId><ArticleId IdType="pmc">PMC4983322</ArticleId><ArticleId IdType="pubmed">27556043</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M., Gong X., Liu F. An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives. Expert Opin. Drug Discov. 2021;16:745&#x2013;761. doi: 10.1080/17460441.2021.1877656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2021.1877656</ArticleId><ArticleId IdType="pubmed">33530771</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Seto E. HDACs and HDAC Inhibitors in Cancer Development and Therapy. Cold Spring Harb. Perspect. Med. 2016;6:a026831. doi: 10.1101/cshperspect.a026831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a026831</ArticleId><ArticleId IdType="pmc">PMC5046688</ArticleId><ArticleId IdType="pubmed">27599530</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Tian Y., Zhu W.-G. The roles of histone deacetylases and their inhibitors in cancer therapy. Front. Cell Dev. Biol. 2020;8:576946. doi: 10.3389/fcell.2020.576946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.576946</ArticleId><ArticleId IdType="pmc">PMC7552186</ArticleId><ArticleId IdType="pubmed">33117804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose P., Dai Y., Grant S. Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights. Pharmacol. Ther. 2014;143:323&#x2013;336. doi: 10.1016/j.pharmthera.2014.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2014.04.004</ArticleId><ArticleId IdType="pmc">PMC4117710</ArticleId><ArticleId IdType="pubmed">24769080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassett S.A., Barnett M.P. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease. Nutrients. 2014;6:4273&#x2013;4301. doi: 10.3390/nu6104273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu6104273</ArticleId><ArticleId IdType="pmc">PMC4210916</ArticleId><ArticleId IdType="pubmed">25322459</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashwood R.H., Ho E. Dietary histone deacetylase inhibitors: From cells to mice to man. Semin. Cancer Biol. 2007;17:363&#x2013;369. doi: 10.1016/j.semcancer.2007.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2007.04.001</ArticleId><ArticleId IdType="pmc">PMC2737738</ArticleId><ArticleId IdType="pubmed">17555985</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran P., Ho E., Williams D.E., Dashwood R.H. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin. Epigenetics. 2011;3:4. doi: 10.1186/1868-7083-3-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1868-7083-3-4</ArticleId><ArticleId IdType="pmc">PMC3255482</ArticleId><ArticleId IdType="pubmed">22247744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino F., Castiello C., Mai A., Rotili D. Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5. J. Med. Chem. 2022;65:9580&#x2013;9606. doi: 10.1021/acs.jmedchem.2c00687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.2c00687</ArticleId><ArticleId IdType="pmc">PMC9340778</ArticleId><ArticleId IdType="pubmed">35802779</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiangyun Y., Xiaomin N., Yunhua X., Ziming L., Yongfeng Y., Zhiwei C., Shun L. Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth. Oncotarget. 2017;8:6984. doi: 10.18632/oncotarget.14346.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14346</ArticleId><ArticleId IdType="pmc">PMC5351684</ArticleId><ArticleId IdType="pubmed">28036303</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen A.S., Olsen C.A. Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro. Angew. Chem. (Int. Ed. Engl.) 2012;51:9083&#x2013;9087. doi: 10.1002/anie.201203754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201203754</ArticleId><ArticleId IdType="pubmed">22890609</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W., Hua F., Li X., Zhang J., Li S., Wang W., Zhou J., Wang W., Liao P., Yan Y. Loss of optineurin drives cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation. Cancer Discov. 2021;11:1826&#x2013;1843. doi: 10.1158/2159-8290.CD-20-1571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-1571</ArticleId><ArticleId IdType="pmc">PMC8292167</ArticleId><ArticleId IdType="pubmed">33627378</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Nihira N.T., Bu X., Chu C., Zhang J., Kolodziejczyk A., Fan Y., Chan N.T., Ma L., Liu J. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nat. Cell Biol. 2020;22:1064&#x2013;1075. doi: 10.1038/s41556-020-0562-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-020-0562-4</ArticleId><ArticleId IdType="pmc">PMC7484128</ArticleId><ArticleId IdType="pubmed">32839551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Liu J., Liu L., Duan G., Wang Q., Xu Y., Xia F., Shan J., Shen J., Yang Z. Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2&#x2013;M Transition GenesPromotion of Cancer Cell Growth by MEF2D in HCC. Cancer Res. 2014;74:1452&#x2013;1462. doi: 10.1158/0008-5472.CAN-13-2171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-13-2171</ArticleId><ArticleId IdType="pubmed">24390737</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H., Lan J., Li C., Shi H., Brosseau J.-P., Wang H., Lu H., Fang C., Zhang Y., Liang L. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat. Biomed. Eng. 2019;3:306&#x2013;317. doi: 10.1038/s41551-019-0375-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-019-0375-6</ArticleId><ArticleId IdType="pubmed">30952982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Hsu J.-M., Sun L., Chan L.-C., Li C.-W., Hsu J.L., Wei Y., Xia W., Hou J., Qiu Y. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res. 2019;29:83&#x2013;86. doi: 10.1038/s41422-018-0124-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0124-5</ArticleId><ArticleId IdType="pmc">PMC6318320</ArticleId><ArticleId IdType="pubmed">30514902</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang H., Huang Y., Luo Y., Tang J., Yu M., Zhang Y., Zhong M. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis. Cell. Immunol. 2022;371:104458. doi: 10.1016/j.cellimm.2021.104458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2021.104458</ArticleId><ArticleId IdType="pubmed">34847407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasko L.M., Jakob C.G., Edalji R.P., Qiu W., Montgomery D., Digiammarino E.L., Hansen T.M., Risi R.M., Frey R., Manaves V., et al. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. Nature. 2017;550:128&#x2013;132. doi: 10.1038/nature24028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24028</ArticleId><ArticleId IdType="pmc">PMC6050590</ArticleId><ArticleId IdType="pubmed">28953875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Yang B., Liu X., Zhang X.D., Zhang L., Liu T. Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents. Theranostics. 2022;12:4935. doi: 10.7150/thno.73223.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.73223</ArticleId><ArticleId IdType="pmc">PMC9274749</ArticleId><ArticleId IdType="pubmed">35836809</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddell A.R., Huang H., Liao D. CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. Cancers. 2021;13:2872. doi: 10.3390/cancers13122872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13122872</ArticleId><ArticleId IdType="pmc">PMC8229436</ArticleId><ArticleId IdType="pubmed">34201346</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000;14:1553&#x2013;1577. doi: 10.1101/gad.14.13.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.14.13.1553</ArticleId><ArticleId IdType="pubmed">10887150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor S., Gustafson T., Zhang M., Chen Y.-S., Li J., Nguyen N., Perez J.E.T., Dashwood W.M., Rajendran P., Dashwood R.H. Deacetylase plus bromodomain inhibition downregulates ERCC2 and suppresses the growth of metastatic colon cancer cells. Cancers. 2021;13:1438. doi: 10.3390/cancers13061438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13061438</ArticleId><ArticleId IdType="pmc">PMC8004213</ArticleId><ArticleId IdType="pubmed">33809839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazur P.K., Herner A., Mello S.S., Wirth M., Hausmann S., S&#xe1;nchez-Rivera F.J., Lofgren S.M., Kuschma T., Hahn S.A., Vangala D. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat. Med. 2015;21:1163&#x2013;1171. doi: 10.1038/nm.3952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3952</ArticleId><ArticleId IdType="pmc">PMC4959788</ArticleId><ArticleId IdType="pubmed">26390243</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran P., Johnson G., Li L., Chen Y.-S., Dashwood M., Nguyen N., Ulusan A., Ertem F., Zhang M., Li J. Acetylation of CCAR2 establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition. Cancer Res. 2019;79:918&#x2013;927. doi: 10.1158/0008-5472.CAN-18-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-2003</ArticleId><ArticleId IdType="pmc">PMC6397680</ArticleId><ArticleId IdType="pubmed">30643017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Wei T., Cai Y., Jin J. Small molecules targeting the specific domains of histone-mark readers in cancer therapy. Molecules. 2020;25:578. doi: 10.3390/molecules25030578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25030578</ArticleId><ArticleId IdType="pmc">PMC7037402</ArticleId><ArticleId IdType="pubmed">32013155</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorstova T., Foulkes W.D., Witcher M. Achieving clinical success with BET inhibitors as anti-cancer agents. Br. J. Cancer. 2021;124:1478&#x2013;1490. doi: 10.1038/s41416-021-01321-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-021-01321-0</ArticleId><ArticleId IdType="pmc">PMC8076232</ArticleId><ArticleId IdType="pubmed">33723398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor S., Damiani E., Wang S., Dharmanand R., Tripathi C., Tovar Perez J.E., Dashwood W.M., Rajendran P., Dashwood R.H. BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells. Nutrients. 2022;14:4317. doi: 10.3390/nu14204317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14204317</ArticleId><ArticleId IdType="pmc">PMC9610492</ArticleId><ArticleId IdType="pubmed">36297001</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X., Panchenko T., Yang S., Zhao S., Yan P., Zhang W., Xie W., Li Y., Zhao Y., Allis C.D. Selective recognition of histone crotonylation by double PHD fingers of MOZ and DPF2. Nat. Chem. Biol. 2016;12:1111&#x2013;1118. doi: 10.1038/nchembio.2218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2218</ArticleId><ArticleId IdType="pmc">PMC5253430</ArticleId><ArticleId IdType="pubmed">27775714</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., He C., Wang M., Ma X., Mo F., Yang S., Han J., Wei X. Targeting epigenetic regulators for cancer therapy: Mechanisms and advances in clinical trials. Signal Transduct. Target. Ther. 2019;4:62. doi: 10.1038/s41392-019-0095-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-019-0095-0</ArticleId><ArticleId IdType="pmc">PMC6915746</ArticleId><ArticleId IdType="pubmed">31871779</ArticleId></ArticleIdList></Reference><Reference><Citation>Neja S.A. Site-Specific DNA Demethylation as a Potential Target for Cancer Epigenetic Therapy. Epigenetics Insights. 2020;13:2516865720964808. doi: 10.1177/2516865720964808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2516865720964808</ArticleId><ArticleId IdType="pmc">PMC8756105</ArticleId><ArticleId IdType="pubmed">35036833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon D.Y., Zhao Y.T., Lamonica J.M., Zhou Z. Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC. Nat. Commun. 2017;8:15315. doi: 10.1038/ncomms15315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15315</ArticleId><ArticleId IdType="pmc">PMC5437308</ArticleId><ArticleId IdType="pubmed">28497787</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S., Eom G.H. HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases. Chonnam. Med. J. 2016;52:1&#x2013;11. doi: 10.4068/cmj.2016.52.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.4068/cmj.2016.52.1.1</ArticleId><ArticleId IdType="pmc">PMC4742605</ArticleId><ArticleId IdType="pubmed">26865995</ArticleId></ArticleIdList></Reference><Reference><Citation>Stimson L., Rowlands M.G., Newbatt Y.M., Smith N.F., Raynaud F.I., Rogers P., Bavetsias V., Gorsuch S., Jarman M., Bannister A., et al. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol. Cancer Ther. 2005;4:1521&#x2013;1532. doi: 10.1158/1535-7163.MCT-05-0135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-05-0135</ArticleId><ArticleId IdType="pubmed">16227401</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wu J., Zhai L., Zhang T., Yin H., Gao H., Zhao F., Wang Z., Yang X., Jin M., et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294&#x2013;311.e221. doi: 10.1016/j.cell.2023.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.11.022</ArticleId><ArticleId IdType="pmc">PMC11725302</ArticleId><ArticleId IdType="pubmed">38128537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W., Sun Y., Yan R., Zhang P., Shen S., Lu H., Zhou Z., Jiang Z., Ye L., Mao Q., et al. OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB. Mol. Cell. 2024. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2023.11.042</ArticleId><ArticleId IdType="pubmed">38176415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozsvari B., Sotgia F., Simmons K., Trowbridge R., Foster R., Lisanti M.P. Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs) Oncotarget. 2017;8:78340&#x2013;78350. doi: 10.18632/oncotarget.21259.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.21259</ArticleId><ArticleId IdType="pmc">PMC5667966</ArticleId><ArticleId IdType="pubmed">29108233</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu B., Zhang M., Liu T., Huang Y. Nanotechnology-based histone deacetylase inhibitors for cancer therapy. Front. Cell Dev. Biol. 2020;8:400. doi: 10.3389/fcell.2020.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00400</ArticleId><ArticleId IdType="pmc">PMC7284110</ArticleId><ArticleId IdType="pubmed">32582697</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Ren Y., Weng S., Xu H., Li L., Han X. A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy. Front. Immunol. 2022;13:809761. doi: 10.3389/fimmu.2022.809761.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.809761</ArticleId><ArticleId IdType="pmc">PMC8818678</ArticleId><ArticleId IdType="pubmed">35140720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez S., Tabernacki T., Kobyra J., Roberts P., Chiappinelli K.B. Combining epigenetic and immune therapy to overcome cancer resistance. Semin. Cancer Biol. 2020;65:99&#x2013;113. doi: 10.1016/j.semcancer.2019.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2019.12.019</ArticleId><ArticleId IdType="pmc">PMC7308208</ArticleId><ArticleId IdType="pubmed">31877341</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva L., &#xc1;lvarez-Errico D., Esteller M. The contribution of epigenetics to cancer immunotherapy. Trends Immunol. 2020;41:676&#x2013;691. doi: 10.1016/j.it.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.06.002</ArticleId><ArticleId IdType="pubmed">32622854</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Lin S., Garcia B.A., Zhao Y. Quantitative proteomic analysis of histone modifications. Chem. Rev. 2015;115:2376&#x2013;2418. doi: 10.1021/cr500491u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr500491u</ArticleId><ArticleId IdType="pmc">PMC4502928</ArticleId><ArticleId IdType="pubmed">25688442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biol. 2019;20:245. doi: 10.1186/s13059-019-1870-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1870-5</ArticleId><ArticleId IdType="pmc">PMC6868810</ArticleId><ArticleId IdType="pubmed">31747960</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragic H., Chaveroux C., Cosset E., Manie S.N. Modelling cancer metabolism in vitro: Current improvements and future challenges. FEBS J. 2022 doi: 10.1111/febs.16704. early view .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16704</ArticleId><ArticleId IdType="pubmed">36516350</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>